Citrus Sinensis ID: 001354
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1093 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.300 | 0.156 | 0.523 | 1e-100 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.295 | 0.186 | 0.472 | 3e-84 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.284 | 0.172 | 0.478 | 4e-84 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.278 | 0.205 | 0.479 | 1e-82 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.278 | 0.230 | 0.482 | 5e-82 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.278 | 0.115 | 0.470 | 7e-82 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.328 | 0.228 | 0.432 | 1e-81 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.295 | 0.123 | 0.460 | 1e-81 | |
| O60307 | 1309 | Microtubule-associated se | no | no | 0.278 | 0.232 | 0.479 | 3e-81 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.319 | 0.222 | 0.435 | 4e-81 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 368 bits (944), Expect = e-100, Method: Compositional matrix adjust.
Identities = 197/376 (52%), Positives = 241/376 (64%), Gaps = 48/376 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
I DFEIIKPISRGAFGRV+LA+K+ TGDL+AIK VLKKLD IRKN + ++ ERNIL V
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIK-VLKKLDTIRKNMVNHVIVERNILAMV 1582
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE VL LEYLH
Sbjct: 1583 QNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLH 1642
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI-------------NNTIDLSGPETD 852
IVHRDLKPDN+LI GHIKLTDFGLSKIG+I N + S T+
Sbjct: 1643 KSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTN 1702
Query: 853 GIMPSDAH-----------------------YPEYQQT----DNRNRHSAVGTPDYLAPE 885
M D+ YP+ + T + VGTPDYL+PE
Sbjct: 1703 TSMMDDSSTTGNPNGNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKKVVGTPDYLSPE 1762
Query: 886 ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL--NRKIPWPCVPSDMSF 943
ILLGT HG DWW++GIIL+EF+TG PPF ++PE+IF +IL +R++ W P ++S
Sbjct: 1763 ILLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPELIFQHILHRDREMEW---PEEISS 1819
Query: 944 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA--VFVPQPESVDDTS 1001
EA+DLI + L DP +RLGANGA EVK HPFF VNWD+L Q+ +F+P+PE+ DT
Sbjct: 1820 EAKDLILKLLNPDPYKRLGANGAYEVKTHPFFANVNWDTLIDQEMDNIFLPKPENNYDTD 1879
Query: 1002 YFLSRFSQISSGLPDD 1017
YF R S DD
Sbjct: 1880 YFWDRQSMYDDEAEDD 1895
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 163/345 (47%), Positives = 221/345 (64%), Gaps = 22/345 (6%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723
DSV + GVS P + E +DFE IK IS GA+G VFL R ++T FA+K++ K+
Sbjct: 433 DSV-EGRGVSQPSQKTPSE----EDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQ 487
Query: 724 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 783
++I +N I++ ER+IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G
Sbjct: 488 -NLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG 546
Query: 784 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843
L D+ R+Y AE VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T
Sbjct: 547 ALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 606
Query: 844 IDLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSV 901
+L Y + + D R GTP+Y+APE++L +G DWW++
Sbjct: 607 TNL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 652
Query: 902 GIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 961
GIIL+EF+ G PF ++PE +F +++ +I WP + +AQDL ++ L +P +RL
Sbjct: 653 GIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNPLERL 712
Query: 962 GANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 1006
G + A EVK HPFF G++W L QKA F+PQ ES DDTSYF +R
Sbjct: 713 GTSSAYEVKQHPFFMGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 757
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 313 bits (803), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 157/328 (47%), Positives = 213/328 (64%), Gaps = 17/328 (5%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
K+ S +DFE IK IS GA+G VFL R ++T FA+K++ K+ ++I +N I++ ER+
Sbjct: 504 KKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQ-NLILRNQIQQAFVERD 562
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G L D+ R+Y AE VLA
Sbjct: 563 ILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLA 622
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
LEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L
Sbjct: 623 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL-------------- 668
Query: 861 YPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918
Y + + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF +
Sbjct: 669 YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 728
Query: 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+PE +F +++ +I WP + +AQDL ++ L +P +RLG A EVK HPFF G+
Sbjct: 729 TPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGL 788
Query: 979 NWDSLALQKAVFVPQPESVDDTSYFLSR 1006
+W L QKA F+PQ ES DDTSYF +R
Sbjct: 789 DWTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 154/321 (47%), Positives = 207/321 (64%), Gaps = 17/321 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
DFE IK IS GA+G V+L R + T FA+K++ K+ ++I +N I ++ ER+IL N
Sbjct: 398 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ-NLILRNQIHQVFVERDILTFAEN 456
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
PFVV F SF R +L +VMEY+ GGD +LL+ +G L D++R+Y AE VLALEYLH+
Sbjct: 457 PFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLALEYLHNY 516
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GIVHRDLKPDNLLI GHIKLTDFGLSK+GL+N T +L Y + +
Sbjct: 517 GIVHRDLKPDNLLITSLGHIKLTDFGLSKVGLMNMTTNL--------------YEGHIEK 562
Query: 868 DNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 563 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 622
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 985
+++ I WP + ++QDLI R L + +RLG GA EVK H FF ++W+ L
Sbjct: 623 QVISDDIIWPGGEEALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFLSLDWNGLLR 682
Query: 986 QKAVFVPQPESVDDTSYFLSR 1006
QKA FVPQ E+ DDTSYF +R
Sbjct: 683 QKAEFVPQLEADDDTSYFDTR 703
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 155/321 (48%), Positives = 204/321 (63%), Gaps = 17/321 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
DFE IK IS GA+G V+L R R T FAIK++ K+ ++I +N I+++ ER+IL N
Sbjct: 388 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQ-NLILRNQIQQVFVERDILTFAEN 446
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
PFVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 447 PFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNY 506
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + +
Sbjct: 507 GIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEK 552
Query: 868 DNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
D R GTP+Y+APE++ +G DWW++G+IL+EF+ G PF ++PE +F
Sbjct: 553 DAREFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFG 612
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 985
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 613 QVVSDEIMWPEGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFFLALDWAGLLR 672
Query: 986 QKAVFVPQPESVDDTSYFLSR 1006
KA FVPQ E+ DDTSYF +R
Sbjct: 673 HKAEFVPQLEAEDDTSYFDTR 693
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 7e-82, Method: Compositional matrix adjust.
Identities = 151/321 (47%), Positives = 208/321 (64%), Gaps = 17/321 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
DFE IK IS GA+G V+ R + + FA+K++ K+ ++I +N I++ ER+IL N
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ-NLILRNQIQQAFVERDILTFAEN 630
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
PFVV + SF R +L +VMEY+ GGD +L++ +G L D+AR+Y AE VLALEYLH+
Sbjct: 631 PFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNY 690
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T +L Y + +
Sbjct: 691 GIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNL--------------YEGHIEK 736
Query: 868 DNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 737 DAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 796
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 985
+++ +I WP +AQDLI L +P +RLG GA EVK H FF+ ++W+SL
Sbjct: 797 QVISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLR 856
Query: 986 QKAVFVPQPESVDDTSYFLSR 1006
QKA F+PQ ES DDTSYF +R
Sbjct: 857 QKAEFIPQLESEDDTSYFDTR 877
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 305 bits (782), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 169/391 (43%), Positives = 232/391 (59%), Gaps = 32/391 (8%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
S K+ +DF+ IK IS GA+G V+L R R T FA+K++ K+ ++I +N I++
Sbjct: 363 SKAKKPPGENDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQ-NLILRNQIQQAFV 421
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
ER+IL NPFVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE
Sbjct: 422 ERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAET 481
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 482 VLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL----------- 530
Query: 858 DAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915
Y + + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF
Sbjct: 531 ---YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 587
Query: 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
++PE +F +++ I WP + EAQ LI+ L +P RLGA GA EVK H FF
Sbjct: 588 FGDTPEELFGQVISDDILWPEGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFF 647
Query: 976 KGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSR 1035
+ ++W L QKA F+P ES DDTSYF +R + SY + DT +
Sbjct: 648 RDLDWTGLLRQKAEFIPHLESEDDTSYFDTRSDRY------HHVNSYDEDDTTE------ 695
Query: 1036 TEMDECGDLAEFGSCPLDLSLINFSFKNLSQ 1066
+E ++ +F SC S + S + LSQ
Sbjct: 696 ---EEPVEIRQFSSCSPRFSKVYSSMEQLSQ 723
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 305 bits (781), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 159/345 (46%), Positives = 219/345 (63%), Gaps = 22/345 (6%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K++ K+
Sbjct: 548 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 602
Query: 724 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 783
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 603 -NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMG 661
Query: 784 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 662 PLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMT 721
Query: 844 IDLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSV 901
+L Y + + D R GTP+Y+APE++L +G DWW++
Sbjct: 722 TNL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 767
Query: 902 GIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 961
GIIL+EF+ G PF ++PE +F +++ +I WP +AQ+LI L +P +RL
Sbjct: 768 GIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQELITLLLRQNPLERL 827
Query: 962 GANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 1006
G GA EVK H FF+ ++W+SL QKA F+PQ ES DDTSYF +R
Sbjct: 828 GTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 872
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 154/321 (47%), Positives = 204/321 (63%), Gaps = 17/321 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
DFE IK IS GA+G V+L R R T FAIK++ K+ ++I +N I+++ ER+IL N
Sbjct: 366 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQ-NLILRNQIQQVFVERDILTFAEN 424
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
PFVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 425 PFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARLYFAETVLALEYLHNY 484
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + +
Sbjct: 485 GIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEK 530
Query: 868 DNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
D R GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F
Sbjct: 531 DAREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFG 590
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 985
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 591 QVVSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFLALDWAGLLR 650
Query: 986 QKAVFVPQPESVDDTSYFLSR 1006
KA FVPQ E+ DDTSYF +R
Sbjct: 651 HKAEFVPQLEAEDDTSYFDTR 671
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 303 bits (777), Expect = 4e-81, Method: Compositional matrix adjust.
Identities = 166/381 (43%), Positives = 228/381 (59%), Gaps = 32/381 (8%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
DF+ IK IS GA+G V+L R R T FA+K++ K+ ++I +N I++ ER+IL N
Sbjct: 375 DFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQ-NLILRNQIQQAFVERDILTFAEN 433
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
PFVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE VLALEYLH+
Sbjct: 434 PFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNY 493
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GIVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L Y + +
Sbjct: 494 GIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL--------------YEGHIEK 539
Query: 868 DNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 540 DAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 599
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 985
+++ I WP + +AQ LI+ L +P RLGA GA EVK H FF+ ++W L
Sbjct: 600 QVISDDILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGLLR 659
Query: 986 QKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLA 1045
QKA F+P ES DDTSYF +R + SY + DT + +E ++
Sbjct: 660 QKAEFIPHLESEDDTSYFDTRSDRY------HHVNSYDEDDTTE---------EEPVEIR 704
Query: 1046 EFGSCPLDLSLINFSFKNLSQ 1066
+F SC S + S + LSQ
Sbjct: 705 QFSSCSPRFSKVYSSMEQLSQ 725
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1093 | ||||||
| 359492673 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.981 | 0.967 | 0.699 | 0.0 | |
| 255538590 | 1106 | kinase, putative [Ricinus communis] gi|2 | 0.935 | 0.924 | 0.710 | 0.0 | |
| 145324180 | 1067 | protein kinase-like protein [Arabidopsis | 0.961 | 0.985 | 0.582 | 0.0 | |
| 7767670 | 1092 | F27F5.23 [Arabidopsis thaliana] | 0.961 | 0.962 | 0.569 | 0.0 | |
| 297852258 | 1101 | predicted protein [Arabidopsis lyrata su | 0.956 | 0.949 | 0.562 | 0.0 | |
| 145336472 | 1042 | protein kinase-like protein [Arabidopsis | 0.911 | 0.955 | 0.584 | 0.0 | |
| 110740013 | 1042 | similar to IRE homolog 1 [Arabidopsis th | 0.911 | 0.955 | 0.583 | 0.0 | |
| 302142471 | 948 | unnamed protein product [Vitis vinifera] | 0.626 | 0.722 | 0.760 | 0.0 | |
| 168060390 | 1073 | predicted protein [Physcomitrella patens | 0.866 | 0.882 | 0.469 | 0.0 | |
| 356529485 | 1395 | PREDICTED: uncharacterized protein LOC10 | 0.855 | 0.670 | 0.485 | 0.0 |
| >gi|359492673|ref|XP_002282958.2| PREDICTED: uncharacterized protein LOC100259179 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1465 bits (3793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 771/1103 (69%), Positives = 868/1103 (78%), Gaps = 30/1103 (2%)
Query: 12 GIPSGLNRIKTRGGVSKP---------DELTESRSYGVSRPPQKHKQKTVAQGHVKLANS 62
GIP+GLNRIKTR SK D+ ESR G+SRPP K +GH K A S
Sbjct: 16 GIPTGLNRIKTRRESSKDQLNWKPDDDDKFHESRPRGISRPPANQKHN---KGHAKFAGS 72
Query: 63 FTEEVRKGKKIAQWFTSYISK-----FNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 117
E KGKKIA+WFTS++SK F+ V P ++S S+ K D E RTK EG H
Sbjct: 73 I-EGFHKGKKIARWFTSHLSKDSSQGFDDVPPKVQDSNSKVKAPDKEGSTRTKQWKEGKH 131
Query: 118 LNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAA 177
L KQS E +SS KV KGLKSFSHELGPKGGIP S+PRAHSYNDLKELL +LHSRFDAA
Sbjct: 132 LTGKQSSPEGLSSIKVPKGLKSFSHELGPKGGIPPSHPRAHSYNDLKELLGSLHSRFDAA 191
Query: 178 KEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQ 237
KEVVN EL++ D+M+ L++ DS S G++M E LLILAQQC+EMT FR CETIVQ
Sbjct: 192 KEVVNVELSSLTGDIMDALQRNDS--SPGQKMAEGLLILAQQCMEMTPSEFRIKCETIVQ 249
Query: 238 DLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVE 297
LTEKRQ CQ +KWL TRMLFILTRCTRLL FQK+SEPI EKSLH F KCLES+PAVE
Sbjct: 250 GLTEKRQHCQTAFLKWLFTRMLFILTRCTRLLRFQKDSEPIDEKSLHNFTKCLESIPAVE 309
Query: 298 TSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKS 354
+W P +S DY S K++AK ++ + +VS++ E + C E D TS S
Sbjct: 310 MNWAPYSRIVDSGSDYDSNGKSDAKHELQWRNRVSSLLEQTWCRSEEPADKSGITSRKDS 369
Query: 355 VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICE 414
+ + Q Q SQ +Q G+ + + GS HE + LDGSDSVICRICE
Sbjct: 370 MVLVQKPLSQNSQIDFLPHIEQDGDYPGKSMNSFED--GSLHEPERGLDGSDSVICRICE 427
Query: 415 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENS 474
E VP SHLESHSYICAYADKC+L LD+DERL KL+EILEQI ES N + SPENS
Sbjct: 428 ENVPTSHLESHSYICAYADKCDLKYLDIDERLSKLAEILEQIIESRNLNFQASFCSPENS 487
Query: 475 RTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKL 533
R Q NSA+ +G SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KL
Sbjct: 488 RMQITNSAVISEGCSPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKL 547
Query: 534 SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDF 593
S YGA SSTGSMTS+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD
Sbjct: 548 SQYGAPSSTGSMTSMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDL 607
Query: 594 SKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSF 652
SKEGS +FLLACM DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S
Sbjct: 608 SKEGSCDFLLACMEDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSD 667
Query: 653 SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 712
++ KE+SRL+ D+ S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTG
Sbjct: 668 NRIKESSRLLFDNASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTG 727
Query: 713 DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772
DLFAIK VLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNG
Sbjct: 728 DLFAIK-VLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNG 786
Query: 773 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832
GDLYSLLRK+GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDF
Sbjct: 787 GDLYSLLRKLGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDF 846
Query: 833 GLSKIGLINNTIDLSGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 890
GLSKIGLIN+T+DLSGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGT
Sbjct: 847 GLSKIGLINSTVDLSGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGT 906
Query: 891 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLIN 950
EHGYAADWWSVGIILFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLIN
Sbjct: 907 EHGYAADWWSVGIILFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLIN 966
Query: 951 RFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQI 1010
RFLIHDP+ RLGANG +EVK HPFFKGVNWD+LALQKAVFVPQP+S DDTSYF+SR+SQI
Sbjct: 967 RFLIHDPDLRLGANGLSEVKTHPFFKGVNWDTLALQKAVFVPQPDSADDTSYFVSRYSQI 1026
Query: 1011 SSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASI 1070
SGLPD+Q+ S S D+ D SNS EMDECGDLAEF S PL+LSLINFSFKNLSQLASI
Sbjct: 1027 PSGLPDEQDCSDSATDSSDLYSNSGLEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASI 1086
Query: 1071 NHEVLVQNVKDSTRSSPAKDAGT 1093
N++VL+Q KD T+ SP+K T
Sbjct: 1087 NYDVLLQTGKDPTKCSPSKSRDT 1109
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538590|ref|XP_002510360.1| kinase, putative [Ricinus communis] gi|223551061|gb|EEF52547.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1464 bits (3791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/1046 (71%), Positives = 841/1046 (80%), Gaps = 24/1046 (2%)
Query: 65 EEVRKGKKIAQWFTSYISKFNI-----VSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLN 119
+E KGKKI +W SY SK VS N E E K +D + RR K + NHL+
Sbjct: 60 KEFHKGKKITRWLASYFSKGTSQVTADVSSNIEKRSLEHKTLDKFEQRRIKFVNGENHLD 119
Query: 120 EKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKE 179
Q E +S SK SKGLKSFSHELGP+GGIP + PRAHSY+DLKELL + HSRFDAAKE
Sbjct: 120 GNQPSVEILSQSKASKGLKSFSHELGPRGGIPPAQPRAHSYSDLKELLGSFHSRFDAAKE 179
Query: 180 VVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDL 239
VVN+ELA+FA+D M+VLE +DS E +M EDLLILAQ C+EM FR CE IVQDL
Sbjct: 180 VVNAELASFARDAMDVLEIIDSSLQEELKMAEDLLILAQLCMEMACSQFRLKCEIIVQDL 239
Query: 240 TEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETS 299
TEKR QCQ GLVKWL TRMLFILTRCTRLL FQK++EPI EKSL K KKCLESVP+V+ S
Sbjct: 240 TEKRLQCQTGLVKWLYTRMLFILTRCTRLLQFQKDTEPIDEKSLRKLKKCLESVPSVDMS 299
Query: 300 WVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKSVF 356
WV + ++DLD A QK + K+K+ GQ +S++PE C ES D TS S+
Sbjct: 300 WVANHVIDDTDLDDALNQKGDIKRKLQGQNNLSSLPEAVCCGSQESDDQSGVTSGKDSLD 359
Query: 357 IEQNFPPQKSQHYSRMQEQQ------------SHIVEGRIVEVTKSNCGSPHEQGQSLDG 404
EQ QKS++ S + +Q + + + K S EQ + LDG
Sbjct: 360 FEQKLSCQKSRNESLFEVRQFCETDKSAISNSVNNSSCSLHDQEKFLDDSLQEQERVLDG 419
Query: 405 SDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSS 464
SD VICRICEE+VPISHLESHSYICAYADKC+LNCLDVDERL L+E+LEQI ES N +
Sbjct: 420 SDLVICRICEEIVPISHLESHSYICAYADKCDLNCLDVDERLSNLAEMLEQIVESRNMNV 479
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLN 524
H GSPENSR Q+ NSA T + SPKISEWRNKGVEGMFEDIHEMDTA IDDSHL +N
Sbjct: 480 HQSHGSPENSRPQNANSATT-EACSPKISEWRNKGVEGMFEDIHEMDTAFIDDSHLPPVN 538
Query: 525 LRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 584
L+GHLG+KL YGA SSTGSMTS+SSTNTPKAGHFD FWLE N+P+ELEDV QMI LADI
Sbjct: 539 LKGHLGMKLCNYGAPSSTGSMTSLSSTNTPKAGHFDSFWLEHNNPSELEDVPQMINLADI 598
Query: 585 ARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACEL 643
AR VA+TD SKEGS EFLLACM DLQDVLQHSKLKALVIDTFG RIEKLLREKY+LAC++
Sbjct: 599 ARSVANTDLSKEGSYEFLLACMQDLQDVLQHSKLKALVIDTFGGRIEKLLREKYLLACDI 658
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
D KSP S SK KENSRL+LD+ SQSS +STP+HSSHKERTSIDDFEIIKPISRGAFG+V
Sbjct: 659 TDAKSPKSDSKLKENSRLLLDNASQSSAMSTPVHSSHKERTSIDDFEIIKPISRGAFGKV 718
Query: 704 FLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763
FLARKR TGDLFAIK VLKKLDM+RKND++RILAERNILITVRNPFVVRFFYSFTCRDNL
Sbjct: 719 FLARKRITGDLFAIK-VLKKLDMLRKNDVQRILAERNILITVRNPFVVRFFYSFTCRDNL 777
Query: 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823
YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAH
Sbjct: 778 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAH 837
Query: 824 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 883
DGHIKLTDFGLSKIGLIN+T+DL+GPET+ SDAH P + QT+ NR SAVGTPDYLA
Sbjct: 838 DGHIKLTDFGLSKIGLINSTMDLAGPETNEDEVSDAHNP-HIQTEETNRQSAVGTPDYLA 896
Query: 884 PEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSF 943
PEILLGTEHGYAADWWSVGIILFE ITGIPPFTAE PEIIFDNILNRKIPWP VP MS+
Sbjct: 897 PEILLGTEHGYAADWWSVGIILFELITGIPPFTAERPEIIFDNILNRKIPWPPVPESMSY 956
Query: 944 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1003
EAQDLINR + +DP+QRLG+NG+AEVK++PFF+G++WD+LALQKAVFVP P+S DDTSYF
Sbjct: 957 EAQDLINRLITYDPDQRLGSNGSAEVKSYPFFRGIDWDNLALQKAVFVPSPDSADDTSYF 1016
Query: 1004 LSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKN 1063
+SRFSQ+SSG+P+D + S+SD D DSS NS EMDECGDLAEF S PL+LSLINFSFKN
Sbjct: 1017 VSRFSQMSSGMPNDCSSSHSDTDAYDSSPNSGVEMDECGDLAEFDSSPLNLSLINFSFKN 1076
Query: 1064 LSQLASINHEVLVQNVKDSTRSSPAK 1089
LSQLASINH+V +Q KDS ++SP++
Sbjct: 1077 LSQLASINHDVYLQTGKDSAKNSPSR 1102
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145324180|ref|NP_001077679.1| protein kinase-like protein [Arabidopsis thaliana] gi|332193965|gb|AEE32086.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1184 bits (3064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/1105 (58%), Positives = 792/1105 (71%), Gaps = 54/1105 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771
GD FAIK VLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLN
Sbjct: 693 GDFFAIK-VLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLN 751
Query: 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 831
GGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTD
Sbjct: 752 GGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTD 811
Query: 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 891
FGLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTE
Sbjct: 812 FGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTE 871
Query: 892 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 951
HGYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 872 HGYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINR 931
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1011
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 932 LLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESS 991
Query: 1012 SGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1071
+ N S S+ D+ D E+DEC +L +F S P LSLINFSFKNLSQLASIN
Sbjct: 992 CSDTETGNNSGSNPDSGD-------ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASIN 1044
Query: 1072 HEVLVQNVKDSTRS---SPAKDAGT 1093
H+VL+Q KD + SP K GT
Sbjct: 1045 HDVLLQ--KDPAKGGGDSPFKSHGT 1067
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7767670|gb|AAF69167.1|AC007915_19 F27F5.23 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1165 bits (3013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/1130 (56%), Positives = 792/1130 (70%), Gaps = 79/1130 (6%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFYSFTCRDN 762
GD FAIK VLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFYSFTCRDN
Sbjct: 693 GDFFAIK-VLKKLDMIRKNDIERILQERNILITVRYPFLAEHLMLLMQVRFFYSFTCRDN 751
Query: 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 822
LYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA
Sbjct: 752 LYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIA 811
Query: 823 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 882
++GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYL
Sbjct: 812 YNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYL 871
Query: 883 APEILLGTEHG----------------YAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
APEILLGTEHG YAADWWS GI+LFE +TGIPPFTA PE IFDN
Sbjct: 872 APEILLGTEHGLDTTFKSGFHEAPVNCYAADWWSAGIVLFELLTGIPPFTASRPEKIFDN 931
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 986
ILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQ
Sbjct: 932 ILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQ 991
Query: 987 KAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAE 1046
KA FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D E+DEC +L +
Sbjct: 992 KAAFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD-------ELDECTNLEK 1044
Query: 1047 FGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRS---SPAKDAGT 1093
F S P LSLINFSFKNLSQLASINH+VL+Q KD + SP K GT
Sbjct: 1045 FDSPPYYLSLINFSFKNLSQLASINHDVLLQ--KDPAKGGGDSPFKSHGT 1092
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852258|ref|XP_002894010.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297339852|gb|EFH70269.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1156 bits (2990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/1145 (56%), Positives = 793/1145 (69%), Gaps = 100/1145 (8%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVS--KPDELTESRSYGVSRPPQKHKQKT-VAQ 54
A +N D G IPSGLNRIKTR S +P++ +++ V +PP QK V +
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGLRPEDSSDT----VVKPPFNRNQKIIVPR 57
Query: 55 GHVKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPN---TENSGSEDKDVDVEDPRRTKL 111
G+ + S +E RKG K+++W SY K++ P + + SED KL
Sbjct: 58 GYGRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSED----------IKL 106
Query: 112 RHEGNHLNEKQSLAEHVSSSKV----SKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELL 167
R G + + + + VS + + S G+KSFSHELGP+GG+ + YPR HSYNDLKELL
Sbjct: 107 R--GKNCGKDEEMIIKVSETNLPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELL 164
Query: 168 DTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCL 227
+LHSRFD AKE V+ +L F DV +EKMD P E +EM E+LL +A+ C+EMTS
Sbjct: 165 GSLHSRFDVAKETVDKKLDVFVIDVKEAMEKMDPPCPEDREMAEELLDVARACMEMTSAQ 224
Query: 228 FRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFK 287
RA CE+IV DLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK
Sbjct: 225 LRATCESIVHDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFK 284
Query: 288 KCLESVPAVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLD 347
+CLE +PA+ET W +P +S Y YQ+ A +K ++ S E + + D
Sbjct: 285 ECLERIPALETDWGSTPRVDDSGSGYPKYQRDEAGQKFKRRETESLESETTFDYVIPN-D 343
Query: 348 HTSENKS---VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDG 404
H++ + +Q FP Q+ Q S++ +Q+ ++ + E P ++ L
Sbjct: 344 HSNNAATEGYAVAKQEFPSQEPQFDSKVVQQRFYLSD----EYEHKMLNEPVKE---LGR 396
Query: 405 SDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSS 464
SD VICRICEE VP+SHLE HSYICAYADKCE+NCLDVDERLLKL EILEQI +S + +S
Sbjct: 397 SDYVICRICEEEVPLSHLEPHSYICAYADKCEINCLDVDERLLKLEEILEQIIDSRSLNS 456
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLN 524
G ENS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ +N
Sbjct: 457 FTQAGGLENSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIN 514
Query: 525 LRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 584
L+ H+G K+ + SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED+Q M++L+DI
Sbjct: 515 LKSHVGAKICHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLQLMMDLSDI 573
Query: 585 ARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACEL 643
ARC A TD SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL
Sbjct: 574 ARCGASTDLSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLYAREL 633
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
+KS K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+V
Sbjct: 634 TADKSSVGNVKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKV 684
Query: 704 FLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFF 754
FLARKRTTGD FAIK VLKKLDMIRKNDIERIL ERNILITVR PF+ VRFF
Sbjct: 685 FLARKRTTGDFFAIK-VLKKLDMIRKNDIERILQERNILITVRYPFLAEHLILLMQVRFF 743
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
YSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDL
Sbjct: 744 YSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDL 803
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
KPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D + +H+ + Q + R RHS
Sbjct: 804 KPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTGSHHFQKNQEEERIRHS 863
Query: 875 AVGTPDYLAPEILLGTEH------------------------GYAADWWSVGIILFEFIT 910
AVGTPDYLAPEILLGTEH GYA+DWWSVGI+LFE IT
Sbjct: 864 AVGTPDYLAPEILLGTEHGLDTTLYLGFSEAIGNYIQLLGLAGYASDWWSVGIVLFELIT 923
Query: 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970
GIPPFTA PEIIFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK
Sbjct: 924 GIPPFTAARPEIIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVK 983
Query: 971 AHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDS 1030
+HPFF+GV+WD+LALQKA FVPQPES+ DTSYF+SRF + S+ + N S S D+ D
Sbjct: 984 SHPFFQGVDWDNLALQKAAFVPQPESIADTSYFVSRFCENSASDSETDNNSGSFPDSGD- 1042
Query: 1031 SSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQN--VKDSTRSSPA 1088
E+DEC +L +F S P LSLINFSFKNLSQLASINH+VL+Q K SP
Sbjct: 1043 ------ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASINHDVLLQKDPAKGGGGDSPF 1096
Query: 1089 KDAGT 1093
K GT
Sbjct: 1097 KSHGT 1101
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145336472|ref|NP_175130.2| protein kinase-like protein [Arabidopsis thaliana] gi|332193964|gb|AEE32085.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1128 bits (2918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/1038 (58%), Positives = 749/1038 (72%), Gaps = 42/1038 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771
GD FAIK VLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLN
Sbjct: 693 GDFFAIK-VLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLN 751
Query: 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 831
GGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTD
Sbjct: 752 GGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTD 811
Query: 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 891
FGLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTE
Sbjct: 812 FGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTE 871
Query: 892 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 951
HGYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 872 HGYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINR 931
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1011
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 932 LLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESS 991
Query: 1012 SGLPDDQNGSYSDADTCD 1029
+ N S S+ D+ D
Sbjct: 992 CSDTETGNNSGSNPDSGD 1009
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110740013|dbj|BAF01910.1| similar to IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1125 bits (2909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/1038 (58%), Positives = 748/1038 (72%), Gaps = 42/1038 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y Q+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPECQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771
GD FAIK VLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLN
Sbjct: 693 GDFFAIK-VLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLN 751
Query: 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 831
GGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTD
Sbjct: 752 GGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTD 811
Query: 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 891
FGLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTE
Sbjct: 812 FGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTE 871
Query: 892 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 951
HGYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 872 HGYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINR 931
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1011
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 932 LLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESS 991
Query: 1012 SGLPDDQNGSYSDADTCD 1029
+ N S S+ D+ D
Sbjct: 992 CSDTETGNNSGSNPDSGD 1009
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142471|emb|CBI19674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1071 bits (2770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/730 (76%), Positives = 607/730 (83%), Gaps = 45/730 (6%)
Query: 376 QSHIVEGRIVEVTKSNCGSPHEQGQSL-------DGSDSVICRICEEVVPISHLESHSYI 428
Q IV GR++ N E G L DGSDSVICRICEE VP SHLESHSYI
Sbjct: 252 QIMIVMGRVM----PNMNYSGETGYLLSLSKLGADGSDSVICRICEENVPTSHLESHSYI 307
Query: 429 CAYADKCELNCLDVDERLLKLSEILEQISES-CNSSSHPILGSPENSRTQSMNSAITYDG 487
CAYADKC+L LD+DERL KL+EILEQI ES C
Sbjct: 308 CAYADKCDLKYLDIDERLSKLAEILEQIIESRC--------------------------- 340
Query: 488 YSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKLSGYGASSSTGSMT 546
SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KLS YGA SSTGSMT
Sbjct: 341 -SPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKLSQYGAPSSTGSMT 399
Query: 547 SVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACM 605
S+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD SKEGS +FLLACM
Sbjct: 400 SMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDLSKEGSCDFLLACM 459
Query: 606 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS 665
DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S ++ KE+SRL+ D+
Sbjct: 460 EDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSDNRIKESSRLLFDN 519
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD 725
S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTGDLFAIK VLKKLD
Sbjct: 520 ASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTGDLFAIK-VLKKLD 578
Query: 726 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 785
MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGGDLYSLLRK+GCL
Sbjct: 579 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGGDLYSLLRKLGCL 638
Query: 786 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845
EEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGLSKIGLIN+T+D
Sbjct: 639 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGLSKIGLINSTVD 698
Query: 846 LSGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903
LSGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTEHGYAADWWSVGI
Sbjct: 699 LSGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTEHGYAADWWSVGI 758
Query: 904 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963
ILFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINRFLIHDP+ RLGA
Sbjct: 759 ILFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINRFLIHDPDLRLGA 818
Query: 964 NGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYS 1023
NG +EVK HPFFKGVNWD+LALQKAVFVPQP+S DDTSYF+SR+SQI SGLPD+Q+ S S
Sbjct: 819 NGLSEVKTHPFFKGVNWDTLALQKAVFVPQPDSADDTSYFVSRYSQIPSGLPDEQDCSDS 878
Query: 1024 DADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDST 1083
D+ D SNS EMDECGDLAEF S PL+LSLINFSFKNLSQLASIN++VL+Q KD T
Sbjct: 879 ATDSSDLYSNSGLEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASINYDVLLQTGKDPT 938
Query: 1084 RSSPAKDAGT 1093
+ SP+K T
Sbjct: 939 KCSPSKSRDT 948
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168060390|ref|XP_001782179.1| predicted protein [Physcomitrella patens subsp. patens] gi|162666345|gb|EDQ53002.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2209), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/1058 (46%), Positives = 653/1058 (61%), Gaps = 111/1058 (10%)
Query: 134 SKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVM 193
S +KSFSHEL P+G + R DL+E++ L +RF AK+ VN+ELA FA D++
Sbjct: 24 STDIKSFSHELDPRGVRSYEFLRPRDLLDLEEVMAALGARFHTAKDEVNAELAVFAGDLV 83
Query: 194 NVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKW 253
VLE +E +EDLLILA+ C M +FR CE IVQDL +KRQ+ +G++K
Sbjct: 84 GVLEDTTDMDPYHQERIEDLLILARDCAFMDPQVFRKECEAIVQDLDDKRQELPMGVLKR 143
Query: 254 LSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKK------CLESVPAVETSWVPSPGTA 307
L TRMLFILTRCTRLL F+KE+ + E LH+ ++ C+ES + SW G A
Sbjct: 144 LHTRMLFILTRCTRLLQFEKEN-GLDEVELHRLQQQAKTGSCIESWKKI-ISW-NEKGKA 200
Query: 308 ------ESDLDYASYQKANAKKKISGQQKVSTVPEISDC------SCSESLDHTSENKSV 355
L +S + + K++S + +S P S S ES+ S
Sbjct: 201 LLKVVRPQRLSLSSKPQEKSSKRVSDEVSISGTPTFSGITEQAVESDKESISKASGGSVS 260
Query: 356 FIEQNFPPQKS--QHYSRM--QEQQSHIVE-------GRIVEVT---------------- 388
I +++ +H+S E +SH E G +V +T
Sbjct: 261 PIHSVVADRQTSWKHFSVAPPNELKSHGGESDVETEMGSVVYITPESSQLCADGGMVISR 320
Query: 389 ---------------KSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYAD 433
+ G +Q + LD + ICRICE+ V S LE HS ICA AD
Sbjct: 321 TSEEVQRIPSSKRHQRVAWGHWTDQPEVLDDNLDFICRICEDEVATSCLEDHSRICALAD 380
Query: 434 KCELNCLDVDERLLKLSEILEQISESCNSSSHPIL--GSPENSRTQSMNSA--------- 482
+C+ LDVD+RL +++E LE+++ES S + GSP+ ++T N+
Sbjct: 381 RCDQQGLDVDDRLRRIAETLERMAESLTPKSFSLAAGGSPDTAKTSGSNNGGCSSDGALS 440
Query: 483 ---ITYDGYSPKI-SEWRNKGVEGMFEDIHEMDTACI--DDSHLGSLNLRGHLGLKL--- 533
ITY ++ K+ E KG E + ED +E+D A + D+ S+ + G K+
Sbjct: 441 ERCITYPTFTDKVWGELLRKGSEELLEDTYEIDAASMGDDNKKANSVTCKTRFGPKIEQS 500
Query: 534 --------SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIA 585
S +SS GS+T S TP+ D +RN E++D Q+ E+ADIA
Sbjct: 501 SVPTSSPGSALAPASSAGSLTPRSPLATPRISQIDVLLSDRNGFNEIDDALQINEIADIA 560
Query: 586 RCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLD 645
RC+A ++G+E+LL+C+ D+QD+L+++K++AL + TFG RIEKL EKY E+LD
Sbjct: 561 RCIAGASPDEDGTEYLLSCLEDVQDILRYNKVEALTVATFGKRIEKLCMEKYHKFLEILD 620
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 705
S ++ +L+ + S STP+H S+K+RT+IDDFEIIKPISRGAFGRVFL
Sbjct: 621 PNGVEVASSVGDDE--LLEDDTFHSYKSTPVHPSYKDRTTIDDFEIIKPISRGAFGRVFL 678
Query: 706 ARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765
ARKRTTGDLFAIK VLKK DMIRKN +E + AERNILI+ RNPFVVRFFYSFTC +NLYL
Sbjct: 679 ARKRTTGDLFAIK-VLKKADMIRKNAVESVKAERNILISARNPFVVRFFYSFTCAENLYL 737
Query: 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 825
VMEYLNGGD+YSLLR +GCL+E +AR+YIAELVLALE LHSLG+VHRDLKPDN+LIAHDG
Sbjct: 738 VMEYLNGGDMYSLLRTLGCLDEALARVYIAELVLALECLHSLGVVHRDLKPDNILIAHDG 797
Query: 826 HIKLTDFGLSKIGLINNTIDLSGPETDGIM------PSDAHYPEYQ-QTDNRNRHSAVGT 878
HIKLTDFGLS++GLIN+T DLSGP G M + P+++ Q R + SAVGT
Sbjct: 798 HIKLTDFGLSRVGLINSTDDLSGPAATGTMVMEESTKNQCASPKHEHQRKIRQQRSAVGT 857
Query: 879 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 938
PDYLAPEILLGT HG AADWWS G+ILFEF+TGIPPF AE P+++FDNILNR IPWP VP
Sbjct: 858 PDYLAPEILLGTSHGPAADWWSTGVILFEFLTGIPPFNAEHPQVVFDNILNRHIPWPAVP 917
Query: 939 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 998
MS+EAQDLI+R L DP +RLGANGAAEVKAHPFFK +NW++LA QKA F+P P+
Sbjct: 918 EYMSYEAQDLIDRLLTEDPTERLGANGAAEVKAHPFFKDINWETLARQKAAFIPSPDGAH 977
Query: 999 DTSYFLSRFSQISS-GLPDDQNGSYSDADTCDSSSNSRTEM----DECGDLAEF---GSC 1050
DTSYF SR++ S+ G D ++ SD ++ S S S + + DE GD+AEF SC
Sbjct: 978 DTSYFSSRYAWNSNEGNFDTEHFDESDDESTCSGSTSDSALVLQTDEFGDMAEFENSSSC 1037
Query: 1051 PLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRSSPA 1088
S NFSFKNLSQLASIN+++L Q+ + + P+
Sbjct: 1038 KYTFS--NFSFKNLSQLASINYDLLQQSERRDSPQGPS 1073
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529485|ref|XP_003533321.1| PREDICTED: uncharacterized protein LOC100776995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2208), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/1009 (48%), Positives = 640/1009 (63%), Gaps = 74/1009 (7%)
Query: 137 LKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVL 196
+KSFSHEL KG P + + N+L+E+L + ++FD AKE VNS+LA FA D++ +L
Sbjct: 295 IKSFSHELNSKGVWPFPFSKPRRLNNLEEILVVIRAKFDKAKEDVNSDLAIFAADLVGIL 354
Query: 197 EKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLST 256
EK + +E +EDLL+LA+ C +S F CE+IVQ+L ++RQ+ G++K L T
Sbjct: 355 EKNADTHPDWQETIEDLLVLARSCAMTSSGEFWLQCESIVQELDDRRQEHPPGMLKQLHT 414
Query: 257 RMLFILTRCTRLLLFQKES-----EPI----AEKSLHKFKKCLESVPAVETSWVPSPGTA 307
RMLFILTRCTRLL F KES EP+ + LH K + +T +A
Sbjct: 415 RMLFILTRCTRLLQFHKESGLAEDEPVFNLRQSRVLHSAGKFIPPSVGRDTK----SSSA 470
Query: 308 ESDLDYASYQKANAKKKISGQQKVSTVPE----ISDCSCSESLDHTSENKSVFIEQNFP- 362
L +S + + ++ + G +K PE +D ++ D +S + + FP
Sbjct: 471 AKALKPSSKKAFSQEQSMMGWKKDVMQPENLSIPADDDNAKLFDSSSGRNRMASWKKFPS 530
Query: 363 -----PQ-----KSQHYSRMQEQQSHIVEGRIVEVT------------------------ 388
P+ K Q+Y R++ ++ + +V
Sbjct: 531 PTGRSPKEAVQLKDQNYGRVESSKASNNKRFTSDVDLSTAKPSELLPVKDSLDHASKHQH 590
Query: 389 KSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLK 448
K + G +Q + +S+ICRICEE VP SH+E HS ICA AD+C+ L V+ERL++
Sbjct: 591 KVSWGYWGDQQNNNSEENSIICRICEEDVPTSHVEDHSRICAVADRCDQKGLSVNERLVR 650
Query: 449 LSEILEQISESCNSS-SHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDI 507
+S+ LE++ ESC + ++GSP+ ++ + + D SPK+S+W +G E M +
Sbjct: 651 ISDTLEKMMESCTQKDTQQMVGSPDVAKVSNSSMTEESDVPSPKLSDWSRRGSEDMLDCF 710
Query: 508 HEMDTACIDDSHLGS--LNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLE 565
E D + D G ++ + G K +SS GSMT S TP+ D
Sbjct: 711 PEADNSVFMDDLKGLPLMSCKTRFGPKSDQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAG 770
Query: 566 RNHPAELEDVQQMIELADIARCVADTDFSKE-GSEFLLACMHDLQDVLQHSKLKALVIDT 624
+ +E +D+ QM ELADIARCVA+ + + +LL+C+ DL+ V+ K AL ++T
Sbjct: 771 KGAYSEHDDLPQMNELADIARCVANAPLDDDRTTSYLLSCLDDLRVVVDRRKFDALTVET 830
Query: 625 FGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERT 684
FG+RIEKL+REKY+ E++D + + S ++ ++ D V +S S P+HSS ++RT
Sbjct: 831 FGTRIEKLIREKYLQLTEMVDVEKIDTESTVDDD--ILEDDVVRSLRTS-PIHSS-RDRT 886
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
SIDDFEIIKPISRGAFGRVFLA+KRTTGDLFAIK VLKK DMIRKN +E ILAER+ILIT
Sbjct: 887 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKADMIRKNAVESILAERDILIT 945
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSLLR +GCL+E+VAR+YIAE+VLALEYL
Sbjct: 946 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEEVARVYIAEVVLALEYL 1005
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG--IMPSDAH-- 860
HSL +VHRDLKPDNLLIAHDGHIKLTDFGLSK+GLIN+T DLSGP +G ++ D
Sbjct: 1006 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVNGTSLLEEDETDV 1065
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ Q + R + SAVGTPDYLAPEILLGT HG+ ADWWSVG+ILFE + GIPPF AE P
Sbjct: 1066 FTSADQRERREKRSAVGTPDYLAPEILLGTGHGFTADWWSVGVILFELLVGIPPFNAEHP 1125
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980
+IIFDNILNRKIPWP VP +MS EA DLI+R L DPNQRLG+ GA+EVK H FFK +NW
Sbjct: 1126 QIIFDNILNRKIPWPAVPEEMSPEALDLIDRLLTEDPNQRLGSKGASEVKQHVFFKDINW 1185
Query: 981 DSLALQKAVFVPQPESVDDTSYFLSRFS-QISSGL--PDDQNGSYSDAD----TCDSSSN 1033
D+LA QKA FVP ES DTSYF SR+S S G P SDAD + SN
Sbjct: 1186 DTLARQKAAFVPASESALDTSYFTSRYSWNTSDGFVYPASDVEDSSDADSLSGSSSCLSN 1245
Query: 1034 SRTEMDECGDLAEFGS-CPLDLSLINFSFKNLSQLASINHEVLVQNVKD 1081
+ E DECG L EF S ++ S NFSFKNLSQLASIN++ L + KD
Sbjct: 1246 RQDEGDECGGLTEFDSGTSVNYSFSNFSFKNLSQLASINYD-LTKGWKD 1293
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1093 | ||||||
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.652 | 0.668 | 0.638 | 8.5e-239 | |
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.650 | 0.548 | 0.528 | 1.1e-221 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.656 | 0.581 | 0.5 | 5.4e-207 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.840 | 0.786 | 0.458 | 2.5e-199 | |
| DICTYBASE|DDB_G0276157 | 1367 | pkgA "MAST family protein kina | 0.247 | 0.197 | 0.435 | 4e-91 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.150 | 0.078 | 0.678 | 7.9e-91 | |
| UNIPROTKB|F1S920 | 729 | MAST3 "Uncharacterized protein | 0.305 | 0.458 | 0.467 | 6.1e-81 | |
| RGD|1310139 | 968 | Mast4 "microtubule associated | 0.309 | 0.349 | 0.459 | 1e-80 | |
| POMBASE|SPAPB18E9.02c | 1318 | ppk18 "serine/threonine protei | 0.179 | 0.148 | 0.49 | 6e-79 | |
| POMBASE|SPCC1450.11c | 1338 | cek1 "serine/threonine protein | 0.156 | 0.127 | 0.566 | 6.9e-78 |
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2302 (815.4 bits), Expect = 8.5e-239, P = 8.5e-239
Identities = 472/739 (63%), Positives = 559/739 (75%)
Query: 359 QNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVP 418
+ + K + S + S +VE R + +E G+ L GSD VICRICEE VP
Sbjct: 351 EGYAAAKQEFPSHEPQFDSKVVEQRFYLSDEYEDKMSNEPGKELGGSDYVICRICEEEVP 410
Query: 419 ISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQS 478
+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G ENS +
Sbjct: 411 LFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLRK 470
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLXXXXX 538
S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 471 --SGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHAT 528
Query: 539 XXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS 598
NTP+ HFD +WLER+ P E ED++ M++L+DIARC A TDFSKEGS
Sbjct: 529 SSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGS 587
Query: 599 -EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKE 657
++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS S KE
Sbjct: 588 CDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKS--SVGNIKE 645
Query: 658 NSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAI 717
S +L+ S +TP K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAI
Sbjct: 646 -SEDVLEHAS-----ATP-QLLLKDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAI 698
Query: 718 KQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 777
K VLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYS
Sbjct: 699 K-VLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYS 757
Query: 778 LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
LL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKI
Sbjct: 758 LLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKI 817
Query: 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897
GLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEHGYAAD
Sbjct: 818 GLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAAD 877
Query: 898 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 957
WWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR L+H+P
Sbjct: 878 WWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEP 937
Query: 958 NQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDD 1017
+RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S +
Sbjct: 938 EKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSCSDTET 997
Query: 1018 QNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQ 1077
N S S+ D+ D E+DEC +L +F S P LSLINFSFKNLSQLASINH+VL+Q
Sbjct: 998 GNNSGSNPDSGD-------ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASINHDVLLQ 1050
Query: 1078 NVKDSTRS---SPAKDAGT 1093
KD + SP K GT
Sbjct: 1051 --KDPAKGGGDSPFKSHGT 1067
|
|
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1820 (645.7 bits), Expect = 1.1e-221, Sum P(3) = 1.1e-221
Identities = 394/746 (52%), Positives = 484/746 (64%)
Query: 360 NFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPI 419
NFPP K H + H + + G EQ + S++CRICEE VP
Sbjct: 565 NFPPAKDSH--EHSSKHRHNI----------SWGYWGEQ-PLISEESSIMCRICEEEVPT 611
Query: 420 SHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSPENSRTQS 478
+H+E HS +C ADK + L VDERL+ ++ L++I+E+ + S SP+ + +
Sbjct: 612 THVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKDSLAAAESPDGMKVSN 671
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHLGLKLXXX 536
+ D SP++S+W KG E M + E D + +DD L ++ R G K
Sbjct: 672 SHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSDQG 731
Query: 537 XXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKE 596
TP+ + + + +D+ QM ELADIA+C AD +
Sbjct: 732 MTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPGDD 791
Query: 597 GS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKY 655
S FLL+C+ DL+ V+ K AL ++TFG+RIEKL+REKY+ CEL+D++ S
Sbjct: 792 QSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLSTV 851
Query: 656 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 715
+ + D V +S S P+H ++RTSIDDFEIIKPISRGAFGRVFLA+KRTTGDLF
Sbjct: 852 IDEDAPLEDDVVRSLRTS-PVHP--RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 716 AIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 775
AIK VLKK DMIRKN +E ILAER+ILI VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL
Sbjct: 909 AIK-VLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 967
Query: 776 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
YSLLR +GCLEED+ R+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGHIKLTDFGLS
Sbjct: 968 YSLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLS 1027
Query: 836 KIGLINNTIDLSGPETDGIMPSDAHYPEY----QQTDNRNRHSAVGTPDYLAPEILLGTE 891
K+GLIN+T DL+GP G D +Q + R + SAVGTPDYLAPEILLGT
Sbjct: 1028 KVGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTG 1087
Query: 892 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 951
HG ADWWSVGIILFE I GIPPF AE P+ IFDNILNRKIPWP VP +MS EA D+I+R
Sbjct: 1088 HGATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDR 1147
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1011
FL DP+QRLGA GAAEVK H FFK +NWD+LA QKA FVP ES DTSYF SR+S +
Sbjct: 1148 FLTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNT 1207
Query: 1012 SG---LPDDQNGSYSDADT------CDSSSNSRTEMDECGDLAEFGS-CPLDLSLINFSF 1061
S P + YSDAD+ C S+ + E +EC AEF S P+D S NFSF
Sbjct: 1208 SDEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSF 1267
Query: 1062 KNLSQLASINHEVLVQNVKDSTRSSP 1087
KNLSQLASIN+++L + KD + P
Sbjct: 1268 KNLSQLASINYDLLSKGWKDEPQQIP 1293
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1694 (601.4 bits), Expect = 5.4e-207, Sum P(3) = 5.4e-207
Identities = 374/748 (50%), Positives = 476/748 (63%)
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
K V I + K S + Q H+ + R ++ G H+ + S+ICRI
Sbjct: 500 KLVAISDDMAVAKLPEVSSAKASQEHMSKNRH-NISWGYWG--HQS--CISEESSIICRI 554
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSP 471
CEE +P +H+E HS ICA ADK + + VDERL+ ++ LE+I+++ S + SP
Sbjct: 555 CEEEIPTTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKDSLAAVESP 614
Query: 472 ENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHL 529
E + + + D SPK+S+W +G E M + E D + +DD L S++ R
Sbjct: 615 EGMKISNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRF 674
Query: 530 GLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVA 589
G K TP+ + + + +D QM ELADIARC A
Sbjct: 675 GPKSDQGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAA 734
Query: 590 DT-DFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKS 648
+ + + LL+C+ DL+ V+ K AL+++TFG+RIEKL++EKY+ CEL+D++
Sbjct: 735 NAIPVDDQSIQLLLSCLEDLRVVIDRRKFDALIVETFGTRIEKLIQEKYLQLCELMDDEK 794
Query: 649 PTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARK 708
T E++ L D V +S S P+H ++R SIDDFE++K ISRGAFG V LARK
Sbjct: 795 GTIID---EDAPLE-DDVVRSLRTS-PVHL--RDRISIDDFEVMKSISRGAFGHVILARK 847
Query: 709 RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768
TTGDLFAIK VL+K DMIRKN +E ILAER+ILI RNPFVVRFFYSFTC +NLYLVME
Sbjct: 848 NTTGDLFAIK-VLRKADMIRKNAVESILAERDILINARNPFVVRFFYSFTCSENLYLVME 906
Query: 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 828
YLNGGD YS+LRK+GCL+E AR+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGH+K
Sbjct: 907 YLNGGDFYSMLRKIGCLDEANARVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHVK 966
Query: 829 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 888
LTDFGLSK+GLINNT DLSGP + P+ D++ SAVGTPDYLAPEILL
Sbjct: 967 LTDFGLSKVGLINNTDDLSGPVSSATSLLVEEKPKLPTLDHKR--SAVGTPDYLAPEILL 1024
Query: 889 GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDL 948
GT HG ADWWSVGIIL+EF+ GIPPF A+ P+ IFDNILNR I WP VP DMS EA+DL
Sbjct: 1025 GTGHGATADWWSVGIILYEFLVGIPPFNADHPQQIFDNILNRNIQWPPVPEDMSHEARDL 1084
Query: 949 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFS 1008
I+R L DP+QRLGA GAAEVK H FFK ++W++LA QKA FVP E+ DTSYF SR+S
Sbjct: 1085 IDRLLTEDPHQRLGARGAAEVKQHSFFKDIDWNTLAQQKAAFVPDSENAFDTSYFQSRYS 1144
Query: 1009 QISSG---LPDDQNGSYSDADT-CDSSSNSRTEMDE-----CGDLAEFG-SCPLDLSLIN 1058
SG P ++N S+ D+ C SS DE CG AEF S + N
Sbjct: 1145 WNYSGERCFPTNENEDSSEGDSLCGSSGRLSNHHDEGVDIPCGP-AEFETSVSENYPFDN 1203
Query: 1059 FSFKNLSQLASINHEVLVQNVKDSTRSS 1086
FSFKNLSQLA IN+ ++ + KD T+ S
Sbjct: 1204 FSFKNLSQLAYINYNLMSKGHKDETQPS 1231
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1909 (677.1 bits), Expect = 2.5e-199, Sum P(2) = 2.5e-199
Identities = 452/985 (45%), Positives = 608/985 (61%)
Query: 142 HELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDS 201
HEL KG P R+ + ++E++ + ++FD KE V+++L FA ++ LE
Sbjct: 201 HELNSKGVRPFPVWRSRAVGHMEEIMAAIRTKFDKQKEDVDADLGVFAGYLVTTLESTPE 260
Query: 202 PSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFI 261
+ E + LEDLL+ A+QC M + F CE IVQ L +KRQ+ +G +K R+LFI
Sbjct: 261 SNKELRVGLEDLLVEARQCATMPASEFWLKCEGIVQKLDDKRQELPMGGLKQAHNRLLFI 320
Query: 262 LTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDL-DYASYQKAN 320
LTRC RL+ F+KES + E L + L + V + + DL QK N
Sbjct: 321 LTRCNRLVQFRKESGYVEEHILGMHQ--LSDLGVYPEQMVEI--SRQQDLLREKEIQKIN 376
Query: 321 AKKKISGQQKVSTVPEISD---CSCSESLDHTSENKSVFIEQNFPP--QKSQHYSRMQEQ 375
K+ ++G+Q +D + + S D TS N + + P +K++ + +
Sbjct: 377 EKQNLAGKQDDQNSNSGADGVEVNTARSTDSTSSNFRMSSWKKLPSAAEKNRSLNNTPKA 436
Query: 376 QSHI-VEGRIV-EVTKSNCGSPHEQGQSLDGS---------------DSVICRICEEVVP 418
+ ++ ++ + N SP Q S D S +S+ICRICE +P
Sbjct: 437 KGESKIQPKVYGDENAENLHSPSGQPASADRSALWGFWADHQCVTYDNSMICRICEVEIP 496
Query: 419 ISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQS 478
+ H+E HS IC AD+C+L ++V+ RL +++E LE+I ES S + +S S
Sbjct: 497 VVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPKSSVTPRAVADSARLS 556
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDI-HEMDTACIDDSHLGSLNLRGHLGLKLXXXX 537
NS+ D + E + + M + + +T +D+ LN+ + +
Sbjct: 557 -NSSRQED-----LDEISQRCSDDMLDCVPRSQNTFSLDE-----LNILNEMSM---TNG 602
Query: 538 XXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEG 597
TP+ D R +ELE+ QQ+ +L DIAR VA+ +
Sbjct: 603 TKDSSAGSLTPPSPATPRNSQVDLLLSGRKTISELENYQQINKLLDIARSVANVNVCGYS 662
Query: 598 S-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLD-EKSPTSFSKY 655
S +F++ + +L+ V+Q K ALV++TFG RIEKLL+EKYI C L+D EK +S +
Sbjct: 663 SLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDEKVDSSNAMP 722
Query: 656 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 715
E S D+V ++PL+ K+RTSI+DFEIIKPISRGAFGRVFLA+KR TGDLF
Sbjct: 723 DEESSADEDTVRSLR--ASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLAKKRATGDLF 780
Query: 716 AIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 775
AIK VLKK DMIRKN +E ILAERNILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDL
Sbjct: 781 AIK-VLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 839
Query: 776 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
+SLLR +GCL+ED+ARIYIAE+VLALEYLHS+ I+HRDLKPDNLLI DGHIKLTDFGLS
Sbjct: 840 FSLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKLTDFGLS 899
Query: 836 KIGLINNTIDLSGPET---DGIMPSDAHYPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTE 891
K+GLIN+T DLSG + G D ++ Q D+R +H+ VGTPDYLAPEILLG
Sbjct: 900 KVGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPEILLGMG 959
Query: 892 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 951
HG ADWWSVG+ILFE + GIPPF AE+P+ IF+NI+NR IPWP VP ++S+EA DLIN+
Sbjct: 960 HGKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISYEAHDLINK 1019
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1011
L +P QRLGA GA EVK H FFK +NWD+LA QKA+FVP E DTSYF+SR+ I
Sbjct: 1020 LLTENPVQRLGATGAGEVKQHHFFKDINWDTLARQKAMFVPSAEP-QDTSYFMSRY--IW 1076
Query: 1012 SGLPDDQN---GS-YSD-ADTCDSSS-NSRTEM-DECGDLAEFGSCP---LDLSLINFSF 1061
+ P+D+N GS + D DTC SSS N++ E DECG LAEFG+ P + S NFSF
Sbjct: 1077 N--PEDENVHGGSDFDDLTDTCSSSSFNTQEEDGDECGSLAEFGNGPNLAVKYSFSNFSF 1134
Query: 1062 KNLSQLASINHEVLVQNVKDSTRSS 1086
KNLSQLASIN++++++N K+S +S
Sbjct: 1135 KNLSQLASINYDLVLKNAKESVEAS 1159
|
|
| DICTYBASE|DDB_G0276157 pkgA "MAST family protein kinase PkgA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 4.0e-91, Sum P(4) = 4.0e-91
Identities = 128/294 (43%), Positives = 187/294 (63%)
Query: 564 LERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVID 623
L R++ E + +IEL +IA + KE L +H + D++++ K +
Sbjct: 676 LTRSNDIPHEKRKMIIELREIALFAVENGI-KEN----LKMIHIMNDIIKNFDPKDDNRE 730
Query: 624 TFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS-----VSQSS------GV 672
+I+ L+ +K + A + D+ +S ++ NS IL S +SQ+
Sbjct: 731 -LAIKIQSLISDK-VNALKRADDVINSSPRIFRTNSPRILKSPREEELSQTPLGGRLRSD 788
Query: 673 STPLHSS---HKER--TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI 727
S P+H + +K + +I DFE IKPI++G +G+VFLA+K TGD++AIK+ LKK DMI
Sbjct: 789 SDPVHQTQIEYKPKGVPTISDFEFIKPITKGGYGKVFLAKKIRTGDIYAIKR-LKKSDMI 847
Query: 728 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE 787
+KN ++ + ERNIL NPFVV+ +YSF ++ YLVMEYL GGD +SLL+ +G ++E
Sbjct: 848 KKNQLDHVKVERNILAYTSNPFVVKMYYSFQTKEYYYLVMEYLQGGDCFSLLQMLGSMDE 907
Query: 788 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841
++A++ IAE VLALEYLHS GIVHRD+KPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 908 NMAKMIIAETVLALEYLHSHGIVHRDVKPDNLLIDKKGHIKLTDFGLSKVGLLD 961
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 7.9e-91, Sum P(7) = 7.9e-91
Identities = 112/165 (67%), Positives = 130/165 (78%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
SS+ SI DFEIIKPISRGAFGRV+LA+K+ TGDL+AIK VLKKLD IRKN + ++
Sbjct: 1516 SSNTTSISIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIK-VLKKLDTIRKNMVNHVIV 1574
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
ERNIL V+N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE
Sbjct: 1575 ERNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAET 1634
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
VL LEYLH IVHRDLKPDN+LI GHIKLTDFGLSKIG+I++
Sbjct: 1635 VLCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDD 1679
|
|
| UNIPROTKB|F1S920 MAST3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 747 (268.0 bits), Expect = 6.1e-81, Sum P(3) = 6.1e-81
Identities = 163/349 (46%), Positives = 218/349 (62%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
DFE IK IS GA+G V+L R R T FAIK++ K+ ++I +N I+++ ER+IL N
Sbjct: 376 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQ-NLILRNQIQQVFVERDILTFAEN 434
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
PFVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 435 PFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNY 494
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L +G + D E+
Sbjct: 495 GIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLY----EGHIEKDTR--EF--V 546
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
D + GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F +
Sbjct: 547 DKQ----VCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQV 602
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 987
++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L K
Sbjct: 603 VSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFWTLDWAGLLRHK 662
Query: 988 AVFVPQPESVDDTSYFLSRFSQISS-GLPDDQ-NGSYSDADTCDSSSNS 1034
A FVPQ E+ DDTSYF +R + G DD+ N S + SS S
Sbjct: 663 AEFVPQLEAEDDTSYFDTRSERYRHLGSEDDETNDEESSTEIPQFSSCS 711
|
|
| RGD|1310139 Mast4 "microtubule associated serine/threonine kinase family member 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 1.0e-80, Sum P(3) = 1.0e-80
Identities = 165/359 (45%), Positives = 229/359 (63%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K++ K+
Sbjct: 301 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 355
Query: 724 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 783
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 356 -NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMG 414
Query: 784 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 415 PLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMT 474
Query: 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903
+L +G + DA E+ D + GTP+Y+APE++L +G DWW++GI
Sbjct: 475 TNLY----EGHIEKDAR--EF--LDKQ----VCGTPEYIAPEVILRQGYGKPVDWWAMGI 522
Query: 904 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963
IL+EF+ G PF ++PE +F +++ +I WP +AQDLI L +P +RLG
Sbjct: 523 ILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGT 582
Query: 964 NGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR---FSQISSGLPDDQN 1019
GA EVK H FF+ ++W+SL QKA F+PQ ES DDTSYF +R + + + DD N
Sbjct: 583 GGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTRSEKYHHMETEEEDDTN 641
|
|
| POMBASE|SPAPB18E9.02c ppk18 "serine/threonine protein kinase Ppk18 (predicted)" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 6.0e-79, Sum P(3) = 6.0e-79
Identities = 98/200 (49%), Positives = 138/200 (69%)
Query: 666 VSQSSGVSTPLH--SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723
+S+ G+ST SS K SI D+EIIKPIS+G FG V+L+RK TTG+++AIK VL+K
Sbjct: 541 LSRQIGISTLSSNISSGKGTPSIQDYEIIKPISKGTFGTVYLSRKNTTGEIYAIK-VLRK 599
Query: 724 LDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 782
+DMI KN + + AER +L+ + FV + +Y+F RD LYLVME++NGGD SLL+ +
Sbjct: 600 VDMISKNQVANVKAERAVLMAQEESAFVAKLYYAFQSRDYLYLVMEFMNGGDCASLLKSL 659
Query: 783 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
+ E A+IYIAE+ L LE+LH LGI+HRD+KPDN+L++ GH+KL DFGLS++GL
Sbjct: 660 YTIPESWAKIYIAEVALGLEHLHRLGIIHRDIKPDNILMSITGHLKLADFGLSQLGLTTR 719
Query: 843 TIDLSGPETDGIMPSDAHYP 862
+ L + + + P P
Sbjct: 720 QLRLQKGKNNILSPPSFQSP 739
|
|
| POMBASE|SPCC1450.11c cek1 "serine/threonine protein kinase Cek1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 6.9e-78, Sum P(3) = 6.9e-78
Identities = 98/173 (56%), Positives = 130/173 (75%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM 726
S S + T + +S E SI+D++I+KPIS+GAFG V+LA+KRTTGD FAIK +LKK +M
Sbjct: 567 SPSPRIHTIVPNSAPEHPSINDYKILKPISKGAFGSVYLAQKRTTGDYFAIK-ILKKSNM 625
Query: 727 IRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 785
I KN + + AER IL++ +PFV + +Y+F +D LYLVMEYLNGGD SLL+ +G L
Sbjct: 626 IAKNQVINVRAERAILMSQGESPFVAKLYYTFQSKDYLYLVMEYLNGGDCGSLLKTMGVL 685
Query: 786 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838
+ D R YIAE VL L LH GI+HRD+KP+NLLI+ +GH+KLTDFGLS++G
Sbjct: 686 DLDWIRTYIAETVLCLGDLHDRGIIHRDIKPENLLISQNGHLKLTDFGLSRVG 738
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1093 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-146 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-118 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-117 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-116 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-116 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-113 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-106 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-100 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-97 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-96 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-93 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-92 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-89 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-85 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-84 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-84 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-82 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-81 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-81 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-79 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-77 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-76 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-76 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-75 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-75 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-74 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-74 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-73 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-73 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-72 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-71 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-71 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-70 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-70 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-69 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-69 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-68 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-68 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-67 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-67 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-66 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-66 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-65 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-65 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-64 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-64 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-63 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-62 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-62 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-62 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-62 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-61 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-61 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-61 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-61 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-60 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-58 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-58 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-56 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-56 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-55 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-55 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-52 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-51 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-50 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-50 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-49 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-48 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-47 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-46 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-46 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-45 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-45 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-44 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-43 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-43 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-42 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-42 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-41 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-40 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-39 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-38 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-37 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-36 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-36 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-35 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-35 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-35 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-34 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-34 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-34 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-33 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-31 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-31 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-30 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-30 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-30 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-30 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-29 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-29 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-28 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-27 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-27 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-27 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-26 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-25 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-24 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-24 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-21 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-12 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 9e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 4e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-08 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 8e-04 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.002 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 438 bits (1129), Expect = e-146
Identities = 166/286 (58%), Positives = 210/286 (73%), Gaps = 21/286 (7%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
IS+GA+GRVFLA+K++TGD++AIK V+KK DMIRKN ++++L ER+IL ++P+VV+ +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIK-VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
YSF + NLYLVMEYL GGDL SLL VG L+EDVARIYIAE+VLALEYLHS GI+HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
KPDN+LI +GH+KLTDFGLSK+GL+ I+L+ E + D R
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE---------------DKR---- 160
Query: 875 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934
VGTPDY+APE++LG H DWWS+G IL+EF+ GIPPF E+PE IF NILN KI W
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW 220
Query: 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980
P S EA DLI++ L+ DP +RLGA E+K HPFFKG++W
Sbjct: 221 PEDVEV-SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 365 bits (939), Expect = e-118
Identities = 131/281 (46%), Positives = 183/281 (65%), Gaps = 31/281 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ +G+FG+V L RK+ TG L+A+K VLKK +I++ ++E L ERNIL + +PF+V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMK-VLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
Y+F + LYLV+EY GG+L+S L K G E+ AR Y AE+VLALEYLHSLGI++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
KP+N+L+ DGHIKLTDFGL+K ++ ++
Sbjct: 120 KPENILLDADGHIKLTDFGLAKELS---------------------------SEGSRTNT 152
Query: 875 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934
GTP+YLAPE+LLG +G A DWWS+G++L+E +TG PPF AE + I++ IL + +
Sbjct: 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF 212
Query: 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
P +S EA+DLI+ L DP +RLG+ GA E+KAHPFF
Sbjct: 213 ---PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 362 bits (930), Expect = e-117
Identities = 155/292 (53%), Positives = 195/292 (66%), Gaps = 34/292 (11%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFV 750
+KPIS+GAFG V+LA+KR+TGD FAIK VLKK DMI KN + + AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIK-VLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 751 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIV 810
+ +YSF +D LYLVMEYLNGGD SL++ +G L ED A+ YIAE+VL +E LH GI+
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119
Query: 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
HRD+KP+NLLI GH+KLTDFGLS+ GL N
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF-------------------------- 153
Query: 871 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 930
VGTPDYLAPE +LG +DWWS+G ++FEF+ G PPF AE+P+ +FDNIL+R
Sbjct: 154 -----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208
Query: 931 KIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981
+I WP V S EA DLINR L DP +RLGANG E+K+HPFFK +NWD
Sbjct: 209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 361 bits (927), Expect = e-116
Identities = 156/317 (49%), Positives = 211/317 (66%), Gaps = 13/317 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+DFE IK IS GA+G V+L R + T FA+K++ K+ ++I +N I+++ ER+IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ-NLILRNQIQQVFVERDILTFAE 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
NPFVV F SF + +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L +G + D +Q
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY----EGHIEKDTREFLDKQ 175
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 176 V--------CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 986
+++ I WP + +AQDLI+R L +P +RLG GA EVK H FF G++W+ L Q
Sbjct: 228 VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQ 287
Query: 987 KAVFVPQPESVDDTSYF 1003
KA F+PQ ES DDTSYF
Sbjct: 288 KAEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 362 bits (932), Expect = e-116
Identities = 149/322 (46%), Positives = 204/322 (63%), Gaps = 11/322 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFE+IK I RGAFG V+L R + TG ++A+K VL+K DMI++N I + AER+IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMK-VLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P++V+ +YSF ++LYLVMEY+ GGDL +LL + E+ AR YIAELVLAL+ +H
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN---TIDLSGPETDGIMPSDAHYPE 863
LG +HRD+KPDN+LI DGHIKL DFGL K + L+ +
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCK-KMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+ +S VGTPDY+APE+L GT +G DWWS+G+IL+E + G PPF +++ +
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 924 FDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981
++ I+N K P D +S EA DLI R L DP RLG+ E+K+HPFFKG++W+
Sbjct: 239 YNKIINWKESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLGS--FEEIKSHPFFKGIDWE 294
Query: 982 SLALQKAVFVPQPESVDDTSYF 1003
+L K FVP+ S DTS F
Sbjct: 295 NLRETKPPFVPELSSPLDTSNF 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 353 bits (907), Expect = e-113
Identities = 137/322 (42%), Positives = 197/322 (61%), Gaps = 40/322 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFE IK + G+FGRV L R + +G +A+K +L K +++ +E +L E+ IL ++R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALK-ILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+PF+V + SF NLYLVMEY+ GG+L+S LRK G E VAR Y A++VLALEYLHS
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
L IV+RDLKP+NLL+ DG+IK+TDFG +K + T
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRT----------------------- 155
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
++ GTP+YLAPEI+L +G A DWW++GI+++E + G PPF ++P I++
Sbjct: 156 ------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK 209
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 984
IL K+ PS S +A+DLI L D +RLG NG ++K HP+F G++W +L
Sbjct: 210 ILEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL- 265
Query: 985 LQKAV---FVPQPESVDDTSYF 1003
LQ+ + F+P+ + DTS F
Sbjct: 266 LQRKIEAPFIPKVKGPGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 337 bits (866), Expect = e-106
Identities = 143/332 (43%), Positives = 202/332 (60%), Gaps = 20/332 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFE IK I RGAFG V L +K+ TG ++A+K L+K +M+ K + + AER+IL
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMK-KLRKSEMLEKEQVAHVRAERDILAEAD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
NP+VV+ +YSF + LYL+MEYL GGD+ +LL K E+ R YIAE +LA++ +H
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPSDAHY 861
LG +HRD+KPDNLL+ GHIKL+DFGL GL + LS
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPS-NFLDFISK 177
Query: 862 PEYQ----QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913
P +T RNR +S VGTPDY+APE+ L T + DWWS+G+I++E + G P
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237
Query: 914 PFTAESPEIIFDNILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKA 971
PF +++P+ + I+N K P ++ S EA+DLI R + +RLG NG E+K+
Sbjct: 238 PFCSDNPQETYRKIINWKETLQ-FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295
Query: 972 HPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1003
HPFFKGV+W+ + + A +P+ +S+ DTS F
Sbjct: 296 HPFFKGVDWEHIRERPAPIIPELKSITDTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 315 bits (809), Expect = e-100
Identities = 128/288 (44%), Positives = 171/288 (59%), Gaps = 35/288 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+EI++ + G+FG+V+LAR + TG L AIK + KK K D ERIL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI---KKDRERILREIKILKKLKHP 57
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
+VR + F D LYLVMEY GGDL+ LL+K G L ED AR Y+ +++ ALEYLHS G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 868
IVHRDLKP+N+L+ DGH+KL DFGL++ Q
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLAR----------------------------QLDP 149
Query: 869 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNI 927
+ VGTP+Y+APE+LLG +G A D WS+G+IL+E +TG PPF + +F I
Sbjct: 150 GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
K P+P D+S EA+DLI + L+ DP +RL A E HPFF
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 311 bits (799), Expect = 1e-97
Identities = 136/327 (41%), Positives = 195/327 (59%), Gaps = 25/327 (7%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
F+ IK + +G GRVFL R + TG LFA+K VL K +MI++N ++R+L E+ IL T+
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALK-VLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYL 804
+PF+ + SF L LVM+Y GG+L+ LL++ CL E+VAR Y AE++LALEYL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET-----DGIMPSDA 859
H LGIV+RDLKP+N+L+ GHI L+DF LSK S E S
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSK---------QSDVEPPPVSKALRKGSRR 170
Query: 860 HYPEYQQTD------NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913
++ + +S VGT +Y+APE++ G HG A DWW++GI+L+E + G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 914 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAH 972
PF + + F NIL +++ +P P S A+DLI + L+ DP++RLG GAAE+K H
Sbjct: 231 PFKGSNRDETFSNILKKEVTFPGSPPV-SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289
Query: 973 PFFKGVNWDSLALQKAVFVPQPESVDD 999
PFF+GVNW + +P+P+ D
Sbjct: 290 PFFRGVNWALIRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 309 bits (792), Expect = 9e-96
Identities = 157/371 (42%), Positives = 211/371 (56%), Gaps = 31/371 (8%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
F IK I GAFG V L RK T L+A+K L+K D++ +N + AER+IL N
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMK-TLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
+VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++G EED+AR YIAEL A+E +H +G
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINN-----TIDLSGPETDGI 854
+HRD+KPDN+LI DGHIKLTDFGL SK + +++ S E I
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS-EEWSEI 180
Query: 855 MPSDAHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911
E ++ R HS VGTP+Y+APE+LL T + DWWSVG+IL+E + G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 912 IPPFTAESPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967
PPF A++P ++N + IP + +S EA DLI R L RLG NGA
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHIP-SQ--AKLSREASDLILR-LCCGAEDRLGKNGAD 296
Query: 968 EVKAHPFFKGVNWDSLAL-QKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 1026
E+KAHPFFKG+++ SL QKA ++P+ DTS F L D +G S
Sbjct: 297 EIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNF-DPVDP--EKLRSDDSGESSPDR 353
Query: 1027 TCDSSSNSRTE 1037
++ RTE
Sbjct: 354 NVKPNNRKRTE 364
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 298 bits (765), Expect = 4e-93
Identities = 108/291 (37%), Positives = 170/291 (58%), Gaps = 13/291 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITV 745
DDF+ K I G+F V LA+++ T +AIK + K+ +I++ ++ + E+ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLN 59
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+P +++ +Y+F +NLY V+EY G+L +RK G L+E R Y AE++LALEYLH
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S GI+HRDLKP+N+L+ D HIK+TDFG +K+ + D+ + +
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL---DPNSSPESNKGDATNIDSQIEKNR 176
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
R S VGT +Y++PE+L G ++D W++G I+++ +TG PPF + + F
Sbjct: 177 ----RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFF 975
IL + + P + +A+DLI + L+ DP RLG N G E+KAHPFF
Sbjct: 233 KILKLEYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 296 bits (760), Expect = 9e-92
Identities = 129/321 (40%), Positives = 193/321 (60%), Gaps = 39/321 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
DF+I+ + +G +G+VFLA+K+ TG++ A+K +KK + + N++ +L ER+IL T ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALK-RMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
++V+ Y+F + LYL MEY+ GGD +LL +G L ED AR Y+AE+ A++ LH L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
G +HRDLKP+N LI GHIKLTDFGLSK + +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYA-------------------- 155
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
+S VG+PDY+APE+L G + + D+WS+G +L+EF+ G PPF+ +P ++N+
Sbjct: 156 -----NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210
Query: 928 LNRK--IPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982
K + P ++S EA DLI + LI+DP++R G ++K HPFFK V+W+
Sbjct: 211 KYWKETLQRPVYDDPRFNLSDEAWDLITK-LINDPSRRFG--SLEDIKNHPFFKEVDWNE 267
Query: 983 LALQKAVFVPQPESVDDTSYF 1003
L K FVP+ ES DT YF
Sbjct: 268 LRELKPPFVPELESEIDTGYF 288
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 3e-89
Identities = 146/353 (41%), Positives = 206/353 (58%), Gaps = 53/353 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+DF +K I +GAFG V L +K+ TG ++A+K +LK +M +K+ + + AER++L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS-EMFKKDQLAHVKAERDVLAESD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P+VV +YSF LYL+ME+L GGDL ++L K EDV R Y+AE VLA+E +H
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLS---------------------------KIGL 839
LG +HRD+KPDN+LI GHIKL+DFGLS + +
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR----HSAVGTPDYLAPEILLGTEHGYA 895
++I+L+ D I T +NR +S VGTPDY+APEI L +G
Sbjct: 180 AVDSINLTMSSKDQI-----------ATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 896 ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP---CVPSD--MSFEAQDLIN 950
DWWS+G I+FE + G PPF +E+ + I+N W P D +S EA+DLI
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIIN----WRETLYFPDDIHLSVEAEDLIR 284
Query: 951 RFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1003
R LI + RLG GA E+K+HPFF+GV+WD++ +A F+PQ +S+ DTSYF
Sbjct: 285 R-LITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF 336
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 2e-85
Identities = 115/332 (34%), Positives = 186/332 (56%), Gaps = 37/332 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVV 751
K + +G+FG+V LA + T +L+A+K VLKK +++ +D+E + E+ +L PF+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVK-VLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
+ F +D L+ VMEY+NGGDL +++ G +E AR Y AE+VL L++LH GI++
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLK DN+L+ +GHIK+ DFG+ K G++
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILG--------------------------GVTT 153
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTPDY+APEIL +G A DWW++G++L+E + G PF + + +F +IL +
Sbjct: 154 S-TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE 212
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV 989
+ + P +S EA+ ++ FL +P +RLG G ++K HPFF+ ++WD L ++
Sbjct: 213 VRY---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIK 269
Query: 990 --FVPQPESVDDTSYFLSRFSQISSGL-PDDQ 1018
F P+ + D S F F++ L P D+
Sbjct: 270 PPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDE 301
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 2e-84
Identities = 129/319 (40%), Positives = 185/319 (57%), Gaps = 45/319 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRK-NDIERILAERNILI 743
+FE+++ + GA+G+VFL RK G L+A+K VLKK +++K E ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLKKATIVQKAKTAEHTRTERQVLE 59
Query: 744 TVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
VR PF+V Y+F L+L+++Y+NGG+L++ L + E R+YIAE+VLAL+
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+LH LGI++RD+K +N+L+ +GH+ LTDFGLSK L
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL----------------------- 156
Query: 863 EYQQTDNRNR-HSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE- 918
+ R +S GT +Y+APE++ G G+ A DWWS+G++ FE +TG PFT +
Sbjct: 157 ----AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
Query: 919 ---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
S I IL K P P MS EA+D I + L DP +RLGANGA E+K HPFF
Sbjct: 213 EQNSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
Query: 976 KGVNWDSLALQ--KAVFVP 992
+G++WD LA + A F P
Sbjct: 270 QGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 273 bits (700), Expect = 7e-84
Identities = 122/321 (38%), Positives = 179/321 (55%), Gaps = 38/321 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DD E IK + G FGRV L R R + +A+K V+ ++IR + + E+ +L V
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALK-VMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+PF++R F++ + LY++MEY+ GG+L+S LR G Y +E+V ALEYLHS
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
IV+RDLKP+N+L+ +GHIKLTDFG +K L + T L
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTL-------------------- 158
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
GTP+YLAPE++ H A DWW++GI+++E + G PPF ++P I++
Sbjct: 159 ---------CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 984
IL K+ + P + A+DLI + L+ D +RLG NGA +VK H +FK V+WD +
Sbjct: 210 ILAGKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP 266
Query: 985 LQKAV--FVPQPESVDDTSYF 1003
+K VP+ DTS F
Sbjct: 267 QRKLKPPIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 271 bits (695), Expect = 1e-82
Identities = 141/341 (41%), Positives = 203/341 (59%), Gaps = 40/341 (11%)
Query: 692 IKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIR-KNDIERILAERNILITVRN 747
+K + +G +G+VF RK T TG +FA+K VLKK ++R + D AERNIL V++
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
PF+V Y+F LYL++EYL+GG+L+ L + G ED A Y++E+ LALE+LH
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GI++RDLKP+N+L+ GH+KLTDFGL K + T+
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---------------------- 157
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
H+ GT +Y+APEIL+ + HG A DWWS+G ++++ +TG PPFTAE+ + D I
Sbjct: 158 -----HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLAL 985
L K+ +P ++ EA+DL+ + L +P+ RLGA AAEV++HPFF+ VNWD L
Sbjct: 213 LKGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLA 269
Query: 986 QK--AVFVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYS 1023
+K F P +S +D S F S+F+ Q PDD S S
Sbjct: 270 RKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSES 310
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 267 bits (686), Expect = 3e-82
Identities = 103/292 (35%), Positives = 160/292 (54%), Gaps = 37/292 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+E+++ + G+FG V+ A+ + TG + A+K + K+ + + E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHP 58
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
+VR +F +D+LYLVMEY GGDL+ L + G L ED A+ +++ LEYLHS G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 868
I+HRDLKP+N+L+ +G +K+ DFGL+K L +++
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS------------------------- 153
Query: 869 NRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIF 924
+ + VGTP Y+APE+LL G +G D WS+G+IL+E +TG PPF+ E +
Sbjct: 154 --SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
Query: 925 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
IL + + S S EA+DLI + L DP++R A E+ HP+F
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 268 bits (688), Expect = 1e-81
Identities = 126/331 (38%), Positives = 191/331 (57%), Gaps = 43/331 (12%)
Query: 681 KERTS---IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
K TS + DFE+ + + G+FGRV +A+ + TG+ +AIK LKK ++++ ++ +
Sbjct: 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-CLKKREILKMKQVQHVAQ 67
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
E++IL+ + +PF+V SF + +Y ++E++ GG+L++ LRK G DVA+ Y AEL
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
VLA EYLHS I++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------------------- 166
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917
P+ T GTP+YLAPE++ HG A DWW++G++L+EFI G PPF
Sbjct: 167 --KVPDRTFT-------LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217
Query: 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 975
++P I++ IL ++ + P+ A+DL+ L D +RLG G A+VK HP+F
Sbjct: 218 DTPFRIYEKILAGRLKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
Query: 976 KGVNWDSLALQKAVFVPQP---ESVDDTSYF 1003
G NWD L + P P +S DTS F
Sbjct: 275 HGANWDKL-YARYYPAPIPVRVKSPGDTSNF 304
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 4e-81
Identities = 105/294 (35%), Positives = 169/294 (57%), Gaps = 40/294 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ G FGRV L + ++ FA+K V KK ++ E I +E+ IL +PF+V+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV-KKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
+F + +Y++MEY GG+L+++LR G +E AR YIA +VLA EYLH+ GI++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR-H 873
KP+NLL+ +G++KL DFG +K + + +
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAK-----------------------------KLKSGQKTW 150
Query: 874 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIFDNIL--N 929
+ GTP+Y+APEI+L + ++ D+WS+GI+L+E +TG PPF E P I+++IL N
Sbjct: 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN 210
Query: 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWD 981
K+ + P+ + A+DLI + L +P +RLG G ++K H +F G +W+
Sbjct: 211 GKLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 263 bits (672), Expect = 4e-79
Identities = 143/330 (43%), Positives = 205/330 (62%), Gaps = 19/330 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFE +K I RGAFG V L +K+ TG ++A+K +L+K DM+ K + I AER+IL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKEQVAHIRAERDILVEAD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ- 865
LG +HRD+KPDNLL+ GH+KL+DFGL GL PSD +
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 866 ----QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917
+T +NR +S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 918 ESPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
E+P+ + ++N K P P VP +S +A+DLI RF D R+G+NG E+K+HP
Sbjct: 239 ETPQETYRKVMNWKETLVFP-PEVP--ISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294
Query: 974 FFKGVNWDSLALQKAVFVPQPESVDDTSYF 1003
FF+GV+W + + A + +S+DDTS F
Sbjct: 295 FFEGVDWGHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 3e-77
Identities = 148/337 (43%), Positives = 200/337 (59%), Gaps = 24/337 (7%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
F IK + GAFG V LARK T L+A+K L+K D++ +N + + AER+IL N
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMK-TLRKKDVLLRNQVAHVKAERDILAEADNE 61
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
+VVR +YSF +DNLY VM+Y+ GGD+ SLL ++G ED+AR YIAEL A+E +H +G
Sbjct: 62 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG 121
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGL--------------SKIGLINNTIDLSGPETD-- 852
+HRD+KPDN+LI DGHIKLTDFGL S + +++D S D
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 853 GIMPSDAHYP-EYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 908
D P E + R HS VGTP+Y+APE+LL T + DWWSVG+IL+E
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 909 ITGIPPFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAA 967
+ G PPF A++P ++N + P + +S EA DLI + L P RLG NGA
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGAD 300
Query: 968 EVKAHPFFKGVNWDS-LALQKAVFVPQPESVDDTSYF 1003
E+KAHPFFK +++ S L Q A ++P+ DTS F
Sbjct: 301 EIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNF 337
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 6e-76
Identities = 135/325 (41%), Positives = 194/325 (59%), Gaps = 36/325 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFEI+K I RGAFG V + + + TG ++A+K +L K +M+++ + ER++L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMK-ILNKWEMLKRAETACFREERDVLVNGD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLH 805
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+VLA++ +H
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
LG VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S+
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLL----------ADGTVQSNV------ 162
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESP 920
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 ---------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 921 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ I+N K +P +D+S EA+DLI R LI P RLG NG + K HPFF+G+
Sbjct: 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGI 272
Query: 979 NWDSLALQKAVFVPQPESVDDTSYF 1003
+WD++ A +VP+ S DTS F
Sbjct: 273 DWDNIRNSTAPYVPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 254 bits (649), Expect = 9e-76
Identities = 141/329 (42%), Positives = 206/329 (62%), Gaps = 17/329 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+DFE +K I RGAFG V L +K+ TG ++A+K +L+K DM+ K + I AER+IL+
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMK-ILRKADMLEKEQVGHIRAERDILVEAD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+ +VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ- 865
LG +HRD+KPDNLL+ GH+KL+DFGL GL + +PSD +
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCT-GLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 866 ----QTDNRNRH----SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917
+T RNR S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 918 ESPEIIFDNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
E+P+ + ++N K I P VP +S +A+DLI RF + R+GA G E+K +PF
Sbjct: 239 ETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPF 295
Query: 975 FKGVNWDSLALQKAVFVPQPESVDDTSYF 1003
F+GV+W+ + + A + +S+DDTS F
Sbjct: 296 FEGVDWEHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 5e-75
Identities = 127/334 (38%), Positives = 180/334 (53%), Gaps = 36/334 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVR 752
K + +G FG+V L R++ TG +A+K +LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 812
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL YLHS +V+R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 813 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 872
DLK +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATM 152
Query: 873 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 212
Query: 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV- 989
+ P +S EA+ L+ L DP QRLG A E+ H FF +NW + +K
Sbjct: 213 RF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP 269
Query: 990 -FVPQPESVDDTSYFLSRF-SQISSGLPDDQNGS 1021
F PQ S DT YF F +Q + P D+ S
Sbjct: 270 PFKPQVTSETDTRYFDEEFTAQSITITPPDRYDS 303
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 252 bits (644), Expect = 7e-75
Identities = 125/329 (37%), Positives = 186/329 (56%), Gaps = 38/329 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
R +DF++IK I RGAFG V L R +++ ++A+K L K +MI+++D ER+I+
Sbjct: 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL-LSKFEMIKRSDSAFFWEERDIM 97
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+ ++V+ Y+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 98 AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALD 156
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+HS+G +HRD+KPDN+L+ GH+KL DFG + + + +G++ D
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--------TCMKM---DANGMVRCD---- 201
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAE 918
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+
Sbjct: 202 -----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
Query: 919 SPEIIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
S + I++ K P D +S +A+DLI FL D RLG NG E+K+HPFFK
Sbjct: 251 SLVGTYSKIMDHKNSL-TFPDDIEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPFFK 308
Query: 977 G--VNWDSLALQKAVFVPQPESVDDTSYF 1003
+D++ A VP+ S DTS F
Sbjct: 309 NDQWTFDNIRETVAPVVPELSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 249 bits (637), Expect = 1e-74
Identities = 125/345 (36%), Positives = 187/345 (54%), Gaps = 42/345 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI-TVRNPFVV 751
K I +G+FG+V LA+ + G +A+K VL+K +++K + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVK-VLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
YSF D LY V++Y+NGG+L+ L++ E AR Y AE+ AL YLHSL I++
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLKP+N+L+ GH+ LTDFGL K +GI S
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK---------------EGIEHSK------------T 152
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNILN+
Sbjct: 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQK--A 988
+ + ++S A+ L+ L D +RLGA + E+K H FF +NWD L +K
Sbjct: 213 LR---LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
Query: 989 VFVPQPESVDDTSYFLSRFSQI----SSGLPDDQN---GSYSDAD 1026
F P D +F F++ S G D S +AD
Sbjct: 270 PFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 5e-74
Identities = 154/383 (40%), Positives = 206/383 (53%), Gaps = 50/383 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
F IK + GAFG V LA K T L+A+K L+K D++ +N + + AER+IL N
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
+VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++ E +AR YIAEL LA+E +H +G
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINNTIDLSGPETDGIMPSD- 858
+HRD+KPDN+LI DGHIKLTDFGL SK + I D + PSD
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI-----RQDSMEPSDL 176
Query: 859 ------------AHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903
E + T R HS VGTP+Y+APE+LL + DWWSVG+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 904 ILFEFITGIPPFTAESPE------IIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIH 955
ILFE + G PPF A +P I ++N L+ +P +S EA DLI + L
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLH-------IPPQVKLSPEAVDLITK-LCC 288
Query: 956 DPNQRLGANGAAEVKAHPFFKGVNWDS-LALQKAVFVPQPESVDDTSYFLSRFSQISSGL 1014
+RLG NGA ++KAHPFF V++ S + Q A +VP+ DTS F + S
Sbjct: 289 SAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDP--VEEESPW 346
Query: 1015 PDDQNGSYSDADTCDSSSNSRTE 1037
D S DT S + E
Sbjct: 347 NDASGDSTRTWDTLCSPNGKHPE 369
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 247 bits (631), Expect = 1e-73
Identities = 132/334 (39%), Positives = 197/334 (58%), Gaps = 38/334 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRK-NDIERILAERNILI 743
+FE++K + GA+G+VFL RK T TG L+A+K VL+K +++K +E ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLE 59
Query: 744 TVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
VR +PF+V Y+F L+L+++Y++GG++++ L + ED R Y E++LALE
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+LH LGIV+RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-------------------------- 153
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 921
E+ + +S GT +Y+APEI+ G HG A DWWS+GI++FE +TG PFT E
Sbjct: 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213
Query: 922 IIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGV 978
+ R + P PS + EAQDL+++ L DP +RLGA GA+E+K HPFFKG+
Sbjct: 214 NTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273
Query: 979 NWDSLALQK--AVFVPQPESVDDTSYFLSRFSQI 1010
+W++LAL+K F P + D F F+ +
Sbjct: 274 DWEALALRKVNPPFRPSIRNELDVGNFAEEFTNL 307
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (628), Expect = 1e-73
Identities = 120/319 (37%), Positives = 183/319 (57%), Gaps = 37/319 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I +G+FG+V RKR T ++A+K ++K ++ ++++ LAER +L V PF+V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK-TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
+SF + LYLV+ ++NGG+L+ L++ G + AR Y AEL+ ALE LH +++RDL
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
KP+N+L+ + GHI L DFGL K+ + + D N +
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKD-------------------------DDKTN--T 152
Query: 875 AVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932
GTP+YLAPE+LLG HGY A DWW++G++L+E +TG+PPF E+ ++ IL +
Sbjct: 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL 210
Query: 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV--F 990
+ P +A+DL+ L DP +RLG NGA E+K HPFF ++W L ++ F
Sbjct: 211 RF---PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPF 267
Query: 991 VPQPESVDDTSYFLSRFSQ 1009
P S DTS F F++
Sbjct: 268 KPAVSSAIDTSNFDEEFTR 286
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 1e-72
Identities = 120/329 (36%), Positives = 178/329 (54%), Gaps = 41/329 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV--- 745
F + + RG FG+V LA + TG+L+AIK LKK D+I ++++E ++ E+ I T
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSE 59
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
R+PF+V F F D++ VMEY GGDL + E A Y A +VL L+YLH
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLH 118
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
IV+RDLK DNLL+ +G +K+ DFGL K +G+ D
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---------------EGMGFGD------- 156
Query: 866 QTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
R S GTP++LAPE+L T + A DWW +G++++E + G PF + E +F
Sbjct: 157 ------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDS 982
D+I+N ++ +P +S EA ++ R L +P +RLG+ A +VK PFF+ +NWD
Sbjct: 211 DSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD 267
Query: 983 LALQK--AVFVPQPESVDDTSYFLSRFSQ 1009
L +K FVP + +D S F F+
Sbjct: 268 LLARKIKPPFVPTIKGPEDVSNFDEEFTS 296
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 2e-71
Identities = 133/343 (38%), Positives = 194/343 (56%), Gaps = 49/343 (14%)
Query: 692 IKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+K + +G+FG+VFL RK T G L+A+K VLKK + + D R ER+IL V +P
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATL-KVRDRVRTKMERDILAEVNHP 58
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL 807
F+V+ Y+F LYL++++L GGDL++ L K V EEDV + Y+AEL LAL++LHSL
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALALDHLHSL 117
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GI++RDLKP+N+L+ +GHIKLTDFGLSK +
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK----------------------------ESI 149
Query: 868 DNRNR-HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
D+ + +S GT +Y+APE++ H +ADWWS G+++FE +TG PF + +
Sbjct: 150 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLA 984
IL K+ +P +S EAQ L+ +P RLGA +G E+K HPFF ++W+ L
Sbjct: 210 ILKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL- 265
Query: 985 LQKAV---FVPQPESVDDTSYFLSRFS----QISSGLPDDQNG 1020
++ + F P DDT YF F+ + S G+P N
Sbjct: 266 YRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANA 308
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 2e-71
Identities = 106/288 (36%), Positives = 158/288 (54%), Gaps = 32/288 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
FE+++ I +GAFG+V + +KR T +FA+K + K+ + K + +L ER IL + +P
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
F+V +YSF +N+YLV++ L GGDL Y L +KV E+ + +I E+VLALEYLHS
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYLHSK 119
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
GI+HRD+KPDN+L+ GH+ +TDF ++ T
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATK----------------------------VT 151
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
+ S GTP Y+APE+L + A DWWS+G+ +E + G P+ S I
Sbjct: 152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
++ P+ S EA D IN+ L DP +RLG N ++K HP+F
Sbjct: 212 AKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 237 bits (605), Expect = 4e-70
Identities = 121/326 (37%), Positives = 179/326 (54%), Gaps = 41/326 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DF++ + RG FG V + R++ TGD++A+K V+KK ++ + + ER+IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMK-VMKKSVLLAQETVSFFEEERDILSISN 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLH 805
+P++ + Y+F +DNLYLVMEY GGDL SLL R +ED+A+ Y+AELVLA+ +H
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+G VHRD+KP+N+LI GHIKL DFG + + ++
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSA-----------------ARLTANKMV---- 158
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAES 919
N VGTPDY+APE+L +G DWWS+G+I +E I G PF +
Sbjct: 159 -----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213
Query: 920 PEIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
++NI+N R + +P P +S + DLI L+ +RLG G + HPFF
Sbjct: 214 SAKTYNNIMNFQRFLKFPEDPK-VSSDFLDLIQS-LLCGQKERLGYEG---LCCHPFFSK 268
Query: 978 VNWDSLALQKAVFVPQPESVDDTSYF 1003
++W+++ FVP +S DDTS F
Sbjct: 269 IDWNNIRNSLPPFVPTLKSDDDTSNF 294
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 4e-70
Identities = 109/338 (32%), Positives = 180/338 (53%), Gaps = 37/338 (10%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITVR 746
DF + + +G+FG+V LA ++ T +L+AIK +LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
GI++RDLK DN+++ +GHIK+ DFG+ K + I
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFGGK-------- 156
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +
Sbjct: 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 984
I+ + + P +S EA + L P +RLG G +++ H FF+ ++W+ L
Sbjct: 213 IMEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLE 269
Query: 985 LQ--KAVFVPQPESVDDTSYFLSRFSQISSGL-PDDQN 1019
+ + F P+ + F F++ L P D+
Sbjct: 270 RREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKL 307
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (597), Expect = 5e-69
Identities = 125/325 (38%), Positives = 184/325 (56%), Gaps = 39/325 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV---RNPFVV 751
I +G FG+V+ RK+ T ++A+K + KK ++ K ++ + ERNIL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE-IVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
+SF +LYLV +Y++GG+L+ L+K G ED A+ YIAELVLALE+LH IV+
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLKP+N+L+ GHI L DFGLSK L TDN+
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANL---------------------------TDNKT 152
Query: 872 RHSAVGTPDYLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 929
++ GT +YLAPE+LL E GY D+WS+G+++FE G PF AE + ++ NI
Sbjct: 153 TNTFCGTTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
Query: 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKA 988
K+ +P + +S E + + L +P RLGA A E+K HPFF ++WD L+ ++
Sbjct: 212 GKVRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQI 269
Query: 989 V--FVPQPESVDDTSYFLSRFSQIS 1011
F P +S +D S F F+ S
Sbjct: 270 TPPFKPIVDSDEDVSNFDPEFTNSS 294
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 9e-69
Identities = 118/322 (36%), Positives = 187/322 (58%), Gaps = 39/322 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF 753
+ +G+FG+V LAR + +G L+A+K VLKK +++ +D+E + E+ IL RN PF+ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVK-VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 813
+ F D L+ VME++NGGDL ++K +E AR Y AE+ AL +LH GI++RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873
LK DN+L+ H+GH KL DFG+ K G+ N G S
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFN-----------GKTTS---------------- 154
Query: 874 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 933
+ GTPDY+APEIL +G + DWW++G++L+E + G PF AE+ + +F+ ILN ++
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 214
Query: 934 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKAV- 989
+ P+ +S +A D++ F+ +P RLG+ G + HPFFK ++W+ L ++ +
Sbjct: 215 Y---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN-RRQIE 270
Query: 990 --FVPQPESVDDTSYFLSRFSQ 1009
F P+ +S +D S F F +
Sbjct: 271 PPFRPRIKSREDVSNFDPDFIK 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 5e-68
Identities = 116/318 (36%), Positives = 179/318 (56%), Gaps = 36/318 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVV 751
K + +G+FG+V LA + T + FAIK LKK ++ +D+E + ER +L +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIK-ALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
F +F +++L+ VMEYLNGGDL ++ G +E AR Y AE++ L++LH GI++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---------------------------K 152
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTPDY+APEIL G ++ + DWWS G++L+E + G PF E + +FD+ILN
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-D 211
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--AV 989
P P +S EA+D +++ DP +RLG +G +++ HPFF+G++W+ L ++
Sbjct: 212 RPH--FPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGIDWERLEKREIPPP 267
Query: 990 FVPQPESVDDTSYFLSRF 1007
F P+ +S D S F F
Sbjct: 268 FKPKVKSPSDASNFDREF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 229 bits (584), Expect = 9e-68
Identities = 123/320 (38%), Positives = 191/320 (59%), Gaps = 46/320 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRK-NDIERILAERNILI 743
+FE++K + GA+G+VFL RK + +G L+A+K VLKK +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMK-VLKKATIVQKAKTTEHTRTERQVLE 59
Query: 744 TVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+R +PF+V Y+F L+L+++Y+NGG+L++ L + +E +IY E+VLALE
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+LH LGI++RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-------------------------- 153
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE-- 918
E+ + + +S GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT +
Sbjct: 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
Query: 919 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPF 974
S I IL + P+ P +MS A+D+I R L+ DP +RLG + A E+K HPF
Sbjct: 214 KNSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
Query: 975 FKGVNWDSLALQKAVFVPQP 994
F+ +NWD LA +K VP P
Sbjct: 271 FQKINWDDLAAKK---VPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 3e-67
Identities = 99/291 (34%), Positives = 154/291 (52%), Gaps = 34/291 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
++ + + RG+FG V+LA + TG+L A+K V +L + ++E + E IL ++++
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV--ELSGDSEEELEALEREIRILSSLQH 58
Query: 748 PFVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
P +VR++ S ++ L + +EY++GG L SLL+K G L E V R Y +++ L YLH
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S GIVHRD+K N+L+ DG +KL DFG +K T +
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE-------------------- 158
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
S GTP ++APE++ G E+G AAD WS+G + E TG PP++ +
Sbjct: 159 -----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213
Query: 926 N-ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
I + P P +P +S EA+D + + L DP +R A E+ HPF
Sbjct: 214 YKIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 8e-67
Identities = 124/343 (36%), Positives = 184/343 (53%), Gaps = 39/343 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVR 752
K + +G FG+V L R++ TG +A+K +L+K +I K+++ + E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 812
Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEYLHS +V+R
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 813 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 872
D+K +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATM 152
Query: 873 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 212
Query: 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV- 989
+ P +S EA+ L+ L DP QRLG + A EV H FF +NW + +K +
Sbjct: 213 RF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 269
Query: 990 -FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDS 1030
F PQ S DT YF F+ S + P D+ Y +
Sbjct: 270 PFKPQVTSEVDTRYFDDEFTAQSITITPPDR---YDSLGLLEL 309
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 5e-66
Identities = 133/348 (38%), Positives = 191/348 (54%), Gaps = 40/348 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVR 752
K + +G FG+V L R++ +G +A+K +LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 812
YSF +D L VMEY+NGG+L+ L + ED R Y AE+V AL+YLHS IV+R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 813 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 872
DLK +NL++ DGHIK+TDFGL K G+ TD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGI---------------------------TDAATM 152
Query: 873 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL I
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI 212
Query: 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV- 989
+ P +S +A+ L++ LI DPN+RLG + A E+ H FF GVNW + +K V
Sbjct: 213 KF---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269
Query: 990 -FVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYSDADTCDSSSNSR 1035
F PQ S DT YF F+ Q + P ++ D D D N R
Sbjct: 270 PFKPQVTSETDTRYFDEEFTAQTITITPPEK----YDEDGMDCMDNER 313
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 6e-66
Identities = 111/324 (34%), Positives = 186/324 (57%), Gaps = 38/324 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITVRNPFVV 751
K + +G+FG+V LA + T +++AIK VLKK +++ +D++ + E+ IL + ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIK-VLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
F +D L+ VMEY+NGGDL +++ +E +R Y AE+ LAL +LH G+++
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLK DN+L+ +GH KL DFG+ K G++N
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT-------------------------- 153
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTPDY+APEIL E+G + DWW++G++++E + G PPF A++ + +F++IL+
Sbjct: 154 -TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLG----ANGAAEVKAHPFFKGVNWDSLALQ- 986
+ +P +S EA ++ F+ +PN+RLG G +K HPFFK ++W L +
Sbjct: 213 VLYPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRK 269
Query: 987 -KAVFVPQPESVDDTSYFLSRFSQ 1009
K F P+ ++ D + F F++
Sbjct: 270 IKPPFKPKIKTKRDVNNFDQDFTK 293
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 1e-65
Identities = 129/325 (39%), Positives = 186/325 (57%), Gaps = 36/325 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFEIIK I RGAFG V + + + T ++A+K +L K +M+++ + ERN+L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMK-ILNKWEMLKRAETACFREERNVLVNGD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 805
++ Y+F + LYLVM+Y GGDL +LL K L ED+AR YIAE+VLA+ +H
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
L VHRD+KPDN+L+ +GHI+L DFG S + + DG + S
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQ----------DGTVQSSV------ 162
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYA-----ADWWSVGIILFEFITGIPPFTAESP 920
AVGTPDY++PEIL E G DWWS+G+ ++E + G PF AES
Sbjct: 163 ---------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 921 EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ I+N + +P +D+S EA+DLI R LI +RLG NG + K H FF+G+
Sbjct: 214 VETYGKIMNHEERFQFPSHITDVSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGI 272
Query: 979 NWDSLALQKAVFVPQPESVDDTSYF 1003
+W+++ +A ++P S DTS F
Sbjct: 273 DWENIRNLEAPYIPDVSSPSDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 7e-65
Identities = 129/325 (39%), Positives = 190/325 (58%), Gaps = 36/325 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+DFEI+K I RGAFG V + + + +FA+K +L K +M+++ + ER++L+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETACFREERDVLVNGD 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 805
N ++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+V+A++ +H
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
L VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLME----------DGTVQSSV------ 162
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESP 920
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 ---------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 921 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ I+N K +P +D+S +A+DLI R LI RLG NG + K HPFF G+
Sbjct: 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR-LICSREHRLGQNGIEDFKQHPFFTGI 272
Query: 979 NWDSLALQKAVFVPQPESVDDTSYF 1003
+WD++ +A ++P+ S DTS F
Sbjct: 273 DWDNIRNCEAPYIPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 2e-64
Identities = 115/320 (35%), Positives = 184/320 (57%), Gaps = 40/320 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITVRNPFVV 751
K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L + +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--IYIAELVLALEYLHSLGI 809
+ +F ++NL+ VMEYLNGGDL ++ C + D+ R Y AE++ L++LHS GI
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
V+RDLK DN+L+ DGHIK+ DFG+ K ++ DA +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENML----------------GDAKTCTF----- 156
Query: 870 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 929
GTPDY+APEILLG ++ + DWWS G++L+E + G PF E +F +I
Sbjct: 157 ------CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-- 208
Query: 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK-- 987
++ PC P ++ EA+D++ + + +P +RLG G +++ HPFF+ ++W +L ++
Sbjct: 209 -RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDWSALEEREIE 265
Query: 988 AVFVPQPESVDDTSYFLSRF 1007
F P+ +S +D S F F
Sbjct: 266 PPFKPKVKSANDCSNFDKEF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 4e-64
Identities = 121/343 (35%), Positives = 190/343 (55%), Gaps = 40/343 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI-TVRNPFVV 751
K I +G+FG+V LA++++ G +A+K VL+K +++K + I+AERN+L+ +++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
YSF + LY V++Y+NGG+L+ L++ C E AR Y AE+ A+ YLHSL I++
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLKP+N+L+ GH+ LTDFGL K +G+ P +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK---------------EGVEPEE------------T 152
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNIL++
Sbjct: 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP 212
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA-AEVKAHPFFKGVNWDSLALQKAV- 989
+ +P + A DL+ L D +RLGA E+K H FF +NWD L ++
Sbjct: 213 LQ---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITP 269
Query: 990 -FVPQPESVDDTSYFLSRFSQ--ISSGL---PDDQNGSYSDAD 1026
+ P D +F F+Q +SS + PD S S +
Sbjct: 270 PYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASS 312
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 4e-63
Identities = 92/277 (33%), Positives = 152/277 (54%), Gaps = 35/277 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
+EIIK I +G+FG+V+L R+++ G L+ +K++ L + + + E L E IL + +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEVKILKKLNH 58
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEEDVARIYIAELVLALEY 803
P +++++ SF + L +VMEY +GGDL ++K E+ + +L LAL+Y
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS I+HRD+KP N+ + +G +KL DFG+SK+ +++T+DL+
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLA---------------- 160
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+ VGTP YL+PE+ + Y +D WS+G +L+E T PF E+ +
Sbjct: 161 ---------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL 211
Query: 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
IL + P P PS S E ++L++ L DP +R
Sbjct: 212 ALKILKGQYP-PI-PSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 2e-62
Identities = 124/334 (37%), Positives = 181/334 (54%), Gaps = 43/334 (12%)
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKQVLKKLDMIRKNDIER 734
K + +DF I+ + G+FGRV LA + D AIK+ +K +I++ ++
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKR-FEKSKIIKQKQVDH 77
Query: 735 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 794
+ +ER IL + +PF V + SF LYLV+E++ GG+ ++ LR+ DV Y
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
A++VL EYL SL IV+RDLKP+NLL+ DG IK+TDFG +K+
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----------------- 180
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
D R ++ GTP+Y+APEILL HG AADWW++GI ++E + G PP
Sbjct: 181 ------------VDTRT-YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
Query: 915 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAH 972
F A P +I+ IL I + P + + L+ + L HD +R G GA VK H
Sbjct: 228 FYANEPLLIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284
Query: 973 PFFKGVNWDSLALQKAVFVP-QP--ESVDDTSYF 1003
P+F ++W SL L K V VP +P ++V D+S F
Sbjct: 285 PWFGNIDWVSL-LHKNVEVPYKPKYKNVFDSSNF 317
|
Length = 340 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-62
Identities = 129/329 (39%), Positives = 186/329 (56%), Gaps = 38/329 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
R +D+E++K I RGAFG V L R ++T ++A+K +L K +MI+++D ER+I+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK-LLSKFEMIKRSDSAFFWEERDIM 97
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALD 156
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+HS+G +HRD+KPDN+L+ GH+KL DFG +G++ D
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-----------KMNKEGMVRCD---- 201
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAE 918
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+
Sbjct: 202 -----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
Query: 919 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
S + I+N K + +P +D+S EA++LI FL D RLG NG E+K H FFK
Sbjct: 251 SLVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 308
Query: 977 GVN--WDSLALQKAVFVPQPESVDDTSYF 1003
W++L A VP S DTS F
Sbjct: 309 NDQWAWETLRDTVAPVVPDLSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 215 bits (548), Expect = 2e-62
Identities = 128/341 (37%), Positives = 186/341 (54%), Gaps = 37/341 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVR 752
K + +G FG+V L +++ TG +A+K +LKK ++ K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVH 811
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGAT 152
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +
Sbjct: 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 212
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRL--GANGAAEVKAHPFFKGVNWDSLALQKAV 989
I + P +S EA+ L++ L DP QRL G + A E+ H FF G+ W + +K V
Sbjct: 213 IRF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLV 269
Query: 990 --FVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYSDADT 1027
F PQ S DT YF F+ Q+ + P DQ+ S D
Sbjct: 270 PPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDN 310
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 4e-62
Identities = 120/321 (37%), Positives = 181/321 (56%), Gaps = 35/321 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI-TVRNPFVV 751
K I +G+FG+V LAR + +A+K VL+K +++K + + I++ERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
+SF D LY V++Y+NGG+L+ L++ C E AR Y AE+ AL YLHSL IV+
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLKP+N+L+ GHI LTDFGL K + I N
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK---------------ENIEH------------NGT 152
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + + ++DNILN+
Sbjct: 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK- 211
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKAV- 989
P P +++ A+ L+ L D +RLGA + E+K H FF +NWD L +K
Sbjct: 212 -PLQLKP-NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITP 269
Query: 990 -FVPQPESVDDTSYFLSRFSQ 1009
F P +D +F F++
Sbjct: 270 PFNPNVSGPNDLRHFDPEFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 2e-61
Identities = 96/291 (32%), Positives = 147/291 (50%), Gaps = 42/291 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
FEI++ I +G FG V+ AR + TG AIK + + K E+I+ E IL ++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIK----VIKLESKEKKEKIINEIQILKKCKH 56
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 806
P +V+++ S+ +D L++VME+ +GG L LL+ L E EL+ LEYLHS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
GI+HRD+K N+L+ DG +KL DFGLS Q
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------QL 148
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFD 925
+D + R++ VGTP ++APE++ G + Y AD WS+GI E G PP++ P + +F
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF- 207
Query: 926 NILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
P + + S E +D + + L +P +R A ++ HPF
Sbjct: 208 --KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 4e-61
Identities = 122/346 (35%), Positives = 186/346 (53%), Gaps = 44/346 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI-TVRNPFVV 751
K I +G+FG+V LA+++ G +A+K + KK+ + RK + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ-KHIMAERNVLLKNVKHPFLV 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
YSF + LY V++++NGG+L+ L++ E AR Y AE+ AL YLHS+ IV+
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLKP+N+L+ GH+ LTDFGL K +GI SD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK---------------EGIAQSD------------T 152
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTP+YLAPE++ + DWW +G +L+E + G+PPF ++DNIL++
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQK--A 988
+ + S A ++ L D +RLGA E++ HPFF+ ++W L +K
Sbjct: 213 L---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
Query: 989 VFVPQPESVDDTSYFLSRFSQ--------ISSGLPDDQNGSYSDAD 1026
F P E DD S F + F++ SS N S +AD
Sbjct: 270 PFNPNVEGPDDISNFDAVFTEETVPYSVCFSSD-YSIVNASVLEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 5e-61
Identities = 125/325 (38%), Positives = 183/325 (56%), Gaps = 38/325 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+D++++K I RGAFG V L R +++ ++A+K +L K +MI+++D ER+I+
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMK-LLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P+VV+ F +F LY+VMEY+ GGDL +L+ + E A+ Y AE+VLAL+ +HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
+G++HRD+KPDN+L+ GH+KL DFG M D +
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTC-------------------MKMD-------E 194
Query: 867 TDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
T +AVGTPDY++PE+L +G DWWSVG+ LFE + G PF A+S
Sbjct: 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254
Query: 923 IFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG--V 978
+ I++ K P D +S A++LI FL D RLG NG E+K HPFFK
Sbjct: 255 TYSKIMDHKNSL-NFPEDVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQW 312
Query: 979 NWDSLALQKAVFVPQPESVDDTSYF 1003
NWD++ A VP+ S D+S F
Sbjct: 313 NWDNIRETAAPVVPELSSDIDSSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 5e-61
Identities = 119/352 (33%), Positives = 192/352 (54%), Gaps = 49/352 (13%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITVRNPFVV 751
K + +G+FG+V LA + G+ FA+K LKK ++ +D+E + E+ +L + NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVK-ALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
+ +F +++L+ VME+LNGGDL ++ G + A Y AE+V L++LHS GI++
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLK DN+++ DGHIK+ DFG+ K + DNR
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFG--------------------------DNRA 153
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ GTPDY+APEIL G ++ ++ DWWS G++L+E + G PF + + +F++I +
Sbjct: 154 S-TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---R 209
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--AV 989
+ P P ++ E++D++ + DP +RLG G ++ HPFFK +NW +L ++
Sbjct: 210 VDTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINWTALEKRELDPP 267
Query: 990 FVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDEC 1041
F P+ +S D S F F L + SYSD + DS MD+
Sbjct: 268 FKPKVKSPSDYSNFDREF------LSEKPRLSYSDKNLIDS-------MDQS 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 2e-60
Identities = 118/340 (34%), Positives = 188/340 (55%), Gaps = 49/340 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF 753
I RG++ +V L + T ++A+K V+KK + DI+ + E+++ T N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMK-VIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 813
F L+ V+E+++GGDL +++ L E+ AR Y AE+ LAL +LH GI++RD
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873
LK DN+L+ +GHIKLTD+G+ K +GI P D
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCK---------------EGIRPGDT------------TS 154
Query: 874 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESPE-----IIF 924
+ GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF +++P+ +F
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWD 981
IL ++I +P +S +A ++ FL DP +RLG + G ++K+HPFF+ ++WD
Sbjct: 215 QVILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271
Query: 982 SLALQKAV---FVPQPESVDDTSYFLSRFSQISSGL-PDD 1017
L QK V + P ES D F +F+ L PDD
Sbjct: 272 LLE-QKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDD 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-58
Identities = 88/155 (56%), Positives = 120/155 (77%), Gaps = 1/155 (0%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
SI++F I+KPISRGAFG+V+L RK+ L+A+K V+KK DMI KN + ++ AER+ L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALAL 60
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
++PF+V +YS +N+YLVMEYL GGD+ SLL G +E++A YI+E+ LAL+YL
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839
H GI+HRDLKPDN+LI+++GHIKLTDFGLSK+ L
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 4e-58
Identities = 98/306 (32%), Positives = 153/306 (50%), Gaps = 38/306 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI-LAERNILITVRNPFVVRF 753
+ +G FG V + + TG ++A K++ KK ++K E++ L E+ IL V + F+V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKK--RLKKRKGEQMALNEKKILEKVSSRFIVSL 58
Query: 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVH 811
Y+F +D+L LVM +NGGDL + VG E A Y A+++ LE+LH IV+
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RDLKP+N+L+ G+++++D GL+ ++
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLA-----------------------VELKGGKKI---- 151
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
GTP Y+APE+L G + ++ DW+++G L+E I G PF ++ + + R
Sbjct: 152 -KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT 210
Query: 932 IPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQKA 988
+ P S EA+DL L DP +RLG G A EV+ HP FK +NW L
Sbjct: 211 LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGML 270
Query: 989 V--FVP 992
F+P
Sbjct: 271 EPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 7e-57
Identities = 111/336 (33%), Positives = 183/336 (54%), Gaps = 36/336 (10%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITVR 746
DF + + +G+FG+V LA ++ T +L+AIK +LKK +I+ +D+E + E+ +L ++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
GI++RDLK DN+++ +GHIK+ DFG+ K + DG+
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-----------DGV------------ 156
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PF E + +F +
Sbjct: 157 ----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLA 984
I+ + + P MS EA + + P +RLG G ++K H FF+ ++W+ L
Sbjct: 213 IMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 269
Query: 985 LQKAVFVPQPESVD-DTSYFLSRFSQISSGL-PDDQ 1018
++ +P++ D F F++ L P DQ
Sbjct: 270 RKEVQPPYKPKACGRDAENFDKFFTRHPPVLTPPDQ 305
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 2e-56
Identities = 92/282 (32%), Positives = 132/282 (46%), Gaps = 70/282 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ G FG V+LAR + TG AIK + K+ ++ R E IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR---EIEILKKLNHPNIVKLY 57
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRD 813
F ++LYLVMEY GG L LL++ G L ED + +++ LEYLHS GI+HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 814 LKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 872
LKP+N+L+ D G +KL DFGLSK+ +D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL---------------------------TSDKSLL 150
Query: 873 HSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
+ VGTP Y+APE+LLG + +D WS+G+IL+E
Sbjct: 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE------------------------ 186
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
+ E +DLI + L DP +R A E+ H
Sbjct: 187 ---------LP-ELKDLIRKMLQKDPEKRPSAK---EILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 2e-56
Identities = 120/342 (35%), Positives = 191/342 (55%), Gaps = 51/342 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRF 753
I RG++ +V L R + ++A+K V K+L + DI+ + E+++ NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-VHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 813
F L+LV+EY+NGGDL +++ L E+ AR Y AE+ +AL +LH GI++RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873
LK DN+L+ DGHIKLTD+G+ K +G+ P D
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK---------------EGLGPGD------------TTS 154
Query: 874 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF--TAESPEI-----IFDN 926
+ GTP+Y+APEIL G E+G++ DWW++G+++FE + G PF ++P++ +F
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSL 983
IL + I +P +S +A ++ FL DP +RLG G +++K+H FF+ ++WD L
Sbjct: 215 ILEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271
Query: 984 ALQKAVFVP-QPESVDDTSYFLSRF-SQISSG----LPDDQN 1019
+K V P +P+ DD Y L F +Q +S PDD++
Sbjct: 272 E-KKQVTPPFKPQITDD--YGLENFDTQFTSEPVQLTPDDED 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 1e-55
Identities = 116/341 (34%), Positives = 187/341 (54%), Gaps = 47/341 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF 753
I RG++ +V L R + T ++A+K V K+L + DI+ + E+++ N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 813
F L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873
LK DN+L+ +GHIKLTD+G+ K +G+ P D
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK---------------EGLRPGDT------------TS 154
Query: 874 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESP-----EIIF 924
+ GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF ++++P + +F
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 214
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWD 981
IL ++I +P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD
Sbjct: 215 QVILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271
Query: 982 SLALQKAV--FVPQPESVDDTSYFLSRFSQISSGL-PDDQN 1019
+ ++ V F P F ++F+ L PDD +
Sbjct: 272 LMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 3e-55
Identities = 102/300 (34%), Positives = 169/300 (56%), Gaps = 34/300 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITVR 746
DF + + +G+FG+V LA ++ T +L+AIK +LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LH
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
GI++RDLK DN+++ +GHIK+ DFG+ K ++ DG+
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-----------DGV------------ 156
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +
Sbjct: 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLA 984
I+ + + P +S EA + + P++RLG G +++ H FF+ ++WD L
Sbjct: 213 IMEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 3e-52
Identities = 96/297 (32%), Positives = 149/297 (50%), Gaps = 42/297 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-MIRKNDIERILAERNILITV 745
D E +K + +G+ G V+ R + TG ++A+K++ D RK ++L E L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK----QLLRELKTLRSC 56
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+P+VV+ + +F + +V+EY++GG L LL+KVG + E V +++ L+YLH
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 806 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+ I+HRD+KP NLLI G +K+ DFG+SK+ + NT+D
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD------------------- 155
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII 923
++ VGT Y++PE + G + YAAD WS+G+ L E G PF P
Sbjct: 156 ------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209
Query: 924 --FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
I + P P + S E +D I+ L DP +R AAE+ HPF K
Sbjct: 210 ELMQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 2e-51
Identities = 97/285 (34%), Positives = 146/285 (51%), Gaps = 34/285 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I G FG+V+ A TG+L A+K++ ++ I+ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
R+ +Y+ MEY +GG L LL L+E V R+Y +L+ L YLHS GIVHRD+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
KP N+ + H+G IKL DFG + + + E Q S
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVK----------------LKNNTTTMGEEVQ-------S 162
Query: 875 AVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESPE--IIFDNILN 929
GTP Y+APE++ G + HG AAD WS+G ++ E TG P++ E I+F
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG 222
Query: 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
K P P +S E +D ++R L DP +R A+E+ HPF
Sbjct: 223 HKPPIP-DSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-51
Identities = 94/290 (32%), Positives = 148/290 (51%), Gaps = 38/290 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
++ ++ I GA G V+ A R TG AIK++ +RK + E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHS 806
+V ++ S+ D L++VMEY++GG L ++ V E +A + E++ LEYLHS
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHS 134
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
++HRD+K DN+L++ DG +KL DFG + L+
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ--------LT------------------- 167
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
+ R+S VGTP ++APE++ ++G D WS+GI+ E G PP+ E P
Sbjct: 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL 227
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
I + IP P S E +D +N+ L+ DP +R A E+ HPF K
Sbjct: 228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 83/288 (28%), Positives = 146/288 (50%), Gaps = 34/288 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
++++ I RGAFG V+ TGD AIKQ+ L+ I++ ++ I+ E ++L +++
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQI--SLEKIKEEALKSIMQEIDLLKNLKH 58
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
P +V++ S D+LY+++EY G L +++K G E + +Y+ +++ L YLH
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
G++HRD+K N+L DG +KL DFG++
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKL---------------------------ND 151
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
+++ S VGTP ++APE++ + A+D WS+G + E +TG PP+ +P I
Sbjct: 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ P +P +S E +D + + DPN R A ++ HP+
Sbjct: 212 VQD--DHPPLPEGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 5e-50
Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 34/282 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITVRNPFVVRF 753
+ G+FG V+ GD FA+K+V L + ++++ E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 813
+ DNLY+ +E + GG L LL+K G E V R+Y +++L LEYLH VHRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873
+K N+L+ +G +KL DFG++K Q +
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK----------------------------QVVEFSFAK 159
Query: 874 SAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932
S G+P ++APE++ +G AAD WS+G + E TG PP++ I K
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
P +P +S EA+D I + L DP+ R AAE+ HPF
Sbjct: 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-49
Identities = 102/314 (32%), Positives = 155/314 (49%), Gaps = 38/314 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI-LAERNILITVRN 747
F + + +G FG V + R TG ++A K++ KK I+K E + L E+ IL V +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKK--RIKKRKGEAMALNEKQILEKVNS 59
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 805
FVV Y++ +D L LV+ +NGGDL + +G +E+ A Y AE+ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLA-----------------------VEIPEGE 156
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
R VGT Y+APE++ + ++ DWW +G +++E I G PF ++ +
Sbjct: 157 TIRGR-----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211
Query: 926 NILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDS 982
+ R S+ S A+ + + L DP RLG GA EVKAHPFF+ N+
Sbjct: 212 EVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271
Query: 983 L--ALQKAVFVPQP 994
L + + F P P
Sbjct: 272 LEAGMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-48
Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 37/291 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITV 745
+ F +++ I +G+FG V+ A + T + AIK + L++ + ++IE I E L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
R+P++ +++ SF L+++MEY GG LL K G L+E + E++L LEYLH
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
G +HRD+K N+L++ +G +KL DFG+S G + +T+
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMS-------------------- 153
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
R++ VGTP ++APE++ + + AD WS+GI E G PP + P +
Sbjct: 154 -----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
I P + S +D ++ L DP +R A E+ H F K
Sbjct: 209 LIPKNNPP-SLEGNKFSKPFKDFVSLCLNKDPKERPSAK---ELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 2e-48
Identities = 107/314 (34%), Positives = 158/314 (50%), Gaps = 38/314 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
F + + +G FG V + R TG ++A K++ KK RK + L E+ IL V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGE-SMALNEKQILEKVNSQ 60
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHS 806
FVV Y++ +D L LV+ +NGGDL + +G EE+ A Y AE++ LE LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
V+RDLKP+N+L+ GHI+++D GL+ KI PE + I
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKI-----------PEGESI----------- 158
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
R R VGT Y+APE+L + + D+W +G +++E I G PF ++ +
Sbjct: 159 ----RGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211
Query: 926 NILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDS 982
+ R + V + S EA+ + L DP QRLG GA EVK HPFF+ +N+
Sbjct: 212 EVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271
Query: 983 L--ALQKAVFVPQP 994
L + FVP P
Sbjct: 272 LEAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 173 bits (438), Expect = 5e-47
Identities = 117/404 (28%), Positives = 181/404 (44%), Gaps = 46/404 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR- 746
+ I++ + G+FG V+LAR R A+K + KKL + ++ER L E IL ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKL-ESKSKEVERFLREIQILASLNH 56
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEY 803
P +V+ + F +LYLVMEY++GG L LL+K G L E A +A+++ ALEY
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 804 LHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
LHS GI+HRD+KP+N+L+ DG +KL DFGL+K+ P
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL---------------------LPDP 155
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPFTAES 919
+ ++VGTP Y+APE+LLG Y ++D WS+GI L+E +TG+PPF E
Sbjct: 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 920 ----PEIIFDNILNRKIPWPCVPSDMSF------EAQDLINRFLIHDPNQRLGANGA--A 967
IL P P S A DL+ + L DP RL ++
Sbjct: 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
Query: 968 EVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT 1027
++ AH K + L + +S + ++ D + + +
Sbjct: 276 DLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKE 335
Query: 1028 CDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1071
+ S + L + SL S ++ S +
Sbjct: 336 LAPNGVSSSP-HNSSSLLLSTASSKRSSLPKISARSSPSSLSSS 378
|
Length = 384 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 4e-46
Identities = 101/303 (33%), Positives = 157/303 (51%), Gaps = 44/303 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI----ERILAERNILITVRNPFV 750
I RG FG V+ RK TG ++A+K + KK +++ + ERI+ +++ T PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML--SLVSTGDCPFI 59
Query: 751 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIV 810
V Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
+RDLKP N+L+ GH++++D GL+ D S +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KK 150
Query: 871 NRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF---TAESPEIIFDN 926
H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF + I
Sbjct: 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 984
L + P S E + L+ L D N+RLG GA EVK HPFF+ ++W +
Sbjct: 211 TLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVF 267
Query: 985 LQK 987
LQK
Sbjct: 268 LQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 5e-46
Identities = 105/314 (33%), Positives = 155/314 (49%), Gaps = 38/314 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
F + + +G FG V + R TG ++A K++ KK RK + L E+ IL V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-SMALNEKQILEKVNSR 60
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHS 806
FVV Y++ +D L LV+ +NGGDL + +G EE A Y AE+ LE LH
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
IV+RDLKP+N+L+ GHI+++D GL+ H PE Q
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLA-----------------------VHVPEGQT 157
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
R VGT Y+APE++ + ++ DWW++G +L+E I G PF +I +
Sbjct: 158 IKGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212
Query: 927 I--LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDS 982
+ L +++ S +A+ L L DP +RLG G A EVK HP FK +N+
Sbjct: 213 VERLVKEVQEE-YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271
Query: 983 LA--LQKAVFVPQP 994
L + + F P P
Sbjct: 272 LEAGMLEPPFKPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 97/321 (30%), Positives = 139/321 (43%), Gaps = 69/321 (21%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVL--KKLDMIRKNDIERILAERNILITV 745
++I+ I GA G VF A+ R TG+ A+K+V + I + I A L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA----LQAC 56
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 804
++P+VV+ F LVMEY+ DL +LR L E + Y+ L+ + Y+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
H+ GI+HRDLKP NLLI+ DG +K+ DFGL++ + +
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLAR-----------------LFSEEEPRLYS 158
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES---- 919
Q V T Y APE+L G D W+VG I E + G P F E+
Sbjct: 159 HQ---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ 209
Query: 920 ----------------PE---------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLI 954
P I F ++ IP + D S EA DL+ L+
Sbjct: 210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPE--SKPIPLEEIFPDASPEALDLLKGLLV 267
Query: 955 HDPNQRLGANGAAEVKAHPFF 975
+DP++RL AAE HP+F
Sbjct: 268 YDPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 99/320 (30%), Positives = 148/320 (46%), Gaps = 71/320 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAERNILIT 744
+E ++ + G +G V+ AR + TG++ A+K++ +LD N+ E I L E ++L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLD----NEEEGIPSTALREISLLKE 54
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEY 803
+++P +V+ LYLV EY + DL L K G L ++ + + +L+ L Y
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
HS I+HRDLKP N+LI DG +KL DFGL++ I P + E
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI---------------PLRTYTHE 158
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 922
V T Y APEILLG++H A D WSVG I E ITG P F +S EI
Sbjct: 159 ------------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-EI 205
Query: 923 -----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFLIH 955
IF + +P + E DL+++ L +
Sbjct: 206 DQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQY 265
Query: 956 DPNQRLGANGAAEVKAHPFF 975
+P +R+ A A + HP+F
Sbjct: 266 NPAKRISAKEALK---HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 92/307 (29%), Positives = 154/307 (50%), Gaps = 37/307 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ +G FG V + R TG L+A K++ KK RK E + E+ IL V + F+V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG-YEGAMVEKRILAKVHSRFIVSLA 59
Query: 755 YSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIV 810
Y+F + +L LVM +NGGDL Y++ + E A Y A+++ LE+LH I+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
+RDLKP+N+L+ +DG+++++D GL+ E + ++
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAV--------------------------ELKDGQSK 153
Query: 871 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 930
+ A GTP ++APE+L G E+ ++ D++++G+ L+E I PF A ++ + R
Sbjct: 154 TKGYA-GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 212
Query: 931 KIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG-ANGA-AEVKAHPFFKGVNWDSL--AL 985
+ D S ++ L DP +RLG +G ++ HP F+ +NW L +
Sbjct: 213 ILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGM 272
Query: 986 QKAVFVP 992
FVP
Sbjct: 273 LPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-45
Identities = 88/300 (29%), Positives = 142/300 (47%), Gaps = 44/300 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN-DIERILAERNILITV 745
DD+E+I+ I GA V+ A + AIK ++D+ + ++ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIK----RIDLEKCQTSVDELRKEVQAMSQC 56
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALE 802
+P VV+++ SF D L+LVM YL+GG L +++ G L+E + + E++ LE
Sbjct: 57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLHS G +HRD+K N+L+ DG +K+ DFG+S A
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS-----------------------ASLA 153
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP 920
+ + R + VGTP ++APE+ + HGY AD WS GI E TG P++ P
Sbjct: 154 DGGDRTRKVRKTFVGTPCWMAPEV-MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEA-----QDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ L P + + ++ + +I+ L DP++R A E+ H FF
Sbjct: 213 MKVLMLTLQN--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKR---PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 7e-44
Identities = 104/305 (34%), Positives = 162/305 (53%), Gaps = 48/305 (15%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI----ERILAERNILITVRNPFV 750
I RG FG V+ RK TG ++A+K + KK +++ + ERI+ +++ T PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML--SLVSTGDCPFI 59
Query: 751 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIV 810
V Y+F D L +++ +NGGDL+ L + G E R Y E++L LE++H+ +V
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
+RDLKP N+L+ GH++++D GL+ D S +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KK 150
Query: 871 NRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF----TAESPEIIFD 925
H++VGT Y+APE+L GT + +ADW+S+G +LF+ + G PF T + EI D
Sbjct: 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--D 208
Query: 926 NI-LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDS 982
+ L + +P S E + L+ L D ++RLG GA EVK H FFKG++W
Sbjct: 209 RMTLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265
Query: 983 LALQK 987
+ LQK
Sbjct: 266 VYLQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 84/293 (28%), Positives = 139/293 (47%), Gaps = 43/293 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ F+I++ + G++G V+ A + TG + AIK V + D++ I+ E +IL
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCD 56
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAELVLALEY 803
+P++V+++ S+ +L++VMEY G D+ + K L E+ + + + LEY
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEY 114
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS +HRD+K N+L+ +G KL DFG+S
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ-------------------------- 148
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EI 922
R++ +GTP ++APE++ + AD WS+GI E G PP++ P
Sbjct: 149 -LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA 207
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
IF I N+ P P S E D + + L+ DP +R A ++ HPF
Sbjct: 208 IF-MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER---PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 100/313 (31%), Positives = 151/313 (48%), Gaps = 36/313 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
F + + +G FG V + R TG ++A K++ KK RK + L E+ IL V +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-AMALNEKRILEKVNSR 60
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHS 806
FVV Y++ +D L LV+ +NGGDL + +G +E A Y AEL LE L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA-----------------------VQIPEGET 157
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
R VGT Y+APE++ ++ ++ DWW +G +++E I G PF + +
Sbjct: 158 VRGR-----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212
Query: 927 ILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSL 983
+ R K S +A+ + L +P +RLG NGAA VK HP FK +N+ L
Sbjct: 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272
Query: 984 A--LQKAVFVPQP 994
+ + F P P
Sbjct: 273 EANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 85/289 (29%), Positives = 142/289 (49%), Gaps = 52/289 (17%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER--ILAERNILITV 745
D+E+++ I +G+FG V R+++ G + K+ +D + E+ +++E NIL +
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKE----IDYGNMTEKEKQQLVSEVNILREL 56
Query: 746 RNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVL 799
++P +VR++ R N LY+VMEY GGDL L++K +EE+ + +L+L
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 800 ALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
AL H+ ++HRDLKP N+ + + ++KL DFGL+KI
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI----------------- 159
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
D+ + VGTP Y++PE L + +D WS+G +++E PP
Sbjct: 160 ----------LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
Query: 915 FTAESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 960
FTA + L KI + +P S E ++I L DP++R
Sbjct: 210 FTARNQL-----QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-42
Identities = 70/131 (53%), Positives = 89/131 (67%), Gaps = 3/131 (2%)
Query: 876 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 935
+GTPDYLAPE+LLG HG A DWW++G+ LFEF+TGIPPF E+P+ +F NILNR IPWP
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 936 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 995
+S AQ+ I L DP +R G E+K HP F GV+W++L Q F+PQP+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLK---ELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 996 SVDDTSYFLSR 1006
DTSYF +R
Sbjct: 658 DETDTSYFEAR 668
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 98/300 (32%), Positives = 138/300 (46%), Gaps = 52/300 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+D+E+I+ I G +G V+ AR TG+L AIK + KL+ +D E I E ++L R
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI--KLE--PGDDFEIIQQEISMLKECR 58
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIA----ELVL 799
+P +V +F S+ RD L++VMEY GG D+Y + R G L E IA E +
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLK 112
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
L YLH G +HRD+K N+L+ DG +KL DFG+S + TI
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATI--------------- 155
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFT 916
R S +GTP ++APE + + GY D W++GI E PP
Sbjct: 156 ----------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205
Query: 917 AESPEIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
P I P P + S D I + L DP +R A ++ HPF
Sbjct: 206 DLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR---PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 89/295 (30%), Positives = 144/295 (48%), Gaps = 40/295 (13%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
R+ +D+F I G+ G V +A ++TG A+K K+D+ ++ E + E I+
Sbjct: 18 RSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVK----KMDLRKQQRRELLFNEVVIM 70
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-AL 801
++P +V + S+ D L++VME+L GG L ++ EE +A + VL AL
Sbjct: 71 RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKAL 128
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
+LH+ G++HRD+K D++L+ DG +KL+DFG + +P
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA-------------QVSKEVP----- 170
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 ---------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL 221
Query: 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
I + P +S + ++R L+ DP QR AAE+ HPF
Sbjct: 222 QAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 97/303 (32%), Positives = 151/303 (49%), Gaps = 49/303 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-MIRKNDIERILAERNILITV 745
DD E + + G G V R TG + A+K + +++ I+K +IL E +IL
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK----QILRELDILHKC 56
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDV-ARIYIAELVLALEY 803
+P++V F+ +F ++ + MEY++GG L +L++V G + E + +I +A ++ L Y
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTY 115
Query: 804 LHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
LH I+HRD+KP N+L+ G IKL DFG+S L+N+
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLAK----------------- 157
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--SP 920
+ VGT Y+APE + G ++ +D WS+G+ L E TG P+ E P
Sbjct: 158 -----------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206
Query: 921 EIIFD---NILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ IF+ I+N P P +PS S + QD +N LI DP +R E+ HPF K
Sbjct: 207 DGIFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK---ELLEHPFIK 261
Query: 977 GVN 979
Sbjct: 262 KYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-41
Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 46/293 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI--LAERNILITV 745
DF+++K + +G++G V+ ++ + +A LK++D+ + ER + E IL +V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYA----LKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-----EEDVARIYIAELVLA 800
+P ++ + +F + L +VMEY GDL + K E+++ RI+I +L+
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRG 115
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L+ LH I+HRDLK N+L+ + +K+ D G+SK+
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV----------------------- 152
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ +GTP Y+APE+ G + Y +D WS+G +L+E T PPF A S
Sbjct: 153 ------LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
+ + + K +P +P S + Q+ I L P R + ++ A P
Sbjct: 207 QDLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCD---KILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 8e-41
Identities = 89/285 (31%), Positives = 140/285 (49%), Gaps = 31/285 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITVRNPFVV 751
K + +GAFGRV+L TG A+KQV K ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
+++ + L + MEY+ GG + L+ G L E V R Y +++ +EYLHS IVH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RD+K N+L G++KL DFG SK TI SG T +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASK---RLQTICSSG------------------TGMK- 165
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNR 930
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF +
Sbjct: 166 --SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IAT 221
Query: 931 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ P +PS +S +A++ + R + + +R A E+ H F
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 102/326 (31%), Positives = 148/326 (45%), Gaps = 78/326 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI--TVR 746
+E I I G +G+V+ AR + TG+L A LKK+ M + + I A R I + +R
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA----LKKIRMENEKEGFPITAIREIKLLQKLR 56
Query: 747 NPFVVRFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEY 803
+P +VR T + ++Y+V EY++ DL LL E + Y+ +L+ L+Y
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS GI+HRD+K N+LI +DG +KL DFGL++ Y +
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-----------------------PYTK 152
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-- 920
D NR V T Y PE+LLG T +G D WSVG IL E G P F +
Sbjct: 153 RNSADYTNR---VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE 209
Query: 921 --EIIFD-----NILNRKIPWPCVPSDMSF------------------------EAQDLI 949
E IF+ N WP V S + + A DL+
Sbjct: 210 QLEKIFELCGSPTDEN----WPGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLL 264
Query: 950 NRFLIHDPNQRLGANGAAEVKAHPFF 975
++ L DP +R+ A+ A + H +F
Sbjct: 265 DKLLTLDPKKRISADQALQ---HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 90/318 (28%), Positives = 148/318 (46%), Gaps = 66/318 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI--LITVR 746
++ + I G +G V+ AR + TG++ AIK++ + +++ A R I L +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR----FESEGIPKTALREIKLLKELN 56
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLH 805
+P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +L+ L + H
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S GI+HRDLKP+NLLI +G +KL DFGL++ Y Y
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARS----------------FGSPVRPYTHY- 158
Query: 866 QTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES----- 919
V T Y APE+LLG + D WSVG I E ++ P F +S
Sbjct: 159 ----------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208
Query: 920 ---------------PEII---FDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDP 957
P+ + + +P P + + S +A DL+++ L +DP
Sbjct: 209 FKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDP 268
Query: 958 NQRLGANGAAEVKAHPFF 975
++R+ A A AHP+F
Sbjct: 269 HKRITAEQAL---AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 1e-39
Identities = 88/326 (26%), Positives = 145/326 (44%), Gaps = 68/326 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE--RILAERNILITVR 746
+E++KPI GA+G V A + TG AIK K+ + + I+ RIL E +L +R
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK----KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 747 NPFVVR---FFY--SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 801
+ ++ S +++Y+V E + DL+ +++ L +D + ++ +++ L
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
+YLHS ++HRDLKP N+L+ + +K+ DFGL++ + + G +
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD-------EDEKGFLT----- 164
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 920
EY V T Y APE+LL + A D WSVG I E +T P F
Sbjct: 165 -EY-----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212
Query: 921 ----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRF 952
+I + I + K P + S EA DL+ +
Sbjct: 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKM 272
Query: 953 LIHDPNQRLGANGAAEVKAHPFFKGV 978
L+ DP +R+ A E AHP+ +
Sbjct: 273 LVFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 88/306 (28%), Positives = 151/306 (49%), Gaps = 39/306 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI-LAERNILITVRNPFVVRF 753
+ +G FG V + + TG ++A K++ KK ++K E++ L E+ IL V +PF+V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKK--RLKKKSGEKMALLEKEILEKVNSPFIVNL 58
Query: 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVH 811
Y+F + +L LVM +NGGDL + VG ++ R+ Y A++ + +LHS+ IV+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RD+KP+N+L+ G+ +L+D GL+ + + R
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLA-----------------------VELKDGKTITQR- 154
Query: 872 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
GT Y+APEIL + Y DW+++G ++E + G PF ++ + + R
Sbjct: 155 ----AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT 210
Query: 932 IPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAA-EVKAHPFFKGVNWDSLALQKA 988
+ +F E++D+ FL P RLG+ + + H FFK +N+ L +A
Sbjct: 211 LEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL---EA 267
Query: 989 VFVPQP 994
+P P
Sbjct: 268 GLIPPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 96/321 (29%), Positives = 143/321 (44%), Gaps = 72/321 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI--LITV- 745
+++IK + G FG V+LAR + TG+L AIK++ KK E + R + L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF-----YSWEECMNLREVKSLRKLN 55
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEY 803
+P +V+ F D LY V EY+ G +LY L+ RK E V R I +++ L +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
+H G HRDLKP+NLL++ +K+ DFGL++ E P Y +
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------------EIRSRPP----YTD 157
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF--TAESP 920
Y V T Y APEILL T + D W++G I+ E T P F ++E
Sbjct: 158 Y-----------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
Query: 921 EI--IFD-----------------NILNRKIPWPCVPSDMSF-------EAQDLINRFLI 954
++ I + L + P P+ + EA DLI L
Sbjct: 207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFP-QFAPTSLHQLIPNASPEAIDLIKDMLR 265
Query: 955 HDPNQRLGANGAAEVKAHPFF 975
DP +R A++ HP+F
Sbjct: 266 WDPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 83/277 (29%), Positives = 141/277 (50%), Gaps = 37/277 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITVR 746
DFEI+ I +G+FG VF ++ ++A+KQ+ L K++ + + + E +L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEA---IDEARVLAKLD 57
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEY 803
+ +++R++ SF + L +VMEY GDL+ LL R E+ V R +I +++L L +
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAH 116
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS I+HRD+K NL + ++K+ D G++K+ L +NT
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTN------------------- 156
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+ T VGTP YL+PE+ + +D W++G++L+E TG PF A + +
Sbjct: 157 FANT-------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209
Query: 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
I+ +P V S + LI++ L D QR
Sbjct: 210 ILKIIRGV--FPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 72/234 (30%), Positives = 112/234 (47%), Gaps = 33/234 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI--ERILAERNILITVR 746
+E++ + GA+G V R + TG++ AIK K ++ + L E +L +R
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLR 58
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+ +V +F + LYLV EY+ L L G L D R YI +L+ A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
I+HRD+KP+N+L++ G +KL DFG ++ L + +Y
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRA-------RPASPLTDY-- 161
Query: 867 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919
V T Y APE+L+G T +G D W++G I+ E + G P F +S
Sbjct: 162 ---------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 86/296 (29%), Positives = 142/296 (47%), Gaps = 40/296 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
D +EII + GAFG+V+ A+ + TG A K + + + ++E + E +IL
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAA----AKIIQIESEEELEDFMVEIDILSEC 59
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYL 804
++P +V + ++ + L++++E+ +GG L S++ ++ L E R +++ AL +L
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
HS ++HRDLK N+L+ DG +KL DFG+S
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK------------------------- 154
Query: 865 QQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES 919
T + R + +GTP ++APE++ + Y AD WS+GI L E PP +
Sbjct: 155 -STLQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212
Query: 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
P + IL + P PS S D + L+ DP+ R AAE+ HPF
Sbjct: 213 PMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 90/282 (31%), Positives = 137/282 (48%), Gaps = 35/282 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I +GA G V+ A TG AIKQ +++ ++ E I+ E ++ ++P +V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQ----MNLQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDI 141
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
K DN+L+ DG +KLTDFG I P + R +
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRST 174
Query: 875 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
P +S +D +NR L D +R A E+ HPF K
Sbjct: 235 LQNPEKLSAIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 99/320 (30%), Positives = 140/320 (43%), Gaps = 67/320 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAERNILIT 744
+E K + G + V+ AR + TG + AIK++ KL RK + I L E +L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI--KLGE-RKEAKDGINFTALREIKLLQE 58
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEY 803
+++P ++ F + N+ LV E++ DL +++ K L + Y+ + LEY
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS I+HRDLKP+NLLIA DG +KL DFGL++ S
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----------------SFGS------ 154
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP-- 920
NR V T Y APE+L G H G D WSVG I E + +P +S
Sbjct: 155 ----PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210
Query: 921 --EIIFDNILNRKIP--WPCVPSDMSF--------------------EAQDLINRFLIHD 956
IF L WP V S + +A DL+ R L +
Sbjct: 211 QLGKIF-EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLN 269
Query: 957 PNQRLGANGAAEVKAHPFFK 976
PN+R+ A A E HP+F
Sbjct: 270 PNKRITARQALE---HPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 92/327 (28%), Positives = 137/327 (41%), Gaps = 80/327 (24%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-------MIRKNDIERILAERNI 741
+E + I GA+G V+ AR TG A+K+V L +R+ + + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE- 59
Query: 742 LITVRNPFVVRFF-YSFTCRDN----LYLVMEYLNGGDLYSLLRKV---GCLEEDVARIY 793
+P +VR R + L LV E+++ DL + L K G L + +
Sbjct: 60 -----HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPETIKDL 112
Query: 794 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+ +L+ +++LHS IVHRDLKP N+L+ DG +K+ DFGL++I
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---------------- 156
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913
Y + S V T Y APE+LL + + D WSVG I E P
Sbjct: 157 -------Y-----SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP 204
Query: 914 PFTAESPEI-----IFDNI---------LNRKIPWPCVPS-----------DMSFEAQDL 948
F S E IFD I N +P PS ++ E DL
Sbjct: 205 LFRGTS-EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDL 263
Query: 949 INRFLIHDPNQRLGANGAAEVKAHPFF 975
+ + L +P++R+ A E HP+F
Sbjct: 264 LKKMLTFNPHKRI---SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 95/298 (31%), Positives = 151/298 (50%), Gaps = 48/298 (16%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
RT +D+F IK I G+ G V +A +++G L A+K K+D+ ++ E + E I+
Sbjct: 19 RTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK----KMDLRKQQRRELLFNEVVIM 71
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
++ VV + S+ D L++VME+L GG L ++ EE +A + +A L AL
Sbjct: 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK-ALS 130
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
LH+ G++HRD+K D++L+ HDG +KL+DFG ++ +
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEV------------------ 170
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-- 920
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 -------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223
Query: 921 --EIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
++I DN+ + K PS F ++R L+ DP QR A E+ HPF
Sbjct: 224 AMKMIRDNLPPKLKNLHKVSPSLKGF-----LDRLLVRDPAQRATAA---ELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 92/304 (30%), Positives = 136/304 (44%), Gaps = 51/304 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
FE+++ I G +G+V+ AR + TG L AIK ++ I +++ E I E NIL
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMD----IIEDEEEEIKEEYNILRKYS 60
Query: 747 N-PFVVRFFYSF------TCRDNLYLVMEYLNGG---DLYSLLRKVG-CLEEDVARIYIA 795
N P + F+ +F D L+LVME GG DL LRK G L+E+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
E + L YLH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA------------------- 161
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFIT 910
+ T R R++ +GTP ++APE++ E + +D WS+GI E
Sbjct: 162 -------QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213
Query: 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970
G PP P I P P + S + D I+ LI + QR E+
Sbjct: 214 GKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR---PFMEELL 270
Query: 971 AHPF 974
HPF
Sbjct: 271 EHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 93/282 (32%), Positives = 138/282 (48%), Gaps = 35/282 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I +GA G VF A TG AIKQ+ ++ ++ E I+ E ++ ++NP +V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI----NLQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
SF D L++VMEYL GG L ++ + C++E E + ALE+LH+ ++HRD+
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDI 141
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
K DN+L+ DG +KLTDFG I P + R +
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRST 174
Query: 875 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
P +S +D +NR L D +R A E+ HPF K
Sbjct: 235 LQNPEKLSPIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 2e-34
Identities = 90/282 (31%), Positives = 138/282 (48%), Gaps = 35/282 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I +GA G V+ A TG AIKQ +++ ++ E I+ E ++ +NP +V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQ----MNLQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
S+ D L++VMEYL GG L ++ + C++E E + AL++LHS ++HRD+
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDI 141
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
K DN+L+ DG +KLTDFG I P + R +
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRST 174
Query: 875 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
P +S +D +NR L D ++R A E+ HPF K
Sbjct: 235 LQNPERLSAVFRDFLNRCLEMDVDRR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 86/289 (29%), Positives = 146/289 (50%), Gaps = 39/289 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVL-----KKLDMIRKNDIERILAERNILITVRNPF 749
I G+FG V+L ++G+L A+KQV +++ ++ + E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 809
+V++ S D+L + +EY+ GG + +LL G EE + R ++ +++ L YLH+ GI
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
+HRD+K N+L+ + G IK++DFG+SK N+ N
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLS---------------------TKTN 166
Query: 870 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF-TAESPEIIF---D 925
R S G+ ++APE++ T + AD WS+G ++ E +TG PF + IF +
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
N P +PS++S EA D + + D N+R AAE+ HPF
Sbjct: 227 NAS------PEIPSNISSEAIDFLEKTFEIDHNKR---PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 79/281 (28%), Positives = 139/281 (49%), Gaps = 38/281 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN---PFVV 751
I RGA+G V+ + TG + A+K + LD +D+ I E +L +R P +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKII--NLDT-PDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
+++ S+ L+++MEY GG + +L+ K G + E + I E+++AL+Y+H +G++H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVGVIH 124
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 871
RD+K N+L+ + G++KL DFG++ Q ++
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVAA--------------------------LLNQNSSK- 157
Query: 872 RHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 930
R + VGTP ++APE++ G + AD WS+GI ++E TG PP++ I
Sbjct: 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS 217
Query: 931 KIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVK 970
K P + + S ++ + L +P +RL A + K
Sbjct: 218 KPPR--LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 99/324 (30%), Positives = 157/324 (48%), Gaps = 69/324 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR-KNDIERILAERNILITVRN 747
+EI++ + +GA+G V+ A R T ++ A+K++ D R D +R E L + +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF---DAFRNATDAQRTFREIMFLQELGD 65
Query: 748 -PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEY 803
P +V+ ++ +YLV EY+ DL++++R LE DV + YI +L+ AL+Y
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA-NILE-DVHKRYIMYQLLKALKY 122
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID-LSGPETDGIMPSDAHYP 862
+HS ++HRDLKP N+L+ D +KL DFGL++ ++ L + ++
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR------SLSELEENPENPVLT------ 170
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG--------- 911
+Y V T Y APEILLG+ Y D WSVG IL E + G
Sbjct: 171 DY-----------VATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTST 218
Query: 912 ----------IPPFTAE------SP--EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRF 952
I P +AE SP + D++ +R P + S +A DL+ +
Sbjct: 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKL 278
Query: 953 LIHDPNQRLGANGAAEVKAHPFFK 976
L+ +PN+RL A A E HP+
Sbjct: 279 LVFNPNKRLTAEEALE---HPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 96/301 (31%), Positives = 149/301 (49%), Gaps = 45/301 (14%)
Query: 689 FEIIKP--ISRGAFGRVFLARKRTTGDLFAIKQV------LKKLDMIRKNDIERILAERN 740
F+ +K I +G +GRV+LA TTG++ A+KQV + D +K+ ++ + +E
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
L + + +V++ T + L + +EY+ GG + S LR G EE + R + +++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L YLHS GI+HRDLK DNLL+ DG K++DFG+SK SD
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-------------------KSDDI 161
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF-TA 917
Y DN S G+ ++APE++ GY+A D WS+G ++ E G P+
Sbjct: 162 Y------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
Query: 918 ESPEIIFDNILNRKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
E+ +F L K P +P D +S A D +N +P+ R A E+ HP
Sbjct: 216 EAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR---ELLQHP 270
Query: 974 F 974
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 91/297 (30%), Positives = 145/297 (48%), Gaps = 40/297 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+EII + GAFG+V+ A+ + TG L A K + K + ++E + E IL T +P
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHP 69
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSL 807
++V+ +F L++++E+ GG + +++ ++ L E ++ +++ AL+YLHS+
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
I+HRDLK N+L+ DG IKL DFG+S N L
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTL--------------------- 164
Query: 868 DNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
+ R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P
Sbjct: 165 --QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979
+ I + P PS S E +D + L P R AA++ HPF V
Sbjct: 223 VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR---PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 86/290 (29%), Positives = 141/290 (48%), Gaps = 40/290 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA--ERNILITVR 746
+ I+ + +GAFG L R+ L K+V ++ R ++ ER A E IL ++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEV----NLTRLSEKERRDALNEIVILSLLQ 57
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYL 804
+P ++ ++ F + L + MEY NGG LY + +K EE++ Y+ ++V A+ Y+
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
H GI+HRD+K N+ + G IKL DFG+SKI + S+ E
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-----------------LGSEYSMAE- 159
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
+ VGTP Y++PE+ G ++ + +D W++G +L+E +T F A +P +
Sbjct: 160 ---------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV 210
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
I+ + V S S E L++ L DP +R A EV P
Sbjct: 211 VKIVQGN--YTPVVSVYSSELISLVHSLLQQDPEKR---PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 90/282 (31%), Positives = 136/282 (48%), Gaps = 35/282 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I +GA G V+ A TG AI+Q +++ ++ E I+ E ++ +NP +V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQ----MNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 814
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 815 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874
K DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRST 175
Query: 875 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934
VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P I P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235
Query: 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
P +S +D +NR L D +R A E+ H F K
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKR---GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 88/295 (29%), Positives = 149/295 (50%), Gaps = 42/295 (14%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
R+ ++++ IK I G+ G V +AR++ +G A+K +D+ ++ E + E I+
Sbjct: 20 RSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKM----MDLRKQQRRELLFNEVVIM 72
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-AL 801
++ VV + S+ + L+++ME+L GG L ++ + EE +A + E VL AL
Sbjct: 73 RDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV--CESVLQAL 130
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAH 860
YLHS G++HRD+K D++L+ DG +KL+DFG ++I
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI----------------------- 167
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
D R S VGTP ++APE++ T +G D WS+GI++ E + G PP+ ++SP
Sbjct: 168 -----SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ + P +S +D + R L +P +R A E+ HPF
Sbjct: 223 VQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 75/279 (26%), Positives = 142/279 (50%), Gaps = 35/279 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITVRN 747
+ +K I G+FG+ L + + G + IK++ + K+ + + + E +L +++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKH 58
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 805
P +V++ SF NLY+VM+Y GGDLY + ++ ED + ++ LAL+++H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
I+HRD+K N+ + DG IKL DFG++++ +N+T++L+
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA------------------ 158
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
+ +GTP YL+PEI + +D W++G +L+E T F A + + +
Sbjct: 159 -------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 964
I+ +P V S S++ ++L+++ +P R N
Sbjct: 212 KIIRGS--YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVN 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 85/290 (29%), Positives = 136/290 (46%), Gaps = 37/290 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND--IERILAERNILITVRNPFVVR 752
+ GAF + AR TG L A+KQV + + + +E + E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 753 FFYSFTCRDNLY-LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
TC D+ + L +E++ GG + LL K G +E V Y +L+ L YLH I+H
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 812 RDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
RD+K NLLI G +++ DFG + + +G E G +
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAG-EFQGQL--------------- 168
Query: 871 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDN 926
+GT ++APE+L G ++G + D WSVG ++ E T PP+ AE +IF
Sbjct: 169 -----LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-K 222
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
I + P +P +S +D+ R L P R + E+ HP F+
Sbjct: 223 IASATTA-PSIPEHLSPGLRDVTLRCLELQPEDR---PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 80/283 (28%), Positives = 135/283 (47%), Gaps = 37/283 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
+ +F+I K I +G F V+ A G + A+K+V + +M+ + L E ++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQL 59
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLAL 801
+P V+++ SF + L +V+E + GDL +++ + E Y +L AL
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
E++HS I+HRD+KP N+ I G +KL D GL + S T
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAA-------- 163
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921
HS VGTP Y++PE + + + +D WS+G +L+E PF +
Sbjct: 164 -----------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
Query: 922 I--IFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRL 961
+ + I K +P +P+D S E +DL++R + DP +R
Sbjct: 213 LYSLCKKI--EKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 4e-32
Identities = 98/348 (28%), Positives = 148/348 (42%), Gaps = 114/348 (32%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI------LAE 738
S+D++E + I G +G V+ AR + TG++ A+K++ K + E+ L E
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL--------KMEKEKEGFPITSLRE 54
Query: 739 RNILITVRNPFVVRFFYSFTCR--------DNLYLVMEYLNGGDLYSLLR---------K 781
NIL+ +++P +V T + D +Y+VMEY+ DL SL+ +
Sbjct: 55 INILLKLQHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSE 107
Query: 782 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841
V CL + +L+ + +LH I+HRDLK NLL+ + G +K+ DFGL++
Sbjct: 108 VKCL--------MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR----- 154
Query: 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWS 900
EY + V T Y APE+LLG E+ A D WS
Sbjct: 155 ---------------------EYGSP-LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWS 192
Query: 901 VGIILFEFITGIPPFTAESP----EIIFD-----------------------------NI 927
VG I E +T P F +S IF N
Sbjct: 193 VGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQ 252
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
L +K P +S DL+NR L +DP +R+ A A + HP+F
Sbjct: 253 LRKKFP----ALSLSDNGFDLLNRLLTYDPAKRISAEDALK---HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 36/278 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI-RKNDIERILAERNILITVRN 747
E+ K + GAFG V+ + G+ K +K L + + E L E +I+ + +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIA-ELVLALEY 803
P +VR T + LY+V EY+ GGDL LRK G L++ + +A ++ +EY
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD---LLQMALQIAKGMEY 117
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
L S VHRDL N L+ + +K++DFGLS+ I D
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRD----------------IYEDD----Y 157
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 922
Y++ ++APE L + +D WS G++L+E T G P+ S E
Sbjct: 158 YRKRGG-----GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ + + + P P + E +L+ + +DP R
Sbjct: 213 VLELLEDGYRL-PR-PENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 83/324 (25%), Positives = 136/324 (41%), Gaps = 62/324 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
++ I+ I GA+G V A +G AIK++ D+ +R L E IL +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP--TLAKRTLRELKILRHFK 62
Query: 747 NPFVVRFFYSFTCRDNL----YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+ ++ Y+VM+ L DL+ ++ L E+ R ++ +L+ L+
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
Y+HS ++HRDLKP NLL+ D +++ DFG+++ GL ++ +
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPTEHKY-----------FMT 169
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFI------------ 909
EY V T Y APE+LL E+ A D WSVG I E +
Sbjct: 170 EY-----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218
Query: 910 ---------TGIPP------FTAESPEIIFDNILNRK-IPWPCVPSDMSFEAQDLINRFL 953
G P ++ N+ ++ +PW + S EA DL+++ L
Sbjct: 219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQML 278
Query: 954 IHDPNQRLGANGAAEVKAHPFFKG 977
DP +R+ A + HPF
Sbjct: 279 QFDPEERITVEQALQ---HPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 84/287 (29%), Positives = 138/287 (48%), Gaps = 46/287 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTG-DLFAIKQV------LKKLDMIRKNDIERILAERNI 741
+ +++ + GAFG V+ RK+ G +L A+K++ K R I I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 742 LI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNG---GDLYSLLRKVG--CLEEDVARIYIA 795
+ +R+P +VR++ +F D LY+VM+ + G G+ ++ L++ EE + I++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 796 ELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
++VLAL YLH IVHRDL P+N+++ D + +TDFGL+K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
Q+ S VGT Y PEI+ +G AD W+ G IL++ T PP
Sbjct: 163 ----------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 915 FTAESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 960
F + + + I+ + +P M S + D+I L D R
Sbjct: 213 FYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 84/280 (30%), Positives = 126/280 (45%), Gaps = 48/280 (17%)
Query: 698 GAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757
G +V L T F +K + K + R ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR---------ERLTIIPHCVPNMVCLHKYI 54
Query: 758 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817
D+++LV+++ GG L+S + K + E+ + + AE+V+AL+ LH GIV RDL P+
Sbjct: 55 VSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPN 114
Query: 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 877
N+L+ GHI+LT F E + +A +N
Sbjct: 115 NILLDDRGHIQLTYFS-------------RWSEVEDSCDGEA-------VENM------- 147
Query: 878 TPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCV 937
Y APE+ +E A DWWS+G ILFE +TG I LN +
Sbjct: 148 ---YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN-------I 197
Query: 938 PSDMSFEAQDLINRFLIHDPNQRLGANGAA--EVKAHPFF 975
P +S EA+ L+ + L +P +RLGA A ++K+HPFF
Sbjct: 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 90/294 (30%), Positives = 144/294 (48%), Gaps = 38/294 (12%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
R +D F IK I G+ G V +A ++ TG A+K K+D+ ++ E + E I+
Sbjct: 21 REYLDSF--IK-IGEGSTGIVCIATEKHTGKQVAVK----KMDLRKQQRRELLFNEVVIM 73
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+ VV + S+ D L++VME+L GG L ++ EE +A + ++ ++ AL
Sbjct: 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALS 132
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLH+ G++HRD+K D++L+ DG IKL+DFG + +P
Sbjct: 133 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA-------------QVSKEVP------ 173
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
R S VGTP ++APE++ +G D WS+GI++ E I G PP+ E P
Sbjct: 174 --------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
I + P +S + ++ L+ +P+QR A E+ HPF K
Sbjct: 226 AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 91/319 (28%), Positives = 146/319 (45%), Gaps = 68/319 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
++ ++ I G +G V+ AR + TG++ A+K++ +L+ + + E ++L + +P
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI--RLETEDEGVPSTAIREISLLKELNHP 58
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHS 806
+VR + LYLV E+L+ DL + L+ + + Y+ +L+ + Y HS
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
++HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAF--------------GV-------PVRTY 156
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEI-- 922
T H V T Y APEILLG+ Y D WS+G I E + P F +S EI
Sbjct: 157 T-----HEVV-TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDS-EIDQ 208
Query: 923 ---IFDNILN--RKIPWPCVPSDMSF---------------------EAQDLINRFLIHD 956
IF L + WP V S + + DL+++ L++D
Sbjct: 209 LFRIF-RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYD 267
Query: 957 PNQRLGANGAAEVKAHPFF 975
P +R+ A A + HP+F
Sbjct: 268 PAKRISAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 98/344 (28%), Positives = 152/344 (44%), Gaps = 79/344 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFE + + G G V R +G + A K L L+ I+ +I+ E +L
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARK--LIHLE-IKPAIRNQIIRELKVLHECN 57
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLH 805
+P++V F+ +F + + ME+++GG L +L+K G + E++ +I IA ++ L YL
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLR 116
Query: 806 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
I+HRD+KP N+L+ G IKL DFG+S LI++ +
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN------------------- 156
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPE 921
S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 157 ---------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207
Query: 922 IIF---------------------------------DNILNRKIPWPCVPSD-MSFEAQD 947
+F D I+N P P +PS S E QD
Sbjct: 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDEFQD 265
Query: 948 LINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFV 991
+++ L +P +R E+ HPF K + + A +V
Sbjct: 266 FVDKCLKKNPKERA---DLKELTKHPFIK--RAELEEVDFAGWV 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 73/280 (26%), Positives = 119/280 (42%), Gaps = 43/280 (15%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR-KNDIERILAERNILITVRNP 748
+ K + GAFG V+ + + G ++ +K L + IE L E I+ + +P
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------AL 801
VV+ T + LY+VMEY+ GGDL S LRK ++ +++L+ +
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIARGM 115
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL----------------------- 152
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920
+ R + ++APE L + +D WS G++L+E T G P+ S
Sbjct: 153 YDDDYYRKRGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 209
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
E + + + N P + E DL+ + DP R
Sbjct: 210 EEVLEYLKNGYRLPQ--PPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 88/322 (27%), Positives = 137/322 (42%), Gaps = 75/322 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-- 746
++I+ I G F V A+ R TG +AIK + K +E++ R I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-----SLEQVNNLREIQALRRLS 55
Query: 747 -NPFVVRF----FYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLA 800
+P ++R F T R L LV E ++ +LY L++ + L E + Y+ +L+ +
Sbjct: 56 PHPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L+++H GI HRD+KP+N+LI D +KL DFG + I P
Sbjct: 113 LDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCR------GIYSKPP----------- 154
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE- 918
Y EY + T Y APE LL +G D W+VG + FE ++ P F
Sbjct: 155 YTEY-----------ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203
Query: 919 ---------------SPEIIFD----NILNRKIP------WPCVPSDMSFEAQDLINRFL 953
E++ +N P + + S E DL+ + L
Sbjct: 204 ELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLL 263
Query: 954 IHDPNQRLGANGAAEVKAHPFF 975
+DP++R+ A A HP+F
Sbjct: 264 AYDPDERITAKQALR---HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 69/281 (24%), Positives = 110/281 (39%), Gaps = 44/281 (15%)
Query: 690 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
+ K + GAFG V+ A+K LK+ IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK-TLKEDASE--QQIEEFLREARIMRKL 58
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY-----IAELVLA 800
+P +V+ T + L +VMEY+ GGDL LRK E ++ + IA
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR---G 115
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL---------------------- 153
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919
+ + + ++APE L + +D WS G++L+E T G P+ S
Sbjct: 154 -YDDDYYKVKGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS 209
Query: 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ + + P + E L+ + DP R
Sbjct: 210 NAEVLEYLKKGYRLPK--PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 76/281 (27%), Positives = 116/281 (41%), Gaps = 43/281 (15%)
Query: 693 KPISRGAFGRVFLAR---KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749
K + GAFG V+ + K A+K LK+ + + + L E ++ + +P
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK-TLKEDAS--EEERKDFLKEARVMKKLGHPN 57
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---------A 800
VVR T + LYLV+EY+ GGDL LRK + + ++ L
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+EYL S VHRDL N L+ D +K++DFGLS+ ++ T G +P
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK---TGGKLP---- 170
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919
R ++APE L +D WS G++L+E T G P+ S
Sbjct: 171 --------IR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212
Query: 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
E + + + P P E +L+ DP R
Sbjct: 213 NEEVLEYLRKGYRL-PK-PEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 5e-30
Identities = 90/301 (29%), Positives = 134/301 (44%), Gaps = 61/301 (20%)
Query: 688 DFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
+ EI+K + G FG+V + + + T LF K + K N IE V
Sbjct: 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKII--KAKNF--NAIE---------PMV 61
Query: 746 R-----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
NP ++ +YS T L+M+Y+ GDL+ LL+K G L E + I +LV A
Sbjct: 62 HQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEA 121
Query: 801 LEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
L LH I+H D+K +N+L I L D+GL KI I T D
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IG---------TPSCY--D- 167
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919
GT DY +PE + G + + DWW+VG++ +E +TG PF +
Sbjct: 168 -----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 920 PEII-FDNILNR---KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
E + +++L R K+P ++S A D + L ++ N RL E+ HPF
Sbjct: 211 DEELDLESLLKRQQKKLP---FIKNVSKNANDFVQSMLKYNINYRL--TNYNEIIKHPFL 265
Query: 976 K 976
K
Sbjct: 266 K 266
|
Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 95/331 (28%), Positives = 139/331 (41%), Gaps = 80/331 (24%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI--LAERNIL 742
S+ +FE + I G +G V+ AR T+G++ A LKK+ M + D I L E +L
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA----LKKVRMDNERDGIPISSLREITLL 60
Query: 743 ITVRNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVL 799
+ +R+P +V + D+++LVMEY DL SLL + E + + +L+
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
L+YLH I+HRDLK NLL+ G +K+ DFGL++
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART---------------------Y 158
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918
P T V T Y APE+LLG T + A D W+VG IL E + P +
Sbjct: 159 GLPAKPMTPK------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212
Query: 919 SP----EIIFD-----------------------------NILNRKIPWPCVPSDMSFEA 945
S ++I N L K PW +S
Sbjct: 213 SEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPW------LSEAG 266
Query: 946 QDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
L+N L++DP +R A E +FK
Sbjct: 267 LRLLNFLLMYDPKKRA---TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 79/287 (27%), Positives = 139/287 (48%), Gaps = 37/287 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER----ILAERNILITVRNPFV 750
+ +GA+G V+ G L A+KQV +LD E+ + E ++L ++++ +
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQV--ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 751 VRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
V+ Y TC D+ + + ME++ GG + S+L + G L E V Y +++ + YLH+
Sbjct: 65 VQ--YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+VHRD+K +N+++ +G IKL DFG ++ + + L G ++ +
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG----LHGTHSNML------------- 165
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
S GTP ++APE++ + +G +D WS+G +FE TG PP + I
Sbjct: 166 -----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
+ P +P S A D + L D ++R A ++ H F
Sbjct: 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER---PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 85/302 (28%), Positives = 135/302 (44%), Gaps = 51/302 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-MIRKNDIERILAERNILITV 745
+D E I + G G V + TG + A K V +RK +IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK----QILRELQIMHEC 60
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
R+P++V F+ +F +N+ + ME+++ G L + +K G + ++ +V L YL+
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 806 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+ I+HRD+KP N+L+ G IKL DFG+S LIN+ D
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD------------------- 160
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA------- 917
+ VGT Y++PE + G ++ +D WS+GI + E G PF
Sbjct: 161 ---------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 918 -ESPEIIFD---NILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972
+ P I D I+ P P +PS D + +D ++ L+ DP +R
Sbjct: 212 QDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDPTER--PTPQQLCAMP 267
Query: 973 PF 974
PF
Sbjct: 268 PF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 83/234 (35%), Positives = 119/234 (50%), Gaps = 30/234 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI-ERILAERNILITV 745
+ FE++ + GA+G V R + T ++ AIK K D ++ E L E +L T+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIK---KFKDSEENEEVKETTLRELKMLRTL 57
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+ +V +F R LYLV EY+ L L + + R YI +L+ A+ + H
Sbjct: 58 KQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
IVHRD+KP+NLLI+H+ +KL DFG ++ +LS +G S+A+Y EY
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS----EG---SNANYTEY- 161
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919
V T Y +PE+LLG +G A D WSVG IL E G P F ES
Sbjct: 162 ----------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 92/329 (27%), Positives = 142/329 (43%), Gaps = 75/329 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV- 745
D +E ++ I G +G+V+ AR + TG L A+K+ L+M + L E ++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTR--LEMDEEGIPPTALREISLLQMLS 58
Query: 746 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLL----RKVGC-LEEDVARIYIA 795
+ ++VR + +LYLV EYL+ DL + R G L + ++
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+L+ + + H G++HRDLKP NLL+ G +K+ D GL + +I +
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----AFSIPVK------- 166
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIP 913
H V T Y APE+LLG+ H D WSVG I E P
Sbjct: 167 ---------------SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
Query: 914 PFTAESPEI-----IFDNI--LNRKIPWPCV-------------PSDMSF-------EAQ 946
F +S E+ IF + ++ WP V P D+S E
Sbjct: 211 LFPGDS-ELQQLLHIFKLLGTPTEQV-WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGL 268
Query: 947 DLINRFLIHDPNQRLGANGAAEVKAHPFF 975
DL+ + L +DP +R+ A A HP+F
Sbjct: 269 DLLQKMLRYDPAKRISAKAALT---HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 86/289 (29%), Positives = 139/289 (48%), Gaps = 42/289 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND-IERILAERNILITVRN 747
F ++ I +G+FG V+ T ++ AIK + D+ D IE I E +L +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKII----DLEEAEDEIEDIQQEITVLSQCDS 61
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
P++ R++ S+ L+++MEYL GG LL K G LEE + E++ L+YLHS
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSE 120
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+HRD+K N+L++ G +KL DFG++ Q T
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLT 152
Query: 868 DNR-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFD 925
D + R++ VGTP ++APE++ + + + AD WS+GI E G PP + P ++F
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF- 211
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
++ + P P + S ++ + L DP R A E+ H F
Sbjct: 212 -LIPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 81/289 (28%), Positives = 141/289 (48%), Gaps = 40/289 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+E I+ + RGAFG V L R++ L IKQ+ ++ + K++ E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI--PVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHS 806
++ ++ +F L +VMEY GG L ++K L+ED + +++LAL ++H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 807 LGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
I+HRDLK N+L+ H +K+ DFG+SKI LS S A
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LSS-------KSKA------ 158
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIF 924
++ VGTP Y++PE+ G + +D W++G +L+E + F A + P ++
Sbjct: 159 -------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
+ P + S + + LI L DP++R + ++ A P
Sbjct: 212 KIMSGTFAP---ISDRYSPDLRQLILSMLNLDPSKRPQLS---QIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 40/278 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRK--NDIERILAERNILITV 745
+EIIK I G+FG+++LA+ ++ + IK++ L K+ + K + E IL + +
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAK-----M 56
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCL-EEDVARIYIAELVLALEY 803
++P +V FF SF L++VMEY +GGDL + R+ G L ED + ++ L L++
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+H I+HRD+K N+ ++ +G + KL DFG+++ +N++++L+
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA--------------- 159
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
++ VGTP YL+PEI + D WS+G +L+E T PF +
Sbjct: 160 ----------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ I P P + S + + LI++ P R
Sbjct: 210 LVLKICQGYFA-PISP-NFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 94/329 (28%), Positives = 145/329 (44%), Gaps = 69/329 (20%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL 724
S S SS S+ S+ S+ + E + I GA G V+ R TG L+A+K +
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 725 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 784
+ + I R E IL V +P VV+ F + +++E+++GG L +
Sbjct: 112 EDTVRRQICR---EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIAD 166
Query: 785 LEE--DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
+ DVAR +++ + YLH IVHRD+KP NLLI ++K+ DFG+S+I +
Sbjct: 167 EQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQ 220
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAAD 897
T+D P + S+VGT Y++PE + G GYA D
Sbjct: 221 TMD----------PCN---------------SSVGTIAYMSPERINTDLNHGAYDGYAGD 255
Query: 898 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW------------PCVPSDMSFEA 945
WS+G+ + EF G PF + R+ W P P+ S E
Sbjct: 256 IWSLGVSILEFYLGRFPFG-----------VGRQGDWASLMCAICMSQPPEAPATASREF 304
Query: 946 QDLINRFLIHDPNQRLGANGAAEVKAHPF 974
+ I+ L +P +R A ++ HPF
Sbjct: 305 RHFISCCLQREPAKRWSAM---QLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 95/318 (29%), Positives = 149/318 (46%), Gaps = 66/318 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
F+ ++ I G +G V+ AR + TG++ A+K++ +LD + + E ++L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKELNHP 59
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+V+ + LYLV E+L+ DL + + + + + Y+ +L+ L + HS
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
++HRDLKP NLLI +G IKL DFGL++ G+ P
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------------------PVRT 156
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI-- 922
T H V T Y APEILLG + + A D WS+G I E +T F +S EI
Sbjct: 157 YT-----HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQ 209
Query: 923 ---IFDNI-LNRKIPWPCV--------------PSDMSF-------EAQDLINRFLIHDP 957
IF + ++ WP V D S + +DL+++ L +DP
Sbjct: 210 LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDP 269
Query: 958 NQRLGANGAAEVKAHPFF 975
N+R+ A A AHPFF
Sbjct: 270 NKRISAKAAL---AHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 86/294 (29%), Positives = 142/294 (48%), Gaps = 40/294 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ +EII + GAFG+V+ A+ + TG L A K + D + ++E + E +IL +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI----DTKSEEELEDYMVEIDILASCD 60
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLH 805
+P +V+ +F +NL++++E+ GG + +++ ++ L E R+ + + AL YLH
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
I+HRDLK N+L DG IKL DFG+S NT +
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTI------------------- 157
Query: 866 QTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 158 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
+ I + P PS S E +D + + L + + R ++ HPF
Sbjct: 214 MRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 50/303 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D+ E++ + +G +G V+ R TG A+K++ +LD + N +I+ E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN---QIIMELDILHKAV 57
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGD---LYSLLRKVGCLEEDVARIYIAELVLALEY 803
+P++V F+ +F +Y+ MEY++ G LY+ + EDV R +V L++
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 804 L-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
L I+HRD+KP N+L+ +G +KL DFG+S + S +T+
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN---------- 161
Query: 863 EYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYA-----ADWWSVGIILFEFITGIPPFT 916
+G Y+APE I G + +D WS+G+ + E G P+
Sbjct: 162 -------------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208
Query: 917 AESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
E+ IF + I P +PS S +AQD + + L PN+R A++ HP
Sbjct: 209 PETYANIFAQL--SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR---PTYAQLLEHP 263
Query: 974 FFK 976
+
Sbjct: 264 WLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 7e-28
Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 34/286 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN-DIERILAERNILITVRNPFVV 751
K + +GAFGRV+L TG A KQV + + ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 752 RFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 809
+++ R L + MEY+ GG + L+ G L E V R Y +++ + YLHS I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
VHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSG---TGI--------------- 166
Query: 870 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 928
S GTP +++PE++ G +G AD WS+G + E +T PP+ E+ IF +
Sbjct: 167 ---RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--I 221
Query: 929 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
+ P +PS +S A+D + + + R A E+ HPF
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFV-EARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 86/288 (29%), Positives = 135/288 (46%), Gaps = 40/288 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND-IERILAERNILITVRN 747
F ++ I +G+FG VF T + AIK + D+ D IE I E +L +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII----DLEEAEDEIEDIQQEITVLSQCDS 61
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
P+V +++ S+ L+++MEYL GG LLR G +E + E++ L+YLHS
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+HRD+K N+L++ G +KL DFG++ Q T
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLT 152
Query: 868 DNR-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
D + R++ VGTP ++APE++ + + AD WS+GI E G PP + P +
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL 212
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
I K P + + S ++ I+ L DP+ R A E+ H F
Sbjct: 213 I--PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 9e-28
Identities = 78/274 (28%), Positives = 135/274 (49%), Gaps = 38/274 (13%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAER--NILITVRNPF 749
++ + +G++G V L R RT G + V+KKL++ + ER AE+ +L +++P
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQY----VIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 750 VVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHS 806
+V + S+ D LY+VM + GGDLY L+ K L E+ + ++ +AL+YLH
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
I+HRDLK N+ + IK+ D G++++ + N D++
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAS------------------ 160
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
+ +GTP Y++PE+ + Y +D W++G ++E T F A+ +
Sbjct: 161 -------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR 213
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
I+ K+ P +P D S E +LI L P +R
Sbjct: 214 IIEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 40/281 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITVR 746
+ +++ + G+FGR L + + +A+K++ L K + +E E +L ++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMK 56
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYL 804
+P +V F SF +LY+VMEY +GGDL ++ + ED + ++ L ++++
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
H ++HRD+K N+ + +G +KL DFG +++ L+ P Y
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSP-----GAYACTY--- 160
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
VGTP Y+ PEI + +D WS+G IL+E T PF A S +
Sbjct: 161 -----------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----W 205
Query: 925 DNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963
N++ + + + +PS S+E + LI + +P R A
Sbjct: 206 KNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 93/336 (27%), Positives = 146/336 (43%), Gaps = 91/336 (27%)
Query: 689 FEI------IKPISRGAFGRVFLARKRTTGDLFAIKQV-------------LKKLDMIRK 729
FE+ IKPI RGA+G V A+ T + AIK++ L+++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 730 NDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 788
D E ++A ++I+ R F +++Y+V E L DL+ ++R L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 789 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848
+ ++ +L+ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------- 159
Query: 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 907
E M EY V T Y APE+LL +E+ A D WSVG I E
Sbjct: 160 -EKGDFM------TEY-----------VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 908 FITGIPPFTAE--------------SP-EIIFDNILN-------RKIP-WPCVP-----S 939
+ P F + SP E I N R +P P
Sbjct: 202 LLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP 261
Query: 940 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ A DL+ + L+ DP++R+ A HP+
Sbjct: 262 HANPLAIDLLEKMLVFDPSKRITVEEALA---HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 4e-27
Identities = 95/306 (31%), Positives = 137/306 (44%), Gaps = 52/306 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D +EII+ I +G +G+V+ + G L A+K LD I D E I AE NIL ++
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK----ILDPISDVD-EEIEAEYNILQSLP 76
Query: 747 N-PFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAE 796
N P VV+F+ F D L+LV+E NGG + L L L+E + +
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+L L++LH+ I+HRD+K +N+L+ +G +KL DFG+S
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA-------------------- 176
Query: 857 SDAHYPEYQQTDNR-NRHSAVGTPDYLAPEILLGTE---HGYAA--DWWSVGIILFEFIT 910
Q T R R+++VGTP ++APE++ + + Y A D WS+GI E
Sbjct: 177 --------QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970
G PP P I P P I++ LI D R E
Sbjct: 229 GDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE-- 286
Query: 971 AHPFFK 976
HPF K
Sbjct: 287 -HPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 73/232 (31%), Positives = 116/232 (50%), Gaps = 38/232 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD--MIRKNDIERILAERNI--L 742
+ +E + I G++G VF R R TG + AIK+ ++ D +I+K +A R I L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK------IALREIRML 54
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+++P +V F + L+LV EY + L L + + E + + I + + A+
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+ H +HRD+KP+N+LI G IKL DFG ++I L+GP D Y
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPGDD--------YT 158
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 913
+Y V T Y APE+L+G T++G D W++G + E +TG P
Sbjct: 159 DY-----------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 88/290 (30%), Positives = 133/290 (45%), Gaps = 49/290 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D +EII+ I +G +G+VF + G K +K LD I D E I AE NIL +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGS----KAAVKILDPIHDID-EEIEAEYNILKALS 72
Query: 747 N-PFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAE 796
+ P VV+F+ + +D L+LV+E NGG + L L++ +EE + + E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
++ L++LH +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-------------------- 172
Query: 857 SDAHYPEYQQTDNR-NRHSAVGTPDYLAPEIL-----LGTEHGYAADWWSVGIILFEFIT 910
Q T R R+++VGTP ++APE++ L + + D WS+GI E
Sbjct: 173 --------QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224
Query: 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
G PP P I P P S E D I + L D +R
Sbjct: 225 GDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 77/235 (32%), Positives = 112/235 (47%), Gaps = 34/235 (14%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
R +DFE+I+ I G +G V+ AR TG+L AIK + KL+ D + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI--KLE--PGEDFAVVQQEIIMM 60
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
++ +V +F S+ RD L++ ME+ GG L + G L E E + L
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLHS G +HRD+K N+L+ +GH+KL DFG+S I TI
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATI------------------ 160
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEI-LLGTEHGY--AADWWSVGIILFEFITGIPP 914
R S +GTP ++APE+ + + GY D W+VGI E PP
Sbjct: 161 -------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 81/266 (30%), Positives = 129/266 (48%), Gaps = 30/266 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN-DIERILAERNILITVRNPFVV 751
K + +GAFGRV+L TG A+KQV + + ++ + E +L + + +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 752 RFFYSF--TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 809
+++ L + ME++ GG + L+ G L E+V R Y +++ + YLHS I
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
VHRD+K N+L G++KL DFG SK TI LSG G+
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSG---TGMK-------------- 167
Query: 870 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 928
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF +
Sbjct: 168 ----SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK--I 221
Query: 929 NRKIPWPCVPSDMSFEAQDLINRFLI 954
+ P +P +S +D + R +
Sbjct: 222 ATQPTNPVLPPHVSDHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 89/310 (28%), Positives = 136/310 (43%), Gaps = 58/310 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL-DMIRKNDIERILAERNILITV 745
+ + + GA G V R + TG +FA+K + ++K +IL E I +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK----QILRELEINKSC 56
Query: 746 RNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------YIAEL 797
++P++V+++ +F ++ + MEY GG L S+ +KV ++ RI IAE
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV---KKRGGRIGEKVLGKIAES 113
Query: 798 VL-ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
VL L YLHS I+HRD+KP N+L+ G +KL DFG+S L+N S T
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVN-----SLAGT----- 162
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916
GT Y+APE + G + +D WS+G+ L E PF
Sbjct: 163 ------------------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 917 AESPEI-----IFDNILNRKIPW----PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967
E + I+N P P S E +D I + L DP +R
Sbjct: 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR---PTPW 261
Query: 968 EVKAHPFFKG 977
++ HP+ K
Sbjct: 262 DMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 87/288 (30%), Positives = 137/288 (47%), Gaps = 38/288 (13%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN-DIERILAERNILITVRNPFVV 751
K + RGAFG V+L TG A+KQV D + ++ + E +L +R+ +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 752 RFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
+++ RD L + +EY+ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 68 QYYGCL--RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
IVHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSG---TGI------------- 166
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDN 926
S GTP +++PE++ G +G AD WSV + E +T PP+ E+ IF
Sbjct: 167 -----KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK- 220
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
+ + P +P +S +D + + + + + A + HPF
Sbjct: 221 -IATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPT----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 84/289 (29%), Positives = 139/289 (48%), Gaps = 42/289 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND-IERILAERNILITVRN 747
F ++ I +G+FG VF T + AIK + D+ D IE I E +L +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----DLEEAEDEIEDIQQEITVLSQCDS 61
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
P+V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 120
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+HRD+K N+L++ G +KL DFG++ Q T
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAG----------------------------QLT 152
Query: 868 DNR-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFD 925
D + R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF- 211
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
++ + P P + + S ++ + L +P+ R A E+ H F
Sbjct: 212 -LIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 90/321 (28%), Positives = 139/321 (43%), Gaps = 79/321 (24%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-------MIRKNDIERILAERNILIT 744
++P+ GAFG V AR + TG AIK+++K R+ + + L NI I+
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-IS 73
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
+ + F+ + +++Y V E L G DL+ LL LE+ + ++ +++ L+Y+
Sbjct: 74 LSDIFI-------SPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
HS G+VHRDLKP N+LI + +K+ DFGL++I D Y
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI-------------------QDPQMTGY 165
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 920
V T Y APEI+L ++ D WS G I E + G P F +
Sbjct: 166 -----------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214
Query: 921 -EIIFD----------------NILN--------RKIPWPCVPSDMSFEAQDLINRFLIH 955
II D N L +P+ + A DL+ + L+
Sbjct: 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274
Query: 956 DPNQRLGANGAAEVKAHPFFK 976
DP +R+ AAE AHP+
Sbjct: 275 DPQKRI---SAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 90/337 (26%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI-- 743
+ +E + I +G FG VF AR + T + A+K+VL M + + I A R I I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL----MENEKEGFPITALREIKILQ 66
Query: 744 TVRNPFVVRFF---------YSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARI 792
+++ VV Y+ + + YLV E+ DL LL + V ++ ++
Sbjct: 67 LLKHENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL++ ++
Sbjct: 125 -MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS----------- 172
Query: 853 GIMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFIT 910
+ NR++ V T Y PE+LLG G D W G I+ E T
Sbjct: 173 -------------KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
Query: 911 GIPPFTAES----------------PEI--------IFDNI-----LNRKIP---WPCVP 938
P + PE+ +F + RK+ P V
Sbjct: 220 RSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK 279
Query: 939 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
A DLI++ L+ DP +R+ A+ A H FF
Sbjct: 280 DP---HALDLIDKLLVLDPAKRIDADTALN---HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 73/236 (30%), Positives = 121/236 (51%), Gaps = 38/236 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD--MIRKNDIERILAERNI--LIT 744
+E + + G++G V + + TG + AIK+ L+ D M++K +A R I L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK------IAMREIRMLKQ 56
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
+R+ +V F + LYLV E+++ L L + L+E R Y+ +++ +E+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P Y +Y
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAPGEV--------YTDY 160
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919
V T Y APE+L+G T++G A D W+VG ++ E +TG P F +S
Sbjct: 161 -----------VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 90/333 (27%), Positives = 150/333 (45%), Gaps = 83/333 (24%)
Query: 688 DFEIIKPISRGAFGRVF----------LARKRTTG---DLFAIKQVLKKLDMIRKNDIER 734
D E +PI GAFG V+ +A K+ +L + K+V ++L M+ +
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 735 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 794
+L+ +IL P + F + +Y+V E + DL+ ++ L D ++++
Sbjct: 61 VLSALDIL----QPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFL 109
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+++ L+YLHS GI+HRD+KP NLL+ + +K+ DFGL+++
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV----------------- 152
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIP 913
+ ++++ V T Y APEIL+G+ H A D WSVG I E +
Sbjct: 153 ---------EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
Query: 914 PFTAESP----EIIFD-------------------NILNRKIPWPCVP------SDMSFE 944
F A+SP ++I D +IL P +P S + E
Sbjct: 204 LFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHE 263
Query: 945 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
A L+ R L+ DP++R+ AA+ AHP+
Sbjct: 264 AVHLLCRMLVFDPDKRI---SAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 89/332 (26%), Positives = 135/332 (40%), Gaps = 65/332 (19%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
+ + D+EI+ + G FG V+ AR+ TG + A LKK+ M + D I A R I I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA----LKKILMHNEKDGFPITALREIKI 60
Query: 744 --TVRNPFVVRF---FYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARI 792
+++P VV R ++Y+V Y++ DL LL L E +
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKC 119
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE-T 851
Y+ +L+ + YLH I+HRD+K N+LI + G +K+ DFGL++ D P
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP------YDGPPPNPK 173
Query: 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 910
G Y + V T Y PE+LLG + A D W +G + E T
Sbjct: 174 GGGGGGTRKYT-----------NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
Query: 911 GIPPFTAESP----EIIFD-----------------NILNRKIPWPCVPS-DMSFEAQ-- 946
P +S +IF + + F
Sbjct: 223 RRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGP 282
Query: 947 ---DLINRFLIHDPNQRLGANGAAEVKAHPFF 975
DL+++ L DP +RL A+ A HP+F
Sbjct: 283 EGLDLLSKLLSLDPYKRLTASDA---LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 78/281 (27%), Positives = 131/281 (46%), Gaps = 39/281 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
+F I K I RG F V+ A G A+K+V + D++ + E ++L + +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEY 803
P V++++ SF + L +V+E + GDL +++ + E Y +L ALE+
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
+HS ++HRD+KP N+ I G +KL D GL +
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--------------------------- 154
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+ + HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214
Query: 924 FDNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 960
L +KI +P +PSD S E + L+N + DP +R
Sbjct: 215 ---SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 97/334 (29%), Positives = 145/334 (43%), Gaps = 77/334 (23%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD---------MIRKNDIE 733
+ +D F+II I G +G+V+ AR + TG+L A+K+V +LD IR+ I
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKIL 60
Query: 734 RILAERNIL----ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEED 788
R L RNI+ I + F + YLV EY++ DL LL + ED
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKD---KGAFYLVFEYMDH-DLMGLLESGLVHFSED 116
Query: 789 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848
+ ++ +L+ L Y H +HRD+K N+L+ + G IKL DFGL+++
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL----------- 165
Query: 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFE 907
Y ++R + V T Y PE+LLG E +G A D WS G IL E
Sbjct: 166 ---------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 210
Query: 908 FITGIPPFTAES--------------------PEII----FDNILNRKIPWPCVPSDMSF 943
T P F A P++I F+ + +K + + SF
Sbjct: 211 LFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF 270
Query: 944 ---EAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
A DL++ L DP++R A E P+
Sbjct: 271 IPTPALDLLDHMLTLDPSKRCTAE---EALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 39/277 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ +G +G V+ AR +T AIK++ ++ ++ + E + +++ +V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVH 811
S + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVH
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 812 RDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
RD+K DN+L+ + G +K++DFG SK GI P +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-------------RLAGINPCTETF--------- 169
Query: 871 NRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTA-ESPEIIFDNI 927
GT Y+APE++ GY AD WS+G + E TG PPF P+ +
Sbjct: 170 -----TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV 224
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 964
KI P +P +S EA++ I R DP++R A+
Sbjct: 225 GMFKIH-PEIPESLSAEAKNFILRCFEPDPDKRASAH 260
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 93/326 (28%), Positives = 146/326 (44%), Gaps = 79/326 (24%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR-KNDIERI----LAERNIL 742
D+ I+ I G +G V+ R + TG + A+K+ IR +++ E + + E ++L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKK-------IRLESEEEGVPSTAIREISLL 53
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVL 799
+++P +V LYL+ E+L+ DL L K ++ ++ + Y+ +++
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
+ + HS ++HRDLKP NLLI + G IKL DFGL++ GI P
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--------------AFGI-PVRV 157
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918
+ E V T Y APE+LLG + D WS+G I E T P F +
Sbjct: 158 YTHE------------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205
Query: 919 SPEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLI 949
S EI IF IL + WP V S ++ + DL+
Sbjct: 206 S-EIDQLFRIF-RILGTPTEDV-WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLL 262
Query: 950 NRFLIHDPNQRLGANGAAEVKAHPFF 975
+ LI+DP +R+ A A HP+F
Sbjct: 263 EKMLIYDPAKRISAKKALN---HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 71/230 (30%), Positives = 109/230 (47%), Gaps = 34/230 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
D+E+I+ + G +G V+ AR TG+L A+K + KL+ +D I E ++ ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKII--KLE--PGDDFSLIQQEIFMVKECKH 65
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
+V +F S+ R+ L++ MEY GG L + G L E E + L YLHS
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
G +HRD+K N+L+ +G +KL DFG++ I TI
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVA--AKITATI----------------------- 160
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPP 914
R S +GTP ++APE+ ++G D W+VGI E PP
Sbjct: 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 88/304 (28%), Positives = 144/304 (47%), Gaps = 53/304 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE--RILAERNI-LI 743
DD E+I+ + RGA+G V R TG + A+K++ + N E R+L + +I +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV-----NSQEQKRLLMDLDISMR 55
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVL 799
+V P+ V F+ + ++++ ME ++ L +KV + ED+ +V
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVK 114
Query: 800 ALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
ALEYLHS L ++HRD+KP N+LI +G +KL DFG+S
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---------------------- 152
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEIL--LGTEHGY--AADWWSVGIILFEFITGIPP 914
D+ + G Y+APE + + GY +D WS+GI + E TG P
Sbjct: 153 ------YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
Query: 915 FTAESPEIIFDNILN-RKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972
+ +S + F + + P P +P++ S E QD +N+ L + +R E+ H
Sbjct: 207 Y--DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP---ELLQH 261
Query: 973 PFFK 976
PFF+
Sbjct: 262 PFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 87/330 (26%), Positives = 149/330 (45%), Gaps = 82/330 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV------------LKKLDMIRKNDIER 734
++ + I GA+G V A + TG AIK++ L+++ ++R+ E
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 735 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 794
I+ +I+ F SF +++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIR-------PPSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+++ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++I + D +G T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT--- 167
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGI 912
EY V T Y APEI+L GY A D WSVG IL E ++
Sbjct: 168 --------EY-----------VATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
Query: 913 PPFTAE--------------SPEII-FDNILNRK-------------IPWPCVPSDMSFE 944
P F + +P + I++ + +PW + + +
Sbjct: 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPK 267
Query: 945 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
A DL+++ L +P++R+ E AHP+
Sbjct: 268 ALDLLDKMLTFNPHKRITVE---EALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 94/329 (28%), Positives = 142/329 (43%), Gaps = 80/329 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI--ERILAERNILIT 744
D ++ + P+ GA+G+V A TG AIK KL ++ I +R E +L
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQSAIHAKRTYRELRLLKH 70
Query: 745 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAEL 797
+ + V+ FT +L YLV L G DL ++++ + L +D + + ++
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQK--LSDDHIQFLVYQI 127
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ L+Y+HS GI+HRDLKP N+ + D +K+ DFGL++ TD M
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------------HTDDEM-- 172
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF 915
T V T Y APEI+L H Y D WSVG I+ E +TG F
Sbjct: 173 ---------TGY------VATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLF 216
Query: 916 TAESPEIIFDNILN----------RKIP----------WPCVP--------SDMSFEAQD 947
I+N +KI P +P S + A D
Sbjct: 217 PGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAID 276
Query: 948 LINRFLIHDPNQRLGANGAAEVKAHPFFK 976
L+ + L+ DP++R+ AAE AHP+
Sbjct: 277 LLEKMLVLDPDKRI---TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 93/337 (27%), Positives = 145/337 (43%), Gaps = 85/337 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFE I + G G VF + +G + A K + ++ +N I R E +L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECN 61
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLH 805
+P++V F+ +F + + ME+++GG L +L+K G + E + ++ IA ++ L YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLR 120
Query: 806 SL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---------------------------- 152
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPE 921
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 153 -QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211
Query: 922 IIF-----------------------------------------DNILNRKIPWPCVPSD 940
++F D I+N P P +PS
Sbjct: 212 LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE--PPPKLPSG 269
Query: 941 M-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ E QD +N+ LI +P +R ++ H F K
Sbjct: 270 VFGAEFQDFVNKCLIKNPAERADLK---QLMVHAFIK 303
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 36/228 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
D + + + G G V+ A T + A+K + LD I ++I++E IL +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP--LD-ITVELQKQIMSELEILYKCDS 58
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
P+++ F+ +F + + + E+++GG L + RK+ E + RI +A +V L YL SL
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIP--EHVLGRIAVA-VVKGLTYLWSL 114
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
I+HRD+KP N+L+ G +KL DFG+S Q
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST-----------------------------QL 145
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915
N + VGT Y+APE + G ++G +D WS+GI E G P+
Sbjct: 146 VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 93/329 (28%), Positives = 151/329 (45%), Gaps = 73/329 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
++I + I +G++G V A TG+ AIK++ + + +D RIL E +L +R+P
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV--SDATRILREIKLLRLLRHP 59
Query: 749 FVV---RFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 803
+V + R+ ++Y+V E L DL+ +++ L + + ++ +L+ AL+Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
+H+ + HRDLKP N+L D +K+ DFGL+++ N+T P+ + +
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDT------------PTAIFWTD 165
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE-- 918
Y V T Y APE L G +++ A D WS+G I E +TG P F +
Sbjct: 166 Y-----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213
Query: 919 --------------SPEII----------FDNILNRKIPWPCVPSDMSFEAQD-----LI 949
SPE I + + + +K P VP F D L+
Sbjct: 214 VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP---VPFSQKFPNADPLALRLL 270
Query: 950 NRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
R L DP R A E A P+FKG+
Sbjct: 271 ERLLAFDPKDR---PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 73/283 (25%), Positives = 135/283 (47%), Gaps = 39/283 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
+ +F+I K I RG F V+ A A+K+V + +M+ + + E ++L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKV-QIFEMMDAKARQDCVKEIDLLKQL 59
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLAL 801
+P V+++ SF + L +V+E + GDL ++ ++ + E Y +L A+
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
E++HS ++HRD+KP N+ I G +KL D GL +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR------------------------- 154
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921
+ + HS VGTP Y++PE + + + +D WS+G +L+E PF +
Sbjct: 155 --FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
Query: 922 IIFDNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 960
+ L +KI +P +P++ S + ++L++ + DP+QR
Sbjct: 213 LF---SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 83/311 (26%), Positives = 141/311 (45%), Gaps = 57/311 (18%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR---KNDIERILA 737
K ++D E + I G G+V+ R + TG + A+KQ M R K + +RIL
Sbjct: 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQ------MRRTGNKEENKRILM 62
Query: 738 ERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIA 795
+ ++++ + P++V+ + F ++++ ME L L LL+++ G + ED+
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTV 121
Query: 796 ELVLALEYL---HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
+V AL YL H G++HRD+KP N+L+ G++KL DFG+S
Sbjct: 122 AIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS----------------- 162
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEF 908
G + D++ + + G Y+APE + ++ AD WS+GI L E
Sbjct: 163 GRL-----------VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
Query: 909 ITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGANG 965
TG P+ E + IL P +P + F + ++ L D +R
Sbjct: 212 ATGQFPYKNCKTEFEVLTKILQE--EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR- 268
Query: 966 AAEVKAHPFFK 976
E+ HPF +
Sbjct: 269 --ELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 89/325 (27%), Positives = 140/325 (43%), Gaps = 71/325 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI--ERILAERNILITVR 746
+E+IK + +GA+G V AR T + +KK+ + I +R L E +L R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSE--EETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 747 N--------PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
+ F +F + LYL E L DL+ ++R L + + +I +++
Sbjct: 60 GHKNITCLYDMDIVFPGNF---NELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 799 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
L+Y+HS ++HRDLKP NLL+ D +K+ DFGL++ G N + +G
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAG---------- 164
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 917
EY V T Y APEI+L + A D WSVG IL E + P F
Sbjct: 165 -FMTEY-----------VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212
Query: 918 ES-----PEIIF------DNILNR-----------------KIPWPCVPSDMSFEAQDLI 949
+ +I+ + L+R K P+ + + + A DL+
Sbjct: 213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLL 272
Query: 950 NRFLIHDPNQRLGANGAAEVKAHPF 974
+ L DP +R+ A E HP+
Sbjct: 273 EKLLAFDPTKRISVEEALE---HPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 82/320 (25%), Positives = 136/320 (42%), Gaps = 70/320 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAERNILIT 744
+E ++ I G +G VF A+ R T ++ A+K+V +LD +D E + L E +L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV--RLD----DDDEGVPSSALREICLLKE 55
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEY 803
+++ +VR + L LV EY + DL G ++ ++ + ++ +L+ L +
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
HS ++HRDLKP NLLI +G +KL DFGL++ GI P + E
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLAR--------------AFGI-PVRCYSAE 159
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEF-------------- 908
V T Y P++L G + + D WS G I E
Sbjct: 160 ------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207
Query: 909 --------ITGIP-----PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 955
+ G P P ++ P+ + V ++ +DL+ L+
Sbjct: 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVC 267
Query: 956 DPNQRLGANGAAEVKAHPFF 975
+P QR+ A A + HP+F
Sbjct: 268 NPVQRISAEEALQ---HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 89/327 (27%), Positives = 136/327 (41%), Gaps = 84/327 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD--------MIRKNDIERILAERN 740
F+ ++ + G + V+ R RTTG++ A+K++ LD IR+ + + L N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI--HLDAEEGTPSTAIREISLMKELKHEN 59
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKV-GCLEEDVARIYIAEL 797
I VR + L LV EY++ DL Y V G L+ + + + +L
Sbjct: 60 I---------VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL 109
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMP 856
+ + + H ++HRDLKP NLLI G +KL DFGL++ G+ NT
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS----------- 158
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF 915
+ V T Y AP++LLG+ + + D WSVG I+ E ITG P F
Sbjct: 159 -----------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
Query: 916 TAESPE----IIFDNI----------------LNRKIPWPCVPSDMSF-------EAQDL 948
+ E IF + P P D+ DL
Sbjct: 202 PGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP-RYPPQDLQQLFPHADPLGIDL 260
Query: 949 INRFLIHDPNQRLGANGAAEVKAHPFF 975
++R L +P R+ A+ A HP+F
Sbjct: 261 LHRLLQLNPELRISAHDAL---QHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-22
Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 50/248 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV--- 745
FE+++ + G +G+V+ R TG L AIK + + +++ E I E N+L
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTEDEEEEIKLEINMLKKYSHH 72
Query: 746 RNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAEL 797
RN + ++ +F + D L+LVME+ G + L++ L+ED E+
Sbjct: 73 RN--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ L +LH+ ++HRD+K N+L+ + +KL DFG+S
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--------------------- 169
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGI 912
+ +T R R++ +GTP ++APE++ E + Y +D WS+GI E G
Sbjct: 170 -----QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223
Query: 913 PPFTAESP 920
PP P
Sbjct: 224 PPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 6e-22
Identities = 94/324 (29%), Positives = 146/324 (45%), Gaps = 69/324 (21%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
+D +E ++ I G +G V+ AR R T + A+K++ +L+ + + E ++L +
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI--RLEQEDEGVPSTAIREISLLKEM 58
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED--VARIYIAELVLALEY 803
++ +VR LYLV EYL+ DL + ++ + + Y+ +++ + Y
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 804 LHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
HS ++HRDLKP NLLI + +KL DFGL++ GI P
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--------------AFGI-PVRTFTH 162
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFTAESP 920
E V T Y APEILLG+ H Y+ D WSVG I E + P F +S
Sbjct: 163 E------------VVTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDS- 208
Query: 921 EI-----IFDNILN--RKIPWPCVPSDMSFEAQ---------------------DLINRF 952
EI IF IL + WP V S +++ DL+++
Sbjct: 209 EIDELFKIF-RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKM 267
Query: 953 LIHDPNQRLGANGAAEVKAHPFFK 976
L DP++R+ A A E H +FK
Sbjct: 268 LRLDPSKRITARAALE---HEYFK 288
|
Length = 294 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 45/235 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER---ILAERNILITV 745
F ++ I G+FG V+ AR T ++ AIK K+ K E+ I+ E L +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK----KMSYSGKQSNEKWQDIIKEVRFLQQL 72
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNG--GDLYSLLRKVGCLEEDVARIYIAELVLALEY 803
R+P + + + +LVMEY G D+ + +K E ++A I L L Y
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQ-GLAY 130
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS +HRD+K N+L+ G +KL DFG + + + P++
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASL----------------VSPAN----- 169
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 915
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 87/327 (26%), Positives = 138/327 (42%), Gaps = 76/327 (23%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE----RILAERNI 741
++ ++ + + G++ V+ R + TG L A+K+ IR E + E ++
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE-------IRLEHEEGAPFTAIREASL 56
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLA 800
L +++ +V + L LV EYL+ DL + G L R+++ +L+
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L Y H ++HRDLKP NLLI+ G +KL DFGL++ + PS +
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---------------PSKTY 160
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF---- 915
E V T Y P++LLG TE+ + D W VG I +E TG P F
Sbjct: 161 SNE------------VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208
Query: 916 -TAESPEIIFDNILNRKIP--WPCVPSDMSF------------------------EAQDL 948
+ IF +L WP V S+ F ++L
Sbjct: 209 DVEDQLHKIF-RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEEL 267
Query: 949 INRFLIHDPNQRLGANGAAEVKAHPFF 975
+FL ++P +R+ AAE HP+F
Sbjct: 268 ALKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-21
Identities = 73/243 (30%), Positives = 117/243 (48%), Gaps = 38/243 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFE I + G G V + + +G + A K + ++ +N I R E +L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECN 61
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLH 805
+P++V F+ +F + + ME+++GG L +L++ + E++ ++ IA ++ L YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLR 120
Query: 806 SL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG---------------------------- 152
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPE 921
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 153 -QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211
Query: 922 IIF 924
IF
Sbjct: 212 AIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 7e-21
Identities = 79/305 (25%), Positives = 137/305 (44%), Gaps = 60/305 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIK----------QVLKKLDMIRKNDIERILAE 738
FE+++ + G +G+V+ R TG L AIK ++ ++++M++K R +A
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAE 796
+NP + D L+LVME+ G + L++ K L+E+ E
Sbjct: 68 YYGAFIKKNPPGMD--------DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
++ L +LH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-------------------- 159
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITG 911
+ +T R R++ +GTP ++APE++ E + + +D WS+GI E G
Sbjct: 160 ------QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
Query: 912 IPPFTAESP-EIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEV 969
PP P +F L + P P + S S + Q I L+ + +QR ++
Sbjct: 213 APPLCDMHPMRALF---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR---PTTEQL 266
Query: 970 KAHPF 974
HPF
Sbjct: 267 MKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-21
Identities = 81/293 (27%), Positives = 142/293 (48%), Gaps = 41/293 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL---DMIRKNDIERILAERNILITV 745
++II+ I +G G V+LA A+K++ + L +++K R L E I +
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK----RFLREAKIAADL 59
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV---GCLEEDVA---------RIY 793
+P +V + + D +Y M Y+ G L SLL+ V L +++A I+
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 794 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG--LSKIGLINNTIDLSGPET 851
++ +EY+HS G++HRDLKPDN+L+ G + + D+G + K + +D+ E
Sbjct: 120 H-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911
I S P VGTPDY+APE LLG + D +++G+IL++ +T
Sbjct: 179 -NICYSSMTIP----------GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227
Query: 912 IPPFTAES-PEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 960
P+ + +I + +++ I P+ +P +S + + L DP +R
Sbjct: 228 SFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-20
Identities = 90/327 (27%), Positives = 140/327 (42%), Gaps = 76/327 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL--DMIRKNDIERILAERNILIT 744
D + +K + GA+G V A R TG AIK++ + ++ K R E +L
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK----RAYRELRLLKH 70
Query: 745 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
+++ V+ FT +L YLVM ++ G DL L+ K L ED + + +++
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLM-KHEKLSEDRIQFLVYQML 128
Query: 799 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
L+Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------------------- 166
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTA 917
QTD+ V T Y APE++L H D WSVG I+ E +TG P F
Sbjct: 167 -------QTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
Query: 918 E--------------SPEIIFDNILN--------------RKIPWPCVPSDMSFEAQDLI 949
+P F L RK + + + + A +++
Sbjct: 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278
Query: 950 NRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ L+ D R+ AAE AHP+F+
Sbjct: 279 EKMLVLDAESRI---TAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 54/295 (18%)
Query: 687 DDFEIIKPISRGAFGRVF--LARKRTTGDLF---AIKQVLKKLDMIRKNDIERILAERNI 741
+ +I+ + +G+FG V+ LA+ G+ AIK V + M + L E ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM---RERIEFLNEASV 62
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA----------R 791
+ VVR + +VME + GDL S LR E +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQK 120
Query: 792 IY--IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849
AE+ + YL + VHRDL N ++A D +K+ DFG+++ I T D
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYET-DYYRK 177
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909
G++P ++APE L +D WS G++L+E
Sbjct: 178 GGKGLLPV----------------------RWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
Query: 910 T-GIPPFTAESPEIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRL 961
T P+ S E + +++ P P + +L+ ++P R
Sbjct: 216 TLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKL----LELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-20
Identities = 69/216 (31%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+V+ F F D L L+MEY +GGDL L++ +E + ++VLAL+ +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S ++HRDLK N+ + G IKL DFG SK + ++D++
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS----------------- 229
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
S GTP YLAPE+ + AD WS+G+IL+E +T PF S I
Sbjct: 230 --------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ 281
Query: 926 NILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+L K P+PC S + L++ L +P R
Sbjct: 282 QVLYGKYDPFPCPVSS---GMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 86/321 (26%), Positives = 134/321 (41%), Gaps = 59/321 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERI---------LAERNILIT 744
+ G +G+V A TG + AIK+V + ++ D + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 803
+++ ++ + D + LVM+ + DL ++ RK+ E V I + +++ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI-LLQILNGLNV 134
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LH +HRDL P N+ I G K+ DFGL++ SD +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR-------------RYGYPPYSDTLSKD 181
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI 922
S V T Y APE+L+G E + +A D WSVG I E +TG P F E+ EI
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-EI 240
Query: 923 -----IFDNILNRKIP--WP---CVPSDMSF-----------------EAQDLINRFLIH 955
IF +L WP +P F +A DL+ L
Sbjct: 241 DQLGRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299
Query: 956 DPNQRLGANGAAEVKAHPFFK 976
+P +R+ A A + H +FK
Sbjct: 300 NPLERISAKEALK---HEYFK 317
|
Length = 335 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 43/276 (15%)
Query: 698 GAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757
GA G V A++ + G+ FA+K V ++ + + D R AE L+ +V+ F
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVV--DMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100
Query: 758 TCRDN--------LYLVMEYLNGGDLYSLLR---KVG-CLEEDVARIYIAELVLALEYLH 805
+D + LV++Y N GDL ++ K E A + +++LA+ ++H
Sbjct: 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH 160
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S ++HRD+K N+L+ +G +KL DFG SK + T+
Sbjct: 161 SKHMIHRDIKSANILLCSNGLVKLGDFGFSK--MYAATV--------------------- 197
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIF 924
+D+ R + GTP Y+APEI + AD +S+G++L+E +T PF E+ E++
Sbjct: 198 -SDDVGR-TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ R P +P +S E Q+++ L DP +R
Sbjct: 256 KTLAGRYDP---LPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 85/332 (25%), Positives = 140/332 (42%), Gaps = 84/332 (25%)
Query: 692 IKPISRGAFGRVFLA-----------RKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
++P+ G+ G VF A +K D ++K L+++ +IR+ D + I+
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 741 ILIT--VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
+L V +++Y+V EY+ DL ++L + G L E+ AR+++ +L+
Sbjct: 70 VLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLL 124
Query: 799 LALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
L+Y+HS ++HRDLKP N+ I D +K+ DFGL++I
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------------V 165
Query: 858 DAHYPEYQQTDNRNRHSA-----VGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 911
D HY H + T Y +P +LL + A D W+ G I E +TG
Sbjct: 166 DPHY----------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
Query: 912 IPPFTA----ESPEIIFDNI----------LNRKIPW--------PCVP-----SDMSFE 944
P F E ++I +++ L IP P P ++ E
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275
Query: 945 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
A D + + L +P RL A A HP+
Sbjct: 276 ALDFLEQILTFNPMDRLTAEEAL---MHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 82/305 (26%), Positives = 143/305 (46%), Gaps = 52/305 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+D + + I RGAFG V + +G + A+K++ +D + + +R+L + ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSS 60
Query: 747 N-PFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSL--LRKVGCLEEDV-ARIYIAELVLA 800
+ P++V+F+ + + ++ ME ++ Y + E++ +I +A V A
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-TVKA 119
Query: 801 LEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
L YL L I+HRD+KP N+L+ +G+IKL DFG+S G + ++I
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI--------------- 162
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFT 916
+T + G Y+APE I GY +D WS+GI L+E TG P+
Sbjct: 163 -----AKTRD------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
Query: 917 AESPEIIFDNILN-RKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971
+ +FD + K P + + S + IN LI D ++R E+
Sbjct: 212 KWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK---ELLE 266
Query: 972 HPFFK 976
HPF K
Sbjct: 267 HPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 1e-19
Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 64/265 (24%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
+ ++++E+IK I G FG VFL + + T + F K + + +++ + +++ E N++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR--GLKEREKSQLVIEVNVMR 67
Query: 744 TVRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAEL 797
+++ +VR+ F + N LY++ME+ + GDL ++K G +EE +L
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 798 VLALEYLHSLG-------IVHRDLKPDNLL----IAHDGHI-------------KLTDFG 833
+ AL Y H+L ++HRDLKP N+ I H G I K+ DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 834 LSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 892
LSK IG+ HS VGTP Y +PE+LL
Sbjct: 188 LSKNIGI-----------------------------ESMAHSCVGTPYYWSPELLLHETK 218
Query: 893 GY--AADWWSVGIILFEFITGIPPF 915
Y +D W++G I++E +G PF
Sbjct: 219 SYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 91/326 (27%), Positives = 135/326 (41%), Gaps = 78/326 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK-------LDMIRKNDIERILAERNI 741
+E + I GA+G V+ AR +G A+K V + L +R E L +R
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR----EVALLKR-- 55
Query: 742 LITVRNPFVVRFF----YSFTCRD-NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYI 794
L +P +VR S T R+ + LV E+++ DL + L KV L + + +
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+ + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++I +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT--------- 165
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
V T Y APE+LL + + D WSVG I E P
Sbjct: 166 -------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
Query: 915 FTAESPE----IIFDNI-LNRKIPWP--------------------CVPSDMSFEAQDLI 949
F S IFD I L + WP VP ++ L+
Sbjct: 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVP-EIEESGAQLL 265
Query: 950 NRFLIHDPNQRLGANGAAEVKAHPFF 975
L +P++R+ A A + HPFF
Sbjct: 266 LEMLTFNPHKRISAFRALQ---HPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 46/244 (18%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
IK + G FG+V L R TG+ A+K + + ++D ER E IL T+ +
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDH 65
Query: 748 PFVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------ 799
+V++ +L L+MEYL G L L++ +I + L+L
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQIC 119
Query: 800 -ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
++YL S +HRDL N+L+ + +K++DFGL+K ++P D
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK-----------------VLPED 162
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918
Y S + + APE L ++ A+D WS G+ L+E T P +
Sbjct: 163 KDY----YYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215
Query: 919 SPEI 922
E
Sbjct: 216 PAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 88/316 (27%), Positives = 132/316 (41%), Gaps = 75/316 (23%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLD------MIRKNDIERILAERNILITVRNP 748
+ G + VF R + T +L A+K++ + + IR+ + + L NI +T+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-VTLHD- 70
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-DVARIYIAELVLALEYLHSL 807
++ T LV EYL+ DL L G L +I++ +L+ L Y H
Sbjct: 71 -IIHTERCLT------LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
I+HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV---------------PTKTYSNE---- 163
Query: 868 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----TAESPEI 922
V T Y P++LLG TE+ D W VG IL+E TG P F E +
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
Query: 923 IFDNI-LNRKIPWPCVPSDMSFE--------AQDLINR--------------FLIHDPNQ 959
IF + + WP + S+ F AQ LIN L+++
Sbjct: 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKS 275
Query: 960 RLGANGAAEVKAHPFF 975
R+ A A H +F
Sbjct: 276 RISAEAALR---HSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 80/319 (25%), Positives = 133/319 (41%), Gaps = 72/319 (22%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAERNILITVRN 747
++ + G++ V+ R G L A+K +I E + + E ++L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALK-------VISMKTEEGVPFTAIREASLLKGLKH 62
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
+V ++ L V EY++ +++ G L R+++ +L+ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
I+HRDLKP NLLI++ G +KL DFGL++ I PS + E
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSI---------------PSQTYSSE---- 163
Query: 868 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF--TAESPEII- 923
V T Y P++LLG T++ A D W G I E + G P F ++ E +
Sbjct: 164 --------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE 215
Query: 924 ----------------FDNILNRKIPW--PCVPSDM---------SFEAQDLINRFLIHD 956
+ N K W PC P + +A+DL ++ L+
Sbjct: 216 KIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMF 275
Query: 957 PNQRLGANGAAEVKAHPFF 975
P R+ A A HP+F
Sbjct: 276 PKDRISAQDAL---LHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 82/247 (33%), Positives = 113/247 (45%), Gaps = 52/247 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLF-AIKQVLKK-------LDMIRKNDIERILAERN 740
+E + I GA+G+VF AR G F A+K+V + L IR+ + R L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE--- 59
Query: 741 ILITVRNPFVVRFF----YSFTCRDN-LYLVMEYLNGGDLYSLLRKV---GCLEEDVARI 792
T +P VVR F S T R+ L LV E+++ DL + L KV G E + +
Sbjct: 60 ---TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 115
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
+ +L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 116 -MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI--------------- 159
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912
+Q S V T Y APE+LL + + D WSVG I E
Sbjct: 160 ---------YSFQMALT----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
Query: 913 PPFTAES 919
P F S
Sbjct: 207 PLFRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 2e-18
Identities = 85/327 (25%), Positives = 136/327 (41%), Gaps = 78/327 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE----RILAERNIL 742
D +E ++ + G++ V+ + + G L A+K +IR + E + E ++L
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALK-------VIRLQEEEGTPFTAIREASLL 57
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+++ +V ++ L LV EY++ + + G L + ++++ +L+ L
Sbjct: 58 KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
Y+H I+HRDLKP NLLI+ G +KL DFGL++ + PS +
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV---------------PSHTYSN 162
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA---- 917
E V T Y P++LLG TE+ D W VG I E I G+ F
Sbjct: 163 E------------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
Query: 918 -ESPEIIFDNILNRKIP----WPCVPSDMSFE------------------------AQDL 948
+ E IF L P WP V S F+ A+DL
Sbjct: 211 QDQLERIF---LVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDL 267
Query: 949 INRFLIHDPNQRLGANGAAEVKAHPFF 975
++ L P RL A A +H +F
Sbjct: 268 ASKLLQCFPKNRLSAQAAL---SHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 79/275 (28%), Positives = 114/275 (41%), Gaps = 46/275 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I RG FG VF R R A+K + L K + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK---AKFLQEARILKQYSHPNIVRLI 59
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSL 807
T + +Y+VME + GGD + LR G R+ + EL+ +EYL S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESK 113
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+HRDL N L+ +K++DFG+S+ E DG+ S +
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSR------------EEEDGVYASTGGMKQ---- 157
Query: 868 DNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFD 925
P + APE L + +D WS GI+L+E F G P+ S + +
Sbjct: 158 ----------IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
I + + PC P L+ R +DP QR
Sbjct: 208 AI-EQGVRLPC-PELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 44/288 (15%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA--ERNILITVRNPFVVR 752
+ +G+FG V+L + + +K VLK++ + N E + A E +L + +P +V+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLK-VLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE----LVLALEYLHSLG 808
F SF RD ++ EY G DL L ++ + ++ + E L+L + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 868
I+HRDLK N+ + ++ +K+ DFG+S+ L+ + DL+ T
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSR--LLMGSCDLATTFT----------------- 166
Query: 869 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 928
GTP Y++PE L + +D WS+G IL+E F ++ F +++
Sbjct: 167 --------GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVV 214
Query: 929 NRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
R + P P +P S + ++ L DP+ R AAE+ +PF
Sbjct: 215 LRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-18
Identities = 87/325 (26%), Positives = 137/325 (42%), Gaps = 74/325 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++ + P+ GA+G V A TG A+K++ + I +R E +L ++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYRELRLLKHMK 74
Query: 747 NPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
+ V+ FT +++YLV +L G DL +++ K L +D + I +++
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQILRG 132
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ TD M
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMT---- 175
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 919
V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 176 -------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
Query: 920 PEIIFDNILN----------RKIP----------WPCVPSDMSFE---------AQDLIN 950
IL +KI +P M+F A DL+
Sbjct: 223 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK-MNFANVFIGANPLAVDLLE 281
Query: 951 RFLIHDPNQRLGANGAAEVKAHPFF 975
+ L+ D ++R+ AA+ AH +F
Sbjct: 282 KMLVLDSDKRI---TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 91/348 (26%), Positives = 144/348 (41%), Gaps = 88/348 (25%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI--ERILAERNILITVRNPF 749
+K + GA+G V A + TG+ AIK KL +++I +R E +L +++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 750 VVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLE--EDVARIYIAELVLAL 801
V+ FT + YLVM Y+ + L+K+ ED + + +++ L
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
+Y+HS GI+HRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADAEM 171
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES- 919
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 172 TGY-----------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220
Query: 920 ---------------PEII--FDNILNRKI--PWPCVPS--------DMSFEAQDLINRF 952
PE + ++ + P P S +A DL+ +
Sbjct: 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKM 280
Query: 953 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 1000
L D ++RL A A E HP+F + + A + + DD+
Sbjct: 281 LELDVDKRLTATEALE---HPYFD-------SFRDADEETEQQPYDDS 318
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 66/248 (26%), Positives = 109/248 (43%), Gaps = 54/248 (21%)
Query: 689 FEIIKPISRGAFGRVFLAR--KRTTGDLFAIKQ-VLKKLDM-------IRKNDIERILAE 738
+EI I RG +GRV+ A+ G +AIK+ K R+ + R L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIY 793
N+ +++ F+ S +YL+ +Y DL+ +++ K + + +
Sbjct: 62 ENV-VSLVEVFLEHADKS------VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 794 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINNTIDLSGP 849
+ +++ + YLHS ++HRDLKP N+L+ +G +K+ D GL++ L N +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLAD 171
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFE 907
D + V T Y APE+LLG H Y A D W++G I E
Sbjct: 172 L-DPV---------------------VVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAE 208
Query: 908 FITGIPPF 915
+T P F
Sbjct: 209 LLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-16
Identities = 65/256 (25%), Positives = 104/256 (40%), Gaps = 30/256 (11%)
Query: 711 TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYLVMEY 769
TG AIK +L+ ++ R E + + +P +V S L+ V EY
Sbjct: 2 TGHEVAIK-LLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 770 LNGGDLYSLLRKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 825
+ G L +L G L + R+ + +++ AL H+ GIVHRDLKP N++++ G
Sbjct: 61 VPGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 826 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE 885
H K+ DFG+ + + +GTP Y APE
Sbjct: 120 HAKVLDFGIGTLL------------------PGVRDADVATLTRT--TEVLGTPTYCAPE 159
Query: 886 ILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFE 944
L G +D ++ G+I E +TG S EI++ + + P P
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP--PWIAGHP 217
Query: 945 AQDLINRFLIHDPNQR 960
++ + L DP QR
Sbjct: 218 LGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 69/230 (30%), Positives = 112/230 (48%), Gaps = 43/230 (18%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKQVLK-KLDMIRKNDIERILAERNILITVR 746
I+ + +G FG V L R + TG++ A+K++ + +R D ER E IL +++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR--DFER---EIEILKSLQ 63
Query: 747 NPFVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLAL 801
+ +V+ Y C R NL LVMEYL G L L+K L+ +Y +++ +
Sbjct: 64 HDNIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
EYL S VHRDL N+L+ + +K+ DFGL+K+ +P D Y
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-----------------LPQDKEY 164
Query: 862 PEYQQTDNRNRHSAVGTPDY-LAPEILLGTEHGYAADWWSVGIILFEFIT 910
+ ++ +P + APE L ++ A+D WS G++L+E T
Sbjct: 165 YKVREPGE--------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-16
Identities = 69/235 (29%), Positives = 104/235 (44%), Gaps = 45/235 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER---ILAERNILITV 745
F ++ I G+FG V+ AR T ++ AIK K+ K E+ I+ E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIK----KMSYSGKQSNEKWQDIIKEVKFLQRI 82
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEY 803
++P + + + +LVMEY G DL + +K E ++A I L L Y
Sbjct: 83 KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAY 140
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS ++HRD+K N+L+ G +KL DFG + I P++
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI----------------ASPAN----- 179
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 915
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 180 ----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 82/311 (26%), Positives = 131/311 (42%), Gaps = 65/311 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ G + V+ R + T +L A+K++ +L+ I E ++L +++ +V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI--RLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRD 813
+L LV EYL+ DL L G + ++++ +L+ L Y H ++HRD
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873
LKP NLLI G +KL DFGL++ I P+ + E
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSI---------------PTKTYSNE---------- 164
Query: 874 SAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE----IIFDNIL 928
V T Y P+ILLG T++ D W VG I +E TG P F + E IF IL
Sbjct: 165 --VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF-RIL 221
Query: 929 NRKI--PWPCVPSDMSF----------------------EAQDLINRFLIHDPNQRLGAN 964
WP + S+ F + +L+++ L + +R+ A
Sbjct: 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281
Query: 965 GAAEVKAHPFF 975
A + HP+F
Sbjct: 282 EAMK---HPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 43/229 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I +G FG V+ + ++ A+K + + + + L E IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTC--RSTLP-PDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSL 807
+ +Y+VME + GG L + LRK R+ + +L+ +EYL S
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+HRDL N L+ + +K++DFG+S+ E GI Y +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR------------EEEGGI---------YTVS 151
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 915
D + T APE L + +D WS GI+L+E F G P+
Sbjct: 152 DGLKQIPIKWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 45/235 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER---ILAERNILITV 745
F ++ I G+FG V+ AR ++ AIK K+ K E+ I+ E L +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIK----KMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEY 803
R+P +++ + +LVMEY G DL + +K E ++A + L L Y
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGAL-QGLAY 130
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS ++HRD+K N+L++ G +KL DFG + I + P++
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----------------MAPAN----- 169
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 915
VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ----------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 43/228 (18%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVV 751
+KPI GA G V A TG AIK++ + + +R E ++ V + ++
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV--THAKRAYRELVLMKLVNHKNII 78
Query: 752 RFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEY 803
FT + +L YLVME ++ L +V ++ D R+ + +++ +++
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKH 133
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS GI+HRDLKP N+++ D +K+ DFGL++ M + Y
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------------GTSFMMTP--Y-- 177
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 178 ------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-15
Identities = 81/338 (23%), Positives = 140/338 (41%), Gaps = 85/338 (25%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
T + ++ +KPI GA G V A G A+K++ + + +R E +L
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLK 75
Query: 744 TVRNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIA 795
V + ++ FT + ++YLVME ++ L +V +E D R+ +
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLY 130
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
+++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ N
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-------------- 176
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT----- 910
+ T V T Y APE++LG + D WSVG I+ E +
Sbjct: 177 --------FMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
Query: 911 ----------------GIPP--FTAESPEIIFDNILNRK----------IPWPCVPSD-- 940
G P F + + + NR P PS+
Sbjct: 223 QGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESE 282
Query: 941 ----MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
+ +A+DL+++ L+ DP++R+ + E HP+
Sbjct: 283 RDKLKTSQARDLLSKMLVIDPDKRISVD---EALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 15/157 (9%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND---IERILAERNI 741
+ + ++ I +G FG V L R G A+K + K+D + LAE ++
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCL--------KDDSTAAQAFLAEASV 53
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVL 799
+ T+R+P +V+ + LY+V EY+ G L LR G + + ++
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+EYL VHRDL N+L++ D K++DFGL+K
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 79/316 (25%), Positives = 135/316 (42%), Gaps = 63/316 (19%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVV 751
++ + G + VF R + T +L A+K++ +L+ I E ++L +++ +V
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAI-REVSLLKDLKHANIV 67
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIV 810
+L LV EYL+ DL + G + +I++ +++ L Y H ++
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126
Query: 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSV---------------PTKTYSNE------- 164
Query: 871 NRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE----IIFD 925
V T Y P++LLG +E+ D W VG I FE +G P F + E +IF
Sbjct: 165 -----VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219
Query: 926 NI-LNRKIPWPCVPSDMSF----------------------EAQDLINRFLIHDPNQRLG 962
+ + WP + S+ F E +L+ +FL ++ +R+
Sbjct: 220 LLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS 279
Query: 963 ANGAAEVKAHPFFKGV 978
A E H +F+ +
Sbjct: 280 AE---EAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 45/229 (19%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER---ILAERNILITVRNPFVV 751
I G+FG V+ A T ++ A+K K+ K E+ I+ E L +++P +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVK----KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 752 RFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 809
+ + +LVMEY G DL + +K E ++A I L L YLHS +
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSHNM 142
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
+HRD+K N+L+ G +KL DFG + S P
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASK---------SSPA------------------- 174
Query: 870 RNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 915
+S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-15
Identities = 83/326 (25%), Positives = 134/326 (41%), Gaps = 80/326 (24%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
++ + P+ GA+G V A A+K++ + + R E +L +++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA--RRTYRELRLLKHMKHE 74
Query: 749 FVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
V+ FT ++ YLV L G DL +++ K L ++ + I +L+ L+
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRGLK 132
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
Y+HS GI+HRDLKP N+ + D +++ DFGL++
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-------------------------- 166
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 921
Q D+ V T Y APEI+L H D WSVG I+ E + G F P
Sbjct: 167 ---QADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF----PG 218
Query: 922 IIFDNILNRKI-----PWPCVPSDMSFE---------------------------AQDLI 949
+ + L R + P P V +S E A DL+
Sbjct: 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278
Query: 950 NRFLIHDPNQRLGANGAAEVKAHPFF 975
+ L+ D ++R+ A+E AHP+F
Sbjct: 279 EKMLVLDSDKRI---SASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 36/232 (15%)
Query: 695 ISRGAFGR--VFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVR 752
I + V LA+ + T L A+K++ LD K D++ + E +++P ++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKI--NLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIV 810
+ SF LY+V + G LL+ L E + +++ AL+Y+HS G +
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI 123
Query: 811 HRDLKPDNLLIAHDGHIKLTDF----GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
HR +K ++L++ DG + L+ + K G +
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP------------------ 165
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFT 916
+ S P +L+PE+L GY D +SVGI E G PF
Sbjct: 166 -----KSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-14
Identities = 89/331 (26%), Positives = 139/331 (41%), Gaps = 76/331 (22%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
R+ +++ I G+FG V+ A T + AIK+VL+ D KN I+ N +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKNRELLIMKNLNHI 119
Query: 743 ITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGG-----DLYSLLRKVGCLEEDVARI 792
+ F+ ++Y+ + N L +VME++ Y+ R L + ++
Sbjct: 120 NII---FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKL 174
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPET 851
Y +L AL Y+HS I HRDLKP NLLI + H +KL DFG +K +L
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLA--- 223
Query: 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 910
+ S + + Y APE++LG T + D WS+G I+ E I
Sbjct: 224 -----------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 911 GIPPFTAESP-------------------EIIFDNILNRKIP-------WPCVPSDMSFE 944
G P F+ +S + + N + K P P +
Sbjct: 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD 326
Query: 945 AQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
A + I++FL ++P +RL E A PFF
Sbjct: 327 AINFISQFLKYEPLKRL---NPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-14
Identities = 82/338 (24%), Positives = 140/338 (41%), Gaps = 85/338 (25%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
T + ++ +KPI GA G V A AIK++ + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMK 71
Query: 744 TVRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIA 795
V + ++ FT + +L YLVME ++ L +V +E D R+ +
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLY 126
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
+++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T G
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTS 172
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------ 909
Y V T Y APE++LG + D WSVG I+ E +
Sbjct: 173 FMMTPY--------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
Query: 910 -----------------TGIPPFTAESPEIIFDNILNRK----------IPWPCVPSD-- 940
T P F + + + + NR P P+D
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 941 ----MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
+ +A+DL+++ L+ DP +R+ + A + HP+
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDEALQ---HPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 42/279 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ +++K + G FG V++ + AIK LK+ M E LAE N++ ++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKS-LKQGSM----SPEAFLAEANLMKQLQ 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYL 804
+P +VR Y+ ++ +Y++ EY+ G L L+ ++ + ++ A++ + ++
Sbjct: 60 HPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+HRDL+ N+L++ K+ DFGL+++ I + EY
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDN-------------------EY 157
Query: 865 QQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPE 921
R A + APE I GT +D WS GI+L E +T IP +PE
Sbjct: 158 TA-----REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
Query: 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+I + L R P P + E +L+ P +R
Sbjct: 212 VIQN--LERGYRMPR-PDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 40/233 (17%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD---MIRKNDIERILAERNILITVRNP 748
+K + G FG V L + R IK +K ++ M ++ IE E +++ + +P
Sbjct: 9 MKELGSGQFGVVHLGKWRAQ-----IKVAIKAINEGAMSEEDFIE----EAKVMMKLSHP 59
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSL 807
+V+ + T + LY+V E++ G L + LR + G L +D+ ++ +EYL
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+HRDL N L++ G +K++DFG+++ L + SG A +P
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG----------AKFP----- 164
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 919
+ PE+ +++ +D WS G++++E F G PF +S
Sbjct: 165 -----------VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 70/303 (23%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN----DIERILAERNILITVRNP 748
K + G FG+V A V K M+++N ++ +L+E N+L V +P
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVK--MLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGC-------------LEEDVARI 792
V++ + + + L L++EY G L S LR KVG L+ R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 793 YIAELVLA--------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844
+++ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-------- 175
Query: 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGI 903
+ + D+ + S P ++A E L + +D WS G+
Sbjct: 176 ------------------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 904 ILFEFIT-GIPPFTAESPEIIFDNI-----LNRKIPWPCVPSDMSFEAQDLINRFLIHDP 957
+L+E +T G P+ +PE +F+ + + R P + S E +L+ +P
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER-------PENCSEEMYNLMLTCWKQEP 270
Query: 958 NQR 960
++R
Sbjct: 271 DKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 68/236 (28%), Positives = 100/236 (42%), Gaps = 49/236 (20%)
Query: 695 ISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749
+ GAFG+VFLA L A+K LK+ + D +R E +L +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQDFQR---EAELLTVLQHQH 68
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLE--EDVA--------RIYIA 795
+VRF+ T L +V EY+ GDL LR G L EDVA + IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 796 ELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+ + + YL SL VHRDL N L+ +K+ DFG+S+
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------------ 170
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
D + +Y + R P PE +L + +D WS G++L+E T
Sbjct: 171 ---DIYSTDYYRVGGRTMLPIRWMP----PESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 50/227 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+ +IK ++ G+ GRVF+A K D V+ K+ IE +L + V +P
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPD-----PVVLKIGQKGTTLIEAMLLQN-----VNHP 117
Query: 749 FVVR-----FFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALE 802
V+R + TC +V+ + + DLY+ L ++ L D A I +++ L
Sbjct: 118 SVIRMKDTLVSGAITC-----MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLR 171
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLH+ I+HRD+K +N+ I + + D G ++ + P G+
Sbjct: 172 YLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-------FPVVAPAFLGL-------- 216
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909
GT + APE+L ++ AD WS GI+LFE +
Sbjct: 217 -------------AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 76/300 (25%), Positives = 120/300 (40%), Gaps = 71/300 (23%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
I+ + G FG+V L TG++ A+K + K + ++N E NIL T+ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNT-SGWKKEINILKTLYH 65
Query: 748 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 799
+V+ Y C + L L+MEY+ G L L K ++ +A+L+L
Sbjct: 66 ENIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQ 115
Query: 800 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+ YLHS +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-------------------- 155
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916
PE + R R + A E L + YA+D WS G+ L+E +T
Sbjct: 156 ---AVPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK- 210
Query: 917 AESPEIIFD----------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+SP F+ +L R + PC P + E L+ + R
Sbjct: 211 -QSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC-PKNCPQEVYILMKNCWETEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ +G FG VF K T D + K D+ ++ I + L+E IL +P +V+
Sbjct: 3 LGKGNFGEVF---KGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLI 58
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----ALEYLHSLGIV 810
T R +Y+VME + GGD S LRK ++++ + + L + YL S +
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
HRDL N L+ + +K++DFG+S+ E DGI S +Q +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR------------QEDDGIYSSSG----LKQIPIK 159
Query: 871 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 915
+ APE L + +D WS GI+L+E F G+ P+
Sbjct: 160 ----------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-13
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
T + ++ +KPI GA G V A AIK++ + + +R E ++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMK 78
Query: 744 TVRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIA 795
V + ++ FT + +L Y+VME ++ L +V +E D R+ +
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLY 133
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
+++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T + P
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY----- 185
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 186 --------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 57/298 (19%)
Query: 688 DFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
D + + + GAFG+VFLA T + + LK + + D +R E +L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 799
+++ +V+F+ D L +V EY+ GDL LR G L + R EL L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 800 A------------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847
+ + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----------- 171
Query: 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907
D + +Y + H+ + ++ PE ++ + +D WS G+IL+E
Sbjct: 172 ----------DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSFGVILWE 217
Query: 908 FIT-GIPPFTAESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRL 961
T G P+ S + + I ++ P C P E D++ +P QRL
Sbjct: 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-PK----EVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR---TTGD--LFAIKQVLKK--LDMIRKNDIERILAER 739
D + + + GAFG+VFL D L A+K LK+ + RK D ER E
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARK-DFER---EA 59
Query: 740 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------C 784
+L ++ +V+F+ T D +V EY+ GDL LR G
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 785 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+ +I + ++ + YL S VHRDL N L+ +D +K+ DFG+S+
Sbjct: 120 TLSQLLQIAV-QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I G FG V + TG A+K + K D+ + L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNI--KCDVT----AQAFLEETAVMTKLHHKNLVRLL 65
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA--LEYLHSLGIVHR 812
+ LY+VME ++ G+L + LR G V ++ L +A +EYL S +VHR
Sbjct: 66 -GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR 124
Query: 813 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 872
DL N+L++ DG K++DFGL+++G +
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVG------------------------------SMGV 154
Query: 873 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 915
++ + APE L + +D WS G++L+E F G P+
Sbjct: 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 45/237 (18%)
Query: 698 GAFG----RVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 753
G FG V+ RK+ AIK VLK + K+ + ++ E I+ + NP++VR
Sbjct: 6 GNFGCVKKGVYKMRKKQID--VAIK-VLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 754 FYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALEYLHSLG 808
C + L LVME +GG L L ++++ + EL+ + ++YL
Sbjct: 61 IG--VCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 868
VHRDL N+L+ + + K++DFGLSK + D++Y
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSK----------------ALGADDSYY------- 152
Query: 869 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESPEII 923
+ R + + APE + + +D WS GI ++E F G P+ + PE++
Sbjct: 153 -KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
+F + + + G FG V+ + + AIK +LK D++++ D ++ E L +R+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIK-ILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-ALEYLH 805
++ F + + +Y++ E + G L + LR VA I +A V + YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+HRDL N+L+ D K+ DFGL+++ I + LS SD P Y+
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLS---------SDKKIP-YK 169
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIP 913
T APE +D WS GI+L+E T +P
Sbjct: 170 WT---------------APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
I+ + G FG+V L R TG+ A+K LK N I + E IL + +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPES--GGNHIADLKKEIEILRNLYH 65
Query: 748 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALE 802
+V+ Y C ++ + L+ME+L G L L R + Y ++ ++
Sbjct: 66 ENIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YL S VHRDL N+L+ + +K+ DFGL+K + +D Y
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----------------IETDKEY- 165
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
Y D+ + S V + APE L+ ++ A+D WS G+ L+E +T
Sbjct: 166 -YTVKDDLD--SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 43/229 (18%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI--ERILAERNILITV 745
D +K + G FG V + R D+ AIK MI++ + + + E +++ +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIK-------MIKEGSMSEDEFIEEAKVMMKL 56
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYL 804
+ +V+ + T + +Y+V EY++ G L + LR+ G + + + + V + YL
Sbjct: 57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
S +HRDL N L+ G +K++DFGLS+ L D Y
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL------------------DDEYT-- 156
Query: 865 QQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
S+VG+ + PE+LL ++ +D W+ G++++E +
Sbjct: 157 ---------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 698 GAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757
G +G V+ + A+K LK+ M ++E L E ++ +++P +V+
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVK-TLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 758 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEED-VARIYIA-ELVLALEYLHSLGIVHRDLK 815
T Y++ E++ G+L LR+ E + V +Y+A ++ A+EYL +HRDL
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 131
Query: 816 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 875
N L+ + +K+ DFGLS++ D H+
Sbjct: 132 ARNCLVGENHLVKVADFGLSRL---------------------------MTGDTYTAHAG 164
Query: 876 VGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 61/262 (23%), Positives = 114/262 (43%), Gaps = 47/262 (17%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN----DIERILAERN 740
S D + KP+ G FG+V +A + V + M++ + D+ +++E
Sbjct: 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 72
Query: 741 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIYIA 795
++ + ++ ++ + T LY+++EY + G+L LR D+AR+
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 796 ELVL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843
++ +EYL S +HRDL N+L+ + +K+ DFGL++ +NN
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VNN- 189
Query: 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903
ID T+G +P ++APE L + + +D WS G+
Sbjct: 190 IDYYKKTTNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSFGV 227
Query: 904 ILFEFIT-GIPPFTAESPEIIF 924
+++E T G P+ E +F
Sbjct: 228 LMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 51/162 (31%), Positives = 73/162 (45%), Gaps = 35/162 (21%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLK----------KLD-MIRKNDIERILAERN 740
+K I RGA ++L GD IK V+K +LD IR+ ER E
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELDERIRR---ERTRREAR 51
Query: 741 ILIT-----VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 795
I+ V P V +N +VMEY+ G L L+ G E +++R
Sbjct: 52 IMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR---- 102
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
E+ + LHS GI+H DL N+++ G I L DFGL++
Sbjct: 103 EIGRLVGKLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 45/228 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI--ERILAERNIL 742
++ + ++++ I +G FG V L R G+ A+K + KND + LAE +++
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI--------KNDATAQAFLAEASVM 53
Query: 743 ITVRNPFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVL 799
+R+ +V+ + LY+V EY+ G L LR G L D + ++
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
A+EYL + VHRDL N+L++ D K++DFGL+K + S + G +P
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPV-- 163
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907
+ APE L + +D WS GI+L+E
Sbjct: 164 --------------------KWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 60/231 (25%), Positives = 90/231 (38%), Gaps = 53/231 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
F I++ + GA G F T + IK + E +IL + +P
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHP 143
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------AL 801
+++ +FT L++ DLY C I I +++ A+
Sbjct: 144 SIIQLKGTFTYNKFTCLILPRYKT-DLY-------CYLAAKRNIAICDILAIERSVLRAI 195
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
+YLH I+HRD+K +N+ I H G + L DFG + P D
Sbjct: 196 QYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA------------------CFPVDI-- 235
Query: 862 PEYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911
N N++ GT APE+L +G A D WS GI+LFE T
Sbjct: 236 -------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 62/262 (23%), Positives = 105/262 (40%), Gaps = 47/262 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDL-FAIKQVLKKLDMIR-KNDIERILAERNILIT 744
D + KP+ GAFG+V A + +K L + D+ +++E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 745 V-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIYIAELVL 799
+ ++ ++ T LY+V+EY G+L LR E D R L
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 800 ------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847
+E+L S +HRDL N+L+ D +K+ DFGL++
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----------- 180
Query: 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILF 906
D H+ +Y + R P ++APE L + + +D WS G++L+
Sbjct: 181 ----------DIHHIDYYRKTTNGR-----LPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225
Query: 907 EFIT-GIPPFTAESPEIIFDNI 927
E T G P+ E +F +
Sbjct: 226 EIFTLGGSPYPGIPVEELFKLL 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 45/235 (19%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
+RTSI ++++ + G FG V+ T + A+K LK M D + LAE I
Sbjct: 4 DRTSI---QLLRKLGAGQFGEVWEGLWNNTTPV-AVK-TLKPGTM----DPKDFLAEAQI 54
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEE--DVARIYIA 795
+ +R+P +++ + T + +Y+V E + G L L+ L + D+A A
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----A 110
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
++ + YL + +HRDL N+L+ + K+ DFGL+++ I
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV----------------IK 154
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
Y+ R A + APE L +D WS GI+L E +T
Sbjct: 155 ED-----IYEA-----REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 55/239 (23%)
Query: 686 IDDFEI--IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
ID E+ +K + G FG V L + R D+ AIK ++++ M + IE E +++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDV-AIK-MIREGAMSEDDFIE----EAKVMM 54
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 799
+ +P +V+ + T + +++V EY+ G L + LR+ E +L
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-------TEWLLDMCS 107
Query: 800 ----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
A+EYL S G +HRDL N L+ D +K++DFGL++ L
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL---------------- 151
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFITG 911
D Y S+ GT + PE+ + +D WS G++++E +
Sbjct: 152 --DDQYT-----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 49/236 (20%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
R S+ ++ + + G FG V++ T + A+K LK M E L E I+
Sbjct: 5 RESL---KLERKLGAGQFGEVWMGTWNGTTKV-AVK-TLKPGTM----SPEAFLQEAQIM 55
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIA 795
+R+ +V+ + + + +Y+V EY++ G L L+ ++ L + A+I A
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--A 113
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGI 854
E + YL S +HRDL N+L+ + + K+ DFGL++ LI E D
Sbjct: 114 E---GMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLAR--LI---------EDD-- 156
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
EY R A + APE +D WS GI+L E +T
Sbjct: 157 --------EYTA-----REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 47/236 (19%)
Query: 693 KPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
+ + GAFG+VFLA L A+K + D RK D R E +L +++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK-DFHR---EAELLTNLQH 66
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR------------IYIA 795
+V+F+ D L +V EY+ GDL LR G +A ++IA
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 796 ELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+ + A + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------------ 168
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
D + +Y + H+ + ++ PE ++ + +D WS+G++L+E T
Sbjct: 169 ---DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 47/285 (16%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN----ILITVRN 747
I + RG FG VFLA+ + + VL K ++K E + +E + + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK--ALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 748 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDV--------ARIYIA-E 796
VVR CR+ Y+++EY + GDL LR +E + ++ + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+ L +++L + VHRDL N L++ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 915
D + EY + N A+ +LAPE + + +D WS G++++E F G PF
Sbjct: 166 -DVYNSEYYKLRN-----ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
Query: 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
S E + + + K+ P VP L+ R +P R
Sbjct: 220 YGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 61/241 (25%), Positives = 98/241 (40%), Gaps = 34/241 (14%)
Query: 693 KPISRGAFGRVFLAR-KRTTGDLF--AIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749
K + G+FG V + G + A+K LK + + ++ L E I+ ++ +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKL--SDIMDDFLKEAAIMHSLDHEN 57
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSL 807
++R Y L +V E G L LRK ++ + Y ++ + YL S
Sbjct: 58 LIRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+HRDL N+L+A D +K+ DFGL + L N + H Y
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN---------------EDH---YVME 157
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDN 926
++ A + APE L +A+D W G+ L+E F G P+ S I
Sbjct: 158 EHLKVPFA-----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212
Query: 927 I 927
I
Sbjct: 213 I 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 48/282 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++IK + G FG V++ + A+K LK M E L E I+ +R
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVK-TLKPGTM----SPESFLEEAQIMKKLR 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVL 799
+ +V+ Y+ + +Y+V EY++ G L L+ K+ L D+A A++
Sbjct: 60 HDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV-DMA----AQVAA 113
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
+ Y+ + +HRDL+ N+L+ K+ DFGL++ LI +
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDN---------------- 155
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918
EY R A + APE L +D WS GI+L E +T G P+
Sbjct: 156 ---EYTA-----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
Query: 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ + + + R PC P D +L+ + DP +R
Sbjct: 208 NNREVLEQV-ERGYRMPC-PQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 64/251 (25%), Positives = 105/251 (41%), Gaps = 51/251 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDL----FAIKQVLKKLDMIRKNDIERILAERNILIT 744
E IK + GAFG V+ G+ AIK + ++ K + IL E ++ +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKA-NKEILDEAYVMAS 65
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLA 800
V +P VVR + L+ + + G L +R +G + IA+
Sbjct: 66 VDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---G 121
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+ YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LDVDEK--------- 164
Query: 861 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GI 912
EY + P ++A E +L + + +D WS G+ ++E +T GI
Sbjct: 165 --EYHAEGGK-------VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215
Query: 913 PPFTAESPEII 923
P E P+++
Sbjct: 216 P--AVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 66/275 (24%), Positives = 115/275 (41%), Gaps = 51/275 (18%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID-------DFEIIKP 694
EL D T + Y + +S+S + V + +S D + I+
Sbjct: 47 ELGDSDDVTHATDYDADE----ESLSPQTDVCQ---EPCETTSSSDPASVVRMQYNILSS 99
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
++ G+ G VF+ K GD K ++K + R E +IL T+ + ++
Sbjct: 100 LTPGSEGEVFVCTKH--GDEQRKKVIVKAV--TGGKTPGR---EIDILKTISHRAIINLI 152
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRD 813
+++ + + +VM DL++ + + G L + A I I +L AL YLH GI+HRD
Sbjct: 153 HAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRGIIHRD 210
Query: 814 LKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 872
+K +N+ + + L DFG + K+ +T P
Sbjct: 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDT------------PQC-------------- 244
Query: 873 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907
+ GT + +PE+L + D WS G++LFE
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/249 (24%), Positives = 103/249 (41%), Gaps = 46/249 (18%)
Query: 727 IRKNDI------ERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLL 779
I KND + +L E N++ + NP++VR C ++ LVME G L L
Sbjct: 29 ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG--ICEAESWMLVMELAELGPLNKFL 86
Query: 780 RKVGCLEEDVARIYIAELV----LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
+K + V I ELV + ++YL VHRDL N+L+ + K++DFGLS
Sbjct: 87 QK----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLS 142
Query: 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895
K + +D +Y + + + APE + +
Sbjct: 143 K-----------------ALGADENYYKAKTHGK-------WPVKWYAPECMNYYKFSSK 178
Query: 896 ADWWSVGIILFE-FITGIPPFTA-ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFL 953
+D WS G++++E F G P+ + E+ ++ C P E DL+
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVT--QMIESGERMEC-PQRCPPEMYDLMKLCW 235
Query: 954 IHDPNQRLG 962
+ ++R G
Sbjct: 236 TYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 49/255 (19%)
Query: 693 KPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-R 746
KP+ G FG+V +A K + + + K D K D+ +++E ++ + +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 82
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------CLEED---VARIYIAEL 797
+ ++ + T LY+++EY + G+L LR C ++ +L
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 798 V-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850
V +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------------- 188
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
D H+ +Y + R ++APE L + + +D WS G++L+E T
Sbjct: 189 -------DIHHIDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
Query: 911 -GIPPFTAESPEIIF 924
G P+ E +F
Sbjct: 238 LGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 12/125 (9%)
Query: 716 AIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 775
A+K LK+ + + L E +++ + +P +VR + L LVME G L
Sbjct: 27 AVK-TLKQEHI--AAGKKEFLREASVMAQLDHPCIVRLI-GVCKGEPLMLVMELAPLGPL 82
Query: 776 YSLLRKVGCLEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 831
L+K ++ + EL + YL S VHRDL N+L+ + K++D
Sbjct: 83 LKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISD 138
Query: 832 FGLSK 836
FG+S+
Sbjct: 139 FGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 69/316 (21%), Positives = 117/316 (37%), Gaps = 80/316 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKQVLKK---LDMIRKNDIERILAER 739
++ E ++ I +GAFGRVF AR ++LK+ DM + D +R E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQR---EA 59
Query: 740 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------------KVGCLE 786
++ +P +V+ + L+ EY+ GDL LR +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 787 EDVARIYIAELVL---------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
+ + ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 838 GLINNTIDLSGPETDGI----MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 893
I + E D I MP PE + +
Sbjct: 180 --IYSADYYKASENDAIPIRWMP---------------------------PESIFYNRYT 210
Query: 894 YAADWWSVGIILFE-FITGIPPFTAES-PEIIF----DNILNRKIPWPCVPSDMSFEAQD 947
+D W+ G++L+E F G+ P+ + E+I+ N+L+ C P + E +
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS------C-PDNCPLELYN 263
Query: 948 LINRFLIHDPNQRLGA 963
L+ P+ R
Sbjct: 264 LMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 50/166 (30%), Positives = 68/166 (40%), Gaps = 52/166 (31%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLK----------KLD-MIRKNDIERILAERNILI 743
I++GA ++L GD +K V+K +LD IR+ ER E +L
Sbjct: 2 IAKGAEAIIYL------GDFLGLKAVIKERVPKSYRHPELDERIRR---ERTRNEARLLS 52
Query: 744 TVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEEDVAR 791
R N VV DN +VMEY+ G L LLR++G V +
Sbjct: 53 RARKAGVNTPVVYDVD----PDNKTIVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK 105
Query: 792 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
LH GIVH DL N+++ D + L DFGL K
Sbjct: 106 ------------LHKAGIVHGDLTTSNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 54/236 (22%), Positives = 104/236 (44%), Gaps = 35/236 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ +++K + G FG V++ + + A+K LK M ++ L E N++ T++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVK-TLKPGTM----SVQAFLEEANLMKTLQ 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYL 804
+ +VR + T + +Y++ EY+ G L L+ + + ++ + A++ + Y+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+HRDL+ N+L++ K+ DFGL+++ D Y
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARV------------------IEDNEYTA- 160
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919
R A + APE + +D WS GI+L+E +T G P+ S
Sbjct: 161 -------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 65/251 (25%), Positives = 104/251 (41%), Gaps = 55/251 (21%)
Query: 695 ISRGAFGRVFL---------ARKRTTGDLFAIKQVLKKLDMIR----KNDIERILAERNI 741
+ G FG V L K + D+ + VL + M+R KN L E I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAEL 797
+ +++P ++R D L ++ EY+ GDL L + + DV I + L
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 798 VL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850
+ ++YL SL VHRDL N L+ + IK+ DFG+S+
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-------------- 178
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFI 909
+ + +Y + R AV +++ E ILLG + A+D W+ G+ L+E +
Sbjct: 179 -------NLYSGDYYRIQGR----AVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEIL 226
Query: 910 TGIPPFTAESP 920
T E P
Sbjct: 227 T----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 35/151 (23%)
Query: 769 YLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-------ALEYLHSLGIVHRDLKPDNLL 820
Y+N G+L L++ E + + + +LV + YLH G++H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 821 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP- 879
I + +K+TD LS+ DL P D H DN NR P
Sbjct: 150 IDEELQVKITDNALSR--------DL--------FPMDYHC----LGDNENR------PV 183
Query: 880 DYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
++A E L+ E+ A+D WS G++L+E +T
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 45/243 (18%)
Query: 695 ISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749
+ GAFG V+ +G + + L+K ++ + L E +++ +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE------ 802
+V+ + Y++ME + GGDL S LR + + EL+ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
YL + +HRDL N L++ G+ +K+ DFGL++ + + D E +G++P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKS--DYYRKEGEGLLPV 177
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916
++APE LL + +D WS G++++E +T G P+
Sbjct: 178 ----------------------RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 917 AES 919
A +
Sbjct: 216 ALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-09
Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 63/225 (28%)
Query: 672 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF------------LARKRTTGDLFAIKQ 719
V PL R S DDF++ + G FG F R + T + +
Sbjct: 130 VGAPLADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRV 189
Query: 720 VLKKLDMIR--------------KNDIERILAERNILITV-RNPFVVR-------FFYSF 757
VLK+++M R K E + E + + RNP +F S
Sbjct: 190 VLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSN 249
Query: 758 TC-----RDNLYLVMEYLNGGDLYSLLR-KVG----CLEE-------------------D 788
T + + +LV ++ + L L K+G CLEE +
Sbjct: 250 TADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309
Query: 789 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833
V + + +++ L LH +GIVHRD+KP+NLL+ DG +K+ DFG
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 62/251 (24%), Positives = 111/251 (44%), Gaps = 51/251 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDL--FAIKQVLK---KLDMIRKNDIERILAERNILITVRNPF 749
+ RG +G V+ A+++ D +A+KQ+ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA------ 62
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 800
+ + F S + R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 915
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 916 TAESPEIIFDN 926
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 45/221 (20%)
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVAR 791
E +++ + +P +V T + ++ EYLN GDL+ L VGC ++
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 792 I----------YIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840
+ +IA ++ +EYL S VH+DL N+LI H+K++D GLS+
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR---- 172
Query: 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 900
I +D + R + ++ ++ PE ++ + +D WS
Sbjct: 173 ------------EIYSADYY---------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 901 VGIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 940
G++L+E F G+ P+ S + + + + R++ PC D
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL-LPC-SED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 61/265 (23%), Positives = 107/265 (40%), Gaps = 69/265 (26%)
Query: 693 KPISRGAFGRVFLA------RKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV- 745
KP+ G FG+V +A + + + ++LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVSEMEMMKMIG 75
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK------------------------ 781
++ ++ + T LY+++EY + G+L LR
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 782 -VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840
V C + VAR +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 136 LVSCAYQ-VAR--------GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---- 182
Query: 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 900
D H +Y + R ++APE L + + +D WS
Sbjct: 183 -----------------DVHNIDYYKKTTNGRLPV----KWMAPEALFDRVYTHQSDVWS 221
Query: 901 VGIILFEFIT-GIPPFTAESPEIIF 924
G++L+E T G P+ E +F
Sbjct: 222 FGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 65/280 (23%), Positives = 116/280 (41%), Gaps = 52/280 (18%)
Query: 683 RTSIDDFEIIKPISRGAFGRV-----FLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
+ ++ + GAFG+V +R + AIK + + + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVAR 791
E ++ +++P +V T ++ EYL GDL+ L VG D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 792 ---------IYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841
++IA + A +EYL S VHRDL N L+ +K++DFGLS+
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-- 175
Query: 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 901
S +Y R + ++ ++ PE +L + +D WS
Sbjct: 176 ---------------SADYY--------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 902 GIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 940
G++L+E F G+ P+ S + + + I +R++ PC P D
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPC-PED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 48/274 (17%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ +G FG V++ T + AIK LK M+ E L E I+ +R+ +V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIK-TLKPGTMMP----EAFLQEAQIMKKLRHDKLVPL- 66
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSL 807
Y+ + +Y+V E++ G L L+ E D + + +LV + Y+ +
Sbjct: 67 YAVVSEEPIYIVTEFMGKGSLLDFLK-----EGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
+HRDL+ N+L+ + K+ DFGL++ LI + EY
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLAR--LIEDN-------------------EYTA- 159
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDN 926
R A + APE L +D WS GI+L E +T G P+ + +
Sbjct: 160 ----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ 215
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ R PC P +L+ DP++R
Sbjct: 216 V-ERGYRMPC-PQGCPESLHELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 62/263 (23%), Positives = 111/263 (42%), Gaps = 56/263 (21%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER----ILAERNILITVRN 747
+K + GAFG V+ G+ I +K ++R+N + IL E ++ V +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIK---VLRENTSPKANKEILDEAYVMAGVGS 68
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------YIAELVLA 800
P+V R + LV + + G L +R E+ RI + ++
Sbjct: 69 PYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVR------ENKDRIGSQDLLNWCVQIAKG 121
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+ YL + +VHRDL N+L+ H+K+TDFGL+++ I+ T
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET----------------- 164
Query: 861 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA- 917
EY + P ++A E +L + +D WS G+ ++E +T G P+
Sbjct: 165 --EYHADGGK-------VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
Query: 918 ---ESPEIIFDNILNRKIPWPCV 937
E P+++ ++P P +
Sbjct: 216 PAREIPDLLEK---GERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 34/235 (14%)
Query: 690 EIIKPISRG--AFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
E++ I RG V LAR + TG+ ++++ L+ + + E ++ +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRI--NLEACTNEMVTFLQGELHVSKLFNH 58
Query: 748 PFVVRFFYSFTCRDNLYLV---MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEY 803
P +V + +F + L++V M Y + DL G E +A YI + VL AL+Y
Sbjct: 59 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA--YILQGVLKALDY 116
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHYP 862
+H +G VHR +K ++LI+ DG + L+ GL S + +IN H
Sbjct: 117 IHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN------------------HGQ 156
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF 915
+ + ++S P +L+PE+L GY A D +SVGI E G PF
Sbjct: 157 RLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 67/269 (24%), Positives = 112/269 (41%), Gaps = 38/269 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ +G FG V++ T + AIK LK M E L E ++ +R+ +V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIK-TLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL- 66
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHR 812
Y+ + +Y+V EY++ G L L+ + ++ A++ + Y+ + VHR
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 813 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 872
DL+ N+L+ + K+ DFGL++ LI + EY R
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR--LIEDN-------------------EYTA-----R 160
Query: 873 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 931
A + APE L +D WS GI+L E T G P+ + D + R
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERG 219
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
PC P + DL+ + +P +R
Sbjct: 220 YRMPC-PPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 733 ERILAERNILITVRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK-VGCLEEDVA 790
E+ L E I+ +P +V+ +N +++VME G+L S L+ L+
Sbjct: 52 EKFLQEAYIMRQFDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASL 109
Query: 791 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+Y +L AL YL S VHRD+ N+L++ +KL DFGLS+
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 42/227 (18%)
Query: 714 LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 773
L A+K + + +ND L E I+ ++NP ++R D L ++ EY+ G
Sbjct: 46 LVAVKMLRADVTKTARNDF---LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102
Query: 774 DLYSLL-----RKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLI 821
DL L ++ + IA L+ ++YL SL VHRDL N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 822 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 881
+ IK+ DFG+S+ + + +Y + R AV +
Sbjct: 163 GNHYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRW 197
Query: 882 LAPEILLGTEHGYAADWWSVGIILFEFITGIP--PFTAESPEIIFDN 926
+A E +L + A+D W+ G+ L+E T P++ S E + +N
Sbjct: 198 MAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 51/256 (19%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN----DIERILAERNILITV-RN 747
KP+ G FG+V A + V + M++ N D+ +++E ++ + ++
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR------------------KVGCLEEDV 789
++ T LY+++EY G+L LR + ++ V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 790 ARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849
+ Y ++ +EYL S +HRDL N+L+ D +K+ DFGL++ G+ + ID
Sbjct: 138 SCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GV--HDIDYYKK 192
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909
++G +P ++APE L + + +D WS GI+++E
Sbjct: 193 TSNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSFGILMWEIF 230
Query: 910 T-GIPPFTAESPEIIF 924
T G P+ E +F
Sbjct: 231 TLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 37/253 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL--DMIRKNDIERILAERNILIT 744
++ K + GAFG+V A A+ +V K+ ++ E +++E I+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 745 VRNPF-VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLAL 801
+ N +V + T + ++ EY GDL + LR+ L + + ++ +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+L S +HRDL N+L+ H G I K+ DFGL++ IM +D++
Sbjct: 155 AFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLAR----------------DIM-NDSN 196
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 919
Y + +A ++APE + + + +D WS GI+L+E F G P+
Sbjct: 197 YV--------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY---- 244
Query: 920 PEIIFDNILNRKI 932
P + D+ + I
Sbjct: 245 PGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 37/235 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL-DMIRKNDIERILAERNILITVR 746
+F+ IK + GAFG V+ G+ I +K+L + + IL E ++ +V
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI----AELVLALE 802
NP V R + L+ + + G L +R+ ++++ Y+ ++ +
Sbjct: 68 NPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMN 123
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LGADEK----------- 164
Query: 863 EYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915
EY + P ++A E +L + + +D WS G+ ++E +T G P+
Sbjct: 165 EYHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 43/230 (18%)
Query: 691 IIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
I K I G FG V R + G AIK + ++ D L+E +I+ +
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF---LSEASIMGQFDH 64
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LA 800
P ++ T + +V EY+ G L + LRK + + +LV
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK------HDGQFTVIQLVGMLRGIASG 118
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
++YL +G VHRDL N+L+ + K++DFGLS++ + + + + G +P
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI--- 173
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
+ APE + + A+D WS GI+++E ++
Sbjct: 174 -------------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 59/266 (22%), Positives = 107/266 (40%), Gaps = 59/266 (22%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAI---------KQVLKKLDMIR----KNDIERILAERNI 741
+ G FG V L DL + + +L + ++R KN L E I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV------------ 789
L +++P ++R D L ++ EY+ GDL L +++
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 790 ------ARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
+ +++A ++ ++YL SL VHRDL N L+ + IK+ DFG+S+
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR------ 186
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902
+ + +Y + R AV ++A E +L + A+D W+ G
Sbjct: 187 ---------------NLYAGDYYRIQGR----AVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 903 IILFEFIT--GIPPFTAESPEIIFDN 926
+ L+E + P+ + E + +N
Sbjct: 228 VTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 42/236 (17%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERI--LAE 738
I K I G FG V R + G AIK LK +D +R+ L E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT-LKA----GSSDKQRLDFLTE 55
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
+I+ +P ++R T + ++ EY+ G L LR+ + + ++
Sbjct: 56 ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGML 112
Query: 799 ----LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
++YL + VHRDL N+L+ + K++DFGLS+ +
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR----------------L 156
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
S+A Y T + T APE + + A+D WS GI+++E ++
Sbjct: 157 EDSEATY-----TTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 46/169 (27%), Positives = 65/169 (38%), Gaps = 52/169 (30%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKK----------LDM-IRKNDIERILAERN 740
+ I +GA ++L D + V+K+ LD +R+ ER E
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREAR 51
Query: 741 ILITVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEED 788
IL R +V DN +VMEY+ G L LLR+VG
Sbjct: 52 ILAKAREAGVPVPIVYDVDP----DNGLIVMEYIEGELLKDALEEARPDLLREVG---RL 104
Query: 789 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
V + LH GIVH DL N++++ G I DFGL +
Sbjct: 105 VGK------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 20/168 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL-DMIRKNDIERILAERNILITV 745
+D + I G FG+V AR + G + +K++ + K+D E +L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 746 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------------ 792
+P ++ + R LYL +EY G+L LRK LE D A
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 793 ----YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 40/244 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKQVLKKL-DMIRKNDIERILAERNILIT 744
D +++ + GAFG V+ R GD ++ +K L + + D L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 745 VRNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE 802
+ +VR SF R ++++E + GGDL S LR+ E + + + +L+ A +
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 803 ------YLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDG 853
YL +HRD+ N L+ G K+ DFG+++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----------------- 167
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGI 912
D + Y + R A+ ++ PE L D WS G++L+E F G
Sbjct: 168 ----DIYRASYYRKGGR----AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219
Query: 913 PPFT 916
P+
Sbjct: 220 MPYP 223
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 51/251 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDL--FAIKQVLK---KLDMIRKNDIERILAERNILITVRNPF 749
+ RG +G V+ A+++ D +A+KQ+ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS------ 62
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 800
+ + F S R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 915
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 916 TAESPEIIFDN 926
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 34/139 (24%)
Query: 774 DLYSLL----RKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 828
DLY+ L R +G + VAR +L+ A++Y+H GI+HRD+K +N+L+ I
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 829 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 888
L DFG + G + HY GT D APE+L
Sbjct: 301 LGDFGAACF-------------ARGSWSTPFHY------------GIAGTVDTNAPEVLA 335
Query: 889 GTEHGYAADWWSVGIILFE 907
G + + D WS G+++FE
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 56/255 (21%), Positives = 91/255 (35%), Gaps = 69/255 (27%)
Query: 690 EIIKPISRGAFGRVFLA-----------------RKRTTGDLFAIKQVLKKLDMIRKNDI 732
++ + G FG V L L A+K + + D
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAP-VLVAVKVLRPDASDNAREDF 66
Query: 733 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------- 781
+ E IL + +P + R T L ++MEY+ GDL L+K
Sbjct: 67 LK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 782 -----VGCLEEDVARIYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
L +Y+A + + + YL SL VHRDL N L+ + IK+ DFG
Sbjct: 124 SKSLSFSTL------LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG-- 175
Query: 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895
M + + +Y + R A ++A E +L +
Sbjct: 176 -------------------MSRNLYSSDYYRVQGR----APLPIRWMAWESVLLGKFTTK 212
Query: 896 ADWWSVGIILFEFIT 910
+D W+ G+ L+E +T
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 56/237 (23%), Positives = 108/237 (45%), Gaps = 41/237 (17%)
Query: 693 KPISRGAFGRVFLA--RKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFV 750
K + G FG V++A K T A+K +K M +E LAE N++ T+++ +
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK---VAVK-TMKPGSM----SVEAFLAEANVMKTLQHDKL 63
Query: 751 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLG 808
V+ ++ ++ +Y++ E++ G L L+ ++ + ++ + A++ + ++
Sbjct: 64 VKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 868
+HRDL+ N+L++ K+ DFGL+++ N G A +P
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----------AKFP------ 166
Query: 869 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-ESPEII 923
+ APE + +D WS GI+L E +T G P+ +PE+I
Sbjct: 167 ----------IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-07
Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
S F+I+ + G FG+V A R + A+K V R IE E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 745 VRNPF----VVRFFYSFTCRDNLYLVM-EYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 799
+ F + R+F + T ++ +VM +Y G L + K G ++A+++
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHR----HLAQIIF 238
Query: 800 ----ALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
AL+Y H+ L ++H DLKP+N+L+ + +D P T+
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETS----------------DTVVD---PVTNRA 279
Query: 855 MPSDAHYPEYQQ----TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909
+P D D R+ +A V T Y +PE++LG Y+ D WS+G I++E
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339
Query: 910 TG 911
TG
Sbjct: 340 TG 341
|
Length = 467 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 34/221 (15%)
Query: 703 VFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT---VRNPFVVRFFYSFTC 759
V+LAR TG L ++ + L+ + E + A +N ++ R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVR--ITDLENCTE---EHLKALQNEVVLSHFFRHPNIMTSWTVFTT 70
Query: 760 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817
L+++ ++ G SLL+ + E + + + L YLH G +HR++K
Sbjct: 71 GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKAS 130
Query: 818 NLLIAHDGHIKLTDFGLSKI-GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 876
++LI+ DG + L+ GLS + L+ N G + + +P++ S
Sbjct: 131 HILISGDGLVSLS--GLSHLYSLVRN-----GQKAKVVY----DFPQF---------STS 170
Query: 877 GTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF 915
P +L+PE+L +GY +D +SVGI E TG PF
Sbjct: 171 VLP-WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 55/238 (23%), Positives = 105/238 (44%), Gaps = 40/238 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ +++ I G FG V+L AIK + ++ M ++ IE E +++ +
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTI-REGAMSEEDFIE----EAQVMMKLS 57
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLH 805
+P +V+ + T R + LV E++ G L LR + G ++ ++ + YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S ++HRDL N L+ + +K++DFG+++ L D Y
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL------------------DDQYT--- 156
Query: 866 QTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 919
S+ GT + +PE+ +++ +D WS G++++E F G P+ S
Sbjct: 157 --------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-07
Identities = 42/129 (32%), Positives = 54/129 (41%), Gaps = 37/129 (28%)
Query: 722 KKLD-MIRKNDIERILAERNILITVRN-----PFVVRFFYSFTCRDNLYLVMEYLNGGDL 775
+LD +R ER AE +L R P + Y + +VMEY+ G DL
Sbjct: 372 PELDERLRT---ERTRAEARLLSEARRAGVPTPVI----YDVD-PEEKTIVMEYIGGKDL 423
Query: 776 Y-------SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 828
L+RKVG E VA+ LH GIVH DL N ++ D +
Sbjct: 424 KDVLEGNPELVRKVG---EIVAK------------LHKAGIVHGDLTTSNFIV-RDDRLY 467
Query: 829 LTDFGLSKI 837
L DFGL K
Sbjct: 468 LIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 57/294 (19%)
Query: 689 FEIIKPISRGAFGRV---FLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
F + + + +G FG V L + + A+K + K D+ +DIE L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML--KADIFSSSDIEEFLREAACMKEF 58
Query: 746 RNPFVVRFF-YSFTCRDNLYL-----VMEYLNGGDLYS--LLRKVG----CLEEDVARIY 793
+P V++ S R L ++ ++ GDL++ L+ ++G L +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 794 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+ ++ +EYL S +HRDL N ++ + + + DFGLSK
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK----------------K 162
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 911
I D Y+Q A P +LA E L + +D W+ G+ ++E +T G
Sbjct: 163 IYSGDY----YRQG------CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRG 212
Query: 912 IPPFTA-ESPEI----IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
P+ E+ EI I N L + P D + +L+ + +P R
Sbjct: 213 QTPYAGVENSEIYNYLIKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 52/277 (18%)
Query: 657 ENSRLILDSVSQSSGVSTPLHSSHKERTS--IDDFEIIKPISRGAFGRVFL-ARKRTTGD 713
+ S L D + PL + + + F +I + GAFG++F+ A + +T +
Sbjct: 116 DASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEE 175
Query: 714 LFAIKQVLKKLDMIRKNDIERILA-------------ERNILITVR--NPFVVRFFYSFT 758
A + V K ER++A E IL R + +++
Sbjct: 176 AEARRGVNSTNQGKPKC--ERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILR 233
Query: 759 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLALEYLHSLGIVHRD 813
N Y++ + + DLYS + +D R + +L+ A+EY+H ++HRD
Sbjct: 234 SEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRD 292
Query: 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873
+K +N+ + DG I L DFG MP +++ +
Sbjct: 293 IKLENIFLNCDGKIVLGDFGT-------------------AMP-------FEKEREAFDY 326
Query: 874 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
VGT +PEIL G + D WS G+IL + ++
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 20/168 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-LFAIKQVLKKLDMIRKNDIERILAERNILITV 745
+D + I G FG+V A + G + A ++LK + +ND E +L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 746 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------------ 792
+P ++ + R LY+ +EY G+L LRK LE D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 793 ----YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+ +++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 68/259 (26%)
Query: 687 DDFEIIKPISRGAFGRVF--LARKRTTGDL---FAIKQVLKKLDMIRKNDIERILAERNI 741
+ +++ + +G+FG V+ AR G+ A+K V + + + IE L E ++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIE-FLNEASV 62
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR---------- 791
+ VVR + +VME + GDL S LR L +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR---SLRPEAENNPGRPPPTLQ 119
Query: 792 ---IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848
AE+ + YL++ VHRDL N ++AHD +K+ DFG+++ D+
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIY- 170
Query: 849 PETD-------GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 901
ETD G++P ++APE L ++D WS
Sbjct: 171 -ETDYYRKGGKGLLPV----------------------RWMAPESLKDGVFTTSSDMWSF 207
Query: 902 GIILFEFITGIPPFTAESP 920
G++L+E + AE P
Sbjct: 208 GVVLWEITS-----LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 695 ISRGAFGRVFLARKRTTG-DLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 752
I G FG+V AR + G + A + +K + K+D E +L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----------------YIAE 796
+ R LYL +EY G+L LRK LE D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 38/150 (25%), Positives = 62/150 (41%), Gaps = 14/150 (9%)
Query: 691 IIKPISRGAFGRVFLARKRTTGDLFA--IKQVLKKLDMIRKNDIERILAERNILITVRNP 748
IK + G RV+L D K D R+ I ++LA + + + P
Sbjct: 2 SIKLLKGGLTNRVYLL-GTKDEDYVLKINPSREKGADREREVAILQLLARKGLPV----P 56
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
V+ S YL+ME++ G L +V E++ +AEL+ L L L
Sbjct: 57 KVL---ASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV 109
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838
+ H DL P N+L+ + + D+ + G
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 693 KPISRGAFGRVF---LARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749
K + G FG V L++ + A+K + KLD+ ++IE L+E + +P
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM--KLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 750 VVRFF-YSFTCRDNLYL-----VMEYLNGGDLYSLL--RKVGCLEEDVAR----IYIAEL 797
V++ F + ++ ++ GDL+S L ++G L E + ++ ++
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
L +EYL + +HRDL N ++ D + + DFGLSK
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 47/229 (20%)
Query: 695 ISRGAFGRVFLARKRTTG---DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVV 751
I G FG V R + G AIK + ++ D L+E +I+ +P ++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDF---LSEASIMGQFDHPNII 68
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYL 804
T + ++ E++ G L S LR ++ + + +LV ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLR------QNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+ VHRDL N+L+ + K++DFGLS+ L ++T D P Y
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSD----------------PTY 165
Query: 865 QQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
S++G + APE + + A+D WS GI+++E ++
Sbjct: 166 T--------SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 45/245 (18%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR--KNDIERILAERNILITVRNPF 749
+K + GAFG V+ G+ I +K L+ K ++E + E I+ ++ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPH 70
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----YIAELVLALEYLH 805
+VR + LV + + G LL V ++++ + ++ + YL
Sbjct: 71 LVRLL-GVCLSPTIQLVTQLMPHG---CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+VHRDL N+L+ H+K+TDFGL+++ L G E EY
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARL--------LEGDEK-----------EY- 166
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIPPFTAE 918
N ++A E + + + +D WS G+ ++E +T GIP T E
Sbjct: 167 -----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TRE 219
Query: 919 SPEII 923
P+++
Sbjct: 220 IPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 49/231 (21%)
Query: 693 KPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749
K I G FG VF + G AIK + ++ D L+E +I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF---LSEASIMGQFSHHN 67
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDL----------YSLLRKVGCLEEDVARIYIAELVL 799
++R T ++ EY+ G L +S + VG L A
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAA--------- 118
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
++YL + VHRDL N+L+ + K++DFGLS++ + + + + + G +P
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPI-- 174
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
+ APE + + A+D WS GI+++E ++
Sbjct: 175 --------------------RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 64/256 (25%), Positives = 103/256 (40%), Gaps = 49/256 (19%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK-NDIERILAERNILITVRNPFVVRF 753
I +G FG V+ + D I +K L+ I ++E+ L E I+ +P V+
Sbjct: 3 IGKGHFGCVYHGTLIDS-DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 754 FYSFTCRDNLYLV-MEYLNGGDLYSLLRK----------VGCLEEDVARIYIAELVLALE 802
+ LV + Y+ GDL + +R +G VA+ +E
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAK--------GME 112
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YL S VHRDL N ++ +K+ DFGL++ D +
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLAR---------------------DIYDK 151
Query: 863 EYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920
EY N H+ P ++A E L + +D WS G++L+E +T G PP+
Sbjct: 152 EYYSVHN---HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208
Query: 921 EIIFDNILN-RKIPWP 935
I +L R++ P
Sbjct: 209 FDITVYLLQGRRLLQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQ---VLKKLDMIRKNDIERILAERNILITVRNPFVV 751
+ +G F ++F +R GD + + +LK LD +N E +++ + + +V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 810
+ C D +V EY+ G L + L+K L ++ +A +L AL +L G+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 811 HRDLKPDNLLIAHDGH--------IKLTDFGLS 835
H ++ N+L+ + IKL+D G+S
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 46.3 bits (111), Expect = 2e-05
Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 765 LVMEYLNGGDLYS-LLRKVGCLEEDVARIY--IAELVLALEYLHSLGIVHRDLKPDNLLI 821
LVME++ G + + L+ V L ED +Y I EL+ L G+VH DL N+L+
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKL--YREAGLVHGDLSEYNILV 148
Query: 822 AHDGHIKLTDFG 833
DG + + D
Sbjct: 149 -DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 38/167 (22%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 762 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 820
+L LV + G L +R+ L+ + ++ + YL +VHR+L N+L
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141
Query: 821 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP- 879
+ D +++ DFG+ +D YP+ D + +S TP
Sbjct: 142 LKSDSIVQIADFGV----------------------ADLLYPD----DKKYFYSEHKTPI 175
Query: 880 DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 925
++A E +L + + +D WS G+ ++E ++ G P+ P + D
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-05
Identities = 53/191 (27%), Positives = 75/191 (39%), Gaps = 41/191 (21%)
Query: 675 PLHSSHKERTSIDDFEIIKPISRGAFGRVFLA-----RKRTTGDLFAIKQVLKKLDMIRK 729
PL + DDF + K + GAFG V+ A + + G VLKK
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKY-----VLKKAT--EY 172
Query: 730 NDIERILAERNILITVRNPFVVRFFYSFTC------RDNLYLVMEYLNGGDLYSL----- 778
+E + ER + N F Y F D +LV Y L L
Sbjct: 173 GAVEIWMNER-VRRACPN-SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKE 230
Query: 779 ---------LRKVGCL------EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823
L KV L E + + + +++ AL+ LHS GIVHRD+KP N++ +
Sbjct: 231 FPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 824 -DGHIKLTDFG 833
G K+ D G
Sbjct: 291 GSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 71/298 (23%)
Query: 693 KPISRGAFGRVFLARKRT--------TGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
I G FG+V L +L A ++L +++ R L N+L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 745 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAEL 797
+ C ++ LV+E+ GDL + LR ++DV + E+
Sbjct: 61 LGQ-----------CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
L +LH +H DL N + D +K+ D+GL+
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL--------------------- 148
Query: 858 DAHYPE-YQQTDNRNRHSAVGTPDYLAPEI-------LLGTEHGYAADWWSVGIILFE-F 908
YPE Y T + + +LAPE+ LL + ++ WS+G+ ++E F
Sbjct: 149 -EQYPEDYYITKDCH----AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
Query: 909 ITGIPPFTAESPEIIFDNIL---NRKIPWPCVP---SDMSFEAQDLINRFLIHDPNQR 960
P+ S E + ++ + K+P P + SD +E + +F DP R
Sbjct: 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE----VMQFCWLDPETR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 50/244 (20%)
Query: 693 KPISRGAFGRVF--LAR---KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
+ + +G+FG V+ +A+ K AIK V + M + IE L E +++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIE-FLNEASVMKEFNC 68
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA---------RIYIA-EL 797
VVR + ++ME + GDL S LR + E+ I +A E+
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------------------- 167
Query: 858 DAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916
+ +TD + P +++PE L +D WS G++L+E T
Sbjct: 168 -----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----L 217
Query: 917 AESP 920
AE P
Sbjct: 218 AEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 35/148 (23%), Positives = 70/148 (47%), Gaps = 28/148 (18%)
Query: 794 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+ ++ +E+L S +VH+DL N+L+ ++K++D GL + + L G +
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG---NS 186
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGI 912
++P +++PE ++ + +D WS G++L+E F G+
Sbjct: 187 LLPI----------------------RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 913 PPFTAESPEIIFDNILNRKIPWPCVPSD 940
P+ S + + + I NR++ PC P D
Sbjct: 225 QPYCGYSNQDVIEMIRNRQV-LPC-PDD 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 30/134 (22%)
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
+E+L S VHRDL N+L+A +K+ DFGL++ IM D+
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----------------DIM-HDS 291
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAE 918
+Y ++ S ++APE + + +D WS GI+L+E F G P+
Sbjct: 292 NYV--------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY--- 340
Query: 919 SPEIIFDNILNRKI 932
P +I D+ KI
Sbjct: 341 -PGMIVDSTFYNKI 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 19/90 (21%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
R +Y F + L + + +++ C + + + + +++ LEY+H GI H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 26/124 (20%)
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
Y ++ +E+L S +HRDL N+L++ + +K+ DFGL++ D+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--------DI------ 224
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITG 911
Y+ D + SA ++APE + + +D WS G++L+E F G
Sbjct: 225 -----------YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 912 IPPF 915
P+
Sbjct: 274 ASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 18/37 (48%), Positives = 21/37 (56%), Gaps = 1/37 (2%)
Query: 800 ALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLS 835
AL LH GI H DL KP N L+ DG + DF L+
Sbjct: 123 ALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159
|
Length = 365 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 31/143 (21%)
Query: 774 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833
DLY +KV LE+ + Y ++ +E+L S +HRDL N+L++ + +K+ DFG
Sbjct: 170 DLY---KKVLTLEDLIC--YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 893
L++ D+ + D + DA P ++APE + +
Sbjct: 225 LAR--------DIY-KDPDYVRKGDARLPL----------------KWMAPETIFDRVYT 259
Query: 894 YAADWWSVGIILFE-FITGIPPF 915
+D WS G++L+E F G P+
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 40/187 (21%), Positives = 61/187 (32%), Gaps = 47/187 (25%)
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
A + L L L HR K N+L+ DG +KL G PE
Sbjct: 21 AVCLQCLGALREL---HRQAKSGNILLTWDGLLKL--DGSVAF---------KTPEQSR- 65
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 915 FTAESP-----EIIFDNILNRKIPWPCVPSDMS--FEAQDLINRFLIHDPNQRLGANGAA 967
+ E EI+ + + +S +D + P +R AN
Sbjct: 104 YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN--- 160
Query: 968 EVKAHPF 974
AH
Sbjct: 161 HYLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 28/147 (19%)
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+E+L S VHRDL N+LI +K+ DFGL++ IM D++
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR----------------DIM-RDSN 294
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919
Y ++ S ++APE + + +D WS GI+L+E T G P+
Sbjct: 295 YI--------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 920 PEIIFDNILNR--KIPWPCVPSDMSFE 944
F N + R ++ P SD +E
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 38/160 (23%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLK--KLDMIRKNDIERILAERNILITVRNPFV 750
K + G FG V + D +K +K K+ + ++++E L+E + +P V
Sbjct: 5 KTLGEGEFGSVM--EGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 751 VRFFYSFTCRDNL--------YLVMEYLNGGDLYSLL--RKVG----CLEEDVARIYIAE 796
+R C + +++ ++ GDL+S L ++G L + ++ +
Sbjct: 63 MRLIG--VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+ +EYL S +HRDL N ++ + ++ + DFGLSK
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 27/176 (15%)
Query: 736 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYI 794
LAE L + +VR T + + +V EY++ G L S LRK G L +
Sbjct: 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
L ++YL +G VH+ L +L+ D K++ F E
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------------RLQEDK-- 158
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
S+A Y T + + APE + A+D WS GI+++E ++
Sbjct: 159 --SEAIY-----TTMSGKSPVLWA----APEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 825
VMEY++G +LY + R + ED + E++ + + GI+H DL N+L+ D
Sbjct: 109 VMEYIDGVELYRV-RVL----EDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162
Query: 826 HIKLTDF 832
I + D+
Sbjct: 163 KIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 5/77 (6%)
Query: 759 CRDNLYLVMEYL-NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKP 816
+ N+ LVME++ + G L+ V EE+ +Y ++V + L G+VH DL
Sbjct: 89 LKKNV-LVMEFIGDDGSPAPRLKDVPLEEEEAEELY-EQVVEQMRRLYQEAGLVHGDLSE 146
Query: 817 DNLLIAHDGHIKLTDFG 833
N+L HDG + D
Sbjct: 147 YNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 26/116 (22%)
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+ +L S +HRDL N+L+ H K+ DFGL++ I N +++ ++ +A
Sbjct: 227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IRN-------DSNYVVKGNAR 277
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 915
P ++APE + + + +D WS GI+L+E F G P+
Sbjct: 278 LP----------------VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 22/80 (27%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 819
L + L LL ++ L E + + L+ AL L +VH DL P NL
Sbjct: 123 LKLLRQLAAALRRLVAAELLDRLAELWERLLA-ALLALLPALP----LVLVHGDLHPGNL 177
Query: 820 LIAHDGHIK-LTDFGLSKIG 838
L+ G + + DF + +G
Sbjct: 178 LVDPGGRVTGVIDFEDAGLG 197
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 7/69 (10%)
Query: 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDLKPDNLLIAH 823
+VMEY+ G +LY L V +E I + +L + + GIVH DL N+L+
Sbjct: 184 VVMEYIEGVELYRLRLDVENPDE------ILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237
Query: 824 DGHIKLTDF 832
DG I + D+
Sbjct: 238 DGDIVVIDW 246
|
Length = 304 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1093 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.56 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.16 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.06 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.02 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.01 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.91 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.82 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.77 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.69 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.69 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.42 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.19 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.5 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.16 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.66 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 95.65 | |
| PLN02236 | 344 | choline kinase | 95.42 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.29 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.96 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.69 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.49 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.46 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.37 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.9 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.28 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 93.05 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.25 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 91.15 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.28 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.04 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 90.01 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 87.43 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 85.71 | |
| PTZ00296 | 442 | choline kinase; Provisional | 85.21 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-78 Score=686.03 Aligned_cols=373 Identities=46% Similarity=0.801 Sum_probs=320.7
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
++.++||+++++||+|+||+||+|+.++||+.|||| +++|..+....++++++.|++||...++||||+||++||+.++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK-~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMK-ILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeee-cccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 568999999999999999999999999999999999 8899999999999999999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+||||||+||||++++|.+.+.|+++.+++|+++++.||+.||++|||||||||+|+|||..||+||+|||||+.....+
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997544433
Q ss_pred cccCCC-----------CCCCCCC---------CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecch
Q 001354 843 TIDLSG-----------PETDGIM---------PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902 (1093)
Q Consensus 843 s~dls~-----------~~td~~~---------p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLG 902 (1093)
.++..+ ....... .....+..|+++++..+++++|||.|||||||++++|+..|||||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 333211 0000011 11223456888888999999999999999999999999999999999
Q ss_pred hhHHHHHhCCCCCCCCChHHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 903 IILFEFITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 903 VILYEMLTGkpPF~~~s~~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
|||||||+|+|||++.++++++++|++.. +.||. ...++++++|||.+||+ ||.+|++.+++.||+.||||++|+|
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 99999999999999999999999999865 67775 46789999999999999 9999999999999999999999999
Q ss_pred chhhcccCcccCCCCCCCCCcccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCccccCCCCCCcccccce
Q 001354 981 DSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFS 1060 (1093)
Q Consensus 981 d~L~~~~pPf~P~~~s~~Dts~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~~~~~~d~~F~g~t 1060 (1093)
+.+...+|||+|.+.++.|++||+. |++.....+..+ ....|+. |. .+...+...+|-+|+|||
T Consensus 454 ~~l~~~~apfvP~v~~~~DT~yFdd-F~e~~~~~~~~~-----------~~~~~~k-~~---~~~~~~~~~~~~~FvgfT 517 (550)
T KOG0605|consen 454 DHLREMPAPFVPQVNSELDTQYFDD-FPEEDSMTPTAD-----------KSGPSRK-ML---SMVDTNNSSKDINFVGFT 517 (550)
T ss_pred chhhcCCCCCCCCCCCccccccccc-CcccccCccccc-----------ccccchh-hh---hcccccCCccccccccee
Confidence 9999999999999999999999996 444322222111 1112221 21 112223456788899999
Q ss_pred Eecchhhhccchhh
Q 001354 1061 FKNLSQLASINHEV 1074 (1093)
Q Consensus 1061 yk~~~~~~~~~~~~ 1074 (1093)
||+|+++.+-+...
T Consensus 518 yk~~~~~~~~~~~~ 531 (550)
T KOG0605|consen 518 YKNFDGLNKANSLL 531 (550)
T ss_pred eecccccccccccc
Confidence 99999999887764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-77 Score=713.78 Aligned_cols=1018 Identities=35% Similarity=0.441 Sum_probs=782.8
Q ss_pred CCCcccccccccCCCC-CCccccccccccCCCCCc---ccccccccccchhcc-hhhH-HHHHhhchH--HHHHH-----
Q 001354 12 GIPSGLNRIKTRGGVS-KPDELTESRSYGVSRPPQ---KHKQKTVAQGHVKLA-NSFT-EEVRKGKKI--AQWFT----- 78 (1093)
Q Consensus 12 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~--~~~~~----- 78 (1093)
-+++|+|+|||+-.-. -+-.|..- -+.|+|- -.||+-|..|+...| |.|. -.-+++-|+ .+|..
T Consensus 80 p~e~df~~IklisngAygavylvrh---~~trqrfa~kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdmvla~ 156 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRH---KETRQRFAMKINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDMVLAV 156 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeec---cccccchhhcccccchhhhccccccCCcceechhhhhcccCCCCcchhhHHh
Confidence 4678999999974221 11111100 1223332 257888888877665 5554 223444444 34443
Q ss_pred hhcccceecCCCCCCCCCCCCCCCcCCccccccccccccchhhhHHHHhhhcccccCCccccccccCCCCCCCCCCccCC
Q 001354 79 SYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAH 158 (1093)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (1093)
.|.-.+.||-+.--+.+.+-+-+ -+.||-..| ..|.+|.-..- -+.+-++++|+||++.||.-.--+.+++
T Consensus 157 Eylh~ygivhrdlkpdnllIT~m-----GhiKlTDfg---Lsk~GLms~at-nl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 157 EYLHSYGIVHRDLKPDNLLITSM-----GHIKLTDFG---LSKKGLMSLAT-NLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred HhhccCCeecCCCCCCcceeeec-----ccccccchh---hhhhhhhhccc-hhhhcchHHHHHHhhhccccCCccccCh
Confidence 37777889988777666554433 234444443 56777765554 6778899999999999998888889999
Q ss_pred CcCCHH--------HHHHHHHHHHHHHHHhhhhh-----HhhhHHHHHHHHhhcCCCCchhhhHHHHHHHHHHHhhhhhc
Q 001354 159 SYNDLK--------ELLDTLHSRFDAAKEVVNSE-----LATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTS 225 (1093)
Q Consensus 159 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (1093)
.|+..+ +.+|.|+.+|.-.++-|..+ +|+|+.|.+...|+++-.-.|-++++++||..+-+|..||.
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 999999 99999999999999999999 99999999999999998899999999999999999999999
Q ss_pred chhhhhhhHHHHhhHHh---HhcCcchHHHHhhhhhHHHhHhhhHHhhccccccchhcc--chhhHhhhcccCCcccccc
Q 001354 226 CLFRANCETIVQDLTEK---RQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEK--SLHKFKKCLESVPAVETSW 300 (1093)
Q Consensus 226 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 300 (1093)
=-||+-||-|+|.||.+ ||+|+-+.++|...+|+||+|||+|+-+|.+|...+++- ..++|.-|.+-..++..+|
T Consensus 308 ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~~~ees~~~~~qFsscs~r~~kv~ss~ 387 (1205)
T KOG0606|consen 308 GALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDTGDEESSLEFRQFSSCSPRFSKVYSSW 387 (1205)
T ss_pred hhhhhhhccceeecccchhhhhhccccccccccccchhhcccchheeeccccCCccccccccccccccccccccccccch
Confidence 99999999999999999 999999999999999999999999999999999999888 6789999999999999999
Q ss_pred cC-------CCCccccchhhHHHHhhhccccccccc--cccccccccccCccCccccccccccceeccCCCCccccchhh
Q 001354 301 VP-------SPGTAESDLDYASYQKANAKKKISGQQ--KVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSR 371 (1093)
Q Consensus 301 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (1093)
-- .+-.-++...+-.++- +-.++. +...-|++..-.-+..+++..+| -.--|.|.+-++-
T Consensus 388 ~~l~~~~t~~~~~~~~~~~~~~~~~-----~~~g~k~~~~~~sp~~~kl~~st~~ss~s~~------~~~s~~~~~~~~~ 456 (1205)
T KOG0606|consen 388 ESLAQLETATPREKSSQSSQGEVSP-----SSAGQKDSWKSNSPESSKLELSTALSSVSPN------HPGSPSKSLTSAA 456 (1205)
T ss_pred hhhhccccccccccccccccccccC-----CccccccccccCChhhhhccccchhhhcccc------cCCCccccccchh
Confidence 65 1111111111111110 111111 12222322222222122222222 0122223332221
Q ss_pred h----hh------hccccccce------EEEEeecC-------C--------------CCCCcCCCCCCCCCceeeeccc
Q 001354 372 M----QE------QQSHIVEGR------IVEVTKSN-------C--------------GSPHEQGQSLDGSDSVICRICE 414 (1093)
Q Consensus 372 ~----~~------~~~~~~~~~------~~~~~~~~-------~--------------~~~~~~~~~~~~~~~~~~~~~~ 414 (1093)
- +. -.+++..+| ++.-++.. | ...|..-+.+..+|+.||||||
T Consensus 457 s~~~~~~~~s~~~~ds~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v~~~d~~i~~~~e 536 (1205)
T KOG0606|consen 457 STLRTALRTSSPSEDSKIFPLRAPPPPSSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCVGTSDSGICRICE 536 (1205)
T ss_pred hhhccccccCCCCCCccccccCCCCCccccccCCCCCCCcccccCCCCCCcccchhhhccccccccccccCCcccccccc
Confidence 1 11 123333443 22111110 1 1345566889999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhHHhHHHHHHHHHhhcc--CCCCCCCCCCcccccccCccceeccCCCccc
Q 001354 415 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCN--SSSHPILGSPENSRTQSMNSAITYDGYSPKI 492 (1093)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 492 (1093)
.++|..|.|.|++||+++++|+.+|++++.|+.|+.+.++++..|.. ++.+| .|+|..+..+ +...-++..| +.
T Consensus 537 ~~~p~~~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~-~~~~l~s~lS--~~~~sS~p~S-rd 612 (1205)
T KOG0606|consen 537 AEGPRLHSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTP-TGGPLCSPLS--PRSLSSNPSS-RD 612 (1205)
T ss_pred cccccccccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCC-cccccccccC--CCCCCCCccc-Cc
Confidence 99999999999999999999999999999999999999999877654 33444 4667776663 5556677777 99
Q ss_pred hhhhccCcchhhhccccccccccccCCCc--ceeecccccccccCCCCcCCCCcccccCCCCCCCCCCccccccccCCch
Q 001354 493 SEWRNKGVEGMFEDIHEMDTACIDDSHLG--SLNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPA 570 (1093)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~s~t~~~~~~~p~~~h~~~~~~~~~~~~ 570 (1093)
+.|+|+++++|+++.+.++.. +.+..+| .+.++-..|-++ .|+-.++.++-+..||.++|...|.|.+|..+|+.-
T Consensus 613 sspsrd~s~~~~~~~ppI~i~-~~~~~yGft~~airVy~Gd~d-~ytvhh~v~sv~egsPA~~agls~~DlIthvnge~v 690 (1205)
T KOG0606|consen 613 SSPSRDSSAAMLSLRPPITIH-FSGKKYGFTLRAIRVYMGDKD-VYTVHHSVGSVEEGSPAFEAGLSAGDLITHVNGEPV 690 (1205)
T ss_pred cccccccchhhcCcCCceeee-ccccccCceeeeEEEecCCcc-cceeeeeeeeecCCCCccccCCCccceeEeccCccc
Confidence 999999999999999987654 4555677 677778889888 999999999999999999999999999999999999
Q ss_pred hhHHHHhchHHHH--HHHhhccccccccCh-HhHHHhhchhHHHhhhcccceeeccchh-HHHHHHhhhhHHHHhhhccc
Q 001354 571 ELEDVQQMIELAD--IARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFG-SRIEKLLREKYILACELLDE 646 (1093)
Q Consensus 571 ~~~d~~~~~~l~~--~a~~~~~t~l~k~~~-~~l~~~l~~l~~~~~~~~~~~~vid~fg-~rI~Kl~r~k~il~~~lL~~ 646 (1093)
.-++..++.+|.. +++....|---+... -.-.++..+.+-+|.+.+.+..++++|+ .|+.++++..+.-.|+++..
T Consensus 691 ~gl~H~ev~~Lll~~gn~v~~~ttplenTSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~ 770 (1205)
T KOG0606|consen 691 HGLVHTEVMELLLKSGNKVTLRTTPLENTSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRKISKQDCELLHT 770 (1205)
T ss_pred chhhHHHHHHHHHhcCCeeEEEeeccccchhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHHHHhhhhhhhcc
Confidence 9999999999999 888877766666645 4455889999999999999999999999 88999999988877777654
Q ss_pred CCCCcccccccchhhhhhhcccCCCC---CCCCCCCccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehh
Q 001354 647 KSPTSFSKYKENSRLILDSVSQSSGV---STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723 (1093)
Q Consensus 647 kspts~sk~~ensrlllds~s~ss~~---~~~~~ss~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK 723 (1093)
......+ . +.+...... ..+..+.. .+.+.++|.+.+.+-+|+|+.++.+....+|...++| +.++
T Consensus 771 ~~s~~ss----~-----eS~pgdp~~sls~sP~sp~~-yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~-v~~~ 839 (1205)
T KOG0606|consen 771 SRSFLSS----S-----ESLPGDPTRSLSASPRSPTK-YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSK-VHGL 839 (1205)
T ss_pred ccccccc----c-----ccCCCCcccccccCCCCccc-ccCCCccceecccccCCCCcccccCCccccccccchh-hhcc
Confidence 3321000 0 111111111 11222222 5678999999999999999999999999999999999 7777
Q ss_pred hhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 001354 724 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 803 (1093)
Q Consensus 724 ~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeY 803 (1093)
..++...+.+..+.+..++....+|.++..+..|.....++|+|+|+.||+|...|++.+..+++.++.++..++.+++|
T Consensus 840 ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~ 919 (1205)
T KOG0606|consen 840 APKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLES 919 (1205)
T ss_pred chhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhc
Confidence 77777778888899999988889999999999998999999999999999999999999999999999999999999999
Q ss_pred HHhcCcEeeecCCCcEEEccCCcEEEEecC-CcccccccccccCCCCCCCCCC---CCCCCCCcccccCcCCccCccCCC
Q 001354 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFG-LSKIGLINNTIDLSGPETDGIM---PSDAHYPEYQQTDNRNRHSAVGTP 879 (1093)
Q Consensus 804 LHs~GIIHRDIKPeNILLD~dG~VKLsDFG-LAk~~~~~~s~dls~~~td~~~---p~~~~~~e~~~~~~~~~~s~vGTp 879 (1093)
||...++|||++|.|+|+..+|+.+++||| +.+.+.....++.++....+.. .....-+.............+||+
T Consensus 920 L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~ 999 (1205)
T KOG0606|consen 920 LHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTP 999 (1205)
T ss_pred cccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCC
Confidence 999999999999999999999999999999 5555555555555543332221 222222233333334567789999
Q ss_pred CCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCC
Q 001354 880 DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 880 ~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~K 959 (1093)
.|.|||.+.+...+..+|||++|++++|.++|.+||....++.+++.|.+...+||.-+...++++++++.++|..+|.+
T Consensus 1000 ~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1000 DYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred cccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCCCCCcccccccccCCCCCCCCCCCCCCCCC-CccCCCCCchhh
Q 001354 960 RLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD-TCDSSSNSRTEM 1038 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~~Dts~Fds~fs~~~~~l~~~d~~~~s~~s-t~~ss~~~~~em 1038 (1093)
|.++.++.++..||||++++|+.+..+.+.|+|++.+..|++||.+.|......+.....+..+... .+...
T Consensus 1080 r~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~~~~~~~e~~sg~s~~~~~~s~~~~~------- 1152 (1205)
T KOG0606|consen 1080 RLGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQPESTQDTSYFESRFSEESQDETVSGSSSGSKLDSPDESP------- 1152 (1205)
T ss_pred ccCcccccccccCCccCCCCccccccccCccCCCCCCCCccchhhcccccccccccccCCCcccCccCccccc-------
Confidence 9998888899999999999999999999999999999999999999988554333322222222211 12222
Q ss_pred hhcCCccccCCCCCCcccccceEecchhhhccchhhhhc
Q 001354 1039 DECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQ 1077 (1093)
Q Consensus 1039 ~Et~~F~e~~~~~~d~~F~g~tyk~~~~~~~~~~~~~~~ 1077 (1093)
++.+-..+....-++.|+||+||+..+|.+|||+++++
T Consensus 1153 -~~~~pe~~~~~~~~~sl~~~~~k~~s~l~s~~p~~~l~ 1190 (1205)
T KOG0606|consen 1153 -ECTTPELKPAMCGNLSLINFSFKNLSQLASINPDKLLQ 1190 (1205)
T ss_pred -cccCccccCCcCccccccccCccChhhccccChHhhcC
Confidence 22222222333347889999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-69 Score=593.22 Aligned_cols=303 Identities=49% Similarity=0.911 Sum_probs=283.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
....++|+++++||+|+||+||+++.++|++.|||| +++|..+....+.+++.+|+.||..++||+||+++++||+.+.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmK-vl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMK-VLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehh-hhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 567899999999999999999999999999999999 7888888888899999999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|||+||++||+|+.+|++.+.|+|..+++|+++|+.||.|||++|||||||||+|||||.+||++|+|||||+...
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--- 176 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--- 176 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999532
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.....+.++|||+.|||||++.+.+|+.++|||||||+|||||+|.+||.+.+...
T Consensus 177 ------------------------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 177 ------------------------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred ------------------------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 12335567999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC-hhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 999 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT-a~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~D 999 (1093)
++++|+.+++..+ |..++.++++||+++|.+||.+|++ .+++.+|.+||||++++|+.+..+ .|||+|......|
T Consensus 233 ~~~~I~~~k~~~~--p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~ 310 (357)
T KOG0598|consen 233 MYDKILKGKLPLP--PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLED 310 (357)
T ss_pred HHHHHhcCcCCCC--CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccc
Confidence 9999999986555 4669999999999999999999997 457999999999999999999777 7999999999999
Q ss_pred CcccccccccCCCCCC
Q 001354 1000 TSYFLSRFSQISSGLP 1015 (1093)
Q Consensus 1000 ts~Fds~fs~~~~~l~ 1015 (1093)
+++|+..|+...+...
T Consensus 311 ~~~Fd~eft~~~~~~~ 326 (357)
T KOG0598|consen 311 TSNFDNEFTSYTVDYS 326 (357)
T ss_pred cccccHHHHhccccCC
Confidence 9999999998855433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-65 Score=545.78 Aligned_cols=289 Identities=43% Similarity=0.837 Sum_probs=275.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+++|+++++||.|+||+|.+++.+.+|..|||| ++++....+..++++..+|..+|+.+.||++++|++.|.+..++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmK-vL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMK-VLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehh-hcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 67899999999999999999999999999999999 88888999999999999999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||||||++||.|+.+|++.++|++..++||++||++||+|||+++|++|||||+|||||++|++||+|||+|+..
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v----- 194 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV----- 194 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999953
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
...+++.||||.|+|||++..++|+.++|||||||++|||+.|++||.+.++..+
T Consensus 195 -------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 195 -------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred -------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 1236889999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhcc--cCcccC-CCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVP-QPESVD 998 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT--a~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P-~~~s~~ 998 (1093)
|++|+.+++.|| ..++++++|||+++|++|-.+|.+ .++..+|++||||++++|..+..+ ++|+.| ....+.
T Consensus 250 Y~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~g 326 (355)
T KOG0616|consen 250 YEKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPG 326 (355)
T ss_pred HHHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCc
Confidence 999999999998 789999999999999999999988 458999999999999999998777 788887 777899
Q ss_pred CCcccccc
Q 001354 999 DTSYFLSR 1006 (1093)
Q Consensus 999 Dts~Fds~ 1006 (1093)
|+++|+..
T Consensus 327 dtsnfd~y 334 (355)
T KOG0616|consen 327 DTSNFDDY 334 (355)
T ss_pred cccccccc
Confidence 99999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-64 Score=586.51 Aligned_cols=303 Identities=38% Similarity=0.766 Sum_probs=284.6
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~ 760 (1093)
.++.+++|.++++||+|+||+|+++..+.+++.|||| +++|..++..++++..+.|..|+.... ||+++.||.+||+.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK-~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIK-VLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEE-EeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 4788999999999999999999999999999999999 899999999999999999999999886 99999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+++|+||||+.||| +.+++..+.|++..+++|+++|+.||.|||++||||||||.+|||||.+||+||+|||||+...
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC-
Confidence 99999999999999 4444556889999999999999999999999999999999999999999999999999999632
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.....+.++||||.|||||++.++.|+.++|||||||+|||||+|.+||.+++.
T Consensus 520 --------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 520 --------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred --------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 123467899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 996 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s 996 (1093)
++++..|++..+.+| ..+|.++.+++++||.+||++|++. .++.+|+.||||+.|+|+.|..+ +|||+|...+
T Consensus 574 ee~FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~ 650 (694)
T KOG0694|consen 574 EEVFDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKG 650 (694)
T ss_pred HHHHHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCC
Confidence 999999999998887 7999999999999999999999995 57999999999999999999877 8999999999
Q ss_pred CCCCcccccccccCCCCCCC
Q 001354 997 VDDTSYFLSRFSQISSGLPD 1016 (1093)
Q Consensus 997 ~~Dts~Fds~fs~~~~~l~~ 1016 (1093)
+.|.+|||.+|+.....+.+
T Consensus 651 ~~D~snFd~eFt~e~p~Lt~ 670 (694)
T KOG0694|consen 651 PEDVSNFDEEFTSEKPALTP 670 (694)
T ss_pred hhhhcccchhhhcCCCccCC
Confidence 99999999999998777664
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-64 Score=606.96 Aligned_cols=296 Identities=44% Similarity=0.773 Sum_probs=276.1
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
..++..+||+++++||+|+||+|.+++++.|+++|||| ++.|..|.++.....|..|++||...+.+|||+|++.|+++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK-~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMK-ILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHH-HhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 45678899999999999999999999999999999999 88999999999999999999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.++|||||||+||||..+|.+.+.+++..|+||+++|+.||+.||+.|+|||||||+|||||..||+||+|||-|-.+..
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999875321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeecchhhHHHHHhCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
.........||||.|++||+|.. +.|+..|||||+||+|||||+|..||
T Consensus 228 --------------------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 228 --------------------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred --------------------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 12234567899999999999963 46899999999999999999999999
Q ss_pred CCCChHHHHHHHhcc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCC
Q 001354 916 TAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQ 993 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~--~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~ 993 (1093)
+.++-.++|.+|++. .+.||. ...+|.++++||+++++ +|..|+|.+|+.+|+.||||.|++|+.++...|||+|.
T Consensus 282 YadslveTY~KIm~hk~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 282 YADSLVETYGKIMNHKESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred hHHHHHHHHHHHhchhhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 999999999999986 677773 45699999999999999 89999999999999999999999999999999999999
Q ss_pred CCCCCCCccccc
Q 001354 994 PESVDDTSYFLS 1005 (1093)
Q Consensus 994 ~~s~~Dts~Fds 1005 (1093)
+.+++||+||+.
T Consensus 360 vssd~DTsnFd~ 371 (1317)
T KOG0612|consen 360 VSSDDDTSNFDV 371 (1317)
T ss_pred CCCCCccccccc
Confidence 999999999954
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-62 Score=544.07 Aligned_cols=433 Identities=32% Similarity=0.523 Sum_probs=350.3
Q ss_pred CCCCCCccccccccCCchhhH-HHHhchHHHHHHHhhccccccccChHhHHHhhchhH--HHhhhc---ccceeeccchh
Q 001354 553 TPKAGHFDPFWLERNHPAELE-DVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQ--DVLQHS---KLKALVIDTFG 626 (1093)
Q Consensus 553 ~p~~~h~~~~~~~~~~~~~~~-d~~~~~~l~~~a~~~~~t~l~k~~~~~l~~~l~~l~--~~~~~~---~~~~~vid~fg 626 (1093)
-|..--+..|| .++.| ++.......+.|+.|++..||++ +.+++++.. ++..+. +...+..+.|.
T Consensus 74 ~~~~~~~i~Fl-----~~v~eYE~~~~~~r~~~~~~i~~~~l~~~----~~~~~~~~s~~~~v~~~~~~l~~~~~~~lf~ 144 (591)
T KOG0986|consen 74 RPELRPAIEFL-----EEVKEYEKADDDERKDKARQILDAYLMKE----LLACLPQFSSKDLVTHVQEHLLEKPPKDLFQ 144 (591)
T ss_pred CchhhhHHHHH-----HHHHHHhcCCcccchhhHHHHHHHHhhcc----ccccCCCcchhhhhHHHhhhccccCchhhhH
Confidence 34445567788 22222 23337788999999999999999 777887763 222222 33345666666
Q ss_pred HHHHHHhhhhHHHHhhhcccCCCCcccccccchhhhhhhcccCCCCCCCCCCCccccccCCCeeEEEeeeccCCeEEEEE
Q 001354 627 SRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706 (1093)
Q Consensus 627 ~rI~Kl~r~k~il~~~lL~~kspts~sk~~ensrlllds~s~ss~~~~~~~ss~~~~isiddFeilr~LGkG~FGeVyla 706 (1093)
..++.. |..|.. ..|..|.+..- .+.+.+..- .+...+..+.|...++||+||||+||-+
T Consensus 145 ~~~~~~--------~~~L~~---~pF~~f~~S~y--f~rFlQWK~-------lE~qpvt~n~F~~~RvlGkGGFGEV~ac 204 (591)
T KOG0986|consen 145 PLARAI--------CAYLRG---DPFQEFLESDY--FTRFLQWKW-------LELQPVTKNTFRVYRVLGKGGFGEVCAC 204 (591)
T ss_pred HHHHHH--------HHHhcc---chHhHhHHHHH--HHHHHHHHH-------HHhhhccccceeeeEEEecccccceeEE
Confidence 555443 222222 11222221111 122222211 1123467789999999999999999999
Q ss_pred EECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCChHHHHHhcC--C
Q 001354 707 RKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--C 784 (1093)
Q Consensus 707 r~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g--~ 784 (1093)
+.+.||++||+| .+.|.++..+......++|..||.+++.|+||.|-|+|++.+.++|||..|+||||..+|.+.+ .
T Consensus 205 qvraTGKMYAcK-kL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~g 283 (591)
T KOG0986|consen 205 QVRATGKMYACK-KLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPG 283 (591)
T ss_pred EEecchhhHHHH-HHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCC
Confidence 999999999999 6667777777788889999999999999999999999999999999999999999999998877 7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcc
Q 001354 785 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864 (1093)
Q Consensus 785 LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~ 864 (1093)
|++..++||++||++||++||+.+||+|||||+|||||+.|||+|+|+|||..+.
T Consensus 284 F~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~------------------------- 338 (591)
T KOG0986|consen 284 FDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP------------------------- 338 (591)
T ss_pred CchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-------------------------
Confidence 9999999999999999999999999999999999999999999999999998532
Q ss_pred cccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC----hHHHHHHHhccCCCCCCCCCC
Q 001354 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----PEIIFDNILNRKIPWPCVPSD 940 (1093)
Q Consensus 865 ~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s----~~ei~~kIl~~~l~fP~ip~~ 940 (1093)
........+||.+|||||++.+..|+++.|||||||+||||+.|+.||.... .+++-+.++.....+| ..
T Consensus 339 ---~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~---~k 412 (591)
T KOG0986|consen 339 ---EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS---DK 412 (591)
T ss_pred ---CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc---cc
Confidence 1233445699999999999999999999999999999999999999997643 4577788888877777 79
Q ss_pred CCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCC-----CCCCcccccccccCC
Q 001354 941 MSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-----VDDTSYFLSRFSQIS 1011 (1093)
Q Consensus 941 IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s-----~~Dts~Fds~fs~~~ 1011 (1093)
+|+++++|.+.+|++||.+|++. +++.++++||||+++||..+... +|||+|.+.. +.|+..|+ +-.+
T Consensus 413 FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs---~VKG 489 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFS---TVKG 489 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcc---cccc
Confidence 99999999999999999999993 58999999999999999999877 8999999965 45665554 2347
Q ss_pred CCCCCCCCCCCCCCCCccCCCCCchhhhhcCCccccCC
Q 001354 1012 SGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGS 1049 (1093)
Q Consensus 1012 ~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~~~ 1049 (1093)
+.++++|..+|..|.|+..+++||+||.||++|.+.+-
T Consensus 490 V~ld~~D~~fy~~F~tg~vsipWQnE~~ET~~f~elnv 527 (591)
T KOG0986|consen 490 VKLDDTDTDFYKNFATGSVSIPWQNEMIETECFEELNV 527 (591)
T ss_pred eecccccHHHHHhccCCcccchHHHHHHHhhhHHHhhc
Confidence 88899999999999999999999999999999998744
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-61 Score=519.76 Aligned_cols=309 Identities=41% Similarity=0.746 Sum_probs=291.6
Q ss_pred CccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 679 s~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
....++.+++|+.+++||+|.||+|.+|+.+.+|+.|||| |++|..+..++++.+.+.|-++|...+||++..|-++||
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiK-IlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIK-ILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehh-hhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 3455688999999999999999999999999999999999 888888899999999999999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
..+++|+||||+.||.|+.+|.+...|+|+.+++|.++|+.||.|||+++||+||||.+|+|||.+||+||+|||||+..
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999953
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. .....+.++||||.|+|||++....|+.++|||.+||+||||++|+.||++.
T Consensus 319 I---------------------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 319 I---------------------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred c---------------------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 2 2345677899999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhcc--cCcccCCC
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 994 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT--a~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~ 994 (1093)
+...++..|+.+.+.|| ..++++++.|+..+|.+||.+|++ .++|.||..|+||.+|+|+.+..+ .|||+|++
T Consensus 372 dh~kLFeLIl~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 372 DHEKLFELILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred chhHHHHHHHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 99999999999999988 799999999999999999999999 568999999999999999998766 89999999
Q ss_pred CCCCCCcccccccccCCCCCCCCC
Q 001354 995 ESVDDTSYFLSRFSQISSGLPDDQ 1018 (1093)
Q Consensus 995 ~s~~Dts~Fds~fs~~~~~l~~~d 1018 (1093)
.+..|++|||..|+..+.++.+.+
T Consensus 449 tSetDTryFD~EFT~q~v~lTPP~ 472 (516)
T KOG0690|consen 449 TSETDTRYFDEEFTSQPVTLTPPD 472 (516)
T ss_pred ccccchhhhhhhhhcceeEecCCC
Confidence 999999999999999988776544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-59 Score=537.65 Aligned_cols=323 Identities=44% Similarity=0.734 Sum_probs=279.2
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
..++..+-|..++.||-|+||+|.+++..+|...|||| .++|.+.+.+.++.++.+|++||...+++|||+||++|++.
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmK-TLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMK-TLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHh-hhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 34566778999999999999999999999999999999 88888999999999999999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+++|+||||++||||+.+|.+.+.|+|+.||||++++.+||+++|+.|+|||||||+|||||.+|||||+|||||+-+.=
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999984321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcc---------------cccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhH
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEY---------------QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 905 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~---------------~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVIL 905 (1093)
-+.....+........+-...++| +...+-.+.+.+||+.|+|||+|...+|+..|||||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 111111111111000000011111 22334567789999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 906 FEFITGIPPFTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 906 YEMLTGkpPF~~~s~~ei~~kIl~~--~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
|||+.|++||-..++.++..+|++. .+.||. ...+|.++.+||.++++ ++++|++.+++.+++.||||++|||..+
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~-~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIPY-QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhcccccc-ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhh
Confidence 9999999999999999888888763 334442 36899999999999888 8999999999999999999999999999
Q ss_pred hcccCcccCCCCCCCCCcccccc
Q 001354 984 ALQKAVFVPQPESVDDTSYFLSR 1006 (1093)
Q Consensus 984 ~~~~pPf~P~~~s~~Dts~Fds~ 1006 (1093)
+.+.++|+|.+..+.|++|||..
T Consensus 940 Rkq~ApYIP~ItHptDTSNFdpv 962 (1034)
T KOG0608|consen 940 RKQRAPYIPRITHPTDTSNFDPV 962 (1034)
T ss_pred hhccCCcCccccCCCccccCCcC
Confidence 99999999999999999999874
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-58 Score=508.63 Aligned_cols=316 Identities=40% Similarity=0.701 Sum_probs=271.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
..+.+++|++++.||+|.-|+||+|+.+.++..+||| ++.|..+..++...++..|.+||..++||+++.||..|+.+.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmK-VmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMK-VMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEE-EecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 3467889999999999999999999999999999999 666777777888999999999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..|+|||||+||+|..+++++ ..|++..++||+++|+.||+|||-+|||+|||||+||||-++|||.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999999999876 469999999999999999999999999999999999999999999999999997643
Q ss_pred ccccccCCCC-CC------------CCCCCCC----C-----------CCCcc-cccCcCCccCccCCCCCCChhhhcCC
Q 001354 840 INNTIDLSGP-ET------------DGIMPSD----A-----------HYPEY-QQTDNRNRHSAVGTPDYLAPEILLGT 890 (1093)
Q Consensus 840 ~~~s~dls~~-~t------------d~~~p~~----~-----------~~~e~-~~~~~~~~~s~vGTp~YmAPEVL~g~ 890 (1093)
...+.-.+.. .. ..+.+.. . ..++. .........++|||-.|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 2221111100 00 0000000 0 00111 11223566789999999999999999
Q ss_pred CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC-hhcHHHH
Q 001354 891 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEV 969 (1093)
Q Consensus 891 ~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT-a~~A~EI 969 (1093)
+++.++|||+|||+|||||.|..||.+.+..+++.+|+...+.||..+ .++..++|||+++|.+||.+|++ ..||.||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999999999999999754 88999999999999999999999 5689999
Q ss_pred HcCCCCCCCCcchhhcccCcccCCCCCCCC
Q 001354 970 KAHPFFKGVNWDSLALQKAVFVPQPESVDD 999 (1093)
Q Consensus 970 L~HPFFkgIdWd~L~~~~pPf~P~~~s~~D 999 (1093)
++||||+||+|.-++-..||++|.+.....
T Consensus 390 K~HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 390 KRHPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred hcCccccCCChhheeccCCCcCCCccccCc
Confidence 999999999999777779999998865443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-59 Score=512.59 Aligned_cols=335 Identities=35% Similarity=0.702 Sum_probs=304.5
Q ss_pred CccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001354 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSF 757 (1093)
Q Consensus 679 s~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsf 757 (1093)
+...++...+|.++.+||+|+||+|.++..+.|.+.|||| |++|..+...+.++..+.|.++|.... -|++++|+.+|
T Consensus 341 ~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiK-iLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 341 SKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred CcccceeecccceEEEeccCccceeeeecccCcchhhhhh-hhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 3445788999999999999999999999999999999999 888888888888999999999998775 78999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
|+-+.+|+||||+.||+|+.++++.+.|-|..|.+|+++|+.||-|||++|||+||||.+|||||.+|||||+|||+|+.
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999995
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
.. .....+.++||||.|||||++..++|+.++||||+||+|||||.|++||.+
T Consensus 500 ni---------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 500 NI---------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred cc---------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 32 224456789999999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCC
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 993 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~ 993 (1093)
++..++++.|...+..+| ..+|.++.++++.+|.+.|.+|++. ++-.+|..||||+.|+|+.++.. .|||+|.
T Consensus 553 eDE~elF~aI~ehnvsyP---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk 629 (683)
T KOG0696|consen 553 EDEDELFQAIMEHNVSYP---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPK 629 (683)
T ss_pred CCHHHHHHHHHHccCcCc---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCc
Confidence 999999999999999888 7999999999999999999999993 46789999999999999999877 8999999
Q ss_pred CCCCCCCcccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCccccCCCCCCcccccceEecchhhhcc
Q 001354 994 PESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASI 1070 (1093)
Q Consensus 994 ~~s~~Dts~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~~~~~~d~~F~g~tyk~~~~~~~~ 1070 (1093)
++.-.+.+|||.+|+..+..+.+.|.-.+.. .++. .|+||||.|.+.+..+
T Consensus 630 ~k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~n----------------------ldq~----eF~gFsfvNpefv~~~ 680 (683)
T KOG0696|consen 630 IKCGRDAENFDKFFTREPTDLTPPDKLVMMN----------------------LDQS----EFEGFSFVNPEFVKPI 680 (683)
T ss_pred cccCCchhhhhHHHhcCCCCCCCchHHHHhc----------------------Cchh----hcCceeeeChhhcCCC
Confidence 9999999999999999988777665433321 1111 3899999999988765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-57 Score=514.91 Aligned_cols=287 Identities=39% Similarity=0.748 Sum_probs=259.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~ 760 (1093)
.+....||.+++.||.|+|++|++|+.+.+++.|||| |+.|..+.++..+..+..|..+|.+| .||.|++||..|+|+
T Consensus 68 ~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiK-Vl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 68 EKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIK-VLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred ccCChhhcchhheeccccceeEEEeeecCCCceeeHh-hhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 3678899999999999999999999999999999999 77787888888899999999999999 799999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..+|+|+||+++|+|.++|++.|.|++..+|+|++||+.||+|||++|||||||||+|||||.+||+||+|||-|+.+..
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997532
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
..... . -+. ..........++|||..|++||+|..+..+..+|+|+||||||.|+.|.|||.+.+.
T Consensus 227 ~~~~~-------~-~~~------~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 227 SQKSQ-------E-NPV------DPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred hhccc-------c-Ccc------CcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 11100 0 000 000011124679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCc
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV 989 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pP 989 (1093)
-.++++|+.-.+.|| .++++.+.|||+++|..||.+|+| +.+|++||||.+|+|+.|..+.||
T Consensus 293 yliFqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 293 YLIFQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred HHHHHHHHHhcccCC---CCCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhhhhcCCC
Confidence 999999999999988 799999999999999999999999 789999999999999999888443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=478.33 Aligned_cols=351 Identities=40% Similarity=0.743 Sum_probs=278.0
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||+||+|+++.+|+.||||++ ++...........+.+|+.+|..++||||++++++|.+...+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 4799999999999999999999999999999944 444444455667889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++..........
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999975321111000
Q ss_pred CCCCCCCC-----------CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 847 SGPETDGI-----------MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 847 s~~~td~~-----------~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
........ .........|.........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 00000000 0000011112222222345678999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhccCC--CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCC
Q 001354 916 TAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQ 993 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l--~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~ 993 (1093)
.+.++.+.+..+..... .+|. ...+++++.+||.+||. +|.+|++...+.+++.||||++++|+.+....+++.|.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 99999888888876443 3332 23579999999999997 99999987779999999999999999988888899999
Q ss_pred CCCCCCCcccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCccccCCCCCCcccccceEecch
Q 001354 994 PESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1065 (1093)
Q Consensus 994 ~~s~~Dts~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~~~~~~d~~F~g~tyk~~~ 1065 (1093)
..+..|.++|+.+ .......+.+. . .. ......+||.|+||||++|+
T Consensus 318 ~~~~~~~~~~~~~-~~~~~~~~~~~-----------~--~~-----------~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 318 LKSITDTSNFDDF-EEIDLDVPTSP-----------G--PP-----------RGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred CCCchhhhhcccc-ccccccccCCC-----------c--cc-----------cccccccCCCCCCCeeeCCC
Confidence 9888899988753 22221111100 0 00 01134569999999999986
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=479.53 Aligned_cols=352 Identities=39% Similarity=0.706 Sum_probs=273.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||+||+|+++.+++.||+| ++++...........+.+|+.++..++||||+++++.+++...+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK-~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMK-ILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEE-EEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 57999999999999999999999999999999 44454444455667889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++..........
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999985321111100
Q ss_pred CCCCCCCCCCCCCC---------CCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 847 SGPETDGIMPSDAH---------YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 847 s~~~td~~~p~~~~---------~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
...... ..+.+.. ...+...........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 160 YRNLNH-SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cccccc-cccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 000000 0010000 011111222234567999999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhcc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCC
Q 001354 918 ESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 995 (1093)
Q Consensus 918 ~s~~ei~~kIl~~--~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~ 995 (1093)
.++.+.+.+|... .+.+|. ...+++++++||.+|++ +|.+|++...+.+|++||||++++|+.+...+++..+...
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~ 316 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIK 316 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCC
Confidence 9999999988864 344553 23589999999999887 7777765445999999999999999999877655556667
Q ss_pred CCCCCcccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCccccCCCCCCcccccceEecch
Q 001354 996 SVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1065 (1093)
Q Consensus 996 s~~Dts~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~~~~~~d~~F~g~tyk~~~ 1065 (1093)
+..|+++|+.... .....+. ...+ .. .+....+.+|.|+||||+.|+
T Consensus 317 ~~~~~~~~~~~~~-~~~~~~~-----------~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~ 363 (363)
T cd05628 317 SIDDTSNFDEFPD-SDILKPT-----------VATS-NH----------PETDYKNKDWVFINYTYKRFE 363 (363)
T ss_pred CcchhhccCCCCc-ccccccc-----------cccc-CC----------cccccCcCCcccCCceeecCC
Confidence 7888888875321 1110000 0000 00 023346779999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=475.74 Aligned_cols=317 Identities=43% Similarity=0.803 Sum_probs=256.8
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||+||+|+++.+|+.||||++. +...........+.+|+.+|..++|||||+++++|.+...+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~-~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEE-HHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999554 43444455677889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||||+.+|++||+|||+++..........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999963211100000
Q ss_pred CC------CCC------CCC--------CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHH
Q 001354 847 SG------PET------DGI--------MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906 (1093)
Q Consensus 847 s~------~~t------d~~--------~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILY 906 (1093)
.. ... ... .........+.........+.+||+.|+|||++.+..|+.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 00 000 000 0000000111111112223578999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 907 EFITGIPPFTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 907 EMLTGkpPF~~~s~~ei~~kIl~~--~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
||++|.+||.+.+..+.+..|... .+.+|. ...++.++++||.+||+ +|.+|++...+.+++.||||++++|+.+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~ 317 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIR 317 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHc
Confidence 999999999999888888888763 334442 23589999999999998 88888755559999999999999999998
Q ss_pred cccCcccCCCCCCCCCcccccc
Q 001354 985 LQKAVFVPQPESVDDTSYFLSR 1006 (1093)
Q Consensus 985 ~~~pPf~P~~~s~~Dts~Fds~ 1006 (1093)
...+|+.|......+..+|...
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T cd05629 318 QIRAPFIPQLKSITDTSYFPTD 339 (377)
T ss_pred cCCCCcccCCCCccccccCCcc
Confidence 8889999999888888887654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=472.09 Aligned_cols=317 Identities=44% Similarity=0.728 Sum_probs=255.9
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.|++++.||+|+||+||+|+++.++..||+|++ .+...........+.+|+.+|..++|||||++++.|++.+.+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i-~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTL-RKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEE-eHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 3699999999999999999999999999999954 444444556678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|...........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999863211000000
Q ss_pred CCC------CCCCC-----CCCCC----CC-----CcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHH
Q 001354 847 SGP------ETDGI-----MPSDA----HY-----PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906 (1093)
Q Consensus 847 s~~------~td~~-----~p~~~----~~-----~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILY 906 (1093)
... ..... .+... .. ............+.+||+.|||||++.+..|+.++|||||||+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 000 00000 00000 00 000001112234578999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 907 EFITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 907 EMLTGkpPF~~~s~~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
||++|++||.+.++.+....+.... ..+|. ...+++++.+||.+|+. ||.+|++..++.++++||||++++|....
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~ 317 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPP-QAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTIDFSSDL 317 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC-cccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCCcChHHHH
Confidence 9999999999998888888877643 33332 24689999999999865 99999997779999999999999998754
Q ss_pred -cccCcccCCCCCCCCCcccccc
Q 001354 985 -LQKAVFVPQPESVDDTSYFLSR 1006 (1093)
Q Consensus 985 -~~~pPf~P~~~s~~Dts~Fds~ 1006 (1093)
...+|+.|....+.|+++|+..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~ 340 (382)
T cd05625 318 RQQSAPYIPKITHPTDTSNFDPV 340 (382)
T ss_pred hcCCCCccCcCCCcchhhhcCCC
Confidence 4478899999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=469.07 Aligned_cols=350 Identities=40% Similarity=0.716 Sum_probs=274.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||+||+|+.+.+++.||+| ++++...........+.+|+.++..++||||+++++.|++.+.+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK-~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEE-EEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999 44454444556678889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..........
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999874321111000
Q ss_pred CCCCCC----C----CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 847 SGPETD----G----IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 847 s~~~td----~----~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
...... . .+........+.........+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 000000 0 00000000111222233345679999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCC
Q 001354 919 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 996 (1093)
Q Consensus 919 s~~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s 996 (1093)
++...+.++.... +.+|. ...+++++++||.+|+. ||.+|++..++.++++||||++++|..+....++..+...+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKS 317 (360)
T ss_pred CHHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCC
Confidence 9999888887643 34442 23489999999999875 99999997789999999999999999987775555556677
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCccccCCCCCCcccccceEecch
Q 001354 997 VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1065 (1093)
Q Consensus 997 ~~Dts~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~~~~~~d~~F~g~tyk~~~ 1065 (1093)
..|.++|+.. ... +..... .. -.+-....++|.|.||+|++|+
T Consensus 318 ~~~~~~~~~~-~~~-------~~~~~~---------~~---------~~~~~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 318 IDDTSNFDEF-PES-------DILQPA---------EN---------TIEPDYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred cchhhhcCCC-Ccc-------cccCCC---------cc---------ccccccCcCCcccCCceeecCC
Confidence 8888887642 111 100000 00 0022346789999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=491.42 Aligned_cols=256 Identities=35% Similarity=0.650 Sum_probs=242.9
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|+..+.||+|||+.||.+++..+|+.||+| ++.|..+.+..+.+.+.+|++|.+.++|||||++|++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~K-vVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVK-VVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEE-EeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 56999999999999999999999999999999 66677778888899999999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
+|+|..|+|+.++++...++|.++++|+.||+.||.|||+++|||||||..||||+++.+|||+|||||....
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le------- 169 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE------- 169 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec-------
Confidence 9999999999999998999999999999999999999999999999999999999999999999999998632
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.+.....+.||||.|+||||+.+.++++.+||||+||+||-||+|+|||...+-.+++.+
T Consensus 170 --------------------~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~ 229 (592)
T KOG0575|consen 170 --------------------YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK 229 (592)
T ss_pred --------------------CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH
Confidence 223456789999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
|....+.+| ..+|.+++|||.+||..||.+||+ +.+||.|+||+
T Consensus 230 Ik~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 230 IKLNEYSMP---SHLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFK 273 (592)
T ss_pred HHhcCcccc---cccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhh
Confidence 999999888 699999999999999999999999 88999999993
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=463.84 Aligned_cols=315 Identities=43% Similarity=0.683 Sum_probs=250.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|++++.||+|+||+||+|+++.++..||+|++ .+...........+.+|+.+|..++||||++++++|.+.+.+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i-~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTL-RKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEE-EHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 3689999999999999999999999999999944 444444556678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++.+.+.+++..++.+++||+.||.|||++||+||||||+||||+.+|++||+|||+++..........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999864211000000
Q ss_pred CCCC----CCCCCCC----C-------CCC-----CcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHH
Q 001354 847 SGPE----TDGIMPS----D-------AHY-----PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906 (1093)
Q Consensus 847 s~~~----td~~~p~----~-------~~~-----~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILY 906 (1093)
.... .....+. . ... ............+.+||+.|||||++.+..|+.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0000 0000000 0 000 000001111234678999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcc--CCCCCCCCCCCCHHHHHHHHhhccCCc--CCCCChhcHHHHHcCCCCCCCCcch
Q 001354 907 EFITGIPPFTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDP--NQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 907 EMLTGkpPF~~~s~~ei~~kIl~~--~l~fP~ip~~IS~eakDLIkrcL~kDP--~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
||++|.+||...++.+....+... .+.+|. ...+++++.+||.+||+.++ ..|++ +.++++||||.+++|..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~---~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNG---ADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCCC---HHHHhcCcccCCCChhH
Confidence 999999999998887777777643 333342 24689999999999776544 44888 88999999999999987
Q ss_pred hh-cccCcccCCCCCCCCCcccccc
Q 001354 983 LA-LQKAVFVPQPESVDDTSYFLSR 1006 (1093)
Q Consensus 983 L~-~~~pPf~P~~~s~~Dts~Fds~ 1006 (1093)
.. ...+|+.|....+.++++|+..
T Consensus 316 ~~~~~~~~~~p~~~~~~~~~~~~~~ 340 (381)
T cd05626 316 DIRTQPAPYVPKISHPMDTSNFDPV 340 (381)
T ss_pred HhhcCCCCccCcCCCcchhhhcCCC
Confidence 54 4477899999999999998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=475.38 Aligned_cols=267 Identities=36% Similarity=0.594 Sum_probs=234.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc---hhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR---KNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~---~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
...+.|.+.+.||+|+||.|.+|..+.||+.||||++-+...... ......+.+|++||++++|||||+++++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 355678889999999999999999999999999995543322221 12344578999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC---CcEEEEecCCccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKI 837 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d---G~VKLsDFGLAk~ 837 (1093)
+..||||||+.||+|++.+-..+.+.+..-+.|++|++.||.|||++||+||||||+||||..+ -.+||+|||+|++
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999876 7899999999996
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC---CccceeecchhhHHHHHhCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y---s~ksDVWSLGVILYEMLTGkpP 914 (1093)
.. ......+.||||.|.|||++.++++ ..++|+|||||+||-||+|++|
T Consensus 329 ~g----------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SG----------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cc----------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 31 1335678999999999999998664 4588999999999999999999
Q ss_pred CCCCChHH-HHHHHhccCCCC-CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 915 FTAESPEI-IFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 915 F~~~s~~e-i~~kIl~~~l~f-P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
|.+..... +.+.|..+.+.| |.....+|.++.+||++||..||++||+ +.|+|+||||+.+.-.
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAPCL 446 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhccccc
Confidence 99877666 899999998876 3456789999999999999999999999 8899999999976543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-54 Score=465.11 Aligned_cols=309 Identities=37% Similarity=0.730 Sum_probs=279.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~ 761 (1093)
.+.+++|.++++||+|+|++|.+++.+.|.+.|||| +++|......+.+..+..|..+.... +||++|.|+.+|+++.
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamk-vvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMK-VVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehh-hHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 467899999999999999999999999999999999 66665555556778889999998876 5999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+++|.||++||+|+.++++...++|+.+++|.++|+.||.|||++|||+||||.+|+|||..||+||+|+|+|+.+.
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-- 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-- 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999642
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC----
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA---- 917 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~---- 917 (1093)
.+...+.++||||.|+|||++.+..|++++|||+|||+||||+.|+.||.-
T Consensus 403 -------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~ 457 (593)
T KOG0695|consen 403 -------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD 457 (593)
T ss_pred -------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC
Confidence 234566789999999999999999999999999999999999999999952
Q ss_pred ----CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhcc--cC
Q 001354 918 ----ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KA 988 (1093)
Q Consensus 918 ----~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa---~~A~EIL~HPFFkgIdWd~L~~~--~p 988 (1093)
.+...+++-|+..++++| ..+|-.+..+++..|++||.+|++. -+..+|+.|+||+.++|+.++++ .|
T Consensus 458 n~d~ntedylfqvilekqirip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~p 534 (593)
T KOG0695|consen 458 NPDMNTEDYLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLP 534 (593)
T ss_pred CcccchhHHHHHHHhhhccccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCC
Confidence 224567788888888877 7899999999999999999999982 37899999999999999999876 79
Q ss_pred cccCCCCCCCCCcccccccccCCCCCCCCCCCCC
Q 001354 989 VFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSY 1022 (1093)
Q Consensus 989 Pf~P~~~s~~Dts~Fds~fs~~~~~l~~~d~~~~ 1022 (1093)
||.|.+.+..+..+|+..|++..+++.+++.+..
T Consensus 535 pf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i 568 (593)
T KOG0695|consen 535 PFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAI 568 (593)
T ss_pred CCCCccccccCccccccccccCCcccCCCCHHHH
Confidence 9999999999999999999999999888775543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-52 Score=452.47 Aligned_cols=289 Identities=42% Similarity=0.760 Sum_probs=254.5
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
+.||+|+||.||+|+++.+|+.||+|++ ++...........+++|+.+|..++||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKIL-KKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEE-EHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999954 444444455667888999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCC
Q 001354 773 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852 (1093)
Q Consensus 773 GSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td 852 (1093)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------------ 147 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------------ 147 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCC
Q 001354 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932 (1093)
Q Consensus 853 ~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 932 (1093)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+...+...+.....
T Consensus 148 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 212 (323)
T cd05571 148 ---------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 212 (323)
T ss_pred ---------------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122356899999999999999999999999999999999999999999988888888888776
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccccc
Q 001354 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1008 (1093)
Q Consensus 933 ~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs 1008 (1093)
.+| ..+++++.+||.+||+.||.+||+. ..+.++++||||.+++|..+... .+|+.|...+..++.+|+..++
T Consensus 213 ~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (323)
T cd05571 213 RFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFT 289 (323)
T ss_pred CCC---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccc
Confidence 665 6899999999999999999999952 24899999999999999988654 6788999989999999987766
Q ss_pred cCCC
Q 001354 1009 QISS 1012 (1093)
Q Consensus 1009 ~~~~ 1012 (1093)
....
T Consensus 290 ~~~~ 293 (323)
T cd05571 290 AQSI 293 (323)
T ss_pred cCCc
Confidence 5533
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-54 Score=482.21 Aligned_cols=294 Identities=35% Similarity=0.692 Sum_probs=275.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+.+.+++.+..||-||||.|-+++.......+|+| +++|..+....+.+++..|++||..+++|+||+||-.|.+..+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlK-ilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALK-ILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHH-HHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 456788999999999999999999988766679999 8889999999999999999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+||+||-|-||+|++.|+..+.|++..++||++.++.|++|||++|||+|||||+|+|||.+|.+||.|||+|+.+
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki---- 570 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI---- 570 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999963
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.....++++||||.|.|||++++++++.++|+||||+++||||+|.|||.+.+++.
T Consensus 571 ------------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 571 ------------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred ------------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 23557889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 998 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT--a~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~ 998 (1093)
+|..|+.+--.+ .+|..++..+.+||++++..+|.+|++ .+++.+|+.|.||.++||+.+..+ +||++|.+.++.
T Consensus 627 tYn~ILkGid~i-~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~pt 705 (732)
T KOG0614|consen 627 TYNLILKGIDKI-EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPT 705 (732)
T ss_pred HHHHHHhhhhhh-hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcc
Confidence 999999863322 234899999999999999999999999 789999999999999999999877 899999999999
Q ss_pred CCcccccc
Q 001354 999 DTSYFLSR 1006 (1093)
Q Consensus 999 Dts~Fds~ 1006 (1093)
|++||+.+
T Consensus 706 D~s~Fd~~ 713 (732)
T KOG0614|consen 706 DVSNFDNF 713 (732)
T ss_pred cchhccCC
Confidence 99999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-51 Score=446.02 Aligned_cols=289 Identities=41% Similarity=0.803 Sum_probs=255.7
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
...+++|++.+.||+|+||.||+|+++.+++.||+|++ ++...........+.+|+.+|..++||||+++++++.+.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL-KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEE-EHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 45678999999999999999999999999999999954 44444444556788999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~--- 169 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--- 169 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.++..
T Consensus 170 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 222 (329)
T PTZ00263 170 ---------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222 (329)
T ss_pred ---------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH
Confidence 01224579999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 998 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~ 998 (1093)
++..+..+.+.+| ..++..+++||.+||+.||.+||+. ..+.++++||||++++|..+..+ .+|+.+......
T Consensus 223 ~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (329)
T PTZ00263 223 IYEKILAGRLKFP---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPG 299 (329)
T ss_pred HHHHHhcCCcCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 9999988877665 6789999999999999999999983 45899999999999999987654 456666666677
Q ss_pred CCccccc
Q 001354 999 DTSYFLS 1005 (1093)
Q Consensus 999 Dts~Fds 1005 (1093)
+..+|..
T Consensus 300 ~~~~~~~ 306 (329)
T PTZ00263 300 DTSNFEK 306 (329)
T ss_pred cchhccC
Confidence 7777754
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-51 Score=443.90 Aligned_cols=315 Identities=46% Similarity=0.799 Sum_probs=258.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||+||+|++..+|+.||+|+ +++...........+.+|+.+|..++||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~-~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV-LRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEE-EEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 479999999999999999999999999999994 4444444445677899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..........
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999975322110000
Q ss_pred CC--CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 847 SG--PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 847 s~--~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.. .......+...................+||+.|+|||++.+..++.++|||||||+||||++|..||...+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00 0000000000000000111122344578999999999999999999999999999999999999999999988888
Q ss_pred HHHhc--cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCCCCCcc
Q 001354 925 DNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSY 1002 (1093)
Q Consensus 925 ~kIl~--~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~~Dts~ 1002 (1093)
..+.. ....+|.. ..+++++.+||.+||. ||.+|++ .+.++++||||++++|+......+|++|...+..++.+
T Consensus 240 ~~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~--s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (350)
T cd05573 240 NKIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLG--SFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSN 315 (350)
T ss_pred HHHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCC--CHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhhhh
Confidence 88887 45555532 3479999999999998 9999998 36799999999999999988778899999988888888
Q ss_pred cccc
Q 001354 1003 FLSR 1006 (1093)
Q Consensus 1003 Fds~ 1006 (1093)
|+..
T Consensus 316 ~~~~ 319 (350)
T cd05573 316 FDDF 319 (350)
T ss_pred cCCC
Confidence 7764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=438.07 Aligned_cols=284 Identities=41% Similarity=0.819 Sum_probs=252.3
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 774 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGS 774 (1093)
||+|+||.||+|+++.+++.||+|++ ++...........+.+|+.+|..++||||++++++|...+.+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i-~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTI-RKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999999999999999954 44444445567788999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001354 775 LYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854 (1093)
Q Consensus 775 L~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~ 854 (1093)
|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-------------- 145 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK-------------- 145 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--------------
Confidence 999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCC
Q 001354 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934 (1093)
Q Consensus 855 ~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~f 934 (1093)
........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 146 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 212 (312)
T cd05585 146 -------------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF 212 (312)
T ss_pred -------------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC
Confidence 0112234679999999999999999999999999999999999999999999999999988877666
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCccccccccc
Q 001354 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1009 (1093)
Q Consensus 935 P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs~ 1009 (1093)
| ..+++++.+||.+||..||.+||+...+.+++.||||..++|..+... .+++.|...+..++++|+..++.
T Consensus 213 ~---~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (312)
T cd05585 213 P---DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTR 286 (312)
T ss_pred C---CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccc
Confidence 5 689999999999999999999999878999999999999999876544 57788888888889998876554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=438.68 Aligned_cols=291 Identities=36% Similarity=0.734 Sum_probs=252.9
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+|++++.||+|+||+||+|+++.++..||+|++ ++...........+..|..++..+ +||+|+++++++.+.+.+|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKIL-KKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 689999999999999999999999999999954 443333444556778888888877 489999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~------ 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW------ 153 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++..
T Consensus 154 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 212 (323)
T cd05616 154 ---------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212 (323)
T ss_pred ---------------------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01122356799999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 1002 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~ 1002 (1093)
|......+| ..++.++.+||.+||++||.+|++. ....++++||||+.++|+.+... .+|+.|... ..|..+
T Consensus 213 i~~~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 288 (323)
T cd05616 213 IMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC-GRDAEN 288 (323)
T ss_pred HHhCCCCCC---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC-Cchhhh
Confidence 988877665 6799999999999999999999984 35789999999999999998755 677888764 477777
Q ss_pred cccccccC
Q 001354 1003 FLSRFSQI 1010 (1093)
Q Consensus 1003 Fds~fs~~ 1010 (1093)
|+.+|...
T Consensus 289 ~~~~~~~~ 296 (323)
T cd05616 289 FDKFFTRH 296 (323)
T ss_pred cCchhccC
Confidence 87766644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=438.51 Aligned_cols=292 Identities=36% Similarity=0.742 Sum_probs=254.0
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCceEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNIVkL~gsfqd~~~LyLV 766 (1093)
+|++++.||+|+||.||+|+++.+++.||+|++ ++...........+..|..++..+.| ++|++++++|...+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~-~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKIL-KKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 689999999999999999999999999999944 44333344566788899999999976 5688999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~------ 153 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------ 153 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..
T Consensus 154 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (324)
T cd05587 154 ---------------------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212 (324)
T ss_pred ---------------------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01122346799999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 1002 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~ 1002 (1093)
+......+| ..++.++.+||.+||.+||.+|++. ....++++||||+.++|..+..+ .+++.|......+.++
T Consensus 213 i~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (324)
T cd05587 213 IMEHNVSYP---KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAEN 289 (324)
T ss_pred HHcCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhh
Confidence 888776655 6799999999999999999999984 34689999999999999988654 6778888888888888
Q ss_pred cccccccC
Q 001354 1003 FLSRFSQI 1010 (1093)
Q Consensus 1003 Fds~fs~~ 1010 (1093)
|+..+...
T Consensus 290 ~~~~~~~~ 297 (324)
T cd05587 290 FDKFFTRE 297 (324)
T ss_pred cCcccccC
Confidence 87764433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-51 Score=436.13 Aligned_cols=285 Identities=41% Similarity=0.784 Sum_probs=253.2
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||+|+||.||+|.++.+|+.||+|++ .............+.+|+.+|..++||||+++++.+.+...+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVM-AIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEE-EHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 4799999999999999999999999999999954 333333334567788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~------- 152 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR------- 152 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc-------
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..
T Consensus 153 -----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~ 209 (291)
T cd05612 153 -----------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209 (291)
T ss_pred -----------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 012345799999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 1002 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT--a~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~ 1002 (1093)
+..+...+| ..+++.+++||++||+.||.+|++ ...+.+++.||||..++|..+... .+++.|......++.+
T Consensus 210 i~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 286 (291)
T cd05612 210 ILAGKLEFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSN 286 (291)
T ss_pred HHhCCcCCC---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCcccccc
Confidence 988877766 678999999999999999999996 235889999999999999987654 6777888888888888
Q ss_pred ccc
Q 001354 1003 FLS 1005 (1093)
Q Consensus 1003 Fds 1005 (1093)
|++
T Consensus 287 ~~~ 289 (291)
T cd05612 287 FDD 289 (291)
T ss_pred ccC
Confidence 764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=437.66 Aligned_cols=287 Identities=40% Similarity=0.771 Sum_probs=246.8
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~-IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|+++.+|+.||+|++. +...........++.|.. ++..++||||+++++.+...+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQ-KKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEE-HHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 47999999999999999999999999553 333333344456666665 4577899999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~----------- 148 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE----------- 148 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-----------
Confidence 999999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+++..+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 149 ----------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred ----------------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 0112234679999999999999999999999999999999999999999999999999988876
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1008 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa-~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs 1008 (1093)
..++ ..++.++.+||.+||+.||.+||++ ....++++||||..++|..+... .+|+.|......+...|+..++
T Consensus 213 ~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (323)
T cd05575 213 LRLK---PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFT 289 (323)
T ss_pred CCCC---CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCcccc
Confidence 6544 6789999999999999999999995 36789999999999999988654 6788888888888888876555
Q ss_pred cC
Q 001354 1009 QI 1010 (1093)
Q Consensus 1009 ~~ 1010 (1093)
+.
T Consensus 290 ~~ 291 (323)
T cd05575 290 EE 291 (323)
T ss_pred cc
Confidence 44
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=438.87 Aligned_cols=287 Identities=39% Similarity=0.771 Sum_probs=251.3
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|+++.+++.||+|++ ++...........+..|..++..+ +||||++++++|...+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVL-KKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEE-EHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 4699999999999999999999999954 443333445567788899988876 69999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~----------- 148 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF----------- 148 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-----------
Confidence 999999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|||||++.+..++.++|||||||++|||++|++||.+.+..+++..+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 149 ----------------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred ----------------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 0112234679999999999999999999999999999999999999999999999999998877
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 1006 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa---~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~ 1006 (1093)
..+| ..++.++.+||.+||+.||.+||++ .+..++++||||++++|+.+..+ .||+.|...+..|.++|+..
T Consensus 213 ~~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (320)
T cd05590 213 VVYP---TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPD 289 (320)
T ss_pred CCCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcc
Confidence 6655 6789999999999999999999995 34589999999999999987654 78899999999999999876
Q ss_pred cccC
Q 001354 1007 FSQI 1010 (1093)
Q Consensus 1007 fs~~ 1010 (1093)
+...
T Consensus 290 ~~~~ 293 (320)
T cd05590 290 FIKE 293 (320)
T ss_pred cccC
Confidence 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-50 Score=439.01 Aligned_cols=287 Identities=43% Similarity=0.781 Sum_probs=251.6
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
+.||+|+||.||+++++.+|..||+|++ ++...........+.+|+.+|..++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~-~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKIL-KKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999954 443334455667889999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCC
Q 001354 773 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852 (1093)
Q Consensus 773 GSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td 852 (1093)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~------------ 147 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT------------ 147 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCC
Q 001354 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932 (1093)
Q Consensus 853 ~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 932 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.....
T Consensus 148 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 212 (328)
T cd05593 148 ---------------DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI 212 (328)
T ss_pred ---------------cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc
Confidence 01112346799999999999999999999999999999999999999999888888888877766
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccccc
Q 001354 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1008 (1093)
Q Consensus 933 ~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs 1008 (1093)
.+| ..+++++.+||.+||.+||.+|++. ..+.++++||||.+++|..+... .+|+.|...+..+..+|+..|+
T Consensus 213 ~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (328)
T cd05593 213 KFP---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFT 289 (328)
T ss_pred cCC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcccc
Confidence 655 6899999999999999999999852 35999999999999999987654 6788888888888888887665
Q ss_pred cC
Q 001354 1009 QI 1010 (1093)
Q Consensus 1009 ~~ 1010 (1093)
..
T Consensus 290 ~~ 291 (328)
T cd05593 290 AQ 291 (328)
T ss_pred cC
Confidence 44
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=437.82 Aligned_cols=286 Identities=38% Similarity=0.754 Sum_probs=246.5
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~-IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|+++.+|+.||+|++. +...........+..|.. +++.++||||+++++.+...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~-~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQ-KKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEE-HHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 46999999999999999999999999553 333333344556666665 4677899999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~----------- 148 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA----------- 148 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|||||++.+..++.++|||||||++|||++|.+||...+..+++..+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 149 ----------------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred ----------------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 0112235679999999999999999999999999999999999999999999999999888876
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1008 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa-~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs 1008 (1093)
..++ ..++..+.++|.+||..||.+||+. ..+.++++||||++++|..+... .+|+.|......+.++|+..+.
T Consensus 213 ~~~~---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (325)
T cd05604 213 LVLR---PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFT 289 (325)
T ss_pred ccCC---CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCccc
Confidence 6544 5789999999999999999999995 36789999999999999987654 6688888888888888876544
Q ss_pred c
Q 001354 1009 Q 1009 (1093)
Q Consensus 1009 ~ 1009 (1093)
.
T Consensus 290 ~ 290 (325)
T cd05604 290 E 290 (325)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=442.86 Aligned_cols=316 Identities=46% Similarity=0.761 Sum_probs=252.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||.||+|+++.+++.||+|+ +.+...........+.+|+.+|..++||||+++++.|.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~-~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEE-EcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 479999999999999999999999999999994 4444444445567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|...........
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999863210000000
Q ss_pred CCC----CCCCCCCCCC-------CCC-----cccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh
Q 001354 847 SGP----ETDGIMPSDA-------HYP-----EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 847 s~~----~td~~~p~~~-------~~~-----e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT 910 (1093)
... ..+...+... ... ...........+.+||+.|||||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 000 0000000000 000 000001112235689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhccCC--CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh-ccc
Q 001354 911 GIPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA-LQK 987 (1093)
Q Consensus 911 GkpPF~~~s~~ei~~kIl~~~l--~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~-~~~ 987 (1093)
|++||.+.++.+....+..... .+|. ...+++++.+||.+|+. +|.+|++...+.++++||||++++|..+. ...
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~ 317 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPS-QAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASLIRRQK 317 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCC
Confidence 9999999988887777765432 2232 24689999999999875 99999965459999999999999999885 347
Q ss_pred CcccCCCCCCCCCccccc
Q 001354 988 AVFVPQPESVDDTSYFLS 1005 (1093)
Q Consensus 988 pPf~P~~~s~~Dts~Fds 1005 (1093)
+|+.|....+.++++|+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~ 335 (376)
T cd05598 318 APYIPKITHPTDTSNFDP 335 (376)
T ss_pred CCCCCcCCCcchhhhcCC
Confidence 788898888888888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-50 Score=436.46 Aligned_cols=287 Identities=41% Similarity=0.738 Sum_probs=248.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||+|+||+||+|+++.+|+.||+|++ ++...........+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVM-KKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 4799999999999999999999999999999954 444333445567788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~---- 155 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN---- 155 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC----
Confidence 9999999999999876 67999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc------CCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~------g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
........+||+.|+|||++. +..++.++|||||||++|||++|..||...+
T Consensus 156 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 156 ----------------------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ----------------------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 011123457999999999997 4567899999999999999999999999988
Q ss_pred hHHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCC
Q 001354 920 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 997 (1093)
Q Consensus 920 ~~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~ 997 (1093)
....+..++... ..+|. ...++.++.+||.+||+ ||.+||+ +.++++||||..++|..+....+++.|.....
T Consensus 214 ~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t---~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLG---YEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSD 288 (330)
T ss_pred HHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCC---HHHHhCCCCcCCCCHHHHhhCCCCccCcCCCc
Confidence 888888887643 33443 24689999999999998 9999999 78999999999999999988788889988888
Q ss_pred CCCccccc
Q 001354 998 DDTSYFLS 1005 (1093)
Q Consensus 998 ~Dts~Fds 1005 (1093)
.|.++|..
T Consensus 289 ~~~~~~~~ 296 (330)
T cd05601 289 DDTSNFDE 296 (330)
T ss_pred chhhhcCC
Confidence 88887754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=442.92 Aligned_cols=291 Identities=40% Similarity=0.772 Sum_probs=255.8
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCC-cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TG-k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
....+..++|++.+.||+|+||.||+|+++.++ ..||+|.+ .+...........+.+|+.+|..++||||+++++++.
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF-EKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEE-EHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 345578899999999999999999999977655 68999954 3434444556678899999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+...+|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. ......+||+.|||||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 182 ~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 182 D------------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred C------------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 1 0123467999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCC
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 994 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~ 994 (1093)
++..++..+..+...+| ..+++.+.+||++||+.||.+|++. ..+.++++||||++++|..+... .+|+.|..
T Consensus 232 ~~~~~~~~i~~~~~~~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~ 308 (340)
T PTZ00426 232 EPLLIYQKILEGIIYFP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKY 308 (340)
T ss_pred CHHHHHHHHhcCCCCCC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 99999999988876665 6789999999999999999999852 35899999999999999987644 67888888
Q ss_pred CCCCCCcccc
Q 001354 995 ESVDDTSYFL 1004 (1093)
Q Consensus 995 ~s~~Dts~Fd 1004 (1093)
....+.++|.
T Consensus 309 ~~~~~~~~~~ 318 (340)
T PTZ00426 309 KNVFDSSNFE 318 (340)
T ss_pred CCCcchhhcC
Confidence 7777777664
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=438.04 Aligned_cols=290 Identities=41% Similarity=0.742 Sum_probs=254.0
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
+.||+|+||.||+++++.+|..||+|++ ++...........+.+|+.+|..++||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEE-EHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 4699999999999999999999999954 343333445667788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCC
Q 001354 773 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852 (1093)
Q Consensus 773 GSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td 852 (1093)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~------------ 147 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------------ 147 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCC
Q 001354 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932 (1093)
Q Consensus 853 ~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 932 (1093)
........+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+.......+.....
T Consensus 148 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~ 212 (323)
T cd05595 148 ---------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 212 (323)
T ss_pred ---------------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112346799999999999999999999999999999999999999999988888888887776
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccccc
Q 001354 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1008 (1093)
Q Consensus 933 ~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs 1008 (1093)
.+| ..+++++.+||.+||+.||.+|++. ..+.++++||||.+++|..+... .||+.|...+..+..+|+..++
T Consensus 213 ~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (323)
T cd05595 213 RFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFT 289 (323)
T ss_pred CCC---CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccc
Confidence 655 6899999999999999999999952 35999999999999999987654 5788999999999999988766
Q ss_pred cCCCC
Q 001354 1009 QISSG 1013 (1093)
Q Consensus 1009 ~~~~~ 1013 (1093)
.....
T Consensus 290 ~~~~~ 294 (323)
T cd05595 290 AQSIT 294 (323)
T ss_pred cCCcc
Confidence 65443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=435.01 Aligned_cols=286 Identities=38% Similarity=0.767 Sum_probs=249.0
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|+++.+++.||+|++ ++...........+..|..++..+ +||||++++++|...+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVL-KKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEE-eHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 4699999999999999999999999944 444444455667788899999866 79999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~----------- 148 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL----------- 148 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+.+..+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 149 ----------------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred ----------------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 0112234679999999999999999999999999999999999999999999999999998877
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh----cHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN----GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLS 1005 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~----~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds 1005 (1093)
..+| ..++.++.+||.+||..||.+|++.. .+.++++||||.+++|..+... .+++.|......+..+|+.
T Consensus 213 ~~~p---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (321)
T cd05591 213 VLYP---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ 289 (321)
T ss_pred CCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCC
Confidence 6655 67899999999999999999999532 4889999999999999988654 5678888877778888776
Q ss_pred cccc
Q 001354 1006 RFSQ 1009 (1093)
Q Consensus 1006 ~fs~ 1009 (1093)
.|..
T Consensus 290 ~~~~ 293 (321)
T cd05591 290 DFTK 293 (321)
T ss_pred cccc
Confidence 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=435.35 Aligned_cols=286 Identities=43% Similarity=0.799 Sum_probs=251.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||.||+|++..+++.||+|++ ++...........+.+|+.+|..++||||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRM-KKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEE-EHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999944 443333345567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~------- 152 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV------- 152 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc-------
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
......+||+.|+|||++.+..++.++|||||||+||||++|.+||.+.+..+.+..
T Consensus 153 -----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 209 (333)
T cd05600 153 -----------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209 (333)
T ss_pred -----------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence 022356799999999999999999999999999999999999999999988888877
Q ss_pred HhccC--CCCCCCC---CCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCCCCCc
Q 001354 927 ILNRK--IPWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTS 1001 (1093)
Q Consensus 927 Il~~~--l~fP~ip---~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~~Dts 1001 (1093)
+.... +..|... ..++.++.+||.+||..+|.+||+ +.++++||||++++|..+....+|+.|......+..
T Consensus 210 i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (333)
T cd05600 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTG 286 (333)
T ss_pred HHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcchhh
Confidence 76532 2223211 256999999999999999999999 889999999999999998877889999988888877
Q ss_pred ccccc
Q 001354 1002 YFLSR 1006 (1093)
Q Consensus 1002 ~Fds~ 1006 (1093)
+|++.
T Consensus 287 ~~~~~ 291 (333)
T cd05600 287 YFDDF 291 (333)
T ss_pred hccCC
Confidence 77653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=436.21 Aligned_cols=292 Identities=36% Similarity=0.731 Sum_probs=245.7
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||.||+|+++.+++.||+|+ +++...........+..|..++..+ +||||++++++|.+...+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~-i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKV-IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEE-EEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 479999999999999999999999994 4443333445567788999999988 69999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----------- 148 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR----------- 148 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC---------ChHH
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEI 922 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~---------s~~e 922 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05588 149 ----------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212 (329)
T ss_pred ----------------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH
Confidence 011223568999999999999999999999999999999999999999632 1223
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh---cHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 997 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~---~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~ 997 (1093)
.+..+......+| ..++.++.+||.+||+.||.+|+++. .+.++++||||..++|+.+... .+++.|.....
T Consensus 213 ~~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (329)
T cd05588 213 LFQVILEKQIRIP---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESD 289 (329)
T ss_pred HHHHHHcCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCc
Confidence 4555666655544 68999999999999999999999853 4889999999999999987654 56778887777
Q ss_pred CCCcccccccccCCCCCC
Q 001354 998 DDTSYFLSRFSQISSGLP 1015 (1093)
Q Consensus 998 ~Dts~Fds~fs~~~~~l~ 1015 (1093)
.+..+|+..|.......+
T Consensus 290 ~~~~~~~~~~~~~~~~~~ 307 (329)
T cd05588 290 RDLDNFDPQFTDEPVQLT 307 (329)
T ss_pred chhhhcCCccccCccccC
Confidence 777888776655544443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=445.91 Aligned_cols=260 Identities=32% Similarity=0.574 Sum_probs=235.1
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
..+..++++.++.||+|..|+||+|+++.|++.||+|.|.- .......+.+.+|+++|+.++|||||++|++|..+.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~---~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL---NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc---cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 34677899999999999999999999999999999996622 234455678999999999999999999999999999
Q ss_pred c-eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 N-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 ~-LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
. ++|+||||.||+|.+++...++++|.....++.+|++||.|||. ++||||||||+||||+..|.|||||||.++...
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 5 99999999999999999999999999999999999999999995 899999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC-
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE- 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~- 918 (1093)
+..+.+++||..|||||.+.+..|+.++||||||+.++||++|+.||...
T Consensus 231 -----------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~ 281 (364)
T KOG0581|consen 231 -----------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN 281 (364)
T ss_pred -----------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC
Confidence 12567899999999999999999999999999999999999999999874
Q ss_pred ----ChHHHHHHHhccCCCCCCCCCC-CCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 919 ----SPEIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 919 ----s~~ei~~kIl~~~l~fP~ip~~-IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+..+++..|+.+.. |.+|.. +|+++++||..||++||.+|++ +.++++|||++..
T Consensus 282 ~~~~~~~~Ll~~Iv~~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 282 PPYLDIFELLCAIVDEPP--PRLPEGEFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKF 341 (364)
T ss_pred CCCCCHHHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhc
Confidence 66788888888654 455676 9999999999999999999999 8899999999854
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=433.38 Aligned_cols=290 Identities=38% Similarity=0.724 Sum_probs=245.5
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|+.+.++..||+|++ ++...........+..|..++..+ +||||+++++++.+...+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVV-KKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 4799999999999999999999999954 443334445667788999999888 59999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~----------- 148 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG----------- 148 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC-------ChHHHH
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEIIF 924 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~-------s~~ei~ 924 (1093)
........+||+.|+|||++.+..|+.++|||||||+||||++|..||... .....+
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 212 (327)
T cd05617 149 ----------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212 (327)
T ss_pred ----------------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH
Confidence 011223568999999999999999999999999999999999999999632 223455
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 999 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa---~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~D 999 (1093)
..+......+| ..++..+.+||.+||+.||.+|+++ .++.++++||||++++|+.+... .++|.|......+
T Consensus 213 ~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (327)
T cd05617 213 QVILEKPIRIP---RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYG 289 (327)
T ss_pred HHHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcc
Confidence 55555555544 6789999999999999999999984 35789999999999999988655 6788998888888
Q ss_pred CcccccccccCCCC
Q 001354 1000 TSYFLSRFSQISSG 1013 (1093)
Q Consensus 1000 ts~Fds~fs~~~~~ 1013 (1093)
.++|+..+...+..
T Consensus 290 ~~~~~~~~~~~~~~ 303 (327)
T cd05617 290 LENFDTQFTSEPVQ 303 (327)
T ss_pred hhhcCCccccCccc
Confidence 88887765544333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=433.35 Aligned_cols=292 Identities=37% Similarity=0.733 Sum_probs=243.8
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|+++.+++.||+|++ ++...........+..|..++..+ +||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVV-KKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEE-EhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 4799999999999999999999999955 343333444566788899988876 79999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
+|+|..++.+...+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~----------- 148 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR----------- 148 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC---------ChHH
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEI 922 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~---------s~~e 922 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|..||... ....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05618 149 ----------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212 (329)
T ss_pred ----------------CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHH
Confidence 011223468999999999999999999999999999999999999999531 1233
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 997 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa---~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~ 997 (1093)
+...+......+| ..++..+.+||.+||+.||.+||++ .++.++++||||++++|+.+... .+++.|.....
T Consensus 213 ~~~~i~~~~~~~p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 289 (329)
T cd05618 213 LFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGE 289 (329)
T ss_pred HHHHHhcCCCCCC---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCc
Confidence 4555666665555 7889999999999999999999984 24789999999999999987654 67788888777
Q ss_pred CCCcccccccccCCCCCC
Q 001354 998 DDTSYFLSRFSQISSGLP 1015 (1093)
Q Consensus 998 ~Dts~Fds~fs~~~~~l~ 1015 (1093)
.+..+|++.++..+....
T Consensus 290 ~~~~~~~~~~~~~~~~~~ 307 (329)
T cd05618 290 FGLDNFDAQFTNEPVQLT 307 (329)
T ss_pred ccchhcCcccccCCccCC
Confidence 777777765544443333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=429.75 Aligned_cols=287 Identities=44% Similarity=0.820 Sum_probs=244.0
Q ss_pred EEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 692 IKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
++.||+|+||.||+++.. .+++.||+|++.+............+.+|+.+|..++||||+++++.|...+.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 57899999954332222223445678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCC
Q 001354 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~ 848 (1093)
|++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-------- 152 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-------- 152 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--------
Confidence 999999999999888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001354 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 928 (1093)
Q Consensus 849 ~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 928 (1093)
........+||+.|+|||++.+..++.++|||||||+||||++|++||.+.+.......+.
T Consensus 153 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 153 -------------------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred -------------------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 0112234679999999999999999999999999999999999999999999888888888
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccc
Q 001354 929 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFL 1004 (1093)
Q Consensus 929 ~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT--a~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fd 1004 (1093)
.+...+| ..+++++.+||.+||++||.+||+ ...+.+++.||||+..+|..+... .+++.+...+..+.+.|+
T Consensus 214 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05584 214 KGKLNLP---PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFD 290 (323)
T ss_pred cCCCCCC---CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcC
Confidence 8776655 678999999999999999999994 234889999999999999887644 566777776666776666
Q ss_pred cccc
Q 001354 1005 SRFS 1008 (1093)
Q Consensus 1005 s~fs 1008 (1093)
..++
T Consensus 291 ~~~~ 294 (323)
T cd05584 291 SKFT 294 (323)
T ss_pred chhc
Confidence 5544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=429.58 Aligned_cols=288 Identities=39% Similarity=0.777 Sum_probs=247.0
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|++..+++.||+|++ ++...........+..|..++... +||||+++++++.....+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKAL-KKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEE-EHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 4699999999999999999999999954 443333344556667777777654 79999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~----------- 148 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN----------- 148 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+++..+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05592 149 ----------------GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR 212 (316)
T ss_pred ----------------CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 0112235689999999999999999999999999999999999999999999888888887655
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCccccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1009 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs~ 1009 (1093)
..+ +..++.++.+||.+||..||.+||+. +.+++.||||+.++|..+... .+++.|......+.++|+..|+.
T Consensus 213 ~~~---~~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (316)
T cd05592 213 PHF---PRWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTN 287 (316)
T ss_pred CCC---CCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccc
Confidence 443 47799999999999999999999983 358899999999999987644 67888888888899999877666
Q ss_pred CCCC
Q 001354 1010 ISSG 1013 (1093)
Q Consensus 1010 ~~~~ 1013 (1093)
....
T Consensus 288 ~~~~ 291 (316)
T cd05592 288 EKVR 291 (316)
T ss_pred cccc
Confidence 5433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=439.03 Aligned_cols=292 Identities=41% Similarity=0.739 Sum_probs=244.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++.+.||+|+||.||+|+++.+++.||+|+ +.+...........+.+|+.++..++||||++++++|.+...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~-~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEE-EEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 456789999999999999999999999999999994 4444444445566788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~--- 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE--- 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc---
Confidence 9999999999999998654 589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.......+.+||+.|||||++.+.. ++.++|||||||+||||++|.+||.+.+
T Consensus 195 -----------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 195 -----------------------TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred -----------------------CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 0011223568999999999997643 7889999999999999999999999999
Q ss_pred hHHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc--hhhcccCcccCCCC
Q 001354 920 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD--SLALQKAVFVPQPE 995 (1093)
Q Consensus 920 ~~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd--~L~~~~pPf~P~~~ 995 (1093)
....+..|.... +.+|. ...++..+++||.+||. ++.+|++..++.++++||||++..|+ .+....+|+.|...
T Consensus 252 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~-~~~~r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~ 329 (370)
T cd05621 252 LVGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELS 329 (370)
T ss_pred HHHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHcc-CchhccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCC
Confidence 888888887644 34442 23579999999999998 44444432338899999999987665 44444778899888
Q ss_pred CCCCCccccc
Q 001354 996 SVDDTSYFLS 1005 (1093)
Q Consensus 996 s~~Dts~Fds 1005 (1093)
+..|.++|+.
T Consensus 330 ~~~~~~~~~~ 339 (370)
T cd05621 330 SDIDSSNFDD 339 (370)
T ss_pred CcchhhhcCC
Confidence 8888888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=438.18 Aligned_cols=292 Identities=40% Similarity=0.700 Sum_probs=248.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++.+.||+|+||.||+|+++.++..||+|+ +++...........+.+|+.+|..++||||+++++++.+...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~-~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL-LSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEE-EEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567899999999999999999999999999999994 444444444555678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||||++||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~-- 194 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-- 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC--
Confidence 9999999999999999865 4589999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC----CCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~----~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.........+||+.|||||++.+. .++.++|||||||++|||++|.+||.+.
T Consensus 195 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 195 ------------------------NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred ------------------------CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 001112346899999999999754 3789999999999999999999999999
Q ss_pred ChHHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCC--CCChhcHHHHHcCCCCCCCCcchh--hcccCcccC
Q 001354 919 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSL--ALQKAVFVP 992 (1093)
Q Consensus 919 s~~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~K--RpTa~~A~EIL~HPFFkgIdWd~L--~~~~pPf~P 992 (1093)
+....+..|.... +.+|. ...+|.++++||.+||+.+|.+ |++ +.++++||||++.+|... ....+|+.|
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s---~~ell~h~~~~~~~~~~~~~~~~~~~~~p 326 (370)
T cd05596 251 SLVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNG---VDEIKSHPFFKNDQWTFDNIRETVAPVVP 326 (370)
T ss_pred CHHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCC---HHHHhcCcccCCCChhhHHhcCCCcCccC
Confidence 9888888887754 34442 2358999999999999988987 888 889999999999888754 344678889
Q ss_pred CCCCCCCCcccccc
Q 001354 993 QPESVDDTSYFLSR 1006 (1093)
Q Consensus 993 ~~~s~~Dts~Fds~ 1006 (1093)
......++++|+..
T Consensus 327 ~~~~~~~~~~~~~~ 340 (370)
T cd05596 327 ELSSDIDTSNFDDI 340 (370)
T ss_pred cCCCcchhhhcCCc
Confidence 88888888887653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=429.98 Aligned_cols=288 Identities=39% Similarity=0.787 Sum_probs=249.9
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|.++.++..||+|+ +++...........+..|..++..+ +||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~-~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKV-LKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEE-EEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 469999999999999999999999994 4444444445567788899999887 69999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----------- 148 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL----------- 148 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+...++..+....
T Consensus 149 ----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~ 212 (318)
T cd05570 149 ----------------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE 212 (318)
T ss_pred ----------------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 0112234579999999999999999999999999999999999999999999888888888777
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRF 1007 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~f 1007 (1093)
..+| ..++.++.+||.+||..||.+||++ ..+.+++.||||+.++|...... .+|+.|......+.++|+..|
T Consensus 213 ~~~~---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (318)
T cd05570 213 VRYP---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEF 289 (318)
T ss_pred CCCC---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchh
Confidence 6655 6789999999999999999999993 22489999999999999876654 678888888888888887765
Q ss_pred ccCC
Q 001354 1008 SQIS 1011 (1093)
Q Consensus 1008 s~~~ 1011 (1093)
....
T Consensus 290 ~~~~ 293 (318)
T cd05570 290 TKEK 293 (318)
T ss_pred ccCc
Confidence 5443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=428.80 Aligned_cols=291 Identities=36% Similarity=0.738 Sum_probs=251.1
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLV 766 (1093)
+|++.+.||+|+||+||+|+++.+|+.||+|+ +++...........+..|..++..+. ||+|+++++++.+.+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~-~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI-LKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEE-EEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 58899999999999999999999999999994 44433334455677888999998886 57888999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------ 153 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------ 153 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC------
Confidence 99999999999999888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...+...
T Consensus 154 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (323)
T cd05615 154 ---------------------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212 (323)
T ss_pred ---------------------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01122346799999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 1002 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~ 1002 (1093)
+......+| ..++.++.+||.+||.+||.+|++. ....++++||||++++|..+... .+|+.|.... ....+
T Consensus 213 i~~~~~~~p---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 288 (323)
T cd05615 213 IMEHNVSYP---KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCG-KGAEN 288 (323)
T ss_pred HHhCCCCCC---ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCC-Cchhh
Confidence 988776655 6789999999999999999999984 35789999999999999988765 5778776544 34677
Q ss_pred cccccccC
Q 001354 1003 FLSRFSQI 1010 (1093)
Q Consensus 1003 Fds~fs~~ 1010 (1093)
|+..+...
T Consensus 289 ~~~~~~~~ 296 (323)
T cd05615 289 FDKFFTRG 296 (323)
T ss_pred cCcccccc
Confidence 77665544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=430.33 Aligned_cols=286 Identities=42% Similarity=0.765 Sum_probs=246.3
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccCCceEEEEEecC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL---~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
||+|+||+||+|+++.+|+.||+|++ .+...........+..|..++... .||||++++..|.....+|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~-~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-SKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEE-eHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 79999999999999999999999954 343333444556677788887765 69999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
+|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~----------- 148 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT----------- 148 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-----------
Confidence 999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhcc
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 930 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~ 930 (1093)
........+||+.|||||++.+. .++.++|||||||++|||++|+.||.+.+..+++..+..+
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 149 ----------------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred ----------------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC
Confidence 01123356899999999999764 5899999999999999999999999999999999888887
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCccccccc
Q 001354 931 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRF 1007 (1093)
Q Consensus 931 ~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa-~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~f 1007 (1093)
...+|. ..+++++.+||.+||+.||.+||+. ..+.++++||||+.++|+.+... .+|+.|......+.++|+..|
T Consensus 213 ~~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (330)
T cd05586 213 KVRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEF 290 (330)
T ss_pred CCCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCccc
Confidence 777663 4689999999999999999999974 36899999999999999987654 678888888888888887665
Q ss_pred ccC
Q 001354 1008 SQI 1010 (1093)
Q Consensus 1008 s~~ 1010 (1093)
...
T Consensus 291 ~~~ 293 (330)
T cd05586 291 TNS 293 (330)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=428.44 Aligned_cols=286 Identities=40% Similarity=0.770 Sum_probs=244.1
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~-IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|+++.++..||+|++. +...........+..|.. ++..++||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~-~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQ-KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEE-HHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999554 333323333445555554 4677899999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~----------- 148 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE----------- 148 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc-----------
Confidence 999999999888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|||||++.+..++.++|||||||++|||++|.+||.+.+..+++..+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05602 149 ----------------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 212 (325)
T ss_pred ----------------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence 0112335679999999999999999999999999999999999999999999999888888776
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1008 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa-~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs 1008 (1093)
..++ ..++..+.+||.+||++||.+|+++ +...++++|+||..++|+.+... .+++.|......+...|+..++
T Consensus 213 ~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (325)
T cd05602 213 LQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFT 289 (325)
T ss_pred cCCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCccc
Confidence 5544 6789999999999999999999995 36779999999999999998654 5677888777778887776554
Q ss_pred c
Q 001354 1009 Q 1009 (1093)
Q Consensus 1009 ~ 1009 (1093)
.
T Consensus 290 ~ 290 (325)
T cd05602 290 E 290 (325)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=425.44 Aligned_cols=290 Identities=42% Similarity=0.781 Sum_probs=247.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||+|+||+||+++.+.+++.||+| ++.+...........+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK-~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEE-EEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999 44444444455566788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~---- 155 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED---- 155 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC----
Confidence 999999999999987 467999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|||||++. ...|+.++|||||||++|||++|+.||...+.
T Consensus 156 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 156 ----------------------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred ----------------------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 011123457999999999986 34688999999999999999999999999999
Q ss_pred HHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCCC
Q 001354 921 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 998 (1093)
Q Consensus 921 ~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~~ 998 (1093)
.+.+.++.... ..+|.....++.++++||.+||+.+ .+|++...+.++++||||.+++|+.+....+|+.|...++.
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~-~~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~ 292 (332)
T cd05623 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSR-EHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPT 292 (332)
T ss_pred HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccCh-hhhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCCCCc
Confidence 99998887754 3445445678999999999999864 44544444899999999999999999888888999888777
Q ss_pred CCcccc
Q 001354 999 DTSYFL 1004 (1093)
Q Consensus 999 Dts~Fd 1004 (1093)
+.+++.
T Consensus 293 ~~~~~~ 298 (332)
T cd05623 293 DTSNFD 298 (332)
T ss_pred ccccCC
Confidence 777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=437.17 Aligned_cols=294 Identities=43% Similarity=0.741 Sum_probs=248.0
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
..+..++|++.+.||+|+||.||+|+++.+++.||+|++ .+...........+.+|+.++..++||||+++++++.+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i-~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEE-EHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 346678999999999999999999999999999999944 4444444455667889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~- 194 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK- 194 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc-
Confidence 999999999999999998654 589999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeecchhhHHHHHhCCCCCCC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
.........+||+.|||||++.+.. ++.++|||||||+||||++|.+||.+
T Consensus 195 -------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 195 -------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred -------------------------CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 0011223568999999999997643 78999999999999999999999999
Q ss_pred CChHHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc--chhhcccCcccCC
Q 001354 918 ESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW--DSLALQKAVFVPQ 993 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW--d~L~~~~pPf~P~ 993 (1093)
.+....+..|.... ..+|. ...++.++++||.+||. +|.+|++...+.+|++||||++..| ..+....+|++|.
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~ 327 (371)
T cd05622 250 DSLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPD 327 (371)
T ss_pred CCHHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCCC
Confidence 99988899888754 44443 34789999999999998 7777766556999999999998655 4555557788888
Q ss_pred CCCCCCCccccc
Q 001354 994 PESVDDTSYFLS 1005 (1093)
Q Consensus 994 ~~s~~Dts~Fds 1005 (1093)
..+..+.++|+.
T Consensus 328 ~~~~~~~~~~~~ 339 (371)
T cd05622 328 LSSDIDTSNFDD 339 (371)
T ss_pred CCCcchhhhcCC
Confidence 877777777654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=426.50 Aligned_cols=291 Identities=44% Similarity=0.806 Sum_probs=248.0
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||+||+++.+.+++.||+| ++.+...........+.+|+.++..++||||++++++|.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK-~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMK-ILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEE-EEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 57999999999999999999999999999999 44444444555667789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 155 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD---- 155 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC----
Confidence 999999999999976 457999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 156 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 156 ----------------------GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ----------------------CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 0011123579999999999973 4578899999999999999999999999988
Q ss_pred HHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCCC
Q 001354 921 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 998 (1093)
Q Consensus 921 ~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~~ 998 (1093)
.+.+..+.... ..+|.....++.++++||++||+. |.+|++...+.++++||||.+++|..+....+++.|...+..
T Consensus 214 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
T cd05597 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPT 292 (331)
T ss_pred HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCCCcc
Confidence 88888887643 344444456899999999999985 556555445999999999999999998877888899888888
Q ss_pred CCccccc
Q 001354 999 DTSYFLS 1005 (1093)
Q Consensus 999 Dts~Fds 1005 (1093)
++++|+.
T Consensus 293 ~~~~~~~ 299 (331)
T cd05597 293 DTSNFDV 299 (331)
T ss_pred hhhhcCC
Confidence 8887754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=424.94 Aligned_cols=286 Identities=39% Similarity=0.769 Sum_probs=244.7
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~-IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||.||+|+++.+|..||+|++. +...........+..|.. +++.++||||+++++.|.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQ-KKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEE-HHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999553 333333334455666654 5788999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.+...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~----------- 148 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE----------- 148 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...++..+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05603 149 ----------------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP 212 (321)
T ss_pred ----------------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Confidence 0112234679999999999999999999999999999999999999999999888888888876
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1008 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa-~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs 1008 (1093)
..+| ...+.++.+||.+||+.||.+|+++ ..+.++++||||..++|..+... .+++.|......+...|+..++
T Consensus 213 ~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (321)
T cd05603 213 LQLP---GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFT 289 (321)
T ss_pred CCCC---CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCccc
Confidence 6555 6789999999999999999999994 46789999999999999987644 5677787777777777776554
Q ss_pred c
Q 001354 1009 Q 1009 (1093)
Q Consensus 1009 ~ 1009 (1093)
.
T Consensus 290 ~ 290 (321)
T cd05603 290 Q 290 (321)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=418.95 Aligned_cols=275 Identities=33% Similarity=0.612 Sum_probs=233.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|++.+.||+|+||+||+|.++.+|+.||+|.+. +...........+.+|+.+|..++||||+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~-~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEee-HhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 4889999999999999999999999999999553 333333334456789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~----- 154 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE----- 154 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC-----
Confidence 999999999888643 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH---
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI--- 922 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e--- 922 (1093)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||...+...
T Consensus 155 -----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~ 211 (285)
T cd05631 155 -----------------------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE 211 (285)
T ss_pred -----------------------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH
Confidence 011234579999999999999999999999999999999999999998765432
Q ss_pred -HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCC
Q 001354 923 -IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 994 (1093)
Q Consensus 923 -i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~ 994 (1093)
+...+...... ++..++.++.+||++||+.||.+||+. ..+.++++||||.+++|+.+... +|||+|.+
T Consensus 212 ~~~~~~~~~~~~---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 212 EVDRRVKEDQEE---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285 (285)
T ss_pred HHHHHhhccccc---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCCC
Confidence 23333333333 346789999999999999999999984 35899999999999999999877 88999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=426.00 Aligned_cols=291 Identities=42% Similarity=0.749 Sum_probs=248.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||+||+++++.+++.||+|+ +.+...........+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~-~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKI-LNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEE-EeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 589999999999999999999999999999994 4444444455567788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||++||+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 155 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD---- 155 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC----
Confidence 999999999999987 467999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|||||++.+ ..++.++|||||||+||||++|+.||...+.
T Consensus 156 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 156 ----------------------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ----------------------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 0011123579999999999976 4678899999999999999999999999988
Q ss_pred HHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCCC
Q 001354 921 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 998 (1093)
Q Consensus 921 ~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~~ 998 (1093)
.+.+..+.... .++|.....++.++++||.+||+.+ .+|++...+.++++||||++++|+.+....+|+.|....+.
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~-~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~~~ 292 (331)
T cd05624 214 VETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPS 292 (331)
T ss_pred HHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCc-hhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCCCcc
Confidence 88888887644 3445444568999999999999954 46665556999999999999999999888889999888877
Q ss_pred CCccccc
Q 001354 999 DTSYFLS 1005 (1093)
Q Consensus 999 Dts~Fds 1005 (1093)
+.++|+.
T Consensus 293 ~~~~~~~ 299 (331)
T cd05624 293 DTSNFDV 299 (331)
T ss_pred hhhhcCC
Confidence 7777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=428.93 Aligned_cols=287 Identities=41% Similarity=0.759 Sum_probs=250.5
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
+.||+|+||.||+++++.+|..||+|++ ++...........+..|..++..++||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~-~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKIL-KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999954 443333445567788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 773 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 773 GSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
|+|..++.+...+++..++.++.||+.||.|||+ .||+||||||+||||+.+|.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~----------- 148 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK----------- 148 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC-----------
Confidence 9999999888889999999999999999999997 7999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|||||++.+..++.++|||||||++|||++|..||.+.+.......+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05594 149 ----------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 212 (325)
T ss_pred ----------------CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC
Confidence 0111234579999999999999999999999999999999999999999998888888888777
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRF 1007 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~f 1007 (1093)
..+| ..+++++.+||.+||++||.+|++. ..+.++++||||.++.|...... .+|+.|...+..++.+|+..+
T Consensus 213 ~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (325)
T cd05594 213 IRFP---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEF 289 (325)
T ss_pred CCCC---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchh
Confidence 6665 6789999999999999999999852 24899999999999999987654 578888888888999998776
Q ss_pred ccC
Q 001354 1008 SQI 1010 (1093)
Q Consensus 1008 s~~ 1010 (1093)
.+.
T Consensus 290 ~~~ 292 (325)
T cd05594 290 TAQ 292 (325)
T ss_pred hcC
Confidence 554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=424.13 Aligned_cols=291 Identities=44% Similarity=0.801 Sum_probs=243.0
Q ss_pred CeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCce
Q 001354 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~L 763 (1093)
+|++++.||+|+||.||+|+.. .++..||+|++.+............+..|+.+|..+. ||||++++++|...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 4789999995533222223344567889999999995 99999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~--- 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--- 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCC----
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE---- 918 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~---- 918 (1093)
.........+||+.|||||++.+. .++.++|||||||+||||++|..||...
T Consensus 158 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 158 -----------------------EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred -----------------------cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 001122356899999999999875 4789999999999999999999999743
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--cCcccCCC
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 994 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~ 994 (1093)
....+...+......+ +..+++.+.+||.+||..||.+||++. .+.++++||||++++|..+... .+++.|..
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 291 (332)
T cd05614 215 TQSEVSRRILKCDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSI 291 (332)
T ss_pred CHHHHHHHHhcCCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 2344555555554443 467999999999999999999999755 6999999999999999987654 67788888
Q ss_pred CCCCCCccccccc
Q 001354 995 ESVDDTSYFLSRF 1007 (1093)
Q Consensus 995 ~s~~Dts~Fds~f 1007 (1093)
....+..+|...+
T Consensus 292 ~~~~~~~~~~~~~ 304 (332)
T cd05614 292 RNELDVGNFAEEF 304 (332)
T ss_pred CCcchhhhcCccc
Confidence 7777777776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=426.01 Aligned_cols=290 Identities=40% Similarity=0.751 Sum_probs=249.7
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHH---hcCCCceEEEeeeeccCCceEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~---kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
|++++.||+|+||.||+|.++.+|+.||+|++ ++.........+.+..|+.++. .++||||+++++++...+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKAL-KKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 78899999999999999999999999999954 4444334455667778877664 5679999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~----- 153 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG----- 153 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC-----
Confidence 9999999999988864 5799999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........+||+.|||||++.+..++.++|||||||++|||++|..||.+.+..+...
T Consensus 154 ----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~ 211 (324)
T cd05589 154 ----------------------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211 (324)
T ss_pred ----------------------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0112235689999999999999999999999999999999999999999999888888
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCc
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTS 1001 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts 1001 (1093)
.+......+| ..++.++.+||.+||..||.+||+.. .+.++++||||++++|..+... .+|+.|......|.+
T Consensus 212 ~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 288 (324)
T cd05589 212 SIVNDEVRYP---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVS 288 (324)
T ss_pred HHHhCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhh
Confidence 8888776655 67899999999999999999999742 5899999999999999987544 678888888888888
Q ss_pred ccccccccC
Q 001354 1002 YFLSRFSQI 1010 (1093)
Q Consensus 1002 ~Fds~fs~~ 1010 (1093)
+|...+...
T Consensus 289 ~~~~~~~~~ 297 (324)
T cd05589 289 NFDEEFTSE 297 (324)
T ss_pred hcCcccccc
Confidence 887654443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=426.45 Aligned_cols=283 Identities=37% Similarity=0.753 Sum_probs=242.8
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||.||+|+++.+|..||+|++ ++...........+..|..++... +||||++++++|.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~-~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKAL-KKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEE-EHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 4799999999999999999999999954 333322334556677888888754 89999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~----------- 148 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----------- 148 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++...+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (316)
T cd05620 149 ----------------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT 212 (316)
T ss_pred ----------------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 0112235679999999999999999999999999999999999999999998888888877665
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1008 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs 1008 (1093)
..+| ..++.++++||.+||..||.+||+. +.++++||||++++|..+... .+|+.|....+.+.++|+..+.
T Consensus 213 ~~~~---~~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (316)
T cd05620 213 PHYP---RWITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFL 286 (316)
T ss_pred CCCC---CCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccc
Confidence 4444 6789999999999999999999993 357999999999999987544 5788888888888888876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=443.34 Aligned_cols=262 Identities=39% Similarity=0.683 Sum_probs=236.9
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh-ch-hHHHHHHHHHHHHHhcC-CCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI-RK-NDIERILAERNILITVR-NPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~-~~-~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd 759 (1093)
....+.|.+.+.||.|+||+|++|++..+|..||+| ++.+.... .. ...+.+.+|+.+++.++ ||||++++.++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiK-ii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIK-IIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEE-EechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 356789999999999999999999999999999999 65553222 11 34556778999999999 9999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFGLAk~~ 838 (1093)
...+|+||||+.||+|++++.+.+++.|..+++|+.||+.|++|||++||+||||||+|||||.+ +++||+|||++...
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999 99999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-C-CccceeecchhhHHHHHhCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-H-GYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Y-s~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
. .......+.||||.|+|||++.+.. | +.++||||+||+||.|++|+.||.
T Consensus 172 ~---------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 172 P---------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred C---------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 1 1123556899999999999999987 8 589999999999999999999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCC-CHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~I-S~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+.+...++.+|..+.+.+| ..+ |+++++||.+||..||.+|++ +.+|+.||||+.-
T Consensus 225 d~~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 225 DSNVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQKE 281 (370)
T ss_pred CccHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhccC
Confidence 9999999999999999887 567 999999999999999999999 8899999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=439.74 Aligned_cols=260 Identities=35% Similarity=0.645 Sum_probs=236.6
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|.+.+.||+|+||+||+|+++.++..||||.|.++. ......+.+..|+.||+.++|||||.|++++.+.+.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~--l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK--LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc--cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 4689999999999999999999999999999999775542 24556778899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC------CcEEEEecCCcccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD------GHIKLTDFGLSKIG 838 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d------G~VKLsDFGLAk~~ 838 (1093)
||||||.||||.++|++.+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875 35899999999963
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. ......+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|++||...
T Consensus 166 ~----------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 Q----------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred C----------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1 244567899999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
++.+++..+-.+....|.++..++....+|+..+|+.+|..|.+ ..+-+.|+|...
T Consensus 218 t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 218 TPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAA 273 (429)
T ss_pred CHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc---hHHhhhhhhccc
Confidence 99999999988877777778889999999999999999999998 556677877753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=420.92 Aligned_cols=284 Identities=43% Similarity=0.783 Sum_probs=243.5
Q ss_pred EEeeeccCCeEEEEEEE---CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 692 IKPISRGAFGRVFLARK---RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~---k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
++.||+|+||.||+++. +.+|..||+|++ ++... .......+..|+.+|.+++||||++++++|.+.+.+|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~-~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEE-EHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 36799999999999986 357899999955 33222 23344567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCC
Q 001354 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~ 848 (1093)
|+++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~--------- 149 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--------- 149 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC---------
Confidence 99999999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001354 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 928 (1093)
Q Consensus 849 ~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 928 (1093)
.........+||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+....+.
T Consensus 150 ------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~ 211 (318)
T cd05582 150 ------------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211 (318)
T ss_pred ------------------CCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH
Confidence 00112345689999999999999999999999999999999999999999999888888888
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc--HHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcccc
Q 001354 929 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFL 1004 (1093)
Q Consensus 929 ~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~--A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fd 1004 (1093)
.....+| ..+++++.+||.+||+.||.+||++.+ +.+++.||||..++|..+... .+++.|......+..+++
T Consensus 212 ~~~~~~p---~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (318)
T cd05582 212 KAKLGMP---QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFD 288 (318)
T ss_pred cCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcC
Confidence 7776655 678999999999999999999999766 899999999999999987654 566777666666666655
Q ss_pred ccc
Q 001354 1005 SRF 1007 (1093)
Q Consensus 1005 s~f 1007 (1093)
+.+
T Consensus 289 ~~~ 291 (318)
T cd05582 289 PEF 291 (318)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=421.52 Aligned_cols=285 Identities=38% Similarity=0.751 Sum_probs=245.2
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~k-L~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||+|+||+||+|+++.++..||+|++ ++...........+..|..++.. ++||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEE-EHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 4699999999999999999999999954 33322233445667778888876 489999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----------- 148 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML----------- 148 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+....
T Consensus 149 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05619 149 ----------------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN 212 (316)
T ss_pred ----------------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 0112234679999999999999999999999999999999999999999998888888876655
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCccccccccc
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1009 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs~ 1009 (1093)
..+| ..++.++++||.+||+.||.+||++. .+++.||||+.++|..+... .+++.|...+..+.++|+..+.+
T Consensus 213 ~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~--~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (316)
T cd05619 213 PCYP---RWLTREAKDILVKLFVREPERRLGVK--GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLN 287 (316)
T ss_pred CCCC---ccCCHHHHHHHHHHhccCHhhcCCCh--HHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhc
Confidence 4444 67899999999999999999999932 38999999999999987654 68899999999999999887654
Q ss_pred C
Q 001354 1010 I 1010 (1093)
Q Consensus 1010 ~ 1010 (1093)
.
T Consensus 288 ~ 288 (316)
T cd05619 288 E 288 (316)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=446.50 Aligned_cols=260 Identities=34% Similarity=0.623 Sum_probs=241.1
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
.++-|++.+.||+|+-|.|.+|++..||+..|||+|. +...........+.+|+-||+.+.||||+.+|+++.+..++|
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~-k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIP-KRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeec-cccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 4677999999999999999999999999999999554 443455666788999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
+|+||++||.|+++|.++|.+++.++..|+.||+.|+.|+|..+|+||||||+|+|||..++|||+|||+|.+-
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------ 162 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------ 162 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999852
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.......+.||+|.|.|||++.|.+| +.++||||.|||||.||+|+.||.+++...+
T Consensus 163 ----------------------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L 220 (786)
T KOG0588|consen 163 ----------------------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL 220 (786)
T ss_pred ----------------------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH
Confidence 22345667899999999999999998 7899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
+.++..+.+.+| ..+|+++++||.+||..||.+|+| ..+|++|||+.+..
T Consensus 221 LlKV~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 221 LLKVQRGVFEMP---SNISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHcCcccCC---CcCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCC
Confidence 999999999887 799999999999999999999999 88999999998754
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=397.90 Aligned_cols=275 Identities=33% Similarity=0.613 Sum_probs=230.8
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|++.+.||+|+||+||++.+..+++.||+|++. +...........+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEe-hhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 4889999999999999999999999999999543 323323334456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++++++++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----- 154 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE----- 154 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC-----
Confidence 999999999988654 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~ 211 (285)
T cd05605 155 -----------------------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211 (285)
T ss_pred -----------------------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH
Confidence 011124579999999999999899999999999999999999999998876543332
Q ss_pred ----HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--cCcccCCC
Q 001354 926 ----NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 994 (1093)
Q Consensus 926 ----kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~ 994 (1093)
.+...... .+..++..+.+||.+||..||.+||+.. .+.++++||||...+|..+... .|||.|.|
T Consensus 212 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05605 212 EVERRVKEDQEE---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285 (285)
T ss_pred HHHHHhhhcccc---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCCC
Confidence 22222222 3367899999999999999999999533 5889999999999999988655 56787754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=436.99 Aligned_cols=256 Identities=36% Similarity=0.624 Sum_probs=235.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|.+.+.||+|+||.||+|+.+.|.+.||||.+.|. . ....++..+.+|++|++.++|||||.++++|++..++++
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~-g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS-G-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhc-C-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 36789999999999999999999999999999965433 2 345678889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|.||+.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+.+|++|+||||+|+.+..+
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~---- 153 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN---- 153 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC----
Confidence 9999987 99999999999999999999999999999999999999999999999999999999999999964321
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.....+..|||.|||||++.++.|+..+|+||||||+|||++|+|||+..+..++.+
T Consensus 154 -----------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~ 210 (808)
T KOG0597|consen 154 -----------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK 210 (808)
T ss_pred -----------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH
Confidence 223456789999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.|+.....+| ..+|..+.+|+..+|.+||.+|++ -.+++.|||.++
T Consensus 211 ~I~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 211 SILKDPVKPP---STASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKG 256 (808)
T ss_pred HHhcCCCCCc---ccccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhh
Confidence 9999998887 689999999999999999999999 668999999986
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=397.25 Aligned_cols=267 Identities=33% Similarity=0.628 Sum_probs=223.7
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 774 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGS 774 (1093)
||+|+||+||+|.++.+|+.||+|.+. +...........+..|+.+|..++||||++++++|.....+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~-~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLN-KKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeee-HHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999999999999999553 3333334455678899999999999999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCC
Q 001354 775 LYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850 (1093)
Q Consensus 775 L~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~ 850 (1093)
|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~---------- 149 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD---------- 149 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC----------
Confidence 9988753 34689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh----HHHHHH
Q 001354 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDN 926 (1093)
Q Consensus 851 td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~----~ei~~k 926 (1093)
.........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......
T Consensus 150 -----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 212 (280)
T cd05608 150 -----------------GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 212 (280)
T ss_pred -----------------CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh
Confidence 00112345799999999999999999999999999999999999999986543 333444
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--cCcccC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 992 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~--~pPf~P 992 (1093)
+......+ +..++.++.+||.+||+.||.+||++. .+.++++||||++++|+.+... ++||.|
T Consensus 213 ~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 213 ILNDSVTY---PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred hcccCCCC---cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 44444333 367899999999999999999999743 4899999999999999987654 455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=395.47 Aligned_cols=305 Identities=51% Similarity=0.899 Sum_probs=258.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||.|+||.||++.++.+++.||+|.+ .+...........+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~-~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKI-NKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEe-ehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 4799999999999999999999999999999954 333333344567788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874321111000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
. ..... ............|++.|+|||.+.+..++.++|+|||||++|||++|..||.+.++.+....
T Consensus 160 ~----~~~~~--------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~ 227 (305)
T cd05609 160 Y----EGHIE--------KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227 (305)
T ss_pred c----ccccc--------cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0 00000 00001112235689999999999988999999999999999999999999999988888888
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCCCCCcccc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFL 1004 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~~Dts~Fd 1004 (1093)
+......+|..+..++.++.+||.+||..||.+||+...+.++++||||.+.+|..+......++|++...++.+||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 228 VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCCccccccCC
Confidence 887776666655578999999999999999999999888999999999999999998877788899998888888864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=402.49 Aligned_cols=262 Identities=35% Similarity=0.655 Sum_probs=241.5
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.....++++|++.+.||+|-||.||+|+.+.++..+|+|++ .|...........+.+|++|...++||||+++|++|.+
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVl-fKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVL-FKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeee-eHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 34457899999999999999999999999999999999954 45556666666778999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~--k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
....||++||.++|+|+..|. ....|++..+..|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||-+..
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999999999999 667899999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
. +.....+.|||..|.+||+..+..++..+|+|++|++.||+|+|.+||..
T Consensus 174 ~-----------------------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 174 A-----------------------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred c-----------------------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh
Confidence 2 12345678999999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.+..++|++|....+.+| ..++.+++|||.+||.++|.+|+. ..+++.|||...
T Consensus 225 ~~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 225 QSHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred hhhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 999999999999998887 789999999999999999999999 889999999753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=413.92 Aligned_cols=261 Identities=35% Similarity=0.597 Sum_probs=222.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--ce
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NL 763 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--~L 763 (1093)
..++...+.||+|+||.||++..+.+|..+|+|.+... .....+.+.+|+.+|.+++|||||++++...... .+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~----~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE----DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc----cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 46688899999999999999999999999999965332 1122677899999999999999999999855555 69
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~~~~~ 841 (1093)
+++|||++||+|.+++.+.+ .|++..+++|++||+.||+|||++|||||||||+||||+. +|.+||+|||+++....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~- 170 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES- 170 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc-
Confidence 99999999999999999887 7999999999999999999999999999999999999999 79999999999985210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCC-CC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTA-ES 919 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~-~s 919 (1093)
............|||.|||||++... ..+.++|||||||++.||+||++||.. ..
T Consensus 171 -----------------------~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~ 227 (313)
T KOG0198|consen 171 -----------------------KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE 227 (313)
T ss_pred -----------------------ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence 00111234567899999999999962 234599999999999999999999988 55
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.....-.|.... ..|.+|..+|.++++||.+||.+||.+||| |.++|+|||.+..
T Consensus 228 ~~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 228 EAEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQN 282 (313)
T ss_pred hHHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcc
Confidence 555555565555 446788999999999999999999999999 8899999998753
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=391.42 Aligned_cols=285 Identities=47% Similarity=0.863 Sum_probs=250.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||+|+||.||++.+..+++.||+|++ .+...........+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-SKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEE-EHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 4799999999999999999999999999999944 444444455667899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||+++|+|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|.||||+.+|.+||+|||+++...
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~------- 152 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK------- 152 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC-------
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
......+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 209 (290)
T cd05580 153 -----------------------GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK 209 (290)
T ss_pred -----------------------CCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 002345789999999999988899999999999999999999999998888888888
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 1002 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~ 1002 (1093)
+..+...+| ..++..++++|.+||..||.+|++. ..+.++++||||+.++|..+... .+|+.|......+.+.
T Consensus 210 ~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (290)
T cd05580 210 ILEGKVRFP---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSN 286 (290)
T ss_pred HhcCCccCC---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCcccccc
Confidence 877665555 6789999999999999999999952 35899999999999999988654 6788887777777776
Q ss_pred ccc
Q 001354 1003 FLS 1005 (1093)
Q Consensus 1003 Fds 1005 (1093)
|++
T Consensus 287 ~~~ 289 (290)
T cd05580 287 FDD 289 (290)
T ss_pred ccC
Confidence 653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=423.06 Aligned_cols=270 Identities=36% Similarity=0.655 Sum_probs=229.4
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc-----------hhHHHHHHHHHHHHHhcCCC
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR-----------KNDIERILAERNILITVRNP 748 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~-----------~~eie~~l~E~~IL~kL~HP 748 (1093)
...+..+++|++++.||+|.||.|.+|+...+++.|||| |+.|..... ...++.+.+|+.||++++||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiK-il~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~ 168 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIK-ILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP 168 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEE-eechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence 455678999999999999999999999999999999999 444433221 12356899999999999999
Q ss_pred ceEEEeeeeccCC--ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc
Q 001354 749 FVVRFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 826 (1093)
Q Consensus 749 NIVkL~gsfqd~~--~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~ 826 (1093)
|||+|+.+..++. .+|||+|||..|.+...--....+++.+||.|+++++.||+|||.+|||||||||+|+||+++|+
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 9999999998864 79999999999988654333333899999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CC-Cccceeecch
Q 001354 827 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EH-GYAADWWSVG 902 (1093)
Q Consensus 827 VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Y-s~ksDVWSLG 902 (1093)
|||+|||.+....... ...........+|||.|||||...+. .| +++.||||+|
T Consensus 249 VKIsDFGVs~~~~~~~----------------------~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGS----------------------DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred EEeeccceeeecccCC----------------------ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 9999999987431100 00011122337999999999998873 22 6799999999
Q ss_pred hhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 903 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 903 VILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
|+||.|+.|+.||.+....+++.+|++..+.||.. +.+..+++|||.+||++||++|++ +.+|+.|||..
T Consensus 307 VTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~---l~~ik~Hpwvt 376 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRIT---LPDIKLHPWVT 376 (576)
T ss_pred hhHHHhhhccCCcccchHHHHHHHHhcCcccCCCc-ccccHHHHHHHHHHhhcChhheee---hhhheecceec
Confidence 99999999999999999999999999999999964 368999999999999999999999 88999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=411.00 Aligned_cols=249 Identities=30% Similarity=0.557 Sum_probs=225.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEee-eeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY-SFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~g-sfqd~~ 761 (1093)
.....+|+++++||+|+||+||++++..+|..+|.|.| +..+......+....|+.+|++++|||||++|+ .|....
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i--~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKI--QFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhc--chhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 45678999999999999999999999999999999966 367777888889999999999999999999998 666665
Q ss_pred c-eEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--cC--cEeeecCCCcEEEccCCcEEEEec
Q 001354 762 N-LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS--LG--IVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 762 ~-LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs--~G--IIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
. ++||||||.+|||..+++. +..++|..++.|+.|++.||.++|+ .. |+||||||.||+|+.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 9999999999999999863 3469999999999999999999999 44 999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCC
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
||++... .....+.+.+|||.||+||++.+.+|+.++|||||||++|||..-.
T Consensus 173 GL~r~l~---------------------------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~ 225 (375)
T KOG0591|consen 173 GLGRFLS---------------------------SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ 225 (375)
T ss_pred hhHhHhc---------------------------chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence 9999642 2234567899999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCC-CCCCHHHHHHHHhhccCCcCCCCC
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip-~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
+||++.+-.++.++|.++.+ |.+| ...|.++..||.-|++.||..||+
T Consensus 226 ~PF~g~n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 226 SPFYGDNLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred CCcccccHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 99999999999999998865 4445 678999999999999999999998
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=389.78 Aligned_cols=267 Identities=32% Similarity=0.592 Sum_probs=222.1
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 774 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGS 774 (1093)
||+|+||+||+++.+.+|+.||+|.+. +...........+..|+.+|..++||||+++++.|.....+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~-~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLD-KKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEc-HHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999553 3233223334456679999999999999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCC
Q 001354 775 LYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852 (1093)
Q Consensus 775 L~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td 852 (1093)
|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------------ 147 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------------ 147 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC------------
Confidence 999886543 488899999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh----HHHHHHHh
Q 001354 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNIL 928 (1093)
Q Consensus 853 ~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~----~ei~~kIl 928 (1093)
........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .++...+.
T Consensus 148 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 211 (277)
T cd05607 148 ----------------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL 211 (277)
T ss_pred ----------------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh
Confidence 0111234689999999999998899999999999999999999999976432 34444444
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh-cHHHHHcCCCCCCCCcchhhcc--cCcccC
Q 001354 929 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 992 (1093)
Q Consensus 929 ~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~-~A~EIL~HPFFkgIdWd~L~~~--~pPf~P 992 (1093)
.....++ ...++.++.+||.+||++||.+||++. ...+++.||||++++|..+... .+||+|
T Consensus 212 ~~~~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 212 EDEVKFE--HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred ccccccc--cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 4444433 356899999999999999999999953 3578999999999999998765 566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=387.72 Aligned_cols=258 Identities=34% Similarity=0.485 Sum_probs=213.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||+|+||.||+|+++.++..||+|++. .. .........+.+|+.++..++||||++++++|...+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~-~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DS-EENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEe-cc-cccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 47999999999999999999999999999999553 22 22233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++++.|..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----- 153 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG----- 153 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-----
Confidence 999999877766555567999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........+||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+..+....
T Consensus 154 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (287)
T cd07848 154 ---------------------SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212 (287)
T ss_pred ---------------------ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01112245799999999999999999999999999999999999999998765444333
Q ss_pred Hhcc-------------------CCCCCCC----------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 927 ILNR-------------------KIPWPCV----------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 927 Il~~-------------------~l~fP~i----------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
+... ...+|.. ...+|.++.+||++||++||.+||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s---~~~~l~hp~f 287 (287)
T cd07848 213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL---TEQCLNHPAF 287 (287)
T ss_pred HHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 3221 0111110 1237889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=389.11 Aligned_cols=276 Identities=34% Similarity=0.626 Sum_probs=229.5
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|++.+.||+|+||.||++.+..+++.||+|.+. +...........+.+|+.+|..++|++|+.+++.+.+.+.+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~-~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEe-hhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 4788999999999999999999999999999543 333333344566788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~----- 154 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE----- 154 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC-----
Confidence 9999999999986543 589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH---H
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE---I 922 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~---e 922 (1093)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|.+||...... .
T Consensus 155 -----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~ 211 (285)
T cd05630 155 -----------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211 (285)
T ss_pred -----------------------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH
Confidence 01112357999999999999999999999999999999999999999875432 2
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhc--ccCcccCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLAL--QKAVFVPQP 994 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~--~~pPf~P~~ 994 (1093)
....+.... . ...+..+++++.+||.+||+.||.+||+.+ .+.++++||||+.++|..+.. .+|+|+|.|
T Consensus 212 ~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 212 EVERLVKEV-Q-EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred HHHhhhhhh-h-hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 222222211 1 123467899999999999999999999853 588999999999999998765 367888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=402.07 Aligned_cols=258 Identities=28% Similarity=0.502 Sum_probs=218.4
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.|+.+..+|+|+||+||+|++++||+.||||+++...+ .....+-.++|+++|++++|||+|.|+.+|.....++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed--d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED--DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc--cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 568899999999999999999999999999996643322 233446678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
+|||.. ++.+-|.+. ..++++.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+...
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~------ 152 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS------ 152 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc------
Confidence 999988 555555544 469999999999999999999999999999999999999999999999999999532
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.+.......+.|.+|+|||.+.| ..|+..+||||+||++.||++|.+-|.+.+..+..
T Consensus 153 ---------------------~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL 211 (396)
T KOG0593|consen 153 ---------------------APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL 211 (396)
T ss_pred ---------------------CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH
Confidence 11223345789999999999998 78999999999999999999999999998876655
Q ss_pred HHHhc-------------------cCCCCCCC---------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 925 DNILN-------------------RKIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 925 ~kIl~-------------------~~l~fP~i---------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
-.|.. .++.+|.. .+.++.-+.||+++||..||++|++ ..+++.||||.
T Consensus 212 y~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s---c~qll~H~yFd 288 (396)
T KOG0593|consen 212 YLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS---CEQLLHHPYFD 288 (396)
T ss_pred HHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc---HHHHhcChHHH
Confidence 44432 12223331 1457788999999999999999999 88999999995
Q ss_pred C
Q 001354 977 G 977 (1093)
Q Consensus 977 g 977 (1093)
+
T Consensus 289 ~ 289 (396)
T KOG0593|consen 289 G 289 (396)
T ss_pred H
Confidence 4
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=399.49 Aligned_cols=261 Identities=33% Similarity=0.546 Sum_probs=235.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|++.+.||+|.|+.||++.++.||..+|+|.| . ....+....+.+.+|+.|-+.++|||||+|...++.....|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kii-n-~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-N-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHh-h-hhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 346789999999999999999999999999999944 3 23334457788999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC---CcEEEEecCCccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d---G~VKLsDFGLAk~~~~~ 841 (1093)
||+|+|.||+|..-+-....++|..+-.|+.||+.||.|+|.+||||||+||+|+||.+. --+||+|||+|...
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l--- 163 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV--- 163 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe---
Confidence 999999999998877766779999999999999999999999999999999999999653 46999999999842
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
........++|||.|||||++...+|+..+|||+-|||||-||.|++||.+.+..
T Consensus 164 -------------------------~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~ 218 (355)
T KOG0033|consen 164 -------------------------NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 218 (355)
T ss_pred -------------------------CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH
Confidence 1244567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 922 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.+|+.|..+.+.+|. ..+.+++++++||++||..||.+|+| |.|.|+|||.++-
T Consensus 219 rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 219 RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNR 273 (355)
T ss_pred HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcch
Confidence 999999999998876 45789999999999999999999999 8899999999863
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=411.19 Aligned_cols=261 Identities=40% Similarity=0.661 Sum_probs=234.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~L 763 (1093)
....|++.+.||+|.||.||+|+.+.||+.||+|.+. |...........+.+|+.||+.+. |||||.+++.|.+...+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~-k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIP-KRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEee-hhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 4467999999999999999999999999999999554 444444446678999999999999 99999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC----CcEEEEecCCccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d----G~VKLsDFGLAk~~~ 839 (1093)
|+|||++.||+|++.+... .++|..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||+++...
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999877 49999999999999999999999999999999999999753 579999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
........||||.|+|||++...+|+..+|+||+||++|.|++|.+||.+.+
T Consensus 191 ----------------------------~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 191 ----------------------------PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred ----------------------------CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 1334567899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 920 PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
....+..|..+.+.|+. ....++..+++||++||..||.+|++ |.++|+|||+++.
T Consensus 243 ~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 243 EFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSI 299 (382)
T ss_pred hhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCC
Confidence 99999999998887654 23578999999999999999999999 8899999998765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=423.04 Aligned_cols=257 Identities=35% Similarity=0.579 Sum_probs=227.2
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
...|.....||+|+.|.||.++...+++.||+|++-.. .....+-+++|+.+|+..+|+|||.++..|...+.+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~----~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR----KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec----cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 34677788999999999999999999999999966322 22334678999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||||+||+|.+++.. ..++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||||..+..
T Consensus 348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~----- 421 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE----- 421 (550)
T ss_pred EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc-----
Confidence 9999999999998865 4599999999999999999999999999999999999999999999999999985321
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
......+.+|||.|||||++..+.|+.++||||||++.+||+-|.|||-.+++.....
T Consensus 422 ----------------------~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly 479 (550)
T KOG0578|consen 422 ----------------------EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 479 (550)
T ss_pred ----------------------ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence 1224567899999999999999999999999999999999999999999988877777
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.|.....+--..+..+|+.++||+.+||+.|+.+|++ |.++|.||||+-
T Consensus 480 LIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 480 LIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLKM 528 (550)
T ss_pred HHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhhh
Confidence 7776544333356889999999999999999999999 889999999953
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=416.76 Aligned_cols=262 Identities=34% Similarity=0.543 Sum_probs=227.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 760 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~-- 760 (1093)
....+.|+.++.||+|+||.||+|++..||+.||+|+|. .+.....-.....+|+.||++++||||++|.+...+.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr--~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVR--FDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEee--cccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 456788999999999999999999999999999999773 3333455567788999999999999999999998887
Q ss_pred CceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..+|||+|||+. ||..++...+ .|++.+++.|+.||+.||+|||.+||+|||||..|||||.+|.+||+|||||++..
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 689999999998 9999998754 69999999999999999999999999999999999999999999999999999632
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. .......+.|-|.+|+|||.|+| ..|+.++|+||.||||.||++|++.|.+.
T Consensus 270 ~--------------------------~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 270 P--------------------------SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred C--------------------------CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 1 11223556789999999999998 57999999999999999999999999999
Q ss_pred ChHHHHHHHhcc-----CCCCC-----C----------------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 919 SPEIIFDNILNR-----KIPWP-----C----------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 919 s~~ei~~kIl~~-----~l~fP-----~----------------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
+..+...+|..- .-.|| . ....++..+.+|+..||+.||.+|.| |.+.|.|
T Consensus 324 tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t---A~~aL~s 400 (560)
T KOG0600|consen 324 TEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT---ASSALQS 400 (560)
T ss_pred cHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc---HHHHhcC
Confidence 999988888751 00122 1 11357899999999999999999999 8899999
Q ss_pred CCCC
Q 001354 973 PFFK 976 (1093)
Q Consensus 973 PFFk 976 (1093)
+||.
T Consensus 401 eyF~ 404 (560)
T KOG0600|consen 401 EYFT 404 (560)
T ss_pred cccc
Confidence 9994
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=384.74 Aligned_cols=307 Identities=42% Similarity=0.789 Sum_probs=247.0
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||.|+||.||+|....+++.||+|.+. +...........+.+|+.+|..++||||+++++.+......|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~-~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLD-KKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEe-ccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 47999999999999999999999999999999554 33333334567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
|||+.|++|.+++.+. ..+++..++.++.||+.||.|||+.|++|+||||+||+|+.+|.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999999999754 46899999999999999999999999999999999999999999999999998753211100
Q ss_pred cCCCCCCCCCC--CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 845 DLSGPETDGIM--PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 845 dls~~~td~~~--p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
........... ....................+||..|+|||++.+..++.++||||||+++|+|++|..||.+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 00000000000 0000000011111223345689999999999999999999999999999999999999999998888
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC-hhcHHHHHcCCCCCCCCcchhhcccCcccCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 995 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT-a~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~ 995 (1093)
.+..+......+|.. ..++.++.+||.+||..||.+||+ ...+.+++.||||++++|..+....+|..|.+.
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 240 TFSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred HHHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 888888777666642 337999999999999999999999 456889999999999999999887777776653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=404.93 Aligned_cols=270 Identities=31% Similarity=0.527 Sum_probs=233.6
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
.+.+..++|++...||.|..++||+|+...+++.||||++ ..+.... ..+.+.+|+..|..++||||++++.+|..+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~i--nLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKII--NLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEe--ehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 4557889999999999999999999999999999999954 3333333 378999999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
..+|+||.||.+|++.+++... ..++|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+-.+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999864 45999999999999999999999999999999999999999999999999987643
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.... .+...+. .+++|||.|||||+++. .+|+.|+||||||++..||.+|..||.
T Consensus 177 ~~~G----------------------~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 177 FDSG----------------------DRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred cccC----------------------ceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 2100 0011111 67899999999999764 689999999999999999999999999
Q ss_pred CCChHHHHHHHhccCCCCCCC-------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 917 AESPEIIFDNILNRKIPWPCV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~i-------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
...++++....+++..+.+.. ...++..++.+|..||.+||.+||+ |.++|+|+||+...
T Consensus 234 k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 234 KYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFKKAK 300 (516)
T ss_pred cCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHhhcc
Confidence 999999988888887764431 1346778999999999999999999 88999999998653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=388.99 Aligned_cols=263 Identities=30% Similarity=0.490 Sum_probs=212.0
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----Cc
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----DN 762 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~-----~~ 762 (1093)
+|++.+.||+|+||.||+|+++.+|..||+|++... .........+.+|+.+|+.++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV--FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechh--hccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 589999999999999999999999999999955321 12233445788999999999999999999887543 24
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 899999995 6999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.
T Consensus 158 ------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 158 ------------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred ------------------------CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 00111234679999999999876 6789999999999999999999999987664
Q ss_pred HHHHHHHhc--------------------------cC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 921 EIIFDNILN--------------------------RK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 921 ~ei~~kIl~--------------------------~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
......+.. .. .++....+.+++++.+||.+||..||.+||+ +.++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~e~l~h 290 (338)
T cd07859 214 VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT---AEEALAD 290 (338)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC---HHHHhcC
Confidence 332221110 00 1111112357889999999999999999999 8899999
Q ss_pred CCCCCCCc
Q 001354 973 PFFKGVNW 980 (1093)
Q Consensus 973 PFFkgIdW 980 (1093)
|||+++..
T Consensus 291 p~f~~~~~ 298 (338)
T cd07859 291 PYFKGLAK 298 (338)
T ss_pred chhhhcCc
Confidence 99987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=384.93 Aligned_cols=256 Identities=29% Similarity=0.504 Sum_probs=213.5
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++.+.||.|+||.||+|+++.++..||+|++. ... .......+.+|+.+|..++||||+++++++.+...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR-LEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEec-ccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 578999999999999999999999999999999552 221 12233567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~---- 155 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV---- 155 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC----
Confidence 9999985 9999887654 478999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.
T Consensus 156 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 156 -----------------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred -----------------------CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0111234578999999999876 5689999999999999999999999998887666
Q ss_pred HHHHhccC-------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 924 FDNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 924 ~~kIl~~~-------------------l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...+.... ..+|. ....++.++.+||++||+.||.+||| +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t---~~~~l~hp~f 288 (288)
T cd07871 213 LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS---AEAALRHSYF 288 (288)
T ss_pred HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC---HHHHhcCCCC
Confidence 55543210 01111 12357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=380.46 Aligned_cols=278 Identities=34% Similarity=0.612 Sum_probs=231.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|+..+.||.|+||+||++.+..+++.||+|.+ .+...........+.+|+.+|..++|+||+.+++.|...+.+|+||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~-~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRL-EKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEe-ehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 378899999999999999999999999999944 3333333334456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~----- 154 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE----- 154 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC-----
Confidence 999999999888654 3699999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........||+.|+|||++.+..++.++|+|||||++|||++|..||.+........
T Consensus 155 -----------------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~ 211 (285)
T cd05632 155 -----------------------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211 (285)
T ss_pred -----------------------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011124579999999999999999999999999999999999999998876544433
Q ss_pred HHhccCCC-CCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--cCcccCCC
Q 001354 926 NILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 994 (1093)
Q Consensus 926 kIl~~~l~-fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~ 994 (1093)
.+...... .+.++..++.++.+||.+||..||.+||+.. .+.+++.|+||+.++|+.+... .|+|+|.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 212 EVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred HHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 33221111 0123467899999999999999999999943 4789999999999999987654 67888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=386.94 Aligned_cols=262 Identities=28% Similarity=0.508 Sum_probs=211.2
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||.|+||+||+|+.+.+++.||+|++ +.... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~-~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-RLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEe-ccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 47899999999999999999999999999999954 32221 2223457789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||++ |+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 155 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV---- 155 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC----
Confidence 999996 5888877654 5689999999999999999999999999999999999999999999999999873210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCCh-HH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-EI 922 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~-~e 922 (1093)
........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+... .+
T Consensus 156 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 212 (303)
T cd07869 156 -----------------------PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212 (303)
T ss_pred -----------------------CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 0111234578999999999876 4588999999999999999999999987543 22
Q ss_pred HHHHHhcc--C---CCCCC------------------------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 923 IFDNILNR--K---IPWPC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 923 i~~kIl~~--~---l~fP~------------------------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
....+... . ..+|. .....++++.+||.+||+.||.+||| +.++++||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s---~~~~l~h~ 289 (303)
T cd07869 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS---AQAALSHE 289 (303)
T ss_pred HHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC---HHHHhcCc
Confidence 22222110 0 00000 00124578999999999999999999 88999999
Q ss_pred CCCCCCcc
Q 001354 974 FFKGVNWD 981 (1093)
Q Consensus 974 FFkgIdWd 981 (1093)
||+++.+.
T Consensus 290 ~f~~~~~~ 297 (303)
T cd07869 290 YFSDLPPR 297 (303)
T ss_pred ccccCChh
Confidence 99988653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=406.24 Aligned_cols=257 Identities=31% Similarity=0.609 Sum_probs=238.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
...|++.+.||+|+||+|-++.....|+.|||| .++|..+..+...-++.+|++||..++||||+.+|.+|...+.+.|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiK-sIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIK-SIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehh-hhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 357999999999999999999999999999999 6677788888889999999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||..+|+|++|+.+.+.++|.+++.+++||+.|+.|+|+++++|||||.+|||||.++++||+||||+-..
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly------- 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY------- 203 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998742
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.......++||+|.|.+||++.|.+| +..+|.|||||+||-|+.|..||.+.+...+.
T Consensus 204 ---------------------~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv 262 (668)
T KOG0611|consen 204 ---------------------ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV 262 (668)
T ss_pred ---------------------ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH
Confidence 12334568999999999999999999 68999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
+.|..+.+.-| .-+.++.-||+.||..||++|.| +.+|..|-|. ||.
T Consensus 263 rQIs~GaYrEP----~~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 263 RQISRGAYREP----ETPSDASGLIRWMLMVNPERRAT---IEDIASHWWV---NWG 309 (668)
T ss_pred HHhhcccccCC----CCCchHHHHHHHHHhcCcccchh---HHHHhhhhee---ecc
Confidence 99999888755 35668899999999999999999 8899999995 565
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=404.94 Aligned_cols=259 Identities=31% Similarity=0.497 Sum_probs=221.9
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcE-EEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL-FAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~-VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+.+...++.+.+.||.|+||+||++.++ |.. +|+|.+ ........ ....|.+|+.+|.+++|||||++++++..
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~-~~~~~~~~-~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKII-SDPDFDDE-SRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEe-cchhcChH-HHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 44566777888888999999999999998 555 999954 33332222 27789999999999999999999999999
Q ss_pred CC-ceEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-cEeeecCCCcEEEccCC-cEEEEecCC
Q 001354 760 RD-NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAHDG-HIKLTDFGL 834 (1093)
Q Consensus 760 ~~-~LyLVMEYm~GGSL~dlL~k--~g~LsEe~ar~yaaQIl~ALeYLHs~G-IIHRDIKPeNILLD~dG-~VKLsDFGL 834 (1093)
+. .+++|||||++|+|..+|++ ...++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 98 79999999999999999988 578999999999999999999999999 99999999999999998 999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--CCCCCccceeecchhhHHHHHhCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~--g~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
++..... ........||+.|||||++. +..|+.++||||||++||||+||.
T Consensus 191 sr~~~~~---------------------------~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~ 243 (362)
T KOG0192|consen 191 SREKVIS---------------------------KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGE 243 (362)
T ss_pred ceeeccc---------------------------cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCC
Confidence 9852100 01223368999999999999 669999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.||.+..+......+.....+ |.+|...++.+..||.+||..||.+||++.++...|.
T Consensus 244 ~Pf~~~~~~~~~~~v~~~~~R-p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 244 IPFEDLAPVQVASAVVVGGLR-PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred CCCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 999999987777777665554 5567789999999999999999999999766655554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=413.86 Aligned_cols=259 Identities=32% Similarity=0.502 Sum_probs=222.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC-
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD- 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~- 761 (1093)
...+.|.+++.||.|+||.||+|+.+.+|+.||||.+.+|... .+.-.-++|+.-|++++ |||||+|++++.+.+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 4567899999999999999999999999999999966554432 23344578999999999 999999999999988
Q ss_pred ceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+|||||.. +|+++++..+ .|++..++.|+.||+.||+|+|++|+.||||||+|||+..+..|||+|||||+...
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~- 161 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR- 161 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc-
Confidence 89999999976 9999998654 59999999999999999999999999999999999999989999999999999532
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
........+-|.+|+|||+|+. ..|+.++|+||+||||+|+.+-++-|.|.+
T Consensus 162 ---------------------------SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 162 ---------------------------SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ---------------------------cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 1112334688999999999986 568999999999999999999999999999
Q ss_pred hHHHHHHHhc-------------------cCCCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 920 PEIIFDNILN-------------------RKIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 920 ~~ei~~kIl~-------------------~~l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
..+..-+|.. -++.||. +-+..+.++.+||.+||.+||.+||| |.+.|+|
T Consensus 215 E~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT---A~~al~~ 291 (538)
T KOG0661|consen 215 EIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT---ASQALQH 291 (538)
T ss_pred HHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc---HHHHhcC
Confidence 8777777653 1223333 22358999999999999999999999 8899999
Q ss_pred CCCCC
Q 001354 973 PFFKG 977 (1093)
Q Consensus 973 PFFkg 977 (1093)
|||+.
T Consensus 292 pffq~ 296 (538)
T KOG0661|consen 292 PFFQV 296 (538)
T ss_pred ccccc
Confidence 99974
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=386.47 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=219.8
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++++.||+|+||.||+++++.+|..||+|.+... ........+.+|+.+|..++||||+++++++...+.+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 3468999999999999999999999999999999955322 1233456789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--- 155 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 155 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc---
Confidence 99999999999999998888899999999999999999999986 69999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.......+||+.|+|||++.+..++.++|+|||||+||||++|+.||...+..+
T Consensus 156 --------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 156 --------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred --------------------------ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 011234579999999999999999999999999999999999999998766544
Q ss_pred HHHHHh----------------------------------------------ccCCCCCCC-CCCCCHHHHHHHHhhccC
Q 001354 923 IFDNIL----------------------------------------------NRKIPWPCV-PSDMSFEAQDLINRFLIH 955 (1093)
Q Consensus 923 i~~kIl----------------------------------------------~~~l~fP~i-p~~IS~eakDLIkrcL~k 955 (1093)
+...+- .... |.. ...+++++++||.+||.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~ 287 (331)
T cd06649 210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIK 287 (331)
T ss_pred HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccC
Confidence 332211 1110 111 124788999999999999
Q ss_pred CcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 956 DPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 956 DP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
||++||+ +.+|++||||+.....
T Consensus 288 ~P~~Rpt---~~ell~h~~~~~~~~~ 310 (331)
T cd06649 288 NPAERAD---LKMLMNHTFIKRSEVE 310 (331)
T ss_pred CcccCCC---HHHHhcChHHhhcccc
Confidence 9999999 8899999999865443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=391.69 Aligned_cols=264 Identities=30% Similarity=0.486 Sum_probs=233.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc----hhHHHHHHHHHHHHHhcC-CCceEEEeeeec
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR----KNDIERILAERNILITVR-NPFVVRFFYSFT 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~----~~eie~~l~E~~IL~kL~-HPNIVkL~gsfq 758 (1093)
-....|+..+.||+|..+.|.++.++.||..+|+|+|........ ..-.+..+.|+.||+++. ||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 345677888899999999999999999999999996643222211 222455678999999986 999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+..+++|+|.|+.|.|+++|...-.++|..++.+++|++.|++|||.++|+||||||+|||+|++.++||+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC------CCCCccceeecchhhHHHHHhCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g------~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
.++......||||+|+|||.+.- .+|+..+|+|++|||||-||.|.
T Consensus 174 ----------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 174 ----------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred ----------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 23445667899999999999853 57899999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+||.....+.+.+.|+.+++.|.. ...++|.+++|||.+||+.||.+|+| +.|.|.||||..+
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~ 289 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQI 289 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHH
Confidence 999999999999999999988743 23679999999999999999999999 8899999999654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.35 Aligned_cols=255 Identities=34% Similarity=0.520 Sum_probs=207.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEECC-CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc---CCCceEEEeeeec----
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKQVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT---- 758 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~-TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL---~HPNIVkL~gsfq---- 758 (1093)
.+|++++.||+|+||+||+|++.. ++..||+|.+... . ........+.+|+.++..+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~-~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ-T-GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecc-c-CCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 479999999999999999999854 4688999954322 1 1222234556777777665 6999999999875
Q ss_pred -cCCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 759 -CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 759 -d~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
....+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 3456899999997 5999998754 35899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
+.... ........||+.|+|||++.+..++.++|||||||++|||++|.+||
T Consensus 158 ~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f 209 (290)
T cd07862 158 RIYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209 (290)
T ss_pred EeccC----------------------------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCc
Confidence 74210 11223467999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhccCC-----CCC-------------------CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 916 TAESPEIIFDNILNRKI-----PWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l-----~fP-------------------~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.+.+..+.+..|+.... .+| .+.+.++..+++||.+||+.||++||+ +.++++
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~l~ 286 (290)
T cd07862 210 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALS 286 (290)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC---HHHHhc
Confidence 99888777777654210 111 012357889999999999999999999 889999
Q ss_pred CCCC
Q 001354 972 HPFF 975 (1093)
Q Consensus 972 HPFF 975 (1093)
||||
T Consensus 287 hp~f 290 (290)
T cd07862 287 HPYF 290 (290)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=365.12 Aligned_cols=257 Identities=60% Similarity=1.045 Sum_probs=221.6
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHH-HhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL-~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||.|+||.||+|.+..+|+.||+|.+ ++...........+..|..++ ...+||||+++++++...+.+|+||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEe-cchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 5799999999999999999999999944 443332233344455665554 44589999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
||+|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++....
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------------ 148 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------ 148 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc------------
Confidence 99999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
......|++.|+|||.+.+..++.++||||||+++|+|++|.+||...+...++..+....
T Consensus 149 -------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (260)
T cd05611 149 -------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209 (260)
T ss_pred -------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 0123468899999999998889999999999999999999999999988888888877666
Q ss_pred CCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 932 IPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 932 l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
..++. ....++.++.++|.+||..||.+||++.++.+++.||||+.++|+
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 55443 234689999999999999999999998889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=418.93 Aligned_cols=316 Identities=50% Similarity=0.930 Sum_probs=261.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|.+++.||+|+||+||+|.+..+++.||||+ +++...........+..|+.++..++||||+++++++.....+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKv-i~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKV-VKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEE-EehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 6789999999999999999999999999999994 444444445556788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc-
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI- 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~- 844 (1093)
||||+.||+|.+++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.+|++||+|||+++........
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~ 161 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999743110000
Q ss_pred -cC---------------------------------------------------------C-----C----------C--
Q 001354 845 -DL---------------------------------------------------------S-----G----------P-- 849 (1093)
Q Consensus 845 -dl---------------------------------------------------------s-----~----------~-- 849 (1093)
++ . . .
T Consensus 162 ~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (669)
T cd05610 162 MDILTTPSMAKPKNDYSRTPGQVLSLISSLGFNTPVGEKDQGSVNSGQNNGTSSVRTGTSHPLLMINKESLPMSLKLSKS 241 (669)
T ss_pred cccccCccccCccccccCCCCceeeeeeecCcCCccccccccccccccccccccccccCCCCcccccccccccccHhhhh
Confidence 00 0 0 0
Q ss_pred -----CCCCCCCC-------------------------------------------------------------------
Q 001354 850 -----ETDGIMPS------------------------------------------------------------------- 857 (1093)
Q Consensus 850 -----~td~~~p~------------------------------------------------------------------- 857 (1093)
......|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (669)
T cd05610 242 CLETSESSPSLPVRSLTPNLLKSRKRPEASTSSTHSCMTNSLSSCESECCSSNLKLLEQASSPSQSPRWSVDEGNIISEG 321 (669)
T ss_pred ccccccCCCCCCccccCcccccccccCCcccccchhhhhhhhhhccccccCcchhhhhhccCCCCCccccccCCCCcccc
Confidence 00000000
Q ss_pred --------------------------------------------------------------------------------
Q 001354 858 -------------------------------------------------------------------------------- 857 (1093)
Q Consensus 858 -------------------------------------------------------------------------------- 857 (1093)
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (669)
T cd05610 322 EKSEKGSVKRSFELVEKSPCQELLQSKKTNAEYKRGCSITETNGNQSTGLTMEIQSLNLSKHKSRPKFLAGNEKRTGPKK 401 (669)
T ss_pred cccccCCccccccccccChHHHHhcccccccccccceeeccccccccccceeecchhhhhhhhcCchhhhccccccCccc
Confidence
Q ss_pred ---------------------------------------------CCC-------CCccc-------c------------
Q 001354 858 ---------------------------------------------DAH-------YPEYQ-------Q------------ 866 (1093)
Q Consensus 858 ---------------------------------------------~~~-------~~e~~-------~------------ 866 (1093)
+.. ...|. .
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (669)
T cd05610 402 KSNPVVAKNLMCELDDDGEKDGKYSNSSTSCGDDREIVLKLSLNSDSSFPEMSKNAVAFRSYNSPINVSNVSEPSTMSSL 481 (669)
T ss_pred CCCcchhhhhhccccccccccCCccccccccCccHHHhhhhhhccccccccccccceeeeccCchhhccccCCCCccccc
Confidence 000 00000 0
Q ss_pred --------------------c------------------------------CcCCccCccCCCCCCChhhhcCCCCCccc
Q 001354 867 --------------------T------------------------------DNRNRHSAVGTPDYLAPEILLGTEHGYAA 896 (1093)
Q Consensus 867 --------------------~------------------------------~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 896 (1093)
. ........+||+.|||||++.+..|+.++
T Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~ 561 (669)
T cd05610 482 DAMKMSGSQSGSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAV 561 (669)
T ss_pred chhhccccccCCCcccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHH
Confidence 0 00001124789999999999999999999
Q ss_pred eeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 897 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 897 DVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
|||||||+||||++|.+||.+....+.+..++...+++|.....++..+.++|.+||..||.+||+ +.+++.||||.
T Consensus 562 DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~t---a~e~l~h~~~~ 638 (669)
T cd05610 562 DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAG---LKELKQHPLFH 638 (669)
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcC---HHHHHhCHhhc
Confidence 999999999999999999999999999999998888888766788999999999999999999999 88999999999
Q ss_pred CCCcchhhcccCcccCCCCCCCCCccccc
Q 001354 977 GVNWDSLALQKAVFVPQPESVDDTSYFLS 1005 (1093)
Q Consensus 977 gIdWd~L~~~~pPf~P~~~s~~Dts~Fds 1005 (1093)
.++|..+.....+|.|.+....|+.||+.
T Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (669)
T cd05610 639 GVDWENLQNQTMPFIPQPDDETDTSYFEA 667 (669)
T ss_pred CCCHHHhcccCCCCCCCCCCccccccccc
Confidence 99999999889999999988888888865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=389.71 Aligned_cols=265 Identities=32% Similarity=0.501 Sum_probs=224.1
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
...-++++|+.+..|+.|+||.||+|+++.|++.||+|++ +.+.....---.-++|+.+|.+++|||||.+-.+....
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~--kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRL--KMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeec--ccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 3446789999999999999999999999999999999955 22222233334568999999999999999998776554
Q ss_pred --CceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 761 --DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 761 --~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+.+|||||||+. ||..++.+.+ .|.+.+++.++.|++.||+|||.++|+||||||+|+|+...|.+||+|||||+.
T Consensus 148 ~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 148 NMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred ccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 469999999988 9999998876 799999999999999999999999999999999999999999999999999995
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.. .+.......+-|.+|+|||.+++ ..|+.++|+||+||||.||++++|-|.
T Consensus 227 yg---------------------------sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 227 YG---------------------------SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred hc---------------------------CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 21 11223455788999999999997 569999999999999999999999999
Q ss_pred CCChHHHHHHHhcc-------------------CCCCCCC---------CC-CCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 917 AESPEIIFDNILNR-------------------KIPWPCV---------PS-DMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~-------------------~l~fP~i---------p~-~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
+.+..+...+|+.. ...|+.. +. .++....+|+..+|.+||.+|+| |.
T Consensus 280 G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t---A~ 356 (419)
T KOG0663|consen 280 GKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT---AE 356 (419)
T ss_pred CCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc---HH
Confidence 99998888888651 1112211 11 26799999999999999999999 88
Q ss_pred HHHcCCCCCCC
Q 001354 968 EVKAHPFFKGV 978 (1093)
Q Consensus 968 EIL~HPFFkgI 978 (1093)
+.|+|.||.+.
T Consensus 357 ~~L~h~~F~e~ 367 (419)
T KOG0663|consen 357 DGLKHEYFRET 367 (419)
T ss_pred HhhcccccccC
Confidence 99999999863
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=388.02 Aligned_cols=261 Identities=31% Similarity=0.506 Sum_probs=216.7
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----c
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 762 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~-----~ 762 (1093)
+|++.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+|..++||||+++++++.... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 588999999999999999999999999999955322 112234567889999999999999999999998877 7
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~- 156 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD- 156 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-
Confidence 999999996 589998888788999999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++.
T Consensus 157 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 157 -------------------------ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred -------------------------ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 01112234689999999999874 5799999999999999999999999988776
Q ss_pred HHHHHHhc-----------------------cCCCCC------CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 922 IIFDNILN-----------------------RKIPWP------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 922 ei~~kIl~-----------------------~~l~fP------~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
.....|.. .....| .+....++++.+||.+||+.||.+||+ +.++++|
T Consensus 212 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t---~~e~l~h 288 (372)
T cd07853 212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS---AADALAH 288 (372)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC---HHHHhcC
Confidence 65555432 111111 122456889999999999999999999 8899999
Q ss_pred CCCCCCCc
Q 001354 973 PFFKGVNW 980 (1093)
Q Consensus 973 PFFkgIdW 980 (1093)
|||++..+
T Consensus 289 p~~~~~~~ 296 (372)
T cd07853 289 PYLDEGRL 296 (372)
T ss_pred HhhCCCcc
Confidence 99998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=369.19 Aligned_cols=254 Identities=31% Similarity=0.499 Sum_probs=205.9
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccC----
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCR---- 760 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL---~HPNIVkL~gsfqd~---- 760 (1093)
+|++++.||+|+||+||+|+++.+|+.||+|.+. ... ........+.+|+.++..+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~-~~~-~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR-VQT-NEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEec-cCc-CCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 4899999999999999999999999999999553 211 1122223455677666654 799999999988653
Q ss_pred -CceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
..+++||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 458999999985 899988764 3489999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
... ........||+.|+|||++.+..++.++|||||||++|||++|.+||.+
T Consensus 158 ~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 158 YSC----------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred ccC----------------------------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 210 0112235789999999999999999999999999999999999999998
Q ss_pred CChHHHHHHHhcc-----CCCCC-------------------CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 918 ESPEIIFDNILNR-----KIPWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 918 ~s~~ei~~kIl~~-----~l~fP-------------------~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
.+......++... ...+| ...+.++..+.+||.+||++||.+||+ +.+++.||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~l~hp 286 (288)
T cd07863 210 NSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS---AFRALQHP 286 (288)
T ss_pred CCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC---HHHHhcCC
Confidence 8776666555431 00111 012357888999999999999999999 88999999
Q ss_pred CC
Q 001354 974 FF 975 (1093)
Q Consensus 974 FF 975 (1093)
||
T Consensus 287 ~f 288 (288)
T cd07863 287 FF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.28 Aligned_cols=266 Identities=36% Similarity=0.660 Sum_probs=221.6
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 774 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGS 774 (1093)
||.|+||+||+|.+..+|+.||+|.+. +...........+.+|+.+|+.++||||+++++.|...+.+|+||||++||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~-~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLD-KKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEe-hhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999553 3333333445667889999999999999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCC
Q 001354 775 LYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852 (1093)
Q Consensus 775 L~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td 852 (1093)
|.+++.+.. .+++..++.++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------ 147 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------ 147 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc------------
Confidence 999998765 699999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh----HHHHHHHh
Q 001354 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNIL 928 (1093)
Q Consensus 853 ~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~----~ei~~kIl 928 (1093)
........|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... ..+...+.
T Consensus 148 ----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 211 (277)
T cd05577 148 ----------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL 211 (277)
T ss_pred ----------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc
Confidence 0111234688999999999988899999999999999999999999987654 23333333
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh-h-cHHHHHcCCCCCCCCcchhhcc--cCcccC
Q 001354 929 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-N-GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 992 (1093)
Q Consensus 929 ~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa-~-~A~EIL~HPFFkgIdWd~L~~~--~pPf~P 992 (1093)
..... .+..+++++.+||.+||..||.+||++ + .+.+++.||||+.++|..+... .+||.|
T Consensus 212 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 212 EMAVE---YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred ccccc---CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 33222 346789999999999999999999963 2 4889999999999999887544 455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=359.19 Aligned_cols=261 Identities=31% Similarity=0.510 Sum_probs=222.8
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhh-hhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL-DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~-~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
++|++.+.||.|+||.||+|....++..||+|.+.... ..........+.+|+.++..++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999999999999999553221 11123345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--- 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
..........|++.|+|||++.+..++.++|+||||+++|||++|++||...+......
T Consensus 159 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 159 ---------------------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred ---------------------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 00001124568899999999999889999999999999999999999998877766666
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+...... +.++..++..+.+||.+||..+|.+||+ +.++++||||
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 218 KIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred HHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 65544333 3356789999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=376.19 Aligned_cols=258 Identities=33% Similarity=0.555 Sum_probs=221.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.|..++.||+|.||.||+|++..||+.||||+|. ....+.......++|+..|+.++||||+.|+++|....++.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIk--l~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIK--LGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEee--ccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 46888999999999999999999999999999773 2233333446789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
+|||+. ||...++... .++...++.|+.++++||+|||.++|+||||||.|+||+.+|.+||+|||+|+....
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~----- 153 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS----- 153 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC-----
Confidence 999987 9999998654 589999999999999999999999999999999999999999999999999996421
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
+.......+-|.+|+|||.+.| ..|+..+|+||.|||+.||+.|.|-|.+.+..+..
T Consensus 154 ----------------------p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 154 ----------------------PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred ----------------------CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 1111222388999999999987 57999999999999999999999999999988888
Q ss_pred HHHhcc-----CCCCCC--------------------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 925 DNILNR-----KIPWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 925 ~kIl~~-----~l~fP~--------------------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
..|+.. .-.||. +....+.++.||+.+||.+||.+|++ |.|.++|+||+.
T Consensus 212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a~qaL~~~yf~~ 286 (318)
T KOG0659|consen 212 SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---ASQALKHPYFKS 286 (318)
T ss_pred HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---HHHHhcchhhhc
Confidence 877651 112222 12346788999999999999999999 889999999975
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=401.31 Aligned_cols=257 Identities=30% Similarity=0.433 Sum_probs=209.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC---
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--- 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--- 760 (1093)
....+|++++.||+|+||.||+|.+..+++.||+|++.... ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 34568999999999999999999999999999999664321 2235799999999999999998876432
Q ss_pred -----CceEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEE
Q 001354 761 -----DNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLT 830 (1093)
Q Consensus 761 -----~~LyLVMEYm~GGSL~dlL~----k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLs 830 (1093)
..+|+||||+++ +|.+++. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 247899999986 7777664 345699999999999999999999999999999999999999765 69999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHH
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEML 909 (1093)
|||+|+.... .......+||+.|||||++.+. .|+.++|||||||+||||+
T Consensus 214 DFGla~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 265 (440)
T PTZ00036 214 DFGSAKNLLA----------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265 (440)
T ss_pred ccccchhccC----------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999984210 1122346789999999998764 6899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCCCCh
Q 001354 910 TGIPPFTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGA 963 (1093)
Q Consensus 910 TGkpPF~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~IS~eakDLIkrcL~kDP~KRpTa 963 (1093)
+|.+||.+.+..+....++.. .+.+|. +|...++++.+||.+||++||.+||+
T Consensus 266 tG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t- 344 (440)
T PTZ00036 266 LGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN- 344 (440)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC-
Confidence 999999998876666555431 111221 23457899999999999999999999
Q ss_pred hcHHHHHcCCCCCCCCc
Q 001354 964 NGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 964 ~~A~EIL~HPFFkgIdW 980 (1093)
+.++++||||..+..
T Consensus 345 --a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 345 --PIEALADPFFDDLRD 359 (440)
T ss_pred --HHHHhCChhHHhhhc
Confidence 889999999987654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=369.97 Aligned_cols=260 Identities=38% Similarity=0.665 Sum_probs=210.0
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHH---hcCCCceEEEeeeeccCCceEEEEEec
Q 001354 694 PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~---kL~HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
.||+|+||.||++.+..++..||+|.+.+. ..........+.+|..++. ..+||+|+.+++.+...+..|+||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcc-ccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 489999999999999999999999955432 2222222233445544443 347999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCC
Q 001354 771 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850 (1093)
Q Consensus 771 ~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~ 850 (1093)
+||+|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~----------- 148 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----------- 148 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc-----------
Confidence 999999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeecchhhHHHHHhCCCCCCCCCh---HHHHHH
Q 001354 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDN 926 (1093)
Q Consensus 851 td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~---~ei~~k 926 (1093)
........||+.|+|||++. +..++.++|+|||||++|||++|..||..... ......
T Consensus 149 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 210 (279)
T cd05633 149 ------------------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (279)
T ss_pred ------------------ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH
Confidence 00112346999999999987 46689999999999999999999999975432 222222
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhcc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 986 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT--a~~A~EIL~HPFFkgIdWd~L~~~ 986 (1093)
...... .++..++.++.+||.+||..||.+|++ ...+.++++||||++++|......
T Consensus 211 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 269 (279)
T cd05633 211 TLTVNV---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269 (279)
T ss_pred hhcCCc---CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcC
Confidence 222222 234678999999999999999999995 234889999999999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=382.72 Aligned_cols=258 Identities=31% Similarity=0.489 Sum_probs=210.8
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.....++|+.++.||+|+||.||+|++..+|+.||+|++.... .......+.+|+.+|+.++||||+++++++...+
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 3456788999999999999999999999999999999553221 2234567889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||+++|+|... ....+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~- 220 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ- 220 (353)
T ss_pred eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc-
Confidence 99999999999998653 3456788889999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
........+||+.|+|||++.. ..++.++|||||||+||||++|+.||.
T Consensus 221 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 221 --------------------------TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred --------------------------ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 0011234579999999999843 234578999999999999999999997
Q ss_pred CCChHH---HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 917 AESPEI---IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 917 ~~s~~e---i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.....+ ....+.... .+..+..++.++.+||.+||..||.+||+ +.++++||||.+.
T Consensus 275 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~ 334 (353)
T PLN00034 275 VGRQGDWASLMCAICMSQ--PPEAPATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRA 334 (353)
T ss_pred CCCCccHHHHHHHHhccC--CCCCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccC
Confidence 543222 222222211 13345678999999999999999999999 8899999999864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=357.70 Aligned_cols=265 Identities=61% Similarity=1.119 Sum_probs=227.9
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 774 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGS 774 (1093)
||.|+||.||++.+..+|+.|++|. +.+...........+.+|+.++..++||||+++++.+.....+|+||||+++|+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~-~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKV-IKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEE-ecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999999999999994 444444344567789999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001354 775 LYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854 (1093)
Q Consensus 775 L~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~ 854 (1093)
|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..........
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--------- 150 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN--------- 150 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc---------
Confidence 99999988889999999999999999999999999999999999999999999999999987532110000
Q ss_pred CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCC
Q 001354 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934 (1093)
Q Consensus 855 ~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~f 934 (1093)
. ...........+++.|+|||++.+..++.++|+||||+++|+|++|..||......+.+..+..+...+
T Consensus 151 ~----------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (265)
T cd05579 151 L----------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW 220 (265)
T ss_pred c----------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC
Confidence 0 000112234568899999999998889999999999999999999999999999888888888766666
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 935 P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
|.. ..++..+.+||.+||+.+|.+||++..+.++++||||++++|
T Consensus 221 ~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 221 PED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred Ccc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 532 235899999999999999999999877899999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=397.95 Aligned_cols=261 Identities=34% Similarity=0.590 Sum_probs=236.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..+-|.+-+.||+|.|+.|-++++.-||..||+| ++.|..+ ..-...+++.|+++|+.++|||||+||.+..+...+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVK-viDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVK-VIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEE-Eeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 3466888999999999999999999999999999 5444433 3344578999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc-cCCcEEEEecCCcccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD-~dG~VKLsDFGLAk~~~~~~ 842 (1093)
||+|+-.||||+++|.++. .+.|+.++.|++||+.||.|+|+..+|||||||+|+.+. .-|-|||+|||++-..
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf---- 169 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF---- 169 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC----
Confidence 9999999999999998874 699999999999999999999999999999999998875 4689999999998632
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC-ccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys-~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.+.....+.||+..|-|||+|+|..|+ .++||||||||||-|++|++||...+..
T Consensus 170 ------------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 170 ------------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred ------------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 235567789999999999999999996 5899999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
++..+|+..++..| ..+|.+++|||..||..||.+|.+ +++|..|+|++++|-.
T Consensus 226 ETLTmImDCKYtvP---shvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 226 ETLTMIMDCKYTVP---SHVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhhhhhcccccCc---hhhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCCC
Confidence 99999999999877 799999999999999999999999 8899999999987753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=376.82 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=207.1
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 755 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~g 755 (1093)
+.+..++|++.+.||+|+||.||+|.+. .++..||+|++ +.. ........+.+|+.+|..+ +||||+++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML-KEG--ATASEHKALMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecc-ccc--cchHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence 3466789999999999999999999852 44678999944 321 1233456789999999999 8999999999
Q ss_pred eeccCC-ceEEEEEecCCCChHHHHHhc----------------------------------------------------
Q 001354 756 SFTCRD-NLYLVMEYLNGGDLYSLLRKV---------------------------------------------------- 782 (1093)
Q Consensus 756 sfqd~~-~LyLVMEYm~GGSL~dlL~k~---------------------------------------------------- 782 (1093)
++...+ .+|+||||++||+|.+++...
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 887654 589999999999999999753
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCC
Q 001354 783 ----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852 (1093)
Q Consensus 783 ----------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td 852 (1093)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~---------- 228 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP---------- 228 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc----------
Confidence 236778888999999999999999999999999999999999999999999997421000
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccC
Q 001354 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 853 ~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~ 931 (1093)
.........+|+.|||||++.+..|+.++|||||||+||||++ |.+||.+....+.+...+...
T Consensus 229 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 293 (338)
T cd05102 229 ---------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293 (338)
T ss_pred ---------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC
Confidence 0011123456789999999999999999999999999999997 999998866544333333332
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.. +..+..+++++.+||.+||..||.+||++.++.+.|
T Consensus 294 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 294 TR-MRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred CC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 22 223577899999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=390.72 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=209.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+...+|++++.||+|+||.||+|.+..+++.||+|.. . ...+.+|+.+|+.++|||||+++++|......
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~-~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAG-Q---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEech-h---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 4567899999999999999999999999999999932 1 23467899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+|||++. ++|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~--- 234 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD--- 234 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc---
Confidence 99999995 69999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC----
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES---- 919 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s---- 919 (1093)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus 235 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~ 291 (391)
T PHA03212 235 -----------------------INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG 291 (391)
T ss_pred -----------------------ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence 00112235689999999999999999999999999999999999998875422
Q ss_pred ---hHHHHHHHhc--------------------------cCCCCCCC------CCCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 920 ---PEIIFDNILN--------------------------RKIPWPCV------PSDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 920 ---~~ei~~kIl~--------------------------~~l~fP~i------p~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
.......++. .....|.. ...++.++.+||.+||+.||.+||+
T Consensus 292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt-- 369 (391)
T PHA03212 292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS-- 369 (391)
T ss_pred cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC--
Confidence 1111111111 00000000 0135678999999999999999999
Q ss_pred cHHHHHcCCCCCCC
Q 001354 965 GAAEVKAHPFFKGV 978 (1093)
Q Consensus 965 ~A~EIL~HPFFkgI 978 (1093)
|.++|+||||+.+
T Consensus 370 -a~elL~hp~f~~~ 382 (391)
T PHA03212 370 -AEALLDFAAFQDI 382 (391)
T ss_pred -HHHHhcChhhccC
Confidence 8899999999764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=377.76 Aligned_cols=258 Identities=31% Similarity=0.519 Sum_probs=216.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++.+.||.|+||.||++.++.++..+|+|.+... ........+.+|+.+|..++||||++++++|.+.+.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 3457999999999999999999999999999999954322 1233456789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+||||++||+|.+++.+.+.+++..+..++.+++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--- 155 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 155 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh---
Confidence 99999999999999999888899999999999999999999985 79999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.......
T Consensus 156 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 156 --------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred --------------------------hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 001123579999999999999899999999999999999999999998655433
Q ss_pred HHHH--------------------------------------------HhccCCCCCCCC-CCCCHHHHHHHHhhccCCc
Q 001354 923 IFDN--------------------------------------------ILNRKIPWPCVP-SDMSFEAQDLINRFLIHDP 957 (1093)
Q Consensus 923 i~~k--------------------------------------------Il~~~l~fP~ip-~~IS~eakDLIkrcL~kDP 957 (1093)
+... +..... |.++ ..++.++++||.+||++||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P 287 (333)
T cd06650 210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNP 287 (333)
T ss_pred HHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCc
Confidence 3211 111111 1111 2367899999999999999
Q ss_pred CCCCChhcHHHHHcCCCCCCC
Q 001354 958 NQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 958 ~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.+||+ +.+++.||||+..
T Consensus 288 ~~Rpt---~~ell~h~~~~~~ 305 (333)
T cd06650 288 AERAD---LKQLMVHAFIKRS 305 (333)
T ss_pred ccCcC---HHHHhhCHHHhcC
Confidence 99999 8899999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=357.42 Aligned_cols=257 Identities=40% Similarity=0.786 Sum_probs=222.2
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 774 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGS 774 (1093)
||.|+||.||+|+...++..||+|++ .+...........+.+|+.+++.++||||+++++.+.+...+|+||||+++|+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCV-KKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEE-ehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 79999999999999999999999954 33333334456789999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001354 775 LYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854 (1093)
Q Consensus 775 L~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~ 854 (1093)
|.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~-------------- 145 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-------------- 145 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc--------------
Confidence 999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC--hHHHHHHHhccCC
Q 001354 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PEIIFDNILNRKI 932 (1093)
Q Consensus 855 ~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s--~~ei~~kIl~~~l 932 (1093)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... +...+..+..+..
T Consensus 146 --------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 211 (262)
T cd05572 146 --------------GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211 (262)
T ss_pred --------------ccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC
Confidence 002234578999999999998889999999999999999999999998877 6777777774222
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcc
Q 001354 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 933 ~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd 981 (1093)
. +..|...++++.+||.+||..||.+||+. ..+.|+++||||++.+|+
T Consensus 212 ~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 212 K-LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred C-CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 2 22346679999999999999999999982 358899999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=378.44 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=208.6
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
..++|++++.||+|+||.||+|.++.+|..||+|++.+. .........+.+|+.++..++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP--FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc--ccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 468999999999999999999999999999999955322 223344567889999999999999999999987554
Q ss_pred ---ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 762 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999976 67666643 4889999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.. ........||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.
T Consensus 174 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CT----------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cc----------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 10 01123457899999999999999999999999999999999999999877
Q ss_pred ChHHHHHHHhc----------------------cCCCCCC-----------------CCCCCCHHHHHHHHhhccCCcCC
Q 001354 919 SPEIIFDNILN----------------------RKIPWPC-----------------VPSDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 919 s~~ei~~kIl~----------------------~~l~fP~-----------------ip~~IS~eakDLIkrcL~kDP~K 959 (1093)
+....+..+.. ....++. .....++++++||.+||+.||.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred CHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 65433322211 1111110 11224678999999999999999
Q ss_pred CCChhcHHHHHcCCCCCC
Q 001354 960 RLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFkg 977 (1093)
||+ +.|+++||||..
T Consensus 306 R~t---~~e~l~hp~~~~ 320 (359)
T cd07876 306 RIS---VDEALRHPYITV 320 (359)
T ss_pred CCC---HHHHhcCchhhh
Confidence 999 889999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=378.51 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=210.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
..++|++++.||+|+||.||+|.+..+++.||+|++.+. .........+.+|+.+++.++||||+++++.+....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcc--ccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 468999999999999999999999999999999955321 122344567889999999999999999998876543
Q ss_pred ---ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 762 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+|+||||+++ +|...+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999976 77777753 4888999999999999999999999999999999999999999999999999742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 177 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 177 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CC----------------------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 10 01123457899999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHhccCC----------------------C--------------CC---CCCCCCCHHHHHHHHhhccCCcCC
Q 001354 919 SPEIIFDNILNRKI----------------------P--------------WP---CVPSDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 919 s~~ei~~kIl~~~l----------------------~--------------fP---~ip~~IS~eakDLIkrcL~kDP~K 959 (1093)
+..+.+..++.... . ++ ......+..+++||.+||+.||.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 308 (364)
T cd07875 229 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 308 (364)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCccc
Confidence 77666665543100 0 00 001123567899999999999999
Q ss_pred CCChhcHHHHHcCCCCC
Q 001354 960 RLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFk 976 (1093)
||| +.++|+||||.
T Consensus 309 R~t---~~e~L~hp~~~ 322 (364)
T cd07875 309 RIS---VDEALQHPYIN 322 (364)
T ss_pred CCC---HHHHhcCcccc
Confidence 999 88999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=365.40 Aligned_cols=268 Identities=33% Similarity=0.568 Sum_probs=226.6
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..+.|++++.||.|+||.||+|++..++..|++|.+ .. ........+.+|+.+++.++||||+++++.+.....+|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~-~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI-ET---KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEe-cc---CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 346799999999999999999999999999999944 22 23345677889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||++||+|..++.+ ...+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--- 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--- 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc---
Confidence 99999999999888765 35689999999999999999999999999999999999999999999999998863210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.........|++.|+|||++. ...++.++|||||||++|||++|.+||...
T Consensus 163 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 163 ------------------------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ------------------------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 011123456889999999985 345788999999999999999999999988
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 986 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~ 986 (1093)
++.....++.....+....+..++.++.+||.+||..||.+||+ +.++++||||..++|......
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~~ 283 (292)
T cd06644 219 NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRPLRE 283 (292)
T ss_pred cHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchhHHH
Confidence 87777666655433322335678899999999999999999999 789999999999999875443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.51 Aligned_cols=254 Identities=28% Similarity=0.527 Sum_probs=218.1
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-CceEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-DNLYLV 766 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~-~~LyLV 766 (1093)
+|++++.||+|+||.||++.++.+++.||+|.+.. ........+.+.+|+.+++.++||||+++++.+... ..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNL--RNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEeh--hhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999995532 222334556788999999999999999999888754 468999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
|||+++++|.+++... ..+++..++.++.+++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~---- 154 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN---- 154 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc----
Confidence 9999999999999763 4589999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 155 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~ 211 (257)
T cd08223 155 -----------------------QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211 (257)
T ss_pred -----------------------cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 011123456899999999999999999999999999999999999999988877776
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+..+.. |..+..+++++.+||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 212 YRIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred HHHHhcCC--CCCccccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 66666544 3345778999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=370.33 Aligned_cols=259 Identities=27% Similarity=0.512 Sum_probs=213.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|.+++.||+|+||.||+|+.+.+++.||+|.+. ... .......+.+|+.++..++||||+++++++...+.+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR-LEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEee-ccc--cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 478999999999999999999999999999999552 221 12223457789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+++ +|..++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 156 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---- 156 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC----
Confidence 9999975 8888887654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.
T Consensus 157 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 157 -----------------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred -----------------------CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 0011123468999999999875 4689999999999999999999999998776555
Q ss_pred HHHHhcc-------------------CCCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 924 FDNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 924 ~~kIl~~-------------------~l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
...+... ...+|. ....+++++.+||.+||+.||.+||| +.+++.||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~ 290 (309)
T cd07872 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS---AEEAMKHAYFR 290 (309)
T ss_pred HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC---HHHHhcChhhh
Confidence 4444321 011111 11357899999999999999999999 88999999998
Q ss_pred CC
Q 001354 977 GV 978 (1093)
Q Consensus 977 gI 978 (1093)
++
T Consensus 291 ~~ 292 (309)
T cd07872 291 SL 292 (309)
T ss_pred hc
Confidence 64
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=362.62 Aligned_cols=270 Identities=44% Similarity=0.823 Sum_probs=225.1
Q ss_pred CeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCce
Q 001354 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~L 763 (1093)
+|++.+.||+|+||.||+++.. .++..||+|.+.+............+.+|+.++..+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5889999999999999999864 467899999543222222334456788999999999 599999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999988778999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC--CCccceeecchhhHHHHHhCCCCCCCCC--
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES-- 919 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~--Ys~ksDVWSLGVILYEMLTGkpPF~~~s-- 919 (1093)
.........|++.|+|||.+.+.. ++.++|+||||+++|||++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 159 ------------------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred ------------------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 011123456899999999987654 7889999999999999999999996543
Q ss_pred --hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc
Q 001354 920 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 986 (1093)
Q Consensus 920 --~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~ 986 (1093)
..++...+.....+ .+..++..+.+||.+||+.||++||++.++.++++||||+.++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~ 280 (288)
T cd05583 215 NSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK 280 (288)
T ss_pred chHHHHHHHHHccCCC---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhh
Confidence 23344444444333 34678999999999999999999999999999999999999999988665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=350.23 Aligned_cols=254 Identities=30% Similarity=0.525 Sum_probs=221.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|.+.+.||+|+||.||+|.++.++..|++|.+. .. .........+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~-~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID-LS-KMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEee-hh-hCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 5889999999999999999999999999999542 22 223445678899999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||++|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~----- 153 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD----- 153 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC-----
Confidence 999999999999764 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+......
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 211 (256)
T cd08529 154 ----------------------NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211 (256)
T ss_pred ----------------------ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0011223568999999999999999999999999999999999999999888877777
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+..+.. +.++..++.++.++|.+||+.+|++||+ +.+++.|||+
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 212 KIIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred HHHcCCC--CCCccccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 7766543 3344678999999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=362.33 Aligned_cols=260 Identities=38% Similarity=0.646 Sum_probs=211.9
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHH---HHHhcCCCceEEEeeeeccCCceEEEEEec
Q 001354 694 PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN---ILITVRNPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~---IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
+||+|+||.||+|.+..+++.||+|.+.++ ..........+..|.. ++....||+|+++++.|...+.+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecc-ccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 489999999999999999999999965433 2211222223344443 344457999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCC
Q 001354 771 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850 (1093)
Q Consensus 771 ~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~ 850 (1093)
+||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~----------- 148 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----------- 148 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC-----------
Confidence 999999999888889999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC---ChHHHHHH
Q 001354 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFDN 926 (1093)
Q Consensus 851 td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~---s~~ei~~k 926 (1093)
.......+||+.|+|||++.+ ..++.++|+||+||++|||++|..||.+. ........
T Consensus 149 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~ 210 (278)
T cd05606 149 ------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (278)
T ss_pred ------------------ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Confidence 001123579999999999975 46899999999999999999999999876 33333333
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 986 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~ 986 (1093)
+......+ +..++.++.+||.+||..||.+||... .+.++++||||++++|+.+...
T Consensus 211 ~~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 211 TLTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred hhccCCCC---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 33333333 466799999999999999999999422 3889999999999999987655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.66 Aligned_cols=338 Identities=20% Similarity=0.281 Sum_probs=295.8
Q ss_pred CCCCCCCCCCccccccccCCchhhHHHHhchHHHHHHHhhccccccccChHhHHHhhchhHHHhhhcccceeeccchhHH
Q 001354 549 SSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSR 628 (1093)
Q Consensus 549 ~~~~~p~~~h~~~~~~~~~~~~~~~d~~~~~~l~~~a~~~~~t~l~k~~~~~l~~~l~~l~~~~~~~~~~~~vid~fg~r 628 (1093)
-+-||| -|||||| ||+++||||+.+||+|.||||+|.|||+|+ ++.|...|.++++.++|+..++.++|
T Consensus 98 ehgntp--lhyacfw---gydqiaedli~~ga~v~icnk~g~tpldka-kp~l~~~l~e~aek~gq~~nripfkd----- 166 (448)
T KOG0195|consen 98 EHGNTP--LHYACFW---GYDQIAEDLISCGAAVNICNKKGMTPLDKA-KPMLKNTLLEIAEKHGQSPNRIPFKD----- 166 (448)
T ss_pred ccCCCc--hhhhhhh---cHHHHHHHHHhccceeeecccCCCCchhhh-chHHHHHHHHHHHHhCCCCCcccccc-----
Confidence 344566 6999999 999999999999999999999999999999 99999999999999999999999999
Q ss_pred HHHHhhhhHHHHhhhcccCCCCcccccccchhhhhhhcccCCCCCCCCCCCccccccCCCeeEEEeeeccCCeEEEEEEE
Q 001354 629 IEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARK 708 (1093)
Q Consensus 629 I~Kl~r~k~il~~~lL~~kspts~sk~~ensrlllds~s~ss~~~~~~~ss~~~~isiddFeilr~LGkG~FGeVylar~ 708 (1093)
+.|.+..++.+....+....+..+++.++.+|.....|+.|+|+|
T Consensus 167 -----------------------------------t~wkgtktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrw 211 (448)
T KOG0195|consen 167 -----------------------------------TTWKGTKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRW 211 (448)
T ss_pred -----------------------------------cccccccccccccccccccCcchhhhhhhhhhccCCCcccccccc
Confidence 567777778888887888889999999999999999999999999
Q ss_pred CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCC--CC
Q 001354 709 RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LE 786 (1093)
Q Consensus 709 k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~--Ls 786 (1093)
+ |+.++.| +++ .+.......+.|..|...|+.+.||||+.+++.|+.+.++.+|..||+.|+|+.+|+.... ++
T Consensus 212 q--gndivak-il~-vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd 287 (448)
T KOG0195|consen 212 Q--GNDIVAK-ILN-VREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVD 287 (448)
T ss_pred c--Ccchhhh-hhh-hhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEe
Confidence 8 5666777 553 3444555667899999999999999999999999999999999999999999999987653 67
Q ss_pred HHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEccCCcEEEE--ecCCcccccccccccCCCCCCCCCCCCCCCCC
Q 001354 787 EDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLT--DFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862 (1093)
Q Consensus 787 Ee~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~dG~VKLs--DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~ 862 (1093)
..++..++.+++.|+.|||+.. |...-|....++||++.+.+|+ |-.++.
T Consensus 288 ~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-------------------------- 341 (448)
T KOG0195|consen 288 HSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------------------------- 341 (448)
T ss_pred cchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--------------------------
Confidence 8889999999999999999985 4455799999999999988876 433332
Q ss_pred cccccCcCCccCccCCCCCCChhhhcCCCCC---ccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCC
Q 001354 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPS 939 (1093)
Q Consensus 863 e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys---~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~ 939 (1093)
+.......|.||+||.++.++-+ .++|+|||.+++|||.|...||.+.++++...+|.-+.++ +.+|+
T Consensus 342 --------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr-v~ipp 412 (448)
T KOG0195|consen 342 --------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR-VHIPP 412 (448)
T ss_pred --------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc-ccCCC
Confidence 11234568999999999876543 4899999999999999999999999999999999988887 56789
Q ss_pred CCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 940 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 940 ~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+++..+..|++-|++.||.+||.++++..||+
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 99999999999999999999999988887775
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=400.62 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=228.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|..+..||+|+||.||+|.+..+++.||+|++ . .+ ....+++.+..|+.+|..++++||.++|++|.....++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii-~-Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKII-D-LE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEe-c-hh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 4577789999999999999999999999999954 2 22 3456788999999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
||||.||++.++|+....+.|..+..++++++.||.|||..+.||||||+.|||+..+|.+||+|||.+....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------- 162 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------- 162 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee-------
Confidence 9999999999999988888999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.......+++|||.||||||+.+.+|+.++||||||++.|||++|.|||....|+.....
T Consensus 163 --------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl 222 (467)
T KOG0201|consen 163 --------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL 222 (467)
T ss_pred --------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe
Confidence 112234789999999999999999999999999999999999999999999998655544
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
|-+... |.+...+|+.+++||..||.+||+.||+ |.++|+|+|.+..
T Consensus 223 Ipk~~P--P~L~~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 223 IPKSAP--PRLDGDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKRA 269 (467)
T ss_pred ccCCCC--CccccccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHhc
Confidence 444332 5566789999999999999999999999 8899999999874
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=394.37 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=203.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC------CCceEEEeeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR------NPFVVRFFYSF 757 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~------HPNIVkL~gsf 757 (1093)
...++|++++.||+|+||+||+|.+..+++.||||++ ++.. .....+..|+.++..+. |++|++++.+|
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i-~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV-RNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEE-ecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3467899999999999999999999999999999954 3211 12233455666666654 45689999888
Q ss_pred ccC-CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCC----------
Q 001354 758 TCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG---------- 825 (1093)
Q Consensus 758 qd~-~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG---------- 825 (1093)
... ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 765 4689999988 77999999888899999999999999999999998 5999999999999998766
Q ss_pred ------cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001354 826 ------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 899 (1093)
Q Consensus 826 ------~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVW 899 (1093)
.+||+|||++... .......+||+.|||||++.+..|+.++|||
T Consensus 280 ~~~~~~~vkl~DfG~~~~~------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 329 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE------------------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMW 329 (467)
T ss_pred cCCCCceEEECCCCccccC------------------------------ccccccccCCccccCcHHhhcCCCCcHHHHH
Confidence 4999999987631 1112356899999999999999999999999
Q ss_pred cchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCC------------------------CC---------------CCC
Q 001354 900 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP------------------------CV---------------PSD 940 (1093)
Q Consensus 900 SLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP------------------------~i---------------p~~ 940 (1093)
||||+||||++|++||.+.+..+....+......+| .. ...
T Consensus 330 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (467)
T PTZ00284 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI 409 (467)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhh
Confidence 999999999999999988776554443322110000 00 001
Q ss_pred CCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 941 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 941 IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.++.+.|||.+||++||.+||+ +.|+|+||||..
T Consensus 410 ~~~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~ 443 (467)
T PTZ00284 410 RDDLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLK 443 (467)
T ss_pred chHHHHHHHHHhCCcChhhCCC---HHHHhcCccccc
Confidence 1456789999999999999999 889999999975
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=395.24 Aligned_cols=259 Identities=29% Similarity=0.410 Sum_probs=223.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCC-CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~T-Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
...|.+.+.||+|+||.||+|....+ +..+|+|.+.. ........+.+|+.+|..++|||||+++++|...+.+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 34599999999999999999998877 78888885422 12344567788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 765 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
|||||++||+|.++|.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999988754 34689999999999999999999999999999999999999999999999999984210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
. .......+.+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 222 ~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 222 S-------------------------VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred c-------------------------cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 001123456899999999999999999999999999999999999999999988
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.+++..++.+... .++..++.++.+||.+||..||.+||+ +.+++.|||++.+
T Consensus 277 ~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~~ 329 (478)
T PTZ00267 277 REIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHHH
Confidence 8888888776543 234678999999999999999999999 7899999998643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.02 Aligned_cols=263 Identities=27% Similarity=0.471 Sum_probs=220.9
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhh--hhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL--DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~--~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+|++.+.||.|+||+||+|.. .+|..+|+|.+..+. ..........+.+|+.+|+.++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578899999999999999986 478899999553221 11223445678999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++||+|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL-- 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999874210000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
............||+.|+|||++.+..++.++|+|||||++|+|++|.+||...+......
T Consensus 158 -------------------~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 218 (265)
T cd06631 158 -------------------HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218 (265)
T ss_pred -------------------cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH
Confidence 0000111234569999999999999899999999999999999999999998877665555
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+.......|.++..++.++.+||.+||..+|.+||+ +.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5554434455667889999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=375.39 Aligned_cols=256 Identities=28% Similarity=0.480 Sum_probs=209.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 760 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~----- 760 (1093)
.+.|++++.||.|+||+||+|.+..++..||+|++.+. .........+.+|+.+|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP--FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch--hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 47899999999999999999999999999999955322 11223445678999999999999999999888644
Q ss_pred -CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
...|++|+++ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3479999998 779988775 4569999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 170 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 170 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ------------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 01224579999999999987 57899999999999999999999999887
Q ss_pred ChHHHHHHHhccCC--------------------CCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRKI--------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~l--------------------~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+.......+..... .++. .....++.+.+||.+||..||.+||+ +.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s---~~ell 296 (343)
T cd07878 220 DYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS---ASEAL 296 (343)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 65554444322100 0011 11346778999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001354 971 AHPFFKGV 978 (1093)
Q Consensus 971 ~HPFFkgI 978 (1093)
+||||...
T Consensus 297 ~hp~~~~~ 304 (343)
T cd07878 297 AHPYFSQY 304 (343)
T ss_pred cCcchhcc
Confidence 99999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=356.37 Aligned_cols=255 Identities=38% Similarity=0.656 Sum_probs=213.1
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|++.+.||+|+||+||+++...++..||+|++.. ... .........+|+.++..++||||+++++++.+...+|+|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~-~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDK-SEI-EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEES-TTH-HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecc-ccc-cccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 7899999999999999999999999999995533 222 22233344569999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCC
Q 001354 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~ 848 (1093)
|+++++|.+++.+...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--------- 149 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--------- 149 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------
Confidence 99999999999988889999999999999999999999999999999999999999999999999987410
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeecchhhHHHHHhCCCCCCCCC---hHHHH
Q 001354 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAES---PEIIF 924 (1093)
Q Consensus 849 ~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s---~~ei~ 924 (1093)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||.... .....
T Consensus 150 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~ 211 (260)
T PF00069_consen 150 ------------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII 211 (260)
T ss_dssp ------------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH
T ss_pred ------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 1112334567899999999998 7889999999999999999999999999873 33334
Q ss_pred HHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..........+. .....+.++.+||.+||..||++||+ +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 212 EKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp HHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred hhcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 333332221110 01123489999999999999999999 8899999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=396.28 Aligned_cols=264 Identities=29% Similarity=0.461 Sum_probs=225.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD- 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~- 761 (1093)
+...++|.+.+.||+|+||+||+|++..+|+.||+|++. .. .........+.+|+.+|..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~-~~-~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD-ME-GMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEe-cc-cCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 345679999999999999999999999999999999552 22 223455677889999999999999999987775432
Q ss_pred -------ceEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEE
Q 001354 762 -------NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 830 (1093)
Q Consensus 762 -------~LyLVMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLs 830 (1093)
.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||||+.++++||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 378999999999999998643 468999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT 910 (1093)
|||+++..... .........+||+.|+|||++.+..|+.++|||||||+||||++
T Consensus 186 DFGls~~~~~~-------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt 240 (496)
T PTZ00283 186 DFGFSKMYAAT-------------------------VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240 (496)
T ss_pred ecccCeecccc-------------------------ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH
Confidence 99999742100 00112235689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 911 GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
|+.||.+.+..+++..++.+... .++..+++++.+||.+||+.||.+||+ +.++++|||++..
T Consensus 241 G~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~~~ 303 (496)
T PTZ00283 241 LKRPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHHHh
Confidence 99999999988888888776543 245789999999999999999999999 7899999998753
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.46 Aligned_cols=262 Identities=32% Similarity=0.519 Sum_probs=220.2
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-----hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-----IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-----~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.|.+...||.|+||.||+|.+..++..||+|.+...... ......+.+.+|+.++..++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999999989999999965432221 122345678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||+|+|||++.++.+||+|||+++....+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987531100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
. ............|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 161 ~---------------------~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 219 (267)
T cd06628 161 L---------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219 (267)
T ss_pred c---------------------cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence 0 0000112234568999999999999889999999999999999999999998876655
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
....+... ..|.++..++..+.+||.+||+.||.+||+ +.++++||||
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 220 AIFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred HHHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 55554442 234456788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=349.90 Aligned_cols=260 Identities=32% Similarity=0.553 Sum_probs=219.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||.|+||+||+|....++..+|+|++ ..... ......+.+|+.+|+.++||||+++++.+...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~-~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEe-ccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 5799999999999999999999999999999944 32221 12567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~---g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|||++|++|.+++... +.+++..++.++.|++.||.|||+.||+||||||+||++++++.+||+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~- 156 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG- 156 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc-
Confidence 9999999999999764 458999999999999999999999999999999999999999999999999987532100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
..........+|++.|+|||++... .++.++|+|||||++|+|++|+.||...+...
T Consensus 157 ----------------------~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 157 ----------------------DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred ----------------------cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 0000123445799999999999876 78999999999999999999999999888777
Q ss_pred HHHHHhccCCC-CCCC--CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 923 IFDNILNRKIP-WPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 923 i~~kIl~~~l~-fP~i--p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+..+...... ++.. ...++..+.+||.+||..||.+||+ +.+|+.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 215 VLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred hHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 77666554321 2211 1367899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=358.57 Aligned_cols=256 Identities=32% Similarity=0.544 Sum_probs=217.5
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|++.+.||.|+||.||+|++..++..+++|.+. . ........+.+|+.++..++||||+++++.|......|+|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~-~---~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVID-T---KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeC-C---CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 688899999999999999999999999999542 2 123456778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 769 YLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 769 Ym~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|+++|+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~------- 155 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR------- 155 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc-------
Confidence 9999999988765 45689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.........||+.|+|||++. +..++.++|+|||||++|||++|.+||...++.+
T Consensus 156 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 215 (282)
T cd06643 156 --------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215 (282)
T ss_pred --------------------cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence 001123457899999999984 3457889999999999999999999999888777
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
....+..........+..++.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 268 (282)
T cd06643 216 VLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEecc
Confidence 7666655433322345678999999999999999999999 7899999999743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=374.66 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=209.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~-- 761 (1093)
...++|++++.||+|+||.||++.+..+++.||+|.+.+. .........+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc--ccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 3468999999999999999999999999999999955322 123344567889999999999999999999886543
Q ss_pred ----ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 762 ----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 762 ----~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+|+||||+++ +|...+.. .+++..++.++.|++.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 47999999976 67776653 488999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
... .......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+
T Consensus 169 ~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 169 AGT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCC----------------------------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 210 0112345799999999999999999999999999999999999999988
Q ss_pred CChHHHHHHHhcc----------------------C-----CCCCC------------CCCCCCHHHHHHHHhhccCCcC
Q 001354 918 ESPEIIFDNILNR----------------------K-----IPWPC------------VPSDMSFEAQDLINRFLIHDPN 958 (1093)
Q Consensus 918 ~s~~ei~~kIl~~----------------------~-----l~fP~------------ip~~IS~eakDLIkrcL~kDP~ 958 (1093)
.+..+.+..++.. . ..+|. .+...+.++++||.+||..||.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 300 (355)
T cd07874 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCch
Confidence 7755444332211 0 00000 1123467889999999999999
Q ss_pred CCCChhcHHHHHcCCCCCC
Q 001354 959 QRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 959 KRpTa~~A~EIL~HPFFkg 977 (1093)
+||+ +.++++||||..
T Consensus 301 ~Rps---~~ell~hp~~~~ 316 (355)
T cd07874 301 KRIS---VDEALQHPYINV 316 (355)
T ss_pred hcCC---HHHHhcCcchhc
Confidence 9999 889999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=380.55 Aligned_cols=261 Identities=34% Similarity=0.552 Sum_probs=219.0
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----CC
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-----RD 761 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd-----~~ 761 (1093)
..|..++.||+|+||.|+.+.++.||+.||||++.+.. ...-..++.++|+.+|+.++|+||+.+++.+.. -+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 45556899999999999999999999999999765333 234556889999999999999999999999877 23
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+|+|+|. -||...++....++++.+++++.||+.||+|+|+.||+||||||.|+|++.+..+||+|||||+.....
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 5999999995 499999988888999999999999999999999999999999999999999999999999999953110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.........+-|.+|.|||++.. ..|+.++||||+||||.|||+|++-|.|.+.
T Consensus 179 -------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 179 -------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred -------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 11123345788999999998874 7899999999999999999999999999775
Q ss_pred HHHHHHHhc----------------------------cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 921 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 921 ~ei~~kIl~----------------------------~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
......|+. .+.+|..+.++.++.+.||+.+||..||.+|+| |+|.|.|
T Consensus 234 v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit---a~eAL~h 310 (359)
T KOG0660|consen 234 VHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT---AEEALAH 310 (359)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC---HHHHhcC
Confidence 554444432 111222233588999999999999999999999 8899999
Q ss_pred CCCCCC
Q 001354 973 PFFKGV 978 (1093)
Q Consensus 973 PFFkgI 978 (1093)
|||...
T Consensus 311 PYl~~~ 316 (359)
T KOG0660|consen 311 PYLAPY 316 (359)
T ss_pred hhhhhh
Confidence 999753
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.79 Aligned_cols=260 Identities=33% Similarity=0.566 Sum_probs=222.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++++.||.|+||.||+|.+..++..+|+|.+. . ........+.+|+.++..++||||+++++.+.....+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~-~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ-I---ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEe-e---CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 467999999999999999999999899999999542 1 233456778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+++|+|..++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~---- 155 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS---- 155 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc----
Confidence 99999999999998764 4699999999999999999999999999999999999999999999999998764210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.........||+.|+|||++. +..++.++|+|||||++|||++|++||...+
T Consensus 156 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 156 -----------------------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred -----------------------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 011123457899999999985 3456789999999999999999999999988
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.......+.....+....+..++.++.+||.+||..||.+||+ +.++++||||....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~ 269 (280)
T cd06611 213 PMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhcccc
Confidence 8777777766543322335678999999999999999999999 88999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.98 Aligned_cols=255 Identities=40% Similarity=0.737 Sum_probs=219.6
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||+|++..++..||+|.+ .+.........+.+.+|+.++++++||||+++++.+.....+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM-NKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEE-ehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 589999999999999999999999999999954 3434444456788999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||++|++|..++.....+++..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~------- 152 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP------- 152 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC-------
Confidence 9999999999998877899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh---HHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIF 924 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~---~ei~ 924 (1093)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ..+.
T Consensus 153 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (258)
T cd05578 153 ---------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211 (258)
T ss_pred ---------------------CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence 0012235688999999999988899999999999999999999999998774 3333
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+.... +..+..++..+.++|.+||..||.+||++. +.++++||||
T Consensus 212 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 212 AKQETAD---VLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred HHhcccc---ccCcccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 3322222 334577899999999999999999999943 4899999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=361.84 Aligned_cols=261 Identities=27% Similarity=0.507 Sum_probs=214.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
.+++|++++.||.|+||.||+|+++.++..||+|.+.... .......+.+|+.++..++||||+++++++.....+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc---ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 4678999999999999999999999999999999553221 1223346778999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||++ ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--- 156 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--- 156 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC---
Confidence 9999997 4999888754 4689999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.........+++.|+|||++.+ ..++.++|||||||++|||++|++||...+..+
T Consensus 157 ------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 157 ------------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred ------------------------CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0011223467899999999876 457889999999999999999999999887665
Q ss_pred HHHHHhcc-------------------CCCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 923 IFDNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 923 i~~kIl~~-------------------~l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
....+... ...+|. ....+++++++||.+||+.||.+||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~eil~h~~f 289 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS---AEEAMKHPYF 289 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCccc
Confidence 54443221 001111 11357889999999999999999999 8899999999
Q ss_pred CCCC
Q 001354 976 KGVN 979 (1093)
Q Consensus 976 kgId 979 (1093)
+.+.
T Consensus 290 ~~~~ 293 (301)
T cd07873 290 HCLG 293 (301)
T ss_pred cccc
Confidence 8654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.50 Aligned_cols=252 Identities=20% Similarity=0.226 Sum_probs=212.0
Q ss_pred cCCCeeEE--EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc---
Q 001354 685 SIDDFEII--KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--- 759 (1093)
Q Consensus 685 siddFeil--r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd--- 759 (1093)
..++++.. ..||.|++|.||+|.. +|+.||+|. +++.........+.+.+|+.+|.+++|||||++++++.+
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~-~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRT-FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEe-ccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 33444444 6799999999999988 589999994 444333333345778899999999999999999999877
Q ss_pred -CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 -RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 -~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
...+++||||++||+|.+++.+...+++..+..++.+++.||.|||+. +++||||||+|||++.+|.+||+|||+++.
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 357899999999999999999888899999999999999999999984 999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||
T Consensus 173 ~~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf 222 (283)
T PHA02988 173 LS------------------------------SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222 (283)
T ss_pred hc------------------------------cccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCC
Confidence 21 01123578999999999976 68999999999999999999999999
Q ss_pred CCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+.+..+++..+......++ ++...++++++||.+||+.||.+||++.++.+.+
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 223 ENLTTKEIYDLIINKNNSLK-LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCCCHHHHHHHHHhcCCCCC-CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 99998888888876655433 4567899999999999999999999966555444
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.63 Aligned_cols=257 Identities=31% Similarity=0.494 Sum_probs=215.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++.+.||+|+||.||+|++..+++.||+|.+ +.. .......+.+|+.++..++||||+++++.+...+.+
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~-~~~---~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI-KLE---PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEE-ecC---chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 3456899999999999999999999999999999954 221 123345678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--- 158 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--- 158 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC---
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999864210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.........||+.|+|||++. ...++.++|+|||||++|+|++|.+||....+
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 159 ------------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ------------------------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 001123457999999999985 45688999999999999999999999987665
Q ss_pred HHHHHHHhccCCCCCCC--CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCC
Q 001354 921 EIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~i--p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPF 974 (1093)
......+.......+.. ...++..+.+||.+||..||.+||+ +.+|+.|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 215 MRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred hhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 55444443333322221 1357889999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=357.77 Aligned_cols=270 Identities=41% Similarity=0.789 Sum_probs=223.0
Q ss_pred CeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCce
Q 001354 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~L 763 (1093)
+|++.+.||.|+||.||+|... .+|..||+|.+............+++.+|+.+|..+ +||||++++++|.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 478999999543222222334457788999999999 599999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+++|+|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-- 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCCCCC--
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES-- 919 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s-- 919 (1093)
.........|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 159 ------------------------EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred ------------------------cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 0111234678999999999875 357889999999999999999999997543
Q ss_pred --hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc
Q 001354 920 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 986 (1093)
Q Consensus 920 --~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~ 986 (1093)
...+...+.....++ +..+++.+.+||.+||..||.+||+. ..+.+++.||||..++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 282 (290)
T cd05613 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282 (290)
T ss_pred ccHHHHHHHhhccCCCC---CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhc
Confidence 234444444444333 46789999999999999999999963 36899999999999999887533
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=376.81 Aligned_cols=261 Identities=31% Similarity=0.553 Sum_probs=220.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCC---
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRD--- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN-IVkL~gsfqd~~--- 761 (1093)
...|+.++.||.|+||+||+|+.+.+|+.||+|++.-..+ .+..-....+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~--~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE--EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc--ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 5668888899999999999999999999999996632222 1233456789999999999999 999999999988
Q ss_pred ---ceEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 762 ---NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~k~g----~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
.+|+||||+.. ||..++.... .++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccch
Confidence 89999999976 9999998765 578889999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
|+... .+......-++|.+|+|||++++. .|+..+||||+|||++||+++++
T Consensus 167 Ara~~---------------------------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 167 ARAFS---------------------------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred HHHhc---------------------------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence 98421 011223456899999999999986 79999999999999999999999
Q ss_pred CCCCCChHHHHHHHhc-----cCCCCCC-------------CC---------CCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 914 PFTAESPEIIFDNILN-----RKIPWPC-------------VP---------SDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~-----~~l~fP~-------------ip---------~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
-|.+.+..+....|.. ....||. .. +..++++.+|+.+||+++|.+|++ |
T Consensus 220 LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S---a 296 (323)
T KOG0594|consen 220 LFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS---A 296 (323)
T ss_pred CCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC---H
Confidence 9999998888777764 1112222 11 233468999999999999999999 7
Q ss_pred HHHHcCCCCCCCC
Q 001354 967 AEVKAHPFFKGVN 979 (1093)
Q Consensus 967 ~EIL~HPFFkgId 979 (1093)
..++.||||..+.
T Consensus 297 ~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 297 KGALTHPYFSELP 309 (323)
T ss_pred HHHhcChhhcccc
Confidence 8899999998763
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=355.63 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=207.8
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||+|..+.++..||+|.+. . ..........+.+|+.++..++||||+++++++.++..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~-~-~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR-L-ESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEec-c-ccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 5899999999999999999999999999999542 2 2222333467789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 768 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~---g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 153 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI---- 153 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC----
Confidence 9997 5898888643 4689999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.........|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+....
T Consensus 154 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~ 210 (285)
T cd07861 154 -----------------------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210 (285)
T ss_pred -----------------------CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 0011123467899999999875 4578999999999999999999999987665433
Q ss_pred HHHHhccC------------------CCCC--------CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 924 FDNILNRK------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 924 ~~kIl~~~------------------l~fP--------~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...+.... ..++ .....+++++++||.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~ll~~~~~ 285 (285)
T cd07861 211 LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS---AKKALNHPYF 285 (285)
T ss_pred HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC---HHHHhcCCCC
Confidence 32221100 0000 012357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=362.72 Aligned_cols=256 Identities=31% Similarity=0.512 Sum_probs=214.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||+|+||.||++++..++..||+|.+... ........+.+|++++..++||||++++++|.+.+.+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 4799999999999999999999999999999954221 1233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------ 151 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------ 151 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc------
Confidence 9999999999999988889999999999999999999997 599999999999999999999999999886321
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+......
T Consensus 152 -----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 208 (308)
T cd06615 152 -----------------------DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208 (308)
T ss_pred -----------------------ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH
Confidence 001234578999999999988889999999999999999999999997665443332
Q ss_pred HHhccCC----------------------------------CCCCCC-CCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 926 NILNRKI----------------------------------PWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 926 kIl~~~l----------------------------------~fP~ip-~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+..... ..|..+ ..++.++.+||.+||..||++||+ +.+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll 285 (308)
T cd06615 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD---LKELT 285 (308)
T ss_pred hhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC---HHHHh
Confidence 2211100 001111 236889999999999999999999 88999
Q ss_pred cCCCCCC
Q 001354 971 AHPFFKG 977 (1093)
Q Consensus 971 ~HPFFkg 977 (1093)
.||||.+
T Consensus 286 ~~~~~~~ 292 (308)
T cd06615 286 KHPFIKR 292 (308)
T ss_pred cChhhhh
Confidence 9999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=354.13 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=215.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++.+.||+|+||.||+|+++.++..||+|++..+ .......+.+|+.++..++||||+++++++.....+
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC----ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 3457899999999999999999999999999999954322 123345678999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--- 158 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--- 158 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.........|++.|+|||.+. ...++.++|+|||||++|||++|.+||....+
T Consensus 159 ------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 159 ------------------------TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ------------------------cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 001122456899999999985 34578899999999999999999999987665
Q ss_pred HHHHHHHhccCCCCCCC--CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCC
Q 001354 921 EIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~i--p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPF 974 (1093)
......+.......+.. ...++..+.+||++||..||.+||+ +.+|++|+|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 215 MRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred hhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 55444443333332221 2457899999999999999999999 789999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=356.86 Aligned_cols=268 Identities=24% Similarity=0.357 Sum_probs=219.5
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
.+..++|++.+.||+|+||.||+|..++ .+..||+|.+ +... .......+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~-~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEEC-CCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 4567899999999999999999997653 3558999943 3221 223345678899999999999999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcE
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g----------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~V 827 (1093)
.+....|+||||+++|+|.+++.+.. .++...++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999999997532 24567788999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHH
Q 001354 828 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 828 KLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYE 907 (1093)
||+|||+++...... .........++..|+|||.+.+..++.++|+|||||++||
T Consensus 159 ~L~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~e 213 (288)
T cd05061 159 KIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 213 (288)
T ss_pred EECcCCccccccccc-------------------------cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHH
Confidence 999999987421000 0001122346788999999998899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc---CCCCCCCCc
Q 001354 908 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGVNW 980 (1093)
Q Consensus 908 MLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~---HPFFkgIdW 980 (1093)
|++ |.+||.+....+....+..... +..+...++.+.+||.+||+.||.+||++.++.+.+. ||||++++|
T Consensus 214 l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 214 ITSLAEQPYQGLSNEQVLKFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 998 8999999888887777765533 2234677899999999999999999999665555443 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.07 Aligned_cols=261 Identities=30% Similarity=0.492 Sum_probs=218.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh-hhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cce
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 763 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~-~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~L 763 (1093)
.+|++.+.||+|+||.||+|.+..+|..||+|.+..... .........+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 589999999999999999999999999999995532211 12234567889999999999999999999998774 468
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~- 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC- 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc-
Confidence 8999999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
..........||..|+|||++.+..++.++|+|||||++|||++|++||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 161 -----------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred -----------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 000112335689999999999988899999999999999999999999988766665
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
...+.... ..|..+..++..+.++|.+||. +|.+||+ +.+|+.|||+.
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 218 IFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred HHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCC---HHHHhcCcccC
Confidence 55554332 2344567888999999999996 9999999 88999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.51 Aligned_cols=261 Identities=31% Similarity=0.493 Sum_probs=217.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhh-hhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cce
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL-DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 763 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~-~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~L 763 (1093)
.+|+..+.||+|+||.||+|.+..++..||+|.+.... ..........+.+|+.++..++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999999999999999553221 112234567789999999999999999999988763 568
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|++|||+++++|.+++.+.+.+++...+.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~- 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
..........|+..|+|||++.+..++.++|+|||||++|||++|++||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 161 -----------------------MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred -----------------------ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 000011235689999999999998899999999999999999999999988776655
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
...+..... .|.++..+++.+++|| +||..+|.+||+ +.+|++||||+
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~li-~~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 218 IFKIATQPT-NPQLPSHISEHARDFL-GCIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCCC-CCCCchhcCHHHHHHH-HHhcCChhhCcC---HHHHhcCcccc
Confidence 555443332 2555677899999999 577789999999 88999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=347.07 Aligned_cols=254 Identities=31% Similarity=0.562 Sum_probs=217.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||.|+||.||+|.++.++..|++|.+ ... .....+.+|+.+++.++||||+++++.+.+...+|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~-~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEe-ecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 36899999999999999999999999999999954 221 126788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
+|||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~---- 151 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---- 151 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc----
Confidence 9999999999999975 45689999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.........|++.|+|||++.+..++.++|||||||++|+|++|++||...++....
T Consensus 152 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~ 208 (256)
T cd06612 152 -----------------------TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208 (256)
T ss_pred -----------------------CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence 001123355899999999999999999999999999999999999999887765555
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+..........+..++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 209 FMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred hhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 44433322222234567889999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=355.13 Aligned_cols=252 Identities=29% Similarity=0.497 Sum_probs=211.2
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|+++++||+|+||.||+|.+..++..||+|.+... ........+.+|+.+|.+++||||+++++.|...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD---ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC---CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999955322 1233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||+++|+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~------- 146 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV------- 146 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc-------
Confidence 999999999654 357899999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC-------
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES------- 919 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s------- 919 (1093)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 147 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 204 (279)
T cd06619 147 ----------------------NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204 (279)
T ss_pred ----------------------cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence 011234579999999999999999999999999999999999999997532
Q ss_pred hHHHHHHHhccCC-CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 920 PEIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 920 ~~ei~~kIl~~~l-~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
+......+..... ..+ ....++++.+||.+||+.||.+||+ +.+++.||||...+
T Consensus 205 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~ 260 (279)
T cd06619 205 PLQLLQCIVDEDPPVLP--VGQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYN 260 (279)
T ss_pred hHHHHHHHhccCCCCCC--CCcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCccccccc
Confidence 1233333333221 111 2457889999999999999999999 88999999998664
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=376.32 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=214.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECC--CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRT--TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~--TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
+...+|++++.||.|+||.||+|.... ++..+|+|.+. +. ....+|+.+|+.++|||||+++++|....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~-~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT-GG--------KTPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecc-cc--------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 344679999999999999999998653 46788999442 21 23457999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+|||++. ++|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999996 599999977788999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh-
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP- 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~- 920 (1093)
.........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+...
T Consensus 239 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 239 -------------------------PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred -------------------------cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 001123356899999999999999999999999999999999999999976542
Q ss_pred --HHHHHHHhc----cCCCCCC----------------------C-----CCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 921 --EIIFDNILN----RKIPWPC----------------------V-----PSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 921 --~ei~~kIl~----~~l~fP~----------------------i-----p~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
...+..|+. ....+|. . ...++.++++||.+||..||.+||+ +.
T Consensus 294 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps---a~ 370 (392)
T PHA03207 294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS---AQ 370 (392)
T ss_pred CcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC---HH
Confidence 122222211 0111110 0 1245778999999999999999999 88
Q ss_pred HHHcCCCCCCCCcchhhc
Q 001354 968 EVKAHPFFKGVNWDSLAL 985 (1093)
Q Consensus 968 EIL~HPFFkgIdWd~L~~ 985 (1093)
++|.||||....|+.+..
T Consensus 371 e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 371 DILSLPLFTKEPINLLNI 388 (392)
T ss_pred HHhhCchhhccchhhhcC
Confidence 999999999998887754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=352.12 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=211.9
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||+|+||.||+|+++.+|+.||+|.+... . ......+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-E-DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeec-c-cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 4799999999999999999999999999999955322 1 1122335678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 153 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP----- 153 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC-----
Confidence 999999988888877778999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........|+..|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+...
T Consensus 154 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~ 211 (286)
T cd07847 154 ----------------------GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211 (286)
T ss_pred ----------------------cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 001123457899999999876 557899999999999999999999998876544433
Q ss_pred HHhcc-------------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~-------------------~l~fP~---------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+... ....|. ....++..+.+||.+||+.||++||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~eil~~~~f 286 (286)
T cd07847 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELLEHPYF 286 (286)
T ss_pred HHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC---HHHHhcCCCC
Confidence 32210 000111 01356889999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=389.05 Aligned_cols=257 Identities=31% Similarity=0.552 Sum_probs=232.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc-eE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~-Ly 764 (1093)
.++|+.++.||+|+||.+++++++..+..|++|+|. .........+....|..+++++.|||||.++++|..++. ++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~--l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKIN--LEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEe--ccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 578999999999999999999999999999999663 233334445578899999999999999999999999998 99
Q ss_pred EEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|||+||+||+|.+.+.+.. .|+|+.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|||.|||+|+...
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~--- 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN--- 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC---
Confidence 9999999999999997543 59999999999999999999999999999999999999999999999999999642
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.....+.+.+|||.||.||++.+.+|+.++|+|||||+||||++-+++|.+.+...
T Consensus 158 ------------------------~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~ 213 (426)
T KOG0589|consen 158 ------------------------PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE 213 (426)
T ss_pred ------------------------CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence 11225667899999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
+..+|....+ ..+|...+.+++.||+.||..+|..||+ |.++|.+|...
T Consensus 214 Li~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~ 262 (426)
T KOG0589|consen 214 LILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLL 262 (426)
T ss_pred HHHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhh
Confidence 9999998873 3357899999999999999999999999 88999998876
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=377.65 Aligned_cols=251 Identities=34% Similarity=0.579 Sum_probs=213.5
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----c
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 762 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~-----~ 762 (1093)
.|.-.+++|.|+||.||.|....+++.+|||+++...+. -.+|+.+|+.++|||||+|.++|.... +
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 578889999999999999999999999999988754332 247899999999999999998886532 5
Q ss_pred eEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecCCccc
Q 001354 763 LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKI 837 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFGLAk~ 837 (1093)
+.+||||||. +|..+++. ...++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 6789999987 99999974 4678999999999999999999999999999999999999986 9999999999996
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
... +....+..-|..|+|||.+.| ..|+.+.||||.||+|.||+-|++-|.
T Consensus 176 L~~----------------------------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 176 LVK----------------------------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred ecc----------------------------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 421 222345667899999999987 579999999999999999999999999
Q ss_pred CCChHHHHHHHhcc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 917 AESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|++..+....|++- ...+|. +...+++++.+|+.++|.++|.+|.+ +.+++
T Consensus 228 G~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~---~~~~l 304 (364)
T KOG0658|consen 228 GDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS---ALEAL 304 (364)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC---HHHHh
Confidence 99887776666430 111222 23568999999999999999999999 89999
Q ss_pred cCCCCCCC
Q 001354 971 AHPFFKGV 978 (1093)
Q Consensus 971 ~HPFFkgI 978 (1093)
.||||..+
T Consensus 305 ~h~fFdel 312 (364)
T KOG0658|consen 305 AHPFFDEL 312 (364)
T ss_pred cchhhHHh
Confidence 99999764
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=349.03 Aligned_cols=263 Identities=29% Similarity=0.499 Sum_probs=216.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh--hhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~--~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+|+..+.||+|+||.||++....++..||+|++..... .........+.+|+.+|+.++||||+++++.+.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999999999999999995532211 1112345788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~-- 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-- 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc--
Confidence 999999999999998888899999999999999999999999999999999999998876 59999999987421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
...........||..|+|||++.+..++.++|+|||||++|+|++|..||.........
T Consensus 159 ---------------------~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 159 ---------------------TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred ---------------------ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 00001122356899999999999889999999999999999999999999765543333
Q ss_pred HHHhc--cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 925 DNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 925 ~kIl~--~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
..+.. .....+.++..+++++.++|.+||..||.+||+ +.++++||||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 218 ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 32221 111224455778999999999999999999999 88999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.54 Aligned_cols=254 Identities=28% Similarity=0.534 Sum_probs=221.0
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||+|+||.||+++...+|..||+|.+. ... ........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~-~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEIN-ISK-MSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEE-hHh-CChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 5899999999999999999999999999999553 222 22344567899999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~----- 153 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----- 153 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc-----
Confidence 9999999999997643 578999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+...
T Consensus 154 ----------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~ 211 (256)
T cd08218 154 ----------------------TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211 (256)
T ss_pred ----------------------chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH
Confidence 0011123468999999999999889999999999999999999999999888888888
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.++.+.. +..+..++.++.++|.+||+.+|.+||+ +.+++.||||
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 212 KIIRGSY--PPVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred HHhcCCC--CCCcccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 8776654 3345788999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=366.12 Aligned_cols=264 Identities=22% Similarity=0.368 Sum_probs=209.2
Q ss_pred EEEeeecc--CCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 691 IIKPISRG--AFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 691 ilr~LGkG--~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
++++||+| +||+||+++.+.+|+.||+|.+ +. ..........+.+|+.+++.++||||++++++|..++.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~-~~-~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRI-NL-EACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEe-ch-hhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 7899999999999999999954 22 22233445677889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 769 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+..... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~-~~--- 155 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN-HG--- 155 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccc-cc---
Confidence 99999999999653 4589999999999999999999999999999999999999999999999987643110 00
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
. .. ..........+++..|+|||++.+ ..|+.++|||||||++|||++|+.||.........
T Consensus 156 -------~---~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 219 (327)
T cd08227 156 -------Q---RL------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219 (327)
T ss_pred -------c---cc------cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 0 00 000011123467888999999976 46899999999999999999999999876654444
Q ss_pred HHHhccCCCC-------------------------------------------CCCCCCCCHHHHHHHHhhccCCcCCCC
Q 001354 925 DNILNRKIPW-------------------------------------------PCVPSDMSFEAQDLINRFLIHDPNQRL 961 (1093)
Q Consensus 925 ~kIl~~~l~f-------------------------------------------P~ip~~IS~eakDLIkrcL~kDP~KRp 961 (1093)
........+. ......+++++.+||.+||+.||.+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 299 (327)
T cd08227 220 LEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299 (327)
T ss_pred HHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC
Confidence 3333221110 001123578899999999999999999
Q ss_pred ChhcHHHHHcCCCCCCCC
Q 001354 962 GANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 962 Ta~~A~EIL~HPFFkgId 979 (1093)
+ +.++++||||+.+.
T Consensus 300 t---~~ell~~p~f~~~~ 314 (327)
T cd08227 300 S---ASTLLNHSFFKQIK 314 (327)
T ss_pred C---HHHHhcChhhhhcc
Confidence 9 88999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.77 Aligned_cols=254 Identities=31% Similarity=0.538 Sum_probs=222.2
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++++.||.|+||.||.++...++..+++|.+-. ..........+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNL--TRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEee--cccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 48999999999999999999999999999995522 2223445667889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~---- 154 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE---- 154 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc----
Confidence 999999999999765 46899999999999999999999999999999999999999999999999998742110
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........|++.|+|||++.+..++.++|+||||+++|||++|..||...+..+...
T Consensus 155 -----------------------~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~ 211 (256)
T cd08221 155 -----------------------YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211 (256)
T ss_pred -----------------------cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 001234578999999999998889999999999999999999999999988888888
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+..+... ..+..++.++.++|.+||..||.+||+ +.++++|||+
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 212 KIVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred HHHcCCCC--CCccccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 88766543 234678999999999999999999999 8899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.07 Aligned_cols=255 Identities=35% Similarity=0.540 Sum_probs=217.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||.|+||.||+|.+..++..+++|.+... .......+.+|+.+++.++||||+++++.+.....+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE----PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC----chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence 36899999999999999999999999999999955321 22256788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
+|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.+|.+||+|||++.....
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~---- 153 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA---- 153 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh----
Confidence 99999999999999876 6899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.........|+..|+|||++.+. .++.++|+|||||++|||++|.+||...++.
T Consensus 154 -----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~ 210 (262)
T cd06613 154 -----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM 210 (262)
T ss_pred -----------------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 00112345789999999999876 8899999999999999999999999988776
Q ss_pred HHHHHHhccCCCCCC--CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCC
Q 001354 922 IIFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~--ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPF 974 (1093)
.....+....+..+. .+..++.++.+||.+||..||.+||+ +.+|+.|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 211 RALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 665555544332221 23456788999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=354.84 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=206.6
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|++.+.||+|+||.||+|+++.+|..||+|.+... .........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~--~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecc--cccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 488999999999999999999999999999955322 122233456778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 768 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 768 EYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
||+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~------ 151 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI------ 151 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC------
Confidence 99975 88888765 46799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCC-CCCChHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 924 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF-~~~s~~ei~ 924 (1093)
.........+++.|+|||++.+. .++.++|+|||||++|||++|..|| .+.+..+.+
T Consensus 152 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~ 210 (284)
T cd07839 152 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210 (284)
T ss_pred ---------------------CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence 00111234678999999998774 4789999999999999999988775 455544444
Q ss_pred HHHhcc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~-----------------~l~fP~---------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+... ...++. ..+.+++++.+||.+||..||.+||| +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~il~h~~f 284 (284)
T cd07839 211 KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS---AEEALQHPYF 284 (284)
T ss_pred HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---HHHHhcCCCC
Confidence 443210 000111 12357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=354.70 Aligned_cols=255 Identities=30% Similarity=0.554 Sum_probs=214.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||.|+||.||+|++..+|..||+|.+... ........+.+|+.++..++||||+++++.+...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 4789999999999999999999999999999955322 1233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 767 MEYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~---g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|||++|++|..++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~--- 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--- 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc---
Confidence 9999999999988763 378999999999999999999997 599999999999999999999999999986321
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeecchhhHHHHHhCCCCCC
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.......+|++.|+|||++.+. .++.++|+|||||++|+|++|..||.
T Consensus 155 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 155 --------------------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred --------------------------CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 0011234688999999998653 35889999999999999999999998
Q ss_pred CCChHHHHHH---HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 917 AESPEIIFDN---ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 917 ~~s~~ei~~k---Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.......... +... ..+.++..++.++.+||.+||..+|.+||+ +.+++.||||...
T Consensus 209 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~ 268 (286)
T cd06622 209 PETYANIFAQLSAIVDG--DPPTLPSGYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKY 268 (286)
T ss_pred CcchhhHHHHHHHHhhc--CCCCCCcccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhc
Confidence 7665554433 3222 223445679999999999999999999999 7899999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=390.54 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=219.8
Q ss_pred CccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 679 s~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
...+.+....+.+++.||+|-||+||+|.+.. ...+|+|.+ +...+ ..+.|++|+.+|++++|++||++|+++.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~i-k~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTI-KEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEE-ecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 34555667778889999999999999999984 347899944 33222 3456889999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k--~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk 836 (1093)
.+..+|||||||+.|+|.++|+. ...+...+...++.||+.||+||+++++|||||-..||||++++.+||+|||||+
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccc
Confidence 99999999999999999999987 4568999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF 915 (1093)
....+... .....--...|.|||++....++.++|||||||+||||+| |+.||
T Consensus 352 ~~~d~~Y~--------------------------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 352 LIGDDEYT--------------------------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred ccCCCcee--------------------------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCC
Confidence 53211110 0111123567999999999999999999999999999999 99999
Q ss_pred CCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
.+.+..++.+.+-.+ .++|. |..+|+++-+++..||..+|++|||++.....+..
T Consensus 406 ~~msn~ev~~~le~G-yRlp~-P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 406 PGMSNEEVLELLERG-YRLPR-PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred CCCCHHHHHHHHhcc-CcCCC-CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 999999999887554 45553 68999999999999999999999998766555543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.62 Aligned_cols=254 Identities=28% Similarity=0.493 Sum_probs=210.9
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR---- 760 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~---- 760 (1093)
.+.|++.+.||+|+||+||+|.++.+++.||+|.+... ......+..|+.++..+ +||||+++++.|...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45788999999999999999999999999999954321 12345678899999988 699999999998753
Q ss_pred --CceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcc
Q 001354 761 --DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836 (1093)
Q Consensus 761 --~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk 836 (1093)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4589999999999999999864 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
.... .........|++.|+|||++. +..|+.++|+|||||++|||++|
T Consensus 160 ~~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 160 QLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred eccc---------------------------ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 4210 001123467999999999986 34688899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 912 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 912 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..||....+......+....... ..+..++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 213 APPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred CCCccccCHHHHHHHHhcCCCCC-CCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 99998776655555444332221 123567899999999999999999999 7899999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.63 Aligned_cols=257 Identities=34% Similarity=0.547 Sum_probs=217.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
..+|++++.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++.|......|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC----CcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 36899999999999999999999999999999955321 12234678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++||+|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~---- 169 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc----
Confidence 9999999999999864 46899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........|++.|+|||.+.+..++.++|+|||||++|+|++|++||...++.....
T Consensus 170 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 170 -----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred -----------------------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 011123568999999999998889999999999999999999999998877655444
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.+.....+....+..++..+.+||.+||..||.+||+ +.+|+.||||..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~ 275 (296)
T cd06654 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (296)
T ss_pred HHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhc
Confidence 3333322222234678899999999999999999999 889999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.62 Aligned_cols=258 Identities=32% Similarity=0.561 Sum_probs=221.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||.|+||.||+|++..++..||+|.+. ... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~-~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEee-ccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 47889999999999999999999999999999543 211 233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
+||+++|+|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.+|.++|+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~----- 151 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST----- 151 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc-----
Confidence 9999999999999765 7899999999999999999999999999999999999999999999999998753100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........|++.|+|||++.+..++.++|||||||++|+|++|.+||...++......
T Consensus 152 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~ 209 (274)
T cd06609 152 ----------------------MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209 (274)
T ss_pred ----------------------ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 0122345789999999999998899999999999999999999999988877766666
Q ss_pred HhccCCCCCCCCCC-CCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 927 ILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 927 Il~~~l~fP~ip~~-IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
+..... |.++.. ++.++.++|.+||..||.+||+ +.++++||||.+..-
T Consensus 210 ~~~~~~--~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~~ 259 (274)
T cd06609 210 IPKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAKK 259 (274)
T ss_pred hhhcCC--CCCcccccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCCc
Confidence 555432 222334 8899999999999999999999 889999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=395.34 Aligned_cols=261 Identities=33% Similarity=0.586 Sum_probs=233.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+-|+|+..||-|+||.||++..+.++-..|.|+| +.....+.+.++-|++||..++||+||+|++.|..++.++|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI----etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI----ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhh----cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 3467888999999999999999999988888844 344567889999999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
.|||.||-+..++-.-+ .+++.+++.+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch------
Confidence 99999999988877654 59999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.......+++|||+|||||++. ..+|++++||||||++|.||.-+.||-...++
T Consensus 182 ---------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 182 ---------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred ---------------------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 1234556899999999999875 46899999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
+.+..+|.....+-...|..++..+.||+++||.+||..||+ +.+|++||||.++.-.
T Consensus 241 MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 241 MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCCcc
Confidence 999999988766544457899999999999999999999999 8899999999976554
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=360.60 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=192.1
Q ss_pred EEeeeccCCeEEEEEEECC--CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCceEEEE
Q 001354 692 IKPISRGAFGRVFLARKRT--TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVM 767 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~--TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd--~~~LyLVM 767 (1093)
.+.||+|+||+||+|+++. ++..||+|.+. ... ....+.+|+.+|+.++||||+++++.|.. ...+|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~-~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEEC-CCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 4689999999999999764 67899999542 211 12346789999999999999999998854 45689999
Q ss_pred EecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE----ccCCcEEEEecCC
Q 001354 768 EYLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGL 834 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~---------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL----D~dG~VKLsDFGL 834 (1093)
||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 99865 898887532 248999999999999999999999999999999999999 4568999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
++..... ..........+||+.|+|||++.+ ..|+.++|||||||++|||++|++
T Consensus 159 a~~~~~~------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 159 ARLFNSP------------------------LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred eeccCCC------------------------CccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9742100 000112234689999999999987 458999999999999999999999
Q ss_pred CCCCCCh---------HHHHHHHhcc-CC----------CCCC------------------------CCCCCCHHHHHHH
Q 001354 914 PFTAESP---------EIIFDNILNR-KI----------PWPC------------------------VPSDMSFEAQDLI 949 (1093)
Q Consensus 914 PF~~~s~---------~ei~~kIl~~-~l----------~fP~------------------------ip~~IS~eakDLI 949 (1093)
||..... ......+... .. .+|. .....+.++.+||
T Consensus 215 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 294 (317)
T cd07868 215 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294 (317)
T ss_pred CccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHH
Confidence 9975332 1112222110 00 0000 0112356789999
Q ss_pred HhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 950 NRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 950 krcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+||+.||.+||| +.|+++||||
T Consensus 295 ~~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 295 QKLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred HHHhccCcccCCC---HHHHhcCCCC
Confidence 9999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.08 Aligned_cols=278 Identities=40% Similarity=0.758 Sum_probs=228.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyL 765 (1093)
++|.+.+.||.|+||.||+|..+.+|..||+| +..+...........+.+|..++..+. ||||+++++.+.....+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik-~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIK-ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEE-EechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 47999999999999999999999999999999 444433334445577889999999998 9999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987532111000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
. .......... .............|++.|+|||++.+..++.++|+||||+++|+|++|..||...+....+.
T Consensus 160 -~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 232 (280)
T cd05581 160 -S--NKGDATNIDS----QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232 (280)
T ss_pred -c--CCCCCccccc----cccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 0 0000000000 00011123345678999999999998889999999999999999999999999888777777
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh-cHHHHHcCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~-~A~EIL~HPFF 975 (1093)
.+......+| ..+++.+.+||.+||+.||.+||++. ...++++||||
T Consensus 233 ~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 233 KILKLEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHhcCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 7776555554 67899999999999999999999931 12899999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=340.63 Aligned_cols=254 Identities=32% Similarity=0.574 Sum_probs=218.1
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCceEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYL 765 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd--~~~LyL 765 (1093)
+|++++.||.|+||.||++.+..++..||+|.+ ... .......+.+..|+.+++.++||||+++++.+.. ...+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~-~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEI-DYG-NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEE-ecc-cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 589999999999999999999999999999944 322 2234456778899999999999999999987754 446899
Q ss_pred EEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH-----hcCcEeeecCCCcEEEccCCcEEEEecCCcc
Q 001354 766 VMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLH-----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLH-----s~GIIHRDIKPeNILLD~dG~VKLsDFGLAk 836 (1093)
+|||+++|+|.+++... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++.
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999999999753 57899999999999999999999 8899999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.... .........|++.|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus 159 ~~~~---------------------------~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 211 (265)
T cd08217 159 ILGH---------------------------DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211 (265)
T ss_pred cccC---------------------------CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCccc
Confidence 4210 0011223568999999999998889999999999999999999999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+...+...+..... +.++..++..+.+||.+||..+|.+||+ +.+|++|||+
T Consensus 212 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 212 ARNQLQLASKIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred CcCHHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 8887777777765543 4456789999999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.38 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=214.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCC-----cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TG-----k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
+..++|++++.||+|+||.||+|.....+ ..||+|.+ +.. ........+.+|+.++..++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~-~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 78 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEec-ccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence 45678999999999999999999987655 67999944 221 12334567889999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 822 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD 822 (1093)
.....|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 999999999999999999999764 4578889999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecch
Q 001354 823 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902 (1093)
Q Consensus 823 ~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLG 902 (1093)
.++.+||+|||+++..... ..........+|+.|+|||.+.+..++.++||||||
T Consensus 159 ~~~~~~L~dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG 213 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSA-------------------------DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFG 213 (283)
T ss_pred CCCcEEECCCcceeecccc-------------------------ccccccCCCcccccccCHHHhccCcCchhhhHHHHH
Confidence 9999999999998742110 001112234678999999999988999999999999
Q ss_pred hhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 903 IILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 903 VILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
|++|||++ |..||.+.+..++...|..... +..+..++.++.+|+.+||+.||.+||++.++.+.
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 214 VVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999998 9999999998888888766543 23457899999999999999999999995544433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=340.57 Aligned_cols=253 Identities=30% Similarity=0.501 Sum_probs=218.8
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||+|....++..+|+|.+.. . .........+.+|+.+|+.++||||+++++.+...+.+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~-~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPV-E-QMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEec-c-ccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 58999999999999999999999999999995532 2 223445678899999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEEecCCcccccccccc
Q 001354 768 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~~~~~~s~ 844 (1093)
||++|++|.+++... ..+++..+..++.+++.||.|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---- 154 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---- 154 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC----
Confidence 999999999999764 3489999999999999999999999999999999999998654 589999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
........|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 155 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 210 (256)
T cd08220 155 ------------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV 210 (256)
T ss_pred ------------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH
Confidence 11122356899999999999888999999999999999999999999988887777
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+..... +.++..++.++.+||.+||..||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 211 LKIMSGTF--APISDRYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred HHHHhcCC--CCCCCCcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 77765433 2345678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=347.93 Aligned_cols=258 Identities=32% Similarity=0.498 Sum_probs=210.5
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeec---
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT--- 758 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfq--- 758 (1093)
....++|++++.||+|+||+||+|.++.+++.||+|+ ++... .....+.+|+.++..+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~-~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-LDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEe-ecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3466899999999999999999999999999999994 33211 2235577899999998 6999999999873
Q ss_pred --cCCceEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEec
Q 001354 759 --CRDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 759 --d~~~LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
....+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 44579999999999999998753 346889999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeecchhhHHH
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDVWSLGVILYE 907 (1093)
|+++.... .........||+.|+|||++.. ..++.++|||||||++||
T Consensus 169 g~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~e 221 (286)
T cd06638 169 GVSAQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221 (286)
T ss_pred Cceeeccc---------------------------CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHH
Confidence 99874210 0011234569999999999853 457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 908 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 908 MLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
|++|.+||....+......+..........+..++.++.+||.+||..||++||+ +.++++|+||
T Consensus 222 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~~~~ 286 (286)
T cd06638 222 LGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQHVFI 286 (286)
T ss_pred HhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhhcccC
Confidence 9999999988776555444433221111123457889999999999999999999 8899999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.92 Aligned_cols=256 Identities=32% Similarity=0.520 Sum_probs=213.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC--
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD-- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~-- 761 (1093)
..++|++.+.||.|+||.||+|.++.+++.|++|.+ ... ......+.+|+.++.++ .||||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~-~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DII----EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEE-ecC----chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 458999999999999999999999999999999944 221 12346788999999998 6999999999997654
Q ss_pred ----ceEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 762 ----NLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 762 ----~LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 48999999999999999865 3478999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeecchhhHHHH
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEF 908 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDVWSLGVILYEM 908 (1093)
++..... .........|++.|+|||++.. ..++.++|+|||||+||+|
T Consensus 159 ~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l 211 (275)
T cd06608 159 VSAQLDS---------------------------TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211 (275)
T ss_pred cceeccc---------------------------chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHH
Confidence 9874210 0111234568999999999864 3467899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 909 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 909 LTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
++|.+||...........+.....+....+..++.++.+||.+||..||.+||+ +.+++.|||+
T Consensus 212 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~~ 275 (275)
T cd06608 212 ADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPFI 275 (275)
T ss_pred HhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCCC
Confidence 999999988776666666655433211122447889999999999999999999 8899999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.34 Aligned_cols=258 Identities=30% Similarity=0.513 Sum_probs=207.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCceEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~I-L~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
++|++.+.||+|+||.||+|+++.+|+.||+|.+... ..... ...+..|..+ ++..+||||+++++++.....+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecC--CCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 5799999999999999999999999999999955322 11222 2345556554 666789999999999999999999
Q ss_pred EEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 766 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
||||++ |+|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999997 588887754 24689999999999999999999997 999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC----CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g----~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
........|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.
T Consensus 157 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (283)
T cd06617 157 ----------------------------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208 (283)
T ss_pred ----------------------------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence 001123468899999999865 457889999999999999999999997
Q ss_pred CC-ChHHHHHHHhcc-CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 917 AE-SPEIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 917 ~~-s~~ei~~kIl~~-~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
.. ...+....+... ...+| ...+|.++.+||.+||..+|.+||+ +.+++.||||....+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 270 (283)
T cd06617 209 SWKTPFQQLKQVVEEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSK 270 (283)
T ss_pred ccccCHHHHHHHHhcCCCCCC--ccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccc
Confidence 53 233333333332 22222 2468899999999999999999999 7899999999887654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.26 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=212.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||+|+||.||+|.++.+++.||+|.+. +... .....+.+.+|+.+|..++||||+++++++.....+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~-~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFL-ESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHh-hccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 47999999999999999999999999999999543 3222 223445678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||+++++|..+......+++..++.++.||+.||.|||+.||+|+||+|+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~------ 152 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA------ 152 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC------
Confidence 99999999988877666799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.........|++.|+|||++.+ ..++.++|||||||++|||++|.+||...+..+...
T Consensus 153 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~ 211 (286)
T cd07846 153 ---------------------PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211 (286)
T ss_pred ---------------------CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence 0011223568999999999876 457889999999999999999999998776544433
Q ss_pred HHhcc-------------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~-------------------~l~fP~---------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+... ....|. ..+.++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~~~~ 286 (286)
T cd07846 212 HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLHHEFF 286 (286)
T ss_pred HHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh---HHHHhcCCCC
Confidence 33210 011111 12467899999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=357.17 Aligned_cols=258 Identities=34% Similarity=0.555 Sum_probs=217.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
..+|++++.||.|+||.||+|....++..||+|.+... .....+.+.+|+.+++.++||||+++++.|.....+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC----ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 37899999999999999999999999999999955321 12234668899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++||+|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~---- 168 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 168 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC----
Confidence 9999999999999865 45889999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........|++.|+|||.+.+..++.++|+|||||++|+|++|.+||.+.++.....
T Consensus 169 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 169 -----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred -----------------------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence 011123468999999999999899999999999999999999999998776544333
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.+.....+....+..++..+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 275 (297)
T cd06656 226 LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLA 275 (297)
T ss_pred eeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhccc
Confidence 3333222222234678899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=348.37 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=212.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
+..++|++.+.||+|+||.||+|.++ ..+..||+|.+ +.. ........+.+|+.+|..++||||+++++++...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~-~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAG--CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEec-CCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 45578999999999999999999875 34678999944 322 2233456789999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+.+|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999999764 578999999999999999999999999999999999999999999999999876311
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
.. .........+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 159 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 159 SE--------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cc--------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 00 0001123345788999999999999999999999999999775 99999998
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+..++...+..+. ..| .+..++..+.++|.+||..+|.+||++.++.+++
T Consensus 213 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 213 SGQDVIKAVEDGF-RLP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred CHHHHHHHHHCCC-CCC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 8887777765442 223 4577899999999999999999999966555554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=355.80 Aligned_cols=257 Identities=35% Similarity=0.570 Sum_probs=219.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|++.+.||.|+||.||+|.+..+|+.||+|.+... .......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc----cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 5699999999999999999999999999999955322 223356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||+++|+|..++.. ..+++..+..++.+++.||.|||+.|++||||||+||+++.+|.+||+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~----- 168 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE----- 168 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-----
Confidence 999999999998865 46899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.++......
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~ 226 (296)
T cd06655 169 ----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (296)
T ss_pred ----------------------cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112235689999999999988899999999999999999999999998877665555
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+.....+....+..+++.+.+||.+||..||.+||+ +.+|+.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~ 275 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLA 275 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhc
Confidence 544333222335678999999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=340.16 Aligned_cols=256 Identities=34% Similarity=0.567 Sum_probs=218.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh-hhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~-~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
.|+..+.||+|+||+||+|....++..|++|.+..... .........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36778899999999999999998999999996533221 12234567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~------ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------ 154 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........|++.|+|||.+.... ++.++|+|||||++|+|++|.+||..........
T Consensus 155 ----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~ 212 (258)
T cd06632 155 ----------------------FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212 (258)
T ss_pred ----------------------cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence 00123456899999999998776 8999999999999999999999998776555554
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+... ...+.++..+++.+.+||.+||..+|.+||+ +.+++.|||+
T Consensus 213 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 213 KIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred HHHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 44331 2334556788999999999999999999999 8899999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=353.95 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=206.1
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECC----------------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~----------------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP 748 (1093)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+. .. ........+.+|+.+|..++||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~-~~--~~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR-PD--ANKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEec-CC--CCHHHHHHHHHHHHHHhhcCCC
Confidence 45689999999999999999998643 34579999543 21 1234456789999999999999
Q ss_pred ceEEEeeeeccCCceEEEEEecCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCc
Q 001354 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-------------------CLEEDVARIYIAELVLALEYLHSLGI 809 (1093)
Q Consensus 749 NIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g-------------------~LsEe~ar~yaaQIl~ALeYLHs~GI 809 (1093)
||+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999986532 35677888999999999999999999
Q ss_pred EeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC
Q 001354 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 889 (1093)
Q Consensus 810 IHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g 889 (1093)
+||||||+|||++.++.+||+|||+++...... .........+++.|||||++.+
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~ 214 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGD-------------------------YYRIQGRAVLPIRWMAWECILM 214 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCc-------------------------eeEecCcCCCCccccCHHHHhc
Confidence 999999999999999999999999987421000 0011223456889999999998
Q ss_pred CCCCccceeecchhhHHHHHh--CCCCCCCCChHHHHHHHhc---c--CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q 001354 890 TEHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDNILN---R--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 890 ~~Ys~ksDVWSLGVILYEMLT--GkpPF~~~s~~ei~~kIl~---~--~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
..++.++|||||||++|||++ +..||...+..+....+.. . ...++..+..++..+.+||.+||..||.+||+
T Consensus 215 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 899999999999999999986 6789988776665544322 1 11122334678899999999999999999999
Q ss_pred hhcHHHHH
Q 001354 963 ANGAAEVK 970 (1093)
Q Consensus 963 a~~A~EIL 970 (1093)
+.++..+|
T Consensus 295 ~~~i~~~l 302 (304)
T cd05096 295 FSDIHAFL 302 (304)
T ss_pred HHHHHHHH
Confidence 66554443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.51 Aligned_cols=257 Identities=32% Similarity=0.513 Sum_probs=212.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR--- 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~--- 760 (1093)
..++|++.+.||.|+||.||+|..+.+++.+|+|.+ .... .....+.+|+.++..+ +||||++++++|...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~-~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEe-cccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 468899999999999999999999999999999954 2211 2235677899999988 799999999988754
Q ss_pred --CceEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 761 --DNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 761 --~~LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998863 35689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-----CCCccceeecchhhHHHHH
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-----~Ys~ksDVWSLGVILYEML 909 (1093)
+..... ........+|++.|+|||++... .++.++|+|||||++|||+
T Consensus 175 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 175 SAQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred chhccc---------------------------ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 874210 00011235689999999998643 3688999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 910 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 910 TGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
+|++||....+......+..........+..++..+.+||.+||..||.+||+ +.+|++||||+
T Consensus 228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~ 291 (291)
T cd06639 228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLEHPFIK 291 (291)
T ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC---HHHHhcCcccC
Confidence 99999998877666655554432211123567889999999999999999999 88999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=340.24 Aligned_cols=258 Identities=35% Similarity=0.605 Sum_probs=221.8
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||.|+||.||+|++..+++.|++|++... .. ......+.+|+.++..++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~-~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD-GD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccC-cc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 4799999999999999999999999999999955322 21 14467789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~----- 152 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN----- 152 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc-----
Confidence 9999999999999888889999999999999999999999 9999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC---ChHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEI 922 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~---s~~e 922 (1093)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|.+||... ...+
T Consensus 153 ----------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 210 (264)
T cd06623 153 ----------------------TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210 (264)
T ss_pred ----------------------CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH
Confidence 011112456899999999999988999999999999999999999999877 4455
Q ss_pred HHHHHhccCCCCCCCCCC-CCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~-IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
....+..... +..+.. ++..+.++|.+||..+|.+||+ +.++++||||+..+
T Consensus 211 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 211 LMQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 5555554332 233455 8999999999999999999999 88999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=343.54 Aligned_cols=258 Identities=30% Similarity=0.442 Sum_probs=209.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...+.+.....||+|+||.||+|.+..++..||+|.+..+ .......+.+|+.++..++||||+++++++...+..
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 3455666667899999999999999999999999954222 233556789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEecCCccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV-GCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~-g~L--sEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~~~ 839 (1093)
|+||||+++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999999764 445 88889999999999999999999999999999999986 6799999999986421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeecchhhHHHHHhCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
. .........|++.|+|||++.+. .++.++|+||||+++|+|++|.+||..
T Consensus 161 ~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 161 G---------------------------INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred c---------------------------CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 0 00111234589999999998764 478899999999999999999999976
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.................|.++..+++++.+||.+||..+|.+||+ +.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 214 LGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred ccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 543221111111111124455788999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=347.34 Aligned_cols=257 Identities=37% Similarity=0.592 Sum_probs=213.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||+|.+..+|..||+|++. ... ........+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~-~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRR-LEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEE-ccc-ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 5899999999999999999999999999999553 222 22344567899999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 768 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~----- 152 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE----- 152 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC-----
Confidence 999 99999998754 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.........|++.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+.
T Consensus 153 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 153 ---------------------EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred ---------------------CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 00112235789999999998754 46899999999999999999999998877666655
Q ss_pred HHhcc-------------------CCCCC--------CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 926 NILNR-------------------KIPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 926 kIl~~-------------------~l~fP--------~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
.++.. ...++ ......+.++.+||.+||..||.+||+ +.+++.||||.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~~l~h~~~~ 286 (286)
T cd07832 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS---AAEALRHPYFT 286 (286)
T ss_pred HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---HHHHhhCcCcC
Confidence 54431 00111 111356789999999999999999999 88999999993
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=349.59 Aligned_cols=257 Identities=32% Similarity=0.535 Sum_probs=208.8
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCc---
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN--- 762 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~--- 762 (1093)
++|++.+.||.|+||.||+|.+..+|+.||+|++. . ..........+.+|+.++..+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~-~-~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTR-L-EMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeeh-h-hccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 47999999999999999999999999999999542 2 2222334467888999999995 6999999999987766
Q ss_pred --eEEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEecCC
Q 001354 763 --LYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGL 834 (1093)
Q Consensus 763 --LyLVMEYm~GGSL~dlL~k~-----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsDFGL 834 (1093)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999986 898888643 34799999999999999999999999999999999999999 89999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
+..... .........+++.|+|||++.+ ..++.++|+|||||++|+|++|.+
T Consensus 158 ~~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 210 (295)
T cd07837 158 GRAFSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210 (295)
T ss_pred ceecCC---------------------------CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCC
Confidence 874210 0011123357899999999875 457899999999999999999999
Q ss_pred CCCCCChHHHHHHHhccC-----CCC------------CC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 914 PFTAESPEIIFDNILNRK-----IPW------------PC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~-----l~f------------P~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
||.+.+.......+...- ..+ |. ..+.++.++.+||.+||.+||.+||+ +.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~---~~e 287 (295)
T cd07837 211 LFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---AKA 287 (295)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC---HHH
Confidence 999887766555543310 000 10 11357899999999999999999999 889
Q ss_pred HHcCCCCC
Q 001354 969 VKAHPFFK 976 (1093)
Q Consensus 969 IL~HPFFk 976 (1093)
++.||||+
T Consensus 288 il~~~~~~ 295 (295)
T cd07837 288 ALTHPYFD 295 (295)
T ss_pred HhcCCCcC
Confidence 99999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=343.23 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=211.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||.|+||.||+|+++.++..||+|.+ +............+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKV-QIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEe-eccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 36899999999999999999999999999999944 33344445556778999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 766 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~- 158 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS- 158 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc-
Confidence 9999999999988853 34589999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh-
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP- 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~- 920 (1093)
.........|++.|+|||.+.+..++.++|+||||+++|||++|..||.....
T Consensus 159 --------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~ 212 (267)
T cd08228 159 --------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212 (267)
T ss_pred --------------------------hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc
Confidence 00112235689999999999998899999999999999999999999976542
Q ss_pred -HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 921 -EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 921 -~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
......+.....+ |..+..++..+.+||.+||..+|.+||++.++.+.+
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 213 LFSLCQKIEQCDYP-PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred HHHHHHHHhcCCCC-CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 3444444332221 222346788999999999999999999955544433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.54 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=210.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc---
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC--- 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd--- 759 (1093)
...+.|++.+.||.|+||.||+|++..+++.+|+|.+. . .......+..|+.++..+ +||||++++++|..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~-~----~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-V----TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEe-c----ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34578999999999999999999999999999999542 2 123345678899999988 69999999999853
Q ss_pred ---CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 760 ---RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 760 ---~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 45789999999999999999753 3588899999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHH
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEML 909 (1093)
+..... ........+|++.|+|||++. +..++.++|+|||||++|||+
T Consensus 168 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~ 220 (282)
T cd06636 168 SAQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220 (282)
T ss_pred hhhhhc---------------------------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH
Confidence 874210 001123467999999999986 356888999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 910 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 910 TGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
+|.+||....+......+...... ......++.++.+||.+||..||.+||+ +.+|++||||
T Consensus 221 ~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 221 EGAPPLCDMHPMRALFLIPRNPPP-KLKSKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred hCCCCccccCHHhhhhhHhhCCCC-CCcccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 999999877665544444332211 1123568899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.76 Aligned_cols=254 Identities=34% Similarity=0.587 Sum_probs=216.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||.|+||.||+|.++.+++.+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 47889999999999999999999999999999553321 124456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.+|.+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~---- 153 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---- 153 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH----
Confidence 9999999999999876 779999999999999999999999 9999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC-----C
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-----S 919 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~-----s 919 (1093)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||... .
T Consensus 154 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 154 -------------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred -------------------------HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 0011267899999999999999999999999999999999999999764 2
Q ss_pred hHHHHHHHhccCCCCCCCCCC-CCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 920 PEIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~-IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
..+....+..... |..+.. ++.++.+||.+||..||.+||+ +.+++.||||+.
T Consensus 209 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~ 262 (265)
T cd06605 209 IFELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhc
Confidence 3344444444322 223333 8999999999999999999999 889999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.04 Aligned_cols=260 Identities=33% Similarity=0.522 Sum_probs=214.7
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh------hhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD------MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~------~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.|.+.+.||.|+||.||+|....+|+.||+|.+..... .......+.+..|+.++..++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 47788999999999999999999999999995522111 111223467889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC--CCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~--Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
..........|+..|+|||++.... ++.++|+||||+++|||++|..||....
T Consensus 162 -------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 162 -------------------------YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred -------------------------ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 0011123456899999999998754 8899999999999999999999998766
Q ss_pred hHHHHHHHhccCC--CCC-CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 920 PEIIFDNILNRKI--PWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 920 ~~ei~~kIl~~~l--~fP-~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+....+..... .++ .....++.++.+||.+||..||.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 6555444433322 222 122456899999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.75 Aligned_cols=249 Identities=28% Similarity=0.521 Sum_probs=214.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||+++++.++..||+|.+. ... .....+.+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~-~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEE-cCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 5899999999999999999999999999999542 211 2335577889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~----- 152 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS----- 152 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc-----
Confidence 999999999988653 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.........|++.|+|||++.+..++.++|+||||+++|+|++|.+||...+......
T Consensus 153 ----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~ 210 (255)
T cd08219 153 ----------------------PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210 (255)
T ss_pred ----------------------cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH
Confidence 0111234578999999999999899999999999999999999999999988877777
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.+..+... .++..++..+.+||.+||+.||.+||+ +.+|+.
T Consensus 211 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~ 251 (255)
T cd08219 211 KVCQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPS---ATTILS 251 (255)
T ss_pred HHhcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCC---HHHHhh
Confidence 77655443 245778999999999999999999999 666664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=370.33 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=211.8
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCC-----cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TG-----k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
..+....++|++.+.||+|+||.||+|++..+| ..||+|.+ +... .......+.+|+.+|+.+ +|||||++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~-~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASA--HTDEREALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEec-cCCC--CHHHHHHHHHHHHHHHhhccCCceeeE
Confidence 445677789999999999999999999865443 57999944 3221 223456788999999999 89999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhc---------------------------------------------------
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKV--------------------------------------------------- 782 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~--------------------------------------------------- 782 (1093)
+++|.....+|+||||+++|+|.+++...
T Consensus 108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 99999999999999999999999998642
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 783 -------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 783 -------------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~- 266 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS- 266 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc-
Confidence 136788899999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~e 922 (1093)
.........+++.|||||++.+..|+.++|||||||++|||++ |..||.......
T Consensus 267 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 267 ------------------------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred ------------------------ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 0001122345678999999999999999999999999999997 999998876655
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+..+.......+ .+..+++++.+||.+||+.||.+||++.++.+.+
T Consensus 323 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 323 KFYKMVKRGYQMS-RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHHHHcccCcc-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 5545554443322 3466799999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=346.15 Aligned_cols=258 Identities=33% Similarity=0.539 Sum_probs=213.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||.|+||.||+|.++.+++.||+|.+ +.. .........+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~-~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehh-hhh-cccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 4799999999999999999999999999999943 322 22333457789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++++.+..++.+...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~----- 153 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR----- 153 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC-----
Confidence 999999888777766677999999999999999999999999999999999999999999999999998753110
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........+|++.|+|||++.+. .++.++|+||||++||+|++|.+||.+.+..+...
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 212 (288)
T cd07833 154 ---------------------PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212 (288)
T ss_pred ---------------------ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 00122345789999999999887 88999999999999999999999998776544333
Q ss_pred HHhcc-------------------CCCCCC----------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNR-------------------KIPWPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~-------------------~l~fP~----------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+... ...++. .+..++.++.+||++||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~f 288 (288)
T cd07833 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT---CDELLQHPYF 288 (288)
T ss_pred HHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc---HHHHhcCCCC
Confidence 32210 000110 12345899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=368.15 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=202.8
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
....+|++++.||.|+||.||+|++..++..||+|+. .+ .....|+.+|..++||||+++++++......
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~-~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIG-QK---------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeC-Cc---------cccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 3456799999999999999999999999999999942 21 1235689999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+||||+. |+|.+++.+ ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred EEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 99999996 588888865 45699999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhC-CCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTG-kpPF~~~s~~ 921 (1093)
........||+.|+|||++.+..|+.++|||||||++|||+++ .++|......
T Consensus 210 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~ 263 (357)
T PHA03209 210 --------------------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263 (357)
T ss_pred --------------------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCc
Confidence 0112345799999999999999999999999999999999985 4444432211
Q ss_pred ---------HHHHHHhcc----CCCCCC---------------------------CCCCCCHHHHHHHHhhccCCcCCCC
Q 001354 922 ---------IIFDNILNR----KIPWPC---------------------------VPSDMSFEAQDLINRFLIHDPNQRL 961 (1093)
Q Consensus 922 ---------ei~~kIl~~----~l~fP~---------------------------ip~~IS~eakDLIkrcL~kDP~KRp 961 (1093)
.....++.. ...+|. ....++.++.+||.+||+.||.+||
T Consensus 264 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 343 (357)
T PHA03209 264 PEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP 343 (357)
T ss_pred HHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc
Confidence 111111110 011110 0124577888999999999999999
Q ss_pred ChhcHHHHHcCCCCCCC
Q 001354 962 GANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 962 Ta~~A~EIL~HPFFkgI 978 (1093)
+ |.++++||||+.+
T Consensus 344 t---a~e~l~hp~f~~~ 357 (357)
T PHA03209 344 S---AEEILNYPMFAQL 357 (357)
T ss_pred C---HHHHhcCchhccC
Confidence 9 8899999999864
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=347.38 Aligned_cols=255 Identities=33% Similarity=0.542 Sum_probs=208.7
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++++.||.|+||.||+|+++.+|..||+|.+. . ..........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~-~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-L-DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcc-c-cccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 5899999999999999999999999999999542 2 1222333457889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||+. ++|..++... ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~---- 153 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---- 153 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC----
Confidence 9996 5899888653 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
........+++.|+|||++.+.. ++.++|+|||||++|||++|+.||.+.+.....
T Consensus 154 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 210 (284)
T cd07860 154 -----------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210 (284)
T ss_pred -----------------------ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 01112335789999999987644 688999999999999999999999887655444
Q ss_pred HHHhccC------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~------------------l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+.... ..++. +...+++++.+||.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~f 284 (284)
T cd07860 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS---AKAALAHPFF 284 (284)
T ss_pred HHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---HHHHhcCCCC
Confidence 3333210 01111 12357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=352.97 Aligned_cols=260 Identities=33% Similarity=0.489 Sum_probs=212.6
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DN 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~ 762 (1093)
..++|++.+.||.|+||.||+|.++.+|..||+|.+... .........+.+|+.++..++||||+++++++... +.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD--NERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEec--cCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 578999999999999999999999999999999955322 11222234567899999999999999999998765 46
Q ss_pred eEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 8999999975 898888753 56899999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+++.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+.
T Consensus 162 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 162 ---------------------------AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred ---------------------------cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 011122346889999999876 5689999999999999999999999999888
Q ss_pred HHHHHHHhccC-------------------CCCCCC--------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 921 EIIFDNILNRK-------------------IPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 921 ~ei~~kIl~~~-------------------l~fP~i--------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
.+.+..+.... ...+.. ...+++++.+||.+||+.||.+||+ +.+++.||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~~il~h~ 291 (309)
T cd07845 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT---AEEALESS 291 (309)
T ss_pred HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC---HHHHhcCh
Confidence 77776665411 011100 1236889999999999999999999 88999999
Q ss_pred CCCC
Q 001354 974 FFKG 977 (1093)
Q Consensus 974 FFkg 977 (1093)
||++
T Consensus 292 ~f~~ 295 (309)
T cd07845 292 YFKE 295 (309)
T ss_pred hhcc
Confidence 9974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=367.53 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=210.1
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEE-----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~-----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~ 754 (1093)
.+.+..++|++.+.||+|+||+||+|++ ..++..||+| +++... .....+.+.+|+.+|..+ +|||||+++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK-~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVK-MLKPSA--HLTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEE-eccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 4456677999999999999999999974 3467789999 443222 223456788999999999 899999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhcC---------------------------------------------------
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG--------------------------------------------------- 783 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~g--------------------------------------------------- 783 (1093)
++|......|+||||++||+|.+++....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999999986421
Q ss_pred ------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 784 ------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 784 ------------------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 36778889999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
... .........+++.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 266 ~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 266 NDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred Ccc-------------------------cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 000 0001112345778999999999999999999999999999998 99999887
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.......+++...... ..+...+.++.+||.+||+.||.+||++.++.+.++
T Consensus 321 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 321 PVDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred CchHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 6554444444443332 234567899999999999999999999665555443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.70 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=213.7
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+ +.. ........+.+|+.+|..++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEee-ccc--CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 45679999999999999999998753 3678999944 322 223345788999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 825 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g--------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG 825 (1093)
...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 999999999999999999997543 378889999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhH
Q 001354 826 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 905 (1093)
Q Consensus 826 ~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVIL 905 (1093)
.+||+|||+++...... .........+++.|+|||++.+..++.++|||||||+|
T Consensus 160 ~~kl~d~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05049 160 VVKIGDFGMSRDVYTTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214 (280)
T ss_pred eEEECCcccceecccCc-------------------------ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHH
Confidence 99999999987421000 00111234568899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 906 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 906 YEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|||++ |..||.+.+..+....+..+.... .+..++..+.+||.+||+.||.+||++.++.+.+
T Consensus 215 ~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 215 WEIFTYGKQPWYGLSNEEVIECITQGRLLQ--RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 99998 999999888888888777655432 3467899999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=349.73 Aligned_cols=259 Identities=33% Similarity=0.519 Sum_probs=213.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~--~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+|++.+.||.|+||.||+|.+..+|..||+|.+. ..... .......+..|+.++..++||||+++++++.+.+.+|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~-~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK-LGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEe-ccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 4889999999999999999999999999999553 22221 12234567789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+ +|+|..++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||+++....
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~---- 154 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS---- 154 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC----
Confidence 99999 889999998766 799999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.........+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.+..+.
T Consensus 155 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~ 211 (298)
T cd07841 155 -----------------------PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211 (298)
T ss_pred -----------------------CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH
Confidence 0011123457889999999865 4678999999999999999999999988777665
Q ss_pred HHHHhccCC-----CC---------------C-----CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 924 FDNILNRKI-----PW---------------P-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 924 ~~kIl~~~l-----~f---------------P-----~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+.++..... .+ + .....++.++.+||.+||..||.+||+ +.+++.||||++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~e~l~~~~~~~~ 288 (298)
T cd07841 212 LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT---ARQALEHPYFSND 288 (298)
T ss_pred HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---HHHHhhCccccCC
Confidence 555542100 00 0 012345789999999999999999999 8899999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.18 Aligned_cols=254 Identities=35% Similarity=0.646 Sum_probs=222.0
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||++.+..++..||+|.+.. ..........+.+|+++++.++|||++++++.+.....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDL--SNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeec--ccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 58999999999999999999999999999995532 2223345667889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 768 EYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||+++++|.+++.+. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~--- 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--- 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc---
Confidence 999999999999764 6799999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...+
T Consensus 156 ------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 211 (258)
T cd08215 156 ------------------------TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL 211 (258)
T ss_pred ------------------------CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH
Confidence 00122345789999999999998899999999999999999999999998888777
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...+..... +.++..++.++.++|.+||..+|.+||+ +.++++||||
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 212 ALKILKGQY--PPIPSQYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred HHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 777765543 3455788999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=349.24 Aligned_cols=256 Identities=30% Similarity=0.510 Sum_probs=216.6
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|++++.||+|+||+||++.+..+|..||+|++... ........+.+|+.++..++||||+++++++.....+|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec---CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 457899999999999999999999999999999955322 12334567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||+++|+|..++.+.+.+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~---- 155 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---- 155 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh----
Confidence 999999999999999888889999999999999999999997 589999999999999999999999999986321
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH--
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 921 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~-- 921 (1093)
.......+||..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 156 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 210 (284)
T cd06620 156 -------------------------NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210 (284)
T ss_pred -------------------------hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh
Confidence 00112357999999999998889999999999999999999999999865542
Q ss_pred ---------HHHHHHhccCCCCCCCC-CCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 922 ---------IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 922 ---------ei~~kIl~~~l~fP~ip-~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+....+..... +.++ ..++.++.+||.+||..||.+||+ +.++++||||..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~ 271 (284)
T cd06620 211 GQDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccc
Confidence 23333333322 1122 237889999999999999999999 789999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=363.08 Aligned_cols=254 Identities=32% Similarity=0.533 Sum_probs=219.5
Q ss_pred ccCCCeeEE-EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc--
Q 001354 684 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC-- 759 (1093)
Q Consensus 684 isiddFeil-r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd-- 759 (1093)
..+++|.+. ++||-|-.|.|..|.++.||+.+|+| ++.. ....++|+++.-..+ |||||.++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALK-vL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALK-VLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHH-HHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 356777765 47999999999999999999999999 4322 234678888776665 9999999987654
Q ss_pred --CCceEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CCcEEEEec
Q 001354 760 --RDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDF 832 (1093)
Q Consensus 760 --~~~LyLVMEYm~GGSL~dlL~k~g~--LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG~VKLsDF 832 (1093)
...+.+|||.|+||+|+..++..+. |+|.++..++.||..|+.|||+.+|.||||||+|+|... |-.+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 4579999999999999999988765 999999999999999999999999999999999999975 457999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCC
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
|+|+... ......+.|.||.|.|||++...+|+.+||+|||||+||-||+|+
T Consensus 209 GFAK~t~----------------------------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGy 260 (400)
T KOG0604|consen 209 GFAKETQ----------------------------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260 (400)
T ss_pred ccccccC----------------------------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCC
Confidence 9999521 122345789999999999999999999999999999999999999
Q ss_pred CCCCCCC----hHHHHHHHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 913 PPFTAES----PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 913 pPF~~~s----~~ei~~kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
|||+... ...+..+|..+.+.||.- ...+|.+++|+|++||..+|.+|+| +.++++|||..+
T Consensus 261 PPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi~~ 327 (400)
T KOG0604|consen 261 PPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWINQ 327 (400)
T ss_pred CcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchhcc
Confidence 9999764 456788999999999862 2468999999999999999999999 889999999865
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.27 Aligned_cols=256 Identities=21% Similarity=0.357 Sum_probs=215.8
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+...+|.+.+.||.|+||.||+|.++.++..+|+|.+ ++. ......+.+|+.+|+.++||||+++++++.....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~-~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 76 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEe-cCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence 35567899999999999999999999999999999944 321 2235678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+|+||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999999999999754 3588999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
.. ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 157 ~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 157 DT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred ce--------------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 00 001112334678999999999999999999999999999998 999999988
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
..+....+.... . +..+..++.++.+||.+||..||.+||++.++.+.++
T Consensus 211 ~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 211 LSQVYELLEKGY-R-MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred HHHHHHHHHCCC-C-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 887777765532 2 2345788999999999999999999999776666554
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.99 Aligned_cols=261 Identities=31% Similarity=0.488 Sum_probs=211.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++.+.||.|+||+||+|.++.+|+.||+|.+ ... .........+.+|+.+++.++||||+++++++.+...+|+
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~-~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLE-QEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEeh-hhc-cccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 36899999999999999999999999999999954 222 1222334668899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~--LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~~~~~~ 842 (1093)
||||++ ++|..++..... +++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++.....
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~-- 155 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-- 155 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC--
Confidence 999996 488888765443 578889999999999999999999999999999999985 55799999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 156 -------------------------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred -------------------------CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011123467899999999876 45789999999999999999999999987766
Q ss_pred HHHHHHhcc---C---------------C---CCCC-----CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 922 IIFDNILNR---K---------------I---PWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 922 ei~~kIl~~---~---------------l---~fP~-----ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
+...++... . . .++. ....+++++.++|.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~~l~~~~~ 287 (294)
T PLN00009 211 DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT---ARAALEHEYF 287 (294)
T ss_pred HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC---HHHHhcCchH
Confidence 655554321 0 0 0000 12457899999999999999999999 8899999999
Q ss_pred CCCC
Q 001354 976 KGVN 979 (1093)
Q Consensus 976 kgId 979 (1093)
.+++
T Consensus 288 ~~~~ 291 (294)
T PLN00009 288 KDLG 291 (294)
T ss_pred hHHh
Confidence 8654
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.42 Aligned_cols=259 Identities=37% Similarity=0.625 Sum_probs=214.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||+|....++..||+|.+ +... ........+.+|+.+++.++||||+++++.+...+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~-~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQD-NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEE-ECcc-cchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 488999999999999999999989999999954 3322 22456788999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||+++++|.+++.....+++..++.++.+++.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~---- 154 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT---- 154 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC----
Confidence 9999999999998877899999999999999999999999999999999999999999999999999875311000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccceeecchhhHHHHHhCCCCCCCCCh-HHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESP-EII 923 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Ys~ksDVWSLGVILYEMLTGkpPF~~~s~-~ei 923 (1093)
..........|++.|+|||++.+.. ++.++|+||||+++|||++|+.||..... ...
T Consensus 155 -------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~ 215 (264)
T cd06626 155 -------------------TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI 215 (264)
T ss_pred -------------------cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH
Confidence 0000022356899999999998766 88999999999999999999999976543 222
Q ss_pred HHHHhcc-CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 924 FDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 924 ~~kIl~~-~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...+... ...+|. ...++..+.+||.+||+.||.+||+ +.+++.|||+
T Consensus 216 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 216 MFHVGAGHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred HHHHhcCCCCCCCc-ccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 2223222 222231 1235899999999999999999999 8899999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.03 Aligned_cols=254 Identities=29% Similarity=0.517 Sum_probs=217.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||+|..+.+|..+|+|.+.. .. ......+.+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~-~~-~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TK-MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeH-hh-ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 58899999999999999999999999999995532 21 22234567789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc-EEEEecCCcccccccccc
Q 001354 768 EYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~-VKLsDFGLAk~~~~~~s~ 844 (1093)
||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+|+|+||||+||+++.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---- 154 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND---- 154 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC----
Confidence 9999999999997643 4799999999999999999999999999999999999998864 69999998874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.........|++.|+|||++.+..++.++|+|||||++|||++|..||...+.....
T Consensus 155 -----------------------~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 211 (257)
T cd08225 155 -----------------------SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211 (257)
T ss_pred -----------------------CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 011122346899999999999888999999999999999999999999988877777
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+..... +.++..++.++.++|.+||..+|.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 212 LKICQGYF--APISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred HHHhcccC--CCCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 76665543 3345678899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=338.91 Aligned_cols=260 Identities=30% Similarity=0.501 Sum_probs=218.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhh-hhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cce
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL-DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 763 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~-~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~L 763 (1093)
.+|++.+.||+|+||.||+|.++.++..||+|.+.... ..........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999553221 112234567888999999999999999999998764 458
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-- 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc--
Confidence 999999999999999988778999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
. ..........|++.|+|||++.+..++.++|+|||||++|+|++|++||........
T Consensus 160 -----------~-----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 160 -----------C-----------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred -----------c-----------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 0 000111235689999999999998899999999999999999999999998777666
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...+...... +.+|..+++.+.++|.+||. +|.+||+ +.+++.|||.
T Consensus 218 ~~~~~~~~~~-~~~p~~~~~~~~~~i~~~l~-~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 218 IFKIATQPTK-PMLPDGVSDACRDFLKQIFV-EEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred HHHHHcCCCC-CCCCcccCHHHHHHHHHHhc-CcccCcc---HHHHhcCCCC
Confidence 6665543332 44568899999999999999 6899999 7799999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.87 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=209.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|++.+.||+|+||.||+++++. +..+|+|.+ ++.. .....+.+|+.+|+.++||||+++++++.....+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~-~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAI-NEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEec-ccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence 35789999999999999999999875 567999944 3222 12356888999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||+++|+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~-- 153 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-- 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC--
Confidence 999999999999999753 56899999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~e 922 (1093)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||...+..+
T Consensus 154 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 154 ------------------------EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred ------------------------ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 0001122345678999999998899999999999999999999 999999998888
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
....+..+... ..+...+..+.+||.+||+.||.+||++.++.+
T Consensus 210 ~~~~i~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 210 VVEMISRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 88888765432 224567889999999999999999999554443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.24 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=207.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEE--EEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~V--AIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd 759 (1093)
.+..++|++.+.||+|+||.||+|.++.++..+ |+|.+ + ..........+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~-~--~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-K--EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEe-c--ccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 456789999999999999999999998887654 55532 2 122344557788999999999 89999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~ 823 (1093)
.+.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 999999999999999999997543 4788999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchh
Q 001354 824 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903 (1093)
Q Consensus 824 dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGV 903 (1093)
++.+||+|||++..... ........+++.|+|||++.+..++.++|||||||
T Consensus 160 ~~~~kl~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 211 (303)
T cd05088 160 NYVAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 211 (303)
T ss_pred CCcEEeCccccCcccch----------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhh
Confidence 99999999999863100 00111223467899999998888999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc
Q 001354 904 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965 (1093)
Q Consensus 904 ILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~ 965 (1093)
++|||++ |.+||.+.+..+....+... .. +..+..+++++.+||.+||..+|.+||++.+
T Consensus 212 il~ellt~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 212 LLWEIVSLGGTPYCGMTCAELYEKLPQG-YR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred HHHHHHhcCCCCcccCChHHHHHHHhcC-Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999998 99999988887777766433 22 2234568899999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=363.86 Aligned_cols=262 Identities=31% Similarity=0.536 Sum_probs=224.2
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEEEecC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+.||.|+|+.|--+....||..||+| |+.|. ......++.+|++++..++ |+||++|+.+|+++.++|||||-|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVK-iidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVK-IIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhh-hhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 47999999999999999999999999 44443 2334578999999999996 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc---EEEEecCCcccccccccccCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSG 848 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~---VKLsDFGLAk~~~~~~s~dls~ 848 (1093)
||.|..+|++...|+|.+|..++.+|+.||+|||.+||.||||||+|||-..-.+ |||+||.|..-...++. ++
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~--~s- 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND--CS- 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC--CC-
Confidence 9999999999999999999999999999999999999999999999999876554 79999998764322211 11
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCCCCC-----
Q 001354 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAE----- 918 (1093)
Q Consensus 849 ~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~----- 918 (1093)
| .......+.||+..|||||++. ...|+..||.||||||+|-||.|++||.+.
T Consensus 237 -------p----------astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 237 -------P----------ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred -------C----------CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 0 1122345789999999999863 246899999999999999999999999653
Q ss_pred --C--------hHHHHHHHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 919 --S--------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 919 --s--------~~ei~~kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
+ ...++..|..+.+.||.- ...+|.+++|||+.+|.+|+.+|++ +.++++|||++.+.-+
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLNHPWVQRCAPE 370 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccCCccccccchh
Confidence 1 467888999999999963 3468999999999999999999999 8899999999987655
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.85 Aligned_cols=255 Identities=30% Similarity=0.509 Sum_probs=212.9
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++.+.||.|+||.||+|....+|+.||+|.+ +............+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~-~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEe-ecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 6899999999999999999999999999999944 333444445567899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 767 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|||+++|+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~-- 158 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-- 158 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC--
Confidence 999999999999864 24589999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC--h
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--P 920 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s--~ 920 (1093)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.... .
T Consensus 159 -------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08224 159 -------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred -------------------------CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH
Confidence 0111234568999999999999999999999999999999999999997653 2
Q ss_pred HHHHHHHhccCCCCCCCCC-CCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 921 EIIFDNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~-~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
......+..+.. +..+. .++..+.++|.+||..+|.+||++.++.+.++
T Consensus 214 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 214 YSLCKKIEKCDY--PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred HHHHhhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 344444443322 22233 78889999999999999999999666655553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.95 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=209.3
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
..++|++++.||+|+||.||+|++..+|+.||+|.+ .+. .........+.+|+.++..++||||++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~-~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL-SRP-FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEec-Ccc-ccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 357899999999999999999999999999999954 221 122334566788999999999999999999886543
Q ss_pred ---ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 762 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+|+||||+.+ +|...+... +++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 57999999965 888887654 899999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 169 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 169 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CC----------------------------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 10 01122356899999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHhccC----------------------C-----C---------CCC----CCCCCCHHHHHHHHhhccCCcC
Q 001354 919 SPEIIFDNILNRK----------------------I-----P---------WPC----VPSDMSFEAQDLINRFLIHDPN 958 (1093)
Q Consensus 919 s~~ei~~kIl~~~----------------------l-----~---------fP~----ip~~IS~eakDLIkrcL~kDP~ 958 (1093)
+....+..+...- . . +|. .+...+..+.+||.+||+.||.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 300 (353)
T cd07850 221 DHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300 (353)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChh
Confidence 7555444443210 0 0 000 0123466789999999999999
Q ss_pred CCCChhcHHHHHcCCCCC
Q 001354 959 QRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 959 KRpTa~~A~EIL~HPFFk 976 (1093)
+||+ +.++|.||||+
T Consensus 301 ~R~t---~~eiL~~~~~~ 315 (353)
T cd07850 301 KRIS---VDDALQHPYIN 315 (353)
T ss_pred hCcC---HHHHhcChhHh
Confidence 9999 88999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.47 Aligned_cols=250 Identities=52% Similarity=0.955 Sum_probs=219.9
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 774 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGS 774 (1093)
||.|+||.||++.+..+++.||+|. +.+...........+..|+.+++.++||||+++++.+.....+|+||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~-~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEE-eehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999999999999999994 444444445567789999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001354 775 LYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854 (1093)
Q Consensus 775 L~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~ 854 (1093)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~-------------- 145 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-------------- 145 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceeccc--------------
Confidence 999998887899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCC
Q 001354 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 934 (1093)
Q Consensus 855 ~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~f 934 (1093)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+......+
T Consensus 146 -------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 212 (250)
T cd05123 146 -------------EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF 212 (250)
T ss_pred -------------CCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 0012234568999999999998888999999999999999999999998888777788877755554
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 935 P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
| ..++..+.+||.+||..||.+||++..+.++++||||
T Consensus 213 ~---~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 213 P---EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred C---CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 4 6779999999999999999999995445899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.19 Aligned_cols=256 Identities=31% Similarity=0.548 Sum_probs=218.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|...+.||.|+||.||++.+..++..+++|++. . ........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~-~---~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD-L---RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEe-c---cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 3555679999999999999999999999999542 1 22233456889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~------- 167 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK------- 167 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc-------
Confidence 99999999999977 6789999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kI 927 (1093)
.........|++.|+|||++.+..++.++|+|||||++|||++|..||...++......+
T Consensus 168 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~ 227 (285)
T cd06648 168 --------------------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227 (285)
T ss_pred --------------------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 001122356899999999999888999999999999999999999999988887777777
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 928 l~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.....+....+..++..+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 275 (285)
T cd06648 228 RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKA 275 (285)
T ss_pred HhcCCCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccC
Confidence 65533332223458899999999999999999999 7899999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.25 Aligned_cols=256 Identities=30% Similarity=0.560 Sum_probs=205.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++.+.||.|+||.||+|..+.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 5789999999999999999999999999999995532211 1223456789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+++ +|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 155 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---- 155 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC----
Confidence 9999985 999988764 4689999999999999999999999999999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCC-hHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES-PEI 922 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s-~~e 922 (1093)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.. ..+
T Consensus 156 -----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 156 -----------------------PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred -----------------------CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 0001122357889999999876 568999999999999999999999997665 222
Q ss_pred HHHHHhcc-------------------CCCCCC--------CCCCCC--HHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 923 IFDNILNR-------------------KIPWPC--------VPSDMS--FEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 923 i~~kIl~~-------------------~l~fP~--------ip~~IS--~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
....+... ...++. ....++ .++.+||.+||+.||.+||+ +.+++.||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps---~~e~l~~~ 289 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS---AAEAMKHP 289 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC---HHHHhcCC
Confidence 22222110 000000 001344 88999999999999999999 88999999
Q ss_pred CC
Q 001354 974 FF 975 (1093)
Q Consensus 974 FF 975 (1093)
||
T Consensus 290 ~f 291 (291)
T cd07844 290 YF 291 (291)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=401.71 Aligned_cols=264 Identities=31% Similarity=0.513 Sum_probs=217.9
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~- 760 (1093)
....+++|++++.||.|+||+||+|+++.++..||+|.+. . ..........+..|+.+|..++|||||+++++|...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk-~-~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS-Y-RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEe-c-cccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 3456789999999999999999999999999999999543 2 223344567889999999999999999999988654
Q ss_pred -CceEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhc-------CcEeeecCCCcEEEcc-----
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSL-------GIVHRDLKPDNLLIAH----- 823 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~-------GIIHRDIKPeNILLD~----- 823 (1093)
..+||||||+++|+|.++|... +.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 5699999999999999999753 5699999999999999999999985 4999999999999964
Q ss_pred ------------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--
Q 001354 824 ------------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-- 889 (1093)
Q Consensus 824 ------------dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-- 889 (1093)
.+.+||+|||++..... .......+||+.|+|||++.+
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~----------------------------~s~~~s~vGTp~YmAPEvL~ge~ 217 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGI----------------------------ESMAHSCVGTPYYWSPELLLHET 217 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccc----------------------------cccccccCCCccccCHHHHhccC
Confidence 23589999999874210 011234679999999999965
Q ss_pred CCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 890 TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 890 ~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
..++.++||||||||||||++|.+||...+.......++.....+| ....+.++.+||..||..+|.+||+ +.++
T Consensus 218 ~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPS---a~Ql 292 (1021)
T PTZ00266 218 KSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPS---ALQC 292 (1021)
T ss_pred CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcC---HHHH
Confidence 4588999999999999999999999987665544444444443333 2467899999999999999999999 8899
Q ss_pred HcCCCCCCCCc
Q 001354 970 KAHPFFKGVNW 980 (1093)
Q Consensus 970 L~HPFFkgIdW 980 (1093)
|.||||+.+..
T Consensus 293 L~h~~ik~i~~ 303 (1021)
T PTZ00266 293 LGYQIIKNVGP 303 (1021)
T ss_pred hccHHHhhcCC
Confidence 99999987644
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=339.65 Aligned_cols=258 Identities=23% Similarity=0.313 Sum_probs=213.1
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCC-----cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TG-----k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
++..++|++.+.||.|+||.||+|..+..+ ..||+|.+ ... ........+.+|+.+|..++||||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~-~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-NEN--ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEec-CCc--cCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 456789999999999999999999987543 78999944 221 1223456788999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcE
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~----------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~V 827 (1093)
......|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 9999999999999999999999643 236778899999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHH
Q 001354 828 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 828 KLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYE 907 (1093)
||+|||+++...... .........+|..|+|||.+.+..++.++|+|||||++||
T Consensus 159 kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 213 (277)
T cd05032 159 KIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE 213 (277)
T ss_pred EECCcccchhhccCc-------------------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHH
Confidence 999999987431100 0011223457889999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 908 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 908 MLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|++ |.+||.+.+..+....+.... .+..+..++.++.+||.+||+.+|.+||++.++.+.+
T Consensus 214 l~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 214 MATLAEQPYQGLSNEEVLKFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred hhccCCCCCccCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 998 999999988888777776433 2334577899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.05 Aligned_cols=249 Identities=33% Similarity=0.537 Sum_probs=201.0
Q ss_pred CCeeEEEee--eccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCce
Q 001354 687 DDFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 687 ddFeilr~L--GkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~k-L~HPNIVkL~gsfqd~~~L 763 (1093)
++|++.+.+ |.|+||.||+++.+.++..||+|.+. +... .. .|..+... .+||||+++++.|...+.+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~-~~~~-~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIK-AKNF-NA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEe-hhhc-ch-------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 456666665 99999999999999999999999543 2211 11 12222222 2699999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~~~~~~ 842 (1093)
|+||||++||+|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~--- 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG--- 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC---
Confidence 99999999999999998877899999999999999999999999999999999999999998 99999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 162 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 162 ----------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred ----------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 0112458999999999999999999999999999999999999998654433
Q ss_pred HH-HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IF-DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~-~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+. ..+.......+..+..+++.+.+||.+||+.||.+||+. +.++|+||||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~--~~~~l~h~~~~~ 267 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN--YNEIIKHPFLKI 267 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCch--HHHHhcCCcccC
Confidence 21 111111111122345799999999999999999999961 589999999974
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.25 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=211.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++.+.||+|+||.||+|+++.+++.||+|.+ .+...........+.+|+.+++.++||||++++++|...+.+|+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~-~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEee-eehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 36799999999999999999999999999999944 33333444556788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 766 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
||||++|++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999999864 345899999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh-
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP- 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~- 920 (1093)
.......+|++.|+|||++.+..++.++|+||||+++|+|++|..||.+...
T Consensus 160 ---------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 212 (267)
T cd08229 160 ---------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212 (267)
T ss_pred ---------------------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch
Confidence 0112245689999999999998999999999999999999999999976543
Q ss_pred -HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 921 -EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 921 -~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
......+.....+ +..+..++..+.+||.+||..||.+||++..+.+++
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 213 LYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred HHHHhhhhhcCCCC-CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 3344444332221 112346889999999999999999999966554544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=342.96 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=211.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEEC----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKR----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
+.+++|++.+.||+|+||.||+|.+. .++..+|+|.+. .. ........+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~-~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 78 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEecc-CC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence 34678999999999999999999863 356789999543 21 223445678899999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 822 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD 822 (1093)
....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 99999999999999999998532 2378888999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecch
Q 001354 823 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902 (1093)
Q Consensus 823 ~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLG 902 (1093)
.++.+||+|||+++...... .........++..|+|||++.+..++.++||||||
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05090 159 EQLHVKISDLGLSREIYSAD-------------------------YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFG 213 (283)
T ss_pred CCCcEEeccccccccccCCc-------------------------ceecccCCCccceecChHHhccCCCCchhhhHHHH
Confidence 99999999999997531100 00112334567889999999988899999999999
Q ss_pred hhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 903 IILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 903 VILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|++|||++ |.+||.+.++..+...+..... +..+..+++.+.+||.+||+.||.+||+++++.+.+
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 214 VVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 99999998 9999998887777666655432 224577899999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.99 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=190.9
Q ss_pred EEeeeccCCeEEEEEEECC--CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCceEEEE
Q 001354 692 IKPISRGAFGRVFLARKRT--TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVM 767 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~--TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd--~~~LyLVM 767 (1093)
...||+|+||+||+|+.+. ++..||+|.+. .. .....+.+|+.+|..++||||+++++++.. ...+|+||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~-~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIE-GT-----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEec-CC-----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 3579999999999999764 56889999542 21 123457789999999999999999998854 55789999
Q ss_pred EecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE----ccCCcEEEEecCC
Q 001354 768 EYLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGL 834 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~---------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL----D~dG~VKLsDFGL 834 (1093)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99875 888877522 248899999999999999999999999999999999999 5678999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
++...... .........+||+.|+|||++.+ ..++.++|||||||+||||++|.+
T Consensus 159 a~~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~ 214 (317)
T cd07867 159 ARLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred eeccCCCc------------------------ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCC
Confidence 97421000 00112234678999999999987 458999999999999999999999
Q ss_pred CCCCCChH---------HHHHHHhcc--------------CCCC---------------------CCCCCCCCHHHHHHH
Q 001354 914 PFTAESPE---------IIFDNILNR--------------KIPW---------------------PCVPSDMSFEAQDLI 949 (1093)
Q Consensus 914 PF~~~s~~---------ei~~kIl~~--------------~l~f---------------------P~ip~~IS~eakDLI 949 (1093)
||...... .....+... ...+ +......+..+.+||
T Consensus 215 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 294 (317)
T cd07867 215 IFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLL 294 (317)
T ss_pred CcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHH
Confidence 99754321 111111100 0000 001123456789999
Q ss_pred HhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 950 NRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 950 krcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+||+.||.+||| +.|+++||||
T Consensus 295 ~~~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 295 QKLLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred HHHhccCcccccC---HHHHhcCCCC
Confidence 9999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.68 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=214.3
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.-.+|.+.+.||.|+||.||++... .++..+|+|.+. + ........+.+|+.+|..++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~-~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-D---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecC-C---cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4568999999999999999999863 345678999442 2 123445678999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 826 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g-------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~ 826 (1093)
.+.+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999997543 3899999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHH
Q 001354 827 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906 (1093)
Q Consensus 827 VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILY 906 (1093)
+||+|||+++...... .........+++.|+|||++.+..++.++|+|||||++|
T Consensus 159 ~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~ 213 (288)
T cd05093 159 VKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213 (288)
T ss_pred EEeccCCccccccCCc-------------------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHH
Confidence 9999999987421000 001112345678999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 907 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 907 EMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+|++ |.+||...........+..+... ..+..++.++.+||.+||+.||.+||++.++...++
T Consensus 214 ~l~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 214 EIFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 9998 99999998888888888776532 234678899999999999999999999766655554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.10 Aligned_cols=255 Identities=22% Similarity=0.373 Sum_probs=213.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++++.||+|+||.||+|... ++..||+|.+ ... ....+.+.+|+.+++.++||||+++++.+.....
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~-~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTL-KPG----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP 75 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEc-cCC----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 356789999999999999999999975 4667999944 221 1235678999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999999999753 4588889999999999999999999999999999999999999999999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. .........++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 156 ~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 156 N--------------------------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred C--------------------------ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 0 0001122346778999999998889999999999999999998 999999888
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.......+... ..+|. ...++.++.+||.+||..||++||+++.+.++|+
T Consensus 210 ~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 210 NSDVMSALQRG-YRMPR-MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred HHHHHHHHHcC-CCCCC-CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 87777776554 33332 3568899999999999999999999777766654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=328.13 Aligned_cols=257 Identities=38% Similarity=0.611 Sum_probs=218.7
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CceEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYL 765 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~LyL 765 (1093)
+|.+.+.||+|+||.||+|....++..+++|++. ... ........+.+|+.++++++||||+++++.+... ..+|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~-~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVE-LSG-DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEee-ccc-cchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4788999999999999999999999999999543 222 2245678899999999999999999999999988 88999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||+++++|.+++.+...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 156 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET-- 156 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC-hHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s-~~ei~ 924 (1093)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .....
T Consensus 157 -----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (260)
T cd06606 157 -----------------------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213 (260)
T ss_pred -----------------------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 001234578999999999998889999999999999999999999998776 33333
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+.. ....+.++..++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 214 YKIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred Hhccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 33332 22334456788999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.43 Aligned_cols=258 Identities=33% Similarity=0.502 Sum_probs=211.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DN 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~ 762 (1093)
.+++|++.+.||.|+||.||+|.++.+++.+|+|.+. ... ........+.+|+.++..++||||+++++++... ..
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~-~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEK-EKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEe-ecc-ccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 3468999999999999999999999999999999553 221 1223344677899999999999999999998877 88
Q ss_pred eEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+|+||||+++ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.+|.+||+|||++.....
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~- 158 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS- 158 (293)
T ss_pred EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC-
Confidence 9999999975 9999987654 589999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.........+++.|+|||++.+. .++.++|+||||+++|||++|.+||...+.
T Consensus 159 --------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~ 212 (293)
T cd07843 159 --------------------------PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212 (293)
T ss_pred --------------------------CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00112234678999999998764 468899999999999999999999998877
Q ss_pred HHHHHHHhccCC-------------------CC---------CCCCCC-CCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 921 EIIFDNILNRKI-------------------PW---------PCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 921 ~ei~~kIl~~~l-------------------~f---------P~ip~~-IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
...+.++..... .+ ..++.. +++.+.+||.+||+.||++||+ +.|++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~ell~ 289 (293)
T cd07843 213 IDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS---AEDALK 289 (293)
T ss_pred HHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC---HHHHhc
Confidence 766655432100 00 011222 6889999999999999999999 889999
Q ss_pred CCCC
Q 001354 972 HPFF 975 (1093)
Q Consensus 972 HPFF 975 (1093)
||||
T Consensus 290 ~~~f 293 (293)
T cd07843 290 HPYF 293 (293)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=381.27 Aligned_cols=259 Identities=33% Similarity=0.582 Sum_probs=235.9
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.......|.+.++||+|.|++|.++++..|+..|||| ++.|.. ......+.+.+|+++|..++|||||++|.+...+.
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK-~idkt~-ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIK-IIDKTQ-LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEE-Eehhcc-cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 4456789999999999999999999999999999999 444433 33444456899999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||+.+|+++++|.+++.+.+..++.++.|++.|++|||+++|+|||||++||||+.+.++||+|||++.+..
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998642
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
......++||+|.|.|||++.+..| +..+|+||+|+++|-|+.|..||.+.+-
T Consensus 207 --------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 207 --------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred --------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 1234567899999999999999888 6799999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
.+.....+.+++.+| ..++.++.+||+++|..+|.+|++ ..+|..|.|..
T Consensus 261 k~Lr~rvl~gk~rIp---~~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n 310 (596)
T KOG0586|consen 261 KELRPRVLRGKYRIP---FYMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRN 310 (596)
T ss_pred ccccchheeeeeccc---ceeechhHHHHHHhhccCccccCC---HHHhhhhcccc
Confidence 888888888888876 679999999999999999999999 88999999985
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.49 Aligned_cols=263 Identities=30% Similarity=0.462 Sum_probs=207.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~-- 761 (1093)
..+++|++.+.||.|+||.||+|.++.+++.||+|.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccC--CcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 35678999999999999999999999999999999653221 12223345678999999999999999999887654
Q ss_pred ------ceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 762 ------NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 762 ------~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
..|+||||+.+ +|.+++.+.. .+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 35999999965 8888887653 689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
+........ ..........+++.|+|||++.+. .++.++|+||||+++|||++|.+
T Consensus 166 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~ 222 (310)
T cd07865 166 ARAFSLSKN-----------------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222 (310)
T ss_pred cccccCCcc-----------------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCC
Confidence 875311000 001112345688999999998764 47889999999999999999999
Q ss_pred CCCCCChHHHHHHHhcc--CC-----------------CCCCC----------CCCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 914 PFTAESPEIIFDNILNR--KI-----------------PWPCV----------PSDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~--~l-----------------~fP~i----------p~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
||.+.++......+... .. .+|.. +...+..+.+||.+||..||.+||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t-- 300 (310)
T cd07865 223 IMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID-- 300 (310)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC--
Confidence 99887765444333221 00 01100 0123567889999999999999999
Q ss_pred cHHHHHcCCCC
Q 001354 965 GAAEVKAHPFF 975 (1093)
Q Consensus 965 ~A~EIL~HPFF 975 (1093)
+.++++||||
T Consensus 301 -~~e~l~h~~f 310 (310)
T cd07865 301 -ADTALNHDFF 310 (310)
T ss_pred -HHHHhcCCCC
Confidence 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=353.34 Aligned_cols=257 Identities=31% Similarity=0.534 Sum_probs=215.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.|.....||.|+||.||++....++..||+|.+- . ........+.+|+.++..++||||+++++.+...+..|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~-~---~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMD-L---RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEe-c---chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 44555678999999999999999999999999542 2 1223456688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~------ 170 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK------ 170 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc------
Confidence 999999999998854 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.........||+.|+|||++.+..++.++|+|||||++|||++|+.||...+.......
T Consensus 171 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 229 (292)
T cd06658 171 ---------------------EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229 (292)
T ss_pred ---------------------ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00112345789999999999988999999999999999999999999998877666655
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+.............++..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~ 278 (292)
T cd06658 230 IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLA 278 (292)
T ss_pred HHhcCCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhcc
Confidence 543221111122467899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=330.00 Aligned_cols=254 Identities=32% Similarity=0.616 Sum_probs=220.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||++++..+++.|++|.+. ... ........+.+|++++.+++||||+++++++.+...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~-~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS-LEK-IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEec-ccc-cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 5889999999999999999999999999999553 322 22355678999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------ 152 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV------ 152 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kI 927 (1093)
........|++.|+|||.+.+..++.++|+||||+++|+|++|.+||...+.......+
T Consensus 153 ---------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (254)
T cd06627 153 ---------------------SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211 (254)
T ss_pred ---------------------cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 01123456899999999998888999999999999999999999999887765555554
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 928 l~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
... ..+.++..++..+.++|.+||..+|++||+ +.+++.||||
T Consensus 212 ~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 212 VQD--DHPPLPEGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred hcc--CCCCCCCCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 432 234456788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=336.08 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=207.1
Q ss_pred eeEEEeeeccCCeEEEEEEECCC---CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc---
Q 001354 689 FEIIKPISRGAFGRVFLARKRTT---GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 762 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~T---Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~--- 762 (1093)
|++.+.||+|+||.||+|....+ +..||+|.+ + ...........+.+|+.+|+.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~-~-~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-K-LDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEe-c-cCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 57889999999999999987653 478999954 2 223334556789999999999999999999988766554
Q ss_pred ---eEEEEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 763 ---LYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 763 ---LyLVMEYm~GGSL~dlL~k~------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence 79999999999999998543 258999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-Gk 912 (1093)
+++....... ........++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 159 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~ 213 (273)
T cd05035 159 LSKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213 (273)
T ss_pred ceeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCC
Confidence 9875321000 001112335678999999988899999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+||.+....+++..+..... +..+..++.++.++|.+||+.||.+||++.++...+
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 214 TPYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred CCCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999888888877765432 334578899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.70 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=210.2
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|++|.||+|+++.+|..||+|++... . .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLD-A--EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccc-c--cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 589999999999999999999999999999955322 1 1223456778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 768 EYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g---~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||+++ +|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~---- 152 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI---- 152 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC----
Confidence 99985 8988886543 589999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.........+|+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..+.
T Consensus 153 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 209 (284)
T cd07836 153 -----------------------PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209 (284)
T ss_pred -----------------------CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 0011123467899999999876 4578899999999999999999999998877666
Q ss_pred HHHHhccC------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 924 FDNILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 924 ~~kIl~~~------------------l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...+.... ..+|. +.+.++..+.++|.+||+.||.+||+ +.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~f 284 (284)
T cd07836 210 LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS---AHDALQHPWF 284 (284)
T ss_pred HHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 66554310 00110 11346788999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.08 Aligned_cols=258 Identities=31% Similarity=0.521 Sum_probs=219.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|+.++.||.|+||.||+|.++.++..||+|.+ +... .......+.+|+.++..+.||||+++++++.+....|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~-~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEE-eccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3578889999999999999999999999999944 3221 234467889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|||++||+|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~------ 153 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD------ 153 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC------
Confidence 999999999999865 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.........|+..|+|||++.+..++.++|+|||||++|||++|.+||...++......
T Consensus 154 ---------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06640 154 ---------------------TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL 212 (277)
T ss_pred ---------------------CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh
Confidence 00112234688999999999988899999999999999999999999998877766655
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
+.... .|.++..++..+.+||.+||..+|.+||+ +.+++.||||.....
T Consensus 213 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06640 213 IPKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKNAK 261 (277)
T ss_pred hhcCC--CCCCchhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhcch
Confidence 43332 23445678899999999999999999999 789999999976544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=375.26 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=206.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
.....|.+.+.||+|+||.||+|.+..++..||+|... ...+.+|+.+|++++|||||++++++......
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~ 235 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLT 235 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 34568999999999999999999999999999999321 12356899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+|||++. |+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 236 ~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 236 CLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 99999995 6998888754 469999999999999999999999999999999999999999999999999997421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC---
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--- 919 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s--- 919 (1093)
........+||+.|||||++.+..++.++|||||||+||||++|..|+....
T Consensus 315 -------------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 315 -------------------------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred -------------------------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 0011234679999999999999999999999999999999999876653321
Q ss_pred -----hHHHHHHHhccCCC---CCCC----------------------------CCCCCHHHHHHHHhhccCCcCCCCCh
Q 001354 920 -----PEIIFDNILNRKIP---WPCV----------------------------PSDMSFEAQDLINRFLIHDPNQRLGA 963 (1093)
Q Consensus 920 -----~~ei~~kIl~~~l~---fP~i----------------------------p~~IS~eakDLIkrcL~kDP~KRpTa 963 (1093)
...+.+.|...... +|.. ...++.++.+||.+||+.||.+||+
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs- 448 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS- 448 (461)
T ss_pred ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC-
Confidence 22333333222111 1100 0135678999999999999999999
Q ss_pred hcHHHHHcCCCCCC
Q 001354 964 NGAAEVKAHPFFKG 977 (1093)
Q Consensus 964 ~~A~EIL~HPFFkg 977 (1093)
+.|+|+||||+.
T Consensus 449 --a~elL~hp~f~~ 460 (461)
T PHA03211 449 --AAELLRLPLFQS 460 (461)
T ss_pred --HHHHhhCcccCC
Confidence 889999999964
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.79 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=208.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
+..++|++.+.||+|+||.||+|.++. ++..||+|.+ .... .......+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~-~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-NEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEec-cccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456789999999999999999998652 4567999944 2221 2234456889999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEE
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 828 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g----------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VK 828 (1093)
.....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999999997532 256778888999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHH
Q 001354 829 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 908 (1093)
Q Consensus 829 LsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEM 908 (1093)
|+|||+++....... ........+++.|||||++.+..++.++|+|||||++|||
T Consensus 160 l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 214 (277)
T cd05062 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214 (277)
T ss_pred ECCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHH
Confidence 999999874210000 0011123567899999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 909 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 909 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
++ |.+||.+.+.......+..... +..+..++..+.+||.+||+.||.+||++.++.
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 272 (277)
T cd05062 215 ATLAEQPYQGMSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272 (277)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99 7999999888887777766543 234577899999999999999999999944333
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=342.54 Aligned_cols=263 Identities=34% Similarity=0.568 Sum_probs=223.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..+.|++.+.||.|+||.||+|.+..++..|++|++. .... ....+.+|+.++..++||||+++++.+......|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~-~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEe-cCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 3456888999999999999999999889999999543 2211 4567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~--- 168 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK--- 168 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc---
Confidence 9999999999999998876 899999999999999999999999999999999999999999999999998763210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...++...
T Consensus 169 ------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~ 224 (286)
T cd06614 169 ------------------------EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224 (286)
T ss_pred ------------------------chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00112234588999999999988899999999999999999999999998877766
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
...+..........+..++.++.+||.+||+.+|.+||+ +.+++.||||+...|..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 225 LFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCchH
Confidence 666654433221122348899999999999999999999 88999999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=378.48 Aligned_cols=253 Identities=32% Similarity=0.530 Sum_probs=211.9
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-C-----CceEEEeeeeccCC
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-N-----PFVVRFFYSFTCRD 761 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-H-----PNIVkL~gsfqd~~ 761 (1093)
.|+++++||+|+||.|.+|.+..|++.||||+| +.. ..-......|+.||..++ | -|+|+++++|...+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIi-KN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKII-KNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEee-ccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 899999999999999999999999999999944 432 223455678999999887 3 49999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC--cEEEEecCCccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKI 837 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG--~VKLsDFGLAk~ 837 (1093)
++|||+|++.. +|+++|+... .|+...++.++.||+.||.+||++||||+||||+||||..-+ .|||+|||.|+.
T Consensus 262 HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999999966 9999998654 589999999999999999999999999999999999997644 799999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
. ....++.+-+..|+|||+|+|.+|+.+.||||||||++||++|.|-|.+
T Consensus 341 ~------------------------------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 E------------------------------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred c------------------------------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 2 1223466778999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhcc--------------------C-C-------------------------------CCC-C-------C
Q 001354 918 ESPEIIFDNILNR--------------------K-I-------------------------------PWP-C-------V 937 (1093)
Q Consensus 918 ~s~~ei~~kIl~~--------------------~-l-------------------------------~fP-~-------i 937 (1093)
.+..+.+..|+.- . . ..| . .
T Consensus 391 ~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~ 470 (586)
T KOG0667|consen 391 DNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGL 470 (586)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhc
Confidence 9987777766430 0 0 001 0 0
Q ss_pred CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 938 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 938 p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
+..-...+.|||.+||..||.+|+| +.+.|+||||.+..
T Consensus 471 ~~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 471 PKADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTGTS 509 (586)
T ss_pred ccccHHHHHHHHHHHhccCchhcCC---HHHHhcCccccccc
Confidence 0011235789999999999999999 77899999998653
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=337.06 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=206.8
Q ss_pred eeeccCCeEEEEEEE--CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 694 PISRGAFGRVFLARK--RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 694 ~LGkG~FGeVylar~--k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
.||+|+||.||+|.+ +.++..+|+|+ ++. ........+.+.+|+.++..++||||+++++++.. +..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~-~~~-~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKI-LKN-DNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEE-ccC-CCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 589999999999965 45688999994 432 22233456788999999999999999999998764 56799999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
+|+|.+++.+...+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~--------- 149 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE--------- 149 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCC---------
Confidence 99999999887889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhcc
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 930 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~ 930 (1093)
..........+++.|+|||++.+..++.++|+|||||++|||++ |.+||...+..++...+..+
T Consensus 150 ---------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~ 214 (257)
T cd05116 150 ---------------NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214 (257)
T ss_pred ---------------CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence 00001122345689999999988889999999999999999998 99999988888877777654
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 931 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 931 ~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
.. +..+..+++++++||.+||+.||.+||++..+.+.|+.
T Consensus 215 ~~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 215 ER--MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 32 33457899999999999999999999997766665543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=340.48 Aligned_cols=256 Identities=29% Similarity=0.554 Sum_probs=214.5
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCceE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~---HPNIVkL~gsfqd~~~Ly 764 (1093)
.|++++.||.|+||.||+|.+..+++.||+|.+ +.. ........+.+|+.+++.+. ||||+++++++......|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~-~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKII-NLD--TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEe-cCC--CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 578889999999999999999999999999944 221 12344567889999999986 999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
+||||++|++|.+++.. +.+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--- 154 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--- 154 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC---
Confidence 99999999999999865 47899999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+......
T Consensus 155 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~ 210 (277)
T cd06917 155 ------------------------SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210 (277)
T ss_pred ------------------------ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 011233568999999999875 4578999999999999999999999988776655
Q ss_pred HHHHhccCCCCCCCCC-CCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~-~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
...+... ..|.++. .++.++.+||.+||..||.+||+ +.+++.||||+...
T Consensus 211 ~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~ 262 (277)
T cd06917 211 MMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHS 262 (277)
T ss_pred hhccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccc
Confidence 5444332 2233333 38899999999999999999999 88999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.62 Aligned_cols=255 Identities=31% Similarity=0.547 Sum_probs=215.9
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|+....||.|+||.||++....++..||+|.+ .... ......+.+|+.++..++||||+++++.|...+..|+|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~-~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMM-DLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEE-Eecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 44455799999999999999999999999954 2211 2234568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCC
Q 001354 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~ 848 (1093)
|+++++|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~-------- 169 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 169 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc--------
Confidence 9999999997754 5689999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001354 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 928 (1093)
Q Consensus 849 ~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 928 (1093)
........+|++.|+|||++.+..++.++|+|||||++|||++|++||...++.+....+.
T Consensus 170 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 170 -------------------DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred -------------------ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0011234578999999999999899999999999999999999999999888777666665
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 929 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 929 ~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.........+..++..+.++|.+||+.+|.+||+ +.++++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~~ 277 (297)
T cd06659 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQT 277 (297)
T ss_pred ccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhccC
Confidence 4433333334578899999999999999999999 8899999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=349.05 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=205.1
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcE----EEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~----VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
+...+|++.+.||+|+||.||+|++..++.. ||+|.+ +.. ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEec-ccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 4567899999999999999999998776664 788843 221 123345678899999999999999999999876
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
. ..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5 578999999999999999874 46889999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.... .........+++.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 160 ~~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCC-------------------------cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1100 0001122345778999999999999999999999999999997 9999998
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~ 965 (1093)
....++.. ++.....+| .+...+.++.++|.+||..||.+||++.+
T Consensus 215 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~ 260 (316)
T cd05108 215 IPASEISS-ILEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRE 260 (316)
T ss_pred CCHHHHHH-HHhCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 87666544 334433333 34678899999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.83 Aligned_cols=251 Identities=31% Similarity=0.501 Sum_probs=203.8
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC--CceEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--DNLYL 765 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~--~~LyL 765 (1093)
|++.+.||.|+||.||+|..+.++..||+|++.+... . .......+|+.++.++. ||||+++++++.+. +.+|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 6789999999999999999999999999995432211 1 12234457888888885 99999999999988 88999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+++ +|.+.+... ..+++..++.++.||+.||.|||+.|++||||||+||+++. +.+||+|||+++....
T Consensus 78 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---- 151 (282)
T cd07831 78 VFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---- 151 (282)
T ss_pred EEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc----
Confidence 9999975 888887753 56899999999999999999999999999999999999999 9999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........+|+.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.
T Consensus 152 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 152 ------------------------KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred ------------------------CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 001122467899999998754 5578899999999999999999999998877665
Q ss_pred HHHHhcc------------------CCCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 924 FDNILNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 924 ~~kIl~~------------------~l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...+... ...+|. ....++.++.+||.+||.+||.+||+ +.+++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~~~~ 282 (282)
T cd07831 208 IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT---AKQALRHPYF 282 (282)
T ss_pred HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC---HHHHhhCCCC
Confidence 5544321 111111 12357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.44 Aligned_cols=264 Identities=26% Similarity=0.438 Sum_probs=211.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~Ly 764 (1093)
.++|+..+.||+|+||.||++.+..++..||+|.+... .. ......+.+|+.++.++. ||||+++++++..+...|
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~-~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST-VD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhc-cC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 45788889999999999999999999999999955322 11 244567889999999996 999999999999999999
Q ss_pred EEEEecCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 765 LVMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~-----k~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
++|||+.+ +|.++.. ....+++..+..++.+++.||+|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99999864 6555432 235699999999999999999999975 9999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CCCccceeecchhhHHHHHhCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|++||
T Consensus 159 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 210 (288)
T cd06616 159 VD----------------------------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210 (288)
T ss_pred cc----------------------------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCc
Confidence 10 0111234689999999999876 6899999999999999999999999
Q ss_pred CCCCh-HHHHHHHhccCC-CCC-CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 916 TAESP-EIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 916 ~~~s~-~ei~~kIl~~~l-~fP-~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
..... .+....+..... .++ ..+..++.++.+||.+||..||.+||+ +.+|+.||||+...|....
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~~~~~~~ 279 (288)
T cd06616 211 PKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDYEERNVD 279 (288)
T ss_pred hhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhchhhcchh
Confidence 76542 222233322221 111 112358899999999999999999999 7899999999987766543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=341.03 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=210.3
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCC----------------cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTG----------------DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TG----------------k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP 748 (1093)
..++|++++.||+|+||.||+|....++ ..||+|.+... . .......+.+|+.+|..++||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-~--~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-A--SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc-c--CHHHHHHHHHHHHHHHhcCCC
Confidence 4578999999999999999999877644 45799954322 1 224567889999999999999
Q ss_pred ceEEEeeeeccCCceEEEEEecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCC
Q 001354 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817 (1093)
Q Consensus 749 NIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g-----------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPe 817 (1093)
||+++++++...+.+++||||+++++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999999999999998765 6899999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
|||++.++.++|+|||+++...... .........+|+.|||||++.+..++.++|
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 214 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSD-------------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214 (296)
T ss_pred ceeecCCCceEEccccceeecccCc-------------------------ceeecCcCCCCceecCHHHhhcCCCCccch
Confidence 9999999999999999987421000 001123456788999999999888999999
Q ss_pred eecchhhHHHHHh--CCCCCCCCChHHHHHHHhcc-----CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 898 WWSVGIILFEFIT--GIPPFTAESPEIIFDNILNR-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 898 VWSLGVILYEMLT--GkpPF~~~s~~ei~~kIl~~-----~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
||||||++|||++ |..||...+...+...+... .......+..++.++.+||.+||+.||.+||++.++.+.
T Consensus 215 v~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 215 VWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred hhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence 9999999999998 78999887777766665432 111112345678999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.31 Aligned_cols=263 Identities=29% Similarity=0.452 Sum_probs=212.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCc
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDN 762 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd----~~~ 762 (1093)
++|++.+.||.|+||.||+|..+.+|..||+|.+.... ........+.+|+.+|..++||||++++++|.. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 68999999999999999999999999999999553221 222345677889999999999999999988764 346
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||||+. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999996 5999999877789999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
. .........+|+..|+|||++.+ ..++.++|+|||||++|||++|++||.+.+..
T Consensus 162 ~-----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 218 (334)
T cd07855 162 T-----------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218 (334)
T ss_pred c-----------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH
Confidence 0 01112234578999999999876 56899999999999999999999999887654
Q ss_pred HHHHHHhcc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 922 IIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 922 ei~~kIl~~----------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
.....+... ..++..+...++.++.+||.+||+.||.+||+ +.+++.||
T Consensus 219 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~ 295 (334)
T cd07855 219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQHP 295 (334)
T ss_pred HHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC---HHHHHhCh
Confidence 433322210 00111112457899999999999999999999 78999999
Q ss_pred CCCCC
Q 001354 974 FFKGV 978 (1093)
Q Consensus 974 FFkgI 978 (1093)
||++.
T Consensus 296 ~~~~~ 300 (334)
T cd07855 296 FLAQY 300 (334)
T ss_pred hhhhc
Confidence 99853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=329.79 Aligned_cols=247 Identities=29% Similarity=0.430 Sum_probs=210.3
Q ss_pred EeeeccCCeEEEEEEECCC---CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEe
Q 001354 693 KPISRGAFGRVFLARKRTT---GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~T---Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
+.||+|+||.||+|.+... +..||+|.+ +.... ......+.+|+.++..++||||+++++++.+...+|+||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~-~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEee-ccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 4699999999999999866 889999944 33222 12567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 770 LNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 770 m~GGSL~dlL~k~---------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999999875 6799999999999999999999999999999999999999999999999999875321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
.. .........+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+
T Consensus 158 ~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 158 DD-------------------------YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred cc-------------------------ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 00 0112234567899999999998899999999999999999999 699999998
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
..+....+..... +..+..++.++.++|.+||+.||.+||+ +.+++++
T Consensus 213 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~l~~~ 260 (262)
T cd00192 213 NEEVLEYLRKGYR--LPKPEYCPDELYELMLSCWQLDPEDRPT---FSELVER 260 (262)
T ss_pred HHHHHHHHHcCCC--CCCCccCChHHHHHHHHHccCCcccCcC---HHHHHHh
Confidence 8888888775322 2345778999999999999999999999 5565543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.11 Aligned_cols=250 Identities=38% Similarity=0.643 Sum_probs=213.7
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||++.+..++..+++|++. ... ......+.+|+.++..++||+|+++++.+......|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~-~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-LES---KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEec-ccc---hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 5889999999999999999999899999999442 221 135678899999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 768 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
||++|++|.+++... ..+++..+..++.|++.||.|||..|++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~------ 150 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------ 150 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccc------
Confidence 999999999999876 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........|+..|+|||.+.+..++.++|+||||++||+|++|..||...+.......
T Consensus 151 ----------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 151 ----------------------TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred ----------------------cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 0002345789999999999988899999999999999999999999988765554444
Q ss_pred HhccCCCCCCCCC--CCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCC
Q 001354 927 ILNRKIPWPCVPS--DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974 (1093)
Q Consensus 927 Il~~~l~fP~ip~--~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPF 974 (1093)
+..... +..+. .++..+.++|.+||..||.+||+ +.+++.|||
T Consensus 209 ~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 209 IATNGP--PGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred HHhcCC--CCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 433222 22222 34899999999999999999999 889999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=347.49 Aligned_cols=258 Identities=34% Similarity=0.556 Sum_probs=216.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||.|+||.||++....++..||+|.+ .. ......+.+.+|+.+++.++||||+++++.|...+..|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~-~~---~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NL---QQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEe-cc---ccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 47899999999999999999999989999999954 22 122345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||+++|+|..++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~----- 167 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----- 167 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc-----
Confidence 99999999999998753 578999999999999999999999999999999999999999999999998863210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|++||...+......
T Consensus 168 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~ 225 (293)
T cd06647 168 ----------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (293)
T ss_pred ----------------------cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence 0011223568999999999998889999999999999999999999998876654433
Q ss_pred HHhcc-CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 926 NILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 926 kIl~~-~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.+... ...++ .+..++..+.+||.+||..+|.+||+ +.+++.||||+...
T Consensus 226 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~~ 276 (293)
T cd06647 226 LIATNGTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIAK 276 (293)
T ss_pred ehhcCCCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcCc
Confidence 33222 22222 23567889999999999999999999 78999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=330.32 Aligned_cols=252 Identities=30% Similarity=0.528 Sum_probs=219.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|++.+.||.|+||.||+++++.++..||+|.+ ..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~-~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEE-ehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 589999999999999999999999999999954 33222 3345667889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 768 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 768 EYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||+++++|..++.+ ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~--- 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK--- 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc---
Confidence 99999999999876 35689999999999999999999999999999999999999999999999999875210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.......|++.|+|||.+.+..++.++|+||||+++|||++|+.||...+..+.
T Consensus 156 --------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08530 156 --------------------------NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL 209 (256)
T ss_pred --------------------------CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011234688999999999999999999999999999999999999999888777
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...+.... ++.++..++.++.++|.+||..+|.+||+ +.++++||+.
T Consensus 210 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 210 RYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred HHHHhcCC--CCCCchhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 77765544 34455688999999999999999999999 8899999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.88 Aligned_cols=254 Identities=31% Similarity=0.535 Sum_probs=209.2
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|++.+.||.|++|.||+|.++.+|..||+|++... .........+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE--TEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecc--cccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 67889999999999999999999999999955322 2223344678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 769 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
|++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~------ 151 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV------ 151 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC------
Confidence 995 69999997765 689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
.........+++.|+|||++.+. .++.++|+||||+++|+|++|++||...+......
T Consensus 152 ---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 210 (283)
T cd07835 152 ---------------------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210 (283)
T ss_pred ---------------------CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 00111233578999999988764 57889999999999999999999998877655444
Q ss_pred HHhccCC------------------CC--------CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 926 NILNRKI------------------PW--------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 926 kIl~~~l------------------~f--------P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+..... .+ ......++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~ 283 (283)
T cd07835 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---AKAALQHPYF 283 (283)
T ss_pred HHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---HHHHhcCCCC
Confidence 4322100 00 1123567889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=346.05 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=213.2
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|++.+.||+|+||+||+|.+..+|..||+|++. ............+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~-~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEe-ccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45889999999999999999999999999999543 32333344556789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||+.| +|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------ 166 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------ 166 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC------
Confidence 999975 77777654 4568999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......|++.|+|||++. ...++.++||||||+++|||++|.+||.+.+...
T Consensus 167 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~ 221 (307)
T cd06607 167 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (307)
T ss_pred -------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence 112346889999999985 3568889999999999999999999999887766
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
....+.....+ ...+..++..+.+||.+||..||.+||+ +.+|+.||||..
T Consensus 222 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 272 (307)
T cd06607 222 ALYHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLR 272 (307)
T ss_pred HHHHHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcc
Confidence 55555443221 1113457889999999999999999999 889999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=378.85 Aligned_cols=269 Identities=23% Similarity=0.333 Sum_probs=202.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcE-EEEE-------------EeehhhhhhchhHHHHHHHHHHHHHhcCCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDL-FAIK-------------QVLKKLDMIRKNDIERILAERNILITVRNPFV 750 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~-VAIK-------------kILkK~~~~~~~eie~~l~E~~IL~kL~HPNI 750 (1093)
..++|++++.||+|+||+||+|..+..... .+.| .++.+...........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 457899999999999999999986543221 1111 01111111222345668899999999999999
Q ss_pred EEEeeeeccCCceEEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC
Q 001354 751 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 825 (1093)
Q Consensus 751 VkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~-----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG 825 (1093)
|++++++...+..|+||+++. ++|..++... .......++.++.||+.||.|||++|||||||||+||||+.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 4888777542 2244667888999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhH
Q 001354 826 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 905 (1093)
Q Consensus 826 ~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVIL 905 (1093)
.+||+|||+++.... .........+||+.|+|||++.+..|+.++|||||||+|
T Consensus 305 ~vkL~DFGla~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 358 (501)
T PHA03210 305 KIVLGDFGTAMPFEK--------------------------EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358 (501)
T ss_pred CEEEEeCCCceecCc--------------------------ccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHH
Confidence 999999999974210 001122346899999999999999999999999999999
Q ss_pred HHHHhCCCC-CCCC--ChHHHHHHHhcc----CCCCCC-------------------------CCCCCCHHHHHHHHhhc
Q 001354 906 FEFITGIPP-FTAE--SPEIIFDNILNR----KIPWPC-------------------------VPSDMSFEAQDLINRFL 953 (1093)
Q Consensus 906 YEMLTGkpP-F~~~--s~~ei~~kIl~~----~l~fP~-------------------------ip~~IS~eakDLIkrcL 953 (1093)
|||++|..| |... .+...+..++.. ...+|. ....++.++.++|.+||
T Consensus 359 ~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL 438 (501)
T PHA03210 359 LDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKML 438 (501)
T ss_pred HHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHh
Confidence 999998754 4332 222222222210 001110 01245678889999999
Q ss_pred cCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 954 IHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 954 ~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
+.||.+||+ +.|++.||||.....+.+
T Consensus 439 ~~DP~~Rps---a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 439 TFDWHLRPG---AAELLALPLFSAEEEEEI 465 (501)
T ss_pred ccCcccCcC---HHHHhhChhhhcCCchHH
Confidence 999999999 889999999998776654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=340.91 Aligned_cols=256 Identities=29% Similarity=0.499 Sum_probs=203.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|.+.+.||+|+||.||+|..+.+|..||+|.+..+ . .......+.+|+.+|+.++|+||+++++++......|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~-~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMK-T--EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEeccc-C--cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 47899999999999999999999999999999955322 1 12223456789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---- 155 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI---- 155 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC----
Confidence 999996 577776654 35688889999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChH-H
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-I 922 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~-e 922 (1093)
.........+++.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+.. +
T Consensus 156 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~ 212 (291)
T cd07870 156 -----------------------PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212 (291)
T ss_pred -----------------------CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH
Confidence 0011223467899999999876 45888999999999999999999999865432 2
Q ss_pred HHHHHhcc-CCC------------------CCC--------C--CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 923 IFDNILNR-KIP------------------WPC--------V--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 923 i~~kIl~~-~l~------------------fP~--------i--p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
....+... ..+ ++. + ....+.++.+||.+||..||.+||+ +.+++.||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t---~~~~l~h~ 289 (291)
T cd07870 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS---AQDALLHP 289 (291)
T ss_pred HHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC---HHHHhcCC
Confidence 22221110 000 000 0 0123678999999999999999999 88999999
Q ss_pred CC
Q 001354 974 FF 975 (1093)
Q Consensus 974 FF 975 (1093)
||
T Consensus 290 ~~ 291 (291)
T cd07870 290 YF 291 (291)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.33 Aligned_cols=258 Identities=31% Similarity=0.487 Sum_probs=211.4
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CceE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 764 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~Ly 764 (1093)
++|+..+.||.|++|.||+|.+..++..+|+|.+. ... .......+.+|+++++.++||||++++++|.+. ..+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~-~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEe-cCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 47999999999999999999999999999999543 221 123456788999999999999999999988654 3689
Q ss_pred EEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 765 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999999988753 34589999999999999999999999999999999999999999999999999864210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC--
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-- 918 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~-- 918 (1093)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 158 -----------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (287)
T cd06621 158 -----------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208 (287)
T ss_pred -----------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence 0111345788999999999999999999999999999999999999865
Q ss_pred ---ChHHHHHHHhccCC-CCCCCC---CCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 919 ---SPEIIFDNILNRKI-PWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 919 ---s~~ei~~kIl~~~l-~fP~ip---~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.+.+....+..... .++..+ ..+++.+.+||.+||..||.+||+ +.|++.||||+...
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~~ 273 (287)
T cd06621 209 PPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKAQM 273 (287)
T ss_pred CCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCccccccc
Confidence 23444444443221 111111 235678999999999999999999 78999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.34 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=213.0
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCC-----cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TG-----k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
..+.+..++|++.+.||+|+||.||++.++..+ ..+|+|.+. .. ........+.+|+.++..+ +||||+++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~-~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DD--ATEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEcc-CC--CCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 345677789999999999999999999987543 689999443 21 1233456788999999999 79999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCC
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPe 817 (1093)
++++.....+|+||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 99999999999999999999999999642 35888999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
|||++.++.+||+|||+++...... .........+++.|+|||++.+..++.++|
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 216 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHID-------------------------YYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216 (293)
T ss_pred eEEEcCCCeEEeCcccccccccccc-------------------------ceeccCCCCCCccccCHHHhccCCcCcccc
Confidence 9999999999999999997421000 000111223567899999999999999999
Q ss_pred eecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 898 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 898 VWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
||||||++|||++ |..||.+.+..+.+..+..... +..+...+.++.+||.+||..||.+||+ +.++++
T Consensus 217 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~eil~ 286 (293)
T cd05053 217 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPT---FKQLVE 286 (293)
T ss_pred eeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcC---HHHHHH
Confidence 9999999999997 9999999888887777655432 2235678899999999999999999999 445543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=352.89 Aligned_cols=256 Identities=31% Similarity=0.495 Sum_probs=211.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
.++|++++.||+|+||.||++....+|..||+|++.+. .........+.+|+.+|+.++||||++++++|....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 56799999999999999999999999999999955322 122333456889999999999999999999988764
Q ss_pred --ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 --~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..|+||||+ |++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 358999999 7799888764 569999999999999999999999999999999999999999999999999987321
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.......|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 170 ------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01123467899999999876 45889999999999999999999999987
Q ss_pred ChHHHHHHHhccCCC----------------------------CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~----------------------------fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+....+..++..... +..+...+++.+.+||.+||+.||.+||+ +.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t---~~~~l 296 (343)
T cd07880 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT---AAEAL 296 (343)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 765555544331111 01122467889999999999999999999 78999
Q ss_pred cCCCCCCC
Q 001354 971 AHPFFKGV 978 (1093)
Q Consensus 971 ~HPFFkgI 978 (1093)
.||||+..
T Consensus 297 ~~~~~~~~ 304 (343)
T cd07880 297 AHPYFEEF 304 (343)
T ss_pred cCccHhhh
Confidence 99999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=346.12 Aligned_cols=258 Identities=31% Similarity=0.528 Sum_probs=217.5
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|+..+.||.|+||.||+|.+..++..||+|.+ +... .......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~-~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEe-cccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 466778899999999999999999999999944 3221 2234567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||+++|+|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~------- 153 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD------- 153 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC-------
Confidence 99999999998864 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kI 927 (1093)
.........|+..|+|||++.+..++.++|+|||||++|||++|.+||....+......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 154 --------------------TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred --------------------cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 001112346889999999999989999999999999999999999999877766655544
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 928 l~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
.... .+.++..++.++.+||.+||..+|.+||+ +.+++.||||....+.
T Consensus 214 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 262 (277)
T cd06642 214 PKNS--PPTLEGQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYTKK 262 (277)
T ss_pred hcCC--CCCCCcccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHhhh
Confidence 3332 23344678899999999999999999999 8899999999765443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.92 Aligned_cols=253 Identities=34% Similarity=0.542 Sum_probs=208.0
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccCCc---
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDN--- 762 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL---~HPNIVkL~gsfqd~~~--- 762 (1093)
|++.+.||.|+||.||+|+++.++..||+|.+.... . .......+.+|+.++..+ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPL-S-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccc-c-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 688999999999999999999999999999553221 1 222334566788777666 59999999999998877
Q ss_pred --eEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 763 --LYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 763 --LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+|++|||+++ +|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++...
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999975 8999887643 5899999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.. ........+++.|+|||++.+..++.++|+|||||++|||++|.+||.+.
T Consensus 158 ~~----------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 158 SF----------------------------EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred cC----------------------------CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 10 01112345789999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHhcc-----CCCCC-----------C--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCC
Q 001354 919 SPEIIFDNILNR-----KIPWP-----------C--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974 (1093)
Q Consensus 919 s~~ei~~kIl~~-----~l~fP-----------~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPF 974 (1093)
+..+...++... ...++ . ....+++.+.+||.+||+.||.+||+ +.+++.|||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~il~~~~ 286 (287)
T cd07838 210 SEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS---AFEALQHPY 286 (287)
T ss_pred ChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC---HHHHhcCcC
Confidence 887777666531 01111 0 11245688899999999999999999 889999999
Q ss_pred C
Q 001354 975 F 975 (1093)
Q Consensus 975 F 975 (1093)
|
T Consensus 287 ~ 287 (287)
T cd07838 287 F 287 (287)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=338.94 Aligned_cols=255 Identities=31% Similarity=0.531 Sum_probs=217.9
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
-|++++.||.|+||.||+|.+..++..||+|.+ .... .......+.+|+.++..++||||+++++++.....+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~-~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEe-cccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 377889999999999999999999999999944 2221 1234567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||+++|+|..++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++.....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~------- 153 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD------- 153 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc-------
Confidence 99999999999865 4689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kI 927 (1093)
.........|+..|+|||.+.+..++.++|+|||||++|+|++|.+||....+......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (277)
T cd06641 154 --------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213 (277)
T ss_pred --------------------chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence 001122356899999999998888899999999999999999999999988777666665
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 928 l~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
..... +.++..++.++.++|.+||..+|.+||+ +.++++||||...
T Consensus 214 ~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~~ 259 (277)
T cd06641 214 PKNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVRF 259 (277)
T ss_pred hcCCC--CCCCcccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhhh
Confidence 44332 3445678999999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=335.41 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=204.7
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCc--EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGD--LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 760 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk--~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~------ 760 (1093)
|.+.+.||+|+||.||+|++..++. .+|+|.+ +. ........+.+.+|..+|..++||||+++++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~-~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KI-AICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEec-cc-CcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 3567899999999999999987775 5899943 22 223455677889999999999999999999876332
Q ss_pred CceEEEEEecCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 761 DNLYLVMEYLNGGDLYSLLRK------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k------~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
...++||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCc
Confidence 257999999999999988742 13488999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-Gkp 913 (1093)
++...... .........+++.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~ 213 (272)
T cd05075 159 SKKIYNGD-------------------------YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT 213 (272)
T ss_pred ccccCccc-------------------------ceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCC
Confidence 88521000 0001122346788999999999999999999999999999999 899
Q ss_pred CCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 914 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
||.+....++...+..+... ..+..++..+.++|.+||+.||.+||++.++.+.+
T Consensus 214 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 214 PYPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred CCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99988888887777665432 23467889999999999999999999955554443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=377.40 Aligned_cols=250 Identities=33% Similarity=0.512 Sum_probs=214.5
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCC
Q 001354 694 PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 773 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GG 773 (1093)
+||+|+||+||.|+++.|...+|||.|-.+ .....+-+.+|+.+.+.++|.|||+++|++...+.+-|.||-+|||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 799999999999999999999999966433 3355678899999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEecCCcccccccccccCCCC
Q 001354 774 DLYSLLRK-VGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGP 849 (1093)
Q Consensus 774 SL~dlL~k-~g~L--sEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~~~~~~s~dls~~ 849 (1093)
+|.++|+. .|++ .|..+-+|.+||+.||.|||.+.|||||||-+|+||+. .|.+||+|||-++....
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--------- 728 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--------- 728 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc---------
Confidence 99999985 4677 88899999999999999999999999999999999975 79999999999985310
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCCCCCh-HHHHHH
Q 001354 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 926 (1093)
Q Consensus 850 ~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~-~ei~~k 926 (1093)
-+..+.++.||..|||||++-. .+|+.++|||||||++.||.||+|||..... +..+-+
T Consensus 729 ------------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 729 ------------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred ------------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 1234567899999999999975 5799999999999999999999999986543 322222
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+---+ .-|.+|..+|.+++.||.+|+..||.+||+ |.++|..||++.-
T Consensus 791 VGmyK-vHP~iPeelsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 VGMYK-VHPPIPEELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHN 838 (1226)
T ss_pred hccee-cCCCCcHHHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccC
Confidence 21111 236677899999999999999999999999 8899999999753
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=353.09 Aligned_cols=260 Identities=30% Similarity=0.475 Sum_probs=212.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
.+.|.+++.||+|+||+||+|++..++..||+|.+... .........+.+|+.+|..++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA--FDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccc--ccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 35799999999999999999999999999999955322 122334566788999999999999999998886543
Q ss_pred -ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 -~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 4899999996 69999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.........||..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+
T Consensus 161 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 161 ---------------------------KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred ---------------------------CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 0011234568999999999875 468999999999999999999999998765
Q ss_pred hHHHHHHHhcc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~----------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.......+... ...+......+++++.+||.+||+.||.+||+ +.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps---~~ell~ 290 (337)
T cd07858 214 YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT---VEEALA 290 (337)
T ss_pred hHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC---HHHHHc
Confidence 44333322210 00011122468899999999999999999999 889999
Q ss_pred CCCCCCC
Q 001354 972 HPFFKGV 978 (1093)
Q Consensus 972 HPFFkgI 978 (1093)
||||+.+
T Consensus 291 h~~~~~~ 297 (337)
T cd07858 291 HPYLASL 297 (337)
T ss_pred Ccchhhh
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=332.33 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=204.2
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
+.||+|+||.||+|+++.++..||+|.+... ........+.+|+.+|+.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 3699999999999999999999999954321 2234456789999999999999999999999999999999999999
Q ss_pred CChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 773 GDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 773 GSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
|+|.+++.+.+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~--------- 147 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED-G--------- 147 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc-c---------
Confidence 99999997644 589999999999999999999999999999999999999999999999999874210 0
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhcc
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 930 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~ 930 (1093)
.. ........++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+.......+...
T Consensus 148 --~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~ 212 (252)
T cd05084 148 --VY-------------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212 (252)
T ss_pred --cc-------------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 00 000011123567999999998889999999999999999998 99999888777666665543
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 931 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 931 ~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
. .. ..+..++..+.+||.+||+.||.+||++.++.+.|
T Consensus 213 ~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 213 V-RL-PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred C-CC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2 21 23467899999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=343.10 Aligned_cols=259 Identities=28% Similarity=0.475 Sum_probs=204.6
Q ss_pred CeeEEEeeeccCCeEEEEEEECC--CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cce
Q 001354 688 DFEIIKPISRGAFGRVFLARKRT--TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 763 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~--TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~L 763 (1093)
.|++.+.||+|+||.||+|.++. ++..||+|.+. ............+.+|+.++..++||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEec-cccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 89999999553 32212233346678899999999999999999999998 789
Q ss_pred EEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc----CCcEEEEecCC
Q 001354 764 YLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGL 834 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~-----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~----dG~VKLsDFGL 834 (1093)
|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +|.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999975 777776432 36899999999999999999999999999999999999999 99999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
++...... .........+||+.|+|||++.+ ..++.++|+|||||+||+|++|++
T Consensus 159 ~~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 214 (316)
T cd07842 159 ARLFNAPL------------------------KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214 (316)
T ss_pred ccccCCCc------------------------ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCC
Confidence 87531100 00112234578999999999876 458999999999999999999999
Q ss_pred CCCCCChHH---------HHHHHhc--------------------------cCCCCCC------C--CCCCCHHHHHHHH
Q 001354 914 PFTAESPEI---------IFDNILN--------------------------RKIPWPC------V--PSDMSFEAQDLIN 950 (1093)
Q Consensus 914 PF~~~s~~e---------i~~kIl~--------------------------~~l~fP~------i--p~~IS~eakDLIk 950 (1093)
||.+..... ....++. ....++. . ....+.++.++|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 294 (316)
T cd07842 215 IFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294 (316)
T ss_pred CCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHH
Confidence 998654321 1111100 0011110 0 0156788999999
Q ss_pred hhccCCcCCCCChhcHHHHHcCCCC
Q 001354 951 RFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 951 rcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
+||..||.+||+ +.+++.||||
T Consensus 295 ~~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 295 KLLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred HHhcCCcccCcC---HHHHhcCCCC
Confidence 999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.57 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=212.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCC---CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~T---Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
..++|++.+.||+|+||.||+|.++.+ ...+|+|.+ +.. ........+.+|+.++..++||||+++++.+....
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~-~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAG--SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEc-CCC--CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 357899999999999999999998754 457999944 322 12334567889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999999999764 4689999999999999999999999999999999999999999999999999985310
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. ..........+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 159 ~-------------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 159 S-------------------------EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred c-------------------------ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 0 00001112345788999999998899999999999999999998 999998888
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
..+....+..... .| .+...+..+.+||.+||+.+|.+||++.++.+.+
T Consensus 214 ~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 214 NQDVIKAVEDGYR-LP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred HHHHHHHHHcCCC-CC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 7777777765422 22 2467899999999999999999999965555444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.76 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=210.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+ .. .........+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~-~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PE--SCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEc-CC--CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 445789999999999999999999987 7788999944 22 122333467899999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---cEE
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIK 828 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g-------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG---~VK 828 (1093)
.....|+||||++||+|.+++.... .+++..+..++.||+.||.|||+++++||||||+|||++.++ .+|
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 9999999999999999999997653 488899999999999999999999999999999999998765 599
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHH
Q 001354 829 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 908 (1093)
Q Consensus 829 LsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEM 908 (1093)
|+|||+++...... .........+++.|+|||++.+..++.++|||||||++|||
T Consensus 160 l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (277)
T cd05036 160 IADFGMARDIYRAS-------------------------YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214 (277)
T ss_pred eccCccccccCCcc-------------------------ceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHH
Confidence 99999987421000 00011122345789999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 909 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 909 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
++ |..||.+.+..+....+..... +..+..++..+.+||.+||+.||.+||+ +.++++|
T Consensus 215 ~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps---~~~vl~~ 274 (277)
T cd05036 215 FSLGYMPYPGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRPN---FATILER 274 (277)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 97 9999999888777766654322 2235778999999999999999999999 5566654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=340.48 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=211.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCC-----CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~T-----Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
+...+|++.+.||+|+||.||+|.+..+ +..||+|.+ +.. ........+.+|..++..++||||+++++++.
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDK--AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEc-cCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3456788999999999999999987643 578999954 221 12234567889999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 822 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD 822 (1093)
....+++++||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 999999999999999999998532 2478888999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecch
Q 001354 823 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902 (1093)
Q Consensus 823 ~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLG 902 (1093)
.++.+||+|||+++...... .........+++.|+|||++.+..++.++||||||
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05091 159 DKLNVKISDLGLFREVYAAD-------------------------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213 (283)
T ss_pred CCCceEecccccccccccch-------------------------heeeccCccCCccccCHHHHhcCCCCcchhHHHHH
Confidence 99999999999987421100 00112234567899999999988899999999999
Q ss_pred hhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 903 IILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 903 VILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
|++|||++ |.+||.+....+....+...... ..+..++.++.+||.+||+.+|.+||++.++..
T Consensus 214 ~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 214 VVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99999998 99999999888888888776543 235789999999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.84 Aligned_cols=262 Identities=31% Similarity=0.477 Sum_probs=218.9
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----c
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 762 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~-----~ 762 (1093)
+|++.+.||.|+||.||+|++..++..||+|++.... ........+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 4889999999999999999999999999999553321 12345577899999999999999999999998876 7
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||||+++ +|..++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999999984 899999887789999999999999999999999999999999999999999999999999988521100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
..........||+.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..
T Consensus 158 ------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~ 213 (330)
T cd07834 158 ------------------------DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213 (330)
T ss_pred ------------------------cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 000122345689999999999887 8899999999999999999999999998877
Q ss_pred HHHHHHhccCCC----------------------------CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 922 IIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 922 ei~~kIl~~~l~----------------------------fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
+.+..+...... +......++.++.+||.+||+.||.+||+ +.+++.||
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~~ 290 (330)
T cd07834 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT---ADEALAHP 290 (330)
T ss_pred HHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCc
Confidence 776666542111 01112347889999999999999999999 88999999
Q ss_pred CCCCCC
Q 001354 974 FFKGVN 979 (1093)
Q Consensus 974 FFkgId 979 (1093)
||+++.
T Consensus 291 ~~~~~~ 296 (330)
T cd07834 291 YLAQLH 296 (330)
T ss_pred cHHhhc
Confidence 998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.19 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=214.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
...+|++++.||.|+||.||+|.++. +..+|+|.+ .... ......+..|+.+|+.++||||+++++++.....+|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~-~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKIL-KSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEec-cccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 44679999999999999999999988 889999944 3322 223456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~-- 156 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-- 156 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC--
Confidence 999999999999999753 3589999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ 921 (1093)
.........+++.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 157 -------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 157 -------------------------DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred -------------------------ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 0001113346778999999998899999999999999999998 89999998888
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+++..+... ...+ .+..+++.+.++|.+||+.||.+||++.++.+.|+
T Consensus 212 ~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 212 EVYDQITAG-YRMP-CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred HHHHHHHhC-CcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 888877654 2222 35788999999999999999999999766666553
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.97 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=206.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcE----EEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~----VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
+..++|++++.||.|+||+||+|++..+|.. ||+|.+ +.. ........+.+|+.++..++||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~-~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL-REN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEe-cCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 4568999999999999999999998877764 788844 221 223345678899999999999999999999875
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
. ..+++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 S-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred C-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4 578999999999999999764 56999999999999999999999999999999999999999999999999998753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
..... ........+++.|+|||.+.+..++.++|||||||++|||++ |.+||..
T Consensus 160 ~~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 160 DIDET-------------------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ccccc-------------------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 11000 001112345678999999999999999999999999999998 9999988
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
.....+...+.... ..+ .+...+.++.++|.+||..||.+||++.++
T Consensus 215 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l 261 (279)
T cd05109 215 IPAREIPDLLEKGE-RLP-QPPICTIDVYMIMVKCWMIDSECRPRFREL 261 (279)
T ss_pred CCHHHHHHHHHCCC-cCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 77766666554432 222 346789999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.86 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=211.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
+...+|.+.+.||+|+||.||+|... .++..+|+|.+ ++ ........+.+|+.++..++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~-~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KE---ASESARQDFQREAELLTVLQHQHIVRFYGVCT 77 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEec-Cc---CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence 34568899999999999999999753 34668899843 22 22345568899999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVG---------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g---------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~ 823 (1093)
.....|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 9999999999999999999997653 4788999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchh
Q 001354 824 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903 (1093)
Q Consensus 824 dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGV 903 (1093)
++.+||+|||++....... .........+++.|+|||++.+..++.++|||||||
T Consensus 158 ~~~~kL~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred CCCEEECCCCceeEcCCCc-------------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 9999999999987421000 001122345678999999999999999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 904 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 904 ILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
++|||++ |.+||...........+..... +..+..+++.+.+||.+||+.||.+||+++++.+.+
T Consensus 213 il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 213 VLWEIFTYGKQPWYQLSNTEAIECITQGRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred HHHHHHcCCCCCCccCCHHHHHHHHHcCcc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 9999998 9999998887777777665432 223467899999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=350.44 Aligned_cols=261 Identities=30% Similarity=0.503 Sum_probs=207.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 760 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~----- 760 (1093)
.++|++.+.||+|+||.||+|.+..+|..||+|++ ... ........+.+|+.+|..++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEe-ccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 36899999999999999999999999999999954 221 1223456688899999999999999999876544
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..+|+||||+.+ +|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 358999999975 88888754 5699999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 159 ~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 159 EH------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred cc------------------------cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 00 00112234578999999998765 568999999999999999999999998765
Q ss_pred hHHHHHHHhc---------------cC-------------CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILN---------------RK-------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~---------------~~-------------l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.......+.. .. .+++...+.++.++.+||.+||+.||.+||+ +.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~e~l~ 291 (336)
T cd07849 215 YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT---VEEALA 291 (336)
T ss_pred HHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC---HHHHhc
Confidence 4333222211 00 0000011356888999999999999999999 889999
Q ss_pred CCCCCCC
Q 001354 972 HPFFKGV 978 (1093)
Q Consensus 972 HPFFkgI 978 (1093)
||||+..
T Consensus 292 hp~~~~~ 298 (336)
T cd07849 292 HPYLEQY 298 (336)
T ss_pred Ccccccc
Confidence 9999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=351.74 Aligned_cols=257 Identities=31% Similarity=0.490 Sum_probs=209.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
.++|.+.+.||+|+||.||+|.++.+|..||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 368999999999999999999999999999999553321 12233456889999999999999999999887653
Q ss_pred --ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 --~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+|+||||+.. +|..++. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 46999999964 7776652 468999999999999999999999999999999999999999999999999987310
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 169 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 169 ------------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred ------------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01123467899999999876 46889999999999999999999999988
Q ss_pred ChHHHHHHHhccC-----------------------CCCC-----CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRK-----------------------IPWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~-----------------------l~fP-----~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+....+..+.... ..++ ...+..+.++.+||.+||+.||.+||+ +.+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~---~~e~l 295 (342)
T cd07879 219 DYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT---ATEAL 295 (342)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC---HHHHh
Confidence 7655554443310 0001 011356788999999999999999999 88999
Q ss_pred cCCCCCCCCc
Q 001354 971 AHPFFKGVNW 980 (1093)
Q Consensus 971 ~HPFFkgIdW 980 (1093)
.||||+.+.+
T Consensus 296 ~h~~f~~~~~ 305 (342)
T cd07879 296 EHPYFDSFRD 305 (342)
T ss_pred cCcchhhccc
Confidence 9999988754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.41 Aligned_cols=247 Identities=23% Similarity=0.395 Sum_probs=205.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
..+|++.+.||+|+||.||+|.++ ++..+|+|.+ .+... ....+.+|+.+++.++||||+++++++......|+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~-~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMI-REGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEe-ccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 457899999999999999999986 4678999954 32221 23467889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-- 154 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-- 154 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc--
Confidence 99999999999999764 468999999999999999999999999999999999999999999999999987421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei 923 (1093)
........++..|+|||.+.+..++.++|+|||||+||||++ |.+||...+..+.
T Consensus 155 ------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 155 ------------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred ------------------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 000111234568999999999999999999999999999999 8999998888777
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
...+.... . +..+...+.++.+||.+||+.+|++||++.++
T Consensus 211 ~~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~ 251 (256)
T cd05059 211 VESVSAGY-R-LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251 (256)
T ss_pred HHHHHcCC-c-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 77765432 2 22346789999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.65 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=211.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
...+|.+.+.||+|+||.||+|++.. ++..+++|.+ +. ........+.+|+.++..++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~-~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KD---PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEec-CC---ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 45689999999999999999998643 4556888843 22 222344678899999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~ 823 (1093)
...+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999997542 3788999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchh
Q 001354 824 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903 (1093)
Q Consensus 824 dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGV 903 (1093)
++.+||+|||+++..... ..........|++.|+|||++.+..++.++|+|||||
T Consensus 159 ~~~~~l~dfg~a~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 213 (291)
T cd05094 159 NLLVKIGDFGMSRDVYST-------------------------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 213 (291)
T ss_pred CCcEEECCCCcccccCCC-------------------------ceeecCCCCCcceeecChHHhccCCCCchhhHHHHHH
Confidence 999999999998742100 0001122356789999999999999999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 904 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 904 ILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
++|||++ |.+||...+..+....+..+... ..+...+..+.+||.+||+.||.+||++.++.+.++
T Consensus 214 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 214 ILWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 9999998 99999988888777776655432 334678899999999999999999999665555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.21 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=205.4
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCc--EEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCce
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk--~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~L 763 (1093)
++|++.+.||+|+||.||+|..+.++. .+++| .++. .......+.+.+|+.++.++ +||||+++++++.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik-~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEE-Eccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 689999999999999999999987765 46777 3322 12233456789999999999 699999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcE
Q 001354 764 YLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~V 827 (1093)
|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999997532 47889999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHH
Q 001354 828 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 828 KLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYE 907 (1093)
||+|||++..... ........++..|+|||++.+..++.++|||||||++||
T Consensus 159 kl~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e 210 (297)
T cd05089 159 KIADFGLSRGEEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210 (297)
T ss_pred EECCcCCCccccc----------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHH
Confidence 9999999863100 000111223567999999999899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 908 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 908 MLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
|++ |.+||......+....+.... . +..+..++.++.+||.+||..||.+||++.++
T Consensus 211 l~t~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 211 IVSLGGTPYCGMTCAELYEKLPQGY-R-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HHcCCCCCCCCCCHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 997 999999998888887776542 2 22346789999999999999999999995544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.07 Aligned_cols=269 Identities=31% Similarity=0.486 Sum_probs=209.7
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
.+++|++.+.||.|+||.||+|.++.++..+|+|++..+. ........+.+|+.+++.++||||+++++.+....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN--EKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEecc--CCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 3689999999999999999999999999999999654332 12222345678999999999999999998875433
Q ss_pred -----ceEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 762 -----NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 762 -----~LyLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
.+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 47999999975 77777764 347999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
......... .... ............||+.|+|||++.+ ..++.++|||||||++|||++|++|
T Consensus 163 ~~~~~~~~~-----------~~~~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 163 RPYDGPPPN-----------PKGG-----GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred hhccCCCcc-----------cccC-----CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence 743210000 0000 0001112244678999999998875 4588999999999999999999999
Q ss_pred CCCCChHHHHHHHhccCCC-----C------CC---------C-------CCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 915 FTAESPEIIFDNILNRKIP-----W------PC---------V-------PSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~~~l~-----f------P~---------i-------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
|.+.+.......+...... + |. . ...+++.+.+||.+||..||.+||+ +.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~ 303 (311)
T cd07866 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT---AS 303 (311)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC---HH
Confidence 9988876666555431000 0 00 0 0234578899999999999999999 88
Q ss_pred HHHcCCCC
Q 001354 968 EVKAHPFF 975 (1093)
Q Consensus 968 EIL~HPFF 975 (1093)
+++.||||
T Consensus 304 ell~~~~f 311 (311)
T cd07866 304 DALEHPYF 311 (311)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.37 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=211.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++.+.||+|+||.||+|.+.. +..||+|.+ +... .....+.+|+.+++.++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~-~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTL-KPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEee-CCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 456789999999999999999999754 578999954 3222 1245688999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999997654 6899999999999999999999999999999999999999999999999999853100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~ 920 (1093)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||.+.+.
T Consensus 157 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 157 --------------------------IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred --------------------------cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0001111233568999999999899999999999999999999 9999999888
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
..+...+.... ..+ .+..++..+.+||.+||+.||.+||+++++...|+
T Consensus 211 ~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 211 AEVLQQVDQGY-RMP-CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred HHHHHHHHcCC-CCC-CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 77777765442 222 34678899999999999999999999776666553
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.69 Aligned_cols=249 Identities=26% Similarity=0.424 Sum_probs=207.9
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee-ccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf-qd~~ 761 (1093)
.+...+|++.+.||+|+||.||++... |..+|+|.+ +. ......+.+|+.+++.++||+|+++++++ ....
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~-~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KN-----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEe-CC-----CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 356679999999999999999999875 788999944 22 12345788999999999999999999865 4556
Q ss_pred ceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+|+||||+++|+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence 7999999999999999997654 48899999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
. ......++..|+|||++.+..++.++|||||||++|||++ |++||...
T Consensus 154 ~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 154 S------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred c------------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 0 0112334678999999999899999999999999999997 99999988
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+..+....+..+. . +..+..+++.+.+||.+||..||.+||++.++.+.|+
T Consensus 204 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 204 PLKDVVPRVEKGY-K-MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred CHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 8777777665432 2 2345778999999999999999999999666655554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.05 Aligned_cols=255 Identities=18% Similarity=0.290 Sum_probs=204.8
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh-chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI-RKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~-~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
+..++|++++.||+|+||+||+|.+..++..+++|+.++..... .......+..|..++..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 45578999999999999999999998888764444333232211 22334667788889999999999999998754 56
Q ss_pred eEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.++||||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 78999999999999999764 56899999999999999999999999999999999999999999999999998743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~ 920 (1093)
. .........|+..|+|||++.+..++.++|||||||++|||++ |..||.+..+
T Consensus 163 ~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 163 D-------------------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred C-------------------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 0 0011123457788999999998899999999999999999998 9999998887
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
..+...+..+.. +..+...+.++.++|.+||..||.+||++.++
T Consensus 218 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 218 HEVPDLLEKGER--LAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred HHHHHHHHCCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 766555544332 22345678899999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.46 Aligned_cols=253 Identities=24% Similarity=0.419 Sum_probs=208.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++++.||+|+||.||+|... .+..+|+|.+ +.... ....+.+|+.+++.++||||+++++.+. ...
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~-~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTL-KPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEP 74 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEe-cCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence 355678999999999999999999876 4567899944 32221 2346889999999999999999998875 456
Q ss_pred eEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.|+||||+++|+|.+++... ..+++..++.++.+++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 89999999999999999763 3589999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. .........++..|+|||++.+..++.++|+||||+++|||++ |.+||.+.+
T Consensus 155 ~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 155 N--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred c--------------------------ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 0 0001122345678999999998889999999999999999999 999999988
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
..+....+... ...+ .+...+..+.+||.+||.+||.+||+++.+.+.|
T Consensus 209 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 209 NREVLEQVERG-YRMP-CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 88877777653 2222 3467899999999999999999999966655554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=361.10 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=212.1
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCC-----CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~T-----Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~ 754 (1093)
.+....++|.+++.||+|+||.||+|.+... +..||+|++ +.. ......+.+++|+.+|..+. |||||+++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l-~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKML-KPT--ARSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEec-CCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 3445678999999999999999999987533 346999944 322 22334567899999999996 99999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhc----------------------------------------------------
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKV---------------------------------------------------- 782 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~---------------------------------------------------- 782 (1093)
+++.....+||||||+++|+|.++|.+.
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 9999999999999999999999988642
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCc
Q 001354 783 --------------------------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 818 (1093)
Q Consensus 783 --------------------------------------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeN 818 (1093)
..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 136778888999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001354 819 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 898 (1093)
Q Consensus 819 ILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDV 898 (1093)
||++.++.+||+|||+++...... .........|++.|||||++.+..++.++||
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 322 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDS-------------------------NYVSKGSTFLPVKWMAPESIFDNLYTTLSDV 322 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccc-------------------------cccccCCcCCCcceEChhhhcCCCCCchhhH
Confidence 999999999999999987421000 0011233467889999999999999999999
Q ss_pred ecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 899 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 899 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
|||||++|||++ |..||............+.....++ .+..++.++.+||.+||+.||++||++.++.+++.
T Consensus 323 wSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 323 WSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 999999999997 9999987655444434444433333 45678999999999999999999999777777664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.96 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=205.9
Q ss_pred eeeccCCeEEEEEEEC--CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 694 PISRGAFGRVFLARKR--TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k--~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
.||+|+||.||+|.++ .++..||+|++ ... ......+.+.+|+.+|+.++||||+++++++.. ..+|+||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~-~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEc-ccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 3899999999999775 44567999944 322 223445678999999999999999999998864 57899999999
Q ss_pred CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCC
Q 001354 772 GGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850 (1093)
Q Consensus 772 GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~ 850 (1093)
+|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~------- 150 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS------- 150 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc-------
Confidence 9999999975 45789999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhc
Q 001354 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 929 (1093)
Q Consensus 851 td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~ 929 (1093)
.........+++.|+|||++.+..++.++|+|||||++|||++ |.+||.+....+....+..
T Consensus 151 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 151 -----------------YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred -----------------ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 0001112234678999999998889999999999999999996 9999999888777766655
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 930 ~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
+.. +..+...++++.+||.+||..||.+||++.++.+.++.-||
T Consensus 214 ~~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 214 GKR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence 432 23457789999999999999999999998888887776665
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=331.42 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=208.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|++++.||+|+||.||++++.. +..+|+|.+ +.... ....+.+|+.++..++||||+++++++.....+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~-~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEc-CCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 35689999999999999999998864 456999954 22221 2356889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~-- 153 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-- 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC--
Confidence 999999999999999764 46899999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~e 922 (1093)
. ........++..|+|||++.+..++.++|+|||||++|||++ |..||...+...
T Consensus 154 -------------------~-----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 154 -------------------E-----YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred -------------------c-----eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 0 001112346678999999998889999999999999999998 999999888887
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
....+......+ .+...+..+.++|.+||..||.+||+ +.+|+.
T Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~---~~~ll~ 253 (256)
T cd05113 210 TVEKVSQGLRLY--RPHLASEKVYAIMYSCWHEKAEERPT---FQQLLS 253 (256)
T ss_pred HHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 877776654332 24567899999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.37 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=207.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 755 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~g 755 (1093)
|.+.-++|++.+.||.|+||.||+|.... +++.||+|++ +.. ........+..|+.++..+ +||||+++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~-~~~--~~~~~~~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEG--ATASEYKALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeec-cCC--CCHHHHHHHHHHHHHHHhhccCcchhheee
Confidence 44556789999999999999999997543 4578999944 321 1233456788999999999 7999999999
Q ss_pred eeccC-CceEEEEEecCCCChHHHHHhc----------------------------------------------------
Q 001354 756 SFTCR-DNLYLVMEYLNGGDLYSLLRKV---------------------------------------------------- 782 (1093)
Q Consensus 756 sfqd~-~~LyLVMEYm~GGSL~dlL~k~---------------------------------------------------- 782 (1093)
++... ..+|++|||+++|+|.+++...
T Consensus 79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 87654 5689999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCC
Q 001354 783 ---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853 (1093)
Q Consensus 783 ---------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~ 853 (1093)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~----------- 227 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP----------- 227 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-----------
Confidence 257888999999999999999999999999999999999999999999999997531100
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCC
Q 001354 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKI 932 (1093)
Q Consensus 854 ~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l 932 (1093)
.........+++.|||||++.+..++.++|||||||++|||++ |.+||.+....+.+...+....
T Consensus 228 --------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 293 (337)
T cd05054 228 --------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293 (337)
T ss_pred --------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC
Confidence 0011223456788999999999999999999999999999998 9999988665554444444333
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 933 ~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
. +..+...++++.+++.+||+.+|.+||++.++.+.|
T Consensus 294 ~-~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l 330 (337)
T cd05054 294 R-MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330 (337)
T ss_pred C-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2 233567889999999999999999999955444443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=328.59 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=204.5
Q ss_pred EeeeccCCeEEEEEEECCCC---cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEe
Q 001354 693 KPISRGAFGRVFLARKRTTG---DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TG---k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
+.||+|+||.||+|.+..++ ..||+|.+ ...... .....+.+|+.+++.++|||||++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~-~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTL-KQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEec-ccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEe
Confidence 46999999999999876655 78999944 332221 345678999999999999999999998764 468999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCC
Q 001354 770 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849 (1093)
Q Consensus 770 m~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~ 849 (1093)
+++|+|.+++.+...+++..+..++.|++.||.|||..||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~------ 150 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD------ 150 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc------
Confidence 99999999998888899999999999999999999999999999999999999999999999999874311000
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHh
Q 001354 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNIL 928 (1093)
Q Consensus 850 ~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl 928 (1093)
.........++..|+|||.+.+..++.++|+|||||+||||++ |.+||...+..+....+.
T Consensus 151 ------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~ 212 (257)
T cd05060 151 ------------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212 (257)
T ss_pred ------------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 0000111234578999999999999999999999999999998 999999888877777665
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 929 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 929 ~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.... ...+..++..+++||.+||..||.+||++.++.+++.
T Consensus 213 ~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 213 SGER--LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred cCCc--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 5432 2245778999999999999999999999766666554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=327.10 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=210.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++.+.||.|+||.||+|... |+.||+|.+... . .....+.+|+.++..++||||+++++++.+....
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~-~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDD-S----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL 75 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccc-h----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence 45678999999999999999999875 889999955322 1 1467789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~- 154 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ- 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc-
Confidence 99999999999999998765 689999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~ 920 (1093)
......++..|+|||++.+..++.++|+||||+++|||++ |..||...+.
T Consensus 155 -----------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 155 -----------------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred -----------------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0012234568999999988889999999999999999997 9999998887
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.++...+.... . +..+..+++.+.+||.+||..+|.+||+++++.+.+
T Consensus 206 ~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 206 KDVVPHVEKGY-R-MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHHHHhcCC-C-CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 77766654432 2 234567899999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=331.02 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=211.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCc---EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk---~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
...+|++.+.||+|+||.||+|+++.++. .+|+|.+ +.. ........+.+|+.+|..++||||+++++++...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~-~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEEC-CCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34689999999999999999999875543 7999944 221 12334567899999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||+++|+|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999999999765 4689999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
.. ..........+++.|+|||++.+..++.++|+|||||++|||++ |..||...+
T Consensus 159 ~~------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 159 DP------------------------EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred cc------------------------ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 00 00001112234678999999998899999999999999999886 999999888
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
..+....+... ...| .+..+++.+.+|+.+||+++|.+||+++++.+++.
T Consensus 215 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 215 NQDVIKAIEEG-YRLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred HHHHHHHHhCC-CcCC-CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 77777776654 2333 34678999999999999999999999766665553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=331.74 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=208.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++.+.||+|+||.||+|++..+ ..||+|++ ++... ....+.+|+.++..++||||+++++.+.. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~-~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 75 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEec-ccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCc
Confidence 4457899999999999999999998765 45999944 33221 23468899999999999999999988754 568
Q ss_pred EEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999999763 35789999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~ 920 (1093)
.........++..|+|||++.+..++.++|+|||||++|||++ |.+||.+...
T Consensus 156 --------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 156 --------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred --------------------------ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 0001123446788999999998899999999999999999999 9999998888
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.++...+.... ..+ .+..++..+.+||.+||+.||.+||++..+.+.++
T Consensus 210 ~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 210 REVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred HHHHHHHhcCC-CCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 77777765542 222 24678999999999999999999999776666553
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.22 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=204.8
Q ss_pred Eeeecc--CCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEec
Q 001354 693 KPISRG--AFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 693 r~LGkG--~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
..||+| +||+||++++..+|+.||+|++ ... .......+.+.+|+.++..++||||++++++|...+.+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~-~~~-~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRIT-DLE-NCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEe-ccc-cCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 356666 9999999999999999999944 322 222344578889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCC
Q 001354 771 NGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848 (1093)
Q Consensus 771 ~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~ 848 (1093)
.+|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~----- 156 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ----- 156 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc-----
Confidence 9999999998643 489999999999999999999999999999999999999999999999986542110000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 849 ~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
+... .........++..|||||++.+. .++.++|+|||||++|||++|.+||.+.........
T Consensus 157 -------~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 221 (328)
T cd08226 157 -------KAKV--------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221 (328)
T ss_pred -------cccc--------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence 0000 00001123456789999999763 578999999999999999999999988765555444
Q ss_pred HhccCCCCC--------------------------------------------CCCCCCCHHHHHHHHhhccCCcCCCCC
Q 001354 927 ILNRKIPWP--------------------------------------------CVPSDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 927 Il~~~l~fP--------------------------------------------~ip~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
++......| ..+..+++.+.+||++||+.||.+||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 301 (328)
T cd08226 222 KLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301 (328)
T ss_pred HhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC
Confidence 333211100 011235678999999999999999999
Q ss_pred hhcHHHHHcCCCCCCC
Q 001354 963 ANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 963 a~~A~EIL~HPFFkgI 978 (1093)
+.++++||||+.+
T Consensus 302 ---a~e~l~~~~~~~~ 314 (328)
T cd08226 302 ---ASSLLSHAFFKQV 314 (328)
T ss_pred ---HHHHhhCHHHHHH
Confidence 8899999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=328.61 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=211.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCc---EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk---~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
+..++|+..+.||+|+||.||+|..+.++. .+|+|.+. .. ........+..|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~-~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PG--YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecc-cc--CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 456789999999999999999999876655 78999442 21 1233456788999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+..|+||||+++|+|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999999999764 578999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
... ...........++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 159 DDP------------------------EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred ccc------------------------ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 000 00000111223567999999998889999999999999999997 99999988
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+..++...+.... ..| .+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 215 ~~~~~~~~i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 215 SNHEVMKAINDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred CHHHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 8877777776542 323 2356889999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.15 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=207.7
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCC--------------cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTG--------------DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFV 750 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TG--------------k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNI 750 (1093)
..++|++.+.||+|+||.||+|++..++ ..||+|.+... ........+.+|+++|..++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999999876432 35899954221 123445678999999999999999
Q ss_pred EEEeeeeccCCceEEEEEecCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCc
Q 001354 751 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 818 (1093)
Q Consensus 751 VkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeN 818 (1093)
+++++++.....+|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999999999999999999999999986532 36788889999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001354 819 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 898 (1093)
Q Consensus 819 ILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDV 898 (1093)
||++.++.+||+|||++....... .........+++.|+|||++.+..++.++|+
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 214 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDV 214 (295)
T ss_pred EEEcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhH
Confidence 999999999999999987421000 0011123456789999999998899999999
Q ss_pred ecchhhHHHHHh--CCCCCCCCChHHHHHHHhc-----cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 899 WSVGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 899 WSLGVILYEMLT--GkpPF~~~s~~ei~~kIl~-----~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|||||++|+|++ |..||...+..+....+.. ....+...+..+++.+.+||.+||..||.+||+++++.+.|
T Consensus 215 wSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 215 WAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999999999988 7789988777666555432 12222333466889999999999999999999966655544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=334.89 Aligned_cols=258 Identities=21% Similarity=0.360 Sum_probs=212.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.+. .. ........+.+|+.++..++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~-~~--~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EE--ASADMQADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecC-CC--cCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 345789999999999999999998753 67899999543 21 12234567889999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCC
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVG----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 816 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g----------------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKP 816 (1093)
+...+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9999999999999999999997432 367888899999999999999999999999999
Q ss_pred CcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001354 817 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 896 (1093)
Q Consensus 817 eNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 896 (1093)
+|||++.++.+||+|||++....... .........+++.|+|||++.+..++.++
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 213 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKASENDAIPIRWMPPESIFYNRYTTES 213 (288)
T ss_pred hheEecCCCceEECccccceecccCc-------------------------cccccCCCccChhhcCHHHHhcCCCCchh
Confidence 99999999999999999987421000 00011122346789999999989999999
Q ss_pred eeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 897 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 897 DVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
|||||||++|||++ |..||.+.+..+....+..+... ..+..++.++.+||.+||+.||.+||++.++..+|+
T Consensus 214 Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 214 DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 99999999999997 88999988888888777665432 234678999999999999999999999776666654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=340.62 Aligned_cols=261 Identities=22% Similarity=0.356 Sum_probs=212.4
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEE-----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~-----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~ 754 (1093)
.+....++|.+.+.||+|+||.||++.+ ..++..+|+|.+ ++.. .....+.+.+|+.+++++ +||||++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~-~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTA--HSSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEec-CccC--ChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 3456678999999999999999999985 334567999943 3221 233456789999999999 799999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEec
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
+++...+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+||
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999999997543 3899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-C
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 911 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-G 911 (1093)
|+++...... .........+++.|+|||++.+..++.++|||||||++|||++ |
T Consensus 186 g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g 240 (302)
T cd05055 186 GLARDIMNDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240 (302)
T ss_pred cccccccCCC-------------------------ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCC
Confidence 9987421100 0001122356789999999999999999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 912 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 912 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+||........+..+.......+ .+...++++.+||.+||..+|++||++.++.+.+
T Consensus 241 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 241 SNPYPGMPVDSKFYKLIKEGYRMA-QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred CCCcCCCCchHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999988776665555555443322 3467889999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=338.74 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=208.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECC-------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 754 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~-------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~ 754 (1093)
.+..++|.+.+.||+|+||.||++++.. ++..+|+|.+ +.. ........+.+|+.++..+ +||||++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~-~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSD--ATEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEec-cCC--CChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 4556889999999999999999998753 2356999944 322 1234456788999999999 799999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCc
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 818 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeN 818 (1093)
+++.....+|+||||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997642 47888899999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001354 819 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 898 (1093)
Q Consensus 819 ILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDV 898 (1093)
||++.++.+||+|||+++...... .........+++.|+|||++.+..++.++|+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 225 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHID-------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225 (307)
T ss_pred eEEcCCCcEEECCCcccccccccc-------------------------hhhccccCCCccceeChHHhccCCCCcHHHH
Confidence 999999999999999987421000 0001112234578999999999899999999
Q ss_pred ecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 899 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 899 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
|||||++|||++ |.+||.+.+..++...+.... . +..+..++.++++||.+||..+|.+||++.++.+
T Consensus 226 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-R-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC-C-CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 999999999998 999998888777777665443 2 2345678999999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=338.66 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=211.6
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECC-------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~-------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
+.+..++|.+.+.||+|+||.||+|++.. ....+|+|.+ ++. ........+..|+.++..+ +||||+++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~-~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDN--ATDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEec-CCC--CChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 34566789999999999999999998642 3457899944 321 2234567788999999999 59999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCC
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPe 817 (1093)
++++.....+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 99999999999999999999999999753 24788889999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
|||++.++.+||+|||+++...... .........+++.|||||++.+..++.++|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDID-------------------------YYKKTSNGRLPVKWMAPEALFDRVYTHQSD 218 (314)
T ss_pred eEEEcCCCcEEEccccccccccccc-------------------------cccccccCCCCccccCHHHHccCCcCccch
Confidence 9999999999999999997421000 000111223457899999999989999999
Q ss_pred eecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 898 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 898 VWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
||||||++|||++ |..||.+.+..+.+..+..... +..+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 219 iwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 219 VWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred hhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999999999999 9999999888888887765432 223467889999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=327.67 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=208.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
++.-++|++++.||.|+||.||+|..+ ++..||+|.+ .+.. .....+.+|+.+++.++||||+++++.+. ...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~-~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 74 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSL-KQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEP 74 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEe-cCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCC
Confidence 355688999999999999999999875 4678999944 3222 23457889999999999999999998874 456
Q ss_pred eEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 89999999999999998754 3588899999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. .........++..|+|||++.+..++.++|+||||+++|||++ |++||.+.+
T Consensus 155 ~--------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 155 N--------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred C--------------------------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 0 0001123356789999999998889999999999999999999 999999888
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
..+....+... ...+ .+...+.++.+||.+||+.+|++||+++.+..+|
T Consensus 209 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 209 NPEVIQNLERG-YRMP-RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred hHHHHHHHHcC-CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 77777665443 2222 3467889999999999999999999976666555
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.41 Aligned_cols=260 Identities=33% Similarity=0.496 Sum_probs=210.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~-- 761 (1093)
...++|++.+.||.|+||.||+|.++.+|+.||+|.+. .. .........+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~-~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR-LD-NEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEe-ec-ccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45689999999999999999999999999999999542 21 112233456778999999999999999999987765
Q ss_pred --------ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEec
Q 001354 762 --------NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 762 --------~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
.+|+||||+++ +|..++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999986 777777654 46899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhC
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
|++...... .........+++.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 161 g~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g 214 (302)
T cd07864 161 GLARLYNSE--------------------------ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214 (302)
T ss_pred cccccccCC--------------------------cccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 998742110 0011122356889999998875 4578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcc---CC--CCCC----------------------CCCCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 912 IPPFTAESPEIIFDNILNR---KI--PWPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 912 kpPF~~~s~~ei~~kIl~~---~l--~fP~----------------------ip~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
++||...+..+....+... .. .+|. ....++..+.+||.+||..||.+||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~-- 292 (302)
T cd07864 215 KPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT-- 292 (302)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC--
Confidence 9999887766555544331 00 0110 01247899999999999999999999
Q ss_pred cHHHHHcCCCC
Q 001354 965 GAAEVKAHPFF 975 (1093)
Q Consensus 965 ~A~EIL~HPFF 975 (1093)
+.+++.||||
T Consensus 293 -~~~il~~~~~ 302 (302)
T cd07864 293 -AEEALNSPWL 302 (302)
T ss_pred -HHHHhcCCCC
Confidence 8899999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=331.94 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=211.1
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCC-----CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~T-----Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..++|++++.||.|+||+||+|+.+.+ ...+++|.+ ... ........+.+|+.+|.+++||||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~-~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-QKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEcc-CCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 346899999999999999999997643 467888843 221 112345678999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEE
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG---------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 830 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g---------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLs 830 (1093)
....|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 999999999999999999998655 68999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT 910 (1093)
|||+++..... .........+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 160 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~ 213 (275)
T cd05046 160 LLSLSKDVYNS--------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213 (275)
T ss_pred ccccccccCcc--------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 99998632100 0011223456788999999998889999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 911 -GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 911 -GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
|..||...........+......++ .+..++..+.++|.+||..||.+||++.++
T Consensus 214 ~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~ 269 (275)
T cd05046 214 QGELPFYGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269 (275)
T ss_pred CCCCCccccchHHHHHHHHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 8999988887777777776666554 246789999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=329.91 Aligned_cols=255 Identities=35% Similarity=0.573 Sum_probs=210.2
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CceEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLV 766 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~LyLV 766 (1093)
|++.+.||.|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++||||+++++.+... ..+|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 688999999999999999999999999999554322 2334456788999999999999999999999988 889999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||+++ +|..++... ..+++..++.++.||+.||+|||+.|++|+||||+|||++++|.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~--- 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN--- 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC---
Confidence 999975 899988765 579999999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
........+++.|+|||.+.+ ..++.++||||||+++|||++|++||...+.....
T Consensus 155 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 155 -----------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred -----------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 011123457889999998775 46789999999999999999999999988876666
Q ss_pred HHHhccC-----CCCCC----------------------CCCC-CCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRK-----IPWPC----------------------VPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~-----l~fP~----------------------ip~~-IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..+.... ..++. .... ++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~~~~ 287 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS---ADQALQHEYF 287 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC---HHHHhhCcCC
Confidence 6554311 01110 0012 3889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=329.61 Aligned_cols=254 Identities=28% Similarity=0.493 Sum_probs=213.6
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh--hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~--~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.|.+.+.||+|+||.||++.+..++..+++| +++.... ........+..|..+++.++||||+++++++.+....|+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLK-VLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEE-EeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 4889999999999999999998887777777 4333221 223344567789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 766 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||+++....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~- 157 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG- 157 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC-
Confidence 9999999999998864 346899999999999999999999999999999999999975 6799999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 158 --------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~ 211 (260)
T cd08222 158 --------------------------SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL 211 (260)
T ss_pred --------------------------CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 001122346889999999998888999999999999999999999999887777
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.....+.... .|..+..++.++.++|.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 212 SVVLRIVEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HHHHHHHcCC--CCCCcchhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 7776665543 34445788999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=340.63 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=214.8
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|+..+.||+|+||.||++++..++..+|+|.+ .............+.+|+.+++.++|||++++++++......|+|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEE-ecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 3488899999999999999999999999999954 332223334556789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||++| +|.+++.. ...+++..+..++.+|+.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------ 176 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------ 176 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC------
Confidence 999975 78777754 4568999999999999999999999999999999999999999999999999876311
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......|++.|+|||++. +..++.++|||||||++|||++|.+||...+...
T Consensus 177 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 231 (317)
T cd06635 177 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231 (317)
T ss_pred -------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 112346889999999984 3568889999999999999999999998887777
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
....+........ ....+++.+.+||.+||+.+|.+||+ +.+++.|+|+..
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~ 282 (317)
T cd06635 232 ALYHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLR 282 (317)
T ss_pred HHHHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhc
Confidence 6666665543322 23567889999999999999999999 889999999953
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=326.31 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=212.1
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++.+.||.|+||.||+|.... +..+|+|.+ .... .....+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~-~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTL-KPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP 75 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEe-cCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc
Confidence 3567899999999999999999999764 577999944 3222 224568899999999999999999999999899
Q ss_pred eEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+|+||||+++++|.+++.... .+++..+..++.+++.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999999997653 689999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. .........++..|+|||.+.+..++.++|+|||||++|||++ |+.||.+.+
T Consensus 156 ~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 156 D--------------------------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred h--------------------------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 0 0001112234678999999999899999999999999999998 999999888
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.......+.... ..+ .+...+.++.++|.+||+.+|.+||+++++.+.++
T Consensus 210 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 210 NREVLEQVERGY-RMP-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred HHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 877777776542 222 34667899999999999999999999666655543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.19 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=210.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCc---EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk---~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
...+|++.+.||+|+||.||+|.++.+++ .||+|.+ ++. ........+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEc-CCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 35679999999999999999999987665 6999944 322 23445678999999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999764 5689999999999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
... .+. ........++..|+|||++.+..++.++|||||||++|||++ |..||...+
T Consensus 159 ~~~-----------------~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 159 DTS-----------------DPT-----YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred Ccc-----------------ccc-----cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 000 000 000111123567999999999999999999999999999886 999999888
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
.......+... ..+| .+..++..+.++|.+||..+|.+||+++++...
T Consensus 217 ~~~~~~~i~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 217 NQDVINAIEQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHHcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87777776443 3333 246788999999999999999999995544433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.79 Aligned_cols=256 Identities=31% Similarity=0.496 Sum_probs=212.7
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc--
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-- 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~-- 762 (1093)
..++|++.+.||.|+||.||+|++..++..||+|++ ... .........+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~-~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-SRP-FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEec-ccc-cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 457899999999999999999999999999999954 221 1223345667889999999999999999988876655
Q ss_pred ----eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 763 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 763 ----LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 6699998865 56999999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
. .......+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+
T Consensus 169 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 169 D------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred c------------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 1 01223468899999999875 4678999999999999999999999998
Q ss_pred CChHHHHHHHhccCCC----------------------------CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 918 ESPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~----------------------------fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
.+.......+...... ++.....++.++.+||.+||+.||.+||+ +.+|
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt---~~el 295 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT---AAEA 295 (343)
T ss_pred CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC---HHHH
Confidence 8776666655432110 01112346899999999999999999999 8899
Q ss_pred HcCCCCCC
Q 001354 970 KAHPFFKG 977 (1093)
Q Consensus 970 L~HPFFkg 977 (1093)
+.||||..
T Consensus 296 l~h~~~~~ 303 (343)
T cd07851 296 LAHPYLAE 303 (343)
T ss_pred hcCCCccc
Confidence 99999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=336.93 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=211.5
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEEC-------CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k-------~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
+.+..++|.+.+.||+|+||.||+|++. .++..+|+|.+ +.. ........+.+|+.++..+ +||||+++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~-~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDD--ATEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeec-ccc--cchHHHHHHHHHHHHHHhhccCCCchhe
Confidence 3467789999999999999999999853 23457999943 221 2234567789999999999 79999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCC
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPe 817 (1093)
++++.....+|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999999763 23677788899999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
|||++.++.+||+|||+++...... .........+++.|+|||++.+..|+.++|
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccc-------------------------ccccccCCCCCceeeCchhhccCCCCchhh
Confidence 9999999999999999987431100 001112335678899999999989999999
Q ss_pred eecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 898 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 898 VWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
|||||+++|||++ |..||.+.+..++...+..... +..+..++.++.+||.+||..+|.+||++.++.+.
T Consensus 222 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 222 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 9999999999998 8999999888888877755432 22346789999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=339.43 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=212.3
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|...+.||.|+||+||+|++..+|..|++|++. ............+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEe-ccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 566778999999999999999999999999543 3223334455678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 769 YLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 769 Ym~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|+.| +|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~--------- 171 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS--------- 171 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc---------
Confidence 9964 78887765 456899999999999999999999999999999999999999999999999987631
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.......|++.|+|||++. +..++.++|+|||||++|||++|.+||...+.....
T Consensus 172 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~ 229 (313)
T cd06633 172 ----------------------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229 (313)
T ss_pred ----------------------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0112356899999999985 356788999999999999999999999888776666
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
..+.....+.. ....++..+++||.+||+++|.+||+ +.+++.||||+...
T Consensus 230 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~ 280 (313)
T cd06633 230 YHIAQNDSPTL-QSNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDR 280 (313)
T ss_pred HHHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 65554433211 12457888999999999999999999 88999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=342.23 Aligned_cols=261 Identities=31% Similarity=0.453 Sum_probs=207.6
Q ss_pred CeeEEEeeeccCCeEEEEEEECCC--CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc----C
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTT--GDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC----R 760 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~T--Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd----~ 760 (1093)
+|++.+.||.|+||.||+++...+ +..||+|.+. . ..........+.+|+.++..+ +||||+++++.+.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~-~-~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-N-VFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEec-c-ccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 488999999999999999999988 8999999542 2 112223356778899999999 59999999986432 2
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..+|++|||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 45889999986 59999998888899999999999999999999999999999999999999999999999999974211
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
... .........+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+
T Consensus 158 ~~~-----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 158 NPG-----------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ccc-----------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 000 00111234679999999998875 578999999999999999999999998766
Q ss_pred hHHHHHHHhcc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~----------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.......++.. ...++.....++..+.+||.+||+.||.+||+ +.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~ll~ 291 (332)
T cd07857 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS---VEEALE 291 (332)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC---HHHHhc
Confidence 44333322210 11122222456889999999999999999999 789999
Q ss_pred CCCCCC
Q 001354 972 HPFFKG 977 (1093)
Q Consensus 972 HPFFkg 977 (1093)
||||+.
T Consensus 292 ~~~~~~ 297 (332)
T cd07857 292 HPYLAI 297 (332)
T ss_pred Chhhhh
Confidence 999953
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.30 Aligned_cols=254 Identities=34% Similarity=0.560 Sum_probs=210.3
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|++.+.||.|++|.||+|....+|+.+++|.+. .. .........+..|+.+|+.++||||+++++.+.+...+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~-~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK-LR-FESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEec-cc-cccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 677889999999999999999999999999543 22 2222345678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 769 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|+++ +|..++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~------ 151 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP------ 151 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC------
Confidence 9976 888888764 57899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+...+
T Consensus 152 ---------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 210 (283)
T cd05118 152 ---------------------VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210 (283)
T ss_pred ---------------------cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011224578899999999876 789999999999999999999999988776665555
Q ss_pred HhccCC-------------------CCC--------CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 927 ILNRKI-------------------PWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 927 Il~~~l-------------------~fP--------~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
+..... .++ .....++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~ll~~~~~ 283 (283)
T cd05118 211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---AEQALAHPYF 283 (283)
T ss_pred HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---HHHHhhCCCC
Confidence 432100 000 112347889999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=345.72 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=207.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~---- 760 (1093)
..++|++.+.||+|+||.||+|.+..+|..||+|++. +. .........+.+|+.++..++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~-~~-~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEec-Cc-chhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 4588999999999999999999999999999999553 21 11223346678899999999999999999887643
Q ss_pred --CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 761 --DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 761 --~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
...|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478888887 7799888764 46899999999999999999999999999999999999999999999999998731
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 171 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 D------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred c------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0 01123468899999999876 5688999999999999999999999987
Q ss_pred CChHHHHHHHhccCC----------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 918 ESPEIIFDNILNRKI----------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l----------------------------~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
.+.......+..... .+.......++++.+||.+||+.||.+||+ +.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~ 297 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQA 297 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC---HHHH
Confidence 765554443322100 001111246889999999999999999999 8899
Q ss_pred HcCCCCCC
Q 001354 970 KAHPFFKG 977 (1093)
Q Consensus 970 L~HPFFkg 977 (1093)
+.||||+.
T Consensus 298 l~h~~f~~ 305 (345)
T cd07877 298 LAHAYFAQ 305 (345)
T ss_pred hcChhhhh
Confidence 99999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.66 Aligned_cols=253 Identities=32% Similarity=0.546 Sum_probs=211.8
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEec
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
....||+|+||.||++..+.+|..||+|++. .........+.+|+.+++.++||||+++++.|...+..|+||||+
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMD----LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEec----ccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 3467999999999999999999999999542 112234567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCC
Q 001354 771 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850 (1093)
Q Consensus 771 ~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~ 850 (1093)
++++|.+++.. +.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~---------- 168 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---------- 168 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc----------
Confidence 99999998754 4689999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhcc
Q 001354 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 930 (1093)
Q Consensus 851 td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~ 930 (1093)
.........||+.|+|||.+.+..++.++|+|||||++|+|++|.+||.+.........+...
T Consensus 169 -----------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~ 231 (292)
T cd06657 169 -----------------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231 (292)
T ss_pred -----------------ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Confidence 001123356899999999998888999999999999999999999999988776665554332
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 931 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 931 ~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
..........++..+.++|.+||..||.+||+ +.+++.||||...
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~ 276 (292)
T cd06657 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 276 (292)
T ss_pred CCcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhcc
Confidence 21111123467899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=359.46 Aligned_cols=256 Identities=31% Similarity=0.539 Sum_probs=224.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+-|.++..||.|+||.||++.++.+|..+|||++-. ....+.+..|+.||.+++.|+||++|++|.....+|+|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 458899999999999999999999999999996632 34578899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||..|+..++++- ...++|.++.-+++..+.||+|||...-||||||..||||+.+|++||+|||.|-...
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------ 180 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------ 180 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh------
Confidence 999999999999974 4679999999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
......++..|||.|||||++..-+|+..+||||||++..||..|+|||.+..++...-
T Consensus 181 ---------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF 239 (502)
T KOG0574|consen 181 ---------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF 239 (502)
T ss_pred ---------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence 01224567899999999999999999999999999999999999999999988876555
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.|-....+--..|..+|.++.|||+.||.+.|++|-| |.++++|||.++.
T Consensus 240 MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA 289 (502)
T KOG0574|consen 240 MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNA 289 (502)
T ss_pred eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCC
Confidence 5433332211235678999999999999999999998 8999999999864
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.55 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=206.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++...||.|+||.||+|.+..+ ..+|+|.+. ... ...+.+.+|+.+++.++||||+++++++. ....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~-~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK-PGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI 75 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcc-cCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence 3456799999999999999999998765 458999442 211 12356788999999999999999998875 4568
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999999997643 4788999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~ 920 (1093)
.........++..|+|||.+.+..++.++|+|||||++|||++ |.+||.+...
T Consensus 156 --------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 156 --------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred --------------------------cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0001122346788999999998889999999999999999999 9999999888
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+....+... ... ..+..++..+.+||.+||.+||.+||+++.+.+.+
T Consensus 210 ~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 210 REVLEQVERG-YRM-PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHHHHcC-CCC-CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 7777776554 222 23467899999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=328.63 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=198.0
Q ss_pred EeeeccCCeEEEEEEECC--CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEec
Q 001354 693 KPISRGAFGRVFLARKRT--TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~--TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
+.||+|+||.||+|.... ....+|+|.+ ... ........+.+|+.+++.++||||+++++.+.....+|+||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~-~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKEL-RAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeec-Ccc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence 368999999999997543 3456777743 221 12334567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 771 NGGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 771 ~GGSL~dlL~k~g-----~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED--- 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch---
Confidence 9999999997643 24678889999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.........+++.|+|||++.. ..++.++|||||||++|||++ |.+||..
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 155 ----------------------YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred ----------------------heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 0001123456788999999753 356789999999999999999 8899988
Q ss_pred CChHHHHHHHhcc-CCCC--CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 918 ESPEIIFDNILNR-KIPW--PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 918 ~s~~ei~~kIl~~-~l~f--P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
..+.+....+... ...+ |.++..++....+++..|+. ||.+||+++++.+++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~~ 269 (269)
T cd05042 213 LSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269 (269)
T ss_pred CCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhc-CcccccCHHHHHHHhcC
Confidence 8776666555443 2222 33456788999999999985 99999998777777765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.28 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=199.3
Q ss_pred EeeeccCCeEEEEEEECCCCcE--EEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEEEEEe
Q 001354 693 KPISRGAFGRVFLARKRTTGDL--FAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~--VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
+.||+|+||.||+|+.+.++.. +++|.+ +. .........+.+|+.++.++ +||||+++++++.....+|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~-~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEc-cc--cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 3689999999999999888764 577733 22 12234456788999999999 799999999999999999999999
Q ss_pred cCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 770 LNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 770 m~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
+++|+|.+++.... .+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999999997543 47888999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-Gk 912 (1093)
++..... ........+++.|+|||++.+..++.++|+|||||++|||++ |.
T Consensus 158 l~~~~~~----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~ 209 (270)
T cd05047 158 LSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209 (270)
T ss_pred Cccccch----------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 9752100 000112234678999999998899999999999999999997 99
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
.||.+.+..+.+..+.... . +..+..++.++.+||.+||..||.+||++.++..
T Consensus 210 ~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 210 TPYCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCccccCHHHHHHHHhCCC-C-CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 9999888777777765432 2 1234568899999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.11 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=205.2
Q ss_pred EeeeccCCeEEEEEEECC-CCc--EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEe
Q 001354 693 KPISRGAFGRVFLARKRT-TGD--LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~-TGk--~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
+.||+|+||.||+|.+.. ++. .+|+|.+ ...... ...+.+.+|+.++.+++||||+++++.+.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~-~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeec-CCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 368999999999999865 333 6899944 332221 566789999999999999999999999988 889999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 770 LNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 770 m~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
+++|+|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~----- 151 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE----- 151 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc-----
Confidence 99999999997754 68999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDN 926 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~k 926 (1093)
. .........++..|+|||++.+..++.++|+|||||++|||++ |.+||...+..+....
T Consensus 152 -----------~--------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 212 (257)
T cd05040 152 -----------D--------HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212 (257)
T ss_pred -----------c--------ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 0 0001113457889999999999999999999999999999998 9999998888877777
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+......++ .+..++..+.+||.+||+.+|.+||++.++.+.+
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 213 IDKEGERLE-RPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred HHhcCCcCC-CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 765333322 3467889999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.98 Aligned_cols=262 Identities=29% Similarity=0.506 Sum_probs=210.1
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC 759 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd 759 (1093)
...+..++|++.+.||.|+||+||+|.+..+++.||+|.+. +.. .......+..|+.++.... ||||+++++++.+
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~-~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR-RTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEe-ccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 34567899999999999999999999999999999999543 222 1223455667777666665 9999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
...+|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 86 DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999999854 78777765 3568999999999999999999997 5999999999999999999999999999864
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeecchhhHHHHHhCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
... ........|++.|+|||.+.+.. ++.++|+||||+++|+|++|+.
T Consensus 165 ~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 165 LVD----------------------------SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred ccC----------------------------CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 210 00112235789999999997653 7889999999999999999999
Q ss_pred CCCCCCh-HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 914 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 914 PF~~~s~-~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
||..... .+....++............++.++.+||.+||..||.+||+ +.+++.||||..
T Consensus 217 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 278 (296)
T cd06618 217 PYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRR 278 (296)
T ss_pred CCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhc
Confidence 9976433 344555554432211112347899999999999999999999 789999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=337.16 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=203.3
Q ss_pred eeecc--CCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 694 PISRG--AFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 694 ~LGkG--~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
+||+| ++|.||+++.+.+++.||+|++.. . .........+..|+.+|..++||||++++++|...+..|++|||++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~-~-~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINL-D-SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEec-c-ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 44544 556677777777999999995532 2 2234566789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCC
Q 001354 772 GGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849 (1093)
Q Consensus 772 GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~ 849 (1093)
+|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~------ 156 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK------ 156 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc------
Confidence 99999999764 4589999999999999999999999999999999999999999999999999874311000
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHH
Q 001354 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927 (1093)
Q Consensus 850 ~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kI 927 (1093)
.............++..|+|||++.+ ..|+.++|+|||||++|||++|.+||............
T Consensus 157 --------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~ 222 (314)
T cd08216 157 --------------RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222 (314)
T ss_pred --------------cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 00001112234567889999999976 46889999999999999999999999876654333221
Q ss_pred hccCCC-------CCC------------------------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 928 LNRKIP-------WPC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 928 l~~~l~-------fP~------------------------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
..+... +|. ....++.++.+||.+||+.||.+||+ +.++++||||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~p~~~ 299 (314)
T cd08216 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS---ASQLLNHSFFK 299 (314)
T ss_pred HhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC---HHHHhcCchHh
Confidence 111100 000 11234578899999999999999999 88999999998
Q ss_pred CCC
Q 001354 977 GVN 979 (1093)
Q Consensus 977 gId 979 (1093)
.+.
T Consensus 300 ~~~ 302 (314)
T cd08216 300 QCK 302 (314)
T ss_pred hhc
Confidence 653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.34 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=204.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECC----------------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~----------------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN 749 (1093)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+ +.. ........+.+|+.+|..++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~-~~~--~~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-RED--ANKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEec-ccc--CCHHHHHHHHHHHHHHHhCCCCC
Confidence 3579999999999999999986543 3457899944 221 12334567899999999999999
Q ss_pred eEEEeeeeccCCceEEEEEecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCc
Q 001354 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 818 (1093)
Q Consensus 750 IVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g-----------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeN 818 (1093)
|+++++++...+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999997643 36677899999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001354 819 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 898 (1093)
Q Consensus 819 ILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDV 898 (1093)
||++.++.++|+|||+++...... .........+++.|+|||+..+..++.++|+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 215 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMSWESILLGKFTTASDV 215 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCc-------------------------ceeccCcCcCccccCCHHHHhcCCccchhhh
Confidence 999999999999999987421000 0001122345788999999988889999999
Q ss_pred ecchhhHHHHHh--CCCCCCCCChHHHHHHHhc------cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 899 WSVGIILFEFIT--GIPPFTAESPEIIFDNILN------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 899 WSLGVILYEMLT--GkpPF~~~s~~ei~~kIl~------~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|||||++|||++ |..||...+..+....... ....+| .+..+++.+.+||.+||..||.+||++.++.++|
T Consensus 216 wSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 216 WAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLP-KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred hHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 999999999998 7899988776665543321 111122 2456789999999999999999999976665555
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.60 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=209.5
Q ss_pred eeEEEeeeccCCeEEEEEEECCCC----cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTG----DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TG----k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
|++.+.||.|+||.||++++..++ ..+|+|.+ +... .......+..|+.+|..++||||+++++.+.+.+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~-~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTL-KEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEc-cCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 457789999999999999998776 89999954 3221 1225678899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~--LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+||||+++++|.+++..... +++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999999976544 9999999999999999999999999999999999999999999999999987531100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ 921 (1093)
.+ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..
T Consensus 158 --------------------~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~ 211 (258)
T smart00219 158 --------------------YY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE 211 (258)
T ss_pred --------------------cc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 00 0001227889999999988889999999999999999998 89999998888
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+...+..... +..+..++.++.++|.+||..||.+||+ +.+++
T Consensus 212 ~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll 255 (258)
T smart00219 212 EVLEYLKKGYR--LPKPENCPPEIYKLMLQCWAEDPEDRPT---FSELV 255 (258)
T ss_pred HHHHHHhcCCC--CCCCCcCCHHHHHHHHHHCcCChhhCcC---HHHHH
Confidence 88887766543 2335678999999999999999999999 55554
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=362.68 Aligned_cols=258 Identities=35% Similarity=0.574 Sum_probs=222.3
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
++||.|.||+||-|+++.+|+.||+| ++.|.+...+ +...+++|+.||..+.||.||.+-..|++.+.+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvK-vIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVK-VIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeee-eeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 58999999999999999999999999 6666665444 447899999999999999999999999999999999999965
Q ss_pred CChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC---CcEEEEecCCcccccccccccCC
Q 001354 773 GDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 773 GSL~dlL~--k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d---G~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|+..++- +.+++++...+|++.||+.||.|||-+||+|+||||+||||.+. -.+||||||+|+++..
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE------- 719 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE------- 719 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch-------
Confidence 7666653 56889999999999999999999999999999999999999764 3699999999997431
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kI 927 (1093)
.....+.+|||.|+|||++..++|+.+-|+||.|||+|--|.|..||..+ +++-..|
T Consensus 720 ---------------------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQI 776 (888)
T KOG4236|consen 720 ---------------------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQI 776 (888)
T ss_pred ---------------------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHh
Confidence 22456789999999999999999999999999999999999999999764 4556667
Q ss_pred hccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC-Ccchhhcc
Q 001354 928 LNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV-NWDSLALQ 986 (1093)
Q Consensus 928 l~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI-dWd~L~~~ 986 (1093)
.+..+-+|.. ...+++++.|||..+|+..-.+|.+ +...|.|||+++. -|-.|+..
T Consensus 777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~DLRel 834 (888)
T KOG4236|consen 777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWLDLREL 834 (888)
T ss_pred hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHHHHHHH
Confidence 7766666543 2578999999999999999999999 7788999999974 46655433
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=341.00 Aligned_cols=274 Identities=27% Similarity=0.398 Sum_probs=213.4
Q ss_pred CCee-EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchh-----------HHHHHHHHHHHHHhcCCCceEEEe
Q 001354 687 DDFE-IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN-----------DIERILAERNILITVRNPFVVRFF 754 (1093)
Q Consensus 687 ddFe-ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~-----------eie~~l~E~~IL~kL~HPNIVkL~ 754 (1093)
+.|. +.+.||.|+||+||+|.++.+++.||+|++... ...... ....+.+|+.++..++||||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeecc-ccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 4554 457799999999999999999999999955322 111100 012477899999999999999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
+++...+.+|+||||+. |+|.+++.....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999997 59999998878899999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
+........... .. ..... ..........+++.|+|||++.+. .++.++|+|||||++|||++|.+
T Consensus 166 ~~~~~~~~~~~~--------~~-~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 166 ARRYGYPPYSDT--------LS-KDETM----QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred eeeccccccccc--------cc-ccccc----cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 875321100000 00 00000 011122335678999999998764 47899999999999999999999
Q ss_pred CCCCCChHHHHHHHhccC-----CCCC--------------------CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 914 PFTAESPEIIFDNILNRK-----IPWP--------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~-----l~fP--------------------~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
||.+.+..+....+.... ..|| ......+.++.+||.+||..||.+||+ +.+
T Consensus 233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~ 309 (335)
T PTZ00024 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS---AKE 309 (335)
T ss_pred CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC---HHH
Confidence 999888777666554310 0011 012345788999999999999999999 889
Q ss_pred HHcCCCCCCC
Q 001354 969 VKAHPFFKGV 978 (1093)
Q Consensus 969 IL~HPFFkgI 978 (1093)
++.||||++.
T Consensus 310 ~l~~~~~~~~ 319 (335)
T PTZ00024 310 ALKHEYFKSD 319 (335)
T ss_pred HhcCcccCCC
Confidence 9999999854
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=328.44 Aligned_cols=254 Identities=36% Similarity=0.565 Sum_probs=210.5
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|++.+.||.|+||.||+|+...+++.||+|.+... . ........+..|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~-~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD-N-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccc-c-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 67788999999999999999999999999955332 2 223345677889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 769 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|++ ++|.+++.+. ..+++..+..++.+++.||.|||++||+||||+|+||+++.++.+||+|||+++....
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~------- 150 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI------- 150 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC-------
Confidence 998 4999999876 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.........+++.|+|||++.+. .++.++|+|||||++|||++|.+||.+.+......+
T Consensus 151 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 210 (282)
T cd07829 151 --------------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK 210 (282)
T ss_pred --------------------CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 00011233567889999999876 789999999999999999999999988876655554
Q ss_pred Hhcc------------------CCCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 927 ILNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 927 Il~~------------------~l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
+... ...++. ..+.++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~p~~ 282 (282)
T cd07829 211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AKEALKHPYF 282 (282)
T ss_pred HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HHHHhhCcCC
Confidence 4321 011111 11245789999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.63 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=206.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 688 DFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
+|++.+.||+|+||.||+|.... ....+|+|.+. +.. .......+.+|+.+|..++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~-~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecC-CCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 57889999999999999998753 23568888442 211 22345778899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 818 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~------------------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeN 818 (1093)
.|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999998642 237788899999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001354 819 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 898 (1093)
Q Consensus 819 ILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDV 898 (1093)
||++.++.+||+|||+++...... .........++..|+|||++.+..++.++|+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di 212 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSKGRIPVKWMAIESLFDHIYTTQSDV 212 (290)
T ss_pred EEEcCCCcEEeccccccccccCcc-------------------------chhcccCCCCCccccCHHHHccCCcchHhHH
Confidence 999999999999999987421100 0001123356778999999998899999999
Q ss_pred ecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 899 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 899 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
||||+++|||++ |.+||.+..+..+...+... ..++ .+..++.++.+||.+||+.||.+||++.++.+.+
T Consensus 213 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 213 WSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 999999999998 99999988887777655433 3322 3577899999999999999999999966554444
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.96 Aligned_cols=248 Identities=22% Similarity=0.383 Sum_probs=206.3
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
...+|++.+.||.|+||.||++.+.. +..+|+|.+ ++... ....+.+|+.+++.++||||+++++++......|
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~-~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTI-REGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeC-CCeEEEEEC-CCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence 35689999999999999999998864 678999944 32211 2346788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||+++|+|.+++... +.++++.++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-- 153 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-- 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC--
Confidence 999999999999999764 46899999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~e 922 (1093)
.........++..|+|||++.+..++.++|+||||+++|||++ |.+||.......
T Consensus 154 ------------------------~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05112 154 ------------------------QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209 (256)
T ss_pred ------------------------cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 0001122345678999999998899999999999999999998 999999888777
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
+...+..+...+ .+...+..+.+|+.+||+.+|++||++.++
T Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~ 251 (256)
T cd05112 210 VVETINAGFRLY--KPRLASQSVYELMQHCWKERPEDRPSFSLL 251 (256)
T ss_pred HHHHHhCCCCCC--CCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 777765543222 235678999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.64 Aligned_cols=252 Identities=35% Similarity=0.536 Sum_probs=206.4
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVM 767 (1093)
|++.+.||.|+||+||+|+...+++.|++|.+..+.. ........+|+..+..++ ||||+++++++.+.+..|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 6788999999999999999999999999995533221 112234457889999999 999999999999999999999
Q ss_pred EecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 768 EYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||+ +|+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++....
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~----- 151 (283)
T cd07830 78 EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS----- 151 (283)
T ss_pred ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC-----
Confidence 999 789999988764 789999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
........|+..|+|||++.+ ..++.++|+||||+++|||++|++||...+..+.+
T Consensus 152 -----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~ 208 (283)
T cd07830 152 -----------------------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL 208 (283)
T ss_pred -----------------------CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH
Confidence 001123468899999998854 56789999999999999999999999887766555
Q ss_pred HHHhccC-------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 925 DNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 925 ~kIl~~~-------------------l~fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.++.... ..++. .....+..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~~~~~~ 283 (283)
T cd07830 209 YKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT---ASQALQHPYF 283 (283)
T ss_pred HHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC---HHHHhhCCCC
Confidence 5443210 00010 11233688999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.60 Aligned_cols=256 Identities=33% Similarity=0.547 Sum_probs=208.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd-~~~L 763 (1093)
..++|++.+.||.|+||.||+|.++.+++.||+|.+.+. .........+..|+.++..++||||++++++|.. ...+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP--FSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccc--ccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 567899999999999999999999999999999955432 2223345678899999999999999999999876 5578
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++....
T Consensus 86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~---- 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD---- 159 (328)
T ss_pred EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC----
Confidence 9999998 5689888764 458889999999999999999999999999999999999999999999999987310
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.......
T Consensus 160 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 160 --------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred --------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 01123467899999999876 678999999999999999999999998766533
Q ss_pred HHHHHhc----------------------------cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCC
Q 001354 923 IFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974 (1093)
Q Consensus 923 i~~kIl~----------------------------~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPF 974 (1093)
....+.. ...++......++..+.++|.+||+.+|.+||+ +.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~ell~~~~ 290 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS---AAEALAHPY 290 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcCCc
Confidence 3222111 011111112457899999999999999999999 889999999
Q ss_pred CCC
Q 001354 975 FKG 977 (1093)
Q Consensus 975 Fkg 977 (1093)
|..
T Consensus 291 ~~~ 293 (328)
T cd07856 291 LAP 293 (328)
T ss_pred ccc
Confidence 963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.26 Aligned_cols=259 Identities=28% Similarity=0.462 Sum_probs=207.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 760 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~------ 760 (1093)
.+|++.+.||.|+||.||+|.++.+|..||+|++..+ .......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~----~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC----CCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 6899999999999999999999999999999965332 124457788999999999999999999776654
Q ss_pred --------CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEe
Q 001354 761 --------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTD 831 (1093)
Q Consensus 761 --------~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsD 831 (1093)
..+|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35799999997 599888754 56899999999999999999999999999999999999985 56789999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHh
Q 001354 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 832 FGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLT 910 (1093)
||++..... .. .........+||+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 159 fg~~~~~~~--~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~ 214 (342)
T cd07854 159 FGLARIVDP--HY----------------------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214 (342)
T ss_pred cccceecCC--cc----------------------ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh
Confidence 999874210 00 00001122368999999998764 568899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhccC-------------------------CC--CCCCCCCCCHHHHHHHHhhccCCcCCCCCh
Q 001354 911 GIPPFTAESPEIIFDNILNRK-------------------------IP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963 (1093)
Q Consensus 911 GkpPF~~~s~~ei~~kIl~~~-------------------------l~--fP~ip~~IS~eakDLIkrcL~kDP~KRpTa 963 (1093)
|..||.+.++.+....++... .. +..+...++.++.+||.+||+.||.+||+
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t- 293 (342)
T cd07854 215 GKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT- 293 (342)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC-
Confidence 999998877655555443210 00 00112357889999999999999999999
Q ss_pred hcHHHHHcCCCCCCC
Q 001354 964 NGAAEVKAHPFFKGV 978 (1093)
Q Consensus 964 ~~A~EIL~HPFFkgI 978 (1093)
+.+++.||||+.+
T Consensus 294 --~~ell~h~~~~~~ 306 (342)
T cd07854 294 --AEEALMHPYMSCY 306 (342)
T ss_pred --HHHHhCCCccccc
Confidence 8899999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=342.74 Aligned_cols=266 Identities=33% Similarity=0.547 Sum_probs=213.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC-
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD- 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~- 761 (1093)
...++|++.+.||.|+||.||+|.+..+|..+|+|.+.+.. ........+.+|+.++..+ +||||++++++|...+
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 34678999999999999999999999999999999664321 2223445677899999999 9999999999886543
Q ss_pred -ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 -~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||+++ +|..++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 68999999974 999988765 788999999999999999999999999999999999999999999999999875321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
... ...........||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+..
T Consensus 160 ~~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 160 LEE----------------------NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccc----------------------cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 000 000112234578999999998865 457889999999999999999999998776
Q ss_pred hHHHHHHHhccC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~~----------------------------l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
..+...++.... ..+......++.++.+||.+||+.||.+||+ +.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~~il~ 294 (337)
T cd07852 218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT---AEEALE 294 (337)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC---HHHHhh
Confidence 555444432211 0111112347899999999999999999999 889999
Q ss_pred CCCCCCC
Q 001354 972 HPFFKGV 978 (1093)
Q Consensus 972 HPFFkgI 978 (1093)
||||+.+
T Consensus 295 ~~~~~~~ 301 (337)
T cd07852 295 HPYVAQF 301 (337)
T ss_pred Chhhhhh
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=363.77 Aligned_cols=262 Identities=29% Similarity=0.450 Sum_probs=225.0
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCc---E-EEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD---L-FAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 755 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk---~-VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~g 755 (1093)
..|.+..++-.+.+.||+|+||+||+|+.+..+. . ||+|.. +......+.++..+++|.++|+.++|||||++||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~-k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTT-KGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEee-cccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3567788888899999999999999999876432 3 899944 3223456778899999999999999999999999
Q ss_pred eeccCCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 756 SFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 756 sfqd~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
++.....+|+|||+|+||+|.++|++.+ .++..+...|+.+.+.||+|||++++|||||-.+|+|++.++.+||+||||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999999999999887 499999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-Gkp 913 (1093)
++.... +.. ......-...|+|||.+...-|+.++|||||||++||+++ |..
T Consensus 309 s~~~~~-----------------------~~~----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~ 361 (474)
T KOG0194|consen 309 SRAGSQ-----------------------YVM----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAE 361 (474)
T ss_pred ccCCcc-----------------------eee----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCC
Confidence 985310 000 0001124578999999999999999999999999999999 899
Q ss_pred CCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 914 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
||.+....++..+|....++.+ .|...+.++..++.+|+..||++||++..+.+.+
T Consensus 362 Py~g~~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 362 PYPGMKNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred CCCCCCHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 9999999999999977776655 3578889999999999999999999976555544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.22 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=209.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCc----EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk----~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
+...+|++++.||+|+||+||+|.++.+|. .+|+|.. ++.. .......+.+|+.+|..++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~-~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEec-cCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 345789999999999999999999887765 5888833 3221 23455678899999999999999999999887
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
...++||||+++|+|.+++.+. +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7899999999999999999864 46899999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.... .........+++.|+|||.+....++.++|+|||||++|||++ |.+||.+
T Consensus 160 ~~~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 160 DVDE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred cCcc-------------------------cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 1000 0000112234678999999988899999999999999999998 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
....++...+..... ++ .+...+..+.++|.+||..||.+||++..+.+
T Consensus 215 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 215 IPAVEIPDLLEKGER-LP-QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHhCCCC-CC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 888888777765432 22 34567899999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=322.11 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=209.1
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++.+.||+|+||.||++.... +..+|+|.+. .. ......+.+|+.+++.++|+||+++++.+.. ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~-~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMK-PG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP 74 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecC-CccEEEEecC-CC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence 4567899999999999999999998654 5669999442 21 2235678899999999999999999999988 77
Q ss_pred eEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 89999999999999999763 3578888999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. .........++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+
T Consensus 155 ~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 155 N--------------------------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred C--------------------------CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 0 0001112346678999999998889999999999999999998 999999888
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.......+... ...+ .+...+.++.++|.+||..||.+||++..+..+|+
T Consensus 209 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 209 NPEVIRALERG-YRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred HHHHHHHHhCC-CCCC-CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 77777666543 2222 34678899999999999999999999776666553
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.01 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=209.9
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCC-------CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVV 751 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~T-------Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIV 751 (1093)
..+.+...+|++.+.||+|+||.||+|++... +..||+|.+ +.. ........+.+|+.++.++ +||||+
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDD--ATDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEc-ccc--cCHHHHHHHHHHHHHHHhhcCCCCee
Confidence 34556667899999999999999999986432 236899943 321 2234567889999999999 799999
Q ss_pred EEeeeeccCCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecC
Q 001354 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLK 815 (1093)
Q Consensus 752 kL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIK 815 (1093)
++++++.....+|+||||+++|+|.+++.+.. .++...+..++.||+.||.|||++||+|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 99999999999999999999999999997532 36778888899999999999999999999999
Q ss_pred CCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 816 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 816 PeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
|+|||++.++.+||+|||+++...... .........++..|+|||++.+..++.+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 216 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQ 216 (334)
T ss_pred cceEEEcCCCcEEECCcccceeccccc-------------------------ccccccCCCcCceEcCHHHhccCCcCch
Confidence 999999999999999999987421000 0001112334578999999999999999
Q ss_pred ceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 896 ADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 896 sDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
+|||||||+||||++ |.+||.+.+..+....+..... +..+...+.++.+||.+||..+|.+||++.++.+
T Consensus 217 ~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 217 SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 999999999999998 8999999888888777755432 2234678899999999999999999999543333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=362.23 Aligned_cols=262 Identities=28% Similarity=0.481 Sum_probs=212.6
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~ 760 (1093)
..+.-..|++++.||+||.++||++...+. ..||+|++ .........+.-+.+|+..|.+++ |.+||+||++-..+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv--~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKV--VLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHH--HHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 345667899999999999999999997654 45666644 233344566788999999999997 99999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~-LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+.+||||||=. .||..+|++... ++...+++|..|++.|+.++|+.||||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99999999865 499999988765 44468999999999999999999999999999999995 6999999999998542
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-----------CCccceeecchhhHHHH
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEF 908 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-----------Ys~ksDVWSLGVILYEM 908 (1093)
.. + -.....+.+||+.||+||.+.... .+.++||||||||||+|
T Consensus 511 ~D-T------------------------TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM 565 (677)
T KOG0596|consen 511 PD-T------------------------TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM 565 (677)
T ss_pred cc-c------------------------cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence 11 1 122346789999999999997543 35689999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHhcc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 909 ITGIPPFTAES-PEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 909 LTGkpPF~~~s-~~ei~~kIl~~--~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+.|++||.... ...-+..|..- .++||.++... ++.++++.||.+||.+||+ +.++|+|||+..+
T Consensus 566 vYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~s---i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 566 VYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWS---IPELLQHPFLQIQ 633 (677)
T ss_pred HhcCCchHHHHHHHHHHHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCC---cHHHhcCcccccc
Confidence 99999997643 33334444443 45777655443 4999999999999999999 8899999999753
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.67 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=195.0
Q ss_pred EeeeccCCeEEEEEEECC--CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEec
Q 001354 693 KPISRGAFGRVFLARKRT--TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~--TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
+.||+|+||.||+|.+.. ++..+|+|.+ +... .......+.+|+.++..++||||+++++++.+...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~-~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEec-CCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 368999999999998653 4567899944 2211 1233457889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 771 NGGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 771 ~GGSL~dlL~k~g-----~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
++|+|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++++||+|||+++......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~--- 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED--- 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc---
Confidence 9999999997532 35667788899999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-------CCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-------~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.........|++.|+|||++.+. .++.++|+|||||++|||++ |.+||..
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 155 ----------------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred ----------------------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 00011235678899999998642 35789999999999999996 9999988
Q ss_pred CChHHHHHHHhcc-CC--CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 918 ESPEIIFDNILNR-KI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 918 ~s~~ei~~kIl~~-~l--~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
....+........ .. +.|.+....+..+.++|.+|+ .+|++||+++++...|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 213 LSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 7766654443332 22 223334467889999999998 58999999666655544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=326.14 Aligned_cols=232 Identities=34% Similarity=0.538 Sum_probs=193.3
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCChHH
Q 001354 698 GAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 777 (1093)
Q Consensus 698 G~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGSL~d 777 (1093)
|.||.||+|+++.+++.||+|.+.+. . .+..|...+....||||+++++++......|+||||++||+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~-~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKS-S--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecch-h--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 89999999999999999999965322 1 12334455556679999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCC
Q 001354 778 LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857 (1093)
Q Consensus 778 lL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~ 857 (1093)
++.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------------------ 136 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------------------ 136 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccc------------------
Confidence 99888889999999999999999999999999999999999999999999999999876321
Q ss_pred CCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCC
Q 001354 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCV 937 (1093)
Q Consensus 858 ~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~i 937 (1093)
.......++..|+|||.+.+..++.++|+||+||++|||++|..||...... + ..... ..+
T Consensus 137 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~-~~~ 197 (237)
T cd05576 137 ------------DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTT-LNI 197 (237)
T ss_pred ------------cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccc-cCC
Confidence 0112345678899999998888999999999999999999999998653221 1 11111 123
Q ss_pred CCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCC
Q 001354 938 PSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 975 (1093)
Q Consensus 938 p~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFF 975 (1093)
+..+++.+++||.+||+.||.+||++ ..+.++++||||
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 46789999999999999999999995 356999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=330.12 Aligned_cols=248 Identities=31% Similarity=0.490 Sum_probs=202.2
Q ss_pred eEEEeeeccCCeEEEEEEEC----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 690 EIIKPISRGAFGRVFLARKR----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
++.+.||.|+||.||+|.+. ..+..|++|.+ +. .......+.+.+|++++.+++||||+++++++.....+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~-~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKIL-KP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEE-ST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEe-cc--ccccccceeeeecccccccccccccccccccccccccccc
Confidence 57789999999999999998 45678999944 32 2233457889999999999999999999999998888999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|+||+|+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~-- 156 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK-- 156 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 99999999999999886 67999999999999999999999999999999999999999999999999998752100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~e 922 (1093)
..........+...|+|||++.+..++.++||||||++||||++ |+.||.+.+..+
T Consensus 157 -----------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 157 -----------------------SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp -----------------------SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred -----------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 00112233456789999999998889999999999999999999 789999998888
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
+...+..... +..+..++..+.+||.+||..||.+||++.++.
T Consensus 214 ~~~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~ 256 (259)
T PF07714_consen 214 IIEKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEIL 256 (259)
T ss_dssp HHHHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHH
T ss_pred cccccccccc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 8888855433 224578899999999999999999999954443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.59 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=202.8
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEE-----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 756 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~-----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gs 756 (1093)
....++|++.+.||+|+||+||+|++ ..+++.||+|++ +.. ........+.+|+.+|..+ +||||++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEe-ccC--CChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 45567899999999999999999985 346789999954 321 1233456788999999999 68999999988
Q ss_pred eccC-CceEEEEEecCCCChHHHHHhc-----------------------------------------------------
Q 001354 757 FTCR-DNLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 782 (1093)
Q Consensus 757 fqd~-~~LyLVMEYm~GGSL~dlL~k~----------------------------------------------------- 782 (1093)
+... ..+|+||||+++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 7654 4689999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCC
Q 001354 783 --------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848 (1093)
Q Consensus 783 --------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~ 848 (1093)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------ 233 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------ 233 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc------
Confidence 136777888899999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHH
Q 001354 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 927 (1093)
Q Consensus 849 ~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kI 927 (1093)
.........+++.|+|||++.+..++.++|+|||||++|||++ |..||............
T Consensus 234 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 294 (343)
T cd05103 234 -------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294 (343)
T ss_pred -------------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence 0001122346778999999999999999999999999999997 99999876544333333
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 928 l~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
+..... +..+..+++++.+++.+||+.||.+||+ +.+|++|
T Consensus 295 ~~~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rps---~~eil~~ 335 (343)
T cd05103 295 LKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 335 (343)
T ss_pred HhccCC-CCCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 333222 2234567899999999999999999999 4555543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.11 Aligned_cols=257 Identities=20% Similarity=0.317 Sum_probs=210.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECC----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
+..++|++.+.||+|+||.||+|.+.. ++..+++|.+ +. .........+.+|..+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~-~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KD--HASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEc-cC--CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 456789999999999999999999876 3578888844 32 2234556788999999999999999999997655
Q ss_pred -CCceEEEEEecCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEE
Q 001354 760 -RDNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 830 (1093)
Q Consensus 760 -~~~LyLVMEYm~GGSL~dlL~k~--------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLs 830 (1093)
....+++++|+++|+|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 56789999999999999999753 358899999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT 910 (1093)
|||+++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 160 d~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~ 214 (280)
T cd05043 160 DNALSRDLFPMDY-------------------------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214 (280)
T ss_pred CCCCcccccCCce-------------------------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhc
Confidence 9999974211000 000112345778999999999899999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 911 -GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 911 -GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|++||...++.++...+... ..++ .+..+++++.++|.+||..||++||++.++.+.|
T Consensus 215 ~g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 215 LGQTPYVEIDPFEMAAYLKDG-YRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred CCCCCcCcCCHHHHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999988887777665543 2322 2456789999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=397.25 Aligned_cols=259 Identities=35% Similarity=0.573 Sum_probs=219.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
++.-...||.|.||.||-|.+.+||+..|+|.|.- ..........+.+|..+|..++|||+|++|++-...+..||.|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~i--q~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKI--QDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhc--CccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34556689999999999999999999999996632 2233556677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|||.||+|.+++...+..+|...+.|..|++.|+.|||+.|||||||||.||||+.+|.+|++|||.|+.+..+ ..+
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~-~~~-- 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN-AQT-- 1390 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc-hhc--
Confidence 99999999999998888999999999999999999999999999999999999999999999999999864211 100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCCCCCChH-HH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 923 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~-ei 923 (1093)
. .......+|||.|||||++.+ ++.+.++|||||||++.||+||+.||...+.. .+
T Consensus 1391 ----------------~----~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI 1450 (1509)
T KOG4645|consen 1391 ----------------M----PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI 1450 (1509)
T ss_pred ----------------C----CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH
Confidence 0 122346789999999999986 46788999999999999999999999876543 33
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
+-.+..+.. |.+|..+|++.+|||.+||..||++|++ +.||++|.|-+
T Consensus 1451 My~V~~gh~--Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1451 MYHVAAGHK--PQIPERLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGK 1498 (1509)
T ss_pred HhHHhccCC--CCCchhhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhccc
Confidence 333333322 5566789999999999999999999998 77999998865
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.38 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=212.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|...+.||.|+||.||+|+++.++..+|+|.+. ............+.+|+.+++.++|||++++++++......|+|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEe-cccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 44778899999999999999999999999999553 22222334456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 166 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec------
Confidence 99997 588877754 4468999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......|++.|+|||++. ...++.++|||||||++|+|++|..||...+..+
T Consensus 167 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 167 -------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred -------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 012346889999999985 3467889999999999999999999998877665
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
....+.....+.. .+..++..+.+||.+||..+|.+||+ +.+++.||||...
T Consensus 222 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~ 273 (308)
T cd06634 222 ALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhcCCCCc-CcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCcccccc
Confidence 5555554433221 23568899999999999999999999 8899999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.34 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=203.1
Q ss_pred EeeeccCCeEEEEEEECCCC------cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 693 KPISRGAFGRVFLARKRTTG------DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TG------k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.||+|+||.||+|+++... ..+|+|.+.+. ........+.+|+.+|+.++||||+++++++......|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 36999999999999987544 67899944222 1123456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-----cEEEEecCC
Q 001354 767 MEYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGL 834 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~-------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-----~VKLsDFGL 834 (1093)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999999743 2478889999999999999999999999999999999999888 899999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-Gkp 913 (1093)
++....... ........++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 158 ~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~ 212 (269)
T cd05044 158 ARDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212 (269)
T ss_pred ccccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCC
Confidence 874211000 001123356789999999999999999999999999999998 999
Q ss_pred CCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 914 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
||...+..+....+..... +..+..++..+.+||.+||..+|.+||+++++.+.++
T Consensus 213 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 213 PYPALNNQEVLQHVTAGGR--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCcccCHHHHHHHHhcCCc--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9998887777776654332 1234678999999999999999999999666655553
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.56 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=205.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++.+.||+|+||.||++.. +++.||+|.+ +. . .....+.+|+.++..++||||+++++++... ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~-~~-~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 73 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNI-KC-D----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL 73 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEee-cC-c----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-Cc
Confidence 4567899999999999999999864 6888999954 22 1 1235788999999999999999999998764 57
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~- 152 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM- 152 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc-
Confidence 99999999999999997654 478999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~ 920 (1093)
.......+..|+|||.+.+..++.++|+|||||++|||++ |.+||...+.
T Consensus 153 -----------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 153 -----------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred -----------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 0011234568999999998899999999999999999997 9999999888
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.+....+..+. .. ..+..++..+.+||.+||+.+|.+||++.++.+.++
T Consensus 204 ~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 204 KEVKECVEKGY-RM-EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHHhCCC-CC-CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 77776665442 22 234678999999999999999999999666655543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=379.00 Aligned_cols=266 Identities=26% Similarity=0.384 Sum_probs=205.6
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++.+.||+|+||.||+|++..+|+.||+|++. +..........++.+|+.++..++||||+++++++.+.+..|+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~-~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEEC-cccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 468999999999999999999999999999999553 2222223345678999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 766 VMEYLNGGDLYSLLRKV-----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~-----------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
||||++||+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999999998642 1245566788999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
++......... .....................+||+.|||||++.+..++.++|||||||++|||++|.+|
T Consensus 160 Ak~i~~~~~~~---------~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 160 AIFKKLEEEDL---------LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred ceecccccccc---------cccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 98531110000 000000000000011122346899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHH-HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q 001354 915 FTAESPEIIFDN-ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 915 F~~~s~~ei~~k-Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
|.......+... .......++ ....+++.+.+++.+||..||.+|++
T Consensus 231 F~~~~~~ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 231 YRRKKGRKISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred CCCcchhhhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcC
Confidence 987655433322 111111111 12468899999999999999999988
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=323.72 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=206.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCC---CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~T---Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
+..++|.+.+.||.|+||.||+|.+... ...+|+|..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC---TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 3456799999999999999999987654 346888944222 113455688999999999999999999998876
Q ss_pred CceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
...|+||||+++|+|.+++.+.. .+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 45789999999999999997644 58999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
... ........+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.
T Consensus 159 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 159 DES--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred ccc--------------------------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 100 001112335678999999988899999999999999999996 99999988
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
+..+....+..+.. +..+..++.++.+||.+||..+|.+||++.++.+
T Consensus 213 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 213 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 87777766655432 2235788999999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=326.32 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=196.8
Q ss_pred eeEEEeeeccCCeEEEEEEE----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cc
Q 001354 689 FEIIKPISRGAFGRVFLARK----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DN 762 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~--~~ 762 (1093)
|++++.||+|+||+||++.. ..++..||+|.+. ... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~-~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-REC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEec-ccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 38999999999999988753 4568899999542 211 123456788999999999999999999987654 35
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 89999999999999999764 59999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH-
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE- 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~- 921 (1093)
..........++..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 162 ------------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~ 217 (283)
T cd05080 162 ------------------------EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF 217 (283)
T ss_pred ------------------------hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh
Confidence 0000111234567899999999888999999999999999999999998654321
Q ss_pred -HH------------HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 922 -II------------FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 922 -ei------------~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+. ....+..... +..+..++.++.+|+.+||+.||.+||++.++.+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 218 EEMIGPKQGQMTVVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhhhcccccccchhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 00 0111111112 123567889999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.95 Aligned_cols=237 Identities=23% Similarity=0.376 Sum_probs=191.7
Q ss_pred EeeeccCCeEEEEEEECCCCcE-------EEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 693 KPISRGAFGRVFLARKRTTGDL-------FAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~-------VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+.||.|+||.||+|.++.++.. +|+|.+ . .......+.+.+|..+|..++||||+++++++......++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~-~---~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL-D---KSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhh-c---chhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 3699999999999998765543 666632 2 2223445678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc--------EEEEecCCcc
Q 001354 766 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSK 836 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~--------VKLsDFGLAk 836 (1093)
||||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999997654 5899999999999999999999999999999999999988765 6889999876
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhC-CCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG-IPP 914 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTG-kpP 914 (1093)
... ......|++.|+|||++.+ ..++.++|||||||++|||++| .+|
T Consensus 157 ~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~ 205 (258)
T cd05078 157 TVL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205 (258)
T ss_pred ccC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 310 1123468899999999986 4589999999999999999998 577
Q ss_pred CCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 915 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
|...++..... +......+| ...+.++.+||.+||+.||.+||+ +.+|++
T Consensus 206 ~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 255 (258)
T cd05078 206 LSALDSQKKLQ-FYEDRHQLP---APKWTELANLINQCMDYEPDFRPS---FRAIIR 255 (258)
T ss_pred hhhccHHHHHH-HHHccccCC---CCCcHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 77766654433 233333333 567789999999999999999999 445543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=363.71 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=213.5
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
+.|++.++...-++-||.|+-|.||+|+.+ ++.||||++ +.+++ .++.-|++|+||||+.+.++|..
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV----~elkE-------TdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKV----RELKE-------TDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHH----hhhhh-------hhHHHHHhccCcceeeEeeeecC
Confidence 445666677777888999999999999987 789999933 32222 35667889999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
...+|||||||+.|-|+.+|+....++......+..+|+.||.|||.+.|||||||.-||||..+..|||+|||-++...
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999887421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
......+++||..|||||++.+.+.+.++|||||||+|||||||..||.+.+
T Consensus 264 ----------------------------~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 264 ----------------------------DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred ----------------------------hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 1223457999999999999999999999999999999999999999999877
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
...++--+-.+.+.+| .|...+.-++-||+.||+-.|.+||+ ..+||.|
T Consensus 316 ssAIIwGVGsNsL~Lp-vPstcP~GfklL~Kqcw~sKpRNRPS---Frqil~H 364 (904)
T KOG4721|consen 316 SSAIIWGVGSNSLHLP-VPSTCPDGFKLLLKQCWNSKPRNRPS---FRQILLH 364 (904)
T ss_pred hheeEEeccCCccccc-CcccCchHHHHHHHHHHhcCCCCCcc---HHHHHHH
Confidence 6655444434444444 45789999999999999999999999 5567766
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=318.58 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=201.8
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
+.||.|+||.||++.+.. ++.||+|.+ +.... ......+.+|+.+++.++||||+++++++......|+||||++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~-~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTC-RSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEec-cccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999987 999999944 22221 23556789999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 773 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 773 GSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
++|.+++.+. ..+++..+..++.+++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~--------- 147 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI--------- 147 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc---------
Confidence 9999999764 468889999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhcc
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 930 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~ 930 (1093)
.........++..|+|||++.+..++.++|+|||||++|||++ |..||...........+...
T Consensus 148 ----------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~ 211 (251)
T cd05041 148 ----------------YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG 211 (251)
T ss_pred ----------------ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC
Confidence 0000112234677999999998899999999999999999999 89999988877777666543
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 931 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 931 ~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
. ..+ .+..++.++.+||.+||+.+|.+||++.++.
T Consensus 212 ~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell 246 (251)
T cd05041 212 Y-RMP-APQLCPEEIYRLMLQCWAYDPENRPSFSEIY 246 (251)
T ss_pred C-CCC-CCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 2 212 3467899999999999999999999954433
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.72 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=200.5
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCC
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
++||.|+||.||+|... ++..+|+|.+. .. ........+.+|+.++..++||||+++++.+......|+||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~-~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCK-ED--LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecC-Cc--CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 36999999999999865 58899999442 21 1223345688999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 773 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 773 GSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
|+|.+++... ..+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~---------- 146 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG---------- 146 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc----------
Confidence 9999998754 46889999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhcc
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 930 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~ 930 (1093)
. ........+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.........+...
T Consensus 147 --~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 147 --I--------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred --c--------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 0 000112234678999999998889999999999999999998 99999988877776666543
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 931 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 931 ~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
. . +..+..++..+.+||.+||..+|++||++.++.+
T Consensus 211 ~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 211 Y-R-MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred C-C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2 1 2234678999999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=351.32 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=211.1
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~ 754 (1093)
.+.+..++|.+.+.||+|+||.||+|++. .++..||+|++ +.. ........+.+|+.+|..+. |||||+++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l-~~~--~~~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKML-KST--ARSSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEec-CCC--CChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 45677889999999999999999999964 34568999954 322 12334457889999999998 99999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhcC---------------------------------------------------
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG--------------------------------------------------- 783 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~g--------------------------------------------------- 783 (1093)
+++.....+|+||||+++|+|.+++++..
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999999999999999999999996531
Q ss_pred -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCC
Q 001354 784 -----------------------------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 816 (1093)
Q Consensus 784 -----------------------------------------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKP 816 (1093)
.++...++.|+.||+.||.|||+.+|+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 256667788999999999999999999999999
Q ss_pred CcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001354 817 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 896 (1093)
Q Consensus 817 eNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 896 (1093)
+|||++.++.+||+|||+++...... .........|++.|||||++.+..++.++
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 322 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDS-------------------------NYISKGSTFLPLKWMAPESIFNNLYTTLS 322 (401)
T ss_pred ceEEEeCCCEEEEEecCcceeccccc-------------------------ccccCCCcCCCCceeChHHhcCCCCCcHh
Confidence 99999999999999999987421000 00111234678999999999988899999
Q ss_pred eeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 897 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 897 DVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|||||||++|||++ |..||......+.....+...... ..+..++.++.+||.+||..+|.+||++.++.+.|
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999998 899998776655554444444332 24567899999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=321.55 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=198.1
Q ss_pred EeeeccCCeEEEEEEECC---CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec-cCCceEEEEE
Q 001354 693 KPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNLYLVME 768 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~---TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq-d~~~LyLVME 768 (1093)
+.||+|+||.||+|.+.. .+..+|+|.+.. .........+.+|+.+++.++||||+++++.+. .+...|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR---ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc---cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 368999999999998754 345799994421 122345678889999999999999999999765 4556899999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 769 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~---- 153 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY---- 153 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc----
Confidence 99999999999764 3467777888999999999999999999999999999999999999999999874210000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDN 926 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~k 926 (1093)
..........+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..++...
T Consensus 154 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 214 (262)
T cd05058 154 -------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214 (262)
T ss_pred -------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 00011123356788999999998899999999999999999999 6788888887777776
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+..... +..+..++..+.++|.+||..+|++||++.++...+
T Consensus 215 ~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 215 LLQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred HhcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 655432 223466789999999999999999999955444443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=324.17 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=198.8
Q ss_pred CCeeEEEeeeccCCeEEEEEEE----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--C
Q 001354 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--R 760 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd--~ 760 (1093)
.+|++++.||+|+||.||+|.. ..++..||+|.+. . ........+.+|+.+|..++||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~-~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-H---STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEec-c---CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 5799999999999999999984 4578899999542 2 233456778999999999999999999987654 3
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..+|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 4689999999999999999764 468999999999999999999999999999999999999999999999999988531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.... .........++..|+|||++.+..++.++|+|||||++|||++|..|+....
T Consensus 160 ~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 215 (284)
T cd05081 160 QDKE------------------------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP 215 (284)
T ss_pred CCCc------------------------ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc
Confidence 1000 0000111234556999999998899999999999999999999887765432
Q ss_pred hHH---------------HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 920 PEI---------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 920 ~~e---------------i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
... ....++.....+| .+..++.++.+||.+||..+|++||++.++...+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 216 AEFMRMMGNDKQGQMIVYHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred hhhhhhcccccccccchHHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 110 0111222232322 3467889999999999999999999955544433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=364.42 Aligned_cols=254 Identities=26% Similarity=0.470 Sum_probs=219.5
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc--eEEEE
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--LYLVM 767 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~--LyLVM 767 (1093)
++..+||+|+|-+||+|.+..+|..||--.+--..........+++..|+.+|+.|+|||||++|+++.+..+ +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4556899999999999999999998885533112223345567999999999999999999999999998876 89999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEcc-CCcEEEEecCCcccccccccc
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~-dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
|++..|+|..|+++.+.++...++.|++||+.||.|||++. |||||||.+||+|+. -|.|||+|+|||++..
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----- 197 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh-----
Confidence 99999999999999999999999999999999999999995 999999999999975 4899999999998631
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC-CChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~-~s~~ei 923 (1093)
...+.+.+|||.|||||++. ..|+..+||||||++|.||+|+..||.. .++.++
T Consensus 198 ------------------------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI 252 (632)
T KOG0584|consen 198 ------------------------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI 252 (632)
T ss_pred ------------------------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence 22345689999999999997 7899999999999999999999999974 678999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
|+++..+..+- .+..--.+++++||.+||.. ...||+ |.|+|.||||..-
T Consensus 253 YKKV~SGiKP~-sl~kV~dPevr~fIekCl~~-~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 253 YKKVTSGIKPA-ALSKVKDPEVREFIEKCLAT-KSERLS---AKELLKDPFFDED 302 (632)
T ss_pred HHHHHcCCCHH-HhhccCCHHHHHHHHHHhcC-chhccC---HHHHhhChhhccc
Confidence 99998876541 12233468999999999998 999999 8999999999853
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=323.45 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=189.9
Q ss_pred EeeeccCCeEEEEEEECCC------------CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 693 KPISRGAFGRVFLARKRTT------------GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~T------------Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
+.||+|+||.||+|..... ...+++|. +.. ........+.+|..++..++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~-~~~---~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKV-LDP---SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEee-cCh---hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3689999999999986432 22467773 222 2234456788899999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc-------EEEEec
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-------IKLTDF 832 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~-------VKLsDF 832 (1093)
...++||||+++|+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++. +|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999999988754 56899999999999999999999999999999999999987664 899999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeecchhhHHHHH-h
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFI-T 910 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDVWSLGVILYEML-T 910 (1093)
|++.... ......||+.|+|||++. +..++.++|||||||+||||+ .
T Consensus 157 g~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 157 GIPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 9886321 112346788999999987 567899999999999999998 5
Q ss_pred CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 911 GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
|.+||......+... +....... ....+.++.+||.+||+.||.+||+ +.+|+.
T Consensus 206 ~~~p~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rp~---~~~il~ 259 (262)
T cd05077 206 GEIPLKDKTLAEKER-FYEGQCML---VTPSCKELADLMTHCMNYDPNQRPF---FRAIMR 259 (262)
T ss_pred CCCCCCCcchhHHHH-HHhcCccC---CCCChHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999998766544432 22332222 2345688999999999999999999 556654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.47 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=197.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEE----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--
Q 001354 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 760 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~-- 760 (1093)
.-|++++.||+|+||.||+++. +.++..||+|.+ +.. ........+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~-~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEc-Ccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3578999999999999999985 457889999954 221 1233456789999999999999999999988875
Q ss_pred CceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..+|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 56899999999999999997653 58999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
... ..........|+..|+|||++.+..++.++|+|||||++|||+++..|+....
T Consensus 161 ~~~------------------------~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~ 216 (284)
T cd05079 161 TDK------------------------EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM 216 (284)
T ss_pred cCc------------------------cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence 000 00011123567888999999998889999999999999999999877653311
Q ss_pred --------------hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc
Q 001354 920 --------------PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965 (1093)
Q Consensus 920 --------------~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~ 965 (1093)
........+.....++ .+..++..+.+||.+||+.||.+||++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 275 (284)
T cd05079 217 TLFLKMIGPTHGQMTVTRLVRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQN 275 (284)
T ss_pred chhhhhcccccccccHHHHHHHHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 0111111222222222 35678999999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.37 Aligned_cols=252 Identities=31% Similarity=0.503 Sum_probs=208.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECC-CCcEEEEEEeehhhh------hhchhHHHHHHHHHHHHHh-cCCCceEEEeeeecc
Q 001354 688 DFEIIKPISRGAFGRVFLARKRT-TGDLFAIKQVLKKLD------MIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC 759 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~-TGk~VAIKkILkK~~------~~~~~eie~~l~E~~IL~k-L~HPNIVkL~gsfqd 759 (1093)
+|++.+.||+|+||.||+|.++. ++..+|+|.+..... .........+..|..++.+ ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 788999996532211 1223445667888888875 789999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
.+.+|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
+..... ........|+..|+|||++.+..++.++|+||||+++|||++|.+|
T Consensus 161 ~~~~~~----------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQP----------------------------ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccc----------------------------ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 874210 0012345689999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 915 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
|...........+...... |.....+++++.+||.+||..||.+||++.++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred ccccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 9888777777666654433 2223467899999999999999999999554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=359.74 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=218.9
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|.-++.||.|+||.||.+++..+.+.||||++-- ...........++.|+..|.+++|||+|.+-+||..+...|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsy-SGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccc-cccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 6667899999999999999999999999995522 122233456789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 769 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||-| +-.++|.-+ .++-+.++.-++.+.+.||.|||+.+.||||||..||||.+.|.|||+|||.|...
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--------- 176 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--------- 176 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---------
Confidence 9965 888888643 46889999999999999999999999999999999999999999999999988752
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
..+.+++|||.||||||++. +.|+-++||||||++..||.-.+||+.+.+.+...
T Consensus 177 ----------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL 234 (948)
T KOG0577|consen 177 ----------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 234 (948)
T ss_pred ----------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH
Confidence 24568999999999999974 57999999999999999999999999999888777
Q ss_pred HHHhccCCC-CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 925 DNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 925 ~kIl~~~l~-fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
--|..+..+ ++ ...+|..+..||..||++-|.+||| ..+++.|+|...
T Consensus 235 YHIAQNesPtLq--s~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~R 283 (948)
T KOG0577|consen 235 YHIAQNESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVLR 283 (948)
T ss_pred HHHHhcCCCCCC--CchhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhcc
Confidence 777665433 23 3678999999999999999999999 789999999853
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.97 Aligned_cols=248 Identities=19% Similarity=0.286 Sum_probs=194.8
Q ss_pred eeeccCCeEEEEEEECCCC--cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecC
Q 001354 694 PISRGAFGRVFLARKRTTG--DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k~TG--k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
.||+|+||.||+++....+ ..+++|.+ +.. ........+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~-~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKEL-KAN--ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEe-cCC--CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 6999999999999765432 34555632 221 123345789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 772 GGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 772 GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
+|+|.+++.+. ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~------ 152 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE------ 152 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc------
Confidence 99999999764 23567778899999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
.........+|++.|+|||++.. ..++.++|||||||++|||++ |.+||...+
T Consensus 153 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 153 -------------------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred -------------------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 00011224578999999999853 245779999999999999997 688998888
Q ss_pred hHHHHHHHhccCC---CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 920 PEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 920 ~~ei~~kIl~~~l---~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
..+.+..++.+.. .-|.++..+++.+.++|..|| .+|.+||+++++.+.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 7777777655422 224455678999999999999 5899999966555544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.87 Aligned_cols=233 Identities=24% Similarity=0.314 Sum_probs=189.7
Q ss_pred EeeeccCCeEEEEEEECCCC----------cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 693 KPISRGAFGRVFLARKRTTG----------DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TG----------k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
+.||+|+||.||+|.+..++ ..+++| ++.... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k-~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLK-VLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeee-ccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 36999999999999998777 246666 322211 115778899999999999999999999888 77
Q ss_pred eEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-------cEEEEecCC
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-------HIKLTDFGL 834 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-------~VKLsDFGL 834 (1093)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998766 789999999999999999999999999999999999999888 899999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeecchhhHHHHHh-C
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFIT-G 911 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDVWSLGVILYEMLT-G 911 (1093)
+.... ......+++.|+|||++.+. .++.++|+|||||++|||++ |
T Consensus 155 a~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 155 PITVL-------------------------------SREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred ccccc-------------------------------cccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 87421 01234577889999999876 78999999999999999999 6
Q ss_pred CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 912 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 912 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
..||...+..+...... .....| ......+.+||.+||..+|.+||++.++
T Consensus 204 ~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i 254 (259)
T cd05037 204 EEPLSTLSSSEKERFYQ-DQHRLP---MPDCAELANLINQCWTYDPTKRPSFRAI 254 (259)
T ss_pred CCCcccCCchhHHHHHh-cCCCCC---CCCchHHHHHHHHHhccChhhCCCHHHH
Confidence 88998776544433332 222222 2234899999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=329.05 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=204.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcE----EEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~----VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
+..++|+..+.||+|+||.||+|++..+|.. +|+|.+ ... ........+.+|+.++..++||||+++++.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NET--TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEec-ccc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 4567899999999999999999999887764 577733 221 122334568899999999999999999999876
Q ss_pred CCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
. ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4 4789999999999999997654 5899999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.... .........+++.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 160 ~~~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDE-------------------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCcc-------------------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1000 0011123456789999999999999999999999999999997 9999988
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
.........+.. ...+| .+...+..+.++|.+||..||++||++.++.+
T Consensus 215 ~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 215 IPTREIPDLLEK-GERLP-QPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred CCHHHHHHHHHC-CCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 776665554433 33323 24567899999999999999999999554333
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.85 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=204.1
Q ss_pred eeEEEeeeccCCeEEEEEEECC---CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 689 FEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~---TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
|.+.++||+|+||.||+|.++. ++..+|+|++. .........+.+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK--ADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEec--cccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 6778899999999999998653 57899999553 22333445677899999999999999999999876542
Q ss_pred --ceEEEEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 762 --NLYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 762 --~LyLVMEYm~GGSL~dlL~k~------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
..+++++|+++|+|.+++... ..++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence 247899999999999887532 247889999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-Gk 912 (1093)
+++...... .........+++.|++||.+.+..++.++|||||||++|||++ |.
T Consensus 159 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~ 213 (273)
T cd05074 159 LSKKIYSGD-------------------------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213 (273)
T ss_pred ccccccCCc-------------------------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCC
Confidence 987421100 0001122346678999999999999999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+||.+.+..+.+..+..... +..+...+..+.+|+.+||..+|.+||++.++.+.+
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 214 TPYAGVENSEIYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred CCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99998888877777665432 122357889999999999999999999965554444
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=358.44 Aligned_cols=258 Identities=19% Similarity=0.340 Sum_probs=214.9
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..|.+..+++.+...||+|.||+||+|+|-. .|||| +++. ......+.+.|.+|+.+|++-+|.||+-+.|++..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK-~Lnv-~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVK-LLNV-DDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEE-EEec-CCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 5678889999999999999999999999974 48999 5543 44456689999999999999999999999999988
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+.. .||+.+|.|-+|+.+|+-. ..|....++.|+.||++||.|||.++|||||||..||+|.+++.|||+||||+..-
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 876 9999999999999999854 46999999999999999999999999999999999999999999999999999741
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
. -| .........-|...|||||++.- .+|++.+|||||||++|||++|..||
T Consensus 539 ~-----------------------~w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 539 T-----------------------RW--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred e-----------------------ee--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 1 01 12223345568899999999974 47899999999999999999999999
Q ss_pred CCCChHHHHHHHhccCC--CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 916 TAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l--~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
...+.+.++-.+-.+.+ ....+....+.++++|+..||.+++++||.+..+..
T Consensus 594 si~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 594 SIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 97666665544433322 111223566779999999999999999999655444
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=325.62 Aligned_cols=236 Identities=25% Similarity=0.331 Sum_probs=189.6
Q ss_pred eeeccCCeEEEEEEECCCC------------------------cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc
Q 001354 694 PISRGAFGRVFLARKRTTG------------------------DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k~TG------------------------k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN 749 (1093)
.||+|+||.||+|....++ ..+|+| ++... .......+.+|..+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k-~~~~~---~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLK-VLDPS---HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEE-ecChH---HHHHHHHHHHHHHHHhcCCCCC
Confidence 5999999999999864322 347777 33221 2234467888999999999999
Q ss_pred eEEEeeeeccCCceEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---
Q 001354 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 825 (1093)
Q Consensus 750 IVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG--- 825 (1093)
|+++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999999875 46789999999999999999999999999999999999998654
Q ss_pred ----cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeec
Q 001354 826 ----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWS 900 (1093)
Q Consensus 826 ----~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWS 900 (1093)
.+||+|||++.... ......|++.|+|||.+.+ ..++.++|+||
T Consensus 158 ~~~~~~kl~d~g~~~~~~-------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 158 GTSPFIKLSDPGVSFTAL-------------------------------SREERVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred CccceeeecCCccccccc-------------------------------cccccccCCcccCchhhcCCCCCCcHHHHHH
Confidence 48999999876310 0112357888999999875 56899999999
Q ss_pred chhhHHHHH-hCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 901 VGIILFEFI-TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 901 LGVILYEML-TGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
|||++|||+ +|.+||....+.+.... ......+| ...++.+.+||.+||+.+|.+||+ +.+|++
T Consensus 207 lG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps---~~~il~ 271 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERTPSEKERF-YEKKHRLP---EPSCKELATLISQCLTYEPTQRPS---FRTILR 271 (274)
T ss_pred HHHHHHHHHhCCCCCccccChHHHHHH-HHhccCCC---CCCChHHHHHHHHHcccChhhCcC---HHHHHH
Confidence 999999995 69999988776554332 23333333 456788999999999999999999 556554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.03 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=203.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECC----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-- 759 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd-- 759 (1093)
..+|++.+.||+|+||.||+|++.. ++..||+|.+ +..... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~-~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEe-ccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 3578899999999999999999753 4889999954 332211 356789999999999999999999998877
Q ss_pred CCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
...+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 557999999999999999997654 5899999999999999999999999999999999999999999999999998753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
..... .........++..|+|||.+.+..++.++|+|||||++|||++|..||...
T Consensus 160 ~~~~~------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKD------------------------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCc------------------------ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 10000 000011234566799999999889999999999999999999999998764
Q ss_pred ChHH--------------HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEI--------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~e--------------i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.... ....++.....++ .+..++.++.+||.+||..+|.+||++.++.+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 216 PAEFLRMIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred cchhccccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 3221 1122233333333 2456788999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=362.15 Aligned_cols=244 Identities=36% Similarity=0.560 Sum_probs=210.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~L 763 (1093)
..++|++...+|.|+|+.|..+.+..++..+++|++ .+. .....+|..++... +||||+++++.+.+..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii-~~~-------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKII-SKR-------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheec-ccc-------ccccccccchhhhhcCCCcceeecceecCCcee
Confidence 567899999999999999999999999999999954 332 12234566565555 699999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE-ccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL-D~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+|||++.||.|.+.+.....+. ..+..|+++|+.|+.|||.+|||||||||+|||+ ++.|+++|+|||+++...
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~--- 467 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE--- 467 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc---
Confidence 99999999999999888766665 7888899999999999999999999999999999 699999999999998421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH-
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE- 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~- 921 (1093)
....+.|-|..|.|||++...+|+.+|||||||++||+||+|+.||......
T Consensus 468 ---------------------------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ 520 (612)
T KOG0603|consen 468 ---------------------------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI 520 (612)
T ss_pred ---------------------------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH
Confidence 1134568899999999999999999999999999999999999999876655
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
++..+|.... +...+|.+++|||++||+.||.+||+ +.+++.||||
T Consensus 521 ei~~~i~~~~-----~s~~vS~~AKdLl~~LL~~dP~~Rl~---~~~i~~h~w~ 566 (612)
T KOG0603|consen 521 EIHTRIQMPK-----FSECVSDEAKDLLQQLLQVDPALRLG---ADEIGAHPWF 566 (612)
T ss_pred HHHHhhcCCc-----cccccCHHHHHHHHHhccCChhhCcC---hhhhccCcch
Confidence 5555554332 33789999999999999999999999 7799999999
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.37 Aligned_cols=261 Identities=16% Similarity=0.240 Sum_probs=193.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCC---CcEEEEEEeehhhhhhc-hh------HHHHHHHHHHHHHhcCCCceEEE
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKQVLKKLDMIR-KN------DIERILAERNILITVRNPFVVRF 753 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~T---Gk~VAIKkILkK~~~~~-~~------eie~~l~E~~IL~kL~HPNIVkL 753 (1093)
+.-+.|++.+.||+|+||+||+|++..+ +..+|+|+......... +. .......+...+..+.|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3447899999999999999999999887 66777773211111000 00 01112233445566789999999
Q ss_pred eeeeccCC----ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEE
Q 001354 754 FYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 829 (1093)
Q Consensus 754 ~gsfqd~~----~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKL 829 (1093)
++++.... ..|++|+++.. ++.+.+.....+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98766554 34788888754 77777776666788999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHH
Q 001354 830 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 830 sDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEML 909 (1093)
+|||+|+....+.. .. . ..........||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 168 ~DFGla~~~~~~~~----------------~~-~---~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 168 IDYGIASHFIIHGK----------------HI-E---YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred EEcCCceeeccCCc----------------cc-c---cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999985321100 00 0 0011223457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-HH--------HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 910 TGIPPFTAESP-EI--------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 910 TGkpPF~~~s~-~e--------i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
+|.+||.+.+. .. ....+......+ ...+.++.+++..|+..+|.+||+++.+.++
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 99999987732 21 223333333332 3568899999999999999999996655444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=366.28 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=223.8
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEe
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~ 754 (1093)
....+...+..+.+.||+|+||+||+|+... ....|||| .+++.. .....++|.+|+++|..++|||||+|+
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK-~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVK-ALKDKA--ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHh-hhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 3445778888999999999999999998643 34579999 554432 234568899999999999999999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEE
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 820 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~g--------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNIL 820 (1093)
|.|...+.+|||+|||..|||..+|+... .++..+...++.||+.||+||-++.+|||||-.+|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 99999999999999999999999997431 2778889999999999999999999999999999999
Q ss_pred EccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeec
Q 001354 821 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 900 (1093)
Q Consensus 821 LD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWS 900 (1093)
|.++..|||+||||++..... | |- +......-...||+||.++..+|+.++||||
T Consensus 636 Vge~l~VKIsDfGLsRdiYss---D------------------YY----k~~~~t~lPIRWMppEsIly~kFTteSDVWs 690 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSS---D------------------YY----KVRGNTLLPIRWMPPESILYGKFTTESDVWS 690 (774)
T ss_pred eccceEEEecccccchhhhhh---h------------------hh----cccCCceeeeecCCHHHhhcCcccchhhhhh
Confidence 999999999999999953211 1 10 0111223467899999999999999999999
Q ss_pred chhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 901 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 901 LGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+||+|||+++ |..||++.+.+++...|..+++ ++ .|.+.|.++.+|+..||+.+|.+||++.++.-+|+
T Consensus 691 ~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~-~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 691 FGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS-CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred hhhhhhhhhccccCcccccchHHHHHHHHcCCc-cc-CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 9999999998 9999999999999999999887 55 47999999999999999999999999777766664
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=329.36 Aligned_cols=258 Identities=30% Similarity=0.529 Sum_probs=216.8
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~ 761 (1093)
...+++.+++..||.|+.|.||+++.+.+|..+|+|.+.+. ....+..+++..++++...+ +|+||+.|++|....
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 35678889999999999999999999999999999976543 34566788888888877765 999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..++.||.|.- -+..+|++ .+.++|..+-.+...++.||.||..+ ||||||+||+|||||+.|++||||||++-.+.
T Consensus 165 dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 165 DVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred hHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 99999999854 45556654 35799999999999999999999865 89999999999999999999999999987532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
. ........|-+.|||||.+.. ..|+..+||||||++++||.||..||.
T Consensus 244 d----------------------------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~ 295 (391)
T KOG0983|consen 244 D----------------------------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK 295 (391)
T ss_pred c----------------------------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence 1 112233579999999999864 479999999999999999999999999
Q ss_pred CCC-hHHHHHHHhccCCCCCCCC--CCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 917 AES-PEIIFDNILNRKIPWPCVP--SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 917 ~~s-~~ei~~kIl~~~l~fP~ip--~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+.+ .-++..+|++... |.++ .++|+.+++|+..||++|+.+||. -.++|+|||+..
T Consensus 296 ~c~tdFe~ltkvln~eP--P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 296 GCKTDFEVLTKVLNEEP--PLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKR 354 (391)
T ss_pred CCCccHHHHHHHHhcCC--CCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceee
Confidence 854 5677777877544 3333 458999999999999999999999 568999999964
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=362.40 Aligned_cols=254 Identities=26% Similarity=0.458 Sum_probs=208.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC-
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR- 760 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~- 760 (1093)
.+.-..+++.+.|.+|||+.||+|+....|..||+|+++.. .+.....+.+|+++|++|+ |+|||.++++....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 45566788999999999999999999988899999976543 4567888999999999998 99999999943221
Q ss_pred ------CceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEccCCcEEEE
Q 001354 761 ------DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLT 830 (1093)
Q Consensus 761 ------~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~dG~VKLs 830 (1093)
-.++|.||||.||.|-+++.+. ..|+|.++..|+.++++|+.+||... |||||||-|||||..+|+.|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 1378999999999999999743 46999999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHH
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYE 907 (1093)
|||.+...... +...+ ........-...-|+.|+|||++. +.+.+.|+|||+|||+||-
T Consensus 189 DFGSatt~~~~--------------~~~~~----e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYk 250 (738)
T KOG1989|consen 189 DFGSATTKILS--------------PTSAQ----EVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYK 250 (738)
T ss_pred cccccccccCC--------------CccHH----HHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHH
Confidence 99998742110 00000 000000111234589999999874 6778999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh
Q 001354 908 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963 (1093)
Q Consensus 908 MLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa 963 (1093)
|+....||..... ..|+++++.||.. +..+..+++||+.||+.||.+||++
T Consensus 251 LCy~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI 301 (738)
T KOG1989|consen 251 LCYFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNI 301 (738)
T ss_pred HHHhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCH
Confidence 9999999987643 3688999999964 6789999999999999999999993
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=340.96 Aligned_cols=264 Identities=27% Similarity=0.368 Sum_probs=204.8
Q ss_pred CCCCCccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEe
Q 001354 675 PLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754 (1093)
Q Consensus 675 ~~~ss~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~ 754 (1093)
..++..+....+++|..-..||+|+||.||+|...+ |..||||++ ..... .. ...|.+|+.+|.+++|||+|+|+
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~-~~~~~-~~--~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRL-SSNSG-QG--EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEe-cCCCC-cc--hhHHHHHHHHHhcCCCcCcccEE
Confidence 334555667788999999999999999999999875 489999943 22111 11 44599999999999999999999
Q ss_pred eeeccCC-ceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---cEeeecCCCcEEEccCCcEE
Q 001354 755 YSFTCRD-NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAHDGHIK 828 (1093)
Q Consensus 755 gsfqd~~-~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~G---IIHRDIKPeNILLD~dG~VK 828 (1093)
|+|.+.+ ..+||+|||++|+|.++|.... .++|.....|+.+++.||+|||... ||||||||+|||||+++.+|
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999998 4999999999999999998665 7899999999999999999999864 99999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCc-cCCCCCCChhhhcCCCCCccceeecchhhHHH
Q 001354 829 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 829 LsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~-vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYE 907 (1093)
|+|||||+..... .....+. .||.+|+|||++..+..+.++|||||||+|.|
T Consensus 218 lsDFGLa~~~~~~---------------------------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllE 270 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG---------------------------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLE 270 (361)
T ss_pred ccCccCcccCCcc---------------------------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHH
Confidence 9999999753210 0001112 79999999999998889999999999999999
Q ss_pred HHhCCCCCCCCC---hHHHH---HHHhc-cCC---CCCCCC-CCCC--HH---HHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 908 FITGIPPFTAES---PEIIF---DNILN-RKI---PWPCVP-SDMS--FE---AQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 908 MLTGkpPF~~~s---~~ei~---~kIl~-~~l---~fP~ip-~~IS--~e---akDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|++|+.|..... ..... ...+. +.+ --|.+. ...+ .. +..+..+|++.+|.+||+..++.+.|
T Consensus 271 litgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 271 LITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 999998887532 11111 11111 111 012221 2223 23 44566799999999999977665555
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=362.67 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=213.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCc-----EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk-----~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
+.....++.+.||+|+||+||.|...+-.. .||+| .+++ ..+..++..|++|..+|..++|||||+++|.+-
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK-~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVK-SLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEE-eccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 456778899999999999999999875433 38888 3333 345677889999999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEe
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 831 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~-------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsD 831 (1093)
+....+|++|||.||||..+|++. ..++......++.+|++|++||+++++|||||..+|+||+....|||+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999999876 2488899999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-
Q 001354 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 910 (1093)
Q Consensus 832 FGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT- 910 (1093)
||||+.+...... ... .. ..-...|||||.|....++.++|||||||+|||+++
T Consensus 846 FGlArDiy~~~yy--------------------r~~-~~----a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifsl 900 (1025)
T KOG1095|consen 846 FGLARDIYDKDYY--------------------RKH-GE----AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSL 900 (1025)
T ss_pred cchhHhhhhchhe--------------------ecc-Cc----cccceecCCHHHHhhcccccccchhhhHHHHHHHHhC
Confidence 9999943211110 000 00 123468999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc
Q 001354 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965 (1093)
Q Consensus 911 GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~ 965 (1093)
|..||.+.+..+++...+.+. +++ .|..++..+.++|..||..+|++||++..
T Consensus 901 G~~PY~~~~n~~v~~~~~~gg-RL~-~P~~CP~~ly~lM~~CW~~~pe~RP~F~~ 953 (1025)
T KOG1095|consen 901 GATPYPSRSNFEVLLDVLEGG-RLD-PPSYCPEKLYQLMLQCWKHDPEDRPSFRT 953 (1025)
T ss_pred CCCCCCCcchHHHHHHHHhCC-ccC-CCCCCChHHHHHHHHHccCChhhCccHHH
Confidence 999999999999988666654 333 35899999999999999999999999543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=367.79 Aligned_cols=273 Identities=31% Similarity=0.490 Sum_probs=209.7
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec------
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT------ 758 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq------ 758 (1093)
-..+|+.+..||+||||.||+|+++-+|..||||+|.-+. .......+.+|+.+|.+++|||||++|.++.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 4679999999999999999999999999999999775433 4556788999999999999999999986540
Q ss_pred ------------------------------------------------------------------------c-------
Q 001354 759 ------------------------------------------------------------------------C------- 759 (1093)
Q Consensus 759 ------------------------------------------------------------------------d------- 759 (1093)
+
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred --------------------------C--------CceEEEEEecCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 001354 760 --------------------------R--------DNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYL 804 (1093)
Q Consensus 760 --------------------------~--------~~LyLVMEYm~GGSL~dlL~k~g~L-sEe~ar~yaaQIl~ALeYL 804 (1093)
+ ..+||=||||+.-.|.+++.+.... ....++.+++||+.||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 1278999999997777777655443 4788999999999999999
Q ss_pred HhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc-ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCC
Q 001354 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN-NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 883 (1093)
Q Consensus 805 Hs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~-~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmA 883 (1093)
|++|||||||||.||+||++++|||+|||+|+....+ ..++.. ... .............+.+||.-|+|
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~----~~~------~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQD----LSF------STNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhc----cCc------cccccCCCCcccccccceeeeec
Confidence 9999999999999999999999999999999852211 010000 000 00011112224567899999999
Q ss_pred hhhhcCCC---CCccceeecchhhHHHHHhCCCCCCC-CChHHHHHHHhccCCCCC-CCCCCCCHHHHHHHHhhccCCcC
Q 001354 884 PEILLGTE---HGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPN 958 (1093)
Q Consensus 884 PEVL~g~~---Ys~ksDVWSLGVILYEMLTGkpPF~~-~s~~ei~~kIl~~~l~fP-~ip~~IS~eakDLIkrcL~kDP~ 958 (1093)
||++.+.. |+.|+|+|||||++|||+. ||.. +....+...+-.+.+++| .+...--+.-..+|++||+.||.
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence 99998754 9999999999999999994 6753 233444444444555544 11233345677899999999999
Q ss_pred CCCChhcHHHHHcCCCCC
Q 001354 959 QRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 959 KRpTa~~A~EIL~HPFFk 976 (1093)
+||| |.|+|++.||-
T Consensus 861 kRPt---A~eLL~s~llp 875 (1351)
T KOG1035|consen 861 KRPT---ATELLNSELLP 875 (1351)
T ss_pred cCCC---HHHHhhccCCC
Confidence 9999 89999999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=359.63 Aligned_cols=276 Identities=41% Similarity=0.733 Sum_probs=246.9
Q ss_pred eeeccCCeEEEEEEE---CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEEEe
Q 001354 694 PISRGAFGRVFLARK---RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 694 ~LGkG~FGeVylar~---k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
++|.|+||.|++++. .+.|..|||| ++++......... +...|+.++..++ ||++|++++.|+.+..+|++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamk-vl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMK-VLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhh-ccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 479999999998764 3568899999 6666554444333 7888999999998 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCC
Q 001354 770 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849 (1093)
Q Consensus 770 m~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~ 849 (1093)
..||+|+..+.+...+++...++|.++++.|++++|+.+|||||+|++||+++.+||+|+.|||+++....
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~--------- 149 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK--------- 149 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhc
Q 001354 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 929 (1093)
Q Consensus 850 ~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~ 929 (1093)
....|||..|||||++. ++..++||||||+++|||++|..||.. ++...|+.
T Consensus 150 ----------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 150 ----------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred ----------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 01129999999999998 788999999999999999999999988 78888888
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCccccc
Q 001354 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLS 1005 (1093)
Q Consensus 930 ~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds 1005 (1093)
..+.+| ..++..+++++..++.++|.+|++. .++.+|++|+||..++|+.+..+ +|||+|....+.|+.+|+.
T Consensus 202 ~~~~~p---~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~ 278 (612)
T KOG0603|consen 202 AELEMP---RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDP 278 (612)
T ss_pred hccCCc---hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCc
Confidence 887766 7899999999999999999999995 68999999999999999988766 8899999999999999999
Q ss_pred ccccCC
Q 001354 1006 RFSQIS 1011 (1093)
Q Consensus 1006 ~fs~~~ 1011 (1093)
+|+...
T Consensus 279 eft~~~ 284 (612)
T KOG0603|consen 279 EFTSQV 284 (612)
T ss_pred hhccCC
Confidence 888763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.03 Aligned_cols=243 Identities=49% Similarity=0.839 Sum_probs=206.2
Q ss_pred CCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCChHHH
Q 001354 699 AFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 778 (1093)
Q Consensus 699 ~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGSL~dl 778 (1093)
+||.||+|.+..+|+.+|+|++... .... ....+.+|+..+..++|+||+++++.+......+++|||+++++|..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKE-KIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccc-cccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 6899999999999999999954322 2111 157889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 001354 779 LRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858 (1093)
Q Consensus 779 L~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~ 858 (1093)
+.....+++..+..++.+++.||.|||+.+++|+||+|.||+++.++.++|+|||++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~------------------ 139 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP------------------ 139 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecc------------------
Confidence 98766689999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC-CChHHHHHHHhccCCCCCCC
Q 001354 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWPCV 937 (1093)
Q Consensus 859 ~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~-~s~~ei~~kIl~~~l~fP~i 937 (1093)
........|++.|++||.+.+..++.++|+||||+++|+|++|..||.. .........+.......+..
T Consensus 140 ----------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 209 (244)
T smart00220 140 ----------GGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP 209 (244)
T ss_pred ----------ccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc
Confidence 0022345688999999999988899999999999999999999999988 55566666555544443321
Q ss_pred CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 938 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 938 p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
...++.++.+++.+||..+|.+||+ +.++++||||
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 1228899999999999999999999 8899999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=304.15 Aligned_cols=259 Identities=31% Similarity=0.548 Sum_probs=217.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|.-.+.||+|.||+||+++++.+++.||+|.+. .+...+..-...++|+-+|+.++|.|||++++....+..+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvr--lddddegvpssalreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEe--ccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 35667789999999999999999999999999763 3333344456789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
+|||.. +|..+.... +.++.+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+++....
T Consensus 80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi----- 153 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI----- 153 (292)
T ss_pred HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC-----
Confidence 999966 888887653 6799999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHh-CCCCCCCCChHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 923 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei 923 (1093)
+.+-...-+-|.+|.+|.++.|. -|+.+.|+||.|||+.|+.. |+|.|.+.+..+.
T Consensus 154 ----------------------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 154 ----------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred ----------------------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 01112234679999999999874 58999999999999999987 9999999998888
Q ss_pred HHHHhcc-----CCCCCC------------CC---------CCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 924 FDNILNR-----KIPWPC------------VP---------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 924 ~~kIl~~-----~l~fP~------------ip---------~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.++|... .-.||. .| +.++...+||++++|..+|.+|++ |++.++||||.+
T Consensus 212 lkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris---aeaalqhpyf~d 288 (292)
T KOG0662|consen 212 LKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS---AEAALQHPYFSD 288 (292)
T ss_pred HHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC---HHHHhcCccccc
Confidence 8888641 112222 11 345667889999999999999999 778899999975
Q ss_pred C
Q 001354 978 V 978 (1093)
Q Consensus 978 I 978 (1093)
.
T Consensus 289 ~ 289 (292)
T KOG0662|consen 289 F 289 (292)
T ss_pred c
Confidence 4
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.42 Aligned_cols=264 Identities=28% Similarity=0.469 Sum_probs=207.4
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCc----EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC- 759 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk----~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd- 759 (1093)
.+..|+.+..||+|+||.||+|..+.++. .||||++ + .............+|+.+++.++||||+.|..+|..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkf-k-~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKF-K-GEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHH-h-ccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 46789999999999999999997665543 7899944 1 111122334567899999999999999999999988
Q ss_pred CCceEEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC----CcEEEE
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLT 830 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d----G~VKLs 830 (1093)
+..++|++||.+. ||+.+++-+ ..++...++.++.||+.|+.|||++.|+||||||.|||+..+ |.|||+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 7789999999988 999998633 358999999999999999999999999999999999999877 899999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHH
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEML 909 (1093)
||||++.... . +. +-......+-|.+|+|||.++| ..|+.+.|+||+|||+.|||
T Consensus 179 DlGlaR~~~~--p-----------------lk-----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL 234 (438)
T KOG0666|consen 179 DLGLARLFNN--P-----------------LK-----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL 234 (438)
T ss_pred cccHHHHhhc--c-----------------cc-----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence 9999996310 0 00 0112234678999999999998 46899999999999999999
Q ss_pred hCCCCCCCCCh---------HHHHHHHhc--c---CCCCCCC-----------------------------CCCCCHHHH
Q 001354 910 TGIPPFTAESP---------EIIFDNILN--R---KIPWPCV-----------------------------PSDMSFEAQ 946 (1093)
Q Consensus 910 TGkpPF~~~s~---------~ei~~kIl~--~---~l~fP~i-----------------------------p~~IS~eak 946 (1093)
+-.|-|.+... .+...+|++ + .-.||.+ ...-++.+.
T Consensus 235 tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~ 314 (438)
T KOG0666|consen 235 TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSAL 314 (438)
T ss_pred ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHH
Confidence 99999976421 233444443 1 1122221 012355688
Q ss_pred HHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 947 DLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 947 DLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+|+.+||++||.+|++ +.+.++|+||...
T Consensus 315 ~LL~klL~yDP~kRIt---a~qAleh~yF~~d 343 (438)
T KOG0666|consen 315 DLLQKLLTYDPIKRIT---AEQALEHPYFTED 343 (438)
T ss_pred HHHHHHhccCchhhcc---HHHHhcccccccC
Confidence 9999999999999999 7888999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=343.04 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=182.6
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCC----CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeee-
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTT----GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS- 756 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~T----Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gs- 756 (1093)
.....++|++.+.||+|+||.||+|++..+ +..||+|++... . ..+....|. +....+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~-~-----~~e~~~~e~--l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY-G-----AVEIWMNER--VRRACPNSCADFVYGF 198 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEeccc-c-----hhHHHHHHH--HHhhchhhHHHHHHhh
Confidence 345788999999999999999999999998 899999954221 1 111112221 112222222222222
Q ss_pred -----eccCCceEEEEEecCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCcEe
Q 001354 757 -----FTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------------LEEDVARIYIAELVLALEYLHSLGIVH 811 (1093)
Q Consensus 757 -----fqd~~~LyLVMEYm~GGSL~dlL~k~g~--------------------LsEe~ar~yaaQIl~ALeYLHs~GIIH 811 (1093)
......+++||||+++|+|.+++..... ..+..++.++.||+.||.|||++||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2455679999999999999999875421 123446679999999999999999999
Q ss_pred eecCCCcEEEcc-CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC
Q 001354 812 RDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 890 (1093)
Q Consensus 812 RDIKPeNILLD~-dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~ 890 (1093)
|||||+||||+. ++.+||+|||+|+.... .........+||+.|||||.+...
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~--------------------------~~~~~~~~~~~t~~Y~APE~~~~~ 332 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRV--------------------------GINYIPKEFLLDPRYAAPEQYIMS 332 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccc--------------------------ccccCCcccccCCCccChHHhhcc
Confidence 999999999996 68999999999974210 001123456899999999976432
Q ss_pred ----------------------CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhc-cCCCC------------C
Q 001354 891 ----------------------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN-RKIPW------------P 935 (1093)
Q Consensus 891 ----------------------~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~-~~l~f------------P 935 (1093)
.++.++|||||||+||||+++..|+.. ....+..++. ....+ +
T Consensus 333 ~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 410 (566)
T PLN03225 333 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASP 410 (566)
T ss_pred CCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccch
Confidence 234567999999999999997666432 2222222211 11100 0
Q ss_pred C------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 936 C------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 936 ~------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
. +.......+++||.+||++||.+||+ +.++|+||||.+..+..+
T Consensus 411 ~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 411 DLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGL 461 (566)
T ss_pred hhhhhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCcccc
Confidence 0 01122345669999999999999999 889999999999887644
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.49 Aligned_cols=263 Identities=27% Similarity=0.390 Sum_probs=211.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.++-++|++.+.||.|||+-||+++...+++.||+|+|+.. ..++.+..++|++..++++||||++++++...+..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 46778999999999999999999999999999999977543 34677889999999999999999999987765544
Q ss_pred -----eEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEccCCcEEEEe
Q 001354 763 -----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTD 831 (1093)
Q Consensus 763 -----LyLVMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~dG~VKLsD 831 (1093)
.||+++|...|+|.+.+... ..++|.++..|+.+|+.||++||... ++||||||.|||+...+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 99999999999999998643 36999999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHH
Q 001354 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEF 908 (1093)
Q Consensus 832 FGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEM 908 (1093)
||.++.... .+.+. .+ -....+| ..-.-|..|+|||.+.- ...+.++|||||||+||+|
T Consensus 173 ~GS~~~a~i----~i~~~-~~-----a~~lQe~--------a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~ 234 (302)
T KOG2345|consen 173 LGSATQAPI----QIEGS-RQ-----ALRLQEW--------AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAM 234 (302)
T ss_pred ccCccccce----Eeech-HH-----HHHHHHH--------HHHhCCCcccCchheecccCcccccccchhhhhHHHHHH
Confidence 999875321 00000 00 0001111 12335889999999964 4457899999999999999
Q ss_pred HhCCCCCCCCC--hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 909 ITGIPPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 909 LTGkpPF~~~s--~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+.|..||...- ...+.-.+.+.++.||.. ..+|..+..||+.||+.||.+||+ +.+++.
T Consensus 235 mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~---i~~ll~ 295 (302)
T KOG2345|consen 235 MFGESPFERIYQQGGSLALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPT---IPELLS 295 (302)
T ss_pred HHcCCcchHHhhcCCeEEEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCC---HHHHHH
Confidence 99999995321 112223355677888864 459999999999999999999999 555554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=323.31 Aligned_cols=256 Identities=30% Similarity=0.526 Sum_probs=208.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC--C----ceEEEeeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN--P----FVVRFFYSF 757 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H--P----NIVkL~gsf 757 (1093)
.-.+.|.++..+|.|+||.|..+.+..++..+|+| |++.... --+..+-|+++|.++.+ | .+|++.++|
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlK-Iik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALK-IIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHH-HHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 34688999999999999999999999999999999 5544322 22445779999998842 2 478899999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc------------
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------ 823 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~------------ 823 (1093)
.-.++.|+|+|.+ |-+++++|.+.. .|+-..++.++.||+.+++|||+++++|-||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999998 559999998754 5899999999999999999999999999999999999853
Q ss_pred --------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 824 --------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 824 --------dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
+-+|||+|||.|+... ....+.+-|..|.|||++++-+++..
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLgLGwS~p 289 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILGLGWSQP 289 (415)
T ss_pred cceeccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheeccCcCCc
Confidence 2368999999988521 12256788999999999999999999
Q ss_pred ceeecchhhHHHHHhCCCCCCCCChHH---HHHHHhc------------------cCCCCCCCC----------------
Q 001354 896 ADWWSVGIILFEFITGIPPFTAESPEI---IFDNILN------------------RKIPWPCVP---------------- 938 (1093)
Q Consensus 896 sDVWSLGVILYEMLTGkpPF~~~s~~e---i~~kIl~------------------~~l~fP~ip---------------- 938 (1093)
|||||+||||+|+.+|...|...+..+ ++++|+. +.+.||...
T Consensus 290 CDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~ 369 (415)
T KOG0671|consen 290 CDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLK 369 (415)
T ss_pred cCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHH
Confidence 999999999999999999998876544 4555542 223333210
Q ss_pred ------CCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 939 ------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 939 ------~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+.--.++.|||++||.+||.+|+| +.|+|.||||+..
T Consensus 370 ~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 370 KYMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARL 412 (415)
T ss_pred HHhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcC
Confidence 001224779999999999999999 8899999999854
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=325.01 Aligned_cols=267 Identities=30% Similarity=0.470 Sum_probs=216.7
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh----hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM----IRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~----~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
-.+.|-++.+||+|||++||++.+...++.||+| |..-... .+..-..+..+|.+|.+.++||-||++|++|.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvK-IHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVK-IHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEe-eehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3467889999999999999999999999999999 5322111 2223457889999999999999999999998754
Q ss_pred -CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CcEeeecCCCcEEEcc---CCcEEEEecCC
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--GIVHRDLKPDNLLIAH---DGHIKLTDFGL 834 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~--GIIHRDIKPeNILLD~---dG~VKLsDFGL 834 (1093)
+.+|-|+|||+|.||..+|+.+..++|.+++.|+.||+.||.||... -|||.||||.||||.. .|.+||+||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 56899999999999999999999999999999999999999999987 4999999999999965 47899999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC----CCCCccceeecchhhHHHHHh
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g----~~Ys~ksDVWSLGVILYEMLT 910 (1093)
++++..... ...+ ....+....||.+|++||+|.- ...+.++||||+|||+|.+|.
T Consensus 620 SKIMdddSy-----~~vd---------------GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 620 SKIMDDDSY-----NSVD---------------GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred hhhccCCcc-----Cccc---------------ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 997531110 0111 1223455789999999999863 245789999999999999999
Q ss_pred CCCCCCCCCh-HHHHH--HHhc-cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 911 GIPPFTAESP-EIIFD--NILN-RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 911 GkpPF~~~s~-~ei~~--kIl~-~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
|+.||...-. .++.+ .|++ ..+.||. -+.++.++++||++||++.-+.|.. +.++..||||.
T Consensus 680 GrKPFGhnqsQQdILqeNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~D---V~qLA~dpyll 745 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDILQENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRID---VQQLACDPYLL 745 (775)
T ss_pred cCCCCCCchhHHHHHhhhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhh---HHHHccCcccc
Confidence 9999976533 33322 2333 3556775 3578999999999999999999987 88999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=339.44 Aligned_cols=259 Identities=32% Similarity=0.540 Sum_probs=222.1
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc---
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC--- 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd--- 759 (1093)
...+-|++..+||.|.+|.||+++.+.++...|+| |+.- ..+..+.+..|.+||+.. +|||++.+||+|.-
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~k-I~~~----~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIK-IMDP----TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeE-eecC----CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 34577999999999999999999999999999999 4322 223446678899999877 49999999988864
Q ss_pred --CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 760 --RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 760 --~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
.+.+|||||||.||+..+++++. ..+.|+.+..++++++.|+.+||.+.+||||||-.||||+.+|.|||+|||++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 45699999999999999999754 56999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeecchhhHHHHHh
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDVWSLGVILYEMLT 910 (1093)
.... .......+.+|||.|||||++.- ..|+..+|+||||++-.||.-
T Consensus 171 aQld---------------------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad 223 (953)
T KOG0587|consen 171 AQLD---------------------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE 223 (953)
T ss_pred eeee---------------------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC
Confidence 7421 12345678999999999999963 357789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 911 GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
|.||+.+..++...-.|-....+-..-|..++.++.+||..||.+|-.+||+ ..+++.|||...
T Consensus 224 G~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~hpFi~e 287 (953)
T KOG0587|consen 224 GAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKHPFITE 287 (953)
T ss_pred CCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccCCcccc
Confidence 9999999999888777765544322235778999999999999999999999 889999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=340.34 Aligned_cols=253 Identities=33% Similarity=0.472 Sum_probs=198.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 761 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~----- 761 (1093)
..+..-+.||+||||.||+++++.||+.+|+|. .++.. .....+...+|+++|++++|||||+++++-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~-~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKT-FNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHh-hhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 345667789999999999999999999999994 33322 3445678899999999999999999998766554
Q ss_pred -ceEEEEEecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc--CC--cEEEEecC
Q 001354 762 -NLYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DG--HIKLTDFG 833 (1093)
Q Consensus 762 -~LyLVMEYm~GGSL~dlL~k~---g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~--dG--~VKLsDFG 833 (1093)
...+|||||+||||..+|.+- ..+++.+.+.++.+++.||.|||++|||||||||.||++-. +| .-||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 468999999999999999753 46999999999999999999999999999999999999853 34 36999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
.|+... +.....+.+||+.|.+||++.. +.|+..+|.|||||++|+++||.
T Consensus 170 ~Arel~----------------------------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~ 221 (732)
T KOG4250|consen 170 AARELD----------------------------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGE 221 (732)
T ss_pred ccccCC----------------------------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccC
Confidence 999531 2235568999999999999994 88999999999999999999999
Q ss_pred CCCCCCCh----H-HHHHHHhc--------------cCCC----CCCCCCCCCHHH----HHHHHhhccCCcCCCC--C-
Q 001354 913 PPFTAESP----E-IIFDNILN--------------RKIP----WPCVPSDMSFEA----QDLINRFLIHDPNQRL--G- 962 (1093)
Q Consensus 913 pPF~~~s~----~-ei~~kIl~--------------~~l~----fP~ip~~IS~ea----kDLIkrcL~kDP~KRp--T- 962 (1093)
.||..... . .++..+.. +.+. +| .|..++... ...+..+|..+|.+|. +
T Consensus 222 lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~ 300 (732)
T KOG4250|consen 222 LPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGF 300 (732)
T ss_pred CCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCc
Confidence 99964322 1 23332221 1221 22 134555443 3566778999999999 4
Q ss_pred ---hhcHHHHHc
Q 001354 963 ---ANGAAEVKA 971 (1093)
Q Consensus 963 ---a~~A~EIL~ 971 (1093)
+....+||+
T Consensus 301 ~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 301 DRFFAEVDDILN 312 (732)
T ss_pred chHHHHHHHHHh
Confidence 234556665
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.54 Aligned_cols=264 Identities=31% Similarity=0.462 Sum_probs=212.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~---- 760 (1093)
..+.|+-+..||+|.||+||+|+.+.+|+.||+|+++-. ..+..--...++|+++|..++|+|++.++..|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme--neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh--ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 345677888999999999999999999999999854321 11223345678999999999999999998877543
Q ss_pred ----CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 761 ----DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 761 ----~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
..+|+||.+|+. ||..+|.+. .+|+...++.++.++..||.|+|.+.|+|||+||.|+||+.+|.+||+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 248999999988 999999765 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
+...... ..........+-|.+|++||.++| ..|+.+.|+|..||||.||.+|.+-
T Consensus 172 r~fs~~~-----------------------n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 172 RAFSTSK-----------------------NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred cceeccc-----------------------ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc
Confidence 8532110 001112345678999999999987 5799999999999999999999999
Q ss_pred CCCCChHHHHHHHhc--c---CCCCCC--------------C-------------CCCCCHHHHHHHHhhccCCcCCCCC
Q 001354 915 FTAESPEIIFDNILN--R---KIPWPC--------------V-------------PSDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~--~---~l~fP~--------------i-------------p~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
|.+.+.......|.. + +-.||. + |-.-.+++.||+.+||..||.+|+.
T Consensus 229 mqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 229 MQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID 308 (376)
T ss_pred ccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc
Confidence 999887766665532 1 112222 0 1122568999999999999999999
Q ss_pred hhcHHHHHcCCCCCC
Q 001354 963 ANGAAEVKAHPFFKG 977 (1093)
Q Consensus 963 a~~A~EIL~HPFFkg 977 (1093)
+.++++|.||..
T Consensus 309 ---ad~alnh~~F~k 320 (376)
T KOG0669|consen 309 ---ADQALNHDFFWK 320 (376)
T ss_pred ---hHhhhchhhhhc
Confidence 778999999953
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=324.09 Aligned_cols=266 Identities=23% Similarity=0.327 Sum_probs=191.6
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEEC----------------CCCcEEEEEEeehhhhhhc----------hhHHHHH
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKR----------------TTGDLFAIKQVLKKLDMIR----------KNDIERI 735 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k----------------~TGk~VAIKkILkK~~~~~----------~~eie~~ 735 (1093)
.+...++|++.++||+|+||+||+|... ..++.||+|.+........ ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3567899999999999999999999752 2356799996532111000 0112234
Q ss_pred HHHHHHHHhcCCCce-----EEEeeeecc--------CCceEEEEEecCCCChHHHHHhcC-------------------
Q 001354 736 LAERNILITVRNPFV-----VRFFYSFTC--------RDNLYLVMEYLNGGDLYSLLRKVG------------------- 783 (1093)
Q Consensus 736 l~E~~IL~kL~HPNI-----VkL~gsfqd--------~~~LyLVMEYm~GGSL~dlL~k~g------------------- 783 (1093)
..|..++.+++|.++ ++++++|.. ....||||||+++|+|.++|+...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 456777777776554 566666543 346899999999999999986421
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 001354 784 -----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858 (1093)
Q Consensus 784 -----~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~ 858 (1093)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~----------------- 362 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG----------------- 362 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-----------------
Confidence 2355678889999999999999999999999999999999999999999998642100
Q ss_pred CCCCcccccCcCCccCccCCCCCCChhhhcCCC--------------------CC--ccceeecchhhHHHHHhCCC-CC
Q 001354 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--------------------HG--YAADWWSVGIILFEFITGIP-PF 915 (1093)
Q Consensus 859 ~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~--------------------Ys--~ksDVWSLGVILYEMLTGkp-PF 915 (1093)
.........+|+.|+|||++.... |+ ...|+||+||+||+|++|.. ||
T Consensus 363 ---------~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 363 ---------INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred ---------CccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 000111234589999999986432 22 24799999999999999875 77
Q ss_pred CCCCh-----------HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCc---CCCCChhcHHHHHcCCCCCC
Q 001354 916 TAESP-----------EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP---NQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 916 ~~~s~-----------~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP---~KRpTa~~A~EIL~HPFFkg 977 (1093)
.+... ...++.+....+.|+ ....+++.++|||.+||.++| .+|++ +.++|+||||..
T Consensus 434 ~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~eaL~Hp~f~~ 505 (507)
T PLN03224 434 ANIRLFNTELRQYDNDLNRWRMYKGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLS---VGQALSHRFFLP 505 (507)
T ss_pred cchhhhhhHHhhccchHHHHHhhcccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCC---HHHHhCCCCcCC
Confidence 64221 112223333444555 245689999999999999876 68999 889999999953
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=324.00 Aligned_cols=263 Identities=21% Similarity=0.348 Sum_probs=222.9
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+|++.-.+.....+||-|.||+||.|.|+.-.-.||+| .++... ..++.|+.|..+|+.++|||+|+|+++|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVK-tLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehh-hhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 567778888889999999999999999999988999999 554433 467899999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~--LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+..+|||+|||..|+|.+||++..+ ++.-....++.||..||+||..+++|||||-..|+|+.++..||++||||+++
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999999997653 66666666777999999999999999999999999999999999999999997
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
+..+..+. .....-...|.|||-|....++.++|||+|||+|||+.| |..||.
T Consensus 415 MtgDTYTA--------------------------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 415 MTGDTYTA--------------------------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred hcCCceec--------------------------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 53221110 011123568999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
+.+..++|..+- ..+++. -|.++++.+..|++.||++.|.+||++.++-+.++.-|-
T Consensus 469 GidlSqVY~LLE-kgyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 469 GIDLSQVYGLLE-KGYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CccHHHHHHHHh-cccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 999988887654 444443 368999999999999999999999997666555554443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=310.65 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=210.8
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~k-L~HPNIVkL~gsfqd~ 760 (1093)
.....++.+-+..||.|+||+|++-.++.+|+.+|+|+|.... ...+..+++.|.+...+ -++||||++|+..-.+
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 3456677888889999999999999999999999999774322 13455677788776554 4699999999999999
Q ss_pred CceEEEEEecCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 761 DNLYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~-----k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
+..|+.||+|.- +|..+-+ +...++|...-.+....+.||+||.. ..||||||||+|||||..|.|||||||+
T Consensus 136 GdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 136 GDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred CceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence 999999999964 6644432 34579999999999999999999986 4899999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
|-.... ......-+|-..|||||.+.. .+|+.++|+||||++|||+.||+
T Consensus 215 cGqLv~----------------------------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~ 266 (361)
T KOG1006|consen 215 CGQLVD----------------------------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN 266 (361)
T ss_pred hHhHHH----------------------------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence 864210 111223468899999999964 57999999999999999999999
Q ss_pred CCCCCCCh-HHHHHHHhccCCCCCCCCC---CCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 913 PPFTAESP-EIIFDNILNRKIPWPCVPS---DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 913 pPF~~~s~-~ei~~kIl~~~l~fP~ip~---~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.||.+.+. .+....++.+..+.-..+. .++..+..||.-||.+|-..||. -.+++++||++.
T Consensus 267 fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 267 FPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFYRM 332 (361)
T ss_pred CCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchhhh
Confidence 99987553 4555556666554332233 48999999999999999999999 668999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=346.27 Aligned_cols=270 Identities=51% Similarity=0.839 Sum_probs=230.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
-.-++|+.+++|..|+||.||+++++.+...+|+| +-++..+.+ +||....+|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR-----------nilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR-----------NILTFAGNPFVV------------ 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh-----------ccccccCCccee------------
Confidence 34579999999999999999999999999999997 533322211 156666677777
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||-.++++..+.++.+. +.|++|||+.||+|||+||+|.||+.-||+|++|||+++.+++..+
T Consensus 136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 67788888877776544 8899999999999999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
+.+....+ .. ..+.-.....||||.|+||||+..++|+..+|||++|+|+||.+.|..||.+++++++
T Consensus 199 tnl~eg~I----------~k--~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 199 TNLKEGHI----------EK--DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred chhhhcch----------HH--HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 32111110 00 1122234457999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccCCCCCCCCCccc
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1003 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P~~~s~~Dts~F 1003 (1093)
+..++...+.||+-...++++++++|.++|..+|..|.+..++.++++|+||+.+||..|..+++.|+|+....+|++||
T Consensus 267 fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyf 346 (1205)
T KOG0606|consen 267 FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYF 346 (1205)
T ss_pred HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhh
Confidence 99999999999987788999999999999999999999988999999999999999999999999999999999999999
Q ss_pred ccc
Q 001354 1004 LSR 1006 (1093)
Q Consensus 1004 ds~ 1006 (1093)
+.+
T Consensus 347 dTR 349 (1205)
T KOG0606|consen 347 DTR 349 (1205)
T ss_pred ccc
Confidence 975
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=329.09 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=220.9
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCC---cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TG---k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
++..+...+-++||.|.||+|++|+.+..| ..|||| .+|. -..+.+...|+.|..||-+++||||++|-++...
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIK-TLK~--GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIK-TLKA--GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEe-eecc--CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 467788899999999999999999998776 469999 5543 2356677899999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
...+.||.|||++|+|..+|+++ +.|+..+..-+++.|+.||+||-++|+|||||-..|||++.+..+|++||||+++.
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999865 56998999999999999999999999999999999999999999999999999964
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccC---CCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG---TPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 914 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vG---Tp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpP 914 (1093)
..+ ....++..| ...|.|||.+...+++.++||||+|++|||.+. |..|
T Consensus 782 edd---------------------------~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP 834 (996)
T KOG0196|consen 782 EDD---------------------------PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 834 (996)
T ss_pred ccC---------------------------CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc
Confidence 211 011122222 468999999999999999999999999999776 9999
Q ss_pred CCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 915 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|.+.+.++++..|..+ +++|. |.+.+..+..|+..||++|-.+||.+.++..+|
T Consensus 835 YWdmSNQdVIkaIe~g-yRLPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 835 YWDMSNQDVIKAIEQG-YRLPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred ccccchHHHHHHHHhc-cCCCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 9999999999888654 45553 689999999999999999999999976655544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=317.79 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=209.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..-+...+.+.||+|-||+|.+|.... +..||+| +++... .......|..|+++|.+++|||||.|+++|..++.+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK-~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVK-ILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEe-ecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 445667888999999999999998763 6889999 544322 234457899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
++|||||.+|+|.++|.++ ..+.......++.||+.||+||.+.+||||||.+.|+|+|.++++||+|||+++-....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999999887 33455566679999999999999999999999999999999999999999999843211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh--CCCCCCCCC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAES 919 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT--GkpPF~~~s 919 (1093)
.. -+.....+-...|||||.++-++++.++|+|+||++||||++ ...||...+
T Consensus 691 ~y-------------------------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 691 DY-------------------------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred Cc-------------------------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 11 111223456789999999999999999999999999999875 789999888
Q ss_pred hHHHHHHHhc-----cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 920 PEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 920 ~~ei~~kIl~-----~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
.+++.+..-. +...++..|.-++..+..||.+||.+|..+||+++.+
T Consensus 746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 7776665432 2223344568899999999999999999999996543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=341.51 Aligned_cols=241 Identities=22% Similarity=0.318 Sum_probs=185.2
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
..|...+.||+|+||.||+|+++.++..||+|.+ +.... ....|+.++.+++|||||++++++.+....|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI-NDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEc-cCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 3456677899999999999999999999999944 22211 112457889999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLH---s~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|||+++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||......
T Consensus 762 ~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 762 HEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred EeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 999999999999964 788999999999999999999 6699999999999999999888876 66543210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh---
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 920 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~--- 920 (1093)
......||+.|||||++.+..|+.++|||||||+||||++|+.||.....
T Consensus 834 ---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 834 ---------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred ---------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 01123689999999999999999999999999999999999999954321
Q ss_pred --HHHHHHHhcc-CC---CCCCC------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 921 --EIIFDNILNR-KI---PWPCV------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 921 --~ei~~kIl~~-~l---~fP~i------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+..+..... .. .-|.+ +.....++.+++.+||..||.+||++.++.+.+
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 1111111100 00 00111 111223577899999999999999966555444
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=320.72 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=213.0
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCC-C--cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTT-G--DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~T-G--k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
-+..++..+++.||.|.||.|++|.|+.. | ..||+| +++.... ......|++|+.+|.+++|||+++||+...+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVK-clr~d~l--~~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVK-CLRDDSL--NAIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEE-eccCCcc--chhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 35667788889999999999999999753 3 358999 4433222 1267899999999999999999999999988
Q ss_pred CCceEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k--~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
..+.||||+++.|+|.+.|++ .+.|.......|+.||+.||.||..+++|||||-..||||.....|||+||||.+.
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 678999999999999999987 35688899999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
...+.. +| ......--...|+|||.|....++.++|+|++||+||||++ |.-||.
T Consensus 262 Lg~ned----------------~Y--------vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 262 LGENED----------------MY--------VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred cCCCCc----------------ce--------EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 322111 01 01111223568999999999999999999999999999998 899999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
+.....+.++|-. +..+| .|..++.++.+++.+||..+|.+||++..+
T Consensus 318 G~~g~qIL~~iD~-~erLp-RPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 318 GCRGIQILKNIDA-GERLP-RPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CCCHHHHHHhccc-cccCC-CCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 9999999999874 33334 368999999999999999999999996544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=314.41 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=207.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCC----CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTT----GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~T----Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
.-....+.++||.|.||.||.|....- .-.||+|.. |.+ ...+..+.|+.|.-+|+.++|||||+|+|.+.+.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtC--K~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTC--KTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehh--ccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 334455667899999999999987532 335778833 222 2344578999999999999999999999999765
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..|||||+++-|.|..+|+.. ..++......|+.||+.||.|||+..+|||||-..|||+.+.--|||+||||++.+.
T Consensus 464 -P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred -ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 479999999999999999864 568999999999999999999999999999999999999999999999999998642
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
.. ..| .+....-...|||||.+.-..++.++|||.|||.|||+|. |..||.+-
T Consensus 543 d~-----------------~yY---------kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 543 DD-----------------AYY---------KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred cc-----------------chh---------hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 11 111 1112233578999999999999999999999999999987 99999998
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
...++...|-++. +.| .|+.+++.+..|+.+||.+||.+||.+.++..+|
T Consensus 597 kNsDVI~~iEnGe-RlP-~P~nCPp~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 597 KNSDVIGHIENGE-RLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred cccceEEEecCCC-CCC-CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 8887777766543 223 4689999999999999999999999975544443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=311.19 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=208.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC------CCceEEEeeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR------NPFVVRFFYSF 757 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~------HPNIVkL~gsf 757 (1093)
+--+.|.+....|+|-|++|..|.+..-|..||||+|. ..+... ..=+.|+.||++|+ --++++|+-.|
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR-nNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR-NNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEee-cchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 44578999999999999999999999999999999554 433322 23368999999986 24899999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecC
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFG 833 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g---~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFG 833 (1093)
...+++|||+|-+.- +|..+|++.| .|....++.|+.|+..||..|-+.||+|.||||+|||+++. ..+||||||
T Consensus 504 ~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 999999999999854 9999999876 47888999999999999999999999999999999999976 468999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
.|.....+. .....-+..|.|||+++|..|++..|+||+||+||||.||+.
T Consensus 583 SA~~~~ene-----------------------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkI 633 (752)
T KOG0670|consen 583 SASFASENE-----------------------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKI 633 (752)
T ss_pred ccccccccc-----------------------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccce
Confidence 987532211 111234567999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhccCCCCCC---------------------------------------------------------
Q 001354 914 PFTAESPEIIFDNILNRKIPWPC--------------------------------------------------------- 936 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~l~fP~--------------------------------------------------------- 936 (1093)
.|.+.+...+.+..+.-+-+||.
T Consensus 634 lFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d 713 (752)
T KOG0670|consen 634 LFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD 713 (752)
T ss_pred ecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc
Confidence 99998877776655443333332
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 937 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 937 ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
-...+-..+++|+.+||..||++|++ +.+.|.||||.+
T Consensus 714 eq~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 714 EQPKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITE 751 (752)
T ss_pred hhHHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccC
Confidence 00011235789999999999999999 778899999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=288.32 Aligned_cols=253 Identities=33% Similarity=0.558 Sum_probs=206.4
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC--
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~-- 761 (1093)
..++|++.+.+|+|.|++||.|.+..+++.++|| +++.. ..+.+.+|+.||..+. ||||++|++...++.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViK-iLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIK-ILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEe-eechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 6789999999999999999999999999999999 65543 3467899999999998 999999999998875
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFGLAk~~~~ 840 (1093)
..-||+||+.+.|...+- ..++...+++|+.|++.||.|+|++||+|||+||.|++||.. -.++|+|+|||.+-.
T Consensus 109 tpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH- 184 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH- 184 (338)
T ss_pred CchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC-
Confidence 578999999997776654 458888999999999999999999999999999999999975 579999999998531
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCC-CCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF-TAE 918 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF-~~~ 918 (1093)
++....-.+.+..|--||.+.. +.|+.+-|+|||||++..|+..+-|| .+.
T Consensus 185 ---------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 185 ---------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred ---------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 1223344677888999999875 67899999999999999999988887 454
Q ss_pred ChHHHHHHHhc-------------cCC----------------CCCC-----CCCCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 919 SPEIIFDNILN-------------RKI----------------PWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 919 s~~ei~~kIl~-------------~~l----------------~fP~-----ip~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
+..+..-+|.. -++ +|.. ...-+++++.|||.++|.+|..+|||
T Consensus 238 dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT-- 315 (338)
T KOG0668|consen 238 DNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT-- 315 (338)
T ss_pred CCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc--
Confidence 44433333321 111 1111 11235799999999999999999999
Q ss_pred cHHHHHcCCCCCCC
Q 001354 965 GAAEVKAHPFFKGV 978 (1093)
Q Consensus 965 ~A~EIL~HPFFkgI 978 (1093)
|.|.+.||||..+
T Consensus 316 -akEam~HpyF~~~ 328 (338)
T KOG0668|consen 316 -AKEAMAHPYFAPV 328 (338)
T ss_pred -hHHHhcCchHHHH
Confidence 8899999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=320.64 Aligned_cols=246 Identities=32% Similarity=0.437 Sum_probs=197.4
Q ss_pred EEeeeccCCeE-EEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEEEe
Q 001354 692 IKPISRGAFGR-VFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 692 lr~LGkG~FGe-Vylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
-+++|.|+-|+ ||+|... |+.||+|.++. .-.....+|+..|+..+ |||||++|+.-++...+||..|+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 34689999986 7999886 88999995532 23456789999999886 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CC--cEEEEecCCcccccc
Q 001354 770 LNGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DG--HIKLTDFGLSKIGLI 840 (1093)
Q Consensus 770 m~GGSL~dlL~k~g~----LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG--~VKLsDFGLAk~~~~ 840 (1093)
|.. +|.+++...+. ......+..+.|++.||++||+.+||||||||.||||+. ++ .++|+|||+|+....
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 976 99999987411 111445778899999999999999999999999999986 34 689999999996421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhC-CCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTG-kpPF~~~s 919 (1093)
+.+ .-....+..||-+|+|||++....-+.++|||||||++|+.++| ..||.+.-
T Consensus 664 ~~s------------------------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 664 GKS------------------------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred Ccc------------------------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 110 11124567899999999999998888899999999999999995 99997653
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
. ....|+.+....-.+...-..++.|||.+||+.||..||+ |.++|.||||.
T Consensus 720 ~--R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs---a~~VL~HPlFW 771 (903)
T KOG1027|consen 720 E--RQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS---ATDVLNHPLFW 771 (903)
T ss_pred H--hhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC---HHHHhCCCccC
Confidence 3 2335666655443332333339999999999999999999 88999999995
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=295.12 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=207.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
....|.-++.+|.|+- .|..+-+.-++..+|+|++..... ......+..+|..++..+.|+||++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~--n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ--NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc--cCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 3457888889999998 788888888899999996654422 2334567889999999999999999999997654
Q ss_pred ---ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 762 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
..|+|||||.+ +|...+. -.++.+.+++++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 47999999976 9988877 34788899999999999999999999999999999999999999999999999841
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. ..-.....+.|..|.|||++.+.+|...+||||+||++.||++|..-|.+.
T Consensus 169 ~----------------------------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 169 D----------------------------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred C----------------------------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 1 001233468899999999999999999999999999999999999999987
Q ss_pred ChHHHHHHHhcc---------------------------CCC----CCC--C------CCCCCHHHHHHHHhhccCCcCC
Q 001354 919 SPEIIFDNILNR---------------------------KIP----WPC--V------PSDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 919 s~~ei~~kIl~~---------------------------~l~----fP~--i------p~~IS~eakDLIkrcL~kDP~K 959 (1093)
+..+.+.+|... ... ||. + +.--+..+.||+.+||..||++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 765555544320 011 111 0 1122456899999999999999
Q ss_pred CCChhcHHHHHcCCCCC
Q 001354 960 RLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFk 976 (1093)
|.+ +.++|.||||+
T Consensus 301 Ris---v~daL~HPY~~ 314 (369)
T KOG0665|consen 301 RIS---VDDALRHPYIK 314 (369)
T ss_pred ccc---HHHHhcCCeee
Confidence 999 88999999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=309.31 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=210.8
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECC-------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEE
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVR 752 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~-------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVk 752 (1093)
.+++..+++.+.+.||.|.||.|++|.... ....||+| .++... ...+.+.+..|+.+|..+. ||||+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK-~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVK-MLKENA--SSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEE-eccccc--CcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 556667777888899999999999997431 14568999 443332 2367788999999999885 999999
Q ss_pred EeeeeccCCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCC
Q 001354 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 816 (1093)
Q Consensus 753 L~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKP 816 (1093)
+.+++.....+++|+||+..|+|..+|+... .++......++.||+.||+||++..+|||||-.
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999999999999998655 388889999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccC--CCCCCChhhhcCCCCCc
Q 001354 817 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG--TPDYLAPEILLGTEHGY 894 (1093)
Q Consensus 817 eNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vG--Tp~YmAPEVL~g~~Ys~ 894 (1093)
.||||..+..+||+|||||+....... .......| ...|||||.+....|+.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~--------------------------y~~~~~~~~LP~kWmApEsl~~~~ft~ 500 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDY--------------------------YRTKSSAGTLPVKWMAPESLFDRVFTS 500 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCc--------------------------eEecCCCCccceeecCHHHhccCcccc
Confidence 999999999999999999984211000 00011122 34599999999999999
Q ss_pred cceeecchhhHHHHHh-CCCCCCCCC-hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 895 AADWWSVGIILFEFIT-GIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 895 ksDVWSLGVILYEMLT-GkpPF~~~s-~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
++|||||||+||||++ |..||.+.. ..++++.+..+. + ...|...++++.++++.||+.+|++||++.+..+.+
T Consensus 501 kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~-r-~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 501 KSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN-R-MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred cchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 9999999999999999 999999866 666666554443 3 224578899999999999999999999976655544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=291.36 Aligned_cols=260 Identities=30% Similarity=0.504 Sum_probs=213.0
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 761 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~----- 761 (1093)
.|.+.-+.||.|+||.||-+.+..+|+.+|+|++..... +-...+++.+|..+|..++|.|++..++..+...
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq--~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ--NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH--HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 455666899999999999999999999999996543322 2234578999999999999999999998887664
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+|+|+|.. ||..++-.-..++.+.++-++.||++||+|||+.||.||||||.|+|+++|..+|||||||++.-.
T Consensus 131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-- 207 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD-- 207 (449)
T ss_pred HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc--
Confidence 47999999976 998888887889999999999999999999999999999999999999999999999999998521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.........-+-|..|.|||+++|. .|+.++||||.|||+.|||-.+..|...++
T Consensus 208 ------------------------~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 208 ------------------------QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred ------------------------hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 1122233345778999999999984 689999999999999999999999998888
Q ss_pred HHHHHHHhc-----------------------cCCCCCCC--------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 921 EIIFDNILN-----------------------RKIPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 921 ~ei~~kIl~-----------------------~~l~fP~i--------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
.+..+.|.. +...-|.+ +..-..++.+++..+|..||.+|++ ..+.
T Consensus 264 iqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris---~~~A 340 (449)
T KOG0664|consen 264 IEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS---VEEA 340 (449)
T ss_pred HHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc---Hhhh
Confidence 776665532 22222322 1234557889999999999999998 6788
Q ss_pred HcCCCCCCC
Q 001354 970 KAHPFFKGV 978 (1093)
Q Consensus 970 L~HPFFkgI 978 (1093)
+.|++....
T Consensus 341 ~~~~~~~e~ 349 (449)
T KOG0664|consen 341 LQHRYLEEG 349 (449)
T ss_pred ccccccccc
Confidence 899998654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=293.06 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=196.2
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHH--hcCCCceEEEeeee
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI--TVRNPFVVRFFYSF 757 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~--kL~HPNIVkL~gsf 757 (1093)
...+....+..+.+.||+|.||+||+|+|+ |+.||+|++. . .+.....+|.+|.. .++|+||+.++++-
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~-s------rdE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS-S------RDERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEec-c------cchhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 455677889999999999999999999998 8999999442 1 23355677777765 56999999999776
Q ss_pred ccCC----ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeeecCCCcEEEccCC
Q 001354 758 TCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDG 825 (1093)
Q Consensus 758 qd~~----~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~--------GIIHRDIKPeNILLD~dG 825 (1093)
...+ .+|||++|.+.|+|+|+|.+ ..++.+....++..++.||+|||.. .|.|||||..|||+.++|
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 5543 59999999999999999987 6789999999999999999999953 499999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----C--Cccceee
Q 001354 826 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----H--GYAADWW 899 (1093)
Q Consensus 826 ~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Y--s~ksDVW 899 (1093)
.+-|+|+|||........ .-....+..|||-.|||||+|...- + -..+|||
T Consensus 354 ~C~IADLGLAv~h~~~t~-----------------------~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTD-----------------------TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred cEEEeeceeeEEecccCC-----------------------cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 999999999975321100 0012345679999999999996532 1 2368999
Q ss_pred cchhhHHHHHhC----------CCCCCCC-----ChHHHHHHHhccCCCCCCCCCCCCH-----HHHHHHHhhccCCcCC
Q 001354 900 SVGIILFEFITG----------IPPFTAE-----SPEIIFDNILNRKIPWPCVPSDMSF-----EAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 900 SLGVILYEMLTG----------kpPF~~~-----s~~ei~~kIl~~~l~fP~ip~~IS~-----eakDLIkrcL~kDP~K 959 (1093)
|||.+|||++.. .+||++. +.+++.+-+...+++ |.+|..+.. .+..||+.||..||.-
T Consensus 411 afgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R-P~ipnrW~s~~~l~~m~klMkeCW~~Np~a 489 (513)
T KOG2052|consen 411 AFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR-PNIPNRWKSDPALRVMAKLMKECWYANPAA 489 (513)
T ss_pred HHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC-CCCCcccccCHHHHHHHHHHHHhhcCCchh
Confidence 999999999863 5799753 234444444444444 545554432 3667899999999999
Q ss_pred CCChhcHHHHH
Q 001354 960 RLGANGAAEVK 970 (1093)
Q Consensus 960 RpTa~~A~EIL 970 (1093)
|+| |..|+
T Consensus 490 Rlt---ALriK 497 (513)
T KOG2052|consen 490 RLT---ALRIK 497 (513)
T ss_pred hhH---HHHHH
Confidence 999 55554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=312.46 Aligned_cols=260 Identities=31% Similarity=0.518 Sum_probs=226.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|+++..+|.|+||.||+++++.+++..|+|+| |.+ ..+.+.-+..|+-+++.++|||||.+++.+...+.++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvV--kLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVV--KLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheee--ecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 457999999999999999999999999999999955 332 2345667788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
++||||.||+|.+.-+-.+.++|.++.+.+++.+.||+|||+.|=+|||||-.|||+++.|.+||+|||.+....
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----
Confidence 999999999999998888999999999999999999999999999999999999999999999999999876321
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---cCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL---~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.--.+..++.|||.|||||+- ...+|+..||+|++|++-.|+---++|-.+..++
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 011245678999999999986 3578999999999999999999999998888887
Q ss_pred HHHHHHhccCCCCCCC--CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 922 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~i--p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.....+.+..+.-|.+ +...++.+.+|++.+|.++|++||+ +..+|.|||....
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc
Confidence 7776666665554443 3568899999999999999999999 7788899998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=303.42 Aligned_cols=205 Identities=29% Similarity=0.522 Sum_probs=181.1
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc-----hhHHHHHHHHHHHHHhcC---CCceEEEe
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR-----KNDIERILAERNILITVR---NPFVVRFF 754 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~-----~~eie~~l~E~~IL~kL~---HPNIVkL~ 754 (1093)
...+.+|..++.+|.|+||.|++|.++.+...|++| ++.|.+++- ....-.+-.|+.||..++ |+||++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK-~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIK-MIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEee-ehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 356778999999999999999999999999999999 555555432 223345678999999997 99999999
Q ss_pred eeeccCCceEEEEEec-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 755 YSFTCRDNLYLVMEYL-NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm-~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
++|++.+++||+||-. +|-||++++..+..++|.+++.+++||+.|+++||+.||||||||-+|+.++.+|-+||+|||
T Consensus 636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 9999999999999975 567999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGk 912 (1093)
.|... ....-..++||.+|.|||++.|.+| +..-|||+||++||-++...
T Consensus 716 saa~~-----------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 716 SAAYT-----------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred chhhh-----------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence 88642 1223356899999999999999888 78899999999999999999
Q ss_pred CCCCC
Q 001354 913 PPFTA 917 (1093)
Q Consensus 913 pPF~~ 917 (1093)
.||++
T Consensus 767 npyyn 771 (772)
T KOG1152|consen 767 NPYYN 771 (772)
T ss_pred CCCcC
Confidence 99975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=242.18 Aligned_cols=212 Identities=43% Similarity=0.734 Sum_probs=183.1
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCC
Q 001354 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 774 (1093)
Q Consensus 695 LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGS 774 (1093)
||.|++|.||++....+++.+++|.+... ... .....+.+|+.++..+.|++|+++++++......+++|||++|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-DSS--SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccc-cch--hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 68999999999999888999999954322 111 135678999999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEecCCcccccccccccCCCCCCC
Q 001354 775 LYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETD 852 (1093)
Q Consensus 775 L~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~~~~~~s~dls~~~td 852 (1093)
|..++... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+......
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~----------- 146 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD----------- 146 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC-----------
Confidence 99999876 57899999999999999999999999999999999999999 899999999998742100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccC
Q 001354 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931 (1093)
Q Consensus 853 ~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 931 (1093)
........+...|++||.+... .++.+.|+|+||++||+|
T Consensus 147 ----------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------- 187 (215)
T cd00180 147 ----------------KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187 (215)
T ss_pred ----------------cchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------
Confidence 0012335678899999999887 888999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 932 l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
..+.+++.+||..||.+||+ +.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~---~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPS---AKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcC---HHHHhhCC
Confidence 57899999999999999999 67888764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=251.00 Aligned_cols=214 Identities=44% Similarity=0.739 Sum_probs=181.9
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
|.+.+.||.|++|.||++....++..+|+|.+... ... .....+.+|+..+..++|+|++++++.+......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKE-KTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccc-cch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 57789999999999999999988999999954322 111 246788899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 769 YLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~-LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|+++++|.+++..... +++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 9999999999987766 8999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh-cCCCCCccceeecchhhHHHHHhCCCCCCC--CChHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIF 924 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL-~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~--~s~~ei~ 924 (1093)
........++..|++||.+ ....++.++|+|+||+++|||++|++||.. .+...+.
T Consensus 153 ---------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 153 ---------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred ---------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 0012345688899999999 667788899999999999999999999988 4444677
Q ss_pred HHHhccC
Q 001354 925 DNILNRK 931 (1093)
Q Consensus 925 ~kIl~~~ 931 (1093)
+.|..+.
T Consensus 212 ~~~~~~~ 218 (225)
T smart00221 212 DVWSFGV 218 (225)
T ss_pred HHHhcCC
Confidence 7776654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=267.34 Aligned_cols=218 Identities=29% Similarity=0.522 Sum_probs=180.5
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~ 761 (1093)
.+..+++.-+..||+|+||.|-+.++..+|...|+|.+.- . ...+...+.++|+++..+. .+|++|.+|+.+..+.
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~--t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA--T-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh--h-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4556777788899999999999999999999999996632 2 2345567788899887655 6999999999999999
Q ss_pred ceEEEEEecCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCcc
Q 001354 762 NLYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dl----L~k~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk 836 (1093)
..++.||.|.- +|..+ +.+.+.++|..+-.++..++.||.|||++ .+||||+||+||||+.+|++|+||||.+-
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999965 77554 34567899999999999999999999976 89999999999999999999999999986
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC----CCCCccceeecchhhHHHHHhCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g----~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
.... ........|-..|||||.+.. .+|+.++||||||++|+||.+++
T Consensus 198 ~L~d----------------------------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr 249 (282)
T KOG0984|consen 198 YLVD----------------------------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILR 249 (282)
T ss_pred eehh----------------------------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcc
Confidence 4210 111122568889999999863 48999999999999999999999
Q ss_pred CCCCC-CChHHHHHHHhccCC
Q 001354 913 PPFTA-ESPEIIFDNILNRKI 932 (1093)
Q Consensus 913 pPF~~-~s~~ei~~kIl~~~l 932 (1093)
.||.. .++-+..+.++....
T Consensus 250 ~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 250 FPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred ccccccCCHHHHHHHHhcCCC
Confidence 99975 567777778777643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=287.05 Aligned_cols=133 Identities=29% Similarity=0.479 Sum_probs=113.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-----C---CceEEEee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-----N---PFVVRFFY 755 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-----H---PNIVkL~g 755 (1093)
..-..|.+.++||.|.|++||+|.+..+.+.|||| |.+.... -.+..+.|+.+|++++ | ..||+|++
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlK-VvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALK-VVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEE-EEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 34478999999999999999999999999999999 5443332 3455788999999874 2 47999999
Q ss_pred eeccC----CceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEc
Q 001354 756 SFTCR----DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIA 822 (1093)
Q Consensus 756 sfqd~----~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD 822 (1093)
.|... .++|||+|++ |-+|..+|... ..++...++.|++||+.||.|||.. ||||-||||+||||.
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99764 4799999999 66999999764 4699999999999999999999975 999999999999994
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=296.08 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=205.2
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCc----EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk----~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
.++..++||.|+||+||+|.|...|+ +||||++... ........++.|.-+|.+++|||+++|++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 44566799999999999999987766 5677743322 23344678999999999999999999999998877 8
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
-||++|||+|.|.++++.+ +.+-......|..||++||.|||.++++||||-..|||+.+-.++||.|||+++......
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 8999999999999999865 568888999999999999999999999999999999999999999999999998632110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ 921 (1093)
....+....-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....
T Consensus 853 -------------------------~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 853 -------------------------KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred -------------------------ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 0111222334678999999999999999999999999999999 99999999888
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
++-..+-.+. +++ .|+-.+-++.-++.+||..|+..||++.
T Consensus 908 eI~dlle~ge-RLs-qPpiCtiDVy~~mvkCwmid~~~rp~fk 948 (1177)
T KOG1025|consen 908 EIPDLLEKGE-RLS-QPPICTIDVYMVMVKCWMIDADSRPTFK 948 (1177)
T ss_pred HhhHHHhccc-cCC-CCCCccHHHHHHHHHHhccCcccCccHH
Confidence 8776654432 333 3678899999999999999999999954
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=280.20 Aligned_cols=244 Identities=26% Similarity=0.411 Sum_probs=190.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHh--cCCCceEEEeeeeccCC-
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~k--L~HPNIVkL~gsfqd~~- 761 (1093)
.....+++++||+|.||.||+|+.. ++.|||| ++ ...+.+.+.+|.+|... +.|+||+++++.-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVK-if------p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVK-IF------PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEE-ec------CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 3667788899999999999999986 6999999 43 23556788999998775 57999999997765554
Q ss_pred ---ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcEeeecCCCcEEEccCCcEEE
Q 001354 762 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGHIKL 829 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~---------GIIHRDIKPeNILLD~dG~VKL 829 (1093)
.++||++|.+.|+|.++|.. ..+++....+++..+++||+|||+. .|+|||||..||||.+++++-|
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 68999999999999999976 4589999999999999999999963 5999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CC-----ccceeecchh
Q 001354 830 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HG-----YAADWWSVGI 903 (1093)
Q Consensus 830 sDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys-----~ksDVWSLGV 903 (1093)
+|||||...... .....+...+||..|||||+|.+.- +. ...||||+|.
T Consensus 358 aDFGLAl~~~p~-------------------------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL 412 (534)
T KOG3653|consen 358 ADFGLALRLEPG-------------------------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL 412 (534)
T ss_pred eccceeEEecCC-------------------------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence 999999864210 0112334579999999999997632 22 3789999999
Q ss_pred hHHHHHhCCC------------CCCC-----CChHHHHHHHhccCCCCCCCCCC-----CCHHHHHHHHhhccCCcCCCC
Q 001354 904 ILFEFITGIP------------PFTA-----ESPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRL 961 (1093)
Q Consensus 904 ILYEMLTGkp------------PF~~-----~s~~ei~~kIl~~~l~fP~ip~~-----IS~eakDLIkrcL~kDP~KRp 961 (1093)
+||||++... ||.. .+-+++...++..+.+ |.++.. --.-+++.|..||..||+-|+
T Consensus 413 VLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~R-P~~p~~W~~h~~~~~l~et~EeCWDhDaeARL 491 (534)
T KOG3653|consen 413 VLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQR-PKIPDAWRKHAGMAVLCETIEECWDHDAEARL 491 (534)
T ss_pred HHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccC-CCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence 9999998533 3431 2234455555544433 443332 234588999999999999999
Q ss_pred Chh
Q 001354 962 GAN 964 (1093)
Q Consensus 962 Ta~ 964 (1093)
|+.
T Consensus 492 TA~ 494 (534)
T KOG3653|consen 492 TAG 494 (534)
T ss_pred hhH
Confidence 964
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=275.96 Aligned_cols=283 Identities=26% Similarity=0.420 Sum_probs=206.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECC---CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~---TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~ 760 (1093)
..+.|.++.+||.|+|+.||++.... .++.||+|.+... ....++.+|+++|..+. +.||+++.+++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t------s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT------SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc------cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34678899999999999999998877 7889999955332 23456899999999986 99999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~~~ 839 (1093)
+...+||||++..+..++... ++-..++.|++.++.||.++|.+|||||||||.|+|.+. -+.-.|.|||||..-.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999888888765 668899999999999999999999999999999999985 4678999999997211
Q ss_pred ccccccCCC-----CCCC--CCCCC-----C-CCCCcc----cccCcCCccCccCCCCCCChhhhcCC-CCCccceeecc
Q 001354 840 INNTIDLSG-----PETD--GIMPS-----D-AHYPEY----QQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 901 (1093)
Q Consensus 840 ~~~s~dls~-----~~td--~~~p~-----~-~~~~e~----~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSL 901 (1093)
.....+.+. ..+. +.... . ..-..+ ....+.......|||+|.|||++.+. ..+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000000000 0000 00000 0 000001 11223345567899999999999864 46889999999
Q ss_pred hhhHHHHHhCCCCCCCCCh--------------HHHHHH-HhccC------CCCCC------------------------
Q 001354 902 GIILFEFITGIPPFTAESP--------------EIIFDN-ILNRK------IPWPC------------------------ 936 (1093)
Q Consensus 902 GVILYEMLTGkpPF~~~s~--------------~ei~~k-Il~~~------l~fP~------------------------ 936 (1093)
|||+.-++++..||..... .++.+. .+.+. -.+|.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999954211 111100 00011 00000
Q ss_pred ----CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 937 ----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 937 ----ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.....+..+.||+.+||..||.+|+| |++.|.||||...+
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEAD 388 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcchh
Confidence 01234568999999999999999999 88999999998543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=301.25 Aligned_cols=223 Identities=16% Similarity=0.186 Sum_probs=154.6
Q ss_pred cCC-CceEEEeeee-------ccCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecC
Q 001354 745 VRN-PFVVRFFYSF-------TCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 815 (1093)
Q Consensus 745 L~H-PNIVkL~gsf-------qd~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIK 815 (1093)
++| +||+.++++| .....++++|||+ +++|.++|... ..+++..++.|+.||+.||.|||++||||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 5777777777 2334678889988 55999999753 459999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEecCCcccccccccccCCCCCCC-CCC------CCC--CCCCcccc-cCcCCccCccCCCCCCChh
Q 001354 816 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD-GIM------PSD--AHYPEYQQ-TDNRNRHSAVGTPDYLAPE 885 (1093)
Q Consensus 816 PeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td-~~~------p~~--~~~~e~~~-~~~~~~~s~vGTp~YmAPE 885 (1093)
|+||||+..|.+|++|||++.......... ....+ +.. +.. ........ .........+||+.|||||
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~--~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDAT--TKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCc--ccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 999999988888888888876421110000 00000 000 000 00000000 0001112357999999999
Q ss_pred hhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc
Q 001354 886 ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965 (1093)
Q Consensus 886 VL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~ 965 (1093)
++.+..|+.++|||||||+||||++|.+||.... .....+..... |.....-.+.+.+++.+||.+||.+||+
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~~~P~~Rps--- 258 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILLNWPKEASFCLWLLHPEPSCRPS--- 258 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--ChhhhhcCHHHHHHHHHhCCCChhhCcC---
Confidence 9999999999999999999999999999986432 12222222211 2111122456789999999999999999
Q ss_pred HHHHHcCCCCCC
Q 001354 966 AAEVKAHPFFKG 977 (1093)
Q Consensus 966 A~EIL~HPFFkg 977 (1093)
+.++++||||..
T Consensus 259 ~~eil~h~~~~~ 270 (793)
T PLN00181 259 MSELLQSEFINE 270 (793)
T ss_pred hHHHhhchhhhh
Confidence 889999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-26 Score=229.60 Aligned_cols=260 Identities=39% Similarity=0.703 Sum_probs=204.8
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeccCCceEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP-NIVkL~gsfqd~~~LyLVM 767 (1093)
|.+.+.||.|+||.||++.+. ..+++|.+ .+...........+.+|..++..+.|+ +|++++..+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~-~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVL-AKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEee-chhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 788999999999999999987 77899944 333333333567899999999999988 7999999998877789999
Q ss_pred EecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEEecCCccccccccc
Q 001354 768 EYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g---~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~~~~~~s 843 (1093)
+|+.+++|..++.... .+++..+..++.|++.++.|+|+.+++||||||+|||++..+ .++++|||++........
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999999998777665 799999999999999999999999999999999999999998 799999999874211000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
. ..........+||+.|+|||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 158 ~---------------------~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 158 T---------------------SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred c---------------------ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 0 000013456789999999999988 5788999999999999999999999887763
Q ss_pred ----HHHHHHHhccCCC-CCC-CCCCC----CHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 921 ----EIIFDNILNRKIP-WPC-VPSDM----SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 921 ----~ei~~kIl~~~l~-fP~-ip~~I----S~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
......+.....+ ... ..... ...+.+++.+++..+|..|.+ ..+...++|..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~ 279 (384)
T COG0515 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLA 279 (384)
T ss_pred cccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhh
Confidence 4555555444432 211 11111 257999999999999999999 44545554443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=233.29 Aligned_cols=161 Identities=25% Similarity=0.284 Sum_probs=129.8
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCC
Q 001354 773 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851 (1093)
Q Consensus 773 GSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~t 851 (1093)
|+|.+++... ..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~------------ 60 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT------------ 60 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeec------------
Confidence 7999999874 45999999999999999999999998 999999999999999 99987421
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh-HHHHHHHhcc
Q 001354 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNILNR 930 (1093)
Q Consensus 852 d~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~-~ei~~kIl~~ 930 (1093)
.....||+.|||||++.+..|+.++|||||||++|||++|.+||..... ......+...
T Consensus 61 --------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 120 (176)
T smart00750 61 --------------------PEQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120 (176)
T ss_pred --------------------cccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH
Confidence 0112689999999999999999999999999999999999999976543 2333333332
Q ss_pred CCCC-C---CCCCCCCH--HHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 931 KIPW-P---CVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 931 ~l~f-P---~ip~~IS~--eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
.... + ..+..++. ++++||.+||..||.+||+ +.+++.|+|+.
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~ 169 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRAL 169 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHH
Confidence 2111 1 01123344 6999999999999999999 78999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=251.77 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=193.6
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEe-eeeccCCce
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF-YSFTCRDNL 763 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~-gsfqd~~~L 763 (1093)
.+.|.+.+.||.|-||.+.+|.++.++..+++|.+.+. ....+.|.+|..---.+. |.||+.-| ..|++.+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 47899999999999999999999999999999955332 234567888887655554 89999988 568889999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc--CCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~--dG~VKLsDFGLAk~~~~~ 841 (1093)
+++|||+|.|||..-+.. ..+-|...+.+++|++.||.|+|+.++||||||.+||||-. ...|||||||+.+...
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 999999999999988755 45889999999999999999999999999999999999953 3479999999987421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---C--CCccceeecchhhHHHHHhCCCCCC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---E--HGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~---~--Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
......-.+..|.|||+.... . ....+|+|.||+++|.+|+|.+||.
T Consensus 175 ----------------------------~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 ----------------------------TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred ----------------------------ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 001112245679999987542 2 3678999999999999999999997
Q ss_pred CCCh----HHHHHHHhc-cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCC
Q 001354 917 AESP----EIIFDNILN-RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974 (1093)
Q Consensus 917 ~~s~----~ei~~kIl~-~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPF 974 (1093)
.... ---+.+... .....|.....+|+.+..+.++.|..+|++|--.-++.......|
T Consensus 227 ka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 227 KASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred hhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 4332 112222222 233456556789999999999999999999933222444433333
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=244.28 Aligned_cols=259 Identities=19% Similarity=0.262 Sum_probs=205.1
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhh--hhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL--DMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RD 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~--~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd-~~ 761 (1093)
.-.++++...+-+|.||+||.|.|++.....-.+.++-|. ..-+.-++..++.|--.|..+.|||+..+.+.... ..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3455777888999999999999988654433333222221 12234567788999999999999999999887654 45
Q ss_pred ceEEEEEecCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~--------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
..++++.++.-|+|..+|... ..++..+...++.|++.||+|||+.||||.||-..|.+||+.-.+||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 688999999999999999732 247777888889999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-Gk 912 (1093)
|++-...... +. ... .---...||+||.+.+..|+.++|+|||||+||||+| |+
T Consensus 442 LSRDLFP~DY----------------hc--LGD-------nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~ 496 (563)
T KOG1024|consen 442 LSRDLFPGDY----------------HC--LGD-------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGK 496 (563)
T ss_pred hccccCcccc----------------cc--cCC-------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCC
Confidence 9884321111 00 000 0112467999999999999999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.|+...+|.++...+..+. ++ ..|.+.++++..++.-||..+|++||++.+....|
T Consensus 497 ~PyaeIDPfEm~~ylkdGy-Rl-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 497 LPYAEIDPFEMEHYLKDGY-RL-AQPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred CCccccCHHHHHHHHhccc-ee-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 9999999999998887653 22 13578999999999999999999999977665544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=268.49 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=206.0
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehh--hhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK--LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK--~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
....++|.|++|.|+.+......+.++.|....+ ...........+..|+-+-..+.|||++.....++.....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999999998888777777777632211 11111111222667777778899999999888888777777779
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|||++ ||+.++...+.+....+..++.|++.|++|||..||.||||||+|+|++.+|.+||+|||.+......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~------ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP------ 473 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC------
Confidence 99999 99999998888999999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCc-cceeecchhhHHHHHhCCCCCCCCChHHHH-H
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY-AADWWSVGIILFEFITGIPPFTAESPEIIF-D 925 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~-ksDVWSLGVILYEMLTGkpPF~~~s~~ei~-~ 925 (1093)
| ..........+|+..|+|||++.+..|+. .+||||.|++++.|++|+.||......+.. .
T Consensus 474 ----------------~-e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~ 536 (601)
T KOG0590|consen 474 ----------------W-EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK 536 (601)
T ss_pred ----------------c-chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh
Confidence 0 01123456789999999999999999964 789999999999999999999754433221 1
Q ss_pred HHh-ccCCC----CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 926 NIL-NRKIP----WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 926 kIl-~~~l~----fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
.+. ..... .-.+...++.+.+.+|.+||+.||.+|.+ +.+|++.+||+.++-..
T Consensus 537 ~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIECCH 595 (601)
T ss_pred hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcceEE
Confidence 110 01000 01123567889999999999999999999 88999999999886543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=225.42 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=192.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCC-cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC----CCceEEEeeee-ccCC
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTG-DLFAIKQVLKKLDMIRKNDIERILAERNILITVR----NPFVVRFFYSF-TCRD 761 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TG-k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~----HPNIVkL~gsf-qd~~ 761 (1093)
.|.+.+.||+|+||.||+|.+..++ ..+|+|.. ...... .. ..+..|..+|..+. .+++..++..+ ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e-~~~~~~--~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLE-KKELGS--KP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEE-EecccC--CC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 8999999999999999999998775 67899843 222111 11 15677888888776 36899999988 5777
Q ss_pred ceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-----CcEEEEecCC
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-----GHIKLTDFGL 834 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-----G~VKLsDFGL 834 (1093)
.-|+||+.+ |.+|.++.... +.|+...+..++.|++.+|++||+.|+|||||||.|+++... ..+.|.|||+
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 899999988 77999988654 479999999999999999999999999999999999999865 3699999999
Q ss_pred ccc--ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCC
Q 001354 835 SKI--GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 835 Ak~--~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
|+. ...... . . ....+.....+.||..|.++.+..+...+...|+||++.++.||+.|.
T Consensus 174 ar~~~~~~~~~----------~-----~----~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 174 ARRFKYVGDSG----------G-----N----LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred CccccccCCCC----------c-----c----cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 983 110000 0 0 001112234577999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCC--CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 913 PPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l--~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
.||.+........++..... .........+.++..+...+-..+...+|....+..+
T Consensus 235 LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 235 LPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred CCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 99977654322222222111 1110123455677788777777888889986555554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=235.29 Aligned_cols=181 Identities=22% Similarity=0.198 Sum_probs=133.6
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECC-CCcEEEEEEeehhhhh-hchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKQVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~-TGk~VAIKkILkK~~~-~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
..+...++|.+.+.||+|+||+||+|+++. ++..+|+|++...... ........+.+|+.+|..++|+||+..+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345667889999999999999999999876 6788899954322110 1223356689999999999999998533322
Q ss_pred cCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeec-CCCcEEEccCCcEEEEecCCccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDI-KPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
...|+||||++|++|.. +.. .. ...++.+++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 45799999999999973 211 11 1467889999999999999999999 99999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 890 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~ 890 (1093)
.... ... ............+|++.|+|||.+...
T Consensus 162 ~~~~--------~~~-----------~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRR--------GAL-----------YRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccC--------cch-----------hhhhhhhhhhhhhccCccCCcccCChh
Confidence 3210 000 000001112367899999999998653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=217.11 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=194.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~L 763 (1093)
.--.|++.++||.|+||++++|.+.-++++||||.--.| .+.-.+..|....+.|. .+.|..+|++.+...+-
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 345799999999999999999999999999999933222 22345666777776665 79999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-----cEEEEecCCccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLSKI 837 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-----~VKLsDFGLAk~ 837 (1093)
.||||++ |-+|.++..=.+ .|+...+..++.|++.-|+|+|++.+|+|||||+|+||..-| .|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 779999887554 599999999999999999999999999999999999998644 589999999995
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
- ..+.+.-.+|. ....+..||..||+-...+|...+..-|+=|||-++++.|.|..||.+
T Consensus 179 Y--------rDp~TkqHIPY------------rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 179 Y--------RDPKTKQHIPY------------REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred h--------cCccccccCcc------------ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 2 12222222222 223467899999999999999999999999999999999999999987
Q ss_pred C---ChHHHHHHHhccCCCCC--CCCCCCCHHHHHHHHhhccCCcCCCCCh
Q 001354 918 E---SPEIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGA 963 (1093)
Q Consensus 918 ~---s~~ei~~kIl~~~l~fP--~ip~~IS~eakDLIkrcL~kDP~KRpTa 963 (1093)
. +..+-|++|-..+..-| .+-.+++.++..-+.-.-..+-.+-|..
T Consensus 239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 5 45666777754332212 1224556666555554444444445553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=207.17 Aligned_cols=280 Identities=23% Similarity=0.313 Sum_probs=214.3
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-CceEEEeeeec
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFT 758 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNIVkL~gsfq 758 (1093)
....+..+.|.+++.||.|+||.+|+|....+|..||||+--.+. .-..+.-|..+...+++ ..|..+..++.
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 344577899999999999999999999999999999999322111 12346778888888874 77888888888
Q ss_pred cCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC---CcEEEEecCC
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGL 834 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d---G~VKLsDFGL 834 (1093)
...+-.+|||++ |-+|.+++.-. ..|+...+..++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+||||
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 999999999998 77999988744 468999999999999999999999999999999999999754 4589999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
|+..... .+..+++ -.......||..|.+-....+...+..-|+=|+|.+|.++..|..|
T Consensus 161 aKky~d~--------------~t~~HIp------yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LP 220 (341)
T KOG1163|consen 161 AKKYRDI--------------RTRQHIP------YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLP 220 (341)
T ss_pred hhhhccc--------------cccccCc------cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCc
Confidence 9853211 0111111 1223456899999998888888888999999999999999999999
Q ss_pred CCCCC---hHHHHHHHhccCCCCCC--CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH-------cCCCCCCCCcch
Q 001354 915 FTAES---PEIIFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-------AHPFFKGVNWDS 982 (1093)
Q Consensus 915 F~~~s---~~ei~~kIl~~~l~fP~--ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL-------~HPFFkgIdWd~ 982 (1093)
|.+.. ..+-+++|...+...|. +-.++|.++.-.+.-|-..--.+-|...-+.++. +|.+=--.||+.
T Consensus 221 WQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~ 300 (341)
T KOG1163|consen 221 WQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM 300 (341)
T ss_pred ccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence 99865 45667778776654432 3467889999999888766666666643333332 333322368888
Q ss_pred hhcc
Q 001354 983 LALQ 986 (1093)
Q Consensus 983 L~~~ 986 (1093)
+.++
T Consensus 301 lkqk 304 (341)
T KOG1163|consen 301 LKQK 304 (341)
T ss_pred HHHH
Confidence 7655
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=199.60 Aligned_cols=141 Identities=24% Similarity=0.179 Sum_probs=108.5
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchh-----------------------HHHHHHHHHHHHHhcCCC
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN-----------------------DIERILAERNILITVRNP 748 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~-----------------------eie~~l~E~~IL~kL~HP 748 (1093)
...||+|+||.||+|... +|+.||+|++ +........ .......|..+|..+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIY-KTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEE-EecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 357999999999999987 8999999954 332111000 012334599999999877
Q ss_pred ceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeeecCCCcEEEccCCcE
Q 001354 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 749 NIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYL-Hs~GIIHRDIKPeNILLD~dG~V 827 (1093)
++...+... .. ..||||||++|++|...+.+.+.+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.+
T Consensus 80 ~v~~p~~~~-~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 80 GIPCPEPIL-LK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCCcEEE-ec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 663322221 12 2389999999988876655557799999999999999999999 799999999999999998 5889
Q ss_pred EEEecCCccc
Q 001354 828 KLTDFGLSKI 837 (1093)
Q Consensus 828 KLsDFGLAk~ 837 (1093)
+|+|||+|..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=191.43 Aligned_cols=142 Identities=24% Similarity=0.145 Sum_probs=109.7
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc----------------------hhHHHHHHHHHHHHHhcCCCc
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR----------------------KNDIERILAERNILITVRNPF 749 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~----------------------~~eie~~l~E~~IL~kL~HPN 749 (1093)
.+.||+|+||.||+|.+. +|+.||+|++........ ......+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999995432211000 001223467899999999988
Q ss_pred eEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEE
Q 001354 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIK 828 (1093)
Q Consensus 750 IVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VK 828 (1093)
|......... ..||||||++|+++.........+++..+..++.|++.+|.+||. .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7443332222 248999999998665443344568888999999999999999999 9999999999999998 89999
Q ss_pred EEecCCccc
Q 001354 829 LTDFGLSKI 837 (1093)
Q Consensus 829 LsDFGLAk~ 837 (1093)
|+|||+++.
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=198.62 Aligned_cols=175 Identities=16% Similarity=0.170 Sum_probs=133.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHH------HHHHHHHHHhcCCCceEEEeeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER------ILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~------~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
+--++|+++++||.|+||.||++.. ++..+|+|+. ............. +.+|+..+.++.||+|..+..++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf-~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVF-APKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEe-chhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 4467899999999999999999755 4668999944 3332222333333 57899999999999999998876
Q ss_pred ccC--------CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEE
Q 001354 758 TCR--------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 829 (1093)
Q Consensus 758 qd~--------~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKL 829 (1093)
.+. ...+|||||++|.+|.++. .+++. ...+++.+|..||..|++||||||.||+++.+| ++|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 644 3589999999999998773 23332 356999999999999999999999999999999 999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHH
Q 001354 830 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 830 sDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEML 909 (1093)
+|||..+..... .+ ...+++...|+.++|+||||+++.-+.
T Consensus 176 iDfg~~~~~~e~-----------------------------~a----------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQR-----------------------------KA----------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccch-----------------------------hh----------HHHHHHHhHhcccccccceeEeehHHH
Confidence 999987631100 00 011455667888999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=203.93 Aligned_cols=234 Identities=27% Similarity=0.376 Sum_probs=150.2
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-----------CceEEEee-
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-----------PFVVRFFY- 755 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-----------PNIVkL~g- 755 (1093)
.+...+.||.|+|+.||.+++..||+.+|+|+.+-.. .......+.+.+|.-....+.+ ..++.+--
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 4567889999999999999999999999999765444 3334456666666543333221 12222110
Q ss_pred -------eeccCC--------ceEEEEEecCCCChHHHHHh---cCCC---CHHHHHHH-HHHHHHHHHHHHhcCcEeee
Q 001354 756 -------SFTCRD--------NLYLVMEYLNGGDLYSLLRK---VGCL---EEDVARIY-IAELVLALEYLHSLGIVHRD 813 (1093)
Q Consensus 756 -------sfqd~~--------~LyLVMEYm~GGSL~dlL~k---~g~L---sEe~ar~y-aaQIl~ALeYLHs~GIIHRD 813 (1093)
++.... +.+++|+-+. +||.+++.- .... ....++.+ ..|++..+++||..|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 111111 3477888885 499888642 2222 22334444 47999999999999999999
Q ss_pred cCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC----
Q 001354 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---- 889 (1093)
Q Consensus 814 IKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---- 889 (1093)
|+|+|++++.+|.++|+||+...... ........+..|.+||....
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g------------------------------~~~~~~~~~~~~~PPe~~~~~~~~ 220 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAG------------------------------TRYRCSEFPVAFTPPELESCAGQF 220 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETT------------------------------EEEEGGGS-TTTS-HHHHHHHTSC
T ss_pred cceeeEEEcCCCCEEEcChHHHeecC------------------------------ceeeccCCCcccCChhhhhhhccc
Confidence 99999999999999999999766310 01111345578999997743
Q ss_pred ----CCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCC
Q 001354 890 ----TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960 (1093)
Q Consensus 890 ----~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KR 960 (1093)
-.++.+.|.|+||+++|.|.+|..||....+...... .|.... ++++.+++||.+||++||.+|
T Consensus 221 ~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 221 GQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 2468899999999999999999999987654322221 233333 788999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=190.64 Aligned_cols=202 Identities=22% Similarity=0.276 Sum_probs=140.0
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh-chhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEE
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI-RKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~-~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.+...|++|+||+|+++.. .+..++.+. +...... ..-....+.+|+++|.++. |++|++++++ ...|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~-l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRD-LSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecc-cccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 4567899999999998765 466666552 2221111 1111235789999999996 5889998875 4579999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeec-CCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDI-KPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~--- 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR--- 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch---
Confidence 99999998765422 1 1346789999999999999999999 79999999999999999999984211000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.. ..+ ...........-..+++.|++|+.-.- ..--...+|++.|+-+|.|+|+..|+.+++
T Consensus 148 -------~~---r~L-~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 -------WM---RLL-AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred -------HH---HHH-HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 000 000000011122347899999986432 222357899999999999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-20 Score=227.05 Aligned_cols=245 Identities=26% Similarity=0.380 Sum_probs=187.4
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+|...+.||.+.|=+|.+|++.. |. +++|+++++.....-......+.|+. ...+++||.+++.-.-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78899999999999999999874 54 88998877765555555555566666 66788999999988888888899999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
+|+.. +|+|.|...+.+..-+.+.|+.||+.||.-+|+.||+|+|||.+||||++=+=+.|+||---+....
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL------- 172 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL------- 172 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC-------
Confidence 99987 9999999888899999999999999999999999999999999999999988899999986553110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-----------CCccceeecchhhHHHHHh-CCCCC
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFIT-GIPPF 915 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-----------Ys~ksDVWSLGVILYEMLT-GkpPF 915 (1093)
+ ...|.+.. -|-. +..--..|+|||.|.... .+.+.||||+||+++||++ |.|||
T Consensus 173 -P---eDNPadf~--fFFD-------TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 173 -P---EDNPADFT--FFFD-------TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred -C---CCCcccce--EEEe-------cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 0 00111111 1111 111224799999986522 4568999999999999998 89999
Q ss_pred CC-----------CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 916 TA-----------ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 916 ~~-----------~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
.- .+++...++| + +..++.||..|++.||.+|++ |++.|+.
T Consensus 240 ~LSQL~aYr~~~~~~~e~~Le~I-------e------d~~~Rnlil~Mi~rdPs~RlS---AedyL~~ 291 (1431)
T KOG1240|consen 240 TLSQLLAYRSGNADDPEQLLEKI-------E------DVSLRNLILSMIQRDPSKRLS---AEDYLQK 291 (1431)
T ss_pred cHHHHHhHhccCccCHHHHHHhC-------c------CccHHHHHHHHHccCchhccC---HHHHHHh
Confidence 42 2233333333 1 125789999999999999999 6666654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.7e-19 Score=195.83 Aligned_cols=211 Identities=27% Similarity=0.413 Sum_probs=156.0
Q ss_pred CCCceEEEeeeeccC---------------------------CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 001354 746 RNPFVVRFFYSFTCR---------------------------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798 (1093)
Q Consensus 746 ~HPNIVkL~gsfqd~---------------------------~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl 798 (1093)
.|||||+++.+|.+. ..+|+||..++. +|..+|-.. ..+....+.+++|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 599999999888652 238999999876 999998653 356777888999999
Q ss_pred HHHHHHHhcCcEeeecCCCcEEEc--cCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccC
Q 001354 799 LALEYLHSLGIVHRDLKPDNLLIA--HDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 874 (1093)
Q Consensus 799 ~ALeYLHs~GIIHRDIKPeNILLD--~dG--~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s 874 (1093)
.|+.|||++||.|||+|.+||||. .++ .+.|+|||.|-- ..++...+ .|.+ ....
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA-d~~hGlql-------------py~S-------~~Vd 410 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA-DDNHGLQL-------------PYES-------DEVD 410 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee-cccccccc-------------cccc-------cccc
Confidence 999999999999999999999984 444 478899998752 11111111 1111 1223
Q ss_pred ccCCCCCCChhhhcCCC-----C-CccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 001354 875 AVGTPDYLAPEILLGTE-----H-GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDL 948 (1093)
Q Consensus 875 ~vGTp~YmAPEVL~g~~-----Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDL 948 (1093)
.-|.-.-||||+....+ . -.++|.|+.|.+-||++....||++...+.+-.... ..-..|.+|..+++.+++|
T Consensus 411 ~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y-qe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 411 LGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY-QESQLPALPSRVPPVARQL 489 (598)
T ss_pred CCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh-hhhhCCCCcccCChHHHHH
Confidence 45778899999987431 1 238999999999999999999999855432222211 2224567789999999999
Q ss_pred HHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 949 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 949 IkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
+..+|+.||.||++.+-|..+++--.|..-+|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence 99999999999999877777776555544444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=181.47 Aligned_cols=136 Identities=18% Similarity=0.215 Sum_probs=106.7
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-----CCCceEEEeeeeccCC---c
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-----RNPFVVRFFYSFTCRD---N 762 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-----~HPNIVkL~gsfqd~~---~ 762 (1093)
-.+.||+|+||.||. +..++.. +||++... .....+.+.+|+.++..+ +||||+++|+++.+.. .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~----~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR----GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecc----ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 346899999999995 6666555 68855322 122346789999999999 5799999999999874 3
Q ss_pred eE-EEEEe--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCcEeeecCCCcEEEccC----CcEEEEecCC
Q 001354 763 LY-LVMEY--LNGGDLYSLLRKVGCLEEDVARIYIAELVLAL-EYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGL 834 (1093)
Q Consensus 763 Ly-LVMEY--m~GGSL~dlL~k~g~LsEe~ar~yaaQIl~AL-eYLHs~GIIHRDIKPeNILLD~d----G~VKLsDFGL 834 (1093)
+| +|||| +++|+|.+++.+. .+++. ..++.+++.++ +|||+++||||||||+|||++.. +.++|+||+.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 34 78999 5689999999764 56666 35678888888 99999999999999999999753 3799999544
Q ss_pred cc
Q 001354 835 SK 836 (1093)
Q Consensus 835 Ak 836 (1093)
+.
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=176.73 Aligned_cols=138 Identities=31% Similarity=0.387 Sum_probs=112.8
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhh----hhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD----MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~----~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
+.||+|++|.||+|.+ .|..+++|+...+.. .........+.+|..++..+.|++|+....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 577889995432211 1111223567889999999999988776666667778899999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 6778899999999999999999999999999999 88999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-19 Score=214.71 Aligned_cols=264 Identities=27% Similarity=0.416 Sum_probs=207.7
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECC-CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~-TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~ 762 (1093)
....|.+.+.||+|+|+.|-+..... +...+|+|.+-.. . .......++..|..+-..+. |+|++.+++.....+.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~-~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIP-P-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCC-C-CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence 35678899999999999999887744 3445666633211 1 23344566677888888887 9999999999999999
Q ss_pred eEEEEEecCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCcEeeecCCCcEEEccCC-cEEEEecCCcccc
Q 001354 763 LYLVMEYLNGGDLYSLL-RKVG-CLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIG 838 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL-~k~g-~LsEe~ar~yaaQIl~ALeYLH-s~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~~ 838 (1093)
.+++++|..||+++..+ .... ..+...+.+|+.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|...
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999999998 5554 6788899999999999999999 99999999999999999999 9999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccC-CCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG-TPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vG-Tp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
... ..........+| ++.|+|||.+.+..| +...|+||.|+++.-|++|..||.
T Consensus 176 ~~~------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 176 RNK------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred ccc------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence 210 112233455678 999999999998544 778999999999999999999997
Q ss_pred CCChHHH-HHHHhccCCC-CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 917 AESPEII-FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 917 ~~s~~ei-~~kIl~~~l~-fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
....... +......... -......++..+.+++.+++..+|..|.+ ..++..+||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 232 FPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred ccccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 6543321 1111121111 01123678999999999999999999999 778999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=179.04 Aligned_cols=145 Identities=23% Similarity=0.119 Sum_probs=112.6
Q ss_pred CeeEEEeeeccCCeEEEEEE-ECCCCcEEEEEEeehhhhhh------------------c--hhHHHHHHHHHHHHHhcC
Q 001354 688 DFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKQVLKKLDMI------------------R--KNDIERILAERNILITVR 746 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar-~k~TGk~VAIKkILkK~~~~------------------~--~~eie~~l~E~~IL~kL~ 746 (1093)
.|.+.+.||+|+||.||+|. +..+|..||+|++....... . ......+..|..++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788899999999999998 66789999999553221100 0 001134568999999997
Q ss_pred CC--ceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-cEeeecCCCcEEEcc
Q 001354 747 NP--FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAH 823 (1093)
Q Consensus 747 HP--NIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~G-IIHRDIKPeNILLD~ 823 (1093)
+. .+.+++.. ...|+||||++|++|...+.....+....+..++.||+.+|.+||+.| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455542 235899999999888776544455677778899999999999999999 99999999999999
Q ss_pred CCcEEEEecCCccc
Q 001354 824 DGHIKLTDFGLSKI 837 (1093)
Q Consensus 824 dG~VKLsDFGLAk~ 837 (1093)
++.++|+|||++..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-17 Score=206.20 Aligned_cols=199 Identities=24% Similarity=0.360 Sum_probs=157.2
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC---CCceEEEeeee
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSF 757 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~---HPNIVkL~gsf 757 (1093)
...+....|.|-+.||+|+||.||+|...+ |+.+|+| +-+......-.. =.+++.+|+ -+-|..++.++
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK-~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALK-VEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEE-eecCCCceeeee------hHHHHHhhchhhhcchHHHHHHH
Confidence 345667889999999999999999999887 9999999 433322211111 111222233 24566666777
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-------CCcEEEE
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLT 830 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-------dG~VKLs 830 (1093)
.-.+.-+||+||.+.|+|.+++.....+++..+.+++.|++.-|++||..+|||+||||+|+||.. +--++|+
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 777778999999999999999998888999999999999999999999999999999999999953 2358999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT 910 (1093)
|||.+--+. .. .+...-...++|-.+--+|+..|..+++.+|.|.|..+++-||.
T Consensus 844 DfG~siDm~--------------lf-----------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF 898 (974)
T KOG1166|consen 844 DFGRSIDMK--------------LF-----------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF 898 (974)
T ss_pred ecccceeee--------------Ec-----------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH
Confidence 999875321 00 11223345788999999999999999999999999999999999
Q ss_pred CC
Q 001354 911 GI 912 (1093)
Q Consensus 911 Gk 912 (1093)
|+
T Consensus 899 G~ 900 (974)
T KOG1166|consen 899 GK 900 (974)
T ss_pred HH
Confidence 85
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=166.70 Aligned_cols=134 Identities=29% Similarity=0.335 Sum_probs=106.1
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEe
Q 001354 694 PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI----RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~----~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
.||+|+||.||+|.+ +|..+++|+...+.... ......++.+|+.++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 47889999544322111 122346778999999999887654444444456667999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 770 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 770 m~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 7788999999999999999999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=189.83 Aligned_cols=140 Identities=26% Similarity=0.249 Sum_probs=113.2
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh----hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM----IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~----~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
..|...+.||+|+||+||++.+.. ..+++|+...+... ........+.+|+.++..++|++|+..+.++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345667899999999999998764 34455533322211 111234678899999999999999887777777778
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.++||||++|++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 346788999999999999999999999999999 688999999999984
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.3e-17 Score=165.51 Aligned_cols=138 Identities=22% Similarity=0.201 Sum_probs=106.1
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc------------------hhHHHHHHHHHHHHHhcCCC--
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR------------------KNDIERILAERNILITVRNP-- 748 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~------------------~~eie~~l~E~~IL~kL~HP-- 748 (1093)
|.+.+.||.|+||.||++... +|+.+|+|++........ .........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 667789999999999999875 799999995422110000 00112367788889888877
Q ss_pred ceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEE
Q 001354 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 828 (1093)
Q Consensus 749 NIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VK 828 (1093)
.++.++. ....++||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+|+.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444443 2356999999999998765431 34567888999999999999999999999999999999999
Q ss_pred EEecCCccc
Q 001354 829 LTDFGLSKI 837 (1093)
Q Consensus 829 LsDFGLAk~ 837 (1093)
|+|||++..
T Consensus 166 liDfg~~~~ 174 (198)
T cd05144 166 IIDWPQMVS 174 (198)
T ss_pred EEECCcccc
Confidence 999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.4e-16 Score=156.13 Aligned_cols=137 Identities=23% Similarity=0.248 Sum_probs=97.0
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHH---------------------HHHHHHHHHHhcCCC--
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE---------------------RILAERNILITVRNP-- 748 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie---------------------~~l~E~~IL~kL~HP-- 748 (1093)
.+.||+|+||+||+|.+. +|..||||++. ........... ....|...+..+.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYR-TGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEe-cCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999987 79999999543 21111111111 113566666666543
Q ss_pred ceEEEeeeeccCCceEEEEEecCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCc
Q 001354 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGH 826 (1093)
Q Consensus 749 NIVkL~gsfqd~~~LyLVMEYm~GGSL~d-lL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~ 826 (1093)
.+.+.++. ...++||||++||.+.. .+.... .. ..++.++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 24444443 23699999999965432 122111 11 6678899999999999999 9999999999999999 999
Q ss_pred EEEEecCCccc
Q 001354 827 IKLTDFGLSKI 837 (1093)
Q Consensus 827 VKLsDFGLAk~ 837 (1093)
++|+|||.+..
T Consensus 153 ~~liDfg~a~~ 163 (187)
T cd05119 153 VYIIDVPQAVE 163 (187)
T ss_pred EEEEECccccc
Confidence 99999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.3e-17 Score=186.10 Aligned_cols=182 Identities=28% Similarity=0.439 Sum_probs=134.3
Q ss_pred ceEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g---~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
++||.|++|.-++|.++|.+.. ..+......++.|++.|++| +|.+|||+||.||....+..+||.||||....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999999999997443 35667788899999999999 99999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.... ..+ .........+||..||+||.+.+..|+.++||||||+||+|+++ =..+|..
T Consensus 407 ~~~~----------~~~-----------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er 465 (516)
T KOG1033|consen 407 DKDE----------TVA-----------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER 465 (516)
T ss_pred ccCC----------ccc-----------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH
Confidence 1100 000 01123345689999999999999999999999999999999997 2233321
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
..++..|-.+.++ |.+-.+ -++-.+|+.+||...|.+||+ +.+.--|+|.
T Consensus 466 ---~~t~~d~r~g~ip-~~~~~d-~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 466 ---IATLTDIRDGIIP-PEFLQD-YPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred ---HHhhhhhhcCCCC-hHHhhc-CcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 2222333333332 111122 235568999999999999996 5565556653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.2e-15 Score=174.76 Aligned_cols=206 Identities=23% Similarity=0.299 Sum_probs=158.1
Q ss_pred HHhcCCCceEEEeeeeccCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCc-EeeecCCCcE
Q 001354 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGI-VHRDLKPDNL 819 (1093)
Q Consensus 742 L~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GI-IHRDIKPeNI 819 (1093)
|+.+.|.|+.++++.+.+....++|.+||..|+|.+.+... -.++.-....++++|+.||.|||.-.| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999999874 357777777889999999999998866 9999999999
Q ss_pred EEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-------C
Q 001354 820 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------H 892 (1093)
Q Consensus 820 LLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-------Y 892 (1093)
++|....+||+|||+...... ... ........-...|.|||.+.+.. -
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~--------------~~~-----------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~ 135 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE--------------TAE-----------PEAHHPIRKALLWTAPELLRGALSQSLESAL 135 (484)
T ss_pred eeeeeEEEEechhhhcccccc--------------ccc-----------ccccchhHHHHhccCHHHhcccccccccccc
Confidence 999999999999999764210 000 00001111245799999997642 3
Q ss_pred CccceeecchhhHHHHHhCCCCCCCC----ChHHHHHHHhccCC--CCCCCC--CCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 893 GYAADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKI--PWPCVP--SDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 893 s~ksDVWSLGVILYEMLTGkpPF~~~----s~~ei~~kIl~~~l--~fP~ip--~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
+.+.|+||||++++|+++..-||... ++.++..++..+.. ..|.++ ..+.+++..++.+||..+|.+||++.
T Consensus 136 ~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 136 TQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 56799999999999999999999762 33456666555222 223332 14566799999999999999999976
Q ss_pred cHHHHHcC
Q 001354 965 GAAEVKAH 972 (1093)
Q Consensus 965 ~A~EIL~H 972 (1093)
.+...+.-
T Consensus 216 ~i~~~~~~ 223 (484)
T KOG1023|consen 216 QIRSKLLT 223 (484)
T ss_pred HHHhhhhh
Confidence 66555443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.7e-15 Score=138.85 Aligned_cols=132 Identities=23% Similarity=0.293 Sum_probs=110.4
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCCceEEEEE
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H--PNIVkL~gsfqd~~~LyLVME 768 (1093)
+++.||.|.++.||++.... ..+++|.+ ..... ...+..|..++..+.+ +++++++..+...+..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~-~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKIN-PSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEec-CCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 45789999999999999853 77899944 22211 4568889999999976 589999998888888999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~---GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
|++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++++|||+++.
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999877654 4456667888999999999985 699999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-14 Score=153.52 Aligned_cols=138 Identities=20% Similarity=0.324 Sum_probs=104.0
Q ss_pred Eeee-ccCCeEEEEEEECCCCcEEEEEEeehhhh---h------hchhHHHHHHHHHHHHHhcCCCce--EEEeeeeccC
Q 001354 693 KPIS-RGAFGRVFLARKRTTGDLFAIKQVLKKLD---M------IRKNDIERILAERNILITVRNPFV--VRFFYSFTCR 760 (1093)
Q Consensus 693 r~LG-kG~FGeVylar~k~TGk~VAIKkILkK~~---~------~~~~eie~~l~E~~IL~kL~HPNI--VkL~gsfqd~ 760 (1093)
..|| .||.|+||.+... +..+++|...+... . ........+.+|+.++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 7888888888764 77889985432110 0 111234568899999999998774 6666554332
Q ss_pred Cc----eEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 761 DN----LYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 761 ~~----LyLVMEYm~G-GSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
.. .++||||++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999997 699988865 3455543 568999999999999999999999999999999999999998
Q ss_pred cc
Q 001354 836 KI 837 (1093)
Q Consensus 836 k~ 837 (1093)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=156.25 Aligned_cols=144 Identities=22% Similarity=0.377 Sum_probs=94.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh-------------------------c-----hhHHHHH
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI-------------------------R-----KNDIERI 735 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~-------------------------~-----~~eie~~ 735 (1093)
..+|+. +.||+|++|+||+|+.+++|+.||+|++.+..... . .+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 79999999999999999889999999553221100 0 0112233
Q ss_pred HHHHHHHH------hcC----CCceEEEeeeecc-CCceEEEEEecCCCChHHH--HHhcC----CCCHHHHHHHHHHHH
Q 001354 736 LAERNILI------TVR----NPFVVRFFYSFTC-RDNLYLVMEYLNGGDLYSL--LRKVG----CLEEDVARIYIAELV 798 (1093)
Q Consensus 736 l~E~~IL~------kL~----HPNIVkL~gsfqd-~~~LyLVMEYm~GGSL~dl--L~k~g----~LsEe~ar~yaaQIl 798 (1093)
.+|++.+. ++. +...+.+-..+.+ ...-+|||||+.|+.+.++ +...+ .+.+..+..|+.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 34444333 331 2222222222211 2345799999999999774 33333 244444555555554
Q ss_pred HHHHHHHhcCcEeeecCCCcEEEccCC----cEEEEecCCccc
Q 001354 799 LALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKI 837 (1093)
Q Consensus 799 ~ALeYLHs~GIIHRDIKPeNILLD~dG----~VKLsDFGLAk~ 837 (1093)
..|++|+|+||.||+++.+| .+++.|||++..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 58999999999999999988 999999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-12 Score=153.60 Aligned_cols=260 Identities=26% Similarity=0.251 Sum_probs=192.1
Q ss_pred CCeeEEEeeec--cCCeEEEEEEE--CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001354 687 DDFEIIKPISR--GAFGRVFLARK--RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 761 (1093)
Q Consensus 687 ddFeilr~LGk--G~FGeVylar~--k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~ 761 (1093)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-. .-........+-++|+.-...++ |++.++.+..+...+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~--~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSK--IPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCccccccccc--CCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 44666778898 99999999998 8889999999321 11111122233456666666665 999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecCCc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLS 835 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~-LsEe~ar~yaaQIl~----ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFGLA 835 (1093)
.+|+-+|++. .+|..+...... +++..++.+..+... ||.++|..+++|-|+||.||++..+ ...+++|||+.
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999985 688888876655 888999999999999 9999999999999999999999999 88999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
..+...+. ... ........|..-|++||.+.+ -++...|+++||.++.+-.+|..++
T Consensus 271 ~~i~~~~~---------------------~~~-~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 271 SKISDGNF---------------------SSV-FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred EEccCCcc---------------------ccc-eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 75321110 000 011122357788999999865 5889999999999999998887665
Q ss_pred CCC--ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 916 TAE--SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 916 ~~~--s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
... +.-...+.+. ++ .++-.+.+.++...+..|+..+|..|++ +..+++|++.....
T Consensus 328 ~~g~~~~W~~~r~~~---ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGY---IP-LEFCEGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSKL 386 (524)
T ss_pred cCCCCCCcccccccc---Cc-hhhhcCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccchh
Confidence 432 1111111111 11 1122456677777999999999999999 77899999987543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.8e-12 Score=148.92 Aligned_cols=251 Identities=26% Similarity=0.267 Sum_probs=183.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEEC-CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k-~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~ 761 (1093)
....+|..+..||.|.|+.|+.+..+ .++..|++|..++.... .. ....-+.|+.+...+. |.+++.++..+..-.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-FA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-hH-hhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 45678999999999999999998876 67889999955433221 12 2223355666666554 999999998888888
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFGLAk~~~~ 840 (1093)
+.|+=.||+.++++...+.-...+.+...+....|++.|+.++|+..++|+|+||+||++..+ +..++.|||..+....
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 899999999999988777555668889999999999999999999999999999999999886 7789999998863110
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCC--ChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL--APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~Ym--APEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. .....++-.++ +|+......+..+.|++|||..++|.++|.+--...
T Consensus 420 ~------------------------------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~ 469 (524)
T KOG0601|consen 420 S------------------------------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG 469 (524)
T ss_pred e------------------------------cccccccccccccchhhccccccccccccccccccccccccCcccCccc
Confidence 0 01112233344 444444567888999999999999999986432111
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
. ....|..+..+.. .....+++.+.+.++..|+..|+. +.++..|+=|
T Consensus 470 ~---~~~~i~~~~~p~~---~~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~ 517 (524)
T KOG0601|consen 470 V---QSLTIRSGDTPNL---PGLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEF 517 (524)
T ss_pred c---cceeeecccccCC---CchHHhhhhhhhhhcCCccccchh---hhhhcccchh
Confidence 1 1122333333222 344488999999999999999998 6666666555
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.8e-11 Score=142.83 Aligned_cols=139 Identities=22% Similarity=0.324 Sum_probs=93.3
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhch--------------------------h---H-H------HHHH
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK--------------------------N---D-I------ERIL 736 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~--------------------------~---e-i------e~~l 736 (1093)
+.||.|++|.||+|+.+ +|+.||||+........-. . + . -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999986 6899999954221100000 0 0 0 1234
Q ss_pred HHHHHHHhcC-----CCce--EEEeeeeccCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhc
Q 001354 737 AERNILITVR-----NPFV--VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL-ALEYLHSL 807 (1093)
Q Consensus 737 ~E~~IL~kL~-----HPNI--VkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~-ALeYLHs~ 807 (1093)
+|...+.++. +++| .++|..+ ....+|||||++|++|.++.... ..++ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555442 3433 2333222 33469999999999998876532 1222 2334455555 46789999
Q ss_pred CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 808 GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
|++|+|+||.||+++.+|.++|+|||++..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 999999999999999999999999999875
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-11 Score=122.91 Aligned_cols=128 Identities=18% Similarity=0.278 Sum_probs=94.5
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCceEEEEEec
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNI-VkL~gsfqd~~~LyLVMEYm 770 (1093)
++.|+.|.++.||+++.. +..|++|.. ..... ....+..|..++..+.+.++ .++++... ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~-~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIP-GNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeC-CCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEec
Confidence 467899999999999865 788999943 22110 12235678888888765443 44554433 3358999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc-----EeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 771 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI-----VHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 771 ~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GI-----IHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+|.++... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 74 ~G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99887643 0 1123456799999999999985 9999999999999 77899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-10 Score=137.07 Aligned_cols=169 Identities=21% Similarity=0.355 Sum_probs=125.5
Q ss_pred EEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCC
Q 001354 705 LARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 784 (1093)
Q Consensus 705 lar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~ 784 (1093)
-|..+.++.++.+... +... ......+.+-+..|+.++||||++++..+..++.+|||+|.+. .|..++.+.+
T Consensus 30 ~~t~k~~~~~vsVF~~-~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVY-KRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG- 102 (690)
T ss_pred ccceeccCCceEEEEE-eCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-
Confidence 3556677777777733 2211 1334556777888999999999999999999999999999984 6777787654
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-hcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCc
Q 001354 785 LEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863 (1093)
Q Consensus 785 LsEe~ar~yaaQIl~ALeYLH-s~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e 863 (1093)
......-+.||+.||.||| +.+++|++|.-+-|+++..|++||++|-++.... +..+
T Consensus 103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~-------------~~~~------- 160 (690)
T KOG1243|consen 103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS-------------GFNA------- 160 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc-------------cCCc-------
Confidence 6666777889999999998 5689999999999999999999999999876311 0000
Q ss_pred ccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhC
Q 001354 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 864 ~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
......---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 161 -------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 -------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 001111122356676554332 568999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.3e-12 Score=138.61 Aligned_cols=214 Identities=24% Similarity=0.334 Sum_probs=151.6
Q ss_pred HHHHHHHhcCCCceEEEeeeeccCC-----ceEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhc
Q 001354 737 AERNILITVRNPFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSL 807 (1093)
Q Consensus 737 ~E~~IL~kL~HPNIVkL~gsfqd~~-----~LyLVMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~ 807 (1093)
.-+.-|..+.|.|||+++.++.+.. ...++.|||..|+|..+|++. ..+.....++|+.||+.||.|||+.
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 3445566778999999998877654 478999999999999999864 3578888899999999999999998
Q ss_pred C--cEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChh
Q 001354 808 G--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE 885 (1093)
Q Consensus 808 G--IIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPE 885 (1093)
. |||+++..+-|++..+|-||+.---... .+.. .............|-++|.|||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s----------------------~h~s-~~~~~~~Ek~~~~~~~g~~a~~ 252 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS----------------------THPS-VNSTREAEKSVNTSLPGFSAPE 252 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccc----------------------cchh-hhhhhHhhhhccccCCccccCC
Confidence 5 9999999999999999988875211111 0000 0011111222235678999999
Q ss_pred hhcCCCCCccceeecchhhHHHHHhCCCC-CCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 886 ILLGTEHGYAADWWSVGIILFEFITGIPP-FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 886 VL~g~~Ys~ksDVWSLGVILYEMLTGkpP-F~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
.=.....+-++|||+||....||..|..- -.+.+.-+.-..|.+-.+-. ..+ --.++|.+||+-.|..||+
T Consensus 253 sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l---en~---lqr~~i~kcl~~eP~~rp~-- 324 (458)
T KOG1266|consen 253 SGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL---ENG---LQRGSITKCLEGEPNGRPD-- 324 (458)
T ss_pred cCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec---cCc---cccCcCcccccCCCCCCcc--
Confidence 76666667799999999999999998764 33333222222222211110 111 2357899999999999999
Q ss_pred cHHHHHcCCCCCCCCcch
Q 001354 965 GAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 965 ~A~EIL~HPFFkgIdWd~ 982 (1093)
+.+++.||..-++--.+
T Consensus 325 -ar~llfHpllfeVhslk 341 (458)
T KOG1266|consen 325 -ARLLLFHPLLFEVHSLK 341 (458)
T ss_pred -hhhhhcCceeeecchHH
Confidence 88999999886664433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.5e-10 Score=118.73 Aligned_cols=139 Identities=22% Similarity=0.169 Sum_probs=99.2
Q ss_pred EeeeccCCeEEEEEEECC------CCcEEEEEEeehhhhh--------h-----------chhHHHH----HHHHHHHHH
Q 001354 693 KPISRGAFGRVFLARKRT------TGDLFAIKQVLKKLDM--------I-----------RKNDIER----ILAERNILI 743 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~------TGk~VAIKkILkK~~~--------~-----------~~~eie~----~l~E~~IL~ 743 (1093)
..||.|-=+.||.|.... .+..+|+| +.+.... . +...... ..+|...|.
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avK-i~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIK-VFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEE-EEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 478999999999997653 35789999 4321110 0 0111222 338999998
Q ss_pred hcCC--CceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeeecCCCcEE
Q 001354 744 TVRN--PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLL 820 (1093)
Q Consensus 744 kL~H--PNIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYL-Hs~GIIHRDIKPeNIL 820 (1093)
++.. -++.+++.+ ..-+|||||+.++.+..-.-+...+++..+..+..+++.+|..| |+.||||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8853 455566553 45689999997755533222333466666777889999999998 8999999999999999
Q ss_pred EccCCcEEEEecCCccc
Q 001354 821 IAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 821 LD~dG~VKLsDFGLAk~ 837 (1093)
++ +|.+.|+|||.+..
T Consensus 158 ~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 158 WH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EE-CCcEEEEECCCcee
Confidence 96 57899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.5e-10 Score=113.53 Aligned_cols=140 Identities=20% Similarity=0.265 Sum_probs=103.2
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccC---CceEEEE
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCR---DNLYLVM 767 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H--PNIVkL~gsfqd~---~~LyLVM 767 (1093)
+.||.|.++.||++...+ |..|++|.. ...... .....+..|..++..+.+ ..+.+++.+.... +..|+||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~-~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRP-PPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeC-CCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 678999999999998754 688999943 222111 134567899999998875 3456677666554 3678999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS----------------------------------------- 806 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs----------------------------------------- 806 (1093)
||++|++|...+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888765432 345666666667777777777763
Q ss_pred ---------------cCcEeeecCCCcEEEcc--CCcEEEEecCCccc
Q 001354 807 ---------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 ---------------~GIIHRDIKPeNILLD~--dG~VKLsDFGLAk~ 837 (1093)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 67789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.8e-09 Score=110.17 Aligned_cols=135 Identities=29% Similarity=0.306 Sum_probs=100.1
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI----RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~----~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
..|++|+=+.++.+.+. |..+++|.-++|.-.. .+-...+..+|..+|.++.--.|.-.+-++.++....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999875 5567788544443211 11123566789999988864444333334556677789999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
|++|-.|.+.+... .-.++..+-.-+.-||..||||+||.++||++...+ +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888765 134566777788889999999999999999997554 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.3e-08 Score=103.11 Aligned_cols=145 Identities=24% Similarity=0.249 Sum_probs=106.2
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh-h---hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-M---IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~-~---~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
.+..|-+|+-+.|+++.+. |+.+.||.-..|.- . ..+-...+..+|.++|.++.--.|.-..-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678889999999999886 89999995433321 1 1122245678899999888643333333345566667899
Q ss_pred EEecCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---cEEEEecCCccc
Q 001354 767 MEYLNG-GDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 837 (1093)
Q Consensus 767 MEYm~G-GSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG---~VKLsDFGLAk~ 837 (1093)
|||++| -++.+++.... .........++..|-..|.-||.++|||+||..+||+|..+| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 47777776542 233333467888999999999999999999999999998766 358999999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.8e-09 Score=125.82 Aligned_cols=169 Identities=21% Similarity=0.330 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCcc
Q 001354 795 AELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873 (1093)
Q Consensus 795 aQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~ 873 (1093)
.+++.||.|+|.. ++||+.|.|++|.++.+|.+||+.|+++....... ......|. .....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~---------------~~p~~~yd---~~lp~ 167 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPT---------------EYPFSEYD---PPLPL 167 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCC---------------ccccccCC---CCCCh
Confidence 3455999999976 89999999999999999999999999987421100 00111111 11112
Q ss_pred CccCCCCCCChhhhcCCCCCccceeecchhhHHHHH-hCCCCCCCCChHHHHHHHhc-cCCCCCCCCCCCCHHHHHHHHh
Q 001354 874 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI-TGIPPFTAESPEIIFDNILN-RKIPWPCVPSDMSFEAQDLINR 951 (1093)
Q Consensus 874 s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEML-TGkpPF~~~s~~ei~~kIl~-~~l~fP~ip~~IS~eakDLIkr 951 (1093)
...-...|.|||++.+...+.++|++||||++|-+. .|+.-|...+....+..-.. .+...-.....++.++++-|.+
T Consensus 168 ~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 168 LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred hhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH
Confidence 223457899999999988899999999999999998 56666666544333332211 2222222347899999999999
Q ss_pred hccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 952 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 952 cL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
+|..++..||+ +..++..|||.+..-..|.
T Consensus 248 ~l~~~~~~rp~---~~~l~~~~ff~D~~~~aLr 277 (700)
T KOG2137|consen 248 LLNGDSAVRPT---LDLLLSIPFFSDPGLKALR 277 (700)
T ss_pred HhcCCcccCcc---hhhhhcccccCCchhhhhh
Confidence 99999999997 7889999999987655554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.2e-07 Score=101.31 Aligned_cols=103 Identities=17% Similarity=0.155 Sum_probs=78.0
Q ss_pred HHHHHHHHHHhcC-----CCceEEEeeeecc--CCceEEEEEecCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Q 001354 734 RILAERNILITVR-----NPFVVRFFYSFTC--RDNLYLVMEYLNGG-DLYSLLRK--VGCLEEDVARIYIAELVLALEY 803 (1093)
Q Consensus 734 ~~l~E~~IL~kL~-----HPNIVkL~gsfqd--~~~LyLVMEYm~GG-SL~dlL~k--~g~LsEe~ar~yaaQIl~ALeY 803 (1093)
.+.+|...+..+. .|-+|-+...-.. ...-|||||++++- +|.+++.. ....+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4678888887764 3333333211111 23478999999885 79988864 2345667788899999999999
Q ss_pred HHhcCcEeeecCCCcEEEcc-------CCcEEEEecCCcc
Q 001354 804 LHSLGIVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 836 (1093)
Q Consensus 804 LHs~GIIHRDIKPeNILLD~-------dG~VKLsDFGLAk 836 (1093)
||..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999999999985 4689999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.8e-07 Score=105.60 Aligned_cols=202 Identities=19% Similarity=0.232 Sum_probs=143.6
Q ss_pred CeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----CceEEEEEecCC-CC
Q 001354 700 FGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----DNLYLVMEYLNG-GD 774 (1093)
Q Consensus 700 FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~----~~LyLVMEYm~G-GS 774 (1093)
-.+.|++....+|..|++|.+.-. +... ......-+++++++.|+|||++..+|.+. ..++||++|.|+ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~-r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGD-RDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccc-cccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 356899999999999999955211 1111 11223456688999999999999998843 358999999986 67
Q ss_pred hHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 775 LYSLLRK---------------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 775 L~dlL~k---------------~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
|+++--. ....+|..++.|+.||..||.++|+.|+.-+-|.|.+||++.+..++|+--|+..+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7776521 1247889999999999999999999999999999999999988888888777654321
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCC-CCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpP-F~~~ 918 (1093)
.+ + + |-+.+ -.+-|.=.||.+++.|.||..- +..+
T Consensus 445 ~d--------------------------~--------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d 480 (655)
T KOG3741|consen 445 ED--------------------------P--------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTD 480 (655)
T ss_pred CC--------------------------C--------C-------cchhH---HhhhhHHHHHHHHHHHhhccccccccc
Confidence 00 0 0 11111 1245777899999999998532 3333
Q ss_pred ChHHH-HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCC
Q 001354 919 SPEII-FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 919 s~~ei-~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~K 959 (1093)
..+.. .+.| ....|.++.++|.-+...++..
T Consensus 481 ~~~~s~~~~I----------~~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 481 STQSSHLTRI----------TTTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred chHHHHHHHh----------hhhhhHHHHHHHHHHHhcCccc
Confidence 33333 2222 2567889999999988888874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.7e-07 Score=95.31 Aligned_cols=127 Identities=25% Similarity=0.272 Sum_probs=81.2
Q ss_pred EEEEEEECCCCcEEEEEEeehhhhh-----------------------hchhHHHHHHHHHHHHHhcCCC--ceEEEeee
Q 001354 702 RVFLARKRTTGDLFAIKQVLKKLDM-----------------------IRKNDIERILAERNILITVRNP--FVVRFFYS 756 (1093)
Q Consensus 702 eVylar~k~TGk~VAIKkILkK~~~-----------------------~~~~eie~~l~E~~IL~kL~HP--NIVkL~gs 756 (1093)
.||.|... .|..+|+| +.+.... ...-......+|...|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~-~~~~~a~K-~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVK-IYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEE-EE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC-CCCEEEEE-EeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 38888874 47799999 4321100 0111235677899999999854 46666644
Q ss_pred eccCCceEEEEEecC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 757 FTCRDNLYLVMEYLN--GGDLYSLLRKVGCLEEDVARIYIAELVLALEY-LHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 757 fqd~~~LyLVMEYm~--GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeY-LHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
- .-+|||||++ |..+..+.... ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred e----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 2 3479999998 65554443321 2244556677788886665 579999999999999999876 99999999
Q ss_pred Cccc
Q 001354 834 LSKI 837 (1093)
Q Consensus 834 LAk~ 837 (1093)
.+..
T Consensus 152 qav~ 155 (188)
T PF01163_consen 152 QAVD 155 (188)
T ss_dssp TEEE
T ss_pred ccee
Confidence 8874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.4e-07 Score=94.45 Aligned_cols=106 Identities=28% Similarity=0.322 Sum_probs=82.4
Q ss_pred HHHHHHHHHHHHhcCC--CceEEEeeeeccC----CceEEEEEecCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 001354 732 IERILAERNILITVRN--PFVVRFFYSFTCR----DNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYL 804 (1093)
Q Consensus 732 ie~~l~E~~IL~kL~H--PNIVkL~gsfqd~----~~LyLVMEYm~GG-SL~dlL~k~g~LsEe~ar~yaaQIl~ALeYL 804 (1093)
.....+|...+..+.. -.+.+.+++.... ..-|||+|+++|- +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3456778877766642 1223333333332 2358999999984 8999998755577788889999999999999
Q ss_pred HhcCcEeeecCCCcEEEccCC---cEEEEecCCccc
Q 001354 805 HSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 837 (1093)
Q Consensus 805 Hs~GIIHRDIKPeNILLD~dG---~VKLsDFGLAk~ 837 (1093)
|..||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.9e-08 Score=117.26 Aligned_cols=243 Identities=23% Similarity=0.218 Sum_probs=162.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCceE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN-IVkL~gsfqd~~~Ly 764 (1093)
..-+.....+++|+++.+++.+...+.... .+.+... ....-++++|.+++||| .+..++.++.+++.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 344566677899999999998877655444 5533211 34556788999999999 788888888899999
Q ss_pred EEEEecCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 765 LVMEYLNGG-DLYSLL-RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 765 LVMEYm~GG-SL~dlL-~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
++|+++.+| +-.... ...-.+.+-+.....+.-+.++++||+.-=+||| |||..+ +..|+.||+.....
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L---- 381 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL---- 381 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc----
Confidence 999999887 221111 1111233444455566778899999998778998 888754 77899999976521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.+.....+..+|+.|+|||+.....+....|.|++|+--.+|.-|-+|-... ..
T Consensus 382 ------------------------~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~ 435 (829)
T KOG0576|consen 382 ------------------------TRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PA 435 (829)
T ss_pred ------------------------CcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--cc
Confidence 1111456778999999999999999999999999999877888888776541 11
Q ss_pred HHHHHhccCCCCCCCCC--CCCH-HHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPS--DMSF-EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~--~IS~-eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
....+-++.-. |.+.. ..++ .-.++...|+..-|..|+. ....+.|.+|.+
T Consensus 436 ~~~~~g~~p~s-~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfng 489 (829)
T KOG0576|consen 436 VLPMIGNGPNS-PMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNG 489 (829)
T ss_pred ccCCCCCCCCc-cccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhcc
Confidence 11111111100 00000 0011 1114666788888888877 556677888876
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.7e-05 Score=85.38 Aligned_cols=140 Identities=16% Similarity=0.229 Sum_probs=100.3
Q ss_pred eccCCeEEEEEEECCCCcEEEEEEeehhhh-hhc-hhHHHHHHHHHHHHHhcCC--CceEEEeeeeccC----CceEEEE
Q 001354 696 SRGAFGRVFLARKRTTGDLFAIKQVLKKLD-MIR-KNDIERILAERNILITVRN--PFVVRFFYSFTCR----DNLYLVM 767 (1093)
Q Consensus 696 GkG~FGeVylar~k~TGk~VAIKkILkK~~-~~~-~~eie~~l~E~~IL~kL~H--PNIVkL~gsfqd~----~~LyLVM 767 (1093)
|+||-+-|+..... |..|-+|+--.... ... ......|.+|+..|..+.. -.+.++.+.-... -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888888887765 44677784421111 111 2345778999999988752 2244444222121 1368999
Q ss_pred EecCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc--EEEEecCCccc
Q 001354 768 EYLNG-GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKI 837 (1093)
Q Consensus 768 EYm~G-GSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~--VKLsDFGLAk~ 837 (1093)
|-++| -+|.+++.+. ...++.....++.+++..|.-||+.|+.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 5898888664 34577777889999999999999999999999999999987777 99999987764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.8e-06 Score=91.12 Aligned_cols=136 Identities=24% Similarity=0.243 Sum_probs=96.4
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-----------------hc--hhHHHHHHHHHHHHHhcCCC--
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-----------------IR--KNDIERILAERNILITVRNP-- 748 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-----------------~~--~~eie~~l~E~~IL~kL~HP-- 748 (1093)
.+...||-|-=+.||.|... .|..+|+| +.+--.. .+ .-......+|..+|.++...
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vK-fHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVK-FHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEE-EeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35678999999999999976 58999999 4321110 00 01123456888899888643
Q ss_pred ceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEE
Q 001354 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 828 (1093)
Q Consensus 749 NIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VK 828 (1093)
.|.+.++ .+.-.+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+-|||++++|.+.
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 5555443 34568999999996665432 13344445555666666666689999999999999999999999
Q ss_pred EEecCCcc
Q 001354 829 LTDFGLSK 836 (1093)
Q Consensus 829 LsDFGLAk 836 (1093)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998765
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.2e-05 Score=82.30 Aligned_cols=141 Identities=21% Similarity=0.309 Sum_probs=89.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHH------HHHHHHHHHhc---CCCceEEEe
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER------ILAERNILITV---RNPFVVRFF 754 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~------~l~E~~IL~kL---~HPNIVkL~ 754 (1093)
+..++|.+++++-......|.+..- .|..|++|.-..+... ....... ..+++..+..+ .--....+|
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 4567888889888888777777665 4788999943222211 1111111 12233333333 222222222
Q ss_pred e-----eeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEE
Q 001354 755 Y-----SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 829 (1093)
Q Consensus 755 g-----sfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKL 829 (1093)
. .+.-....+|||||++|..|.++.. +++. +...|+.+|.-||+.|+.|+|..|.|++++.++ +++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEE
Confidence 2 2222334578999999988866542 3332 345677889999999999999999999998555 999
Q ss_pred EecCCcc
Q 001354 830 TDFGLSK 836 (1093)
Q Consensus 830 sDFGLAk 836 (1093)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998655
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.5e-05 Score=100.83 Aligned_cols=205 Identities=25% Similarity=0.295 Sum_probs=147.3
Q ss_pred hHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 001354 730 NDIERILAERNILITVRNPFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805 (1093)
Q Consensus 730 ~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~----~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLH 805 (1093)
.++.....|...+.+..|+|++.++.+..... .+.+..+++++-++...+...+.++.+.++.+..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34455566778888899999999987655443 24456788999999999999999999999999999999999999
Q ss_pred hcCcEeeecCCC---cEEEccCCcEEEE--ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCC
Q 001354 806 SLGIVHRDLKPD---NLLIAHDGHIKLT--DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 880 (1093)
Q Consensus 806 s~GIIHRDIKPe---NILLD~dG~VKLs--DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~ 880 (1093)
+....|.-|... +-..+..+.+.++ ||+.++.... .....+..-+..
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d----------------------------~~~~~~~~~~~~ 355 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD----------------------------NEKSFSDLLAEI 355 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCC----------------------------cccchhhcCccc
Confidence 996666655554 4445566677776 8887764211 112223344567
Q ss_pred CCChhhhcCCCCCcc--ceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcC
Q 001354 881 YLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 958 (1093)
Q Consensus 881 YmAPEVL~g~~Ys~k--sDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~ 958 (1093)
|.|||......+..+ .|+|.+|.+...+..|..+-.... . +.+..+.....+..+++.+|+..+++
T Consensus 356 ~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~---~---------~~~~l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 356 RNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA---V---------PVSLLDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred cccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc---c---------hhhhhccccchhhhhhhhhhcchhhh
Confidence 889998887766554 799999999999988754421110 0 00111122222678899999999999
Q ss_pred CCCChhcHHHHHcCCCCCC
Q 001354 959 QRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 959 KRpTa~~A~EIL~HPFFkg 977 (1093)
+|++ +.+++.|||.+.
T Consensus 424 ~Rl~---~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 424 ERLS---ALELLTHPFLRF 439 (1351)
T ss_pred hccc---hhhhhhchhccc
Confidence 9999 889999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.1e-05 Score=89.75 Aligned_cols=234 Identities=17% Similarity=0.220 Sum_probs=144.7
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEE--------EeeeeccCC
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVR--------FFYSFTCRD 761 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVk--------L~gsfqd~~ 761 (1093)
..+.||+|+-+.+|-.-.- ...+.|+.....-.. -...+..|... .||-+-. |++- ....
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~-------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~ 83 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA-------QAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGK 83 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchH-------HHHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccc
Confidence 3467999999999865332 123446333221111 11112223332 3553332 1111 1122
Q ss_pred ceEEEEEecCCCChH-HHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 762 NLYLVMEYLNGGDLY-SLLR------KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~-dlL~------k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
.+-+.|..++|-.-- .++. ......+..+.+.+++|+.|..-||..|.+-+|++++|+|+.+++.|.|.|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 367888888774221 1211 123477888999999999999999999999999999999999999999986432
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHH
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEML 909 (1093)
-.+. .........+|.+.|.+||.-. +.+-+...|-|.||+++|++|
T Consensus 164 fqi~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL 215 (637)
T COG4248 164 FQIN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLL 215 (637)
T ss_pred eeec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHH
Confidence 1110 0111223468999999999764 334466899999999999999
Q ss_pred hC-CCCCCCCC-----hHHHHHHHhccCC-----------CCCCC--CCCCCHHHHHHHHhhccC--CcCCCCCh
Q 001354 910 TG-IPPFTAES-----PEIIFDNILNRKI-----------PWPCV--PSDMSFEAQDLINRFLIH--DPNQRLGA 963 (1093)
Q Consensus 910 TG-kpPF~~~s-----~~ei~~kIl~~~l-----------~fP~i--p~~IS~eakDLIkrcL~k--DP~KRpTa 963 (1093)
.| +.||.+.. +.-.-..|..+.+ +-|.- ..-++++++.|..+|+.. ++.-||++
T Consensus 216 ~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 216 FGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred hcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 96 99998632 1111112222111 11110 134788999999999984 24579994
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00014 Score=74.80 Aligned_cols=138 Identities=28% Similarity=0.371 Sum_probs=80.6
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC--ceEEEeeee---ccCCceEEE
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSF---TCRDNLYLV 766 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP--NIVkL~gsf---qd~~~LyLV 766 (1093)
++.|+.|..+.||++.... ..+++|.. ... .....+..|..++..+... .+.+++... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~-~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFY-RPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEE-SSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEe-CCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 5789999999999999865 48889943 211 3445677888888777522 345555533 223347999
Q ss_pred EEecCCCChHH----------------HHH---hc--C--CCCHHH------HHHH---------------HHHHHH-HH
Q 001354 767 MEYLNGGDLYS----------------LLR---KV--G--CLEEDV------ARIY---------------IAELVL-AL 801 (1093)
Q Consensus 767 MEYm~GGSL~d----------------lL~---k~--g--~LsEe~------ar~y---------------aaQIl~-AL 801 (1093)
|++++|..+.. .+. .. . .+.... .... ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999987777 111 11 0 001000 0000 111222 23
Q ss_pred HHHHh-------cCcEeeecCCCcEEEc-cCCcEEEEecCCccc
Q 001354 802 EYLHS-------LGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKI 837 (1093)
Q Consensus 802 eYLHs-------~GIIHRDIKPeNILLD-~dG~VKLsDFGLAk~ 837 (1093)
..+++ ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33332 3599999999999999 667778999998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.91 E-value=7.8e-05 Score=80.32 Aligned_cols=135 Identities=16% Similarity=0.139 Sum_probs=82.5
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC--ceEEEeeeeccCCceEEEEEec
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP--NIVkL~gsfqd~~~LyLVMEYm 770 (1093)
..||.|..+.||+. .|..+++|.. .. . .....+.+|.+++..+..- .+.+.+++..+.+..++|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~-~~-~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLY-NP-G----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeC-CC-C----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 57899999999983 2556778833 21 1 1234568899999887632 2466677777777789999999
Q ss_pred CCCC-hH--------------HHH-------Hhc--CCCCHH-HHHHHHH----------HHHH-HHHHHHh----cCcE
Q 001354 771 NGGD-LY--------------SLL-------RKV--GCLEED-VARIYIA----------ELVL-ALEYLHS----LGIV 810 (1093)
Q Consensus 771 ~GGS-L~--------------dlL-------~k~--g~LsEe-~ar~yaa----------QIl~-ALeYLHs----~GII 810 (1093)
+|.+ +. ..+ +.. ...... ....+.. .+.. ...+|.. ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9964 11 111 110 001100 0001100 0111 1222221 2478
Q ss_pred eeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 811 HRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
|+|+.|.||+++.++ +.|+||+.+..+
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999999888 999999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=3.6e-06 Score=107.69 Aligned_cols=287 Identities=18% Similarity=0.131 Sum_probs=178.2
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCC-cEEEEEEeehhh--hhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKQVLKKL--DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 760 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TG-k~VAIKkILkK~--~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~-- 760 (1093)
..++++.--||-|.++ ++++.... ..+.+| |.+.. ....+...+..+.|++-++...|+++...+.-....
T Consensus 1228 ~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~-I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHF---RNKWLRSKIDWFKFS-IYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred hhhhheeeecccceee---ccchHhhhhceeEEE-eehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 4556665556555544 33332211 123344 33222 223444556777888888888999998877555443
Q ss_pred CceEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC-----cEeeecCCCcEEEccCCcEEEEe
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTD 831 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g----~LsEe~ar~yaaQIl~ALeYLHs~G-----IIHRDIKPeNILLD~dG~VKLsD 831 (1093)
...|.+++|+.+|.+++.|.+.- .+.+..+-....+.+.+..-+|++. .+|++||+-|.+|+.+..+|+.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 34789999999999999997652 2333444333445578888877652 78999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhC
Q 001354 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 832 FGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
+|+.+.-. .........+++|.|++|++...-.++.++|+|..|+.+|+.-.|
T Consensus 1384 ~gLdKIkn---------------------------p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1384 GGLDKIKN---------------------------PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred cccccccC---------------------------chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 99998310 112233456789999999999998999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhccCC---CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC--Ccchhhcc
Q 001354 912 IPPFTAESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV--NWDSLALQ 986 (1093)
Q Consensus 912 kpPF~~~s~~ei~~kIl~~~l---~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI--dWd~L~~~ 986 (1093)
.+||.. ..+.++.+.+ .+-.++.-.|.++-.+...+|-..-..||+ -..++.-+.|.-- +.+.....
T Consensus 1437 n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~---q~isls~d~~a~~~~d~~k~i~~ 1508 (2724)
T KOG1826|consen 1437 NAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPG---QYISLSRDHFAVGLRDICKMIYL 1508 (2724)
T ss_pred cHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcch---hhhhcccccccccccCcchhHHH
Confidence 998843 3333333221 112222333444444444555555677888 4455666666421 11111111
Q ss_pred -cCcccCCCCCCCCCcccccccccCC
Q 001354 987 -KAVFVPQPESVDDTSYFLSRFSQIS 1011 (1093)
Q Consensus 987 -~pPf~P~~~s~~Dts~Fds~fs~~~ 1011 (1093)
.-.-.|.+....|.+.+-.+|....
T Consensus 1509 ~a~rglpEH~~iad~s~v~s~~~~i~ 1534 (2724)
T KOG1826|consen 1509 LAYRGLPEHAPIADGSFVFSRFKEIA 1534 (2724)
T ss_pred HHhhCCCCCCccCCCCcceehccccc
Confidence 1112345555556665555554443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00012 Score=87.86 Aligned_cols=139 Identities=23% Similarity=0.373 Sum_probs=86.3
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-------------------------hc-----hhHHHH------HH
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-------------------------IR-----KNDIER------IL 736 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-------------------------~~-----~~eie~------~l 736 (1093)
..|+.++-|.||.|+.++ |+.||+|+.....+. .. .+-.+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999986 999999943211110 00 000112 23
Q ss_pred HHHHHHHhcC-----CCce--EEEeeeeccCCceEEEEEecCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 001354 737 AERNILITVR-----NPFV--VRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLHSL 807 (1093)
Q Consensus 737 ~E~~IL~kL~-----HPNI--VkL~gsfqd~~~LyLVMEYm~GGSL~dlL--~k~g~LsEe~ar~yaaQIl~ALeYLHs~ 807 (1093)
+|..-+.++. .|+| .++|.-+. ..-.|+|||+.|-.+.+.. .. ..++...+.....++. +.-+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t--~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT--TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc--CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence 3444443332 3333 33333232 3458999999998888874 34 3455332222222111 2223347
Q ss_pred CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 808 GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
|++|.|.+|.||+++.+|.+-+.|||+...
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceec
Confidence 999999999999999999999999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00014 Score=77.71 Aligned_cols=135 Identities=13% Similarity=0.089 Sum_probs=81.6
Q ss_pred eeeccCC-eEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEEEecC
Q 001354 694 PISRGAF-GRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 694 ~LGkG~F-GeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
.|-.|.+ ..||++... +..+.+| +..... ...+.+|+.++..+. +--+.+++++....+..++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk-~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLK-IAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEE-ecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 3445555 789998753 4567788 322211 234667888887774 3446677777777677899999999
Q ss_pred CCChHHHH-------------------HhcC----CCCHH------HHHHHHH----------------HHHHHHHHH--
Q 001354 772 GGDLYSLL-------------------RKVG----CLEED------VARIYIA----------------ELVLALEYL-- 804 (1093)
Q Consensus 772 GGSL~dlL-------------------~k~g----~LsEe------~ar~yaa----------------QIl~ALeYL-- 804 (1093)
|.+|.... +... .+... .....+. .+...+..|
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 97765431 1100 01100 0000000 011111222
Q ss_pred -----HhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 805 -----HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 805 -----Hs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00013 Score=87.82 Aligned_cols=139 Identities=24% Similarity=0.356 Sum_probs=85.7
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh---------------------------chhHHHH------HHHHH
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI---------------------------RKNDIER------ILAER 739 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~---------------------------~~~eie~------~l~E~ 739 (1093)
+.||.-+.|.|++|+.+. |+.||+|+-....+.. -.+-.+. |..|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 479999999999999987 9999999421111100 0001111 22333
Q ss_pred HHHHh----cCCCc------eEEEeeeeccCCceEEEEEecCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 001354 740 NILIT----VRNPF------VVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLHSL 807 (1093)
Q Consensus 740 ~IL~k----L~HPN------IVkL~gsfqd~~~LyLVMEYm~GGSL~dlL--~k~g~LsEe~ar~yaaQIl~ALeYLHs~ 807 (1093)
+-..+ +.|-+ |.++|..+... -.|+||||+|.-+.++- .+.+ ++...+...+.+...-+ |=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~--RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~q--If~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTK--RVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQ--IFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcc--eEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHH--HHhc
Confidence 22222 23433 56666555444 48999999998776653 3333 55443333222222111 2345
Q ss_pred CcEeeecCCCcEEEcc----CCcEEEEecCCccc
Q 001354 808 GIVHRDLKPDNLLIAH----DGHIKLTDFGLSKI 837 (1093)
Q Consensus 808 GIIHRDIKPeNILLD~----dG~VKLsDFGLAk~ 837 (1093)
|++|.|-.|.||++.. ++.+.+-|||+...
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 8999999999999994 56899999999875
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00029 Score=77.68 Aligned_cols=137 Identities=25% Similarity=0.203 Sum_probs=92.3
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc---------------------hhHHHHHHHHHHHHHhcC--CCc
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR---------------------KNDIERILAERNILITVR--NPF 749 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~---------------------~~eie~~l~E~~IL~kL~--HPN 749 (1093)
..|..|--+.||+|.. .++..+|+| +.+...... ........+|+.-|.++. +-.
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avK-iyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVK-IYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEE-EEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 3788888889999876 358899999 432211100 111233456777777764 333
Q ss_pred eEEEeeeeccCCceEEEEEecCCCC-hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcE
Q 001354 750 VVRFFYSFTCRDNLYLVMEYLNGGD-LYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 750 IVkL~gsfqd~~~LyLVMEYm~GGS-L~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~V 827 (1093)
+.+-+.++ .-.|||||+.... -.-.|.. -.+..+++..+..+++..|.-|-. .++||+||..=|||+. +|.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 44444333 2479999996531 1111221 123344788888899999998877 8999999999999999 8999
Q ss_pred EEEecCCccc
Q 001354 828 KLTDFGLSKI 837 (1093)
Q Consensus 828 KLsDFGLAk~ 837 (1093)
.|+|||-|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00034 Score=88.31 Aligned_cols=145 Identities=20% Similarity=0.351 Sum_probs=89.3
Q ss_pred EEEeeeccCCeEEEEEEECCCC--cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCce--EEEeeeeccC---Cc
Q 001354 691 IIKPISRGAFGRVFLARKRTTG--DLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFV--VRFFYSFTCR---DN 762 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TG--k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNI--VkL~gsfqd~---~~ 762 (1093)
.++.|+.|.+..+|+......+ ..+++|+.. .... ......+.+|..+|..+. |++| .+++.++.+. +.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p-~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKP-PGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCC-CCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 3577899999999998875432 367777321 1111 112345779999999885 5554 7778777665 46
Q ss_pred eEEEEEecCCCChHH--------------------HH---HhcC----CC---------CHHHHHHHHH-----------
Q 001354 763 LYLVMEYLNGGDLYS--------------------LL---RKVG----CL---------EEDVARIYIA----------- 795 (1093)
Q Consensus 763 LyLVMEYm~GGSL~d--------------------lL---~k~g----~L---------sEe~ar~yaa----------- 795 (1093)
.|+||||++|..+.+ .| +... .+ ...++..+..
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 799999999854321 11 1100 00 0112221111
Q ss_pred ----HHHHHHHHHHh-----------cCcEeeecCCCcEEEccC-Cc-EEEEecCCcccc
Q 001354 796 ----ELVLALEYLHS-----------LGIVHRDLKPDNLLIAHD-GH-IKLTDFGLSKIG 838 (1093)
Q Consensus 796 ----QIl~ALeYLHs-----------~GIIHRDIKPeNILLD~d-G~-VKLsDFGLAk~~ 838 (1093)
.+...+.+|.. ..+||+|++|.|||++.+ +. +-|.||+++..+
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12233556632 249999999999999853 33 579999999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00073 Score=72.68 Aligned_cols=128 Identities=27% Similarity=0.387 Sum_probs=90.9
Q ss_pred CCeeEEEeeeccCC-eEEEEEEECCCCcEEEEEEeehhhhh---------hc---------hhHHHHHHHHHHHHHhcC-
Q 001354 687 DDFEIIKPISRGAF-GRVFLARKRTTGDLFAIKQVLKKLDM---------IR---------KNDIERILAERNILITVR- 746 (1093)
Q Consensus 687 ddFeilr~LGkG~F-GeVylar~k~TGk~VAIKkILkK~~~---------~~---------~~eie~~l~E~~IL~kL~- 746 (1093)
.+++.++.||.|.- |.||+++.. |+.||+|. .+.-.. .. .....-|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKl-f~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKL-FRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEE-eeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 79999999999999 999999886 88999995 111000 00 012345777877766554
Q ss_pred --CCce--EEEeeeeccC------------------CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 001354 747 --NPFV--VRFFYSFTCR------------------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804 (1093)
Q Consensus 747 --HPNI--VkL~gsfqd~------------------~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYL 804 (1093)
+..+ |+.|++..-. ...-||.||++... .+.. .-+.+|..-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHH
Confidence 4455 8998887322 12467888887643 1222 2356788889999
Q ss_pred HhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 805 Hs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
|+.||+-+|+++.|.. +| ||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc---CC--EEEecccC
Confidence 9999999999999987 22 89999964
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0008 Score=71.95 Aligned_cols=73 Identities=16% Similarity=0.169 Sum_probs=44.5
Q ss_pred EEeeeccCCe-EEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC---ceEEEeeeeccC---CceE
Q 001354 692 IKPISRGAFG-RVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFTCR---DNLY 764 (1093)
Q Consensus 692 lr~LGkG~FG-eVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP---NIVkL~gsfqd~---~~Ly 764 (1093)
++.|+.|+.. .||+. +..+++| +... ......+.+|..+|..+... -+.++++..... ...|
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR-~~~~-----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~ 70 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVR-LPSA-----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPW 70 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEE-cCCc-----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcce
Confidence 3567877777 48876 2346778 3221 11234688899998877521 344444443332 2458
Q ss_pred EEEEecCCCCh
Q 001354 765 LVMEYLNGGDL 775 (1093)
Q Consensus 765 LVMEYm~GGSL 775 (1093)
+||++++|.++
T Consensus 71 ~l~~~i~G~~l 81 (235)
T cd05155 71 SVYRWLEGETA 81 (235)
T ss_pred EEEEeecCCCC
Confidence 99999999765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.004 Score=73.06 Aligned_cols=81 Identities=20% Similarity=0.232 Sum_probs=55.7
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc---hhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCceEE
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR---KNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~---~~eie~~l~E~~IL~kL~---HPNIVkL~gsfqd~~~LyL 765 (1093)
.+.||.|.+..||++...+.++.+++|+......... .-..++...|...|..+. ..+++++|.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999865446899996543222111 124567777888888763 3456777766 4456789
Q ss_pred EEEecCCCC
Q 001354 766 VMEYLNGGD 774 (1093)
Q Consensus 766 VMEYm~GGS 774 (1093)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.001 Score=70.39 Aligned_cols=131 Identities=24% Similarity=0.338 Sum_probs=91.6
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 768 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVME 768 (1093)
.+..+.||+|.+|.||+|.+. |..+|+| +.+. ..-...+..|.++|..+.--++-+=.+.+.. .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~K-vrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALK-VRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEE-EecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhh
Confidence 345678999999999999997 6789999 4222 1223567889999998886655443332221 245599
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecC-CCcEEEccCCcEEEEecCCccc
Q 001354 769 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK-PDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 769 Ym~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIK-PeNILLD~dG~VKLsDFGLAk~ 837 (1093)
|+.|-.|.++-... + +.-+..++.+---|-..||-|..|. |..++|..++.+.|+||.-|++
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99998887765421 1 2223445555444677899999994 7777777777999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.005 Score=65.89 Aligned_cols=131 Identities=23% Similarity=0.243 Sum_probs=88.3
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-------------hchhHHHHHHHHHHHHHhcC------CCceEE
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-------------IRKNDIERILAERNILITVR------NPFVVR 752 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-------------~~~~eie~~l~E~~IL~kL~------HPNIVk 752 (1093)
...||+|+.=.||.- ..+....||++ ..... ..........+|+.-...+. +.+|.+
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~-~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVM-RPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEE-ccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 357999999999863 23445678844 33220 01122345556655544444 789999
Q ss_pred EeeeeccCCceEEEEEecCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-
Q 001354 753 FFYSFTCRDNLYLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG- 825 (1093)
Q Consensus 753 L~gsfqd~~~LyLVMEYm~G------GSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG- 825 (1093)
+||..++...+-+|+|.+.. -+|.+++.+ +.+++ ..+. .+-.-..||-+.+|+.+||+|.||++...+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99999999999999998753 368888854 44665 3332 333445678899999999999999997542
Q ss_pred ---cEEEEe
Q 001354 826 ---HIKLTD 831 (1093)
Q Consensus 826 ---~VKLsD 831 (1093)
.+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0012 Score=69.72 Aligned_cols=98 Identities=23% Similarity=0.263 Sum_probs=79.0
Q ss_pred HHHHHHHHhcCC-CceEEEeeeeccCCceEEEEEecCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 001354 736 LAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL---LRKVGCLEEDVARIYIAELVLALEYLHS---LG 808 (1093)
Q Consensus 736 l~E~~IL~kL~H-PNIVkL~gsfqd~~~LyLVMEYm~GGSL~dl---L~k~g~LsEe~ar~yaaQIl~ALeYLHs---~G 808 (1093)
..|.-+|..+.+ +++++++|+|- -++|.||...+++... +......++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888875 69999999984 3679999988776532 2222346788888999999999999997 34
Q ss_pred cEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 809 IIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+.-.|++|+|+-++++|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77789999999999999999999997754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0033 Score=66.60 Aligned_cols=137 Identities=17% Similarity=0.238 Sum_probs=79.5
Q ss_pred EEeeeccCCeEEEEEEECC-CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEEEe
Q 001354 692 IKPISRGAFGRVFLARKRT-TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~-TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
++.|..|-...||++.... .+..|++| +..... . ......+|..++..+. +...+++++.+.. .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR-~~~~~~---~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVR-VYGNKT---E-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEE-EccCCc---c-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEe
Confidence 4678888888999997543 35678888 433211 1 1112346888888774 3334555554432 479999
Q ss_pred cCCCChHHH--------------HH---hcC-CC----------C-HHHHHHHHHH----------------------HH
Q 001354 770 LNGGDLYSL--------------LR---KVG-CL----------E-EDVARIYIAE----------------------LV 798 (1093)
Q Consensus 770 m~GGSL~dl--------------L~---k~g-~L----------s-Ee~ar~yaaQ----------------------Il 798 (1093)
++|-++... |. ... .. . ...+..|... +.
T Consensus 74 i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 153 (235)
T cd05157 74 IPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLR 153 (235)
T ss_pred eCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHH
Confidence 998665211 11 111 11 0 1122222111 11
Q ss_pred HHHHHH----H----hcCcEeeecCCCcEEEcc-CCcEEEEecCCccc
Q 001354 799 LALEYL----H----SLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 837 (1093)
Q Consensus 799 ~ALeYL----H----s~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~ 837 (1093)
..+..| - ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 154 ~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 154 DEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111111 1 235999999999999998 57899999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0082 Score=67.35 Aligned_cols=77 Identities=13% Similarity=0.068 Sum_probs=53.9
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC---CceEEEeeeecc---CCceE
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC---RDNLY 764 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H---PNIVkL~gsfqd---~~~Ly 764 (1093)
-.+.||.|..+.||.....+ + .+.+| +.+.. .....+..|...|+.+.- ..+.++++.+.+ .+..|
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k-~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPL-MARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEE-Eeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 45689999999999986432 3 46667 33221 122568889999988752 467778877654 35689
Q ss_pred EEEEecCCCCh
Q 001354 765 LVMEYLNGGDL 775 (1093)
Q Consensus 765 LVMEYm~GGSL 775 (1093)
||||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.004 Score=67.33 Aligned_cols=133 Identities=20% Similarity=0.204 Sum_probs=74.7
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCceEEEEEecCC
Q 001354 694 PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLVMEYLNG 772 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN-IVkL~gsfqd~~~LyLVMEYm~G 772 (1093)
.+..|-.+.+|+.. .++..|++| +..... ....-...+|..+|..+.... ..++++.+. -++||||++|
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR-~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWR-PQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEe-eCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 35567778899887 346678888 322111 000012467888888775322 233444432 3699999998
Q ss_pred CChHH--------------HH---HhcC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------cCcEeee
Q 001354 773 GDLYS--------------LL---RKVG----CLEE-DVARIYIAEL---------VLALEYLHS--------LGIVHRD 813 (1093)
Q Consensus 773 GSL~d--------------lL---~k~g----~LsE-e~ar~yaaQI---------l~ALeYLHs--------~GIIHRD 813 (1093)
..+.. .| +... .++. ..+..|..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 66431 11 1111 1111 1222222122 111222211 2489999
Q ss_pred cCCCcEEEccCCcEEEEecCCccc
Q 001354 814 LKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 814 IKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+.|.|||++.++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999877 78999999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0082 Score=66.33 Aligned_cols=76 Identities=12% Similarity=0.100 Sum_probs=46.8
Q ss_pred EEeeeccCCeEEEEEEECC------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCceE
Q 001354 692 IKPISRGAFGRVFLARKRT------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNIVkL~gsfqd~~~Ly 764 (1093)
++.|..|-...||++.... +++.|++| +..... .......+|..++..+.. ....++++.+.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlR-i~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLR-VYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEE-EecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence 4556667777899887543 25788899 433211 122345678888877752 223455665542 3
Q ss_pred EEEEecCCCChH
Q 001354 765 LVMEYLNGGDLY 776 (1093)
Q Consensus 765 LVMEYm~GGSL~ 776 (1093)
+||||++|..+.
T Consensus 74 ~v~e~i~G~~l~ 85 (302)
T cd05156 74 RIEEFIPSRTLT 85 (302)
T ss_pred chhheeCCCcCC
Confidence 689999987653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.014 Score=67.91 Aligned_cols=77 Identities=25% Similarity=0.308 Sum_probs=53.0
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh---chhHHHHHHHHHHHHHhcC--CC-ceEEEeeeeccCCceEEEE
Q 001354 694 PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI---RKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 694 ~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~---~~~eie~~l~E~~IL~kL~--HP-NIVkL~gsfqd~~~LyLVM 767 (1093)
.||-|....||++.....++.++||+-+...+.. ..-...+..-|...|+... .| .++++|+ | ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-ccccceehH
Confidence 5799999999999976444689999876655532 1334567778888887664 35 4444443 3 444567999
Q ss_pred EecCC
Q 001354 768 EYLNG 772 (1093)
Q Consensus 768 EYm~G 772 (1093)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.02 Score=62.88 Aligned_cols=139 Identities=19% Similarity=0.159 Sum_probs=82.1
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC--ceEEEeee------eccCC
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYS------FTCRD 761 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP--NIVkL~gs------fqd~~ 761 (1093)
.-++.|..|....+|++... +..+++| +... .....+..|..++..+.+. .+.+++.. ....+
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~--~~~~vLr-~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTD--SGRYVLT-LFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred hheecccCccccceEEEEeC--CCcEEEE-EcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 33667888888899998653 4568888 3322 1223456677777766421 24444432 22345
Q ss_pred ceEEEEEecCCCChHH----HH----------HhcC-CCCH--------HHHH------------HHHHHHHHHHHHHHh
Q 001354 762 NLYLVMEYLNGGDLYS----LL----------RKVG-CLEE--------DVAR------------IYIAELVLALEYLHS 806 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~d----lL----------~k~g-~LsE--------e~ar------------~yaaQIl~ALeYLHs 806 (1093)
..++||+|++|..+.. .+ +... .+.. .... .....+..++.++.+
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999999866421 11 1100 0100 0000 011123334455543
Q ss_pred -------cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 -------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 -------~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3699999999999999887789999998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.039 Score=61.52 Aligned_cols=31 Identities=32% Similarity=0.430 Sum_probs=26.8
Q ss_pred cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 ~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999998665568999999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.035 Score=61.88 Aligned_cols=142 Identities=21% Similarity=0.209 Sum_probs=81.2
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC--CceEEEeeee------cc
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSF------TC 759 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H--PNIVkL~gsf------qd 759 (1093)
....++.|+.|....+|++... +..|++|+. ... .....+..|..++..+.. -.+.+++... ..
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~-~~~-----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTD--VGRYILTLY-EKR-----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CceeccccCCccccceEEEEeC--CCcEEEEEe-cCC-----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 3445677888888899998643 335778833 221 012334556666666532 1234443321 22
Q ss_pred CCceEEEEEecCCCChH-----------HH---HHhc-CCCC---------HHHHH--------------HHHHHHHHHH
Q 001354 760 RDNLYLVMEYLNGGDLY-----------SL---LRKV-GCLE---------EDVAR--------------IYIAELVLAL 801 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~-----------dl---L~k~-g~Ls---------Ee~ar--------------~yaaQIl~AL 801 (1093)
.+..+++|+|++|..+. .. ++.. ..++ ..... .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 35678999999985431 11 1110 0110 00000 0011233455
Q ss_pred HHHHh-------cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 802 EYLHS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 802 eYLHs-------~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+++.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 55543 5799999999999999988778999999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0053 Score=70.31 Aligned_cols=136 Identities=17% Similarity=0.218 Sum_probs=90.6
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh----c-hh------------H--HHHHHHHHHHHHhcC-CC
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI----R-KN------------D--IERILAERNILITVR-NP 748 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~----~-~~------------e--ie~~l~E~~IL~kL~-HP 748 (1093)
+.+...||-|--+.||.+-+. .|+++++| +.+--+.. + .. . .-...+|+..|+.+. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK-~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILK-LHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHH-HHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 456788999999999999876 48899999 42211110 0 00 0 112346777777764 32
Q ss_pred c-eEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcE
Q 001354 749 F-VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 749 N-IVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~V 827 (1093)
+ |.+.+ +.+.-++|||++.|-.|...-+- .+ +..+...+..-|.-|...|+||+|.+-=||++++++++
T Consensus 172 fpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPI----DHNRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCcc----cccceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 2 22222 33457899999999777654321 11 12233445555667889999999999999999999999
Q ss_pred EEEecCCcc
Q 001354 828 KLTDFGLSK 836 (1093)
Q Consensus 828 KLsDFGLAk 836 (1093)
+++||--+.
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999998654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.057 Score=63.70 Aligned_cols=79 Identities=23% Similarity=0.196 Sum_probs=55.6
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh--chhHHHHHHHHHHHHHhcC--CC-ceEEEeeeeccCCceEEE
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI--RKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~--~~~eie~~l~E~~IL~kL~--HP-NIVkL~gsfqd~~~LyLV 766 (1093)
++.||-|.-..||++.....++.++||+-+...+.. -.-...+..-|..+|+... .| .++++|++ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999985445789999876655521 1234677788888888764 45 45555533 45556789
Q ss_pred EEecCC
Q 001354 767 MEYLNG 772 (1093)
Q Consensus 767 MEYm~G 772 (1093)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.0097 Score=51.22 Aligned_cols=35 Identities=37% Similarity=0.702 Sum_probs=28.9
Q ss_pred CCCCcchhhcc--cCcccCCCCCCCCCcccccccccC
Q 001354 976 KGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 1010 (1093)
Q Consensus 976 kgIdWd~L~~~--~pPf~P~~~s~~Dts~Fds~fs~~ 1010 (1093)
++++|+.|..+ .|||+|...+..|+++|+..|...
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~ 37 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEE 37 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCC
Confidence 47999999754 799999999999999998755444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.096 Score=60.13 Aligned_cols=137 Identities=18% Similarity=0.221 Sum_probs=77.1
Q ss_pred EEeeeccCCeEEEEEEECC----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCceEEE
Q 001354 692 IKPISRGAFGRVFLARKRT----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNIVkL~gsfqd~~~LyLV 766 (1093)
+..|-.|-.-.+|++.... +++.|++| +..... ...+. ..+|..++..+.. .--.++++.+... .|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~R-i~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVR-IYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEE-EccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 3445457777899887532 24678888 433211 11122 2568888887753 2333455665432 58
Q ss_pred EEecCCCChHHH--------------H---HhcC----C-C-CHHHHHHHHHHH-----------------HHHHHHH--
Q 001354 767 MEYLNGGDLYSL--------------L---RKVG----C-L-EEDVARIYIAEL-----------------VLALEYL-- 804 (1093)
Q Consensus 767 MEYm~GGSL~dl--------------L---~k~g----~-L-sEe~ar~yaaQI-----------------l~ALeYL-- 804 (1093)
++|++|.+|... | +... . + ....+..++.++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987665311 1 1111 0 1 112222332111 1112222
Q ss_pred --H----hcCcEeeecCCCcEEEcc-CCcEEEEecCCccc
Q 001354 805 --H----SLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 837 (1093)
Q Consensus 805 --H----s~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~ 837 (1093)
. ...++|+|+++.|||+++ ++.+.|+||.+|..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 47899999999874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.12 Score=57.71 Aligned_cols=31 Identities=39% Similarity=0.677 Sum_probs=26.1
Q ss_pred CcEeeecCCCcEEEccCCc-EEEEecCCcccc
Q 001354 808 GIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIG 838 (1093)
Q Consensus 808 GIIHRDIKPeNILLD~dG~-VKLsDFGLAk~~ 838 (1093)
.++|+|++|.|||++.++. .-|+||+.+..+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 3899999999999997565 569999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.18 Score=57.96 Aligned_cols=108 Identities=19% Similarity=0.267 Sum_probs=66.6
Q ss_pred HHHHHHHHHHHHHhcCC--CceEEEeeeeccCC--ceEEEEEecCCCCh------------------HHHHHh---cC--
Q 001354 731 DIERILAERNILITVRN--PFVVRFFYSFTCRD--NLYLVMEYLNGGDL------------------YSLLRK---VG-- 783 (1093)
Q Consensus 731 eie~~l~E~~IL~kL~H--PNIVkL~gsfqd~~--~LyLVMEYm~GGSL------------------~dlL~k---~g-- 783 (1093)
......+|..+|..+.- .-+...++.+.++. ..|.||+|+.|..+ .+.|.. .+
T Consensus 64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~ 143 (321)
T COG3173 64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAA 143 (321)
T ss_pred hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCc
Confidence 44556678888877653 33445566676665 67999999998422 112211 00
Q ss_pred ---------CCCHHHHHHHHHHH--------------HHHHHHHHhc--------CcEeeecCCCcEEEccCCcEEEEec
Q 001354 784 ---------CLEEDVARIYIAEL--------------VLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 784 ---------~LsEe~ar~yaaQI--------------l~ALeYLHs~--------GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
.+...+...+..+. ..-+.+|+.+ .++|+|+.+.||+|+.++-+-|.||
T Consensus 144 ~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDw 223 (321)
T COG3173 144 GLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDW 223 (321)
T ss_pred CCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEec
Confidence 00111111122222 2234555543 3899999999999999999999999
Q ss_pred CCcccc
Q 001354 833 GLSKIG 838 (1093)
Q Consensus 833 GLAk~~ 838 (1093)
+++.++
T Consensus 224 e~~~lG 229 (321)
T COG3173 224 ELATLG 229 (321)
T ss_pred cccccC
Confidence 999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.18 Score=59.10 Aligned_cols=141 Identities=28% Similarity=0.226 Sum_probs=89.7
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh-----------------------chhHHHHHHHHHHHHHhcCCC
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI-----------------------RKNDIERILAERNILITVRNP 748 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~-----------------------~~~eie~~l~E~~IL~kL~HP 748 (1093)
-.+|..|--+.||.|... +|..+||| |.+..-.. ++...-....|++-|.+++..
T Consensus 149 nGCiSTGKEANVYHat~~-dG~~~AIK-IYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE-DGSEFAIK-IYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ccccccCccceeEeeecC-CCceEEEE-EEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 346888888999999865 57889999 43321110 000112234566667776543
Q ss_pred ceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeeecCCCcEEEccCCcE
Q 001354 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 749 NIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLH-s~GIIHRDIKPeNILLD~dG~V 827 (1093)
.|.-.--. .- ..-.|||+|+.+.....-.-+.-.++...++.+-.+++.-|.-|- ..++||.||.--|+|+ .+|.+
T Consensus 227 GIP~PePI-lL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPI-LL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCce-ee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 32110000 00 124799999964222221223345777888888888888888775 4589999999999999 57999
Q ss_pred EEEecCCccc
Q 001354 828 KLTDFGLSKI 837 (1093)
Q Consensus 828 KLsDFGLAk~ 837 (1093)
.|+|.+-+..
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999998763
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.21 Score=58.61 Aligned_cols=84 Identities=20% Similarity=0.227 Sum_probs=47.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCC-CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~T-Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~Ly 764 (1093)
+++++. .|..|-...+|++..... +..+.+|.++...........-.-.+|..++..+. +..-.++++.|.. +
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 444444 555588889999976433 22333332221111111111122356888888886 4455566777753 6
Q ss_pred EEEEecCCCCh
Q 001354 765 LVMEYLNGGDL 775 (1093)
Q Consensus 765 LVMEYm~GGSL 775 (1093)
+|.||++|-.|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 99999998765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.33 Score=57.62 Aligned_cols=78 Identities=23% Similarity=0.237 Sum_probs=52.6
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhch---hHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCceE
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK---NDIERILAERNILITVR---NPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~---~eie~~l~E~~IL~kL~---HPNIVkL~gsfqd~~~Ly 764 (1093)
..+.||-|....||++... +..|+||+-......... ....+...|...|..+. ...+.++|.++. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999998863 456889965433322111 13455556677776554 247788887776 3457
Q ss_pred EEEEecCC
Q 001354 765 LVMEYLNG 772 (1093)
Q Consensus 765 LVMEYm~G 772 (1093)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.22 Score=56.83 Aligned_cols=141 Identities=16% Similarity=0.195 Sum_probs=76.8
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCC---CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCc
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDN 762 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~T---Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNI-VkL~gsfqd~~~ 762 (1093)
+++++.. |..|=...+|++..... +..|++| +..... . ..-.-.+|..+++.+..-.+ .++++.+.. +
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~R-i~g~~t---~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVR-LFGPNT---D-YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEE-EecCCc---C-eEechHHHHHHHHHHHhcCCCCceeEEeCC-c-
Confidence 4555544 44477777888875432 2378888 432211 1 11223567888877764333 455555532 2
Q ss_pred eEEEEEecCCCChHH--------------HH---HhcC-C----C-CHHHHHHHHHHH----------------------
Q 001354 763 LYLVMEYLNGGDLYS--------------LL---RKVG-C----L-EEDVARIYIAEL---------------------- 797 (1093)
Q Consensus 763 LyLVMEYm~GGSL~d--------------lL---~k~g-~----L-sEe~ar~yaaQI---------------------- 797 (1093)
+|.+|++|-.|.. .| +... . + ....+..|..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 5899998765421 11 1111 0 1 112233332221
Q ss_pred HHHHHHHH----hcC----cEeeecCCCcEEEcc-CCcEEEEecCCccc
Q 001354 798 VLALEYLH----SLG----IVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 837 (1093)
Q Consensus 798 l~ALeYLH----s~G----IIHRDIKPeNILLD~-dG~VKLsDFGLAk~ 837 (1093)
..-+..+. ..+ +.|.|+.+.|||+++ ++.++++||..|..
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11122221 112 789999999999975 57899999999874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.6 Score=52.87 Aligned_cols=75 Identities=20% Similarity=0.282 Sum_probs=46.5
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCceEEE
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~---HPNIVkL~gsfqd~~~LyLV 766 (1093)
+-.+.|+.|....+|+.. .++..|.+|.- . ......+..|..-|+.+. .-.+.+++.+....+.-|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~-~------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVN-S------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEE-E------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEec-C------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 445678999999999987 56888999932 1 122345777888887773 44677888888777778999
Q ss_pred EEecCCC
Q 001354 767 MEYLNGG 773 (1093)
Q Consensus 767 MEYm~GG 773 (1093)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.28 E-value=0.88 Score=51.10 Aligned_cols=30 Identities=17% Similarity=0.204 Sum_probs=28.2
Q ss_pred CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 808 GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.034 Score=46.48 Aligned_cols=22 Identities=27% Similarity=0.193 Sum_probs=15.7
Q ss_pred CCCCCCCcccccccccCCCCCC
Q 001354 994 PESVDDTSYFLSRFSQISSGLP 1015 (1093)
Q Consensus 994 ~~s~~Dts~Fds~fs~~~~~l~ 1015 (1093)
+.+..|++|||..|+++.....
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~t 23 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVDT 23 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS-
T ss_pred CCchhhhhhcCcccccCCCCCC
Confidence 5678999999999998865443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.25 E-value=0.44 Score=55.94 Aligned_cols=72 Identities=26% Similarity=0.400 Sum_probs=51.6
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
..++|++|++- |+.+.- + .....+++..++.+.+.-+.-+..+ .+=|||+...||||+ +|+|.|+||-+|+.
T Consensus 298 ~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34678888875 445432 1 1233455666666666655555544 588999999999999 99999999999985
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.15 E-value=0.2 Score=60.63 Aligned_cols=163 Identities=21% Similarity=0.280 Sum_probs=100.6
Q ss_pred HHHHHHHHHHHhcCCCceEEEeeeeccC-CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEe
Q 001354 733 ERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811 (1093)
Q Consensus 733 e~~l~E~~IL~kL~HPNIVkL~gsfqd~-~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIH 811 (1093)
..++.-..+++.+.|++....+..-... ....+|||++. -+|++++..+. +-.. ++. .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchh-------hhc-------ccccce
Confidence 3456677889999999999887765543 35889999995 49999987654 2111 111 122222
Q ss_pred eecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC
Q 001354 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 891 (1093)
Q Consensus 812 RDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~ 891 (1093)
- | .++++| -++.. ..+..|
T Consensus 91 ~-----~-------~~~~td-~~~t~----------------------------------~~~~~~-------------- 109 (725)
T KOG1093|consen 91 L-----N-------IIYITD-HFLTK----------------------------------YPSPIG-------------- 109 (725)
T ss_pred e-----h-------hhhccc-ccccc----------------------------------CCCCCC--------------
Confidence 1 1 223333 11100 011112
Q ss_pred CCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC----------CCCCCCHHHHHHHHhhccCCcCCCC
Q 001354 892 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC----------VPSDMSFEAQDLINRFLIHDPNQRL 961 (1093)
Q Consensus 892 Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~----------ip~~IS~eakDLIkrcL~kDP~KRp 961 (1093)
.++||||+|.++.|+..|..-|......+....|..-... +. +.-.++....++..+|+-..|..||
T Consensus 110 --pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~-d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 110 --PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTD-DQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred --cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccC-chhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 2999999999999999998888776665555555432110 00 1122455667888899999999999
Q ss_pred ChhcHHHHHcCCCCCCC
Q 001354 962 GANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 962 Ta~~A~EIL~HPFFkgI 978 (1093)
. ..++.+|+-|..+
T Consensus 187 l---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 L---PMELSKRCSFTEV 200 (725)
T ss_pred c---hhHHhcCccHHHH
Confidence 7 4566777777543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.28 E-value=0.47 Score=52.42 Aligned_cols=30 Identities=27% Similarity=0.522 Sum_probs=26.5
Q ss_pred cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 ~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.04 E-value=0.79 Score=50.92 Aligned_cols=86 Identities=17% Similarity=0.177 Sum_probs=59.1
Q ss_pred HHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--cCc
Q 001354 732 IERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--LGI 809 (1093)
Q Consensus 732 ie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs--~GI 809 (1093)
..-+.++.+++.++. .|++|..- ....+-+|+|+|---.. ...-++.+ =+.+|.-.|+ .+.
T Consensus 102 ~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~N~i~a-gi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 102 DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFSNFITA-GIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chhHHHHH-hHHHHHHhhccCCCe
Confidence 345678888988875 57777632 33346789999843111 01112222 2456777784 379
Q ss_pred EeeecCCCcEEEccCCcEEEEecCC
Q 001354 810 VHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 810 IHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
+|+|-.|+||+-|..|.+||.|=+.
T Consensus 165 lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ecCCCChhheeecCCCCEEecChhh
Confidence 9999999999999999999999774
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.01 E-value=5 Score=52.90 Aligned_cols=31 Identities=32% Similarity=0.518 Sum_probs=26.4
Q ss_pred cCcEeeecCCCcEEEccCC--cEE-EEecCCccc
Q 001354 807 LGIVHRDLKPDNLLIAHDG--HIK-LTDFGLSKI 837 (1093)
Q Consensus 807 ~GIIHRDIKPeNILLD~dG--~VK-LsDFGLAk~ 837 (1093)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998864
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.43 E-value=0.55 Score=54.57 Aligned_cols=51 Identities=27% Similarity=0.445 Sum_probs=35.8
Q ss_pred HHHHHHHHHHHHHHHHHHHh----cCcEeeecCCCcEEEccCC------------------cEEEEecCCccc
Q 001354 787 EDVARIYIAELVLALEYLHS----LGIVHRDLKPDNLLIAHDG------------------HIKLTDFGLSKI 837 (1093)
Q Consensus 787 Ee~ar~yaaQIl~ALeYLHs----~GIIHRDIKPeNILLD~dG------------------~VKLsDFGLAk~ 837 (1093)
.+-+++++.||+.-.-.+-. .+++|-||||+||||-... .++|.||.++.+
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 35677888888776544433 3699999999999985432 246667777664
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.71 E-value=18 Score=41.34 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=24.8
Q ss_pred cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 ~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.++||+|+.+.|||++ + .+.|+||+.|..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999998874
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.21 E-value=7.8 Score=46.61 Aligned_cols=29 Identities=28% Similarity=0.495 Sum_probs=24.6
Q ss_pred CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 808 GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+.|.|+-+.|||.+.++ ++|+||-.|..
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeeccccc
Confidence 479999999999986544 99999998863
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1093 | ||||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-63 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-63 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-58 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-57 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-57 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-57 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-57 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-57 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-57 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-57 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-57 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-57 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-57 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-57 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-57 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-57 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-57 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-57 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-57 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-57 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-57 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-57 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-57 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-57 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-56 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-56 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-56 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-56 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-56 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-56 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-56 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-56 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-56 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-56 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-56 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-56 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-56 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-56 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-56 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-56 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-56 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-56 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-56 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-56 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-56 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-56 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-56 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-56 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-56 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-56 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-56 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-56 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-56 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-56 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-56 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-56 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-56 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-56 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-56 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-56 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-56 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-56 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-56 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-56 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-56 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-56 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-56 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-55 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-55 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-55 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-55 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-55 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-55 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-55 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-55 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-54 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-54 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-54 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-54 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-54 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-54 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-53 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-53 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-52 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-52 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-51 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-51 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-50 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-49 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-49 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-49 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-49 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-49 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-49 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-49 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-49 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-49 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-49 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-49 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-49 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-49 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-49 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-49 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-49 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-49 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-49 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-49 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-49 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-49 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-48 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-48 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-48 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-40 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-40 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-40 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-40 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-40 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-39 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-39 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-39 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-39 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-39 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-39 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-39 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-38 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-38 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-38 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-38 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-38 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-38 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-38 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-38 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-38 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-38 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-38 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-38 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-37 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-37 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-37 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-37 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-37 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-37 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-37 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-37 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-37 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-37 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-37 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-37 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-36 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-36 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-35 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-35 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-34 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-33 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-33 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-33 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-33 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-33 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-32 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-32 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-32 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-32 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-32 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-32 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-32 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-31 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-31 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-31 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-31 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-31 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-31 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-31 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-31 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-31 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-31 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-31 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-30 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-30 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-30 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-30 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-30 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-30 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-30 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-29 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-29 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-29 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-29 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-29 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-29 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-28 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-28 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-28 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-28 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-28 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-28 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-28 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-28 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-28 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-28 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-28 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-28 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-28 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-28 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-27 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-27 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-27 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-27 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-27 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-27 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-26 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-26 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-26 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-26 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-26 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-26 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-26 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-26 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-25 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-25 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-25 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-25 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-25 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-25 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-25 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-25 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-25 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-25 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-25 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-24 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-24 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-24 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-24 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-24 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-24 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-24 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-24 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-24 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-24 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-23 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-23 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-23 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-23 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-23 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-23 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-23 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-23 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-23 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-23 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-22 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-22 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-21 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-21 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-21 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-21 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-21 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-21 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-20 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-19 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-19 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-19 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-19 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-18 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-18 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-18 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-18 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-18 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-15 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-15 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-15 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-15 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-15 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-15 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-15 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-15 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-15 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-15 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-15 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-15 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-15 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-15 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-15 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-15 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-15 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-15 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-08 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 8e-08 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 |
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1093 | |||
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-141 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-138 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-133 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-133 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-130 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-129 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-129 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-128 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-128 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-127 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-126 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-125 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-124 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-124 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-122 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-121 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-120 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-119 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-115 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-114 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-111 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-110 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-103 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-103 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-89 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-89 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-84 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-83 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-81 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-81 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-78 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-76 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-73 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-73 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-73 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-72 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-71 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-71 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-71 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-71 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-71 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-70 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-70 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-70 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-70 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-69 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-69 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-69 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-69 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-68 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-68 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-68 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-68 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-68 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-68 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-68 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-67 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-67 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-67 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-67 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-67 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-66 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-66 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-66 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-66 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-65 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-65 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-65 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-65 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 7e-65 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 9e-65 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-64 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-64 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-64 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-63 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-63 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-63 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-63 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-63 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-63 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-62 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-62 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 7e-62 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-61 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-61 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-61 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-61 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-61 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-61 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-60 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-60 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-60 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-58 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-58 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-58 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-57 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-56 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-56 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-56 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 6e-56 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-55 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-55 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 8e-55 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-54 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-52 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-52 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-52 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-51 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-51 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-51 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-50 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-50 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-49 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-48 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 8e-46 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-45 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 5e-45 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-45 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-44 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-43 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-43 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-43 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-43 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-43 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-43 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-43 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-42 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-42 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-42 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-42 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-42 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-42 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-42 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-42 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-42 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 9e-42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 9e-41 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-40 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-40 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-40 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-39 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-39 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-39 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-39 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-38 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-38 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-37 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-37 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-37 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-36 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-36 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-36 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-36 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-35 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-35 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-35 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-35 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-34 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-34 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-34 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-34 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-34 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 9e-34 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-33 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-32 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-32 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-32 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-32 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-32 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-31 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-29 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 7e-25 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-24 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-24 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-23 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-22 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-22 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 5e-22 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-22 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-21 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-21 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-21 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-21 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-20 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-20 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-20 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 8e-20 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-19 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-19 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-19 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 7e-19 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-19 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-18 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-18 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-18 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-18 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-18 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-18 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-18 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 7e-18 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-17 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-17 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-17 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-17 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-17 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-17 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-17 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-17 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-17 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-16 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-16 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-16 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-16 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-16 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 3e-16 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-16 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-16 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-15 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-15 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-15 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-15 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-15 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-15 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-15 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-05 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-15 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-15 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 8e-15 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-14 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-14 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-14 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-14 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-14 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-12 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-12 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 2e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 2e-04 |
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 430 bits (1108), Expect = e-141
Identities = 133/463 (28%), Positives = 212/463 (45%), Gaps = 69/463 (14%)
Query: 617 LKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPL 676
++ LV+D +E LL L + E + ++ K + + +
Sbjct: 2 MQQLVLDPGFLGLEPLLD----LLLGVHQELGASELAQDKYVADFL-------QWAEPIV 50
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERIL 736
+ R DDFEI+K I RGAF V + + + TG ++A+K ++ K DM+++ ++
Sbjct: 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMK-IMNKWDMLKRGEVSCFR 109
Query: 737 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIA 795
ER++L+ ++ + ++F + LYLVMEY GGDL +LL K G + ++AR Y+A
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
E+V+A++ +H LG VHRD+KPDN+L+ GHI+L DFG + T+
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV----------- 218
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------HGYAADWWSVGIILFEF 908
AVGTPDYL+PEIL +G DWW++G+ +E
Sbjct: 219 ---------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 909 ITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966
G PF A+S + I++ K + P V + EA+D I R L P RLG GA
Sbjct: 264 FYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGA 322
Query: 967 AEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 1026
+ + HPFF G++WD L F P E DT F ++ G + +D
Sbjct: 323 GDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLT---AMVSGGGETLSD 379
Query: 1027 TCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLAS 1069
+ + L + +S+ ++ S
Sbjct: 380 IREGAPLGV-----------------HLPFVGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 421 bits (1085), Expect = e-138
Identities = 134/424 (31%), Positives = 213/424 (50%), Gaps = 47/424 (11%)
Query: 615 SKLKALVIDTFGSRIEKLLREKYIL--ACELLDEKSPTSFSKYKENSRLILDSVSQSSGV 672
+L+ ++D + + +L L DE + + + K +
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYL-------EWA 59
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI 732
+ R +DFEI+K I RGAFG V + + + +FA+K +L K +M+++ +
Sbjct: 60 KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAET 118
Query: 733 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVAR 791
ER++L+ + ++ Y+F +NLYLVM+Y GGDL +LL K L E++AR
Sbjct: 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR 178
Query: 792 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851
Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG + + T+
Sbjct: 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ------ 232
Query: 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILF 906
AVGTPDY++PEIL E +G DWWS+G+ ++
Sbjct: 233 --------------------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272
Query: 907 EFITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 964
E + G PF AES + I+N K +P +D+S A+DLI R LI RLG N
Sbjct: 273 EMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQN 331
Query: 965 GAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRF--SQISSGLPDDQNGSY 1022
G + K HPFF G++WD++ +A ++P+ S DTS F + S +P + ++
Sbjct: 332 GIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAF 391
Query: 1023 SDAD 1026
S
Sbjct: 392 SGHH 395
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-133
Identities = 117/327 (35%), Positives = 186/327 (56%), Gaps = 41/327 (12%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
+ S+ DF+I++ + G+FGRV L R R G +A+K VLKK ++R +E ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMK-VLKKEIVVRLKQVEHTNDERLML 60
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
V +PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALE
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLHS I++RDLKP+N+L+ +GHIK+TDFG +K + + T
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVT------------------- 160
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
++ GTPDY+APE++ + + DWWS GI+++E + G PF +
Sbjct: 161 ----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNW 980
++ ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W
Sbjct: 211 TYEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267
Query: 981 DSLALQKAV---FVPQPESVD-DTSYF 1003
+ L L + + + P + DTS F
Sbjct: 268 EKL-LSRNIETPYEPPIQQGQGDTSQF 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-133
Identities = 101/328 (30%), Positives = 172/328 (52%), Gaps = 32/328 (9%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723
+ + + + +DF+ K + G+F V LAR+ T +AIK +L+K
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK-ILEK 65
Query: 724 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 783
+I++N + + ER+++ + +PF V+ +++F + LY + Y G+L +RK+G
Sbjct: 66 RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG 125
Query: 784 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843
+E R Y AE+V ALEYLH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 126 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS---- 181
Query: 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903
++ +S VGT Y++PE+L ++D W++G
Sbjct: 182 ---------------------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 220
Query: 904 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963
I+++ + G+PPF A + +IF I+ + + P +A+DL+ + L+ D +RLG
Sbjct: 221 IIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGC 277
Query: 964 N---GAAEVKAHPFFKGVNWDSLALQKA 988
G +KAHPFF+ V W++L Q
Sbjct: 278 EEMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-130
Identities = 134/346 (38%), Positives = 198/346 (57%), Gaps = 41/346 (11%)
Query: 671 GVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMI 727
G S + E+ + FE+++ + +G +G+VF RK T TG +FA+K VLKK ++
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIV 59
Query: 728 RK-NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 786
R D AERNIL V++PF+V Y+F LYL++EYL+GG+L+ L + G
Sbjct: 60 RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM 119
Query: 787 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846
ED A Y+AE+ +AL +LH GI++RDLKP+N+++ H GH+KLTDFGL K +
Sbjct: 120 EDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI------- 172
Query: 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906
D H+ GT +Y+APEIL+ + H A DWWS+G +++
Sbjct: 173 --------------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 907 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--N 964
+ +TG PPFT E+ + D IL K+ P ++ EA+DL+ + L + RLGA
Sbjct: 213 DMLTGAPPFTGENRKKTIDKILKCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPG 269
Query: 965 GAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1007
A EV+AHPFF+ +NW+ L L + V F P +S +D S F S+F
Sbjct: 270 DAGEVQAHPFFRHINWEEL-LARKVEPPFKPLLQSEEDVSQFDSKF 314
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-129
Identities = 127/339 (37%), Positives = 183/339 (53%), Gaps = 38/339 (11%)
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI 732
++ R +D+E++K I RGAFG V L R ++T ++A+K +L K +MI+++D
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK-LLSKFEMIKRSDS 113
Query: 733 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI 792
ER+I+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARF 172
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
Y AE+VLAL+ +HS+G +HRD+KPDN+L+ GH+KL DFG
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---------------- 216
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEF 908
+ + +AVGTPDY++PE+L +G DWWSVG+ L+E
Sbjct: 217 ----------KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 909 ITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966
+ G PF A+S + I+N K + +P D+S EA++LI FL D RLG NG
Sbjct: 267 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLICAFL-TDREVRLGRNGV 324
Query: 967 AEVKAHPFFKGVNWDSLALQKAV--FVPQPESVDDTSYF 1003
E+K H FFK W L+ V VP S DTS F
Sbjct: 325 EEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 363
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-129
Identities = 117/328 (35%), Positives = 185/328 (56%), Gaps = 40/328 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
+ +D F+ IK + G+FGRV L + + +G+ +A+K +L K +++ IE L E+
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK-ILDKQKVVKLKQIEHTLNEKR 93
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
IL V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
EYLHSL +++RDLKP+NLLI G+I++TDFG +K + T
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRT----------------- 195
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 196 ------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGV 978
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F
Sbjct: 244 IQIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 979 NWDSLALQKAV---FVPQPESVDDTSYF 1003
+W ++ Q+ V F+P+ + DTS F
Sbjct: 301 DWIAI-YQRKVEAPFIPKFKGPGDTSNF 327
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-128
Identities = 121/349 (34%), Positives = 186/349 (53%), Gaps = 37/349 (10%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723
+ + L S DF +K I +G+FG+V LAR + +A+K VL+K
Sbjct: 15 PAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVK-VLQK 73
Query: 724 LDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 782
+++K + + I++ERN+L+ V++PF+V +SF D LY V++Y+NGG+L+ L++
Sbjct: 74 KAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE 133
Query: 783 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
C E AR Y AE+ AL YLHSL IV+RDLKP+N+L+ GHI LTDFGL K +
Sbjct: 134 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--- 190
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902
N + GTP+YLAPE+L + DWW +G
Sbjct: 191 ------------------------EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 903 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 962
+L+E + G+PPF + + ++DNILN+ + +++ A+ L+ L D +RLG
Sbjct: 227 AVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLG 283
Query: 963 A-NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1007
A + E+K+H FF +NWD L + K + F P +D +F F
Sbjct: 284 AKDDFMEIKSHVFFSLINWDDL-INKKITPPFNPNVSGPNDLRHFDPEF 331
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-128
Identities = 122/338 (36%), Positives = 185/338 (54%), Gaps = 41/338 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRKNDIER 734
E+ FE++K + +G+FG+VFL +K + L+A+K VLKK ++ D R
Sbjct: 15 KEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK-VLKK-ATLKVRDRVR 72
Query: 735 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 794
ER+IL+ V +PF+V+ Y+F LYL++++L GGDL++ L K E+ + Y+
Sbjct: 73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
AEL LAL++LHSLGI++RDLKP+N+L+ +GHIKLTDFGLSK +
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--------------- 177
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
+ +S GT +Y+APE++ H +ADWWS G+++FE +TG P
Sbjct: 178 ------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 915 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAH 972
F + + IL K+ P +S EAQ L+ +P RLGA +G E+K H
Sbjct: 226 FQGKDRKETMTMILKAKLGM---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282
Query: 973 PFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1007
FF ++W+ L ++ + F P +DT YF F
Sbjct: 283 SFFSTIDWNKL-YRREIHPPFKPATGRPEDTFYFDPEF 319
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-127
Identities = 127/358 (35%), Positives = 193/358 (53%), Gaps = 38/358 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
+ +++DF+ +K + +G FG+V L R++ TG +A+K +L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVL 59
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALE
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLHS +V+RD+K +NL++ DGHIK+TDFGL K G+
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----------------------- 156
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E
Sbjct: 157 ----SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNW 980
+F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 213 LFELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269
Query: 981 DSLALQKAV---FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDSSSNS 1034
+ +QK + F PQ S DT YF F+ S + P D+ S +
Sbjct: 270 QDV-VQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQE 326
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 388 bits (1000), Expect = e-126
Identities = 129/375 (34%), Positives = 200/375 (53%), Gaps = 47/375 (12%)
Query: 645 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF 704
S + + ++ + T + H E+ I++FE++K + GA+G+VF
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 705 LARKRT---TGDLFAIKQVLKKLDMIRK-NDIERILAERNILITVRN-PFVVRFFYSFTC 759
L RK + TG L+A+K VLKK +++K E ER +L +R PF+V Y+F
Sbjct: 72 LVRKISGHDTGKLYAMK-VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130
Query: 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 819
L+L+++Y+NGG+L++ L + E +IY+ E+VLALE+LH LGI++RD+K +N+
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 190
Query: 820 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP 879
L+ +GH+ LTDFGLSK + + + + GT
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVAD--------------------------ETERAYDFCGTI 224
Query: 880 DYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKIP 933
+Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT + S I IL + P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 934 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 989
+ P +MS A+DLI R L+ DP +RLG A E+K H FF+ +NWD L K V
Sbjct: 285 Y---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL-AAKKVPA 340
Query: 990 -FVPQPESVDDTSYF 1003
F P D S F
Sbjct: 341 PFKPVIRDELDVSNF 355
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 386 bits (995), Expect = e-125
Identities = 125/348 (35%), Positives = 195/348 (56%), Gaps = 39/348 (11%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM 726
+SS + + R ID+FE I+ + +G+FG+V LAR + TGDL+A+K VLKK +
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVK-VLKKDVI 61
Query: 727 IRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 785
++ +D+E + E+ IL RN PF+ + F F D L+ VME++NGGDL ++K
Sbjct: 62 LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF 121
Query: 786 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845
+E AR Y AE++ AL +LH GI++RDLK DN+L+ H+GH KL DFG+ K G+
Sbjct: 122 DEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------ 175
Query: 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 905
+ + GTPDY+APEIL +G A DWW++G++L
Sbjct: 176 ---------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 906 FEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-- 963
+E + G PF AE+ + +F+ ILN ++ + P+ + +A ++ F+ +P RLG+
Sbjct: 215 YEMLCGHAPFEAENEDDLFEAILNDEVVY---PTWLHEDATGILKSFMTKNPTMRLGSLT 271
Query: 964 -NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1007
G + HPFFK ++W L + + F P+ +S +D S F F
Sbjct: 272 QGGEHAILRHPFFKEIDWAQL-NHRQIEPPFRPRIKSREDVSNFDPDF 318
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-124
Identities = 117/334 (35%), Positives = 185/334 (55%), Gaps = 38/334 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
S + + I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E +
Sbjct: 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMV 66
Query: 738 ERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 796
E+ +L +PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE
Sbjct: 67 EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
++L L++LHS GIV+RDLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM----------------- 169
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF
Sbjct: 170 ----------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219
Query: 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ E +F +I + P + EA+DL+ + + +P +RLG G +++ HP F+
Sbjct: 220 GQDEEELFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFR 274
Query: 977 GVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1007
+NW+ L +K + F P+ +S D S F F
Sbjct: 275 EINWEEL-ERKEIDPPFRPKVKSPFDCSNFDKEF 307
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-124
Identities = 106/345 (30%), Positives = 182/345 (52%), Gaps = 39/345 (11%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR 728
++ VS ++ +++R + DF + + +G+FG+V L+ ++ T +L+A+K +LKK +I+
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVK-ILKKDVVIQ 60
Query: 729 KNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE 787
+D+E + E+ +L PF+ + F D LY VMEY+NGGDL +++VG +E
Sbjct: 61 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE 120
Query: 788 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847
A Y AE+ + L +L S GI++RDLK DN+++ +GHIK+ DFG+ K +
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-------- 172
Query: 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907
D + GTPDY+APEI+ +G + DWW+ G++L+E
Sbjct: 173 -------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213
Query: 908 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NG 965
+ G PF E + +F +I+ + + P MS EA + + P +RLG G
Sbjct: 214 MLAGQAPFEGEDEDELFQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEG 270
Query: 966 AAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1007
++K H FF+ ++W+ L +K + + P+ + F F
Sbjct: 271 ERDIKEHAFFRYIDWEKL-ERKEIQPPYKPKACG-RNAENFDRFF 313
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-122
Identities = 115/344 (33%), Positives = 181/344 (52%), Gaps = 48/344 (13%)
Query: 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAER 739
+ + DF++++ I RG++ +V L R + T ++A+K V+KK + DI+ + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK-VVKKELVNDDEDIDWVQTEK 60
Query: 740 NILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
++ N PF+V F L+ V+EY+NGGDL +++ L E+ AR Y AE+
Sbjct: 61 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 799 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
LAL YLH GI++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL------------------- 161
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT-- 916
+ GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF
Sbjct: 162 --------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213
Query: 917 -------AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGA 966
+ + +F IL ++I P +S +A ++ FL DP +RLG G
Sbjct: 214 GSSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGF 270
Query: 967 AEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1007
A+++ HPFF+ V+WD + QK V F P F S+F
Sbjct: 271 ADIQGHPFFRNVDWDMM-EQKQVVPPFKPNISGEFGLDNFDSQF 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-121
Identities = 129/380 (33%), Positives = 198/380 (52%), Gaps = 39/380 (10%)
Query: 634 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIK 693
RE++ A + + + + + S + + L + K R ++++FE +K
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSL-AKPKHRVTMNEFEYLK 154
Query: 694 PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 753
+ +G FG+V L +++ TG +A+K +LKK ++ K+++ L E +L R+PF+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHR 812
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 813 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 872
DLK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATM 306
Query: 873 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366
Query: 933 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV- 989
+ P + EA+ L++ L DP QRLG A E+ H FF G+ W + +K +
Sbjct: 367 RF---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV-YEKKLS 422
Query: 990 --FVPQPESVDDTSYFLSRF 1007
F PQ S DT YF F
Sbjct: 423 PPFKPQVTSETDTRYFDEEF 442
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-120
Identities = 119/382 (31%), Positives = 193/382 (50%), Gaps = 49/382 (12%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
D PT+ + Y + + + + ++T + DF++++ I RG++
Sbjct: 8 HHHDYDIPTTENLYFQGA-MGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 702 RVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCR 760
+V L R + T ++A++ V+KK + DI+ + E+++ N PF+V F
Sbjct: 67 KVLLVRLKKTDRIYAMR-VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125
Query: 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 820
L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDLK DN+L
Sbjct: 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 185
Query: 821 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 880
+ +GHIKLTD+G+ K GL + GTP+
Sbjct: 186 LDSEGHIKLTDYGMCKEGL---------------------------RPGDTTSTFCGTPN 218
Query: 881 YLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---------AESPEIIFDNILNRK 931
Y+APEIL G ++G++ DWW++G+++FE + G PF + + +F IL ++
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKA 988
I P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD + QK
Sbjct: 279 IRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM-EQKQ 334
Query: 989 V---FVPQPESVDDTSYFLSRF 1007
V F P F S+F
Sbjct: 335 VVPPFKPNISGEFGLDNFDSQF 356
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-119
Identities = 101/414 (24%), Positives = 187/414 (45%), Gaps = 54/414 (13%)
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI 732
S P E + D FEI++ I +G+FG+V + +K T ++A+K + K + +N++
Sbjct: 1 SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMK-YMNKQKCVERNEV 59
Query: 733 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI 792
+ E I+ + +PF+V +YSF +++++V++ L GGDL L++ +E+ ++
Sbjct: 60 RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL 119
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
+I ELV+AL+YL + I+HRD+KPDN+L+ GH+ +TDF ++ +
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-------------- 165
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFI 909
+ GT Y+APE+ G + +A DWWS+G+ +E +
Sbjct: 166 --------------PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
Query: 910 TGIPPF---TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966
G P+ ++ S + I + + PS S E L+ + L +P+QR
Sbjct: 212 RGRRPYHIRSSTSSKEIVHTFETTVVTY---PSAWSQEMVSLLKKLLEPNPDQRFS--QL 266
Query: 967 AEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF---SQISSGLPDDQNG 1020
++V+ P+ +NWD++ QK + F+P F I P +
Sbjct: 267 SDVQNFPYMNDINWDAV-FQKRLIPGFIPNK----GRLNCDPTFELEEMILESKPLHKKK 321
Query: 1021 ---SYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1071
+ + D S+ + E D + + +N F ++
Sbjct: 322 KRLAKKEKDMRKCDSSQTCLLQEHLDSVQKEFIIFNREKVNRDFNKRQPNLALE 375
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-115
Identities = 109/372 (29%), Positives = 189/372 (50%), Gaps = 39/372 (10%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
+E+ F + K ++ +S ++ +++R + DF + + +G+FG
Sbjct: 296 SEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFG 355
Query: 702 RVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCR 760
+V L+ ++ T +L+A+K +LKK +I+ +D+E + E+ +L PF+ + F
Sbjct: 356 KVMLSERKGTDELYAVK-ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414
Query: 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 820
D LY VMEY+NGGDL +++VG +E A Y AE+ + L +L S GI++RDLK DN++
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 821 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 880
+ +GHIK+ DFG+ K + D + GTPD
Sbjct: 475 LDSEGHIKIADFGMCKENI---------------------------WDGVTTKTFCGTPD 507
Query: 881 YLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 940
Y+APEI+ +G + DWW+ G++L+E + G PF E + +F +I+ + + P
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---PKS 564
Query: 941 MSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPE 995
MS EA + + P +RLG G ++K H FF+ ++W+ L +K + + P+
Sbjct: 565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL-ERKEIQPPYKPKA- 622
Query: 996 SVDDTSYFLSRF 1007
S + F F
Sbjct: 623 SGRNAENFDRFF 634
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-114
Identities = 98/382 (25%), Positives = 170/382 (44%), Gaps = 47/382 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
+ D F + + RG FG VF + + TG L+A K L K + ++ + + E+
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKK 237
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAE 796
IL V + F+V Y+F + +L LVM +NGGD+ Y++ +E A Y A+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+V LE+LH I++RDLKP+N+L+ DG+++++D GL+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----------------- 340
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916
GTP ++APE+LLG E+ ++ D++++G+ L+E I PF
Sbjct: 341 ----------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
Query: 917 AE----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVK 970
A + + +L + + + P S ++D L DP +RLG ++
Sbjct: 391 ARGEKVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447
Query: 971 AHPFFKGVNWDSLALQK--AVFVPQPESVDDTSYF-LSRFSQI--SSGLPDDQNGSYSDA 1025
HP F+ ++W L FVP +V + + FS + + D + +
Sbjct: 448 THPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTE-FFQEF 506
Query: 1026 DTCDSSSNSRTEMDECGDLAEF 1047
+ + EM E G +
Sbjct: 507 ASGTCPIPWQEEMIETGVFGDL 528
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 360 bits (925), Expect = e-111
Identities = 113/394 (28%), Positives = 175/394 (44%), Gaps = 57/394 (14%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
E+ F K+ E+ + + + +++DF + + I RG FG
Sbjct: 152 EICQNLRGDVFQKFIESDK--------FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFG 203
Query: 702 RVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFT 758
V+ RK TG ++A+K L K + K L ER +L V PF+V Y+F
Sbjct: 204 EVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262
Query: 759 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 818
D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+RDLKP N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 819 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 878
+L+ GH++++D GL+ H++VGT
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKP-----------------------------HASVGT 353
Query: 879 PDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNILNRKIPW 934
Y+APE+L G + +ADW+S+G +LF+ + G PF I L +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 413
Query: 935 PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK--AVF 990
P S E + L+ L D N+RLG GA EVK PFF+ ++W + LQK
Sbjct: 414 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470
Query: 991 VPQPESVD-----DTSYFLSRFSQISSGLPDDQN 1019
+P V+ D F ++ L DQ
Sbjct: 471 IPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQE 504
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-110
Identities = 126/490 (25%), Positives = 197/490 (40%), Gaps = 65/490 (13%)
Query: 633 LREKYILACELLDEKSPTSFSKYKENSRLILDSVSQ--------SSGVSTPLHSSHKERT 684
+ + + C E+ P ++E +RL + +S S + L ER
Sbjct: 121 VPRQLVTNCTQRLEQGPCK-DLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ 179
Query: 685 --SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
+ + F + + +G FG V + R TG ++A K L+K + ++ L E+ IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQIL 238
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLA 800
V + FVV Y++ +D L LV+ +NGGDL + +G E A Y AE+
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
LE LH IV+RDLKP+N+L+ GHI+++D GL+ TI
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---------------- 342
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-- 918
VGT Y+APE++ + ++ DWW++G +L+E I G PF
Sbjct: 343 ------------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390
Query: 919 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPF 974
E + + + S +A+ L ++ L DP +RLG A EVK HP
Sbjct: 391 KIKREEVERLVKEVPEEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
Query: 975 FKGVNWDSLALQKAV--FVPQPESVD--DTSYFLSRFSQISSGL-PDDQNGSYSDADTCD 1029
FK +N+ L F P P+++ D + L P DQ+ Y T
Sbjct: 448 FKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQD-FYQKFATGS 506
Query: 1030 SSSNSRTEMDECGDLAEF------GSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDST 1083
+ EM E E GS P DL + + +
Sbjct: 507 VPIPWQNEMVETECFQELNVFGLDGSVPPDLDWKGQP--PAPPKKGLLQRLFSRQDSSGN 564
Query: 1084 RSSPAKDAGT 1093
S ++ T
Sbjct: 565 SSDSEEELPT 574
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 324 bits (834), Expect = e-103
Identities = 95/309 (30%), Positives = 152/309 (49%), Gaps = 36/309 (11%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAE 738
S K + +++DFEI +P+ +G FG V+LAR++ + + A+K VL K + + ++ E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGVEHQLRRE 59
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
I +R+P ++R + F +YL++EY G +Y L+K+ +E YI EL
Sbjct: 60 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 799 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
AL Y HS ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---------------------- 157
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918
+ R GT DYL PE++ G H D WS+G++ +EF+ G PPF A
Sbjct: 158 -------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
Query: 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ + + I + + P ++ A+DLI+R L H+P+QR EV HP+
Sbjct: 211 TYQETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITAN 264
Query: 979 NWDSLALQK 987
+ Q
Sbjct: 265 SSKPSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-103
Identities = 94/303 (31%), Positives = 153/303 (50%), Gaps = 36/303 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE 733
T L K + +IDDF+I +P+ +G FG V+LAR++ + A+K VL K + ++
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALK-VLFKSQLEKEGVEH 59
Query: 734 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 793
++ E I +R+P ++R + F R +YL++E+ G+LY L+K G +E + +
Sbjct: 60 QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 119
Query: 794 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+ EL AL Y H ++HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV----------------- 162
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913
+ R + GT DYL PE++ G H D W G++ +EF+ G+P
Sbjct: 163 ------------HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
Query: 914 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
PF + S I+N + + P +S ++DLI++ L + P QRL V HP
Sbjct: 211 PFDSPSHTETHRRIVNVDLKF---PPFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHP 264
Query: 974 FFK 976
+ K
Sbjct: 265 WVK 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 3e-89
Identities = 72/362 (19%), Positives = 141/362 (38%), Gaps = 77/362 (21%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723
D +S S + ++ I+D+ II+ +++G F ++ L K +A+K +K
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALK-KYEK 64
Query: 724 LDMIRK--------------NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 769
+ +K + + E I+ ++N + + T D +Y++ EY
Sbjct: 65 SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124
Query: 770 LNGGDLYSLLRKVGCLE--------EDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLL 820
+ + L+ V + I ++ + Y+H+ I HRD+KP N+L
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184
Query: 821 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 880
+ +G +KL+DFG S+ ++ + GT +
Sbjct: 185 MDKNGRVKLSDFGESEY-----------------------------MVDKKIKGSRGTYE 215
Query: 881 YLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWPCV 937
++ PE +G D WS+GI L+ + PF+ + S +F+NI + I +P
Sbjct: 216 FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLD 275
Query: 938 PSD----------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981
+ +S E D + FL +P +R+ + + H + N +
Sbjct: 276 RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIE 332
Query: 982 SL 983
L
Sbjct: 333 DL 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 4e-89
Identities = 89/313 (28%), Positives = 146/313 (46%), Gaps = 39/313 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DFE I + +GAFG+V AR +AIK++ + + IL+E +L ++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLN 60
Query: 747 NPFVVRFFYSFTCRDN-------------LYLVMEYLNGGDLYSLLRKVGC-LEEDVARI 792
+ +VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
+++ AL Y+HS GI+HRDLKP N+ I ++K+ DFGL+K ++ ++D+ ++
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN--VHRSLDILKLDSQ 178
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 911
+ S N SA+GT Y+A E+L GT H D +S+GII FE I
Sbjct: 179 NLPGSS-----------DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226
Query: 912 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970
P T I + + I +P + + +I + HDPN+R GA +
Sbjct: 227 -PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLL 282
Query: 971 AHPFFKGVNWDSL 983
+ + D +
Sbjct: 283 NSGWLPVKHQDEV 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-84
Identities = 85/337 (25%), Positives = 131/337 (38%), Gaps = 44/337 (13%)
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHS-SHKERTSIDDFEIIKPISRGAFGR 702
L ++ S ++ R + S + +P + S E F+ + + G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 703 VFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 761
VF R + G L+A+K+ D R LAE V ++P VR ++
Sbjct: 73 VFKVRSKEDGRLYAVKRS--MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 762 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 820
LYL E G L G L E Y+ + +LAL +LHS G+VH D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 821 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 880
+ G KL DFGL L G P
Sbjct: 190 LGPRGRCKLGDFGLLVE--------LGTAGA--------------------GEVQEGDPR 221
Query: 881 YLAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTAESPEIIFDNILNRKIPWPCVPS 939
Y+APE+L G +G AAD +S+G+ + E + P E + + L P +
Sbjct: 222 YMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----PEFTA 275
Query: 940 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+S E + ++ L DP R A + A P +
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAE---ALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 270 bits (694), Expect = 2e-83
Identities = 81/299 (27%), Positives = 148/299 (49%), Gaps = 35/299 (11%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAE 738
+ I+DF++ + +G+F V+ A TG AIK ++ K M + ++R+ E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQRVQNE 61
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAEL 797
I +++P ++ + F + +YLV+E + G++ L+ +V E+ AR ++ ++
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ + YLHS GI+HRDL NLL+ + +IK+ DFGL+
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA---------------------- 159
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917
+ + ++ GTP+Y++PEI + HG +D WS+G + + + G PPF
Sbjct: 160 -TQL----KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214
Query: 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
++ + + ++ +PS +S EA+DLI++ L +P RL + V HPF
Sbjct: 215 DTVKNTLNKVVLADYE---MPSFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMS 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 3e-81
Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 34/296 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
+ S + + + +G F + F T ++FA K ++ K +++ + E++ E +
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEIS 67
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
I ++ + VV F F D +++V+E L L ++ L E AR Y+ ++VL
Sbjct: 68 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG 127
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV---------------- 165
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ D + GTP+Y+APE+L H + D WS+G I++ + G PPF
Sbjct: 166 -----EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ + I + P ++ A LI + L DP R E+ FF
Sbjct: 221 KETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---TINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 5e-81
Identities = 75/312 (24%), Positives = 133/312 (42%), Gaps = 34/312 (10%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL 724
++ + + + S + + + +G F + F T ++FA K ++ K
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKS 77
Query: 725 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 784
+++ + E++ E +I ++ + VV F F D +++V+E L L ++
Sbjct: 78 LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA 137
Query: 785 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844
L E AR Y+ ++VL +YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV 191
Query: 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 904
+ D + GTP+Y+APE+L H + D WS+G I
Sbjct: 192 ---------------------EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 905 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 964
++ + G PPF + + I + P ++ A LI + L DP R
Sbjct: 231 MYTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP--- 284
Query: 965 GAAEVKAHPFFK 976
E+ FF
Sbjct: 285 TINELLNDEFFT 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 3e-78
Identities = 77/311 (24%), Positives = 150/311 (48%), Gaps = 38/311 (12%)
Query: 668 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI 727
SSGV + + + S++ + ++ I G+FG+ L + G + IK++ + +
Sbjct: 7 HSSGVDLGTENLYFQ--SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRM 62
Query: 728 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCL 785
+ E E +L +++P +V++ SF +LY+VM+Y GGDL+ + +K
Sbjct: 63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122
Query: 786 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845
+ED + ++ LAL+++H I+HRD+K N+ + DG ++L DFG++++ +N+T++
Sbjct: 123 QEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVE 180
Query: 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 905
L+ + +GTP YL+PEI + +D W++G +L
Sbjct: 181 LA-------------------------RACIGTPYYLSPEICENKPYNNKSDIWALGCVL 215
Query: 906 FEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965
+E T F A S + + I++ P V S++ + L+++ +P R N
Sbjct: 216 YELCTLKHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPSVN- 272
Query: 966 AAEVKAHPFFK 976
+ F
Sbjct: 273 --SILEKGFIA 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-76
Identities = 82/326 (25%), Positives = 132/326 (40%), Gaps = 50/326 (15%)
Query: 667 SQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL 724
SSGV + + + S+ + I+K I G +VF ++AIK V L
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYV--NL 62
Query: 725 DMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 782
+ ++ E L ++ + ++R + +Y+VME DL S L+K
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 121
Query: 783 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
++ + Y ++ A+ +H GIVH DLKP N LI DG +KL DFG++
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIAN------ 174
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----------E 891
M D T + + S VGT +Y+ PE + +
Sbjct: 175 -----------QMQPD--------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 892 HGYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLIN 950
+D WS+G IL+ G PF +I I++ P + QD++
Sbjct: 216 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLK 274
Query: 951 RFLIHDPNQRLGANGAAEVKAHPFFK 976
L DP QR+ E+ AHP+ +
Sbjct: 275 CCLKRDPKQRISIP---ELLAHPYVQ 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-73
Identities = 81/304 (26%), Positives = 144/304 (47%), Gaps = 45/304 (14%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
+ +D+E++ I G++GR R+++ G + K++ + + + + +++E N+L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLR 60
Query: 744 TVRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAEL 797
+++P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 798 VLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
LAL+ H ++HRDLKP N+ + ++KL DFGL++I +N+ +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA----- 173
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912
+ VGTP Y++PE + + +D WS+G +L+E +
Sbjct: 174 --------------------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972
PPFTA S + + I K +P S E ++I R L R E+ +
Sbjct: 214 PPFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILEN 268
Query: 973 PFFK 976
P
Sbjct: 269 PLIL 272
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 3e-73
Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 48/303 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR- 746
+ I+K I G +VF ++AIK V L+ ++ E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 747 -NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+ ++R + +Y+VME DL S L+K ++ + Y ++ A+ +H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
GIVH DLKP N LI DG +KL DFG++ M D
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIAN-----------------QMQPD------- 160
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGT-----------EHGYAADWWSVGIILFEFITGIPP 914
T + + S VGT +Y+ PE + + +D WS+G IL+ G P
Sbjct: 161 -TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
Query: 915 FTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
F +I I++ P + QD++ L DP QR+ E+ AHP
Sbjct: 220 FQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIP---ELLAHP 275
Query: 974 FFK 976
+ +
Sbjct: 276 YVQ 278
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 247 bits (631), Expect = 4e-73
Identities = 84/345 (24%), Positives = 135/345 (39%), Gaps = 50/345 (14%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFL 705
S + + R +DS + SS E S+ + I+K I G +VF
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ 74
Query: 706 ARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNL 763
++AIK V L+ ++ E L ++ + ++R + +
Sbjct: 75 VLNEK-KQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131
Query: 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823
Y+VME DL S L+K ++ + Y ++ A+ +H GIVH DLKP N LI
Sbjct: 132 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 824 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 883
DG +KL DFG++ M D T + + S VG +Y+
Sbjct: 190 DGMLKLIDFGIAN-----------------QMQPD--------TTSVVKDSQVGAVNYMP 224
Query: 884 PEILLGT-----------EHGYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRK 931
PE + + +D WS+G IL+ G PF +I I++
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
P + QD++ L DP QR+ E+ AHP+ +
Sbjct: 285 HEIE-FPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 325
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 6e-72
Identities = 71/309 (22%), Positives = 132/309 (42%), Gaps = 40/309 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
+ DFE I+ + RG FG VF A+ + +AIK++ +L R+ E+++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPN-RELAREKVMREVKALAKL 60
Query: 746 RNPFVVRFFYSFTCRDN------------LYLVMEYLNGGDLYSLLRK---VGCLEEDVA 790
+P +VR+F ++ ++ LY+ M+ +L + + E V
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 791 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850
++ A+E+LHS G++HRDLKP N+ D +K+ DFGL ++
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQD------- 171
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
+ VGT Y++PE + G + + D +S+G+ILFE +
Sbjct: 172 ------EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
Query: 911 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970
P T ++ R + +P + + ++ L P +R A +
Sbjct: 226 --PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI---NII 278
Query: 971 AHPFFKGVN 979
+ F+ ++
Sbjct: 279 ENAVFEDLD 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 1e-71
Identities = 82/356 (23%), Positives = 137/356 (38%), Gaps = 73/356 (20%)
Query: 668 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLK-KLD 725
S L+ + + + I +G++G V +A + T + AIK + K K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 726 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 785
I D+ERI E ++ + +P + R + + + LVME +GG L L
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 786 E----------------------------------------EDVARIYIAELVLALEYLH 805
E + + ++ AL YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 806 SLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
+ GI HRD+KP+N L + + IKL DFGLSK + +
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-----------------------FYK 222
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 921
+ + GTP ++APE+L T Y D WS G++L + G PF +
Sbjct: 223 LNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282
Query: 922 IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+LN+K+ + + +S A+DL++ L + ++R A HP+
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF---DAMRALQHPWIS 335
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-71
Identities = 92/299 (30%), Positives = 142/299 (47%), Gaps = 48/299 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
F ++ + GAF VFL ++R TG LFA+K + K + E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS----PAFRDSSLENEIAVLKKIK 64
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+ +V + + YLVM+ ++GG+L+ + + G E A + I +++ A++YLH
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
GIVHRDLKP+NLL + I +TDFGLSK+ E +GIM
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM------------EQNGIM-------- 164
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +
Sbjct: 165 ---------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215
Query: 924 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
F+ I W + S A+D I L DPN+R + +HP+ G
Sbjct: 216 FEKIKEGYYEFESPFWDDI----SESAKDFICHLLEKDPNERY---TCEKALSHPWIDG 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-71
Identities = 84/320 (26%), Positives = 141/320 (44%), Gaps = 51/320 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D++++ + + +GAF V +TTG FA K + K + D +++ E I ++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQKLEREARICRKLQ 63
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
GIVHR+LKP+NLL+A +KL DFGL+ ++
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE------VN------------------ 159
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
D+ H GTP YL+PE+L + D W+ G+IL+ + G PPF E +
Sbjct: 160 ----DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215
Query: 924 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ I W V + EA+ LI+ L +P +R+ A + P+
Sbjct: 216 YAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN- 267
Query: 979 NWDSLALQKAVFVPQPESVD 998
+ A + + ++VD
Sbjct: 268 -----RERVASAIHRQDTVD 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 3e-71
Identities = 81/299 (27%), Positives = 131/299 (43%), Gaps = 46/299 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + I+ + +G+FG V + R T +A+K + K + D IL E +L +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKDTSTILREVELLKKLD 79
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-------------------------- 173
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
N +GT Y+APE+L GT + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 --FQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
Query: 924 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+ K W + S +A+DLI + L P+ R+ A + HP+ +
Sbjct: 231 LKRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQK 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 6e-71
Identities = 81/311 (26%), Positives = 140/311 (45%), Gaps = 45/311 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D ++ + + +G+FG V L + + TG A+K + K+ + +K D E +L E +L +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR-QVKQKTDKESLLREVQLLKQLD 84
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P +++ + F + YLV E GG+L+ + E A I +++ + Y+H
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
IVHRDLKP+NLL+ D +I++ DFGLS
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-------------------------- 178
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
++ +GT Y+APE+L G + D WS G+IL+ ++G PPF + I
Sbjct: 179 --FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235
Query: 924 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ K W V S A+DLI + L + P+ R+ A + H + +
Sbjct: 236 LKKVEKGKYTFELPQWKKV----SESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTY 288
Query: 979 NWDSLALQKAV 989
+ +++
Sbjct: 289 TKEQISVDVPS 299
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-70
Identities = 83/322 (25%), Positives = 137/322 (42%), Gaps = 46/322 (14%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK 723
S++ + T D +++ + + +GAF V +TTG FA K + K
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65
Query: 724 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 783
+ D +++ E I +++P +VR S YLV + + GG+L+ +
Sbjct: 66 K--LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123
Query: 784 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLI 840
E A I +++ ++ Y HS GIVHR+LKP+NLL+A +KL DFGL+
Sbjct: 124 FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--- 180
Query: 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 900
++ D+ H GTP YL+PE+L + D W+
Sbjct: 181 ---VN----------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215
Query: 901 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 955
G+IL+ + G PPF E ++ I W V + EA+ LI+ L
Sbjct: 216 CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTV 271
Query: 956 DPNQRLGANGAAEVKAHPFFKG 977
+P +R+ A + P+
Sbjct: 272 NPKKRI---TADQALKVPWICN 290
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-70
Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 42/297 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D F + + GAFG V L +R++G IK + K + +E+I AE +L ++
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLD 78
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLLRKVGCLEEDVARIYIAELVLALE 802
+P +++ F F N+Y+VME GG+L S + L E + +++ AL
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 803 YLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
Y HS +VH+DLKP+N+L IK+ DFGL+++
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---------------------- 176
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919
+ + +A GT Y+APE+ + + D WS G++++ +TG PFT S
Sbjct: 177 ------FKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229
Query: 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
E + ++ + ++ +A DL+ + L DP +R AA+V H +FK
Sbjct: 230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFK 283
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 4e-70
Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 46/301 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + I+ + +G+FG V + R T +A+K + K + D IL E +L +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA--SAKNKDTSTILREVELLKKLD 79
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-------------------------- 173
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
N +GT Y+APE+L G + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 --FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
Query: 924 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ K W + S +A+DLI + L P+ R+ A + HP+ +
Sbjct: 231 LKRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKY 283
Query: 979 N 979
+
Sbjct: 284 S 284
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 6e-70
Identities = 76/301 (25%), Positives = 130/301 (43%), Gaps = 37/301 (12%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM 726
++ +F I K I RG F V+ A G A+K+V + D+
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDL 70
Query: 727 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--- 783
+ + E ++L + +P V++++ SF + L +V+E + GDL +++
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 784 -CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
+ E Y +L ALE++HS ++HRD+KP N+ I G +KL D GL + ++
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSS 188
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902
HS VGTP Y++PE + + + +D WS+G
Sbjct: 189 KTTA-------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 903 IILFEFITGIPPFTAESPEI--IFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQ 959
+L+E PF + + + I P +PSD S E + L+N + DP +
Sbjct: 224 CLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEK 281
Query: 960 R 960
R
Sbjct: 282 R 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-69
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + I RG++G V +A ++ T A K++ K D++R E I+ ++
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRFKQEIEIMKSLD 64
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P ++R + +F ++YLVME GG+L+ + E A + +++ A+ Y H
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
L + HRDLKP+N L D +KL DFGL+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-------------------------- 158
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+ + VGTP Y++P++L G +G D WS G++++ + G PPF+A + +
Sbjct: 159 --FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215
Query: 924 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
I W V S +A+ LI R L P QR+ + + H +F+
Sbjct: 216 MLKIREGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-69
Identities = 87/326 (26%), Positives = 137/326 (42%), Gaps = 48/326 (14%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLK-K 723
S S G L + + D +E+ + I +G F V R TG FA+K V K
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 724 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLL 779
E + E +I +++P +V +++ LY+V E+++G DL
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 780 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSK 836
E VA Y+ +++ AL Y H I+HRD+KP +L+A +KL FG++
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 896
+ SG G VGTP ++APE++ +G
Sbjct: 182 Q------LGESGLVAGGR---------------------VGTPHFMAPEVVKREPYGKPV 214
Query: 897 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINR 951
D W G+ILF ++G PF +F+ I+ K W + S A+DL+ R
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI----SESAKDLVRR 269
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKG 977
L+ DP +R+ E HP+ K
Sbjct: 270 MLMLDPAERI---TVYEALNHPWLKE 292
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 6e-69
Identities = 89/343 (25%), Positives = 150/343 (43%), Gaps = 50/343 (14%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLK 722
+ Q +TP ++ + + ++ +K + GA+G V L R + T AIK + K
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK 72
Query: 723 KLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 782
+ + ++L E +L + +P +++ + F + N YLVME GG+L+ +
Sbjct: 73 T--SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130
Query: 783 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGL 839
E A + I +++ + YLH IVHRDLKP+NLL+ D IK+ DFGLS +
Sbjct: 131 MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-- 188
Query: 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 899
+ + +GT Y+APE+L ++ D W
Sbjct: 189 --------------------------FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVW 221
Query: 900 SVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLI 954
S+G+ILF + G PPF ++ + I + K W V S A+DLI + L
Sbjct: 222 SIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----SEGAKDLIKQMLQ 277
Query: 955 HDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 997
D +R+ A + HP+ K + + +P +
Sbjct: 278 FDSQRRI---SAQQALEHPWIKE---MCSKKESGIELPSLANA 314
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 8e-69
Identities = 63/313 (20%), Positives = 123/313 (39%), Gaps = 64/313 (20%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
++ DF+ I+ I G FG+VF A+ R G + IK+ ++ N+ E+ E
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-------VKYNN-EKAEREVKA 57
Query: 742 LITVRNPFVVRFFYSF----------------TCRDNLYLVMEYLNGGDLYSLL--RKVG 783
L + + +V + + + L++ ME+ + G L + R+
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 784 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843
L++ +A ++ ++Y+HS +++RDLKP N+ + +K+ DFGL + N
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKND 175
Query: 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903
R + GT Y++PE + ++G D +++G+
Sbjct: 176 GK--------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209
Query: 904 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963
IL E + TA F ++ + I + + L+ + L P R
Sbjct: 210 ILAELLH--VCDTAFETSKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPEDRPNT 262
Query: 964 NGAAEVKAHPFFK 976
+ E+
Sbjct: 263 S---EILRTLTVW 272
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-68
Identities = 75/320 (23%), Positives = 136/320 (42%), Gaps = 53/320 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK---------LDMIRKNDIERILA 737
+ + ++ + GA+G V L +++ AIK + K + + E I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
E ++L ++ +P +++ F F + YLV E+ GG+L+ + +E A + ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+ + YLH IVHRD+KP+N+L+ + +IK+ DFGLS
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF----------------- 198
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
+ + +GT Y+APE+L ++ D WS G+I++ + G PP
Sbjct: 199 -----------FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 915 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969
F ++ + I + K W + S EA++LI L +D N+R A E
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNI----SDEAKELIKLMLTYDYNKRC---TAEEA 299
Query: 970 KAHPFFKGVNWDSLALQKAV 989
+ K + +
Sbjct: 300 LNSRWIKKYANNINKSDQKT 319
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-68
Identities = 78/299 (26%), Positives = 136/299 (45%), Gaps = 44/299 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+++++ + + +GAF V K G +A + K + D +++ E I ++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK--KLSARDHQKLEREARICRLLK 68
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
+G+VHR+LKP+NLL+A +KL DFGL+
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--------------------------- 161
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+ + + GTP YL+PE+L +G D W+ G+IL+ + G PPF E +
Sbjct: 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221
Query: 924 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+ I W V + EA+DLIN+ L +P++R+ AAE HP+
Sbjct: 222 YQQIKAGAYDFPSPEWDTV----TPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-68
Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 52/314 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLK-KLDMIRKNDI----ERILAERNI 741
+++E + + RG V + T +A+K + ++ E L E +I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 742 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ----------------------- 173
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 914
GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 174 -----LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 915 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969
F ++ I++ W S +DL++RFL+ P +R A E
Sbjct: 229 FWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVVQPQKRY---TAEEA 281
Query: 970 KAHPFFKGVNWDSL 983
AHPFF+ + +
Sbjct: 282 LAHPFFQQYVVEEV 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-68
Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 47/306 (15%)
Query: 684 TSIDDF-EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK--LDMIRKNDIERILAERN 740
+ ++D E+ + + G F V R++ TG +A K + K+ R E I E N
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
IL +R+P ++ F + ++ L++E ++GG+L+ L + L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 801 LEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+ YLHS I H DLKP+N+++ + IKL DFG++ I +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKN-------- 170
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916
GTP+++APEI+ G AD WS+G+I + ++G PF
Sbjct: 171 ------------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212
Query: 917 AESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971
E+ + NI + S A+D I R L+ DP +R+ A+
Sbjct: 213 GETKQETLTNISAVNYDFDEEYFSNT----SELAKDFIRRLLVKDPKRRM---TIAQSLE 265
Query: 972 HPFFKG 977
H + K
Sbjct: 266 HSWIKA 271
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 4e-68
Identities = 87/303 (28%), Positives = 145/303 (47%), Gaps = 44/303 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK----LDMIRKNDIERILAERNIL 742
D++ + K + GA G V LA +R T AI+ + K+ + + E IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+ +P +++ F ++ Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 803 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 291
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFT 916
+ + GTP YLAPE+L+ A D WS+G+ILF ++G PPF+
Sbjct: 292 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 917 AES-PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
+ D I + K + +++S +A DL+ + L+ DP R E HP+
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPW 402
Query: 975 FKG 977
+
Sbjct: 403 LQD 405
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 4e-68
Identities = 80/316 (25%), Positives = 140/316 (44%), Gaps = 46/316 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK--LDMIRKNDIERILAERNILIT 744
D ++I + + G F V R+++TG +A K + K+ R E I E +IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
V + V+ + R ++ L++E ++GG+L+ L + L E+ A +I +++ + YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 805 HSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
H+ I H DLKP+N+++ HIKL DFGL+ I
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE----------------IEDGVEF 175
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 176 K------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 921 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ NI + + S A+D I + L+ + +RL E HP+
Sbjct: 224 QETLANITSVSYDFDEEFFSHT----SELAKDFIRKLLVKETRKRL---TIQEALRHPWI 276
Query: 976 KGVNWDSLALQKAVFV 991
V+ +++ V
Sbjct: 277 TPVDNQQAMVRRESVV 292
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 7e-68
Identities = 91/316 (28%), Positives = 144/316 (45%), Gaps = 52/316 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK----LDMIRKNDIERILAERNIL 742
D++ + K + GA G V LA +R T AIK + K+ + + E IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+ +P +++ F D Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 803 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 166
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFT 916
+ + GTP YLAPE+L+ + A D WS+G+ILF ++G PPF+
Sbjct: 167 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220
Query: 917 AES-PEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970
+ D I + K W V S +A DL+ + L+ DP R E
Sbjct: 221 EHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARF---TTEEAL 273
Query: 971 AHPFFKGVNWDSLALQ 986
HP+ + +
Sbjct: 274 RHPWLQDEDMKRKFQD 289
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-67
Identities = 79/316 (25%), Positives = 141/316 (44%), Gaps = 46/316 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK--LDMIRKNDIERILAERNILIT 744
D ++ + + G F V R+++TG +A K + K+ R E I E +IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 805 HSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
HSL I H DLKP+N+++ IK+ DFGL+ I +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----------------IDFGNEF 174
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 175 ------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222
Query: 921 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ N+ + S A+D I R L+ DP +R+ + HP+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNT----SALAKDFIRRLLVKDPKKRM---TIQDSLQHPWI 275
Query: 976 KGVNWDSLALQKAVFV 991
K + +KA V
Sbjct: 276 KPKDTQQALSRKASAV 291
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-67
Identities = 67/338 (19%), Positives = 117/338 (34%), Gaps = 77/338 (22%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
+ TS + + + +GA VF R + TGDLFAIK ++ + E
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFE 59
Query: 741 ILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIA 795
+L + + +V+ F T + L+ME+ G LY++L + L E I +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPET 851
++V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-------------- 165
Query: 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGI 903
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 --------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 904 ILFEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCV 937
+ TG PF ++ + I +
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 938 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ ++ L D + G + + A
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCWGFD---QFFAETSD 306
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 3e-67
Identities = 85/300 (28%), Positives = 144/300 (48%), Gaps = 37/300 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
S E+ I ++ ++K I +G F +V LAR TG AIK + K + ++++
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT--QLNPTSLQKLFR 63
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
E I+ + +P +V+ F LYL+MEY +GG+++ L G ++E AR ++
Sbjct: 64 EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
V A++Y H IVHRDLK +NLL+ D +IK+ DFG S
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN--------------------- 162
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 916
+ T + G P Y APE+ G + G D WS+G+IL+ ++G PF
Sbjct: 163 -------EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
Query: 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
++ + + + +L K +P MS + ++L+ RFL+ +P +R ++ +
Sbjct: 216 GQNLKELRERVLRGKYR---IPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWIN 269
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-67
Identities = 92/302 (30%), Positives = 141/302 (46%), Gaps = 50/302 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D FE+ + RGA V+ +++ T +A+K + K D + + E +L+ +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLS 106
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P +++ F + LV+E + GG+L+ + + G E A + +++ A+ YLH
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
GIVHRDLKP+NLL A D +K+ DFGLSKI E +M
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-----------EHQVLM-------- 207
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-I 922
+ GTP Y APEIL G +G D WSVGII + + G PF E +
Sbjct: 208 ---------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258
Query: 923 IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+F ILN + W V S A+DL+ + ++ DP +RL + HP+ G
Sbjct: 259 MFRRILNCEYYFISPWWDEV----SLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTG 311
Query: 978 VN 979
Sbjct: 312 KA 313
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-67
Identities = 81/324 (25%), Positives = 144/324 (44%), Gaps = 46/324 (14%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK--LDMIRKNDIERIL 736
+ K++ D ++I + + G F V R+++TG +A K + K+ R E I
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 737 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 796
E +IL V +P ++ + R ++ L++E ++GG+L+ L + L E+ A +I +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETD 852
++ + YLH+ I H DLKP+N+++ HIKL DFGL+
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------------- 168
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912
I + GTP+++APEI+ G AD WS+G+I + ++G
Sbjct: 169 -IEDGVEFK------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 913 PPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967
PF ++ + NI + S A+D I + L+ + +RL
Sbjct: 216 SPFLGDTKQETLANITAVSYDFDEEFFSQT----SELAKDFIRKLLVKETRKRL---TIQ 268
Query: 968 EVKAHPFFKGVNWDSLALQKAVFV 991
E HP+ V+ +++ V
Sbjct: 269 EALRHPWITPVDTQQAMVRRESVV 292
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-66
Identities = 89/326 (27%), Positives = 144/326 (44%), Gaps = 59/326 (18%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK-------------- 723
S + ++ + + I +G++G V LA +A+K + KK
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 724 --------LDMIRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGG 773
+ + IE++ E IL + +P VV+ D+LY+V E +N G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 774 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833
+ + L ED AR Y +L+ +EYLH I+HRD+KP NLL+ DGHIK+ DFG
Sbjct: 124 PVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 893
+S + + + VGTP ++APE L T
Sbjct: 183 VSNE---------------------------FKGSDALLSNTVGTPAFMAPESLSETRKI 215
Query: 894 Y---AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLIN 950
+ A D W++G+ L+ F+ G PF E + I ++ + +P P D++ + +DLI
Sbjct: 216 FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDLKDLIT 274
Query: 951 RFLIHDPNQRLGANGAAEVKAHPFFK 976
R L +P R+ E+K HP+
Sbjct: 275 RMLDKNPESRI---VVPEIKLHPWVT 297
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-66
Identities = 88/347 (25%), Positives = 136/347 (39%), Gaps = 51/347 (14%)
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 705
+ + + QS G L + ++ I RG V
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 706 ARKRTTGDLFAIKQVLKKLDMIRKNDI----ERILAERNILITVRN-PFVVRFFYSFTCR 760
R TG FA+K + + + + E E +IL V P ++ S+
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 820
++LV + + G+L+ L + L E R + L+ A+ +LH+ IVHRDLKP+N+L
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 821 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 880
+ + I+L+DFG S + P + GTP
Sbjct: 233 LDDNMQIRLSDFGFSCH----------------LEPGEKLR------------ELCGTPG 264
Query: 881 YLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-- 932
YLAPEIL + +G D W+ G+ILF + G PPF ++ I+ +
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 933 ---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
W S +DLI+R L DP RL A + HPFF+
Sbjct: 325 SSPEWDDR----SSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 2e-66
Identities = 70/299 (23%), Positives = 130/299 (43%), Gaps = 48/299 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + I + + RG FG V + ++ + K V + D + E +IL R
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIAR 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLH 805
+ ++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 806 SLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
S I H D++P+N++ IK+ +FG ++ + P D
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----------------LKPGDNF--- 160
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 161 ---------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211
Query: 924 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+NI+N + + + S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 212 IENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-66
Identities = 79/300 (26%), Positives = 139/300 (46%), Gaps = 36/300 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
S H R I + + + G FG+V + + TG A+K +L + + + + +I
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKR 60
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
E L R+P +++ + + + ++VMEY++GG+L+ + K G +EE AR ++
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ A++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------------------- 160
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 916
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 161 --------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
Query: 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
E +F I +P ++ L+ L DP +R +++ H +FK
Sbjct: 213 DEHVPTLFKKIRGGVFY---IPEYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFK 266
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-65
Identities = 69/301 (22%), Positives = 121/301 (40%), Gaps = 37/301 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
++ R + + RG+FG V + + TG A+K+V +L++ R ++
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVEELV---- 102
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
+ +P +V + + + + ME L GG L L++++GCL ED A Y+ +
Sbjct: 103 ---ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+ LEYLH+ I+H D+K DN+L++ DG L DFG + L +
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC--------LQPDGLGKSLL 211
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916
GT ++APE+++G D WS ++ + G P+T
Sbjct: 212 --------------TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
Query: 917 AESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ I + P +P + I L +P R A E++
Sbjct: 258 QYFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA---SAMELRRKVGK 313
Query: 976 K 976
Sbjct: 314 A 314
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-65
Identities = 80/329 (24%), Positives = 134/329 (40%), Gaps = 49/329 (14%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD 725
S + T + + + K + RG F V ++TG +A K + K+
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR- 66
Query: 726 MIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKV 782
++ IL E +L + P V+ + + L++EY GG+++SL
Sbjct: 67 -RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA 125
Query: 783 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGL 839
+ E+ I +++ + YLH IVH DLKP N+L++ G IK+ DFG+S+
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-- 183
Query: 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 899
I +GTP+YLAPEIL A D W
Sbjct: 184 ----IG----------------------HACELREIMGTPEYLAPEILNYDPITTATDMW 217
Query: 900 SVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLI 954
++GII + +T PF E + + NI + + V S A D I L+
Sbjct: 218 NIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQLATDFIQSLLV 273
Query: 955 HDPNQRLGANGAAEVKAHPFFKGVNWDSL 983
+P +R A +H + + ++++L
Sbjct: 274 KNPEKRP---TAEICLSHSWLQQWDFENL 299
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-65
Identities = 84/324 (25%), Positives = 138/324 (42%), Gaps = 56/324 (17%)
Query: 668 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM 726
Q+ GV + + H+ D +E+ + I G++ + T FA+K + K
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---- 57
Query: 727 IRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 785
K D E IL+ P ++ + +Y+V E + GG+L + +
Sbjct: 58 -SKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF 113
Query: 786 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLIN 841
E A + + +EYLH+ G+VHRDLKP N+L + I++ DFG +K
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--- 170
Query: 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 901
+ +N + T +++APE+L + A D WS+
Sbjct: 171 ------------------------RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSL 206
Query: 902 GIILFEFITGIPPFTA---ESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFL 953
G++L+ +TG PF ++PE I I + K W V S A+DL+++ L
Sbjct: 207 GVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDLVSKML 262
Query: 954 IHDPNQRLGANGAAEVKAHPFFKG 977
DP+QRL AA V HP+
Sbjct: 263 HVDPHQRL---TAALVLRHPWIVH 283
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-65
Identities = 82/335 (24%), Positives = 135/335 (40%), Gaps = 57/335 (17%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVV 751
KP+ G+F + + FA+K +I K E L P +V
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVK-------IISKRMEANTQKEITALKLCEGHPNIV 69
Query: 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 811
+ F + + +LVME LNGG+L+ ++K E A + +LV A+ ++H +G+VH
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 812 RDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 868
RDLKP+NLL + IK+ DFG +++ + D
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARL---------------------------KPPD 162
Query: 869 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPE 921
N+ + T Y APE+L + + D WS+G+IL+ ++G PF + S
Sbjct: 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222
Query: 922 IIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
I I W V S EA+DLI L DPN+RL + ++ + + +
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNV----SQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQ 275
Query: 977 GVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1011
+ S + + + F +
Sbjct: 276 DGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFN 310
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 7e-65
Identities = 45/353 (12%), Positives = 100/353 (28%), Gaps = 88/353 (24%)
Query: 670 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK 729
+G + S ER + + A + TG+ F + V +
Sbjct: 58 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVH-VPYFTERPPS 114
Query: 730 NDIE-------------------------RILAERNILITVRNPFVVRFFYSFTCRD--N 762
N I+ R + +++ + ++R +
Sbjct: 115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 174
Query: 763 LYLVMEYLN------GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 816
+ + + G L S L +++ L LH G+VH L+P
Sbjct: 175 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 234
Query: 817 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 876
++++ G + LT F + R +
Sbjct: 235 VDIVLDQRGGVFLTGFEHLV-------------------------------RDGARVVSS 263
Query: 877 GTPDYLAPEILL-----------GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
+ + PE+ T ++ D W++G++++ P T ++ +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE 323
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
I ++ + L+ FL + RL + P ++ +
Sbjct: 324 WIFRS-------CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 9e-65
Identities = 71/341 (20%), Positives = 136/341 (39%), Gaps = 48/341 (14%)
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVF 704
KY D + ++ S+ D ++I++ + GAFG V
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 705 LARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764
++ TG +F K + D + E +I+ + +P ++ +F + +
Sbjct: 69 RCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124
Query: 765 LVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823
L++E+L+GG+L+ + + + E Y+ + L+++H IVH D+KP+N++
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184
Query: 824 --DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 881
+K+ DFGL+ + P + T ++
Sbjct: 185 KKASSVKIIDFGLATK----------------LNPDEIV------------KVTTATAEF 216
Query: 882 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPC 936
APEI+ G+ D W++G++ + ++G+ PF E N+ +
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276
Query: 937 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
V S EA+D I L +P +RL + HP+ KG
Sbjct: 277 V----SPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKG 310
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-64
Identities = 66/326 (20%), Positives = 116/326 (35%), Gaps = 74/326 (22%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
+ TS + + + +GA VF R + TGDLFAIK + ++ + E +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEV 60
Query: 742 LITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAE 796
L + + +V+ F T + L+ME+ G LY++L + L E I + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
+V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------------- 165
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGII 904
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 -------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 905 LFEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVP 938
+ TG PF ++ + I +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 939 SDMSFEAQDLINRFLIHDPNQRLGAN 964
+ ++ L D + G +
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGFD 298
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 4e-64
Identities = 82/339 (24%), Positives = 132/339 (38%), Gaps = 51/339 (15%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK--LDM 726
G TP ++ + + +G FG VF + T AIK + + L
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72
Query: 727 IRKNDIERILAERNILITVRN----PFVVRFFYSFTCRDNLYLVMEY-LNGGDLYSLLRK 781
+D E +L V P V+R F ++ LV+E L DL+ + +
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 782 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 840
G L E +R + ++V A+++ HS G+VHRD+K +N+LI G KL DFG +
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--- 189
Query: 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 899
D Y GT Y PE + + H A W
Sbjct: 190 ---------------LHDEPY-----------TDFDGTRVYSPPEWISRHQYHALPATVW 223
Query: 900 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959
S+GI+L++ + G PF + IL ++ P+ +S + LI R L P+
Sbjct: 224 SLGILLYDMVCGDIPFERD------QEILEAELH---FPAHVSPDCCALIRRCLAPKPSS 274
Query: 960 RLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 998
R E+ P+ + + + L + P P +
Sbjct: 275 RP---SLEEILLDPWMQ-TPAEDVPLNPSKGGPAPLAWS 309
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 5e-64
Identities = 76/344 (22%), Positives = 141/344 (40%), Gaps = 48/344 (13%)
Query: 645 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRV 703
D + K D+ + + D ++I + + GAFG V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 704 FLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763
+R TG+ FA K V+ ++D E + E + +R+P +V +F + +
Sbjct: 174 HRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229
Query: 764 YLVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 822
++ E+++GG+L+ + + + ED A Y+ ++ L ++H VH DLKP+N++
Sbjct: 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 289
Query: 823 H--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 880
+KL DFGL+ ++ GT +
Sbjct: 290 TKRSNELKLIDFGLTA----------------------------HLDPKQSVKVTTGTAE 321
Query: 881 YLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWP 935
+ APE+ G GY D WSVG++ + ++G+ PF E+ + N+ + +
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 381
Query: 936 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979
+ S + +D I + L+ DPN R+ + HP+ N
Sbjct: 382 GI----SEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGN 418
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-63
Identities = 67/301 (22%), Positives = 118/301 (39%), Gaps = 38/301 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV- 745
+F ++ I G FG VF KR G ++AIK+ K + D + L E +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS--KKPLAGSVDEQNALREVYAHAVLG 68
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLAL 801
++ VVR+F ++ D++ + EY NGG L + R + +E + + ++ L
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMP 856
Y+HS+ +VH D+KP N+ I+ + +N + DL G +
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL------GHV- 181
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF 915
T + G +LA E+L H AD +++ + + P
Sbjct: 182 ----------TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231
Query: 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ I R+ P +P +S E +L+ + DP +R A + H
Sbjct: 232 RNGDQ---WHEI--RQGRLPRIPQVLSQEFTELLKVMIHPDPERRP---SAMALVKHSVL 283
Query: 976 K 976
Sbjct: 284 L 284
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 2e-63
Identities = 74/296 (25%), Positives = 136/296 (45%), Gaps = 40/296 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
++D+++++ + GA+G V LA R T + A+K ++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAV--DCPENIKKEICINKML 62
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL------------------- 163
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEII 923
+ GT Y+APE+L E H D WS GI+L + G P+
Sbjct: 164 ------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 924 FDNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ + +K PW + L+++ L+ +P+ R+ ++K ++
Sbjct: 218 YSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-63
Identities = 68/303 (22%), Positives = 137/303 (45%), Gaps = 47/303 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
+ + G FG+V + TG A K + + D E + E +++ + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDH 145
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+++ + +F ++++ LVMEY++GG+L+ ++ + L E +++ ++ + ++H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 807 LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+ I+H DLKP+N+L + IK+ DFGL++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARR--------------------------- 238
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
GTP++LAPE++ + D WSVG+I + ++G+ PF ++
Sbjct: 239 -YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297
Query: 925 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979
+NIL + + + S EA++ I++ LI + + R+ A+E HP+
Sbjct: 298 NNILACRWDLEDEEFQDI----SEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHK 350
Query: 980 WDS 982
S
Sbjct: 351 LHS 353
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-63
Identities = 75/339 (22%), Positives = 136/339 (40%), Gaps = 47/339 (13%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV---- 720
++ + + E + + P+ GAFG V+ A + +K +
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 721 LKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME-YLNGGDLYSLL 779
+ + I + ++ E IL V + +++ F + LVME + +G DL++ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 780 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839
+ L+E +A +LV A+ YL I+HRD+K +N++IA D IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-- 179
Query: 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADW 898
+ ++ GT +Y APE+L+G G +
Sbjct: 180 --------------------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 899 WSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 958
WS+G+ L+ + PF + + I P +S E L++ L P
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIH---PPYLVSKELMSLVSGLLQPVPE 264
Query: 959 QRLGANGAAEVKAHPFF-KGVNWDSLALQKAVFVPQPES 996
+R ++ P+ + VN ++ V +PES
Sbjct: 265 RRT---TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-63
Identities = 78/320 (24%), Positives = 132/320 (41%), Gaps = 48/320 (15%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKK--L 724
+ +T L ++ +++ + G FG V+ + + AIK V K
Sbjct: 23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82
Query: 725 DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEYLNG-GDLYSLLRK 781
D + R+ E +L V + V+R F D+ L++E DL+ + +
Sbjct: 83 DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 142
Query: 782 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 840
G L+E++AR + +++ A+ + H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--- 199
Query: 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 899
D Y GT Y PE + HG +A W
Sbjct: 200 ---------------LKDTVY-----------TDFDGTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 900 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959
S+GI+L++ + G PF E E I + +S E Q LI L P+
Sbjct: 234 SLGILLYDMVCGDIPF--EHDEEIIRGQVF-------FRQRVSSECQHLIRWCLALRPSD 284
Query: 960 RLGANGAAEVKAHPFFKGVN 979
R E++ HP+ + V
Sbjct: 285 RP---TFEEIQNHPWMQDVL 301
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 3e-62
Identities = 77/336 (22%), Positives = 123/336 (36%), Gaps = 67/336 (19%)
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERIL 736
S + +E+ + + G FG V + TG+ AIKQ ++L + ER
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWC 60
Query: 737 AERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEE 787
E I+ + +P VV D L MEY GGDL L + L+E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 788 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTI 844
R ++++ AL YLH I+HRDLKP+N+++ K+ D G +K
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE------- 173
Query: 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 904
VGT YLAPE+L ++ D+WS G +
Sbjct: 174 ---------------------LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212
Query: 905 LFEFITGIPPFTAESPEIIFDNILNRK--------------------IPWPC-VPSDMSF 943
FE ITG PF + + + K +P P + ++
Sbjct: 213 AFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272
Query: 944 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979
+ + + L+ QR + F+ ++
Sbjct: 273 KLERWLQCMLMWHQRQR---GTDPQNPNVGCFQALD 305
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-62
Identities = 81/349 (23%), Positives = 150/349 (42%), Gaps = 43/349 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
++D+++++ + GA+G V LA R T + A+K ++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAV--DCPENIKKEICINKML 62
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL------------------- 163
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF--TAESPEI 922
+ GT Y+APE+L E H D WS GI+L + G P+ ++S +
Sbjct: 164 ------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 923 IFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF-KGVN 979
D PW + L+++ L+ +P+ R+ ++K ++ K +
Sbjct: 218 YSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKPLK 270
Query: 980 WDSL--ALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 1026
+ + P FS ++S +G +
Sbjct: 271 KGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHH 319
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-62
Identities = 83/297 (27%), Positives = 143/297 (48%), Gaps = 37/297 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
+ I + I + + G+FG+V LA T A+K + + + + + R+ E +
Sbjct: 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVEREIS 61
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
L +R+P +++ + T ++ +V+EY GG+L+ + + + ED R + +++ A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+EY H IVHRDLKP+NLL+ + ++K+ DFGLS I
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI----------------------- 157
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 919
TD ++ G+P+Y APE++ G G D WS GI+L+ + G PF E
Sbjct: 158 -----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212
Query: 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+F + + +P +S AQ LI R ++ DP QR+ E++ P+F
Sbjct: 213 IPNLFKKVNSCVYV---MPDFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFN 263
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-61
Identities = 82/321 (25%), Positives = 137/321 (42%), Gaps = 61/321 (19%)
Query: 687 DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
D +++ + + GA RV T +A+K + K+ + R+ E +L
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQC 67
Query: 746 RN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
+ V+ F D YLV E + GG + S + K E A + + ++ AL++L
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 805 HSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
H+ GI HRDLKP+N+L H +K+ DF L I L+G +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG------IKLNGDCSP--------- 172
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFT 916
+ G+ +Y+APE++ + + D WS+G+IL+ ++G PPF
Sbjct: 173 -----ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
Query: 917 AE---------------SPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHD 956
++F++I K W + S A+DLI++ L+ D
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SCAAKDLISKLLVRD 283
Query: 957 PNQRLGANGAAEVKAHPFFKG 977
QRL AA+V HP+ +G
Sbjct: 284 AKQRL---SAAQVLQHPWVQG 301
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-61
Identities = 103/395 (26%), Positives = 165/395 (41%), Gaps = 53/395 (13%)
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD 725
+ ++ + PL D ++ +K I G FG L R + T +L A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHD--SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK-YIERGA 57
Query: 726 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 785
I +N ++R E ++R+P +VRF +L ++MEY +GG+LY + G
Sbjct: 58 AIDEN-VQR---EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF 113
Query: 786 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNT 843
ED AR + +L+ + Y HS+ I HRDLK +N L+ + +K+ DFG SK
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS------ 167
Query: 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVG 902
P S VGTP Y+APE+LL E G AD WS G
Sbjct: 168 ------SVLHSQP----------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205
Query: 903 IILFEFITGIPPFTAESPEIIFDNILNR------KIPWPCVPSDMSFEAQDLINRFLIHD 956
+ L+ + G PF + + R IP +S E LI+R + D
Sbjct: 206 VTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVAD 262
Query: 957 PNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS--GL 1014
P R+ E+K H +F N + + ++ Q + + L QI S +
Sbjct: 263 PATRI---SIPEIKTHSWFL-KNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATI 318
Query: 1015 PDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGS 1049
P +N D T + + + + + S
Sbjct: 319 PAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDS 353
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 2e-61
Identities = 63/379 (16%), Positives = 105/379 (27%), Gaps = 78/379 (20%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID----DFEIIKPISR 697
+LL + +E + V + P ++ + + ++++P+
Sbjct: 13 DLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV 72
Query: 698 GAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF--- 754
G VFL R + FA+K V ++++ER+ +
Sbjct: 73 GDRSVVFLVRDVERLEDFALK-VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 755 -----------------------YSFTCRDNLYLVMEYLNG--GDLYSLLRKV----GCL 785
N L+M + L+S L V G
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191
Query: 786 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845
I A+L+ L S G+VH PDNL I DG + L D
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--------- 242
Query: 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGI 903
++ Y E L +A + W +G+
Sbjct: 243 ---------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 904 ILFEFITGIPPFTAESPEIIFDNILN-----RKIPWP-CVPSDMSFEAQDLINRFLIHDP 957
++ PF +P I + + + LI RFL D
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR 341
Query: 958 NQRLGANGAAEVKAHPFFK 976
+RL E P F
Sbjct: 342 RRRL---LPLEAMETPEFL 357
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-61
Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 38/300 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
+ I+ + G F V L G +A+K++L + D E E ++ +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNH 85
Query: 748 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVL 799
P ++R +L++ + G L++ + ++ L ED + +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
LE +H+ G HRDLKP N+L+ +G L D G + +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ---------------ACIHVEG 190
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFT 916
D + T Y APE+ H D WS+G +L+ + G P+
Sbjct: 191 SRQALTLQDWAAQR---CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247
Query: 917 AESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
+ + ++ P S L+N + DP+QR + +
Sbjct: 248 MVFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIP---LLLSQLEA 303
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 5e-61
Identities = 75/300 (25%), Positives = 138/300 (46%), Gaps = 36/300 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
H R I + + + G FG+V + + TG A+K +L + + + + +I
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRR 65
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
E L R+P +++ + + ++++VMEY++GG+L+ + K G L+E +R ++
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ ++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------------------- 165
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 916
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 166 --------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
Query: 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ +F I + P ++ L+ L DP +R +++ H +FK
Sbjct: 218 DDHVPTLFKKICDGIFY---TPQYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFK 271
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 8e-61
Identities = 85/290 (29%), Positives = 133/290 (45%), Gaps = 44/290 (15%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ +G +G V+ R + AIK++ + + E + +++ +V++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI----PERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 755 YSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVH 811
SF+ + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVH
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 812 RDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 870
RD+K DN+LI + G +K++DFG SK L+G N
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKR--------LAG-------------------INP 178
Query: 871 NRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT--AESPEIIFDN 926
+ GT Y+APEI+ GY AAD WS+G + E TG PPF E +F
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-K 237
Query: 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ K+ P +P MS EA+ I + DP++R A ++ F K
Sbjct: 238 VGMFKVH-PEIPESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLK 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-60
Identities = 81/330 (24%), Positives = 135/330 (40%), Gaps = 66/330 (20%)
Query: 669 SSGVSTPLHSSHKERTSI-DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM 726
SSG+ ++ ++ DD+++ K + G G+V R TG A+K +
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 727 IRKNDIERILAERNILITVRNPFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLR 780
++ D + P +V + + L ++ME + GG+L+S R
Sbjct: 69 RQEVDHHWQAS--------GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 781 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKI 837
E A + ++ A+++LHS I HRD+KP+NLL D +KLTDFG +K
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897
T + TP Y+APE+L ++ + D
Sbjct: 181 -----------------------------TTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 898 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI----------PWPCVPSDMSFEAQD 947
WS+G+I++ + G PPF + + + I + R+I W V S +A+
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMK-RRIRLGQYGFPNPEWSEV----SEDAKQ 266
Query: 948 LINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
LI L DP +RL + HP+
Sbjct: 267 LIRLLLKTDPTERL---TITQFMNHPWINQ 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 3e-60
Identities = 74/298 (24%), Positives = 130/298 (43%), Gaps = 40/298 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE-RILAERNILIT 744
I + + + G++G+V T A+K +LKK + R + E + E +L
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 745 VRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLA 800
+R+ V++ + +Y+VMEY G + +L V A Y +L+
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
LEYLHS GIVH+D+KP NLL+ G +K++ G++ +
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA------EALH--------------- 160
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAE 918
+ ++ G+P + PEI G + G+ D WS G+ L+ TG+ PF +
Sbjct: 161 ----PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216
Query: 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ +F+NI +P D DL+ L ++P +R +++ H +F+
Sbjct: 217 NIYKLFENIGKGSYA---IPGDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-60
Identities = 50/369 (13%), Positives = 102/369 (27%), Gaps = 77/369 (20%)
Query: 670 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK 729
+G + S ER + + A + TG+ F + V +
Sbjct: 63 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVH-VPYFTERPPS 119
Query: 730 NDIERILAERNI---LITVRNP------------------------FVVRFFYSFTCRDN 762
N I+++ E L ++N VR +
Sbjct: 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179
Query: 763 LYLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 816
+ + + L S L +++ L LH G+VH L+P
Sbjct: 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 239
Query: 817 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 876
++++ G + LT F + P
Sbjct: 240 VDIVLDQRGGVFLTGFEHLVR-----------DGASAVSPI---------------GRGF 273
Query: 877 GTPDYLAPEILLGTEHG-----YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 931
P+ A +L +H +A D W++G+ ++ P T ++ + I
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS- 332
Query: 932 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFV 991
++ + L+ FL + RL + P ++ + + A
Sbjct: 333 ------CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLRTELSAALPLYQT 383
Query: 992 PQPESVDDT 1000
+ +
Sbjct: 384 DGEPTREGG 392
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-58
Identities = 58/289 (20%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
I RG+F V+ T A ++ + + K++ +R E +L +++P +VRF+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 755 YSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG-- 808
S+ + + LV E + G L + L++ ++ V R + +++ L++LH+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 809 IVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
I+HRDLK DN+ I G +K+ D GL+
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLAT-----------------------------LK 182
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
+ +GTP+++APE + ++ + D ++ G+ + E T P++
Sbjct: 183 RASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241
Query: 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ + E +++I + + ++R ++ H FF+
Sbjct: 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 67/349 (19%), Positives = 125/349 (35%), Gaps = 79/349 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV------------------LKKLD--- 725
DFE I+ + RG FG VF A+ + +AIK++ L KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 726 ---------------------------------MIRKNDIERILAERNILITVRNPFVVR 752
+ + ++ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGI 809
+ + LY+ M+ +L + + + E V ++ A+E+LHS G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
+HRDLKP N+ D +K+ DFGL ++ + T
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLTP-------------MPAY 230
Query: 870 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 929
VGT Y++PE + G + + D +S+G+ILFE + T I ++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV-- 286
Query: 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
R + +P + + + ++ L P +R A ++ + F+ +
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT---DIIENAIFENL 332
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 1e-58
Identities = 46/333 (13%), Positives = 94/333 (28%), Gaps = 69/333 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITV 745
+ + GAF +V+ A + D ++ LK + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----CLEEDVARIYIAELVLA 800
++F+ + ++ LV E + G L + + + + + + ++
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 801 LEYLHSLGIVHRDLKPDNLLIAH-----------DGHIKLTDFGLSKIGLINNTIDLSGP 849
+E +H I+H D+KPDN ++ + + L D G S ID+
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------IDMKLF 236
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909
I + T + E+L Y D++ V ++ +
Sbjct: 237 PKGTIF-----------------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279
Query: 910 TGIPPFTAESPEI------------------IFDNILNRKIPWPCVPSDMSFEAQDLINR 951
G F +LN +P + DL+ +
Sbjct: 280 FGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN-------IPDCHHLPSLDLLRQ 332
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984
L Q + + +
Sbjct: 333 KLKKVFQQHYTNKI--RALRNRLIVLLLECKRS 363
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-57
Identities = 83/350 (23%), Positives = 135/350 (38%), Gaps = 64/350 (18%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLA 706
P + + ++ Q K+ IDD+++ + + G G+V
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 707 RKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF--FY--SFTCRD 761
+ T + FA+K + R E + P +VR Y + R
Sbjct: 82 FNKRTQEKFALKMLQDCPKARR---------EVELHWRASQCPHIVRIVDVYENLYAGRK 132
Query: 762 NLYLVMEYLNGGDLYS--LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 819
L +VME L+GG+L+S R E A + + A++YLHS+ I HRD+KP+NL
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 192
Query: 820 LIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 876
L + +KLTDFG +K + + +
Sbjct: 193 LYTSKRPNAILKLTDFGFAKE-----------TTSHNSL-----------------TTPC 224
Query: 877 GTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----IFDNILNRKI 932
TP Y+APE+L ++ + D WS+G+I++ + G PPF + + I +
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 933 -----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
W V S E + LI L +P QR+ E HP+
Sbjct: 285 EFPNPEWSEV----SEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-56
Identities = 85/315 (26%), Positives = 140/315 (44%), Gaps = 44/315 (13%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
S+ + DD+E+ + I GA V A + AIK++ L+ + ++ +L
Sbjct: 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQ-TSMDELLK 62
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--------KVGCLEEDV 789
E + +P +V ++ SF +D L+LVM+ L+GG + +++ K G L+E
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 790 ARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849
+ E++ LEYLH G +HRD+K N+L+ DG +++ DFG+S + D
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGD---- 176
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEF 908
T N+ R + VGTP ++APE + + + AD WS GI E
Sbjct: 177 ----------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
Query: 909 ITGIPPFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRL 961
TG P+ P + L P + + +I+ L DP +R
Sbjct: 221 ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
Query: 962 GANGAAEVKAHPFFK 976
AAE+ H FF+
Sbjct: 281 ---TAAELLRHKFFQ 292
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-56
Identities = 81/291 (27%), Positives = 141/291 (48%), Gaps = 37/291 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ I G+ G V LAR++ +G A+K + D+ ++ E + E I+ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRDYQ 100
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+ VV + S+ + L+++ME+L GG L ++ +V EE +A + ++ AL YLH+
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV-CEAVLQALAYLHA 159
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
G++HRD+K D++L+ DG +KL+DFG Q
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCA----------------------------QI 191
Query: 867 TDNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
+ + R S VGTP ++APE++ + + D WS+GI++ E + G PP+ ++SP
Sbjct: 192 SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ + P +S +D + R L+ DP +R A E+ HPF
Sbjct: 252 RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLL 299
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-56
Identities = 67/311 (21%), Positives = 106/311 (34%), Gaps = 47/311 (15%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILA 737
+ F + GA G + A+K++L +
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPE-------CFSFADR 66
Query: 738 ERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIA 795
E +L P V+R+F + R Y+ +E L + +K +
Sbjct: 67 EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQ 125
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPE 850
+ L +LHSL IVHRDLKP N+LI+ ++DFGL K
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK-------------- 171
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFE 907
+ + +R R GT ++APE+L Y D +S G + +
Sbjct: 172 ---------KLAVGRHSFSR-RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221
Query: 908 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966
I+ G PF + + A++LI + + DP +R A
Sbjct: 222 VISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SA 278
Query: 967 AEVKAHPFFKG 977
V HPFF
Sbjct: 279 KHVLKHPFFWS 289
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-56
Identities = 90/291 (30%), Positives = 139/291 (47%), Gaps = 37/291 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + I +GA G V+ A TG AI+Q+ ++ ++ E I+ E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENK 75
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
NP +V + S+ D L++VMEYL GG L ++ + E +A + E + ALE+LHS
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHS 134
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
++HRD+K DN+L+ DG +KLTDFG Q
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCA----------------------------QI 166
Query: 867 TDNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
T ++ R + VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
I P P +S +D +NR L D +R A E+ H F K
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHQFLK 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-55
Identities = 71/324 (21%), Positives = 125/324 (38%), Gaps = 66/324 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ K + G+ G V G A+K++L + L E +L
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLID-------FCDIALMEIKLLTESD 66
Query: 747 N-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-------ARIYIAELV 798
+ P V+R++ S T LY+ +E +L L+ +E++ + ++
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 799 LALEYLHSLGIVHRDLKPDNLLIAH-------------DGHIKLTDFGLSKIGLINNTID 845
+ +LHSL I+HRDLKP N+L++ + I ++DFGL K
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-------- 177
Query: 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-------GYAADW 898
Q + N ++ GT + APE+L + + + D
Sbjct: 178 ---------------LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222
Query: 899 WSVGIILFEFIT-GIPPFTAESPEI--IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 955
+S+G + + ++ G PF + I I + + EA DLI++ + H
Sbjct: 223 FSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 956 DPNQRLGANGAAEVKAHPFFKGVN 979
DP +R A +V HP F +
Sbjct: 283 DPLKRP---TAMKVLRHPLFWPKS 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-55
Identities = 83/292 (28%), Positives = 141/292 (48%), Gaps = 40/292 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITV 745
+ F ++ I +G+FG VF T + AIK + L++ + ++IE I E +L
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQC 77
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+P+V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLH
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLH 136
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S +HRD+K N+L++ G +KL DFG++ G + +T
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQI-------------------- 174
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 924
R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F
Sbjct: 175 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
L K P + + S ++ + L +P+ R A E+ H F
Sbjct: 230 ---LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIL 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-55
Identities = 77/322 (23%), Positives = 137/322 (42%), Gaps = 44/322 (13%)
Query: 663 LDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLK 722
S + +G T + + I+D E + + G G+V+ R R TG + A+KQ+ +
Sbjct: 3 SGSSGKQTGYLTI--GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 723 KLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK 781
+ K + +RIL + ++++ + P++V+ F +F ++++ ME + R
Sbjct: 61 SGN---KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRM 117
Query: 782 VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840
G + E + +V AL YL G++HRD+KP N+L+ G IKL DFG+S
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG---- 173
Query: 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYA 895
+ D++ + + G Y+APE + ++
Sbjct: 174 ------------------------RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209
Query: 896 ADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLI 954
AD WS+GI L E TG P+ + + +L + P S + Q + L
Sbjct: 210 ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLT 269
Query: 955 HDPNQRLGANGAAEVKAHPFFK 976
D +R ++ H F K
Sbjct: 270 KDHRKRP---KYNKLLEHSFIK 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-54
Identities = 83/299 (27%), Positives = 144/299 (48%), Gaps = 42/299 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ +EI+ + GAFG+V+ A+ + TG L A K + + + ++E + E IL T
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELEDYIVEIEILATCD 74
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 805
+P++V+ ++ L++++E+ GG + +++ ++ L E ++ +++ AL +LH
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S I+HRDLK N+L+ +G I+L DFG+S T+
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQ-------------------- 172
Query: 866 QTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P
Sbjct: 173 -----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
Query: 921 -EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
++ I P PS S E +D + L +P R AA++ HPF +
Sbjct: 228 MRVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFVSSI 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-52
Identities = 85/336 (25%), Positives = 135/336 (40%), Gaps = 81/336 (24%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
DDFE I + G G VF + +G + A K + ++ +I+ E +L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHE 87
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
+P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 88 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 805 HS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
I+HRD+KP N+L+ G IKL DFG+S G + +++
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSM------------------- 186
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES---- 919
+S VGT Y++PE L GT + +D WS+G+ L E G P
Sbjct: 187 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238
Query: 920 -----------------------------------PEIIFD---NILNRKIP-WPCVPSD 940
P IF+ I+N P P
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGV 296
Query: 941 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
S E QD +N+ LI +P +R ++ H F K
Sbjct: 297 FSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIK 329
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 83/293 (28%), Positives = 139/293 (47%), Gaps = 41/293 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ F++++ + G++G V+ A + TG + AIKQ + ++D++ I+ E +I+
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ------VPVESDLQEIIKEISIMQQCD 82
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 805
+P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+ +HRD+K N+L+ +GH KL DFG++ Q
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAG----------------------------Q 174
Query: 866 QTDNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 923
TD R++ +GTP ++APE++ + AD WS+GI E G PP+ P I
Sbjct: 175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234
Query: 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
F I P P S D + + L+ P QR A ++ HPF +
Sbjct: 235 F-MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVR 283
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-52
Identities = 78/303 (25%), Positives = 134/303 (44%), Gaps = 47/303 (15%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI- 743
DD E I + RGA+G V R +G + A+K++ ++ + +R+L + +I +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMR 61
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLY-SLLRKVGCLEEDVARIYIAELVLA 800
TV PF V F+ + ++++ ME ++ Y ++ K + ED+ +V A
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 801 LEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
LE+LHS L ++HRD+KP N+LI G +K+ DFG+S
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG----------------------- 158
Query: 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILFEFITGIPPF 915
D+ + G Y+APE + + +D WS+GI + E P+
Sbjct: 159 -----YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213
Query: 916 TA-ESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
+ +P ++ P P +P+D S E D ++ L + +R E+ HP
Sbjct: 214 DSWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHP 268
Query: 974 FFK 976
FF
Sbjct: 269 FFT 271
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-51
Identities = 75/317 (23%), Positives = 117/317 (36%), Gaps = 85/317 (26%)
Query: 681 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAER 739
K+ IDD+++ + + G G+V + T + FA+K + R E
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR---------EV 61
Query: 740 NILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLRKVGCLEEDVARI 792
+ P +VR + R L +VME L+GG+L+S R E A
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGP 849
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------- 165
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909
A E G ++ + D WS+G+I++ +
Sbjct: 166 --------------------------------FAKET-TGEKYDKSCDMWSLGVIMYILL 192
Query: 910 TGIPPFTAESPEI----IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQR 960
G PPF + + I + W V S E + LI L +P QR
Sbjct: 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKMLIRNLLKTEPTQR 248
Query: 961 LGANGAAEVKAHPFFKG 977
+ E HP+
Sbjct: 249 M---TITEFMNHPWIMQ 262
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-51
Identities = 68/314 (21%), Positives = 131/314 (41%), Gaps = 47/314 (14%)
Query: 676 LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI 735
+ + +D + + I RGA+G V + +G + A+K++ +D + + +++
Sbjct: 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQL 67
Query: 736 LAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKV--GCLEEDVA 790
L + ++++ + P++V+F+ + + ++ ME ++ Y + V + E++
Sbjct: 68 LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127
Query: 791 RIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849
V AL +L L I+HRD+KP N+L+ G+IKL DFG+S
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG------------- 174
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIIL 905
Q D+ + G Y+APE + + +D WS+GI L
Sbjct: 175 ---------------QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219
Query: 906 FEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLG 962
+E TG P+ + ++ P + F + +N L D ++R
Sbjct: 220 YELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP- 278
Query: 963 ANGAAEVKAHPFFK 976
E+ HPF
Sbjct: 279 --KYKELLKHPFIL 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-50
Identities = 66/302 (21%), Positives = 112/302 (37%), Gaps = 43/302 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN- 747
+ + ++ G F V+ A+ +G +A+K++L + I+ E + +
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGH 85
Query: 748 PFVVRFFYSFTCRDN--------LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAEL 797
P +V+F + + L+ E G + L + G L D +
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 798 VLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
A++++H I+HRDLK +NLL+++ G IKL DFG + +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT------------TISHYPD 193
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGI 912
S + + R+ TP Y PEI+ G D W++G IL+
Sbjct: 194 YSWSAQRRALVEEEITRN---TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
Query: 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972
PF + I+N K P + LI L +P +RL EV
Sbjct: 251 HPFEDGAKL----RIVNGKYSIPPHDT-QYTVFHSLIRAMLQVNPEERLSIA---EVVHQ 302
Query: 973 PF 974
Sbjct: 303 LQ 304
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-50
Identities = 62/339 (18%), Positives = 120/339 (35%), Gaps = 74/339 (21%)
Query: 687 DDFEIIKPISRGA--FGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
+E++ I +G V LAR + TG+ ++++ L+ + + E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSKL 82
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALE 802
+P +V + +F + L++V ++ G L+ + + E + ++ AL+
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
Y+H +G VHR +K ++LI+ DG + L+ + + +
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSN--LSMISHGQ----------------- 183
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF----- 915
Q+ + +V +L+PE+L GY +D +SVGI E G PF
Sbjct: 184 -RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
Query: 916 --------------------------------------TAESPEIIFDNILNRKIPWPCV 937
++S N P
Sbjct: 243 TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302
Query: 938 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
S + + L +P+ R A+ + H FFK
Sbjct: 303 HRTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFK 338
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-49
Identities = 71/295 (24%), Positives = 112/295 (37%), Gaps = 43/295 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI-RKNDIERILAERNILITV 745
F ++ I G+FG V+ AR ++ AIK++ + I+ E L +
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
R+P +++ + +LVMEY G L L+E + L YLH
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S ++HRD+K N+L++ G +KL DFG +
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----------------------------S 202
Query: 866 QTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP-E 921
N S VGTP ++APE IL E Y D WS+GI E PP +
Sbjct: 203 IMAPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260
Query: 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
++ +I + P S ++ ++ L P R + + H F
Sbjct: 261 ALY-HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 310
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 76/305 (24%), Positives = 133/305 (43%), Gaps = 52/305 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV- 745
FE+++ + G +G+V+ R TG L AIK + + ++ E I E N+L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVT---GDEEEEIKQEINMLKKYS 78
Query: 746 RNPFVVRFFYSF------TCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAEL 797
+ + ++ +F D L+LVME+ G + L++ K L+E+ E+
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ L +LH ++HRD+K N+L+ + +KL DFG+S ++ T+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVG------------ 184
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-----GYAADWWSVGIILFEFITGI 912
R++ +GTP ++APE++ E+ + +D WS+GI E G
Sbjct: 185 -------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 913 PPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971
PP P +F I P S + Q I L+ + +QR ++
Sbjct: 232 PPLCDMHPMRALF-LIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMK 286
Query: 972 HPFFK 976
HPF +
Sbjct: 287 HPFIR 291
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-45
Identities = 81/353 (22%), Positives = 143/353 (40%), Gaps = 76/353 (21%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM 726
+Q+ G + S+ TSID + I + G +G V+ A T + AIK++ +L+
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--RLE- 70
Query: 727 IRKNDIERI----LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 782
++ E + + E ++L +++ ++ L+L+ EY DL + K
Sbjct: 71 ---HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN 126
Query: 783 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKI 837
+ V + ++ +L+ + + HS +HRDLKP NLL+ + +K+ DFGL++
Sbjct: 127 PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR- 185
Query: 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAA 896
+ + H + T Y PEILLG+ H +
Sbjct: 186 -------------------------AFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSV 219
Query: 897 DWWSVGIILFEFITGIPPFTAESPEI-----IFD-----------------NILNRKIPW 934
D WS+ I E + P F +S EI IF+ + +
Sbjct: 220 DIWSIACIWAEMLMKTPLFPGDS-EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKF 278
Query: 935 P------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981
+ + + E DL+ L DP +R+ A A E HP+F ++D
Sbjct: 279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE---HPYFSHNDFD 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-45
Identities = 60/275 (21%), Positives = 118/275 (42%), Gaps = 18/275 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D + + +G FG+ R TG++ +K++++ + ++ L E ++ +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT----FLKEVKVMRCLE 65
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALEYLH 805
+P V++F L + EY+ GG L +++ + R+ A+ + + YLH
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S+ I+HRDL N L+ + ++ + DFGL+++ + + P
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKP--------- 174
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
D + R++ VG P ++APE++ G + D +S GI+L E I + P +
Sbjct: 175 --DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
Query: 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ R P + + R DP +R
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-45
Identities = 81/327 (24%), Positives = 139/327 (42%), Gaps = 71/327 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAER--NILIT 744
+ +E I I G++G VF R R TG + AIK+ L+ D + + + +A R +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED----DPVIKKIALREIRMLKQ 58
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEY 803
+++P +V F + L+LV EY + + L + + E + + + + A+ +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
H +HRD+KP+N+LI IKL DFG +++ L+GP +Y +
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARL--------LTGP--------SDYYDD 161
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 922
V T Y +PE+L+G G D W++G + E ++G+P + +S ++
Sbjct: 162 E-----------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-DV 209
Query: 923 -----IFDNIL------------------NRKIPWPCVPSD-------MSFEAQDLINRF 952
I L KIP P +S+ A L+
Sbjct: 210 DQLYLIR-KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGC 268
Query: 953 LIHDPNQRLGANGAAEVKAHPFFKGVN 979
L DP +RL HP+F+ +
Sbjct: 269 LHMDPTERLTCEQLLH---HPYFENIR 292
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-44
Identities = 85/327 (25%), Positives = 140/327 (42%), Gaps = 72/327 (22%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAERNI 741
++ + ++ I G +G V+ A+ G+ FA+K++ +L+ + E I + E +I
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKI--RLE----KEDEGIPSTTIREISI 53
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 800
L +++ +V+ + + L LV E+L+ DL LL LE A+ ++ +L+
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+ Y H ++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------------------------ 148
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 919
+ + H V T Y AP++L+G++ D WSVG I E + G P F S
Sbjct: 149 --AFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 920 PEI-----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRF 952
E IF + +P + DL+++
Sbjct: 206 -EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264
Query: 953 LIHDPNQRLGANGAAEVKAHPFFKGVN 979
L DPNQR+ A A E H +FK N
Sbjct: 265 LKLDPNQRITAKQALE---HAYFKENN 288
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-43
Identities = 84/341 (24%), Positives = 134/341 (39%), Gaps = 92/341 (26%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM--------IRKNDIERI 735
+S F+ ++ + G + V+ +TTG A+K+V KLD IR
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTAIR------- 52
Query: 736 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------LEEDV 789
E +++ +++ +VR + + L LV E+++ DL + LE ++
Sbjct: 53 --EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109
Query: 790 ARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849
+ + +L+ L + H I+HRDLKP NLLI G +KL DFGL++
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR------------- 156
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEF 908
GI P + E V T Y AP++L+G+ + D WS G IL E
Sbjct: 157 -AFGI-PVNTFSSE------------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202
Query: 909 ITGIPPFTAESPEI-----IFD----------------------------NILNRKIPWP 935
ITG P F + + IFD L + +
Sbjct: 203 ITGKPLFPGTN-DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH 261
Query: 936 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ D ++ L +P+ RL A A HP+F
Sbjct: 262 TKEP-LDGNLMDFLHGLLQLNPDMRLSAKQALH---HPWFA 298
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-43
Identities = 80/338 (23%), Positives = 135/338 (39%), Gaps = 91/338 (26%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAE 738
++ +E + + G F V+ AR + T + AIK++ KL + + I L E
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAK-DGINRTALRE 62
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAEL 797
+L + +P ++ +F + N+ LV +++ DL +++ L + Y+
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ LEYLH I+HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK--------------------- 160
Query: 858 DAHYPEYQQTDNRNRHSAVGTPD-----------YLAPEILLGTEH-GYAADWWSVGIIL 905
+ G+P+ Y APE+L G G D W+VG IL
Sbjct: 161 -----------------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 203
Query: 906 FEFITGIPPFTAESPEI-----IFDNIL---NRKI--------------PWPCVP----- 938
E + +P +S ++ IF+ L + +P +P
Sbjct: 204 AELLLRVPFLPGDS-DLDQLTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 261
Query: 939 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
S + DLI + +P R+ A A + +F
Sbjct: 262 SAAGDDLLDLIQGLFLFNPCARITATQALK---MKYFS 296
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 83/331 (25%), Positives = 140/331 (42%), Gaps = 73/331 (22%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAE 738
+ ++ ++ ++ + G +G V+ A+ G + A+K++ +LD + E I + E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRI--RLD----AEDEGIPSTAIRE 69
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAEL 797
++L + +P +V L LV E++ DL +L + L++ +IY+ +L
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ + + H I+HRDLKP NLLI DG +KL DFGL++
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR--------------------- 167
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFT 916
+ H V T Y AP++L+G++ + D WS+G I E ITG P F
Sbjct: 168 -----AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221
Query: 917 AESPEI-----IFD-----------------NILNRKIP-WPCVP-----SDMSFEAQDL 948
+ + IF R + P E DL
Sbjct: 222 GVT-DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDL 280
Query: 949 INRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979
++ L DPN+R+ A A HP+FK ++
Sbjct: 281 LSNMLCFDPNKRISARDAMN---HPYFKDLD 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 83/330 (25%), Positives = 135/330 (40%), Gaps = 76/330 (23%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAERNI 741
+ +E ++ I G +G VF A+ R T ++ A+K+V +LD +D E + L E +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV--RLD----DDDEGVPSSALREICL 54
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 800
L +++ +VR L LV E+ + DL L+ ++ + ++ +L+
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L + HS ++HRDLKP NLLI +G +KL +FGL++ GI P +
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR--------------AFGI-PVRCY 158
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFIT-GIPPFTAE 918
E V T Y P++L G + + D WS G I E G P F
Sbjct: 159 SAE------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206
Query: 919 SPEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLI 949
IF +L + WP + ++ +DL+
Sbjct: 207 D-VDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 950 NRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979
L +P QR+ A A + HP+F
Sbjct: 264 QNLLKCNPVQRISAEEALQ---HPYFSDFC 290
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-43
Identities = 79/332 (23%), Positives = 126/332 (37%), Gaps = 77/332 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI----LAERN 740
+ +E + I GA+G V+ AR +G A+K V ++ + + E
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVPN-GGGGGGGLPISTVREVA 63
Query: 741 ILITVRN---PFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVA 790
+L + P VVR + LV E+++ DL + L K L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 791 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850
+ + + + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMAL 176
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
T V T Y APE+LL + + D WSVG I E
Sbjct: 177 T----------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
Query: 911 GIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDMSFE 944
P F S E IFD ++ + +P P +M
Sbjct: 215 RKPLFCGNS-EADQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES 272
Query: 945 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
L+ L +P++R+ A A + H +
Sbjct: 273 GAQLLLEMLTFNPHKRISAFRALQ---HSYLH 301
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 77/346 (22%), Positives = 135/346 (39%), Gaps = 71/346 (20%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAER--NIL 742
S++ +E + + G++G V R + TG + AIK+ + + + +A R +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF--LES--DDDKMVKKIAMREIKLL 78
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 801
+R+ +V + YLV E+++ + L L+ V + Y+ +++ +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
+ HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAP-----GEVYDDE 184
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 920
V T Y APE+L+G G A D W++G ++ E G P F +S
Sbjct: 185 --------------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS- 229
Query: 921 EI-----IFDNILNRKIP--WPCVPS-----------------------DMSFEAQDLIN 950
+I I L IP +S DL
Sbjct: 230 DIDQLYHIM-MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAK 288
Query: 951 RFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 996
+ L DP++R H FF+ + Q+ Q ++
Sbjct: 289 KCLHIDPDKRPFCAELLH---HDFFQMDGFAERFSQELQLKVQKDA 331
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 79/309 (25%), Positives = 135/309 (43%), Gaps = 44/309 (14%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFA 716
+ T + + DD +I + I G+FG V A G A
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVA 64
Query: 717 IKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 776
+K +L + D + L E I+ +R+P +V F + T NL +V EYL+ G LY
Sbjct: 65 VK-ILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 777 SLLRKVGCLEE--DVARIYIA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTD 831
LL K G E+ + R+ +A ++ + YLH+ IVHR+LK NLL+ +K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 891
FGLS++ + + + SA GTP+++APE+L
Sbjct: 183 FGLSRL---------------------------KASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 892 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 951
+D +S G+IL+E T P+ +P + + + +P +++ + +I
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEG 274
Query: 952 FLIHDPNQR 960
++P +R
Sbjct: 275 CWTNEPWKR 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-42
Identities = 77/315 (24%), Positives = 119/315 (37%), Gaps = 57/315 (18%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN 747
+E+ I+ G G ++LA + G +K ++ D +AER L V +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD---AEAQAMAMAERQFLAEVVH 138
Query: 748 PFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
P +V+ F Y+VMEY+ G L L A Y+ E++ AL
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALS 196
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLHS+G+V+ DLKP+N+++ + +KL D G I+ G
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS------RINSFG-------------- 235
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
GTP + APEI+ A D ++VG L +P +
Sbjct: 236 -----------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVD- 282
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982
L P S+ L+ R + DP QR A E+ A GV +
Sbjct: 283 ----GLPEDDPVLKTYD--SYGR--LLRRAIDPDPRQRFTT--AEEMSAQ--LTGVLREV 330
Query: 983 LALQKAVFVPQPESV 997
+A V P ++
Sbjct: 331 VAQDTGVPRPGLSTI 345
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 80/331 (24%), Positives = 130/331 (39%), Gaps = 85/331 (25%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM--------IRKNDIERILA 737
++ + + + G + V+ + + T +L A+K++ +L+ IR
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI--RLEHEEGAPCTAIR--------- 49
Query: 738 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAE 796
E ++L +++ +V +L LV EYL+ DL L G + ++++ +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
L+ L Y H ++HRDLKP NLLI G +KL DFGL++ S P
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA--------KSIP------- 153
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 915
+ + V T Y P+ILLG+ D W VG I +E TG P F
Sbjct: 154 ------------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201
Query: 916 TAESPEI-----IFDNIL---NRKIPWPCVPS----------------------DMSFEA 945
+ IF IL + WP + S + +
Sbjct: 202 PGST-VEEQLHFIFR-ILGTPTEET-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDG 258
Query: 946 QDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
DL+ + L + R+ A A + HPFF
Sbjct: 259 ADLLTKLLQFEGRNRISAEDAMK---HPFFL 286
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 84/340 (24%), Positives = 141/340 (41%), Gaps = 81/340 (23%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
+ R +D F++ + +G FG V L ++++TG AIK+V+ D +N R L
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRN---RELQIMQ 71
Query: 741 ILITVRNPFVVR---FFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC----LEEDV 789
L + +P +V+ +FY+ RD L +VMEY+ L+ R +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 790 ARIYIAELVLALEYLH--SLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDL 846
++++ +L+ ++ LH S+ + HRD+KP N+L+ DG +KL DFG +K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK---------- 180
Query: 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIIL 905
+ Y + + Y APE++ G + A D WSVG I
Sbjct: 181 -------KLSPSEPNVAY-----------ICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 906 FEFITGIPPFTAESP-----EII----------FDNILN----------RKIPW----PC 936
E + G P F ++ EI+ + + IPW
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 937 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ EA DL++ L + P +R+ E HP+F
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFD 319
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 71/293 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ E+ + + RGAFG V A+ R AIKQ+ + ++ + + E L V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE------SERKAFIVELRQLSRVN 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-----------DVARIYIA 795
+P +V+ + + C + + LVMEY GG LY++L L ++
Sbjct: 60 HPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ---- 113
Query: 796 ELVLALEYLHSL---GIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPET 851
+ YLHS+ ++HRDLKP NLL+ G +K+ DFG + +
Sbjct: 114 ----GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------------DI 156
Query: 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911
M T + G+ ++APE+ G+ + D +S GIIL+E IT
Sbjct: 157 QTHM-----------T------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR 199
Query: 912 IPPF--TAESPEIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
PF I + N R P + ++ + L+ R DP+QR
Sbjct: 200 RKPFDEIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 46/288 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI---LAERNILI 743
++ E K I +G FG V R + AIK ++ IE+ E I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALE 802
+ +P +V+ + + +VME++ GDLY L + ++ + ++ L +E
Sbjct: 79 NLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 803 YLHSLG--IVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
Y+ + IVHRDL+ N+ + K+ DFGLS+ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------------SVHSVS 184
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIP 913
+G ++APE + E Y AD +S +IL+ +TG
Sbjct: 185 ------------------GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 914 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
PF S +I F N++ + P +P D +++I DP +R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 89/337 (26%), Positives = 137/337 (40%), Gaps = 89/337 (26%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKQVLKKLDM---------IRKNDIE- 733
+ +E + I GA+G+VF AR + G A+K+V ++ IR E
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIR----EV 62
Query: 734 RILAERNILITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LE 786
+L L T +P VVR F L LV E+++ DL + L KV +
Sbjct: 63 AVLRH---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 787 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846
+ + + +L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI--------Y 170
Query: 847 SGPETDGIMPSDAHY-PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 905
S V T Y APE+LL + + D WSVG I
Sbjct: 171 SFQMA---------LTSV------------VVTLWYRAPEVLLQSSYATPVDLWSVGCIF 209
Query: 906 FEFITGIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------S 939
E P F S ++ I D ++ + +P +
Sbjct: 210 AEMFRRKPLFRGSS-DVDQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 267
Query: 940 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
D+ +DL+ + L +P +R+ A A HP+F+
Sbjct: 268 DIDELGKDLLLKCLTFNPAKRISAYSALS---HPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-42
Identities = 87/336 (25%), Positives = 132/336 (39%), Gaps = 78/336 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM---------IRKNDIERI 735
+ +E + I +G FG VF AR R TG A+K+V ++ +R+ I ++
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQL 72
Query: 736 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYI 794
L N+ + + + C+ ++YLV ++ DL LL V + +
Sbjct: 73 LKHENV-VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDG 853
L+ L Y+H I+HRD+K N+LI DG +KL DFGL+ L
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL-------------- 176
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 912
++ Y T NR V T Y PE+LLG G D W G I+ E T
Sbjct: 177 --AKNSQPNRY--T-NR-----VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
Query: 913 PPFTAESPEI-----IFDNIL---NRKIPWPCVPS------------------------D 940
P + E I + ++ WP V +
Sbjct: 227 PIMQGNT-EQHQLALIS-QLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAYV 283
Query: 941 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
A DLI++ L+ DP QR+ ++ A H FF
Sbjct: 284 RDPYALDLIDKLLVLDPAQRIDSDDALN---HDFFW 316
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-42
Identities = 66/312 (21%), Positives = 119/312 (38%), Gaps = 47/312 (15%)
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIK 718
+S S S P +S + + +++I + I +G FG+V+ R G++ AI+
Sbjct: 6 LSLLSARSFPRKAS-QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEV-AIR 61
Query: 719 QVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 778
+ ++ ++ ++ E R+ VV F + +L ++ G LYS+
Sbjct: 62 LI--DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 779 LRKVGCLEEDVARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
+R + + IA E+V + YLH+ GI+H+DLK N+ +G + +TDFGL I
Sbjct: 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSI 178
Query: 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--- 894
+ G +LAPEI+
Sbjct: 179 SGVLQAGRREDKLR----------------------IQNGWLCHLAPEIIRQLSPDTEED 216
Query: 895 ------AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDL 948
+D +++G I +E PF + E I + P M E D+
Sbjct: 217 KLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-NLSQIGMGKEISDI 275
Query: 949 INRFLIHDPNQR 960
+ + +R
Sbjct: 276 LLFCWAFEQEER 287
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-42
Identities = 90/335 (26%), Positives = 133/335 (39%), Gaps = 82/335 (24%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
+R + K I G+FG V+ A+ +G+L AIK+VL D E I
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRFKNRELQI 100
Query: 742 LITVRNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGC----LEEDVAR 791
+ + + +VR FFYS + + L LV++Y+ +Y + R L +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 792 IYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPE 850
+Y+ +L +L Y+HS GI HRD+KP NLL+ +KL DFG +K
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK-------------- 205
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 909
+ Y + + Y APE++ G T++ + D WS G +L E +
Sbjct: 206 ---QLVRGEPNVSY-----------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251
Query: 910 TGIPPFTAESP-----EII----------------------FDNILNRKIPWP-CVPSDM 941
G P F +S EII F I + PW
Sbjct: 252 LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KAHPWTKVFRPRT 309
Query: 942 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
EA L +R L + P RL E AH FF
Sbjct: 310 PPEAIALCSRLLEYTPTARL---TPLEACAHSFFD 341
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-42
Identities = 84/336 (25%), Positives = 141/336 (41%), Gaps = 89/336 (26%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DD+++++ + RG + VF A T + +K +++ ++I E IL +R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-------ILKPVKKKKIKREIKILENLR 88
Query: 747 N-PFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 799
P ++ S LV E++N D L + L + R Y+ E++
Sbjct: 89 GGPNIITLADIVKDPVSR----TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILK 141
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
AL+Y HS+GI+HRD+KP N++I H+ ++L D+GL++ P +
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------HPGQE------ 186
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF-- 915
Y V + + PE+L+ + Y+ D WS+G +L I PF
Sbjct: 187 --YNVR-----------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233
Query: 916 ----------------TAESPEII----------FDNILNR--KIPW-PCVPSD----MS 942
T + + I F++IL R + W V S+ +S
Sbjct: 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 293
Query: 943 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
EA D +++ L +D RL A A E HP+F V
Sbjct: 294 PEALDFLDKLLRYDHQSRLTAREAME---HPYFYTV 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 65/298 (21%), Positives = 125/298 (41%), Gaps = 45/298 (15%)
Query: 677 HSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK 729
H H R + DD+EI + I G+FG V+ + GD+ A+K +L
Sbjct: 7 HHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVK-MLNVTAP-TP 61
Query: 730 NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV 789
++ E +L R+ ++ F ++ L +V ++ G LY L E
Sbjct: 62 QQLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 790 ARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848
I IA + ++YLH+ I+HRDLK +N+ + D +K+ DFGL+
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE----------- 169
Query: 849 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIIL 905
+ + + + G+ ++APE++ + + +D ++ GI+L
Sbjct: 170 --------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215
Query: 906 FEFITGIPPFTAESP-EIIFDNIL--NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+E +TG P++ + + I + + + V S+ + L+ L ++R
Sbjct: 216 YELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-40
Identities = 97/328 (29%), Positives = 141/328 (42%), Gaps = 83/328 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+ K I G+FG VF A+ + + AIK+VL D KN R E I+ V++P
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL--QDKRFKN---R---ELQIMRIVKHP 92
Query: 749 FVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELV 798
VV FFYS + + L LV+EY+ +Y R + + ++Y+ +L+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 799 LALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+L Y+HS+GI HRD+KP NLL+ G +KL DFG +KI ++
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI----------------LIAG 195
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 916
+ Y + + Y APE++ G T + D WS G ++ E + G P F
Sbjct: 196 EP-NVSY-----------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243
Query: 917 AESP-----EII----------------------FDNILNRKIPWP-CVPSDMSFEAQDL 948
ES EII F I R P+ +A DL
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI--RPHPFSKVFRPRTPPDAIDL 301
Query: 949 INRFLIHDPNQRLGANGAAEVKAHPFFK 976
I+R L + P+ RL A E HPFF
Sbjct: 302 ISRLLEYTPSARL---TAIEALCHPFFD 326
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 68/279 (24%), Positives = 120/279 (43%), Gaps = 31/279 (11%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND-IERILAERNIL 742
T + + + + RG G V+ A + A+K ++ + R+ E
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMS-ETLSSDPVFRTRMQREARTA 88
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
++ P VV LY+ M +NG DL ++LR+ G L A + ++ AL+
Sbjct: 89 GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
H+ G HRD+KP+N+L++ D L DFG++ + + T
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKL------T----------- 190
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
Q + VGT Y+APE + Y AD +++ +L+E +TG PP+ + +
Sbjct: 191 ---QLG-----NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242
Query: 923 IFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQR 960
+ + +N+ IP P V + +I R + +P R
Sbjct: 243 MGAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 67/285 (23%), Positives = 111/285 (38%), Gaps = 44/285 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + + I G FG+V+ A GD A+K D IE + E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P ++ NL LVME+ GG L +L + D+ + ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHD 123
Query: 807 LG---IVHRDLKPDNLLIAHDGH--------IKLTDFGLSKIGLINNTIDLSGPETDGIM 855
I+HRDLK N+LI +K+TDFGL++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------------------ 165
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915
+ SA G ++APE++ + +D WS G++L+E +TG PF
Sbjct: 166 -----------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ + K+ +PS L+ DP+ R
Sbjct: 215 RGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 31/275 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND-IERILAERNILITVRN 747
++I+ + G V+LA AIK + + K + ++R E + + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIF-IPPREKEETLKRFEREVHNSSQLSH 70
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
+V D YLVMEY+ G L + G L D A + +++ +++ H +
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 867
IVHRD+KP N+LI + +K+ DFG++K L ++ +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTN------------------- 170
Query: 868 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
+GT Y +PE G D +S+GI+L+E + G PPF E+ I
Sbjct: 171 ------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224
Query: 928 LNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 960
+ +P V D+ ++I R D R
Sbjct: 225 IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-39
Identities = 79/327 (24%), Positives = 133/327 (40%), Gaps = 62/327 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN-DIERILAERNILITV 745
DF++ + GA+G V A + TG++ AIK K++ K R L E IL
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK----KIEPFDKPLFALRTLREIKILKHF 66
Query: 746 RNPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
++ ++ F +N +Y++ E + DL+ ++ L +D + +I + + A
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRA 124
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
++ LH ++HRDLKP NLLI + +K+ DFGL++I + + M
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM----- 179
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919
E+ V T Y APE++L ++ A D WS G IL E P F
Sbjct: 180 -VEF-----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
Query: 920 ----------------PEIIFDNILN-------------RKIPWPCVPSDMSFEAQDLIN 950
+ I + P + ++ + DL+
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 951 RFLIHDPNQRLGANGAAEVKAHPFFKG 977
R L+ DP +R+ A E HP+ +
Sbjct: 288 RMLVFDPAKRI---TAKEALEHPYLQT 311
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-39
Identities = 82/359 (22%), Positives = 135/359 (37%), Gaps = 114/359 (31%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+ + K + G+FG V +G FA+K+VL D E +I+ + +
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDIMKVLDHV 60
Query: 749 FVVRFFYSFTCRDN--------------------------------------LYLVMEYL 770
+++ F + L ++MEY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 771 NGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDG 825
L+ +L+ + ++ IYI +L A+ ++HSLGI HRD+KP NLL+ + D
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 826 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE 885
+KL DFG +K + Y + + Y APE
Sbjct: 180 TLKLCDFGSAK-----------------KLIPSEPSVAY-----------ICSRFYRAPE 211
Query: 886 ILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-----EII---------------- 923
++LG TE+ + D WS+G + E I G P F+ E+ II
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP 271
Query: 924 ------FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975
F + + W + P A DL+ + L ++P+ R+ E AHPFF
Sbjct: 272 HYTEVRFPTL--KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFF 325
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 32/278 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND-IERILAERNILITVRN 747
+E+ + + G V LAR A+K VL+ D+ R R E + +
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLR-ADLARDPSFYLRFRREAQNAAALNH 71
Query: 748 PFVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 803
P +V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
H GI+HRD+KP N++I+ +K+ DFG+++ + ++ ++
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVT---------------- 174
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EI 922
QT + +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 175 --QTA-----AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ ++ IP +S + ++ + L +P R
Sbjct: 228 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 53/297 (17%), Positives = 102/297 (34%), Gaps = 57/297 (19%)
Query: 678 SSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERI 735
+ H ID + ++ G ++ R + G+ +K + K+
Sbjct: 2 NKHSG---IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVL--KVRDWSTRKSRDF 54
Query: 736 LAERNILITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA-RI 792
E L +P V+ + + L+ ++ G LY++L + D + +
Sbjct: 55 NEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV 114
Query: 793 YIA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849
A ++ + +LH+L I L +++I D +++ +
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF------------- 161
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILF 906
+Q + P ++APE L +AD WS ++L+
Sbjct: 162 -------------SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 907 EFITGIPPFTAESP-EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
E +T PF S EI L R P +P +S L+ + DP +R
Sbjct: 203 ELVTREVPFADLSNMEIGMKVALEGLR----PTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 83/332 (25%), Positives = 130/332 (39%), Gaps = 76/332 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAE---------R 739
+ +KP+ G G VF A AIK K+ + ++ L E
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK----KIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 740 NI-----LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 794
NI ++ + S T +++Y+V EY+ DL ++L + G L E+ AR+++
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARLFM 126
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+L+ L+Y+HS ++HRDLKP NL I D +K+ DFGL++I D
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI-------------MDP 173
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGI 912
H E + T Y +P +LL + A D W+ G I E +TG
Sbjct: 174 HYSHKGHLSEG-----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
Query: 913 PPFTAESP----EIIFD-------------------NILN----RKIPWPCVPSDMSFEA 945
F ++I + I N P + +S EA
Sbjct: 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREA 282
Query: 946 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
D + + L P RL A E +HP+
Sbjct: 283 VDFLEQILTFSPMDRL---TAEEALSHPYMSI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-37
Identities = 78/326 (23%), Positives = 131/326 (40%), Gaps = 73/326 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + GA+G V A + +G+ AIK++ + + +R E +L ++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQ 81
Query: 747 NPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
+ V+ F + N YLVM ++ DL ++ E+ + + +++
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLKG 138
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L+Y+HS G+VHRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADAE 179
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 919
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 180 MTGY-----------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228
Query: 920 P----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINR 951
I + + + + + S +A DL+ +
Sbjct: 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKG 977
L D ++RL AA+ HPFF+
Sbjct: 289 MLELDVDKRL---TAAQALTHPFFEP 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-37
Identities = 69/334 (20%), Positives = 118/334 (35%), Gaps = 76/334 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI-------ERILAER 739
+ + + IS G++G V + G AIK+V + R +I +R+L E
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 740 NILITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSLLR-KVGCLEEDVARIY 793
+L +P ++ F + LYLV E + DL ++ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 794 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+ ++L L LH G+VHRDL P N+L+A + I + DF L++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----------EDTADA 188
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 912
Y V Y APE+++ + D WS G ++ E
Sbjct: 189 NK------THY-----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 913 PPFTAESP----EIIFD-----------NILN--------------RKIPWPCVPSDMSF 943
F + I + + W V
Sbjct: 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP 291
Query: 944 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
A DLI + L +P +R+ + HP+F+
Sbjct: 292 VALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 80/325 (24%), Positives = 133/325 (40%), Gaps = 72/325 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++ + P+ GA+G V A TG A+K++ + +R E +L ++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMK 86
Query: 747 NPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
+ V+ F + +YLV + G DL ++++ L +D + I +++
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRG 144
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ T M
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTADEM----- 186
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 919
Y V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 187 -TGY-----------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234
Query: 920 P----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINR 951
++I I + K+ + V + A DL+ +
Sbjct: 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 294
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFK 976
L+ D ++R+ AA+ AH +F
Sbjct: 295 MLVLDSDKRI---TAAQALAHAYFA 316
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 79/326 (24%), Positives = 131/326 (40%), Gaps = 68/326 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN-DIERILAERNILITV 745
+ + I GA+G V A AIK K+ +R L E IL+
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----KISPFEHQTYCQRTLREIKILLRF 82
Query: 746 RNPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
R+ ++ + +Y+V + + DLY LL+ L D ++ +++
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQILRG 140
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L+Y+HS ++HRDLKP NLL+ +K+ DFGL+++ D
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------------ADPDHDHTGF 187
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 919
EY V T Y APEI+L ++ + D WSVG IL E ++ P F +
Sbjct: 188 LTEY-----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236
Query: 920 P----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINR 951
I I+N K+PW + + +A DL+++
Sbjct: 237 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 296
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKG 977
L +P++R+ + AHP+ +
Sbjct: 297 MLTFNPHKRI---EVEQALAHPYLEQ 319
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 81/326 (24%), Positives = 134/326 (41%), Gaps = 72/326 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++P+ GA+G V A TG AIK++ + + +R E +L +R
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMR 82
Query: 747 NPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
+ V+ + + YLVM ++ G DL L++ L ED + + +++
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKG 140
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L Y+H+ GI+HRDLKP NL + D +K+ DFGL++ +D+
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QADSE 181
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919
Y V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 182 MTGY-----------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230
Query: 920 P----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINR 951
+ I + + K + + ++ S A +L+ +
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKG 977
L+ D QR+ A E AHP+F+
Sbjct: 291 MLVLDAEQRV---TAGEALAHPYFES 313
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 78/355 (21%), Positives = 127/355 (35%), Gaps = 75/355 (21%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLAR 707
S T + LI S S SG PL +RT +++K I +G +G V++ +
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLV---QRTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 708 KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFF----YSFTCRD 761
R G+ A+K + + E I TV R+ ++ F
Sbjct: 58 WR--GEKVAVK-------VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108
Query: 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRD 813
LYL+ +Y G LY L+ + + ++ V L +LH+ I HRD
Sbjct: 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 873
LK N+L+ +G + D GL+ E D +
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVK------FISDTNEVDIPP-----------------N 204
Query: 874 SAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGI----------PPFTA 917
+ VGT Y+ PE+L + + AD +S G+IL+E P+
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 918 ESP-----EIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963
P E + + + +K P + + L+ H+P RL A
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 87/357 (24%), Positives = 134/357 (37%), Gaps = 71/357 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D +EI I G++G V A + + AIK++L+ + D +RIL E IL +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE--DLIDCKRILREIAILNRLN 110
Query: 747 NPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 801
+ VV+ D LY+V+E D L R L E + + L++ +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
+Y+HS GI+HRDLKP N L+ D +K+ DFGL++ + P + +
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 920
+ + R V T Y APE++L E+ A D WS+G I E + I A
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289
Query: 921 -----------------------------------EIIFD-------------------N 926
+IF+
Sbjct: 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR 349
Query: 927 ILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ S +A L+ R L+ +PN+R+ N HPFFK V
Sbjct: 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA---HPFFKEV 403
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 70/323 (21%), Positives = 118/323 (36%), Gaps = 69/323 (21%)
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
LD + + K+ LI D + SG PL +RT + + I +G FG V
Sbjct: 5 LDRPFISEGTTLKD---LIYDMTTSGSGSGLPLLV---QRTIARTIVLQESIGKGRFGEV 58
Query: 704 FLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD 761
+ + R G+ A+K + + E I T +R+ ++ F + +
Sbjct: 59 WRGKWR--GEEVAVK-------IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 109
Query: 762 N----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGI 809
L+LV +Y G L+ L + E + ++ L +LH I
Sbjct: 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAI 168
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
HRDLK N+L+ +G + D GL+ + T +
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVR-----------------------HDSATDTID 205
Query: 870 RNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+ VGT Y+APE+L + E AD +++G++ +E
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY-- 263
Query: 924 FDNILNRKIPWP-CVPSDMSFEA 945
++P+ VPSD S E
Sbjct: 264 -------QLPYYDLVPSDPSVEE 279
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 71/336 (21%), Positives = 130/336 (38%), Gaps = 81/336 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
++ +KPI GA G V A AIK++ + + +R E ++ V
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVN 82
Query: 747 NPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
+ ++ FT + + +Y+VME + +L +++ L+ + + +++
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCG 139
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM----- 183
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----- 915
Y V T Y APE++LG + D WSVG I+ E I G F
Sbjct: 184 -TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231
Query: 916 --------------TAESPEIIFDNILN--------RKIPW------------PCVPSDM 941
E + + + +
Sbjct: 232 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK 291
Query: 942 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+ +A+DL+++ L+ D ++R+ E HP+
Sbjct: 292 ASQARDLLSKMLVIDASKRI---SVDEALQHPYINV 324
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 62/284 (21%), Positives = 107/284 (37%), Gaps = 63/284 (22%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
+RT D +++ + +G +G V+ + G+ A+K + D + E +
Sbjct: 3 QRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVK-------IFSSRDEKSWFRETEL 53
Query: 742 LITV--RNPFVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 795
TV R+ ++ F S L+L+ Y G LY L+ RI +
Sbjct: 54 YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VL 112
Query: 796 ELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847
+ L +LH I HRDLK N+L+ +G + D GL+ +
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---------- 162
Query: 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSV 901
+ + + + VGT Y+APE+L T + D W+
Sbjct: 163 -------------HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209
Query: 902 GIILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 944
G++L+E + + + K P+ VP+D SFE
Sbjct: 210 GLVLWEVARRMVS---------NGIVEDYKPPFYDVVPNDPSFE 244
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 75/355 (21%), Positives = 123/355 (34%), Gaps = 105/355 (29%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-- 746
+E++K I +G+FG+V A A+K +++ + E IL +R
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQ----AAEEIRILEHLRKQ 153
Query: 747 ----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLA 800
V+ +FT R+++ + E L +LY L++K + R + ++
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
L+ LH I+H DLKP+N+L+ G IK+ DFG S
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------CYEHQ 254
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF--- 915
Y Y Q+ R Y APE++LG +G D WS+G IL E +TG P
Sbjct: 255 RVYT-YIQS----RF-------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302
Query: 916 -------------------------------------------TAESPEIIFDNILNRKI 932
T ++ + +R+
Sbjct: 303 DEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRG 362
Query: 933 PWPCVPSDMSFEAQ----------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
P + D + + L DP R+ A HP+ +
Sbjct: 363 KLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA---LRHPWLRR 414
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 86/339 (25%), Positives = 148/339 (43%), Gaps = 61/339 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+E++K + +GA+G V+ + R TG++ A+K++ D +R E IL +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ--NSTDAQRTFREIMILTELS 66
Query: 747 N-PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 803
+V ++ +YLV +Y+ DL++++R LE + + +L+ ++Y
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIKVIKY 124
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LHS G++HRD+KP N+L+ + H+K+ DFGLS+ + + + P + + +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-- 920
TD V T Y APEILLG T++ D WS+G IL E + G P F S
Sbjct: 185 PILTD------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 921 --EIIFD-------------------NILNRKIPWPCVP--------------------- 938
E I ++ +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 939 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+D + EA DL+++ L +PN+R+ A + HPF
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSI 334
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 84/355 (23%), Positives = 140/355 (39%), Gaps = 75/355 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D++ I I RG++G V+LA + T AIK+V + + D +RIL E IL ++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE--DLIDCKRILREITILNRLK 83
Query: 747 NPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 801
+ +++R + D LY+V+E DL L + L E+ + + L+L
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
++H GI+HRDLKP N L+ D +K+ DFGL++ ++ + P +
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 862 PEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 919
+Q T + V T Y APE++L E+ + D WS G I E + + +
Sbjct: 203 NLKKQLTSH------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 920 P--------------------------------EIIFD-----------NILN------- 929
IIF+ NI
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316
Query: 930 ------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ I +S + +L+ L +PN+R+ + HP+ K V
Sbjct: 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDV 368
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 76/364 (20%), Positives = 138/364 (37%), Gaps = 102/364 (28%)
Query: 678 SSHKERTSIDDFEIIKP-ISRGAFGRVFLARKR--TTGDLFAIKQVLKKLDM----IRKN 730
SS +ER D FE + RG +G V+ A+++ +A+KQ+ + + R+
Sbjct: 12 SSERER-VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACREI 69
Query: 731 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------ 784
+ R L N+ I+++ F+ ++L+ +Y DL+ +++
Sbjct: 70 ALLRELKHPNV-ISLQKVFLSH------ADRKVWLLFDYAEH-DLWHIIKFHRASKANKK 121
Query: 785 ---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKI 837
L + + + +++ + YLH+ ++HRDLKP N+L+ + G +K+ D G +++
Sbjct: 122 PVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAA 896
+ P D V T Y APE+LLG H A
Sbjct: 182 ---------------------FNSPLKPLADLDPV---VVTFWYRAPELLLGARHYTKAI 217
Query: 897 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNR----KI------P----WPCVPS--- 939
D W++G I E +T P F +I N + +I P W +
Sbjct: 218 DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPE 277
Query: 940 ---------------------------DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972
+A L+ + L DP +R+ + A +
Sbjct: 278 HSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ---D 334
Query: 973 PFFK 976
P+F
Sbjct: 335 PYFL 338
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-34
Identities = 72/336 (21%), Positives = 132/336 (39%), Gaps = 81/336 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
++ +KPI GA G V A AIK++ + + +R E ++ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVN 119
Query: 747 NPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
+ ++ FT + +YLVME + +L +++ L+ + + +++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCG 176
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM----- 220
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----- 915
Y V T Y APE++LG + D WSVG I+ E + F
Sbjct: 221 -TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268
Query: 916 --------------TAESPEIIFDNILN--------RKIPWPCV------------PSDM 941
E + + + N + +P +
Sbjct: 269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 328
Query: 942 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 329 ASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 72/349 (20%), Positives = 119/349 (34%), Gaps = 86/349 (24%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND--IERILAERNILITVR 746
F +I+ + G FGRV L + +A+K ++R E +IL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-------VVRNIKKYTRSAKIEADILKKIQ 89
Query: 747 -----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVL 799
N +V++ F D++ L+ E L G LY ++ + + ++Y E++
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI----- 854
AL YL + + H DLKP+N+L+ K I + ++ GI
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD--GKKIQIYRTKSTGIKLIDF 206
Query: 855 ----MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
SD H T R Y APE++L ++D WS G +L E T
Sbjct: 207 GCATFKSDYHGS-IINT----RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 911 GIPPFTAES----------------PEII----------FDNILNRKIPWPCVPSDMSF- 943
G F ++ + N K+ WP S ++
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314
Query: 944 ----------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
D + L DP R + H F +
Sbjct: 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK---HKFLE 360
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 74/360 (20%), Positives = 124/360 (34%), Gaps = 112/360 (31%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDI--ERILAERNILITVR 746
+ +++ + G F V+LA+ A+K ++R + + E E +L V
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-------IVRGDKVYTEAAEDEIKLLQRVN 73
Query: 747 NP-----------FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC--LEEDV 789
+ +++ F + + +V E L G +L +L++K +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIY 132
Query: 790 ARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAH------DGHIKLTDFGLSKIGLINN 842
+ +L+L L+Y+H GI+H D+KP+N+L+ IK+ D G +
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------- 185
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902
D HY QT R Y +PE+LLG G AD WS
Sbjct: 186 ------------CWYDEHYTNSIQT----RE-------YRSPEVLLGAPWGCGADIWSTA 222
Query: 903 IILFEFITGIPPFTAESPEI-------------------------------IFDNILNRK 931
++FE ITG F + F++ +
Sbjct: 223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 282
Query: 932 I-----PWP---CVPSDMSFEAQ------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
WP + F D ++ L DP +R A G HP+ K
Sbjct: 283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN---HPWLKD 339
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 33/287 (11%), Positives = 70/287 (24%), Gaps = 61/287 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP 748
+ ++ + + A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
V R R +V E++ GG L + R + L A + H G
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAG 149
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 868
+ P + ++ DG + L
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----------------------------------- 174
Query: 869 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 928
+ D +G L+ + P
Sbjct: 175 ------------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
Query: 929 NRKIPWPCVPS----DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971
P P+ D+ F+ + R + D R + ++
Sbjct: 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-32
Identities = 74/347 (21%), Positives = 109/347 (31%), Gaps = 84/347 (24%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKQVLKKLDMIRKNDIERILA--ERNILITV 745
+EI+ + G FG+V A+K +IR R A E N+L +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALK-------IIRNVGKYREAARLEINVLKKI 73
Query: 746 RNP------FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAEL 797
+ V F ++ + E L G + + L++ R +L
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLSGPETD 852
AL +LH + H DLKP+N+L + L + S D
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS---- 188
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912
+ H T RH Y PE++L D WS+G ILFE+ G
Sbjct: 189 ATFDHEHHTT-IVAT----RH-------YRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
Query: 913 PPFTAES---------------PEIIFDNILNRK------IPWPCVPSD----------- 940
F P + +K + W SD
Sbjct: 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 296
Query: 941 ---------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ DL+ R L DP QR+ A HPFF G+
Sbjct: 297 KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL---HPFFAGL 340
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 73/238 (30%), Positives = 108/238 (45%), Gaps = 38/238 (15%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE-RILAERNILITVRN 747
+EI I +G+FG+V A R + AIK + K + + IE R+L N T
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLH 805
++V F R++L LV E L +LY LLR + ++ R + ++ AL +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 806 S--LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
+ L I+H DLKP+N+L+ + IK+ DFG S Y
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS------------------CQLGQRIY 216
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919
Y Q+ R Y +PE+LLG + A D WS+G IL E TG P F+ +
Sbjct: 217 Q-YIQS----RF-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 71/349 (20%), Positives = 119/349 (34%), Gaps = 88/349 (25%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKQVLKKLDMIRKNDI--ERILAERNILITV 745
+EI+ + GAFG+V + G A+K +++ D E +E +L +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVK-------IVKNVDRYCEAARSEIQVLEHL 68
Query: 746 RNP------FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAEL 797
V+ F ++ +V E L G Y +++ G D R ++
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLSGPETD 852
++ +LHS + H DLKP+N+L + + + + + +D
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF------ 181
Query: 853 G--IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
G + H T RH Y APE++L D WS+G IL E+
Sbjct: 182 GSATYDDEHHST-LVST----RH-------YRAPEVILALGWSQPCDVWSIGCILIEYYL 229
Query: 911 GIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSDMSF------ 943
G F P+ + RK + W S +
Sbjct: 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289
Query: 944 --------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
DLI + L +DP +R+ A + HPFF +
Sbjct: 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK---HPFFDLL 335
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 59/283 (20%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT- 744
+D+ ++++ I RG +G V+ A+K + + + + E+NI
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVK-------VFSFANRQNFINEKNIYRVP 62
Query: 745 -VRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
+ + + RF + R LVMEY G L L R+ +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVT 121
Query: 799 LALEYLHS---------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 849
L YLH+ I HRDL N+L+ +DG ++DFGLS
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR------------ 169
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVG 902
+ ++ S VGT Y+APE+L G D +++G
Sbjct: 170 -------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
Query: 903 IILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 944
+I +E + +++ ++ + V + +FE
Sbjct: 223 LIYWEIFMR------CTDLFPGESVPEYQMAFQTEVGNHPTFE 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 53/300 (17%), Positives = 106/300 (35%), Gaps = 68/300 (22%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM 726
SSGV + ++ ++++ +RG FG V+ A+ + A+K +
Sbjct: 7 HHSSGVDLGT-ENLYFQS--MPLQLLEVKARGRFGCVWKAQLL--NEYVAVK-------I 54
Query: 727 IRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLR 780
D + E + +++ +++F + + L+L+ + G L L+
Sbjct: 55 FPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 781 KVGCLEEDVARIYIAELVLALEYLHS----------LGIVHRDLKPDNLLIAHDGHIKLT 830
++ I + L YLH I HRD+K N+L+ ++ +
Sbjct: 115 ANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 887
DFGL+ + + H VGT Y+APE+L
Sbjct: 174 DFGLALKFEAGKSAG-------------------------DTHGQVGTRRYMAPEVLEGA 208
Query: 888 LGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 944
+ + D +++G++L+E + E +P+ + S E
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--------YMLPFEEEIGQHPSLE 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-25
Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 50/277 (18%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN- 747
+ +I+ + G F V+L+ A+K V+K ++ E L E +L +VRN
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS----AEHYTETALDEIRLLKSVRNS 93
Query: 748 -------PFVVRFFYSFT---------CRDNLYLVMEYLNGGDLYSLLRK--VGCLEEDV 789
VV+ F C +V E L G L + K L
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPC 147
Query: 790 ARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 848
+ I +++ L+YLH+ I+H D+KP+N+L++ + + + SG
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 849 PETDGIM------------PSDAHYPEYQQTD-------NRNRHSAVGTPDYLAPEILLG 889
P +A + + D +++ + T Y + E+L+G
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 890 TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926
+ + AD WS + FE TG F S E +
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/258 (21%), Positives = 98/258 (37%), Gaps = 39/258 (15%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN- 747
+++ + I G+FG +F AIK R++D ++ E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLH 805
+ +Y + LV++ L G L LL G + VA +++ ++ +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK-QMLARVQSIH 123
Query: 806 SLGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+V+RD+KPDN LI + I + DFG+ K T H
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--------------KQH 169
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTA 917
P R + + GT Y++ LG E D ++G + F+ G P A
Sbjct: 170 IPY------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223
Query: 918 ESPEIIFDNILNRKIPWP 935
+ + ++ I +K P
Sbjct: 224 ATNKQKYERIGEKKQSTP 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 58/253 (22%), Positives = 95/253 (37%), Gaps = 37/253 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN- 747
+ + + I G+FG ++L G+ AIK K ++ E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMMQGG 64
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLH 805
+ + D +VME L G L L + V + +++ +EY+H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD-QMISRIEYIH 122
Query: 806 SLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
S +HRD+KPDN L+ + + DFGL+K D + H P
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-----KYRDARTHQ---------HIP 168
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAES 919
R + GT Y + LG E D S+G +L F G P A +
Sbjct: 169 ------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222
Query: 920 PEIIFDNILNRKI 932
++ I +K+
Sbjct: 223 KRQKYERISEKKM 235
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 39/255 (15%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN- 747
F + K I G FG + L + T + AIK + K+ ++ E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEP-----MKSRAPQLHLEYRFYKQLGSG 64
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLH 805
+ + +Y C +V+E L G L L + V I I +L+ +EY+H
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAI-QLISRMEYVH 122
Query: 806 SLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
S +++RD+KP+N LI G+ I + DF L+K ID + H
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE-----YIDPETKK---------H 168
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTA 917
P R S GT Y++ LG E D ++G + F+ G P A
Sbjct: 169 IPY------REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222
Query: 918 ESPEIIFDNILNRKI 932
++ + + I + K
Sbjct: 223 DTLKERYQKIGDTKR 237
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 32/232 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+D + + I RG FG VF R R L A+K ++ + + L E IL
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLP--PDLKAKFLQEARILKQYS 170
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLH 805
+P +VR T + +Y+VME + GGD + LR G + + + +EYL
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S +HRDL N L+ +K++DFG+S+ +
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSR-----------------EEADGVYAA--- 270
Query: 866 QTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915
P + APE L + +D WS GI+L+E + G P+
Sbjct: 271 ------SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 50/258 (19%)
Query: 668 QSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKQVL 721
G L + T + I+ + G FG+V L T D + A+K L
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-L 68
Query: 722 KKLDMIRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLL 779
K E +IL T+ + ++++ +L LVMEY+ G L L
Sbjct: 69 K--ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL 126
Query: 780 RKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832
+ I +A+L+L + YLH+ +HRDL N+L+ +D +K+ DF
Sbjct: 127 PR--------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178
Query: 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 892
GL+K + + DG P + APE L +
Sbjct: 179 GLAK--AVPEGHEYYRVREDGDSPV----------------------FWYAPECLKEYKF 214
Query: 893 GYAADWWSVGIILFEFIT 910
YA+D WS G+ L+E +T
Sbjct: 215 YYASDVWSFGVTLYELLT 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 58/253 (22%), Positives = 91/253 (35%), Gaps = 44/253 (17%)
Query: 681 KERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-------------LK 722
E +DD + + K I G FG ++LA + A V LK
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELK 85
Query: 723 KLDMIRKNDIERILAERNILITVRNPFVVRF-FYSFTCRDNLYLVMEYLNGGDLYSLLRK 781
+ K D + ER L + P F R ++VME L G DL + +
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 782 VGCL-EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIG 838
G + V ++ I ++ LEY+H VH D+K NLL+ + + L D+GLS
Sbjct: 145 NGTFKKSTVLQLGI-RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 898
N Y E R GT ++ + + G +D
Sbjct: 204 CPNGN--------------HKQYQE------NPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 899 WSVGIILFEFITG 911
+G + ++ G
Sbjct: 244 EILGYCMLRWLCG 256
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
+ ++ + +G FG V + R + TG++ A+K+ L+ D E IL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDF---EREIEIL 65
Query: 743 ITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL- 799
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQY 119
Query: 800 ------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+EYL + +HRDL N+L+ ++ +K+ DFGL+K
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK----------------- 162
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
++P D + ++ + +P + APE L ++ A+D WS G++L+E T
Sbjct: 163 VLPQDKEF--FKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 65/255 (25%), Positives = 110/255 (43%), Gaps = 50/255 (19%)
Query: 672 VSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKQVLKKLD 725
VS ++ + T + + I+ + G FG+V L R GD A+K LK
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LK--P 60
Query: 726 MIRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG 783
N I + E IL + + +V++ + + + L+ME+L G L L K
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-- 118
Query: 784 CLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+ +I + + + ++YL S VHRDL N+L+ + +K+ DFGL+K
Sbjct: 119 ----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174
Query: 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYA 895
+ +D Y Y D+R+ +P + APE L+ ++ A
Sbjct: 175 -----------------AIETDKEY--YTVKDDRD------SPVFWYAPECLMQSKFYIA 209
Query: 896 ADWWSVGIILFEFIT 910
+D WS G+ L E +T
Sbjct: 210 SDVWSFGVTLHELLT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 52/263 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
+ ++ + +G FG V + R + TG++ A+K+ L+ D E IL
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDF---EREIEIL 96
Query: 743 ITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL- 799
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------HKERIDHIKLLQY 150
Query: 800 ------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+EYL + +HRDL N+L+ ++ +K+ DFGL+K
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK----------------- 193
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912
++P D Y Y+ + +P + APE L ++ A+D WS G++L+E T I
Sbjct: 194 VLPQDKEY--YKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245
Query: 913 PPFTAESPEIIFDNILNRKIPWP 935
++SP F ++
Sbjct: 246 EK--SKSPPAEFMRMIGN-DKQG 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 69/266 (25%), Positives = 107/266 (40%), Gaps = 50/266 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKQVLKKLDMIRKNDIERILAERNIL 742
+ I + +G FG V L R GD L A+KQ L+ ++ D E IL
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ-LQHSGPDQQRDF---QREIQIL 78
Query: 743 ITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL- 799
+ + F+V++ R +L LVMEYL G L L++ AR+ + L+L
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRLLLY 132
Query: 800 ------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+EYL S VHRDL N+L+ + H+K+ DFGL+K
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK----------------- 175
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 911
++P D Y Y + +P + APE L +D WS G++L+E T
Sbjct: 176 LLPLDKDY--YVVREPG------QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227
Query: 912 IPPFTAESPEIIFDNILNRKIPWPCV 937
+ + + +
Sbjct: 228 DKSCSPSAEFLRMMGCERDVPALSRL 253
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 5e-21
Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 37/256 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN- 747
F + + I G+FG ++L T + AIK K ++L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQLLYESKIYRILQGG 62
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLH 805
+ + D LVM+ L G L L + V + +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD-QMINRVEFVH 120
Query: 806 SLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
S +HRD+KPDN L+ + + DFGL+K D S + H P
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-----KYRDTSTHQ---------HIP 166
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---AES 919
R + GT Y + LG E D S+G +L F+ G P+ A +
Sbjct: 167 Y------RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
Query: 920 PEIIFDNILNRKIPWP 935
+ ++ I +K+
Sbjct: 221 KKQKYEKISEKKVATS 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 45/278 (16%), Positives = 88/278 (31%), Gaps = 53/278 (19%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDLFAIKQ 719
+ S L I D +++ PI +G FG ++LA ++ + +
Sbjct: 8 QAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP 67
Query: 720 VLKKLDMIRKNDIERILAERNILITVRNPFV-----------------VRFFYSFTCRDN 762
+ K++ +D + E P
Sbjct: 68 CVVKVE---PSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGK 124
Query: 763 LY--LVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 818
Y ++M+ G DL + + V ++ + ++ LEY+H VH D+K N
Sbjct: 125 SYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSL-RILDILEYIHEHEYVHGDIKASN 182
Query: 819 LLI--AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 876
LL+ + + L D+GL+ Y +
Sbjct: 183 LLLNYKNPDQVYLVDYGLAYRYCPEGV--------------HKAYAA------DPKRCHD 222
Query: 877 GTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
GT ++ + + G D +G + +++TG P
Sbjct: 223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-20
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 48/238 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + + +G FG V++ T + AIK LK M E L E ++ +R
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIK-TLKPGTM----SPEAFLQEAQVMKKLR 237
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 799
+ +V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 238 HEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIAS 291
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LI 330
Query: 860 HYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915
EY P + APE L +D WS GI+L E T G P+
Sbjct: 331 EDNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-20
Identities = 57/242 (23%), Positives = 98/242 (40%), Gaps = 49/242 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKQVLKKLDMIRKNDIERILAERNIL 742
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATS--PKANKEILDEAYVM 71
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL--- 799
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 72 ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCV 124
Query: 800 ----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LL 167
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 913
++ Y + P ++A E +L + + +D WS G+ ++E +T G
Sbjct: 168 GAEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 914 PF 915
P+
Sbjct: 219 PY 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 8e-20
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 36/233 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D + + G +G V+ + A+K LK+ M ++E L E ++ ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTM----EVEEFLKEAAVMKEIK 274
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYL 804
+P +V+ T Y++ E++ G+L LR+ E +Y+A ++ A+EYL
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+HR+L N L+ + +K+ DFGLS++ D Y
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-----------MTGD----------TY 373
Query: 865 QQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 374 TAHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 58/278 (20%)
Query: 679 SHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKQVLKKLDMIR 728
S + + ++D I + + +G FG V A+ + F A+K + K D+I
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML--KADIIA 65
Query: 729 KNDIERILAERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKV 782
+DIE L E + +P V + + +++ ++ GDL++ L
Sbjct: 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 783 GCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
E + + LV +EYL S +HRDL N ++A D + + DFGLS
Sbjct: 126 RIGENP-FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN---RHSAVGTPDYLAPEILLGTEH 892
+ I D Y+Q + +LA E L +
Sbjct: 185 R----------------KIYSGD----YYRQGCASKLPVK--------WLALESLADNLY 216
Query: 893 GYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 929
+D W+ G+ ++E +T G P+ I++ ++
Sbjct: 217 TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 48/238 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + + +G FG V++ T + AIK LK M E L E ++ +R
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIK-TLKPGTM----SPEAFLQEAQVMKKLR 320
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 799
+ +V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 321 HEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIAS 374
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LI 413
Query: 860 HYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915
EY P + APE L +D WS GI+L E T G P+
Sbjct: 414 EDNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 55/243 (22%), Positives = 90/243 (37%), Gaps = 49/243 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF--AIKQVLKKLDMIRKNDIERILAERNILI 743
D +++ + G+FG V +G A+K LK + + ++ + E N +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNAMH 76
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 799
++ + ++R Y + +V E G L LRK + L
Sbjct: 77 SLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQ 129
Query: 800 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+ YL S +HRDL NLL+A +K+ DFGL + +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQ 173
Query: 857 SDAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 912
+D HY P + APE L +A+D W G+ L+E T G
Sbjct: 174 NDDHY-----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222
Query: 913 PPF 915
P+
Sbjct: 223 EPW 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D + + G +G V+ + A+K LK+ M ++E L E ++ ++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTM----EVEEFLKEAAVMKEIK 67
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYL 804
+P +V+ T Y++ E++ G+L LR+ E + ++ A+EYL
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
+HRDL N L+ + +K+ DFGLS++
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 35/158 (22%), Positives = 66/158 (41%), Gaps = 19/158 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++ I G FG V L + AIK +++ M E + E +++ +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKT-IREGAM----SEEDFIEEAEVMMKLS 61
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 799
+P +V+ + + + LV E++ G L LR L+
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCE 115
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
+ YL ++HRDL N L+ + IK++DFG+++
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 687 DDFEI--------IKPISRGAFGRVFLARKRTTGDLF--AIKQVLKKLDMIRKNDIERIL 736
+ + K + G FG V + + A+K + K + + +L
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALKDELL 66
Query: 737 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 796
AE N++ + NP++VR ++ LVME G L L++ +++ + +
Sbjct: 67 AEANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
+ + ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 53/276 (19%), Positives = 94/276 (34%), Gaps = 57/276 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLK---KLDMIRKNDIERILAERNILITV 745
+++ +R G ++ A +T + Q K KLD K+ R+ E+N
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLD--AKD--GRLFNEQNFFQRA 99
Query: 746 RNPFVVRF--------------FYSFTCRDNLY--LVMEYLNGGDLYSLLRKVGCL---E 786
P V F + Y LV+ L G L S L E
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE 158
Query: 787 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTI 844
V ++ L+ ALE+LH VH ++ +N+ + + L +G +
Sbjct: 159 RSVLQVAC-RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR------- 210
Query: 845 DLSGPETDGIMPSDAH--YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902
PS H Y E +R G ++++ ++ G +D S+G
Sbjct: 211 ---------YCPSGKHVAYVE------GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255
Query: 903 IILFEFITGIPP---FTAESPEIIFDNILNRKIPWP 935
+ +++ G P + +I+ P P
Sbjct: 256 YCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 38/152 (25%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
++ ++K + G FG V L + + D+ A+K +K+ M + E ++ +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKM-IKEGSM----SEDEFFQEAQTMMKLS 61
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLH 805
+P +V+F+ + +Y+V EY++ G L + LR G E + + ++ + +L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
S +HRDL N L+ D +K++DFG+++
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 58/254 (22%), Positives = 100/254 (39%), Gaps = 49/254 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKQVLKKLDMIRKNDIERILAERNIL 742
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATS--PKANKEILDEAYVM 71
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL--- 799
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 72 ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCV 124
Query: 800 ----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LL 167
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 913
++ Y + P ++A E +L + + +D WS G+ ++E +T G
Sbjct: 168 GAEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 914 PFTAESPEIIFDNI 927
P+ I +
Sbjct: 219 PYDGIPASEISSIL 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 34/153 (22%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++++ + G FG V++ + A+K LK+ M + LAE N++ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVK-SLKQGSM----SPDAFLAEANLMKQLQ 66
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYL 804
+ +VR + T ++ +Y++ EY+ G L L+ ++ + + + +A ++ + ++
Sbjct: 67 HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D +K + G FG V + R D+ AIK +K+ M + + E +++ +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKM-IKEGSM----SEDEFIEEAKVMMNLS 77
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 799
+ +V+ + T + ++++ EY+ G L + LR++ R +L+
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCE 131
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
A+EYL S +HRDL N L+ G +K++DFGLS+
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 47/198 (23%), Positives = 78/198 (39%), Gaps = 27/198 (13%)
Query: 663 LDSVSQSSGVSTPLHSSHKE--RTSIDDFEI-------IKPISRGAFGRVFLARKRTTGD 713
+ S S+ L E + ++D I K + G FG V +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 714 LF---AIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-----YSFTCRDNLYL 765
A+K + KLD + +IE L+E + +P V+R S +
Sbjct: 61 TSLKVAVKTM--KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118
Query: 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDN 818
++ ++ GDL++ L LE I + L+ +EYL + +HRDL N
Sbjct: 119 ILPFMKYGDLHTYLLYSR-LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177
Query: 819 LLIAHDGHIKLTDFGLSK 836
++ D + + DFGLSK
Sbjct: 178 CMLRDDMTVCVADFGLSK 195
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 65/254 (25%), Positives = 100/254 (39%), Gaps = 46/254 (18%)
Query: 675 PLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLF---AIKQVLKKLDMIRK 729
P + I+ I K I G G V R R G AIK LK +
Sbjct: 35 PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA-LKAGYT--E 91
Query: 730 NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV 789
L+E +I+ +P ++R T +V EY+ G L + LR
Sbjct: 92 RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------ 145
Query: 790 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
+ I +LV + YL LG VHRDL N+L+ + K++DFGLS+ ++ +
Sbjct: 146 GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLED 203
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902
D + T G +P + T APE + A+D WS G
Sbjct: 204 DPDAAYTTTGGKIP-------IRWT---------------APEAIAFRTFSSASDVWSFG 241
Query: 903 IILFEFIT-GIPPF 915
++++E + G P+
Sbjct: 242 VVMWEVLAYGERPY 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 34/166 (20%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKQVLKKLDMIRKNDIERILAER 739
+D + + +G F ++F +R GD +K VL K
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK-VLDKAHRNYSESF---FEAA 63
Query: 740 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELV 798
+++ + + +V + C D LV E++ G L + L+K + ++ +A +L
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 799 LALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSK 836
A+ +L ++H ++ N+L+ + IKL+D G+S
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 35/158 (22%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++ K + G FG V++A + A+K +K M +E LAE N++ T++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVK-TMKPGSM----SVEAFLAEANVMKTLQ 241
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 799
+ +V+ T ++ +Y++ E++ G L L+ ++ ++ + +L+
Sbjct: 242 HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAE 295
Query: 800 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
+ ++ +HRDL+ N+L++ K+ DFGL+++
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 58/274 (21%), Positives = 102/274 (37%), Gaps = 56/274 (20%)
Query: 659 SRLILDSVSQSSGVSTPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF- 715
+ + + S + + E + + K I G FG V+ +T+
Sbjct: 17 TENLYFQGAMGSDPNQAVLKFTTEIHPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKE 73
Query: 716 ---AIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 772
AIK LK + L E I+ + ++R + + ++ EY+
Sbjct: 74 VPVAIK-TLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 130
Query: 773 GDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDG 825
G L LR+ + +LV ++YL ++ VHRDL N+L+ +
Sbjct: 131 GALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL 184
Query: 826 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT--P-DYL 882
K++DFGLS++ D Y + G P +
Sbjct: 185 VCKVSDFGLSRV------------------LEDDPEATY---------TTSGGKIPIRWT 217
Query: 883 APEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915
APE + + A+D WS GI+++E +T G P+
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 48/256 (18%), Positives = 97/256 (37%), Gaps = 54/256 (21%)
Query: 675 PLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKQVLKKLDMIR 728
+ + T + +K + G FG V G+ IK V++ D
Sbjct: 2 AMKVLARIFKETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK-VIE--DKSG 55
Query: 729 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 788
+ + + + ++ + +VR +L LV +YL G L +R+
Sbjct: 56 RQSFQAVTDHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQ------H 108
Query: 789 VARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841
+ L+ + YL G+VHR+L N+L+ +++ DFG++
Sbjct: 109 RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD----- 163
Query: 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWS 900
++P D ++ + TP ++A E + ++ + +D WS
Sbjct: 164 ------------LLPPDDKQ--LLYSEAK-------TPIKWMALESIHFGKYTHQSDVWS 202
Query: 901 VGIILFEFIT-GIPPF 915
G+ ++E +T G P+
Sbjct: 203 YGVTVWELMTFGAEPY 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 66/257 (25%), Positives = 103/257 (40%), Gaps = 51/257 (19%)
Query: 673 STPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKQVLKKLDMI 727
+ +H KE T+I I K + G FG V R + AIK LK
Sbjct: 32 TQTVHEFAKELDATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT-LKVGYT- 86
Query: 728 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE 787
+ L E +I+ +P ++R T + +V EY+ G L S LRK
Sbjct: 87 -EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---- 141
Query: 788 DVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840
A+ + +LV ++YL +G VHRDL N+LI + K++DFGL ++
Sbjct: 142 --AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV--- 196
Query: 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWW 899
D Y + P + +PE + + A+D W
Sbjct: 197 ---------------LEDDPEAAYTTRGGK-------IPIRWTSPEAIAYRKFTSASDVW 234
Query: 900 SVGIILFEFIT-GIPPF 915
S GI+L+E ++ G P+
Sbjct: 235 SYGIVLWEVMSYGERPY 251
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 54/267 (20%), Positives = 103/267 (38%), Gaps = 58/267 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKQVLKKLDMIRKNDIERILAERNI 741
+ + + + +G+FG V+ K D AIK + + +R + L E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMR--ERIEFLNEASV 81
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELV 798
+ VVR + ++ME + GDL S LR +A +++++
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 799 L-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851
+ YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------------- 186
Query: 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL-----APEILLGTEHGY--AADWWSVGII 904
D + +Y + + L +PE L + + +D WS G++
Sbjct: 187 ------DIYETDYYRKGGKGL---------LPVRWMSPESLK--DGVFTTYSDVWSFGVV 229
Query: 905 LFEFIT-GIPPFTAESPEIIFDNILNR 930
L+E T P+ S E + ++
Sbjct: 230 LWEIATLAEQPYQGLSNEQVLRFVMEG 256
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 51/243 (20%)
Query: 687 DDFEIIK-PISRGAFGRVFLARKRTTGDLF--AIKQVLKKLDMIRKNDIERILAERNILI 743
D+ I + G FG V R AIK VLK+ K D E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTE--KADTEEMMREAQIMH 65
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 799
+ NP++VR + L LVME GG L+ L I ++ +
Sbjct: 66 QLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQ 118
Query: 800 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
++YL VHRDL N+L+ + + K++DFGLSK +
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA----------------LGA 162
Query: 857 SDAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 912
D++Y + P + APE + + +D WS G+ ++E ++ G
Sbjct: 163 DDSYY-----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 913 PPF 915
P+
Sbjct: 212 KPY 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 20/161 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKQVLKKLDMIRKNDIERILAERNILI 743
+D + + + G FG V+ A+K KK + E+ ++E I+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK-TCKKDCTLDNK--EKFMSEAVIMK 68
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 799
+ +P +V+ + +++ME G+L L + + + LVL
Sbjct: 69 NLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQ 121
Query: 800 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 684 TSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKQVLKKLDMIRKNDIE 733
+S D+EI + I G FG V + + AIK K E
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDS--VRE 61
Query: 734 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 793
+ L E + +P +V+ + ++++ME G+L S L+ +
Sbjct: 62 KFLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK------YSLD 114
Query: 794 IAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
+A L+L AL YL S VHRD+ N+L++ + +KL DFGLS+
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 70/282 (24%), Positives = 109/282 (38%), Gaps = 64/282 (22%)
Query: 653 SKYKENSRLILDSVSQSSGVSTPLHS-SHKE-RTSIDDFEIIKPISRGAFGRVFLARKRT 710
SKY + + I D++S S V + + + ++F+ I G FG+V+ R
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 711 TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTC--RDNLYLVM 767
G A+K+ IE E L R+P +V + C R+ + L+
Sbjct: 63 -GAKVALKR----RTPESSQGIEEFETEIETLSFCRHPHLVSLIGF---CDERNEMILIY 114
Query: 768 EYLNGGDLYSLLRKVGCLEED---VARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAH 823
+Y+ G+L L R+ I L YLH+ I+HRD+K N+L+
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174
Query: 824 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH--SAV-GTPD 880
+ K+TDFG+SK G E QT H + V GT
Sbjct: 175 NFVPKITDFGISKKG-----------------------TELDQT-----HLSTVVKGTLG 206
Query: 881 YLAPEILLGTEHGYA--------ADWWSVGIILFEFITGIPP 914
Y+ PE Y +D +S G++LFE +
Sbjct: 207 YIDPE--------YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++++ I +G FG V L R A+K +K + LAE +++ +R
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVK-CIKNDATAQA-----FLAEASVMTQLR 72
Query: 747 NPFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEY 803
+ +V+ + LY+V EY+ G L LR G + + V A+EY
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
L VHRDL N+L++ D K++DFGL+K
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-16
Identities = 56/247 (22%), Positives = 100/247 (40%), Gaps = 37/247 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKQVLKKLDMIRKNDIERILAERNILI 743
+ E+ + I G FG V + + AIK K + E+ L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTS--DSVREKFLQEALTMR 446
Query: 744 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALE 802
+P +V+ + ++++ME G+L S L+ L+ +Y +L AL
Sbjct: 447 QFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YL S VHRD+ N+L++ + +KL DFGLS+ + ++
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDST------------------ 545
Query: 863 EYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920
Y+ + + P ++APE + A+D W G+ ++E + G+ PF
Sbjct: 546 YYKASKGK-------LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598
Query: 921 EIIFDNI 927
+ I
Sbjct: 599 NDVIGRI 605
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 55/303 (18%), Positives = 109/303 (35%), Gaps = 61/303 (20%)
Query: 647 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706
K+ + ++ + + +D + + + + S + I RG FG V+
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHG 108
Query: 707 RKRTTGDLF---AIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDN 762
A+K L ++ I ++ + L E I+ +P V+ +
Sbjct: 109 TLLDNDGKKIHCAVK-SLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165
Query: 763 LYLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAELVLALEYLHSLGIVHR 812
+V+ Y+ GDL + +R +G VA+ +++L S VHR
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK--------GMKFLASKKFVHR 216
Query: 813 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN--- 869
DL N ++ +K+ DFGL++ + + +
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARD----------------MYDKE--FDSVHNKTGAKL 258
Query: 870 --RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDN 926
+ ++A E L + +D WS G++L+E +T G PP+ + I
Sbjct: 259 PVK----------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308
Query: 927 ILN 929
+L
Sbjct: 309 LLQ 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 56/255 (21%), Positives = 98/255 (38%), Gaps = 50/255 (19%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLF---AIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ I RG FG V+ A+K L ++ I ++ + L E I+
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIG--EVSQFLTEGIIMKDFS 84
Query: 747 NPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIA 795
+P V+ + +V+ Y+ GDL + +R +G VA+
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK---- 139
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
++YL S VHRDL N ++ +K+ DFGL++ + + +T +
Sbjct: 140 ----GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKL 194
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 914
P V ++A E L + +D WS G++L+E +T G PP
Sbjct: 195 P-------------------V---KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
Query: 915 FTAESPEIIFDNILN 929
+ + I +L
Sbjct: 233 YPDVNTFDITVYLLQ 247
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 39/234 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754
+ G FG V+ + A+K++ +D+ + ++ E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 755 -YSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEED-VARIYIAELVLA--LEYLHSLGI 809
+S D+L LV Y+ G L L G R IA A + +LH
Sbjct: 97 GFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA-QGAANGINFLHENHH 154
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
+HRD+K N+L+ K++DFGL++ ++ QT
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARAS-----------------------EKFAQTVM 191
Query: 870 RNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 921
+R VGT Y+APE L G T +D +S G++L E ITG+P
Sbjct: 192 TSR--IVGTTAYMAPEALRGEITPK---SDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 25/170 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKQVLKKLDMIRKNDIERILAERNI 741
D + + + GAFG+VFLA + L A+K LK + + D E +
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA-LKDPTLAARKDF---QREAEL 70
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVARI 792
L +++ +V+F+ D L +V EY+ GDL LR G + +
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 793 YIAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
+++++ + YL S VHRDL N L+ + +K+ DFG+S
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 5e-16
Identities = 66/297 (22%), Positives = 111/297 (37%), Gaps = 52/297 (17%)
Query: 634 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII- 692
+ + P + + + +D+ S S P K+ D +I
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 693 -KPISRGAFGRVFLARKRTTGDLF--AIKQVLKKLDMIRKNDIERILAERNILITVRNPF 749
+ G FG V R AIK VLK+ K D E ++ E I+ + NP+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTE--KADTEEMMREAQIMHQLDNPY 397
Query: 750 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALE 802
+VR + L LVME GG L+ L I ++ + ++
Sbjct: 398 IVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMK 450
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YL VHR+L N+L+ + + K++DFGLSK + D++Y
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA----------------LGADDSYY- 493
Query: 863 EYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915
+ P + APE + + +D WS G+ ++E ++ G P+
Sbjct: 494 ----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 48/169 (28%), Positives = 72/169 (42%), Gaps = 24/169 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKQVLKKLDMIRKNDIERILAERNI 741
D + + GAFG+VFLA + L A+K LK+ + D E +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA-LKEASESARQDF---QREAEL 96
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIY 793
L +++ +VRFF T L +V EY+ GDL LR G + +
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 794 IAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
+ +L+ + YL L VHRDL N L+ +K+ DFG+S
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 44/179 (24%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
+ + K + G FG+V A R A+K LK+ ++ +L+E N+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPS--ELRDLLSEFNV 79
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGC 784
L V +P V++ + + + L L++EY G L LR+
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 785 LEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
D + + +L+ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 48/169 (28%), Positives = 71/169 (42%), Gaps = 22/169 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKQVLKKLDMIRKNDIERILAERNILIT 744
+D + I G FG+V AR + G AIK+ +K+ K+D E +L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYAS--KDDHRDFAGELEVLCK 81
Query: 745 V-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL-- 801
+ +P ++ + R LYL +EY G+L LRK LE D A L
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 802 --------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 25/172 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN--DIERI--LAERNIL 742
+ K + GAFG+V A A V K M++ + ER ++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTEREALMSELKVL 80
Query: 743 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------VGCLEEDVA 790
+ N +V + T ++ EY GDL + LR+ +E+D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 791 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
+ + +L+ + +L S +HRDL N+L+ H K+ DFGL+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++++ I +G FG V L R G+ A+K +K + LAE +++ +R
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVK-CIKNDATAQA-----FLAEASVMTQLR 244
Query: 747 NPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEY 803
+ +V+ + LY+V EY+ G L LR G + + V A+EY
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 804 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
L VHRDL N+L++ D K++DFGL+K
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 27/174 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKQVLKKLDMIRKNDIERILAER 739
D + KP+ GAFG+V +A A+K LK + D+ +++E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEK--DLSDLVSEM 91
Query: 740 NILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDV 789
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 790 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 45/204 (22%), Positives = 79/204 (38%), Gaps = 25/204 (12%)
Query: 654 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLA----- 706
KY+ ++I S P + E+ ++ + K + GAFG+V A
Sbjct: 11 KYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 707 RKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYL 765
K A+K LK + E +++E I+ + +V + T + +
Sbjct: 71 GKEDAVLKVAVKM-LKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127
Query: 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--------------EYLHSLGIVH 811
+ EY GDL + LR+ + E IA + +L S +H
Sbjct: 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH 187
Query: 812 RDLKPDNLLIAHDGHIKLTDFGLS 835
RD+ N+L+ + K+ DFGL+
Sbjct: 188 RDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 52/260 (20%), Positives = 95/260 (36%), Gaps = 47/260 (18%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKQVLKKLDMIRKNDIERILAE 738
ER + I +G FG V+ AIK L ++ ++ +E L E
Sbjct: 19 ERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK-SLSRITEMQ--QVEAFLRE 72
Query: 739 RNILITVRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
++ + +P V+ + ++++ Y+ GDL +R + +L
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ------RNPTVKDL 126
Query: 798 VL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850
+ +EYL VHRDL N ++ +K+ DFGL++ +++
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQH 185
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
+P V + A E L +D WS G++L+E +T
Sbjct: 186 RHARLP-------------------V---KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
Query: 911 -GIPPFTAESPEIIFDNILN 929
G PP+ P + +
Sbjct: 224 RGAPPYRHIDPFDLTHFLAQ 243
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 79.1 bits (194), Expect = 5e-15
Identities = 101/727 (13%), Positives = 194/727 (26%), Gaps = 241/727 (33%)
Query: 396 HEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKL--SEIL 453
H +D ++++ E A +C DV + + E +
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS--VFED-------AFVDNFDCKDVQDMPKSILSKEEI 51
Query: 454 EQISESCNSSSHP------ILGSPENSRTQSMNSAITYDGYSPKISEWRNK-----GVEG 502
+ I S ++ S +L E + + + + Y +S + + +
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTR 110
Query: 503 MFEDIHEM---DTACIDDSHLGS----LNLRGHLGLKLS-----------GYGASSSTGS 544
M+ + + D ++ L LR L L+L G G +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-LELRPAKNVLIDGVLGSGKTWVALD 169
Query: 545 MTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLAC 604
S F FWL ++ C + + + L
Sbjct: 170 --VCLSYKVQCKMDFKIFWL------------------NLKNCNSPETVLEMLQKLLYQI 209
Query: 605 MHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILD 664
+ HS L I + + + +LL+ K Y+ N L+L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-----------------PYE-NCLLVLL 251
Query: 665 SV------------------SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706
+V ++ V+ L ++ S+D
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS-------MTLT----- 299
Query: 707 RKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVV----RFFYSFTCR-- 760
L K LD R D L + NP +
Sbjct: 300 -PDEVKSLLL-----KYLDC-RPQD----LPREVLTT---NPRRLSIIAESIRDGLATWD 345
Query: 761 -------DNLYLVME----YLNGGDLYSLLRKVGCLEEDVARIYIAELVLA--------- 800
D L ++E L + + ++ +I ++L+
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA---HIPTILLSLIWFDVIKS 402
Query: 801 -----LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
+ LH +V + K + I +++L ++ L + +D
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISI-PSIYLELKVKLENEYALHRSIVD---------- 451
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------ 909
HY + D+ D L P Y + I
Sbjct: 452 ----HYNIPKTFDS----------DDLIPP----YLDQY----------FYSHIGHHLKN 483
Query: 910 TGIPPFTAESPEIIFD-NILNRKI-----PWPCVPSDMSFEAQDLIN--RFLI-HDP-NQ 959
P + D L +KI W S ++ Q L ++ +DP +
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKFYKPYICDNDPKYE 542
Query: 960 RLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQI-SSGLPDDQ 1018
RL VN A+ F+P+ E + S+++ + L +
Sbjct: 543 RL----------------VN----AILD--FLPKIE----ENLICSKYTDLLRIALMAED 576
Query: 1019 NGSYSDA 1025
+ +A
Sbjct: 577 EAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.3 bits (179), Expect = 3e-13
Identities = 78/598 (13%), Positives = 166/598 (27%), Gaps = 170/598 (28%)
Query: 606 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDE--KSPTSFSKYKENSRLIL 663
+ +D+L A V + ++ + + IL+ E +D S + + +
Sbjct: 16 YQYKDILSVF-EDAFVDNFDCKDVQDMPKS--ILSKEEIDHIIMSKDA----VSGTLRLF 68
Query: 664 DSV--SQSSGVSTPLHSSHKERTSIDDFEII------KPISRGAFGRVFL-ARKRTTGDL 714
++ Q V + + +++ + + R+++ R R D
Sbjct: 69 WTLLSKQEEMVQKFVEEVLR-----INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND- 122
Query: 715 FAIKQVLKKLDMIRKNDIERI-------------------------LAE---RNILITVR 746
QV K ++ R ++ +A + + +
Sbjct: 123 ---NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
F + F+ + ++ V+E L L + D + + L
Sbjct: 180 MDFKI-FWLNLKNCNSPETVLEMLQ--KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 807 LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI----NNTIDLSGPETDGIMPSD 858
L + + + LL+ + + KI L+ D T + D
Sbjct: 237 L-LKSKPY-ENCLLVLLNVQNAKAWNAFNLS-CKI-LLTTRFKQVTDFLSAATTTHISLD 292
Query: 859 AHYPEYQQTDNRN-------------RHSAVGT-PDYLAPEILLGTE-HGYAADW----- 898
H + ++ + T P L+ ++ A W
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS---IIAESIRDGLATWDNWKH 349
Query: 899 ---WSVGIILFEFITGIPPFTAESPEI-----IFDNILNRKIP-------WP-CVPSDMS 942
+ I+ + + P AE ++ +F + IP W + SD+
Sbjct: 350 VNCDKLTTIIESSLNVLEP--AEYRKMFDRLSVFPP--SAHIPTILLSLIWFDVIKSDVM 405
Query: 943 FEAQDLINRFL-----------IHDPNQRLGANGAAEVKAH-------PFFKGVNWDSLA 984
L L I L E H K + D L
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 985 LQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGS--------YSDAD--------TC 1028
P +D YF +S I L + ++ + D
Sbjct: 466 ---------PPYLDQ--YF---YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS 511
Query: 1029 DSSSNSRTEMDECGDLAEFG-----SCP----LDLSLINFSFKNLSQLASINHEVLVQ 1077
+ + S + ++ L + + P L ++++F K L + L++
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR 569
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 5e-05
Identities = 68/541 (12%), Positives = 139/541 (25%), Gaps = 162/541 (29%)
Query: 38 YGVSRPPQKHKQKTVAQ--------------GHVK--LA----NSFTEEVRKGKKIAQWF 77
Y VSR K + G K +A S+ + + KI W
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WL 187
Query: 78 T--------SYISKFNIVSPNTENSGSEDKDVDVEDPRRT-----KLRHEGNHLNEKQSL 124
+ + + + + + D R +LR + L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 125 A--EHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDL--KELLDTLHSRFDAAKEV 180
+V ++K +F +L K LL T RF K+V
Sbjct: 248 LVLLNVQNAKA---WNAF---------------------NLSCKILLTT---RF---KQV 277
Query: 181 VNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLT 240
+ A + L+ + E+ +L + ++ QDL
Sbjct: 278 TDFLSAATTTHI--SLDHHSMTLTP-DEVKS---LLL-KYLDCR-----------PQDL- 318
Query: 241 EKRQQCQVG--LVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVET 298
R+ + ++ + L +K + L +
Sbjct: 319 -PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC------DKLTTIIESSLNVL----- 366
Query: 299 SWVPSPGTAESDLDYASYQK-----ANAKKKISGQQKVSTVPEI----SDCSCSESLDHT 349
E + + +A I + + + S + +
Sbjct: 367 ---------EPAEYRKMFDRLSVFPPSA--HIP-----TILLSLIWFDVIKSDVMVVVNK 410
Query: 350 SENKSVFIEQNFPPQKSQH--YSRMQEQQSHIVE--GRIVEVTKSNCGSPHEQGQSLDGS 405
S+ +Q S Y ++ + + IV+ +
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYL 469
Query: 406 DSVICRICEEVVPISHLESHSYICAYADKCEL-NCLDVDERLLKLSEILEQISESCNSSS 464
D SH+ H + ++ L + +D R L+ ++I
Sbjct: 470 DQYFY---------SHIGHHLKNIEHPERMTLFRMVFLDFRFLE-----QKIRHD----- 510
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGV-EGMFEDI----HEMDTACIDDSH 519
+ N+ +N+ Y P I + N E + I +++ I +
Sbjct: 511 ----STAWNASGSILNTLQQLKFYKPYICD--NDPKYERLVNAILDFLPKIEENLICSKY 564
Query: 520 L 520
Sbjct: 565 T 565
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 36/170 (21%), Positives = 60/170 (35%), Gaps = 24/170 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKQVLKKLDMIRKNDIERILAERNI 741
++ + FG+V+ AIK LK E E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAE--GPLREEFRHEAML 65
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 801
+++P VV T L ++ Y + GDL+ L + + + AL
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 802 ----------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
EYL S +VH+DL N+L+ ++K++D GL
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 27/174 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKQVLKKLDMIRKNDIERILAER 739
D + KP+ G FG+V +A K A+K LK + D+ +++E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEK--DLSDLVSEM 137
Query: 740 NILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDV 789
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 790 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 44/179 (24%), Positives = 67/179 (37%), Gaps = 32/179 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
++ E ++ I GAFGRVF AR + A+K LK+ + E +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEAS--ADMQADFQREAAL 103
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGC 784
+ NP +V+ + L+ EY+ GDL LR
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 785 LEEDVARIYIAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+ AE + + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
D ++ KP+ RGAFG+V A K T A+K LK+ + +++E I
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHS--EHRALMSELKI 83
Query: 742 LITV-RNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 790
LI + + VV + T L +++E+ G+L + LR V +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 791 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
+ + L+ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKQVLKKLDMIRKNDIERILAERNI 741
+ +I+ + GAFG V+ + D A+K L ++ + D L E I
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQ--DELDFLMEALI 86
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LA 800
+ + +VR +++ME + GGDL S LR+ + + + +L+ +A
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 801 L------EYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 836
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 37/165 (22%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKQVLKKLDMIRKNDIERILAERNI 741
+ +I+ + GAFG V+ + D A+K L ++ + D L E I
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQ--DELDFLMEALI 127
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV--- 798
+ + +VR ++++E + GGDL S LR+ + + + +L+
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 799 ----LALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 836
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 27/174 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKQVLKKLDMIRKNDIERILAER 739
D + KP+ GAFG+V LA K A+K LK + D+ +++E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEK--DLSDLISEM 125
Query: 740 NILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDV 789
++ + ++ + T LY+++EY + G+L L+
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 790 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
++ +LV +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 32/178 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
++ E K + GAFG+V A K A+K LK+ + E +++E +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSS--EREALMSELKM 101
Query: 742 LITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGC 784
+ + + +V + T +YL+ EY GDL + LR
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 785 LEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835
EED+ + +L+ +E+L VHRDL N+L+ H +K+ DFGL+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 2e-12
Identities = 45/219 (20%), Positives = 70/219 (31%), Gaps = 55/219 (25%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVL----KKLDMIRKNDIERILAERN 740
+ + + I G FG VF AIK + ++ + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 741 IL-----------------ITVRNPFVVRFFY----------------------SFTCRD 761
I I + + V+ Y F D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 762 NLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNL 819
L++V+E+ GG DL + K+ A+ + +L +L SL HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 820 LIAHDGHIKLTDFGLSKI------GLINNTIDLSGPETD 852
L+ KL K GL + ID + +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 67/248 (27%), Positives = 96/248 (38%), Gaps = 61/248 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIER-ILAERNILITV 745
D+F + RG FG+V+ R G L A+K+ L R E E ++
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKR----LKEERTQGGELQFQTEVEMISMA 84
Query: 746 RNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELV 798
+ ++R F C LV Y+ G + S LR E R IA L
Sbjct: 85 VHRNLLRL-RGF-CMTPTERLLVYPYMANGSVASCLR--ERPESQPPLDWPKRQRIA-LG 139
Query: 799 LA--LEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
A L YLH I+HRD+K N+L+ + + DFGL+K+ +T
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---------- 189
Query: 854 IMPSDAHYPEYQQTDNRNRH--SAV-GTPDYLAPEILLGTEHGYA---ADWWSVGIILFE 907
H +AV GT ++APE L G + D + G++L E
Sbjct: 190 -------------------HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLE 227
Query: 908 FITGIPPF 915
ITG F
Sbjct: 228 LITGQRAF 235
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-07
Identities = 37/151 (24%), Positives = 59/151 (39%), Gaps = 24/151 (15%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKQVLKK------LD-MIRKNDIERILAERNILITVRN 747
I +GA + R IK+ +KK LD IRK R E L V++
Sbjct: 344 IGKGAEADIK--RDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVKD 398
Query: 748 PFV-VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+ + + DN ++M Y+NG ++ + + I + LH
Sbjct: 399 FGIPAPYIFDVD-LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEI--------VGKLHK 449
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
++H DL N + D + + DFGL KI
Sbjct: 450 NDVIHNDLTTSNFIF--DKDLYIIDFGLGKI 478
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 35/184 (19%), Positives = 66/184 (35%), Gaps = 9/184 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKQVLKKL-DMIRKNDIERILAERNILIT 744
D ++ KP+ RGAFG+V A +K L + ++ +++E ILI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 745 VRN-PFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+ + VV + T L +++E+ G+L + LR + + Y + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARFRQ 137
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHY 861
+G + DLK I + F K + + D +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 862 PEYQ 865
+Q
Sbjct: 198 YSFQ 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 28/115 (24%)
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR------------------------- 241
Query: 862 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 914
+ + + R P ++APE + + +D WS G++L+E + G P
Sbjct: 242 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 30/169 (17%), Positives = 58/169 (34%), Gaps = 29/169 (17%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK----------QVLKKLDM-- 726
+D I K + G VF +K +V +K D
Sbjct: 84 RLVRSGKVDA--IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGD 140
Query: 727 IRKNDIERILAER--NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 784
+ + + A L ++ V + + N ++ME ++ +LY +
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYA---WEGNA-VLMELIDAKELYRVR----- 191
Query: 785 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833
E+ + ++ + + GIVH DL N+L+ + I + DF
Sbjct: 192 -VENPDEVL-DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFP 237
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1093 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.07 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.01 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.49 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.43 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.17 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.26 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.23 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.7 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-65 Score=564.01 Aligned_cols=279 Identities=36% Similarity=0.722 Sum_probs=253.0
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
+...++|++++.||+|+||+||+|+++.+|+.|||| ++.+.........+.+.+|+.+|+.++|||||+++++|++.+.
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK-~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEE-EEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEE-EEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 345689999999999999999999999999999999 4445444455667889999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|||||||+||+|.++|.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~- 185 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE- 185 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999853110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.......+.||||.|||||++.+..|+.++|||||||+||||++|++||.+.+..+
T Consensus 186 ------------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 241 (311)
T 4aw0_A 186 ------------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241 (311)
T ss_dssp ------------------------TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11223467899999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc---HHHHHcCCCCCCCCcchhhcccCcc
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG---AAEVKAHPFFKGVNWDSLALQKAVF 990 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~---A~EIL~HPFFkgIdWd~L~~~~pPf 990 (1093)
++.+|++..+.+| ..+|+++++||.+||++||.+|||+.+ ..+|++||||++++|+.+..+.||.
T Consensus 242 ~~~~i~~~~~~~p---~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~ 309 (311)
T 4aw0_A 242 IFAKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 309 (311)
T ss_dssp HHHHHHHTCCCCC---TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCC
T ss_pred HHHHHHcCCCCCC---cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCC
Confidence 9999999988776 689999999999999999999999653 4679999999999999998887664
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-64 Score=551.23 Aligned_cols=278 Identities=41% Similarity=0.783 Sum_probs=242.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
+...++|++++.||+|+||+||+|++. .+++.||+|++ ++... .......+.+|+.+|+.++|||||+++++|++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i-~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATL-KVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEE-ESEEE-EEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEE-ehHHc-ChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 345678999999999999999999984 46889999954 33322 22233468889999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
++.+|||||||+||+|.++|.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+
T Consensus 178 ---------------------------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 178 ---------------------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp ------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------------------------CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 01123456899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccC
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVP 992 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P 992 (1093)
..+++.+|.+..+.+| ..+|+++++||.+||++||.+|||+ ..+.|+++||||++++|+.+..+ .|||+|
T Consensus 231 ~~~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 231 RKETMTMILKAKLGMP---QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HHHHHHHHHcCCCCCC---CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 9999999999887766 7899999999999999999999995 35889999999999999999765 688887
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-63 Score=594.31 Aligned_cols=327 Identities=33% Similarity=0.560 Sum_probs=267.9
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHH---HHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI---LITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~I---L~kL~HPNIVkL~gsfqd 759 (1093)
.+++++|+++++||+|+||+||+|+++.+|+.|||| ++++...........+.+|+.+ +..++|||||+++++|++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK-~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEE-EEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEE-EEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 467899999999999999999999999999999999 5555555444555566666544 456689999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+.+|||||||+||+|+++|.+.+.|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.....+.||||.|||||++.+ ..|+.++|||||||+||||++|++||.+.
T Consensus 344 -----------------------------~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 344 -----------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp -----------------------------SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred -----------------------------CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 123456899999999999974 68999999999999999999999999864
Q ss_pred ---ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCccc
Q 001354 919 ---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFV 991 (1093)
Q Consensus 919 ---s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~ 991 (1093)
+..+++..+....+.+| ..+|+++++||.+||++||.+|+|. .++.+|++||||++++|+.+..+ .|||+
T Consensus 395 ~~~~~~~i~~~i~~~~~~~p---~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~ 471 (689)
T 3v5w_A 395 KTKDKHEIDRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471 (689)
T ss_dssp GCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred ChHHHHHHHHhhcCCCCCCC---ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCcc
Confidence 34567777888777666 7899999999999999999999994 57999999999999999999766 79999
Q ss_pred CCCCCCCCC-----cccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCcc
Q 001354 992 PQPESVDDT-----SYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLA 1045 (1093)
Q Consensus 992 P~~~s~~Dt-----s~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~ 1045 (1093)
|.+..+.++ ++|++.|+.. ......|...+..|++ ..+..|+.+|.++ .|.
T Consensus 472 P~~~~~~~~~~fD~~~fd~e~~~~-~~~~~~d~~~f~~Fs~-~~~~~~q~e~~et-~~~ 527 (689)
T 3v5w_A 472 PPRGEVNAADAFDIGSFDEEDTKG-IKLLDSDQELYRNFPL-TISERWQQEVAET-VFD 527 (689)
T ss_dssp CCTTCSSTTBCCC---------CC-CCCCHHHHTTTTTCCE-ECHHHHHHHHHTT-THH
T ss_pred CCCCCCCcCCCCCCccCCccccCC-CCCCchHHHHHhCCCc-cCccchhhhhhhh-hhh
Confidence 987665544 4555544432 2223334455666655 3445677777665 444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=520.71 Aligned_cols=302 Identities=40% Similarity=0.774 Sum_probs=265.5
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~ 760 (1093)
..+.+++|++++.||+|+||+||+|+++.+|+.|||| ++++...........+.+|+.+|..+ +||||++++++|++.
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK-~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVK-VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEE-EEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEE-EEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 3577899999999999999999999999999999999 44454444556678899999999988 699999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+.+|+||||++||+|..++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~- 175 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI- 175 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc-
Confidence 9999999999999999999998999999999999999999999999999999999999999999999999999998421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.......+.+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+.
T Consensus 176 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 176 --------------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp --------------------------C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 011234567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPE 995 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa---~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~ 995 (1093)
.+++..|......+| ..+++++.+||.+||++||.+||++ .++.+|++||||++++|+.+..+ .|||+|...
T Consensus 230 ~~~~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~ 306 (353)
T 3txo_A 230 DDLFEAILNDEVVYP---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK 306 (353)
T ss_dssp HHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC
Confidence 999999999888776 6799999999999999999999995 45689999999999999998655 799999999
Q ss_pred CCCCCcccccccccCCCCC
Q 001354 996 SVDDTSYFLSRFSQISSGL 1014 (1093)
Q Consensus 996 s~~Dts~Fds~fs~~~~~l 1014 (1093)
+..|+++|+..|+......
T Consensus 307 ~~~~~~~f~~~~~~~~~~~ 325 (353)
T 3txo_A 307 SREDVSNFDPDFIKEEPVL 325 (353)
T ss_dssp STTCCTTSCHHHHTSCCCC
T ss_pred CcccccccCcccccCCCcC
Confidence 9999999999888765433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=527.88 Aligned_cols=303 Identities=37% Similarity=0.739 Sum_probs=266.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~ 761 (1093)
.+.+++|+++++||+|+||+||+|+++.+++.||+| ++++...........+.+|+.+|..+ +|||||+++++|++..
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK-~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR-VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEE-EEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEE-EEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 467789999999999999999999999999999999 44444444455567788999999887 7999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+||||||++||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~-- 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-- 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc--
Confidence 999999999999999999998999999999999999999999999999999999999999999999999999998421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC---
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 918 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~--- 918 (1093)
.......+.+||+.|+|||++.+..|+.++|||||||+||||++|++||...
T Consensus 205 -------------------------~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~ 259 (396)
T 4dc2_A 205 -------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 259 (396)
T ss_dssp -------------------------CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-
T ss_pred -------------------------cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccc
Confidence 1122345679999999999999999999999999999999999999999643
Q ss_pred ------ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhcc--c
Q 001354 919 ------SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--K 987 (1093)
Q Consensus 919 ------s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa---~~A~EIL~HPFFkgIdWd~L~~~--~ 987 (1093)
....++..|....+.+| ..+++++++||++||++||.+||++ .++.+|++||||++++|+.+..+ .
T Consensus 260 ~~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~ 336 (396)
T 4dc2_A 260 DNPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 336 (396)
T ss_dssp -----CCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSC
T ss_pred cccchhhHHHHHHHHhccccCCC---CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCC
Confidence 23457778888877766 6899999999999999999999996 36899999999999999998765 7
Q ss_pred CcccCCCCCCCCCcccccccccCCCCCCC
Q 001354 988 AVFVPQPESVDDTSYFLSRFSQISSGLPD 1016 (1093)
Q Consensus 988 pPf~P~~~s~~Dts~Fds~fs~~~~~l~~ 1016 (1093)
|||+|...+..|+++|++.|+..+..+.+
T Consensus 337 pp~~p~~~~~~d~~~fd~~~~~~~~~~~~ 365 (396)
T 4dc2_A 337 PPFKPNISGEFGLDNFDSQFTNEPVQLTP 365 (396)
T ss_dssp CSCCCCCCSSTTGGGSCHHHHTSCCCCCC
T ss_pred CCCcCCCCCccchhhcChhhccCCCccCC
Confidence 99999999999999999999887655443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=509.26 Aligned_cols=257 Identities=34% Similarity=0.606 Sum_probs=217.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+++|++++.||+|+||+||+|+++.+|+.||+|++ .+...........+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i-~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEE-ECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEE-eHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 3468999999999999999999999999999999954 444444445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||||||+ +|+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~---- 163 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---- 163 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC----
Confidence 9999999 68999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......+.+|||.|||||++.+..| +.++|||||||+||||++|++||.+.+..+
T Consensus 164 ------------------------~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~ 219 (275)
T 3hyh_A 164 ------------------------DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV 219 (275)
T ss_dssp -----------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 1112346799999999999998886 689999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
+++.|..+...+| ..+|+++++||.+||++||.+||| +.|+++||||+
T Consensus 220 ~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hpw~k 267 (275)
T 3hyh_A 220 LFKNISNGVYTLP---KFLSPGAAGLIKRMLIVNPLNRIS---IHEIMQDDWFK 267 (275)
T ss_dssp HHHHHHHTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHCHHHH
T ss_pred HHHHHHcCCCCCC---CCCCHHHHHHHHHHccCChhHCcC---HHHHHcCcccc
Confidence 9999998887765 789999999999999999999999 88999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=508.94 Aligned_cols=300 Identities=41% Similarity=0.757 Sum_probs=270.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+.+++|++++.||+|+||+||+|+++.+|+.||+| ++++...........+.+|+.+|..++||||++++++|++.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK-~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEE-EEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEE-EEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 56789999999999999999999999999999999 44444444455678899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|..++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~---- 156 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI---- 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC----
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...+
T Consensus 157 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 157 -----------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp -----------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -----------------------cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH
Confidence 011233467899999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 999 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~D 999 (1093)
+..|......+| ..+++++++||.+||..||.+||+. .++.+|++||||++++|+.+..+ .|||+|.+.+..|
T Consensus 214 ~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d 290 (337)
T 1o6l_A 214 FELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVD 290 (337)
T ss_dssp HHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTC
T ss_pred HHHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcch
Confidence 999998887766 6899999999999999999999963 35999999999999999998655 7899999999999
Q ss_pred CcccccccccCCCCC
Q 001354 1000 TSYFLSRFSQISSGL 1014 (1093)
Q Consensus 1000 ts~Fds~fs~~~~~l 1014 (1093)
+++|+..|+......
T Consensus 291 ~~~f~~~~~~~~~~~ 305 (337)
T 1o6l_A 291 TRYFDDEFTAQSITI 305 (337)
T ss_dssp CTTSCHHHHTSCCC-
T ss_pred hhcccchhccCccCc
Confidence 999998887765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-59 Score=514.71 Aligned_cols=299 Identities=34% Similarity=0.722 Sum_probs=265.5
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~ 760 (1093)
.++.+++|++++.||+|+||+||+|+++.+|+.|||| ++++...........+..|+.+|..+ +||||++++++|++.
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK-~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVK-ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEE-EEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEE-EEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 3567899999999999999999999999999999999 54454444455678899999999887 799999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+.+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~- 172 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 172 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC-
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc-
Confidence 9999999999999999999988899999999999999999999999999999999999999999999999999998421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.
T Consensus 173 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 173 --------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp --------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 011234567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 996 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s 996 (1093)
.+++..|+...+.+| ..+++++++||.+||++||.+||+. .++.+|++||||++++|+.+..+ .|||+|...+
T Consensus 227 ~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~ 303 (353)
T 2i0e_A 227 DELFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACG 303 (353)
T ss_dssp HHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred HHHHHHHHhCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCC
Confidence 999999999887766 6899999999999999999999985 46899999999999999998655 7999999988
Q ss_pred CCCCcccccccccCCC
Q 001354 997 VDDTSYFLSRFSQISS 1012 (1093)
Q Consensus 997 ~~Dts~Fds~fs~~~~ 1012 (1093)
. |+++|+.+|+....
T Consensus 304 ~-~~~~f~~~~~~~~~ 318 (353)
T 2i0e_A 304 R-NAENFDRFFTRHPP 318 (353)
T ss_dssp C---CHHHHHHHHSCC
T ss_pred c-chhhccchhccCCc
Confidence 8 99999998876643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=523.98 Aligned_cols=259 Identities=26% Similarity=0.509 Sum_probs=227.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
.+++|++++.||+|+||+||+|+++.+|+.||||++. +.. ......+.+.+|+.+|+.++|||||+++++|++.+.+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~-~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-ISR-MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEE-CTT-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEe-hHH-CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4689999999999999999999999999999999553 322 23455778999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
||||||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 177 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-- 177 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence 999999999999999754 3579999999999999999999999999999999999999999999999999985210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+
T Consensus 178 -------------------------~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 232 (350)
T 4b9d_A 178 -------------------------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232 (350)
T ss_dssp -------------------------HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -------------------------CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 1112346789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
++.+|+.+.. |.++..+|+++++||.+||++||.+||+ +.|+|+||||+.
T Consensus 233 ~~~~i~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~ 282 (350)
T 4b9d_A 233 LVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPS---VNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHT
T ss_pred HHHHHHcCCC--CCCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHHhhc
Confidence 9999998765 3456889999999999999999999999 889999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-59 Score=520.95 Aligned_cols=256 Identities=32% Similarity=0.539 Sum_probs=228.4
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.|++++.||+|+||+||+|+++.+|+.||||++- +... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~-~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMD-LRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE-GGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEe-cCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46999999999999999999999999999999553 3222 2335678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~------- 221 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS------- 221 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC-------
Confidence 999999999999875 579999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.......+.||||.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..
T Consensus 222 --------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~ 281 (346)
T 4fih_A 222 --------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 281 (346)
T ss_dssp --------------------SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred --------------------CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence 011234568999999999999999999999999999999999999999999999999998
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
|.....+....+..+|+++++||.+||++||.+||| +.|+|+||||+.
T Consensus 282 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~e~l~Hp~~~~ 329 (346)
T 4fih_A 282 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAK 329 (346)
T ss_dssp HHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhcC
Confidence 877644333344679999999999999999999999 889999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=529.06 Aligned_cols=335 Identities=35% Similarity=0.651 Sum_probs=278.7
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.++..++|+++++||+|+||+||+|+++.+++.||+| ++++...........+.+|+.+|..++||||++++++|++..
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK-~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEE-EEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEE-EEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 3466789999999999999999999999999999999 444544444445566899999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+||||||++||+|.+++.+ .+.+++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999987 46899999999999999999999999999999999999999999999999999975311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
.........+||+.|||||++. +..|+.++|||||||+||||++|++||
T Consensus 228 --------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf 281 (437)
T 4aw2_A 228 --------------------------DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281 (437)
T ss_dssp --------------------------TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred --------------------------CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence 0111234568999999999997 567899999999999999999999999
Q ss_pred CCCChHHHHHHHhcc--CCCCCCCCCCCCHHHHHHHHhhccCCcCC--CCChhcHHHHHcCCCCCCCCcchhhcccCccc
Q 001354 916 TAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLALQKAVFV 991 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~--~l~fP~ip~~IS~eakDLIkrcL~kDP~K--RpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~ 991 (1093)
.+.+..+++.+|+.. .+.+|.....+++++++||++||+.+|.+ |++ +.++++||||++++|+.+....|||+
T Consensus 282 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~---~~eil~Hpff~~i~w~~l~~~~~p~~ 358 (437)
T 4aw2_A 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNG---IEDFKKHPFFSGIDWDNIRNCEAPYI 358 (437)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTT---THHHHTSGGGTTCCTTTGGGSCCSCC
T ss_pred CCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCC---HHHHhCCCccCCCCHHHHhhCCCCCC
Confidence 999999999999864 45667655679999999999999988776 666 88999999999999999988899999
Q ss_pred CCCCCCCCCcccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCccccCCCCCCcccccceEecchhhhccc
Q 001354 992 PQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1071 (1093)
Q Consensus 992 P~~~s~~Dts~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~~~~~~d~~F~g~tyk~~~~~~~~~ 1071 (1093)
|.+.++.|+++|+.++......... .. .. .......+++|.||||++++.+..-+
T Consensus 359 P~~~~~~d~~~fd~~~~~~~~~~~~------------~~--~~-----------~~~~~~~~~~f~~~~~~~~~~~~~~~ 413 (437)
T 4aw2_A 359 PEVSSPTDTSNFDVDDDCLKNSETM------------PP--PT-----------HTAFSGHHLPFVGFTYTSSCVLSDRS 413 (437)
T ss_dssp CCCSSTTCCTTSCCC-------------------------------------------CCTTGGGTTCCEESSCTTSTTS
T ss_pred CcCCCccchhhcCCcccccccccCC------------CC--Cc-----------cccccccCccccCCCcCCchhhccCC
Confidence 9999999999998764332111000 00 00 00122357899999999998876655
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=522.39 Aligned_cols=296 Identities=40% Similarity=0.739 Sum_probs=255.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
++..++|++++.||+|+||+||+|+++.+|+.|||| ++++...........+.+|+.+|..++||||++++++|++.+.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK-~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMK-IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEE-EEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEE-EEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 456789999999999999999999999999999999 5555444455566778999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+||||||++||+|.+++.+.+ .+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~- 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA- 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC-
Confidence 999999999999999998764 799999999999999999999999999999999999999999999999999985311
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-------CCCCCccceeecchhhHHHHHhCCCC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-------GTEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-------g~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
.........+||+.|||||++. +..|+.++|||||||+||||++|++|
T Consensus 215 -------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 269 (412)
T 2vd5_A 215 -------------------------DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269 (412)
T ss_dssp -------------------------TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred -------------------------CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCC
Confidence 0011234578999999999997 35689999999999999999999999
Q ss_pred CCCCChHHHHHHHhcc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcccCcccC
Q 001354 915 FTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVP 992 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~~--~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~~pPf~P 992 (1093)
|.+.+..+++.+|+.. .+.+|..+..+|+++++||++||+ +|.+|++..++.+|++||||++++|+.+....|||+|
T Consensus 270 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p 348 (412)
T 2vd5_A 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP 348 (412)
T ss_dssp TCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred CCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 9999999999999863 355665567899999999999999 9999987667999999999999999999888999999
Q ss_pred CCCCCCCCcccccc
Q 001354 993 QPESVDDTSYFLSR 1006 (1093)
Q Consensus 993 ~~~s~~Dts~Fds~ 1006 (1093)
...+..|++||+..
T Consensus 349 ~~~~~~d~~~f~~~ 362 (412)
T 2vd5_A 349 DFEGATDTCNFDLV 362 (412)
T ss_dssp C-----CCSSCC--
T ss_pred cCCCcccccccCcc
Confidence 99999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=514.13 Aligned_cols=300 Identities=39% Similarity=0.756 Sum_probs=247.6
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHH-HHhcCCCceEEEeeeecc
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~I-L~kL~HPNIVkL~gsfqd 759 (1093)
......++|++++.||+|+||+||+|+++.++..|||| ++++...........+..|..+ +..++|||||+++++|++
T Consensus 32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK-~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEE-EEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEE-EEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence 34577899999999999999999999999999999999 5555454455566778888887 467899999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+.+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
. ......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 191 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 191 E---------------------------HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp C---------------------------CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred c---------------------------CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 0 1123456789999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCC
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 996 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa-~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s 996 (1093)
..+++..|+...+.+| ..++.++++||.+||++||.+||++ +++.+|++||||++++|+.+..+ .|||+|...+
T Consensus 244 ~~~~~~~i~~~~~~~~---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~ 320 (373)
T 2r5t_A 244 TAEMYDNILNKPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSG 320 (373)
T ss_dssp HHHHHHHHHHSCCCCC---SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC
T ss_pred HHHHHHHHHhcccCCC---CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCC
Confidence 9999999999877665 6899999999999999999999996 46889999999999999998655 7999999999
Q ss_pred CCCCcccccccccCC
Q 001354 997 VDDTSYFLSRFSQIS 1011 (1093)
Q Consensus 997 ~~Dts~Fds~fs~~~ 1011 (1093)
..|+++|+..|+...
T Consensus 321 ~~d~~~f~~~~~~~~ 335 (373)
T 2r5t_A 321 PNDLRHFDPEFTEEP 335 (373)
T ss_dssp ---------------
T ss_pred cchhhhcCccccccc
Confidence 999999998777654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=508.60 Aligned_cols=296 Identities=39% Similarity=0.747 Sum_probs=243.8
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~ 760 (1093)
..+.+++|++++.||+|+||+||+|+++.+|+.||+| ++++...........+..|+.+|..+ +||||++++++|++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK-~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEE-EEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEE-EEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 4567899999999999999999999999999999999 44444444445667889999999877 899999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 171 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 171 ---------------------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp ---------------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 11224567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 998 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~ 998 (1093)
.+++..|......+| ..+++++++||.+||+.||.+||++. .+|++||||++++|+.+..+ .|||+|...++.
T Consensus 224 ~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dp~~R~~~~--~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~ 298 (345)
T 1xjd_A 224 EELFHSIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPF 298 (345)
T ss_dssp HHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC----------
T ss_pred HHHHHHHHhCCCCCC---cccCHHHHHHHHHHhcCCHhHcCCCh--HHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcc
Confidence 999999988876665 68999999999999999999999943 28999999999999998665 789999999999
Q ss_pred CCcccccccccC
Q 001354 999 DTSYFLSRFSQI 1010 (1093)
Q Consensus 999 Dts~Fds~fs~~ 1010 (1093)
|+++|+..|++.
T Consensus 299 d~~~f~~~~~~~ 310 (345)
T 1xjd_A 299 DCSNFDKEFLNE 310 (345)
T ss_dssp ------------
T ss_pred hhhhcchhhccc
Confidence 999999877654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=501.20 Aligned_cols=299 Identities=37% Similarity=0.743 Sum_probs=264.5
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~ 761 (1093)
.+.+++|++++.||+|+||.||+|+++.+++.||+|+ +++...........+.+|+.+|..+ +||||++++++|++..
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~-~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEE-EEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEE-EEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 3567899999999999999999999999999999994 4444444556678899999999988 8999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~-- 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-- 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC--
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC----
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA---- 917 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~---- 917 (1093)
.......+.+||+.|+|||++.+..|+.++|||||||+||||++|.+||..
T Consensus 162 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 216 (345)
T 3a8x_A 162 -------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216 (345)
T ss_dssp -------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-
T ss_pred -------------------------CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccc
Confidence 011233467899999999999999999999999999999999999999975
Q ss_pred -----CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhcc--c
Q 001354 918 -----ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--K 987 (1093)
Q Consensus 918 -----~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa---~~A~EIL~HPFFkgIdWd~L~~~--~ 987 (1093)
.....++..|......+| ..++.++++||.+||+.||.+||++ .++.+|++||||++++|+.+..+ .
T Consensus 217 ~~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~ 293 (345)
T 3a8x_A 217 DNPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 293 (345)
T ss_dssp ------CHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred cccccccHHHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCC
Confidence 334567777877777665 6899999999999999999999996 35789999999999999998655 7
Q ss_pred CcccCCCCCCCCCcccccccccCCC
Q 001354 988 AVFVPQPESVDDTSYFLSRFSQISS 1012 (1093)
Q Consensus 988 pPf~P~~~s~~Dts~Fds~fs~~~~ 1012 (1093)
|||+|...+..|+++|+..|+....
T Consensus 294 ~p~~p~~~~~~~~~~~~~~~~~~~~ 318 (345)
T 3a8x_A 294 PPFKPNISGEFGLDNFDSQFTNEPV 318 (345)
T ss_dssp CSCCCCCCTTTCGGGSCHHHHTSCS
T ss_pred CCcCCCCCCcchhhhcCcccccCcc
Confidence 8999999999999999987776543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=516.98 Aligned_cols=296 Identities=42% Similarity=0.705 Sum_probs=258.8
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.++..++|++++.||+|+||+||+|+++.+++.||+| ++++...........+.+|+.+|..++|||||+++++|++..
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK-~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK-LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEE-EEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEE-EEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3467789999999999999999999999999999999 554544444445567889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+||||||++||+|.+++.+ ..+++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~- 220 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK- 220 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc-
Confidence 99999999999999999975 4699999999999999999999999999999999999999999999999999975210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeecchhhHHHHHhCCCCCCC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
.......+.+||+.|||||++.+.. |+.++|||||||+||||++|++||.+
T Consensus 221 -------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 221 -------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp -------------------------TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -------------------------CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 0111234678999999999998765 88999999999999999999999999
Q ss_pred CChHHHHHHHhccC--CCCCCCCCCCCHHHHHHHHhhccCCcCC--CCChhcHHHHHcCCCCCCCCcchhhcc--cCccc
Q 001354 918 ESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFV 991 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~K--RpTa~~A~EIL~HPFFkgIdWd~L~~~--~pPf~ 991 (1093)
.+...++.+|+... +.+|. ...+|+++++||.+||+.+|.+ |++ +.+|++||||++++|+.+..+ .|||+
T Consensus 276 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~---~~ei~~Hp~f~~~~w~~~~~~~~~~p~~ 351 (410)
T 3v8s_A 276 DSLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNG---VEEIKRHLFFKNDQWAWETLRDTVAPVV 351 (410)
T ss_dssp SSHHHHHHHHHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSC---HHHHHTSGGGCCSSCCSTTGGGSCCSCC
T ss_pred CChhhHHHHHHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCCC---HHHHhcCccccCCCHHHHhhcccCCCCC
Confidence 99999999998753 45553 3579999999999999988877 777 889999999999999866544 89999
Q ss_pred CCCCCCCCCccccccccc
Q 001354 992 PQPESVDDTSYFLSRFSQ 1009 (1093)
Q Consensus 992 P~~~s~~Dts~Fds~fs~ 1009 (1093)
|.+.+..|++||+..+..
T Consensus 352 p~~~~~~d~~~fd~~~~~ 369 (410)
T 3v8s_A 352 PDLSSDIDTSNFDDLEED 369 (410)
T ss_dssp CCCSSTTCCTTSCCCCSC
T ss_pred CcCCCccchhhcCCcccc
Confidence 999999999999986443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=497.74 Aligned_cols=253 Identities=24% Similarity=0.454 Sum_probs=218.5
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCceE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLY 764 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd----~~~Ly 764 (1093)
|++.+.||+|+||+||+|+++.++..||+|++.+. .......+.+.+|+.+|+.++|||||++|++|.+ ...+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR--KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG--GSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh--hCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 47788899999999999999999999999965432 2344556789999999999999999999999875 35689
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEcc-CCcEEEEecCCccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~-dG~VKLsDFGLAk~~~~~ 841 (1093)
||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-- 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-- 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--
Confidence 99999999999999999999999999999999999999999999 999999999999984 8999999999998421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC-h
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-P 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s-~ 920 (1093)
.....+.+|||.|||||++.+ .|+.++|||||||+||||+||++||.+.+ .
T Consensus 184 ---------------------------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~ 235 (290)
T 3fpq_A 184 ---------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp ---------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred ---------------------------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH
Confidence 112346799999999999875 69999999999999999999999998755 4
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
..++..+..+..+ +.++..+++++++||.+||.+||.+||| +.++|+||||+.
T Consensus 236 ~~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 236 AQIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred HHHHHHHHcCCCC-CCCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccC
Confidence 5555555554332 3345778999999999999999999999 889999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=521.76 Aligned_cols=256 Identities=32% Similarity=0.542 Sum_probs=228.9
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.|++++.||+|+||+||+|+++.+|+.||||++- +.. ....+.+.+|+.+|+.++|||||++|++|.+.+.+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~-~~~---~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMD-LRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE-STT---CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEe-ccc---hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 56999999999999999999999999999999553 222 22335688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~------- 298 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS------- 298 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC-------
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC-------
Confidence 999999999999865 569999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.......+.|||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..
T Consensus 299 --------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~ 358 (423)
T 4fie_A 299 --------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 358 (423)
T ss_dssp --------------------SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred --------------------CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence 011234568999999999999999999999999999999999999999999999999998
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
|.....+....+..+|+++++||.+||++||.+||| +.|+|+||||+.
T Consensus 359 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~ell~Hp~~~~ 406 (423)
T 4fie_A 359 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAK 406 (423)
T ss_dssp HHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHHhcC
Confidence 887654333345789999999999999999999999 889999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=543.38 Aligned_cols=302 Identities=34% Similarity=0.724 Sum_probs=270.0
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC 759 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd 759 (1093)
..++.+++|++++.||+|+||+||+|+++.+++.|||| ++++...........+..|..+|..+ +||||++++++|++
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK-~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVK-ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEE-EEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEE-EEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence 34577899999999999999999999999999999999 54454444555677889999999987 69999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+.+||||||++||+|.+++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+
T Consensus 494 ---------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 494 ---------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp ---------------------------CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------------------------cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 01123456799999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCC
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPE 995 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~ 995 (1093)
..+++..|+...+.+| ..+++++++||.+||++||.+||++ +++.+|++||||++++|+.+..+ .|||+|.+.
T Consensus 547 ~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 547 EDELFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp HHHHHHHHHSSCCCCC---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred HHHHHHHHHhCCCCCC---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 9999999999888776 6899999999999999999999995 56899999999999999999765 799999998
Q ss_pred CCCCCcccccccccCCCCC
Q 001354 996 SVDDTSYFLSRFSQISSGL 1014 (1093)
Q Consensus 996 s~~Dts~Fds~fs~~~~~l 1014 (1093)
. .|++||+.+|+..+..+
T Consensus 624 ~-~~~~~f~~~~~~~~~~~ 641 (674)
T 3pfq_A 624 G-RNAENFDRFFTRHPPVL 641 (674)
T ss_dssp G-GGHHHHTTTTTSSCSSC
T ss_pred C-CchhhcCchhccCCCcc
Confidence 8 99999999988765443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=508.13 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=227.3
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
+...+.|++.+.||+|+||+||+|+++.+|+.||||++ ++... ..+|+.+|+.++|||||++|++|.+.+.
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i-~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPW 124 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE-ETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEE-CHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34567899999999999999999999999999999955 32211 2469999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~~~~~ 841 (1093)
+|||||||+||+|.++|++.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999999999999999999999999999999999999999999999999999998 6999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.. ........+.+|||.|||||++.+..|+.++|||||||+||||++|++||.+.+..
T Consensus 205 ~~----------------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 205 GL----------------------GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp -------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred Cc----------------------ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 00 00011234578999999999999999999999999999999999999999999988
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH-------------HcCCCCCCC
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-------------KAHPFFKGV 978 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI-------------L~HPFFkgI 978 (1093)
+++.+|.....+++.++..+|+++++||.+||++||.+||| +.|| ++|||+...
T Consensus 263 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 263 PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS---AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcC---HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 88999988877666677899999999999999999999999 4454 568888653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=486.61 Aligned_cols=288 Identities=40% Similarity=0.781 Sum_probs=263.8
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+++|++++.||+|+||.||+|+++.+|+.||+| ++++...........+.+|+.+|..++||||++++++|.+...+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK-~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK-ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEE-EEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEE-EEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 46789999999999999999999999999999999 44444444455678899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~---- 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---- 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS----
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999998421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..++
T Consensus 193 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 246 (350)
T 1rdq_E 193 --------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp --------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred --------------------------CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH
Confidence 122456899999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 999 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT--a~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~D 999 (1093)
+..|..+...+| ..+++++.+||.+||+.||.+||+ .+++.+|++||||++++|+.+..+ .|||+|...++.|
T Consensus 247 ~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~ 323 (350)
T 1rdq_E 247 YEKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGD 323 (350)
T ss_dssp HHHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTC
T ss_pred HHHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCccc
Confidence 999999887766 689999999999999999999998 356899999999999999998755 7999999999999
Q ss_pred Cccccc
Q 001354 1000 TSYFLS 1005 (1093)
Q Consensus 1000 ts~Fds 1005 (1093)
+++|+.
T Consensus 324 ~~~f~~ 329 (350)
T 1rdq_E 324 TSNFDD 329 (350)
T ss_dssp CTTSCC
T ss_pred cccccc
Confidence 999984
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=480.22 Aligned_cols=289 Identities=39% Similarity=0.753 Sum_probs=252.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+++|++++.||+|+||+||+|+++.+|+.||+|+ +++.........+.+.+|+.+|..++||||++++++|++...+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~-~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV-LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEE-EEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEE-EEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 567899999999999999999999999999999994 4444444445677889999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~---- 157 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---- 157 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC----
Confidence 9999999999999999998899999999999999999999999999999999999999999999999999998421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...+
T Consensus 158 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 211 (318)
T 1fot_A 158 --------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211 (318)
T ss_dssp --------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred --------------------------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 123457899999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCC-CCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPE-SVD 998 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~-s~~ 998 (1093)
+..|+.....+| ..+++++++||.+||..||.+||+. .++.+|++||||++++|+.+..+ .|||.|... ...
T Consensus 212 ~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~ 288 (318)
T 1fot_A 212 YEKILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQG 288 (318)
T ss_dssp HHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----
T ss_pred HHHHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCcc
Confidence 999999887766 6899999999999999999999963 25899999999999999998665 789999987 488
Q ss_pred CCcccccc
Q 001354 999 DTSYFLSR 1006 (1093)
Q Consensus 999 Dts~Fds~ 1006 (1093)
|+++|+..
T Consensus 289 d~~~f~~~ 296 (318)
T 1fot_A 289 DTSQFDKY 296 (318)
T ss_dssp --------
T ss_pred chhhcCCC
Confidence 99999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=526.35 Aligned_cols=334 Identities=29% Similarity=0.559 Sum_probs=281.5
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|+++++||+|+||+||+|+++.+|+.||||+ +.+...........+.+|+.+|..++||||++++++|++...
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~-l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKK-LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEE-EEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEE-EEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 4567899999999999999999999999999999994 444444444566789999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+|+||||++||+|.+++.+. ..+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999999764 36999999999999999999999999999999999999999999999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.. ........+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.
T Consensus 340 ~~---------------------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 340 KA---------------------------GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CT---------------------------TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred cC---------------------------CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 10 011234568999999999999999999999999999999999999999875
Q ss_pred ----ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--cCcc
Q 001354 919 ----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVF 990 (1093)
Q Consensus 919 ----s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~--~pPf 990 (1093)
...++...+......+| ..+++++++||.+||++||.+||++. ++.+|++||||++++|+.+..+ .|||
T Consensus 393 ~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~ 469 (543)
T 3c4z_A 393 GEKVENKELKQRVLEQAVTYP---DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPF 469 (543)
T ss_dssp TCCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred ccchhHHHHHHHHhhcccCCC---cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCC
Confidence 35678888888776665 78999999999999999999999963 5899999999999999998765 7999
Q ss_pred cCCCCC-----CCCCcccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCccccCCC
Q 001354 991 VPQPES-----VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSC 1050 (1093)
Q Consensus 991 ~P~~~s-----~~Dts~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~~~~ 1050 (1093)
+|.+.. ..|..+|+. ..+..++..+...+..|+++..+.+|+.+|.++++|.+++..
T Consensus 470 ~P~~~~~~~~~~~d~~~f~~---~~~~~~~~~~~~~f~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (543)
T 3c4z_A 470 VPDSRTVYAKNIQDVGAFST---VKGVAFEKADTEFFQEFASGTCPIPWQEEMIETGVFGDLNVW 531 (543)
T ss_dssp CCCSSSCCSCC----CCCC------CCCCCHHHHHHHHHHCCEECHHHHHHHHHHTTHHHHHTCS
T ss_pred CCCccccccCCchhhhhccc---cCCCCCCcchhhHhhcCCCCCCChhHHHhhhccccHHHhcCC
Confidence 998753 344555543 223344444555667778877778899999999999987754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=496.10 Aligned_cols=264 Identities=29% Similarity=0.434 Sum_probs=224.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------C
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------R 760 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd------~ 760 (1093)
++|++++.||+|+||+||+|+++.+|+.||||++ ++. .........+++|+.+|+.++|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i-~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNA-FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE-TTT-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEE-Ccc-ccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 5799999999999999999999999999999955 332 2234456788999999999999999999998764 3
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+.+|||||||. |+|.+++.+.+.+++..++.|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67999999996 68999999889999999999999999999999999999999999999999999999999999985311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.. ........+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+
T Consensus 211 ~~-----------------------~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 211 SP-----------------------AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp ----------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred Cc-----------------------cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 00 0112234568999999999999875 56999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCC--------------------CC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNRKIPW--------------------PC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~f--------------------P~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
..+++..|+...... |. +.+.+++++.|||.+||++||.+||| |.|+|+
T Consensus 268 ~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~ 344 (398)
T 4b99_A 268 YVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS---AAAALR 344 (398)
T ss_dssp HHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC---HHHHTT
T ss_pred HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC---HHHHhc
Confidence 988888886522111 10 12357999999999999999999999 889999
Q ss_pred CCCCCCCC
Q 001354 972 HPFFKGVN 979 (1093)
Q Consensus 972 HPFFkgId 979 (1093)
||||+...
T Consensus 345 Hp~f~~~~ 352 (398)
T 4b99_A 345 HPFLAKYH 352 (398)
T ss_dssp SGGGTTTC
T ss_pred CHhhCcCC
Confidence 99998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=479.62 Aligned_cols=270 Identities=26% Similarity=0.451 Sum_probs=205.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
+++|++++.||+|+||+||+|+++.+|+.||||++... . .....+.+.+|+.+|+.++|||||++|++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-N--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-S--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-C--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 35799999999999999999999999999999965322 1 2334567899999999999999999999987654
Q ss_pred --------ceEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEE
Q 001354 762 --------NLYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 830 (1093)
Q Consensus 762 --------~LyLVMEYm~GGSL~dlL~k~g~---LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLs 830 (1093)
.+|||||||+||+|.+++...+. .++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999987654 4456788999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT 910 (1093)
|||+|+......... ... ..........+.+|||.|||||++.+..|+.++|||||||+||||++
T Consensus 161 DFGla~~~~~~~~~~-------~~~--------~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQ-------TVL--------TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCCCC-----------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred cCccceecCCCcccc-------ccc--------cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 999998632111000 000 00011123356799999999999999999999999999999999996
Q ss_pred CCCCCCCCCh-HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 911 GIPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 911 GkpPF~~~s~-~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
||.+... ......+.. ..+|..+...++.+.+||.+||++||.+||+ +.++++||||++++|.
T Consensus 226 ---Pf~~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 226 ---PFSTQMERVRTLTDVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPE---AINIIENAVFEDLDFP 289 (299)
T ss_dssp ---CCSSHHHHHHHHHHHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGCCC---
T ss_pred ---CCCCccHHHHHHHHHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCCCCCC
Confidence 8865432 223333333 3444334556788999999999999999999 8899999999999984
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=491.90 Aligned_cols=298 Identities=41% Similarity=0.763 Sum_probs=250.3
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.++..++|++++.||+|+||.||+|+++.+|+.||+|+ +++...........+.+|+.+|..++||||++++++|.+.+
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~-~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEE-EEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEE-EEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 34667899999999999999999999999999999994 44443344556678889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+||||+.+|++||+|||+|+...
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~- 300 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI- 300 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC-
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc-
Confidence 999999999999999999988899999999999999999999998 999999999999999999999999999997421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.........+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+.
T Consensus 301 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 301 --------------------------KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp --------------------------C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 011123457899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 996 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s 996 (1093)
..++..+......+| ..+++++.+||.+||..||.+||+. ..+.++++||||++++|+.+..+ .|||+|.+.+
T Consensus 355 ~~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~ 431 (446)
T 4ejn_A 355 EKLFELILMEEIRFP---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTS 431 (446)
T ss_dssp HHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSS
T ss_pred HHHHHHHHhCCCCCC---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCC
Confidence 999999998887766 6899999999999999999999931 24899999999999999998655 7899999999
Q ss_pred CCCCcccccccccC
Q 001354 997 VDDTSYFLSRFSQI 1010 (1093)
Q Consensus 997 ~~Dts~Fds~fs~~ 1010 (1093)
..|+++|++.|+..
T Consensus 432 ~~~~~~~~~~~~~~ 445 (446)
T 4ejn_A 432 ETDTRYFDEEFTAQ 445 (446)
T ss_dssp TTCCTTC-------
T ss_pred ccchhhcchhhhcC
Confidence 99999999988753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=468.66 Aligned_cols=299 Identities=42% Similarity=0.790 Sum_probs=239.8
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
..+..++|++++.||+|+||.||+|++. .+|+.||+|++.+............+.+|+.+|..++||||++++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3466789999999999999999999985 6899999995533222222344567889999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 172 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 172 IH---------------------------DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp ----------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc---------------------------CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 10 011234568999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--cCcccCCC
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 994 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~ 994 (1093)
+...+...|......+| ..+++++.+||.+||..||.+||++. .+.++++||||++++|+.+... .|||.|..
T Consensus 225 ~~~~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~ 301 (327)
T 3a62_A 225 NRKKTIDKILKCKLNLP---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLL 301 (327)
T ss_dssp SHHHHHHHHHHTCCCCC---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-
T ss_pred CHHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCc
Confidence 99999999988877665 68999999999999999999999754 6999999999999999988655 78999999
Q ss_pred CCCCCCcccccccccC
Q 001354 995 ESVDDTSYFLSRFSQI 1010 (1093)
Q Consensus 995 ~s~~Dts~Fds~fs~~ 1010 (1093)
.+..|.++|+..|+..
T Consensus 302 ~~~~~~~~~~~~~~~~ 317 (327)
T 3a62_A 302 QSEEDVSQFDSKFTRQ 317 (327)
T ss_dssp ----------------
T ss_pred CChhhhhhcchhhhcc
Confidence 9999999998876554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-55 Score=516.08 Aligned_cols=330 Identities=32% Similarity=0.539 Sum_probs=273.8
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++++.||+|+||.||+|+++.+|+.||+|+ +.+...........+.+|+.+|..++|||||+++++|++.+.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~-l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEE-EEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEE-EEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 3677899999999999999999999999999999994 444444445566788999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~--LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+|+||||++||+|.+++...+. +++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999999987654 99999999999999999999999999999999999999999999999999985210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC-
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s- 919 (1093)
.......+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+
T Consensus 339 ----------------------------~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 339 ----------------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp ----------------------------TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred ----------------------------CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 112234689999999999999999999999999999999999999998763
Q ss_pred ---hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--cCcccC
Q 001354 920 ---PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 992 (1093)
Q Consensus 920 ---~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~--~pPf~P 992 (1093)
...+...+......+| ..+++++++||.+||+.||.+||+.. ++.+|++||||++++|+.+..+ .|||+|
T Consensus 391 ~~~~~~i~~~i~~~~~~~p---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p 467 (576)
T 2acx_A 391 KIKREEVERLVKEVPEEYS---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKP 467 (576)
T ss_dssp CCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred chhHHHHHHHhhcccccCC---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCC
Confidence 4567777776666555 78999999999999999999999743 6899999999999999998765 789999
Q ss_pred CCCC-----CCCCcccccccccCCCCCCCCCCCCCCCCCCccCCCCCchhhhhcCCcccc
Q 001354 993 QPES-----VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEF 1047 (1093)
Q Consensus 993 ~~~s-----~~Dts~Fds~fs~~~~~l~~~d~~~~s~~st~~ss~~~~~em~Et~~F~e~ 1047 (1093)
.+.. ..|..+|.. ..+...+..+..++..+.++..+.+|+.+|.++++|.++
T Consensus 468 ~~~~~~~~~~~d~~~f~~---~~~~~~~~~~~~~f~~f~~~~~~~~~~~e~~~~~~~~~l 524 (576)
T 2acx_A 468 DPQAIYCKDVLDIEQFST---VKGVELEPTDQDFYQKFATGSVPIPWQNEMVETECFQEL 524 (576)
T ss_dssp CCCCCCC--------------------CHHHHHHHHHHCCEECHHHHHHHHHHTTHHHHH
T ss_pred CccccccCCcccHhhccc---cCCCCCCccHHHHHhhhccCCCCcccchhhhhcchhhhh
Confidence 8753 334444432 234445555666677777777778899999999988643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=506.62 Aligned_cols=265 Identities=28% Similarity=0.513 Sum_probs=237.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
.+++|++++.||+|+||+||+|+++.+|+.||+|++.+. .....+.+.+|+.+|..++|||||+++++|.+...+|
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 467999999999999999999999999999999965432 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC--CcEEEEecCCccccccc
Q 001354 765 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d--G~VKLsDFGLAk~~~~~ 841 (1093)
||||||+||+|+++|.+ .+.+++..++.|++||+.||.|||++|||||||||+||||+.+ |++||+|||+|+...
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~-- 308 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 308 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC--
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc--
Confidence 99999999999999964 4679999999999999999999999999999999999999864 899999999998531
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..
T Consensus 309 --------------------------~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~ 362 (573)
T 3uto_A 309 --------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362 (573)
T ss_dssp --------------------------TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred --------------------------CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 112334679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 922 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
+++..|......++. .+..+|+++++||.+||++||.+||+ +.|+|+||||+..+|....
T Consensus 363 ~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t---~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 363 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTSCCCCTTTT
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcCcCCCCCCCch
Confidence 999999988776653 34679999999999999999999999 8899999999998886543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=467.78 Aligned_cols=265 Identities=21% Similarity=0.300 Sum_probs=217.9
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..|++..++|++.+.||+|+||+||+|+++. .+||| +++. ........+.|.+|+.+|++++|||||++++++..
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK-~~~~-~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVK-ILKV-VDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEE-ECCC-SSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEE-EEEe-cCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 3567888999999999999999999998753 58999 4433 22345567889999999999999999999998754
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+.+|||||||+||+|.++|... +.+++..+..|+.||+.||+|||+++||||||||+||||++++++||+|||+|+..
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 5789999999999999999764 57999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
... .......+.+||+.|||||++.+ ..|+.++|||||||+||||+||++||
T Consensus 183 ~~~-------------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 183 SRW-------------------------SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp ------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccC-------------------------CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 110 01123346789999999999974 35899999999999999999999999
Q ss_pred CCCChHHHHHHHhccCCCCC---CCCCCCCHHHHHHHHhhccCCcCCCCChhcH---HHHHcCCCC
Q 001354 916 TAESPEIIFDNILNRKIPWP---CVPSDMSFEAQDLINRFLIHDPNQRLGANGA---AEVKAHPFF 975 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l~fP---~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A---~EIL~HPFF 975 (1093)
.+.+.......++......| .++..+++++.+||.+||+.||.+||++.++ .+.++|+|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 238 SHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 98877666666655444333 4567899999999999999999999996543 355677764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=476.12 Aligned_cols=280 Identities=28% Similarity=0.436 Sum_probs=209.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCc
Q 001354 687 DDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~ 762 (1093)
+.|++.+.||+|+||+||+|+++ .+++.||+|++.+. .....+.+|+.+|..+ +|||||+++++|.+.++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 67999999999999999999875 46789999965432 2235678999999988 69999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFGLAk~~~~~ 841 (1093)
+|||||||+||+|.+++. .+++..++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999984 59999999999999999999999999999999999999987 89999999999853211
Q ss_pred ccc--cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 842 NTI--DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 842 ~s~--dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
... +............. ..............+.+||+.|||||++.+. .|+.++||||+||++|||++|++||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQ-NKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC---------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccc-ccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 000 00000000000000 0000001122344567999999999999875 5899999999999999999999999643
Q ss_pred -ChHHHHHHHhc--------------------------------------cCCCCC-------------CCCCCCCHHHH
Q 001354 919 -SPEIIFDNILN--------------------------------------RKIPWP-------------CVPSDMSFEAQ 946 (1093)
Q Consensus 919 -s~~ei~~kIl~--------------------------------------~~l~fP-------------~ip~~IS~eak 946 (1093)
+..+....|.. ....+| .....+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 34344333321 000011 01246899999
Q ss_pred HHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 947 DLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 947 DLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
|||.+||++||.+||| |.|+|+||||++++
T Consensus 331 DLl~~lL~~dP~~R~t---a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 331 DLLDKLLDLNPASRIT---AEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHTCSCTTTSCC---HHHHHTSGGGTTC-
T ss_pred HHHHHHCcCChhHCcC---HHHHhcCcccCCCC
Confidence 9999999999999999 88999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-54 Score=467.78 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=218.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
.+..++|.+.+.||+|+||+||+|++. .++..||||++ ++. .....+.|.+|+.+|.+++|||||+++++|
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l-~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDA---SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEE-CSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEe-CCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 355678999999999999999999975 35789999944 332 344567899999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 824 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g-------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d 824 (1093)
.+.+.+|||||||+||+|.++|++.+ .+++..+..++.||+.||.|||+++||||||||+||||+.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 99999999999999999999997643 59999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhh
Q 001354 825 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 904 (1093)
Q Consensus 825 G~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVI 904 (1093)
+++||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+
T Consensus 165 ~~~Ki~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvv 219 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 219 (299)
T ss_dssp GCEEECCCSCHHHHTGGG-------------------------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CcEEECCcccceecCCCC-------------------------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHH
Confidence 999999999998532110 0112334679999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 905 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 905 LYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
||||+| |++||.+.+..++...|..+.. +..|..+|+++.+||.+||+.||.+||++.++.+
T Consensus 220 l~Ellt~G~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 220 LWEIFTYGKQPWYQLSNNEVIECITQGRV--LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 9999999999999999887654 3346889999999999999999999999554433
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=464.09 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=214.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
.+..++|.+.+.||+|+||+||+|+++. ++..||||++ ++. .....+.|.+|+.+|.+++|||||+++++|
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l-~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEA---SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEE-SCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEE-CcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4566899999999999999999999763 6889999944 332 344567899999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKV---------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 822 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~---------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD 822 (1093)
.+.+.+|||||||+||+|.++|++. +.+++..+..|+.||+.||.|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999999754 3589999999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecch
Q 001354 823 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902 (1093)
Q Consensus 823 ~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLG 902 (1093)
.++++||+|||+|+..... .........+||+.|||||++.+..|+.++||||||
T Consensus 193 ~~~~~Ki~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~G 247 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYST-------------------------DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247 (329)
T ss_dssp TTTEEEECCCC-----------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHH
T ss_pred CCCcEEEcccccceeccCC-------------------------CcceecCcccccccccChhhhcCCCCCccccccchH
Confidence 9999999999999853110 001123356899999999999999999999999999
Q ss_pred hhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 903 IILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 903 VILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
|+||||+| |++||.+.+..++...|..+.. +..|..+++++.+||.+||..||.+||++.++.+
T Consensus 248 vvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 248 VVLWEIFTYGKQPWYQLSNTEAIDCITQGRE--LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999 9999999999999988877642 2345789999999999999999999999554433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=469.34 Aligned_cols=282 Identities=31% Similarity=0.685 Sum_probs=247.9
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
...+..++|++++.||+|+||.||+|+++.+++.||+|+ +.+...........+.+|+.+|..++|||||+++++|++.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~-~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKY-MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEE-EEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEE-EehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 345778999999999999999999999999999999994 4444444555678899999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..+|+||||++||+|..++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~- 166 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP- 166 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc-
Confidence 9999999999999999999988899999999999999999999999999999999999999999999999999998521
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
......+.+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||..
T Consensus 167 ---------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 167 ---------------------------RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp ---------------------------TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------------------CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 1123346789999999999974 4689999999999999999999999975
Q ss_pred C---ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc--cCcccC
Q 001354 918 E---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVP 992 (1093)
Q Consensus 918 ~---s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P 992 (1093)
. ...++...+......+| ..+++++.+||.+||..||.+||+ .+.++++||||++++|+.+..+ .|||+|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p 294 (384)
T 4fr4_A 220 RSSTSSKEIVHTFETTVVTYP---SAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIP 294 (384)
T ss_dssp CTTSCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTSGGGTTCCHHHHHTTCSCCCCCC
T ss_pred CCCccHHHHHHHHhhcccCCC---CcCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcChhhhcCCHHHHHhCCCCCCCCC
Confidence 4 34566666666666555 789999999999999999999998 3789999999999999998766 788998
Q ss_pred CCCC
Q 001354 993 QPES 996 (1093)
Q Consensus 993 ~~~s 996 (1093)
....
T Consensus 295 ~~~~ 298 (384)
T 4fr4_A 295 NKGR 298 (384)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 7643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=460.26 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=221.7
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
.+..+++++++.||+|+||+||+|++. .+++.||||++ +.. ......+.|.+|+.+|.+++|||||+++++|
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l-~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDK--AEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEEC-CC---CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEE-Ccc--cChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 466788999999999999999999974 36789999954 322 1233457899999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 821 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL 821 (1093)
.+.+.+|||||||++|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999653 358999999999999999999999999999999999999
Q ss_pred ccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecc
Q 001354 822 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 901 (1093)
Q Consensus 822 D~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSL 901 (1093)
++++++||+|||+|+..... .........+||+.|||||++.+..|+.++|||||
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf 233 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAA-------------------------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGG-------------------------GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCCCCEEECCcccceeccCC-------------------------CceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence 99999999999999853211 11122345789999999999999999999999999
Q ss_pred hhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 902 GIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 902 GVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
||+||||+| |.+||.+.+..++...|..+.. +..|..+++++.+||.+||..||.+||++.++.+.|+
T Consensus 234 Gvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 234 GVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV--LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999999998 8999999999999988877643 2346889999999999999999999999666655554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=459.46 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=216.2
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCC-----cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-CceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TG-----k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNIVkL~ 754 (1093)
+|++..++|++.+.||+|+||+||+|++..++ +.||+|.+ ++. ......+.+.+|+.+|.++.| ||||+++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l-~~~--~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEG--ATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEE-CTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEE-ccc--cChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 45678899999999999999999999987543 57999944 322 223456789999999999975 8999999
Q ss_pred eeeccC-CceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCC
Q 001354 755 YSFTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817 (1093)
Q Consensus 755 gsfqd~-~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPe 817 (1093)
++|... ..+|||||||++|+|.++|++. ..+++..+..|+.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998664 5799999999999999999753 24899999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
||||+.++++||+|||+|+..... .......+.+||+.|||||++.+..|+.++|
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksD 269 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSD 269 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTC-------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred ceeeCCCCCEEECcchhhhhcccC-------------------------CCceeeccccccccccCHHHHhcCCCCCccc
Confidence 999999999999999999853110 0011234578999999999999999999999
Q ss_pred eecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 898 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 898 VWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
||||||+||||+| |.+||.+.+..+.+..++..... +..|..+++++.+||.+||+.||.+||+ +.+|++|
T Consensus 270 VwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~-~~~p~~~~~~~~~li~~c~~~dP~~RPt---~~eil~~ 341 (353)
T 4ase_A 270 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 341 (353)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred EeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCcChhHCcC---HHHHHHH
Confidence 9999999999998 99999987765555444444433 3356889999999999999999999999 5555554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=438.33 Aligned_cols=261 Identities=31% Similarity=0.561 Sum_probs=235.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
...+++|++++.||+|+||.||+|++..+|+.||+|++. +. .........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~-~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIID-KT-QLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE-GG-GSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEE-hh-cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 456789999999999999999999999999999999553 32 2244556788999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~--- 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT--- 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS---
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC---
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC-ccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys-~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
........+||+.|+|||++.+..+. .++|||||||++|||++|.+||.+.+..
T Consensus 166 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 220 (328)
T 3fe3_A 166 -------------------------VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220 (328)
T ss_dssp -------------------------SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 01123457899999999999988875 7999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
++...+..+...+| ..+++++.+||.+||..||.+||| +.++++||||+...
T Consensus 221 ~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 221 ELRERVLRGKYRIP---FYMSTDCENLLKRFLVLNPIKRGT---LEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHCCSSTTTSCC---HHHHTTCTTTTTTC
T ss_pred HHHHHHHhCCCCCC---CCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCHhhcCCC
Confidence 99999999887766 679999999999999999999999 88999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=447.93 Aligned_cols=270 Identities=29% Similarity=0.488 Sum_probs=238.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~--~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
..+.|++++.||+|+||+||+|+++.+|..||+|++.+...... ....+.+.+|+.+|..++||||++++++|.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 45679999999999999999999999999999995543322111 1135678999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC----cEEEEecCCcccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 838 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG----~VKLsDFGLAk~~ 838 (1093)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999999888899999999999999999999999999999999999998877 7999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.
T Consensus 170 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 170 E----------------------------DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp C----------------------------TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred C----------------------------CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011234568999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhc
Q 001354 919 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 985 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~ 985 (1093)
+..+++..|......++. .+..+++++++||.+||..||.+||+ +.++++||||++++|.....
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~~~~~~~~~ 286 (361)
T 2yab_A 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDTQQAMV 286 (361)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSTTTSCSSHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcCcCCCchhhhhh
Confidence 999999999888776652 23578999999999999999999999 88999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=440.03 Aligned_cols=292 Identities=42% Similarity=0.781 Sum_probs=242.1
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhh-hchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDM-IRKNDIERILAERNILITV-RNPFVVRFFYS 756 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~-~~~~eie~~l~E~~IL~kL-~HPNIVkL~gs 756 (1093)
..+.+++|++++.||+|+||+||+|++. .+|+.||+|++ ++... ........+.+|+.+|..+ +||||++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL-KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEE-SEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEE-eHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 3567789999999999999999999984 58999999954 33221 1222345577899999999 69999999999
Q ss_pred eccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcc
Q 001354 757 FTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836 (1093)
Q Consensus 757 fqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk 836 (1093)
+.....+|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
.... .........+||+.|+|||++.+ ..++.++|||||||+||||++|..|
T Consensus 208 ~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 208 EFVA--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp ECCG--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred eccc--------------------------CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 4211 01112345689999999999986 4578999999999999999999999
Q ss_pred CCCC----ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhcc--
Q 001354 915 FTAE----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ-- 986 (1093)
Q Consensus 915 F~~~----s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~--~A~EIL~HPFFkgIdWd~L~~~-- 986 (1093)
|... ....+...+......+ +..++..+.+||.+||..||.+||+.. .+.++++||||+.++|+.+..+
T Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~ 338 (355)
T 1vzo_A 262 FTVDGEKNSQAEISRRILKSEPPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV 338 (355)
T ss_dssp TSCTTSCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CccCCccchHHHHHHHHhccCCCC---CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccC
Confidence 9754 3345555665555444 478999999999999999999999532 4999999999999999998766
Q ss_pred cCcccCCCCCCCCCccc
Q 001354 987 KAVFVPQPESVDDTSYF 1003 (1093)
Q Consensus 987 ~pPf~P~~~s~~Dts~F 1003 (1093)
++||.|......|.++|
T Consensus 339 ~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 339 PAPFKPVIRDELDVSNF 355 (355)
T ss_dssp CCSCCCCCCC-CCC---
T ss_pred CCCCCCccccccccccC
Confidence 68899999888888876
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=417.27 Aligned_cols=258 Identities=34% Similarity=0.549 Sum_probs=226.2
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++++.||+|+||+||+|++..+|+.||+|++... . ....+.+.+|+.+++.++||||++++++|...+.+|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-Q---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG-G---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc-c---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 46799999999999999999999999999999955322 1 2234668899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 168 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----- 168 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC-----
Confidence 99999999999999764 699999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.++.....
T Consensus 169 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 226 (297)
T 3fxz_A 169 ----------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (297)
T ss_dssp ----------------------TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0112345689999999999999999999999999999999999999999988877777
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.+.....+....+..+++.+.+||.+||..||.+||+ +.++++||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~ 276 (297)
T 3fxz_A 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhccc
Confidence 7665544333345789999999999999999999999 8899999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=419.81 Aligned_cols=268 Identities=28% Similarity=0.490 Sum_probs=234.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~--~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
.+.|++.+.||+|+||.||+|+++.+|..||+|++.+...... ....+.+.+|+.+|..++||||++++++|.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999995543221111 11356789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC----cEEEEecCCccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG----~VKLsDFGLAk~~~ 839 (1093)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999999888 89999999998521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
. .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 170 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 170 F----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp T----------------------------TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred C----------------------------CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 0 111234679999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 920 PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
..+....+......++. ....++..+.+||.+||..||.+||+ +.++++||||++.+|....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~~~~ 284 (326)
T 2y0a_A 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 284 (326)
T ss_dssp HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTSCCSHHHHH
T ss_pred HHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcCCCccCCcchhhh
Confidence 88888888776655442 22578999999999999999999999 8899999999999887643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=417.50 Aligned_cols=265 Identities=29% Similarity=0.515 Sum_probs=219.3
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
....++|++++.||+|+||+||+|++. +|+.||+|++... .........+.+|+.+|..++||||+++++++.+...
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLD--AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecc--cccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 345689999999999999999999986 4899999955322 2233345678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~- 171 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI- 171 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS-
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC-
Confidence 9999999985 888888764 4599999999999999999999999999999999999999999999999999985210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 172 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 172 --------------------------PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp --------------------------CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred --------------------------CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 0112234578999999999986 5689999999999999999999999998877
Q ss_pred HHHHHHHhcc--CC---CC----------------------CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 921 EIIFDNILNR--KI---PW----------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 921 ~ei~~kIl~~--~l---~f----------------------P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
.+....+... .. .+ ..+...+++++.+||.+||+.||.+||| +.++++||
T Consensus 226 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp 302 (311)
T 3niz_A 226 DDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS---ARDAMNHP 302 (311)
T ss_dssp TTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSG
T ss_pred HHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC---HHHHhcCc
Confidence 6666665431 00 00 0112457899999999999999999999 88999999
Q ss_pred CCCCCCcc
Q 001354 974 FFKGVNWD 981 (1093)
Q Consensus 974 FFkgIdWd 981 (1093)
||++++++
T Consensus 303 ~f~~~~~~ 310 (311)
T 3niz_A 303 YFKDLDPQ 310 (311)
T ss_dssp GGTTSCTT
T ss_pred ccccCCcc
Confidence 99998865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=426.85 Aligned_cols=274 Identities=22% Similarity=0.353 Sum_probs=223.6
Q ss_pred ccCCCeeEEEeeecc--CCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 684 TSIDDFEIIKPISRG--AFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 684 isiddFeilr~LGkG--~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
...++|++++.||+| +||+||+|+++.+|+.||+|++.. ..........+.+|+.+|+.++|||||+++++|.+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL--EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEG--GGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecc--cccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 456789999999999 999999999999999999995533 2234456678899999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999875 679999999999999999999999999999999999999999999999999987432
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
..... ...........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+
T Consensus 180 ~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 180 SHGQR--------------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ETTEE--------------------CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccc--------------------ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 11000 0001112334589999999999987 6799999999999999999999999998
Q ss_pred CChHHHHHHHhccCCC-------------------------------------------CCCCCCCCCHHHHHHHHhhcc
Q 001354 918 ESPEIIFDNILNRKIP-------------------------------------------WPCVPSDMSFEAQDLINRFLI 954 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~-------------------------------------------fP~ip~~IS~eakDLIkrcL~ 954 (1093)
.+.......++.+..+ ....+..+++++.+||.+||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 7766655554433221 001235689999999999999
Q ss_pred CCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 955 HDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 955 kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
.||.+||+ +.++++||||+.+.|..
T Consensus 320 ~dP~~Rpt---a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 320 RNPDARPS---ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp SCTTTSCC---HHHHTTSGGGGGC---C
T ss_pred cCcccCCC---HHHHhcCHHHHHHhhcc
Confidence 99999999 88999999999887754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=405.68 Aligned_cols=260 Identities=35% Similarity=0.642 Sum_probs=231.0
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
....+++|++.+.||+|+||+||+|++..++..||+|++. +...........+.+|+.++..++||||+++++++.+..
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE-HHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEe-ccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 4567899999999999999999999999999999999553 333333334567889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||+++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~-- 160 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 160 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999886321
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.......+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 161 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 213 (279)
T 3fdn_A 161 ---------------------------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213 (279)
T ss_dssp ----------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ---------------------------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence 11123457999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+....+......+| ..+++++.+||.+||..||.+||+ +.++++||||++
T Consensus 214 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~h~~~~~ 263 (279)
T 3fdn_A 214 ETYKRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 263 (279)
T ss_dssp HHHHHHHHTCCCCC---TTSCHHHHHHHHHHCCSSGGGSCC---HHHHHHCHHHHH
T ss_pred HHHHHHHhCCCCCC---CcCCHHHHHHHHHHhccChhhCCC---HHHHhhCccccC
Confidence 99888887776655 679999999999999999999999 889999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=406.91 Aligned_cols=260 Identities=28% Similarity=0.474 Sum_probs=216.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++++.||+|+||+||+|+++.+|+.||+|++... .........+.+|+.+|..++||||+++++++.+...+|+
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESS--CSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeecc--CCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 46899999999999999999999999999999955322 2234455778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~-k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+++ +|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~----- 152 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG----- 152 (292)
T ss_dssp EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC-----
Confidence 9999986 5555554 46789999999999999999999999999999999999999999999999999997521
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeecchhhHHHHHhCCCC-CCCCChHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPP-FTAESPEI 922 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDVWSLGVILYEMLTGkpP-F~~~s~~e 922 (1093)
.........+||+.|+|||++.+.. |+.++|||||||++|||++|..| |.+.+..+
T Consensus 153 ----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~ 210 (292)
T 3o0g_A 153 ----------------------IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp ----------------------SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred ----------------------CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 0111223468999999999998765 89999999999999999987666 66666666
Q ss_pred HHHHHhccCC-----------------C---------CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 923 IFDNILNRKI-----------------P---------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 923 i~~kIl~~~l-----------------~---------fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
....+..... + .......+++++.+||.+||+.||.+||| +.++++||||+
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~ 287 (292)
T 3o0g_A 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFS 287 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGT
T ss_pred HHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC---HHHHhcCcccc
Confidence 6666643100 0 01122468899999999999999999999 88999999998
Q ss_pred CC
Q 001354 977 GV 978 (1093)
Q Consensus 977 gI 978 (1093)
++
T Consensus 288 ~~ 289 (292)
T 3o0g_A 288 DF 289 (292)
T ss_dssp TC
T ss_pred cC
Confidence 64
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=428.17 Aligned_cols=259 Identities=31% Similarity=0.526 Sum_probs=230.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||+|+||.||+|.++.+|..||+|++..+ .......+.+.+|+.+|..++|||||++++++.+...+|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK--KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcc--cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 46799999999999999999999999999999955322 2234556789999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---cEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG---~VKLsDFGLAk~~~~~~ 842 (1093)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++...
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~--- 182 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--- 182 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT---
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec---
Confidence 999999999999998888899999999999999999999999999999999999998654 59999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...
T Consensus 183 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 237 (362)
T 2bdw_A 183 -------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237 (362)
T ss_dssp -------------------------TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 0112235689999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
++..|..+...+|.. ...+++++++||.+||..||.+||+ +.++++||||.+
T Consensus 238 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~ 290 (362)
T 2bdw_A 238 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSHHHHT
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCcccCC
Confidence 999998887776632 2468999999999999999999999 889999999964
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=425.81 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=191.4
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----c
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----N 762 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~----~ 762 (1093)
.+|.+.+.||+|+||+||+|++ +|+.||||++ +... ........|+..+..++|||||++++++...+ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l-~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF-SSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEE-CGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEE-Cccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 4688999999999999999998 4899999954 3211 11122334555567889999999999998764 5
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~--------GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
+|||||||+||+|.++|++. .++++.+..++.|++.||.|||++ +||||||||+||||+.+|++||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 89999999999999999764 589999999999999999999987 999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeecchhhHHHH
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEF 908 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Ys~ksDVWSLGVILYEM 908 (1093)
|+....... .........+||+.|||||++.+. .|+.++|||||||+||||
T Consensus 155 a~~~~~~~~-----------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El 211 (303)
T 3hmm_A 155 AVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp CEEEETTTT-----------------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CccccCCCC-----------------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence 985321100 001123456899999999999764 367799999999999999
Q ss_pred HhCCCCCCCC---------------ChHHHHHHHhccCCCCCCCCCC-----CCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 909 ITGIPPFTAE---------------SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 909 LTGkpPF~~~---------------s~~ei~~kIl~~~l~fP~ip~~-----IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
+||.+||... ....+...+....++ |.+|.. .+..+.+||.+||..||.+|||+.++.+
T Consensus 212 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~r-p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHCCCCCCccccccccchhcccccchHHHHHHHHhcccCC-CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 9998766421 123444445544443 333332 2357889999999999999999655544
Q ss_pred HH
Q 001354 969 VK 970 (1093)
Q Consensus 969 IL 970 (1093)
.|
T Consensus 291 ~L 292 (303)
T 3hmm_A 291 TL 292 (303)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=430.37 Aligned_cols=258 Identities=32% Similarity=0.565 Sum_probs=225.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+++|++.+.||+|+||+||+|++..+|+.||+|++. +...........+.+|+.+|+.++||||+++++++.+...+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~-~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-HHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEe-hHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45689999999999999999999999999999999553 33222233346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~---- 159 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---- 159 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT----
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc----
Confidence 9999999 78999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
........+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.....
T Consensus 160 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 160 ------------------------DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp ------------------------TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred ------------------------CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 1122345689999999999998876 789999999999999999999999877666
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
++..+......+ |..+++++.+||.+||..||.+||| +.++++||||+.
T Consensus 216 ~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 264 (336)
T 3h4j_B 216 LFKKVNSCVYVM---PDFLSPGAQSLIRRMIVADPMQRIT---IQEIRRDPWFNV 264 (336)
T ss_dssp CBCCCCSSCCCC---CTTSCHHHHHHHHTTSCSSGGGSCC---HHHHTTCHHHHT
T ss_pred HHHHHHcCCCCC---cccCCHHHHHHHHHHcCCChhHCcC---HHHHHhChhhcc
Confidence 665555554444 4789999999999999999999999 889999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=398.02 Aligned_cols=265 Identities=30% Similarity=0.508 Sum_probs=234.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||+|+||.||+|.++.+|..||+|++... .........+.+|+.++..++||||+++++++......|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK--KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG--GCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecc--cCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 57899999999999999999999999999999955322 2344556788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc---EEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~---VKLsDFGLAk~~~~~~ 842 (1093)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~--- 159 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--- 159 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc---
Confidence 9999999999999998889999999999999999999999999999999999999987665 9999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+...
T Consensus 160 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 160 -------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp -------------------------SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 0112234679999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 923 IFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 923 i~~kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
....+......+|.. ...+++++.+||.+||..||.+||+ +.++++||||++..+...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 215 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICNRERVAS 273 (284)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSHHHHSCCCGGG
T ss_pred HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC---HHHHhcCccccCChhHHh
Confidence 998888877665532 2578999999999999999999999 889999999988766543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=434.19 Aligned_cols=292 Identities=31% Similarity=0.431 Sum_probs=208.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----- 759 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd----- 759 (1093)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .........+.+|+.+|..++|||||+++++|..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 357899999999999999999999999999999966432 2234556789999999999999999999999844
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
...+|+||||+ +|+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 35799999998 56999999988889999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCC--CCCCCcc--cccCcCCccCccCCCCCCChhhhc-CCCCCccceeecchhhHHHHHh----
Q 001354 840 INNTIDLSGPETDGIMPS--DAHYPEY--QQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFIT---- 910 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~--~~~~~e~--~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDVWSLGVILYEMLT---- 910 (1093)
....... .....+. ......+ ...........+||+.|+|||++. +..|+.++|||||||+||||++
T Consensus 208 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 208 YPENGNS----QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp SCTTCCC----CCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred Ccccccc----ccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 1110000 0000000 0000000 001122345679999999999874 5679999999999999999999
Q ss_pred -------CCCCCCCCCh--------------------HHHHHHHhc----------------------------cCCCCC
Q 001354 911 -------GIPPFTAESP--------------------EIIFDNILN----------------------------RKIPWP 935 (1093)
Q Consensus 911 -------GkpPF~~~s~--------------------~ei~~kIl~----------------------------~~l~fP 935 (1093)
|.+||.+.+. ......|.. ....+.
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 7888876541 112222211 000111
Q ss_pred CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc
Q 001354 936 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 986 (1093)
Q Consensus 936 ~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~ 986 (1093)
...+.+++++.+||.+||..||.+||| +.|+|+||||+++.|......
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t---~~e~L~Hp~f~~~~~~~~e~~ 411 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRIT---INECLAHPFFKEVRIAEVETN 411 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGTTTCCGGGCCC
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCC---HHHHhcCHhhhhcCCCccCCC
Confidence 122467999999999999999999999 889999999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=437.29 Aligned_cols=260 Identities=30% Similarity=0.536 Sum_probs=229.9
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++++.||+|+||+||+|.++.+|+.||+|++.++ . ........+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~-~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-K-LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESC-S-CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcc-c-CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999955432 2 233456778999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc---cCCcEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD---~dG~VKLsDFGLAk~~~~~~ 842 (1093)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~--- 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--- 164 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC---
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec---
Confidence 999999999999999989999999999999999999999999999999999999998 46889999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 165 ------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~ 220 (444)
T 3soa_A 165 ------------------------GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220 (444)
T ss_dssp ------------------------TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ------------------------CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence 01112245689999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
++..+..+...+|.. ...+++++++||.+||..||.+||+ +.++++||||++
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~L~hp~~~~ 273 (444)
T 3soa_A 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT---AAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSCTTHH
T ss_pred HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC---HHHHhcCccccC
Confidence 999999887776542 2478999999999999999999999 889999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=406.71 Aligned_cols=260 Identities=30% Similarity=0.517 Sum_probs=214.6
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++++.||+|+||+||+|++ .+|+.||+|++.... ........+.+|+.+|..++||||+++++++.+.+.+|+
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSS--GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccc--cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 46899999999999999999998 678999999653221 222334678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 152 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI---- 152 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc----
Confidence 9999986 999998764 6799999999999999999999999999999999999999999999999999974210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.
T Consensus 153 -----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (288)
T 1ob3_A 153 -----------------------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (288)
T ss_dssp --------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -----------------------cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01122345789999999999764 589999999999999999999999999887777
Q ss_pred HHHHhcc--C---CCC---------------------CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 924 FDNILNR--K---IPW---------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 924 ~~kIl~~--~---l~f---------------------P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
...+... . ..+ ......+++++.+||.+||..||.+||+ +.++++||||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~ 286 (288)
T 1ob3_A 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKE 286 (288)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC
T ss_pred HHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC---HHHHhcCcchhh
Confidence 6666431 0 000 1122468999999999999999999999 889999999986
Q ss_pred CC
Q 001354 978 VN 979 (1093)
Q Consensus 978 Id 979 (1093)
.+
T Consensus 287 ~n 288 (288)
T 1ob3_A 287 NN 288 (288)
T ss_dssp --
T ss_pred cC
Confidence 53
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=430.54 Aligned_cols=261 Identities=30% Similarity=0.506 Sum_probs=224.3
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~L 763 (1093)
..++|++++.||+|+||+||+|.++.+|+.||+|++ ++... ...+|+.+|.++ +||||++++++|.+...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~-~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII-DKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-ETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEE-EcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 346899999999999999999999999999999954 33221 234678888877 799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC----CcEEEEecCCccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d----G~VKLsDFGLAk~~~ 839 (1093)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+... +.+||+|||+++...
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999999988899999999999999999999999999999999999998543 359999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC--
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-- 917 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~-- 917 (1093)
. ......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+
T Consensus 172 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 172 A---------------------------ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp C---------------------------TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred C---------------------------CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 0 01123457899999999999988899999999999999999999999986
Q ss_pred -CChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhc
Q 001354 918 -ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 985 (1093)
Q Consensus 918 -~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~ 985 (1093)
.+..++...|..+...++. .+..+++++++||.+||..||.+||+ +.++++||||. +|+.+..
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~--~~~~~~~ 289 (342)
T 2qr7_A 225 DDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT---AALVLRHPWIV--HWDQLPQ 289 (342)
T ss_dssp TSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHH--TGGGSCC
T ss_pred cCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCCeec--Ccccccc
Confidence 4567788888887766543 23579999999999999999999999 88999999994 5776643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=419.05 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=228.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||+|+||.||+|+++.++..||+|.+. . .......+.+|+.+|..++||||+++++++.+.+.+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~-~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-V----KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-C----CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEe-c----CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 578999999999999999999999999999999543 2 12345668899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc--CCcEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~--dG~VKLsDFGLAk~~~~~~ 842 (1093)
||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~--- 155 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC---
Confidence 999999999999997654 6999999999999999999999999999999999999997 7899999999998521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 156 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 156 -------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------------------------CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 0112234679999999999999889999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+...+......++. ....++.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~ 263 (321)
T 1tki_A 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC---HHHHhcChhhcc
Confidence 99999888776542 12478999999999999999999999 889999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=402.03 Aligned_cols=261 Identities=34% Similarity=0.654 Sum_probs=232.2
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
.....+++|++.+.||+|+||.||+|++..++..||+|++. +...........+.+|+.++..++||||+++++++.+.
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEE-HHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEc-ccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 34567789999999999999999999999999999999553 33222233456789999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~- 165 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP- 165 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS-
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc-
Confidence 9999999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.......+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+.
T Consensus 166 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 217 (284)
T 2vgo_A 166 ----------------------------SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217 (284)
T ss_dssp ----------------------------SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----------------------------ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH
Confidence 0112346799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.+....+......+| ..++.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 218 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~h~~~~~ 268 (284)
T 2vgo_A 218 TETHRRIVNVDLKFP---PFLSDGSKDLISKLLRYHPPQRLP---LKGVMEHPWVKA 268 (284)
T ss_dssp HHHHHHHHTTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHTCHHHHH
T ss_pred hHHHHHHhccccCCC---CcCCHHHHHHHHHHhhcCHhhCCC---HHHHhhCHHHHh
Confidence 888888888776655 679999999999999999999999 889999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=410.44 Aligned_cols=271 Identities=29% Similarity=0.473 Sum_probs=235.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~--~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
..++|++.+.||+|+||.||+|+++.+|..||+|++........ ....+.+.+|+.+|..++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 35679999999999999999999999999999995543221111 1135678999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC----cEEEEecCCcccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 838 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG----~VKLsDFGLAk~~ 838 (1093)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999999888899999999999999999999999999999999999999988 8999999999742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 170 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 170 ED----------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CT----------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred Cc----------------------------cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 10 11123457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc
Q 001354 919 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 986 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~ 986 (1093)
+..+....+......++. .+..++..+.+||.+||..||.+||+ +.++++||||.+++|+....+
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~hp~~~~~~~~~~~~~ 287 (321)
T 2a2a_A 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDNQQAMVR 287 (321)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC---HHHHHHSTTTSCSSHHHHHHH
T ss_pred CHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhcCccccCCCccccccc
Confidence 998888888776655432 23578999999999999999999999 889999999999998875443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=416.24 Aligned_cols=267 Identities=27% Similarity=0.422 Sum_probs=216.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
....+++|++++.||+|+||+||+|++..+++.||+|++ +.. .........+.+|+.+|..++||||+++++++.+..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLE-HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEEC-CCC-C--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEE-ccc-ccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 346778999999999999999999999999999999955 222 223334567789999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc-----cCCcEEEEecCCcc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-----HDGHIKLTDFGLSK 836 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD-----~dG~VKLsDFGLAk 836 (1093)
.+|+||||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999999985 9999999888899999999999999999999999999999999999994 55569999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
.... ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||
T Consensus 186 ~~~~---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 238 (329)
T 3gbz_A 186 AFGI---------------------------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238 (329)
T ss_dssp HHC--------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCC---------------------------cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 5210 01122345789999999999874 5899999999999999999999999
Q ss_pred CCCChHHHHHHHhccCC-----CCC-------------CC---------CCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 916 TAESPEIIFDNILNRKI-----PWP-------------CV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l-----~fP-------------~i---------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
.+.+..+....+..... .++ .. +..+++++.+||.+||..||.+||+ +.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e 315 (329)
T 3gbz_A 239 PGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS---AKN 315 (329)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC---HHH
T ss_pred CCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC---HHH
Confidence 99988877777654211 011 00 0127899999999999999999999 889
Q ss_pred HHcCCCCCCCCcc
Q 001354 969 VKAHPFFKGVNWD 981 (1093)
Q Consensus 969 IL~HPFFkgIdWd 981 (1093)
+++||||++++|+
T Consensus 316 ~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 316 ALEHPYFSHNDFD 328 (329)
T ss_dssp HHTSGGGSSSCSC
T ss_pred HhCCcccCCCCCC
Confidence 9999999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=406.54 Aligned_cols=261 Identities=34% Similarity=0.591 Sum_probs=220.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh----------------------chhHHHHHHHHHHH
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI----------------------RKNDIERILAERNI 741 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~----------------------~~~eie~~l~E~~I 741 (1093)
+.+++|++.+.||+|+||.||+|+++.+|+.||+|++.+..... .....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 55789999999999999999999999999999999553322110 11224568899999
Q ss_pred HHhcCCCceEEEeeeecc--CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcE
Q 001354 742 LITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 819 (1093)
Q Consensus 742 L~kL~HPNIVkL~gsfqd--~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNI 819 (1093)
|..++||||+++++++.+ ...+|+||||+++|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 567999999999999988653 45799999999999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccc
Q 001354 820 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAA 896 (1093)
Q Consensus 820 LLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Ys~ks 896 (1093)
|++.+|.+||+|||+++.... ........+||+.|+|||++.+.. ++.++
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 221 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKG---------------------------SDALLSNTVGTPAFMAPESLSETRKIFSGKAL 221 (298)
T ss_dssp EECTTSCEEECCCTTCEECSS---------------------------SSCEECCCCSCGGGCCGGGCCTTCCCEESHHH
T ss_pred EECCCCCEEEecCCCcccccc---------------------------ccccccCCcCCccccChhhhccCCCCCCCchh
Confidence 999999999999999975210 011123468999999999998765 37889
Q ss_pred eeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 897 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 897 DVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
|||||||++|||++|..||.+.+...+...+......+|. ...+++++.+||.+||..||.+||+ +.++++||||+
T Consensus 222 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~R~s---~~e~l~hp~~~ 297 (298)
T 2zv2_A 222 DVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD-QPDIAEDLKDLITRMLDKNPESRIV---VPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTCHHHH
T ss_pred hhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC-ccccCHHHHHHHHHHhhcChhhCCC---HHHHhcCcccc
Confidence 9999999999999999999999888888888877776663 4579999999999999999999999 88999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=421.43 Aligned_cols=282 Identities=30% Similarity=0.534 Sum_probs=213.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC-
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD- 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~- 761 (1093)
...++|++++.||+|+||.||+|.++.+|+.||+|++.+. .........+.+|+.+|..+. ||||++++++|...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 3467999999999999999999999999999999965332 233455677889999999997 999999999997654
Q ss_pred -ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 -~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+|||||. |+|..++.. ..+++..++.++.||+.||+|||+.||+||||||+||||+.+|++||+|||+|+....
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 7999999997 599999876 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
..... .... . ........ ...........+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+
T Consensus 162 ~~~~~--~~~~--~-~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 162 IRRVT--NNIP--L-SINENTEN-FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCC--CCGG--G-CCC----------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccc--cccc--c-cccccccc-cccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10000 0000 0 00000000 0011223455789999999999987 679999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCC---------------------------------------------CCCCCCHHHHHHHHhhcc
Q 001354 920 PEIIFDNILNRKIPWPC---------------------------------------------VPSDMSFEAQDLINRFLI 954 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~---------------------------------------------ip~~IS~eakDLIkrcL~ 954 (1093)
....+..|+.. +.+|. .+..+++++.+||.+||+
T Consensus 236 ~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 236 TMNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 88887777531 11110 012678999999999999
Q ss_pred CCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 955 HDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 955 kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.||.+||| +.++|+||||+.+.
T Consensus 315 ~dP~~R~t---~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 315 FNPNKRIS---ANDALKHPFVSIFH 336 (388)
T ss_dssp SSGGGSCC---HHHHTTSTTTTTTC
T ss_pred cCcccCCC---HHHHhCCHHHHHhc
Confidence 99999999 88999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=422.81 Aligned_cols=265 Identities=31% Similarity=0.480 Sum_probs=224.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+.|++.+.||+|+||+||+|+++.+|+.||+|++...... ......+.+.+|+.+|..++||||++++++|.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346799999999999999999999999999999955322111 1112356789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc---EEEEecCCcc
Q 001354 764 YLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 836 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~---VKLsDFGLAk 836 (1093)
|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888643 24899999999999999999999999999999999999987655 9999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.
T Consensus 182 ~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 182 QLGE---------------------------SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp ECCT---------------------------TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EecC---------------------------CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 5210 0112235689999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 917 AESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
+. ...++..+..+...++. ....+++++++||.+||..||.+||+ +.++++||||++.++
T Consensus 235 ~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 235 GT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT---VYEALNHPWLKERDR 295 (351)
T ss_dssp SS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTHHH
T ss_pred Cc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcChhhcCCcc
Confidence 85 45667777776655431 12468999999999999999999999 889999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=401.71 Aligned_cols=265 Identities=28% Similarity=0.457 Sum_probs=218.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++++.||+|+||+||+|++..+|+.||+|++... .........+.+|+.++..++||||+++++++...+.+|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC--CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc--ccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 47899999999999999999999999999999965332 2233445678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 154 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG----- 154 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+..
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 212 (311)
T 4agu_A 155 ----------------------PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212 (311)
T ss_dssp ---------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ----------------------cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112234579999999999986 67899999999999999999999999998876665
Q ss_pred HHHhcc-------------------CCCCCCC---------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 925 DNILNR-------------------KIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 925 ~kIl~~-------------------~l~fP~i---------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
..+... ....|.. ...++.++.+||.+||..||.+||| +.++++||||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~ 289 (311)
T 4agu_A 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT---CEQLLHHPYFE 289 (311)
T ss_dssp HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC---HHHHHTSGGGT
T ss_pred HHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC---HHHHhcChHHH
Confidence 544321 1111110 1468899999999999999999999 88999999999
Q ss_pred CCCcch
Q 001354 977 GVNWDS 982 (1093)
Q Consensus 977 gIdWd~ 982 (1093)
++.|..
T Consensus 290 ~~~~~~ 295 (311)
T 4agu_A 290 NIREIE 295 (311)
T ss_dssp TCC---
T ss_pred hccCHH
Confidence 987764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=397.75 Aligned_cols=260 Identities=31% Similarity=0.589 Sum_probs=202.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
.+++|++.+.||+|+||.||+|++..+|+.||+|.+ .+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-DKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-EHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEe-ehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 457899999999999999999999999999999954 3333333344578899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~--- 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--- 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC---
Confidence 999999999999999875 5699999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........+||+.|+|||++.+..++.++|+|||||++|||++|.+||...+....
T Consensus 165 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 220 (278)
T 3cok_A 165 ------------------------PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220 (278)
T ss_dssp ---------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred ------------------------CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence 01122346799999999999999999999999999999999999999998877777
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
...+......+| ..++.++.+||.+||..||.+||+ +.++++||||...
T Consensus 221 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 269 (278)
T 3cok_A 221 LNKVVLADYEMP---SFLSIEAKDLIHQLLRRNPADRLS---LSSVLDHPFMSRN 269 (278)
T ss_dssp ---CCSSCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSTTTC--
T ss_pred HHHHhhcccCCc---cccCHHHHHHHHHHcccCHhhCCC---HHHHhcCccccCC
Confidence 766665554444 678999999999999999999999 8899999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=413.46 Aligned_cols=263 Identities=28% Similarity=0.469 Sum_probs=220.1
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|++++.||+|+||+||+|+++.+++.||+|++..+.. ....+.+.+|+.++..++||||+++++++.+.+..|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 35799999999999999999999999999999995532211 122356889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN--- 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET---
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC---
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999753110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCChH-H
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE-I 922 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~-e 922 (1093)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.. .
T Consensus 159 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 159 ----------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp ----------------------TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred ----------------------CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 01122345789999999999988775 78999999999999999999999876553 3
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.+..+.......+ ....+++++.+||.+||..||.+||+ +.++++||||+..-
T Consensus 217 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~ 269 (323)
T 3tki_A 217 EYSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCCC
T ss_pred HHHHHhcccccCC-ccccCCHHHHHHHHHHccCChhhCcC---HHHHhhChhhcccc
Confidence 3333333332222 23578999999999999999999999 88999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=438.04 Aligned_cols=261 Identities=28% Similarity=0.556 Sum_probs=233.9
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
..+.+++|.+.+.||+|+||.||+|+++.+|+.||+|++ .+...........+.+|+.+|+.++||||+++++++.+..
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i-~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKIL-NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEE-EHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEE-EhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 346778999999999999999999999999999999954 3433333345678999999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~-- 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-- 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc--
Confidence 999999999999999999988889999999999999999999999999999999999999999999999999998521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
......+.+||+.|+|||++.+..| +.++|||||||++|||++|.+||.+.+.
T Consensus 168 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 168 --------------------------DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp --------------------------TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred --------------------------ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 0112345689999999999998776 7899999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
..++.+|..+....| ..+++++.+||.+||..||.+||+ +.+|++||||+.
T Consensus 222 ~~~~~~i~~~~~~~p---~~~s~~~~~Li~~~L~~dP~~Rpt---~~eil~hp~~~~ 272 (476)
T 2y94_A 222 PTLFKKICDGIFYTP---QYLNPSVISLLKHMLQVDPMKRAT---IKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHHTTCCCCC---TTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHT
T ss_pred HHHHHHHhcCCcCCC---ccCCHHHHHHHHHHcCCCchhCcC---HHHHHhCHHhhh
Confidence 999999988776554 679999999999999999999999 889999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=409.98 Aligned_cols=264 Identities=29% Similarity=0.472 Sum_probs=207.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|++++.||+|+||+||+|+++.+|+.||+|++.... .......+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS---EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS---TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc---ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 3578999999999999999999999999999999553221 2223456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 765 LVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9999998 5999998754 35899999999999999999999999999999999999999999999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
.. ........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+
T Consensus 159 ~~---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 159 GI---------------------------PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp TS---------------------------CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CC---------------------------CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 10 0112234579999999999987 4689999999999999999999999999
Q ss_pred CChHHHHHHHhccCC-----CC--------------------------CCCCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 918 ESPEIIFDNILNRKI-----PW--------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l-----~f--------------------------P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
.+..+....|..... .+ +..+..++.++.+||.+||+.||.+||+ +
T Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~ 288 (317)
T 2pmi_A 212 TNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS---A 288 (317)
T ss_dssp SSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC---H
T ss_pred CChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC---H
Confidence 988877776653100 00 0012367899999999999999999999 8
Q ss_pred HHHHcCCCCCCCCcch
Q 001354 967 AEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 967 ~EIL~HPFFkgIdWd~ 982 (1093)
.++++||||++..|..
T Consensus 289 ~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 289 KQALHHPWFAEYYHHA 304 (317)
T ss_dssp HHHTTSGGGGGGCC--
T ss_pred HHHhCChhhhcccchh
Confidence 8999999999876653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=393.60 Aligned_cols=261 Identities=29% Similarity=0.542 Sum_probs=222.7
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
..+..++|++.+.||+|+||.||+|+++.+|+.||+|++ .............+.+|+.++..++||||+++++++....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL-NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-EHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEe-ccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 346678999999999999999999999999999999954 3333333345678899999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~- 163 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 163 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence 9999999999999999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.......+||+.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.
T Consensus 164 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 216 (276)
T 2h6d_A 164 ---------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216 (276)
T ss_dssp ----------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 111234579999999999988766 6899999999999999999999999988
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
......+......+| ..++.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 217 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps---~~~~l~h~~~~~ 267 (276)
T 2h6d_A 217 PTLFKKIRGGVFYIP---EYLNRSVATLLMHMLQVDPLKRAT---IKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHT
T ss_pred HHHHHHhhcCcccCc---hhcCHHHHHHHHHHccCChhhCCC---HHHHHhChhhcc
Confidence 888888877665544 678999999999999999999999 889999999964
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=394.14 Aligned_cols=270 Identities=30% Similarity=0.472 Sum_probs=230.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh-----hhchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-----MIRKNDIERILAERNILITVR-NPFVVRFFYSF 757 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~-----~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsf 757 (1093)
...++|++.+.||+|+||.||+|+++.+|+.||+|++..... .......+.+.+|+.+|.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 346899999999999999999999999999999995532210 111233567889999999996 99999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.....+|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999999888899999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc------CCCCCccceeecchhhHHHHHhC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~------g~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
... .......+||+.|+|||++. ...++.++||||||+++|+|++|
T Consensus 174 ~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 174 LDP----------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp CCT----------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cCC----------------------------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence 210 11223467999999999985 45688999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 912 IPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 912 kpPF~~~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
..||.+.+.......+......++. ....++..+.+||.+||..||.+||+ +.++++||||++..|+.+.
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCTTC-----
T ss_pred CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC---HHHHHhChHhhhccchhhc
Confidence 9999999988888888887666542 12468999999999999999999999 8899999999999887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=415.35 Aligned_cols=256 Identities=34% Similarity=0.552 Sum_probs=212.8
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++++.||+|+||+||+|+++.+++.||+|++. +... ....+.+|+.+++.++||||+++++++.+...+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~-~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE-RGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEE-SSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEe-cCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 45689999999999999999999999999999999553 2221 224578999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc--EEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~--VKLsDFGLAk~~~~~ 841 (1093)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++...
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-- 169 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 169 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc--
Confidence 999999999999999998889999999999999999999999999999999999999988765 9999999987321
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc-ceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA-ADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k-sDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+...
T Consensus 170 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 170 --------------------------LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred --------------------------ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 0112234679999999999998887655 9999999999999999999987543
Q ss_pred ----HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 921 ----EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 921 ----~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
......+......+|. ...+++++.+||.+||..||.+||+ +.++++||||.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~ 279 (361)
T 3uc3_A 224 PRDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRIS---IPEIKTHSWFL 279 (361)
T ss_dssp CCCHHHHHHHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcC---HHHHHhCcchh
Confidence 4555566666666553 3468999999999999999999999 88999999995
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=395.19 Aligned_cols=261 Identities=29% Similarity=0.490 Sum_probs=232.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|.+.+.||+|+||.||+|+++.+++.||+|++ .+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE-EGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEe-chhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 4567899999999999999999999999999999954 343333455667889999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--- 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--- 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc---
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999875210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........+||+.|+|||++.+..++.++|+||||+++|+|++|..||......+.
T Consensus 168 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 168 ------------------------DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp ------------------------TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ------------------------CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01122346799999999999999999999999999999999999999999988888
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+..+......+| ..+++.+.+||.+||..||.+||+ +.++++||||...
T Consensus 224 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~~~~~~~ 272 (294)
T 2rku_A 224 YLRIKKNEYSIP---KHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 272 (294)
T ss_dssp HHHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred HHHHhhccCCCc---cccCHHHHHHHHHHcccChhhCcC---HHHHhhChheecC
Confidence 888877766554 689999999999999999999999 7789999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=409.65 Aligned_cols=271 Identities=29% Similarity=0.456 Sum_probs=224.7
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh-hhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~-~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..++|++.+.||+|+||+||+|.++.++..||+|++.+... .......+.+.+|+.+|..++||||+++++++.+.+.+
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 34789999999999999999999999999999995533211 12345567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 001354 764 YLVMEYLNGGDLYSLLRKV----------------------------------------GCLEEDVARIYIAELVLALEY 803 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~----------------------------------------g~LsEe~ar~yaaQIl~ALeY 803 (1093)
|+||||++||+|.+++... ..+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999998521 124677888999999999999
Q ss_pred HHhcCcEeeecCCCcEEEccCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCC
Q 001354 804 LHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 881 (1093)
Q Consensus 804 LHs~GIIHRDIKPeNILLD~dG--~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~Y 881 (1093)
||++||+||||||+||||+.++ .+||+|||+++...... ..........+||+.|
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~-----------------------~~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN-----------------------NGEYYGMTTKAGTPYF 240 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTT-----------------------CC--------CCCGGG
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccC-----------------------ccccccccccCCCccc
Confidence 9999999999999999998777 89999999998532100 0011123456799999
Q ss_pred CChhhhcC--CCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcC
Q 001354 882 LAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPN 958 (1093)
Q Consensus 882 mAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~ 958 (1093)
+|||++.+ ..|+.++|||||||+||||++|..||.+.+..+....+......++. ....+++++.+||.+||+.||.
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 99999975 67899999999999999999999999999999998888887765542 1234899999999999999999
Q ss_pred CCCChhcHHHHHcCCCCCCCCcc
Q 001354 959 QRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 959 KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
+||+ +.++++||||+++.|.
T Consensus 321 ~Rps---~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 321 ERFD---AMRALQHPWISQFSDK 340 (345)
T ss_dssp TSCC---HHHHHHSHHHHTTSSC
T ss_pred HCCC---HHHHhcChhhccChHh
Confidence 9999 8899999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=412.47 Aligned_cols=261 Identities=34% Similarity=0.563 Sum_probs=213.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...+.|++.+.||+|+||.||+|+++.+++.||+|++. +. ...+.+.+|+.+|..++||||++++++|.+...+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~-~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-KT-----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE-C---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEec-cc-----hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 34578999999999999999999999999999999543 21 1335678999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CCcEEEEecCCcccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG~VKLsDFGLAk~~~~ 840 (1093)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++...
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~- 202 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE- 202 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC-
Confidence 999999999999999998888999999999999999999999999999999999999976 8999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+...
T Consensus 203 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 203 ---------------------------HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp -------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred ---------------------------cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 01122346799999999999999999999999999999999999999987665
Q ss_pred HH-HHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 921 EI-IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 921 ~e-i~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
.. ++..+......++. ....++.++.+||.+||..||.+||+ +.++++||||.+..+.
T Consensus 256 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT---TFQALQHPWVTGKAAN 315 (349)
T ss_dssp HHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTTSTTCC
T ss_pred cHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCccc
Confidence 44 67777776554432 23578999999999999999999999 8899999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=420.01 Aligned_cols=262 Identities=25% Similarity=0.467 Sum_probs=228.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++++.||+|+||.||+|.++.+|+.||+|++... . ......+.+|+.+|..++||||++++++|.+...+
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-Y---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-S---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-c---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 3457899999999999999999999999999999955322 1 22345788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc--CCcEEEEecCCcccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~--dG~VKLsDFGLAk~~~~ 840 (1093)
|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999997654 6999999999999999999999999999999999999984 47899999999985210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.
T Consensus 204 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 255 (387)
T 1kob_A 204 ----------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255 (387)
T ss_dssp ----------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ----------------------------CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence 1112345799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 921 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
.+....+......++. ....+++++++||.+||..||.+||+ +.++++||||++..+
T Consensus 256 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 256 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSCCT
T ss_pred HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhhCccccCCcc
Confidence 8888888876655442 23578999999999999999999999 889999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=403.01 Aligned_cols=270 Identities=30% Similarity=0.527 Sum_probs=216.7
Q ss_pred CCCeeEE-EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCce
Q 001354 686 IDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 686 iddFeil-r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~L 763 (1093)
.+.|++. +.||+|+||+||+|+++.+++.||+|++.+. .......+.+|+.+|.++ +||||+++++++.+.+.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC----SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC----cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 4678885 7899999999999999999999999955322 123456788999999885 799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc---EEEEecCCcccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLI 840 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~---VKLsDFGLAk~~~~ 840 (1093)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999999998889999999999999999999999999999999999999998776 99999999874321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeecchhhHHHHHhCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
.... ...........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||
T Consensus 167 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 226 (316)
T 2ac3_A 167 NGDC--------------------SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226 (316)
T ss_dssp -----------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcc--------------------ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence 1000 0001112335679999999999975 45889999999999999999999999
Q ss_pred CCCC---------------hHHHHHHHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 916 TAES---------------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 916 ~~~s---------------~~ei~~kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.+.. ...++..+......+|.. ...+++++++||.+||..||.+||+ +.++++||||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS---AAQVLQHPWVQGCA 303 (316)
T ss_dssp CCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSTTCC---
T ss_pred cccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC---HHHHhcChhhcCCC
Confidence 8764 244666777776665521 1468999999999999999999999 88999999999877
Q ss_pred cch
Q 001354 980 WDS 982 (1093)
Q Consensus 980 Wd~ 982 (1093)
|..
T Consensus 304 ~~~ 306 (316)
T 2ac3_A 304 PEN 306 (316)
T ss_dssp ---
T ss_pred Ccc
Confidence 654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=414.03 Aligned_cols=259 Identities=31% Similarity=0.501 Sum_probs=215.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
.+.|++++.||+|+||.||+|.++.+|+.||+|++.+. .........+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc--ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 57899999999999999999999999999999955332 223445678899999999999999999999998764
Q ss_pred --ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 --~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 8899999876 579999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.
T Consensus 180 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 180 ------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01234689999999999987 78999999999999999999999999998
Q ss_pred ChHHHHHHHhcc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~----------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+..+....|+.. ...+..+...+++++.+||.+||..||.+||| +.+++
T Consensus 230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t---~~e~l 306 (367)
T 1cm8_A 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEAL 306 (367)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC---HHHHh
Confidence 877776666431 11222234578999999999999999999999 88999
Q ss_pred cCCCCCCCCcc
Q 001354 971 AHPFFKGVNWD 981 (1093)
Q Consensus 971 ~HPFFkgIdWd 981 (1093)
+||||+.+.+.
T Consensus 307 ~hp~f~~~~~~ 317 (367)
T 1cm8_A 307 AHPYFESLHDT 317 (367)
T ss_dssp HSGGGTTTC--
T ss_pred cChHHHhhcCC
Confidence 99999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=433.08 Aligned_cols=266 Identities=30% Similarity=0.516 Sum_probs=233.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++.+.||+|+||+||+|+++.+|+.||+|++ .+...........+.+|+.+|..++|||||+++++|.+...+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~-~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE-ETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEE-EhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3456899999999999999999999999999999954 333333344567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE---ccCCcEEEEecCCcccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL---D~dG~VKLsDFGLAk~~~~ 840 (1093)
|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE- 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC-
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc-
Confidence 9999999999999999988899999999999999999999999999999999999999 567899999999997421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.
T Consensus 181 ---------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 181 ---------------------------ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp ---------------------------CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 0112234679999999999987 699999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 921 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
.++...+..+.+.++. ....+|+++++||.+||..||.+||+ +.++++||||+...++.
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 233 YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS---ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHHHTC--
T ss_pred HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhhChhhccccccc
Confidence 9999999888766542 12468999999999999999999999 88999999998765543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=395.48 Aligned_cols=259 Identities=32% Similarity=0.534 Sum_probs=221.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|.+.+.||+|+||.||+|+++.++..+|+|.+.... .....+.+.+|+.+|..++||||+++++++.+...+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc---cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 44578999999999999999999999999999999554322 223456789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE---ccCCcEEEEecCCcc
Q 001354 764 YLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSK 836 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL---D~dG~VKLsDFGLAk 836 (1093)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999999998643 579999999999999999999999999999999999999 456889999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.... .......+||+.|+|||++. ..++.++|||||||++|||++|..||.
T Consensus 176 ~~~~----------------------------~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 176 LFKS----------------------------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp C--------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCC----------------------------cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 4210 11223467999999999986 568999999999999999999999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+.+..+....+......++.....+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~f~~ 284 (285)
T 3is5_A 227 GTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS---AAQVLHHEWFKQ 284 (285)
T ss_dssp CSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGGC
T ss_pred CCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHhhc
Confidence 9998888888776665555444568999999999999999999999 889999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=392.14 Aligned_cols=256 Identities=30% Similarity=0.541 Sum_probs=226.5
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++.+.||+|+||.||+|.++.++..+|+|++.+. . ....+.+.+|+.+|..++||||+++++++.+...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-F---VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG-G---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhh-c---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 45799999999999999999999999999999955332 1 2335678999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE---ccCCcEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL---D~dG~VKLsDFGLAk~~~~~~ 842 (1093)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~--- 160 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--- 160 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc---
Confidence 99999999999999988889999999999999999999999999999999999999 788999999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
........+||+.|+|||++.+. ++.++||||||+++|||++|..||...+..+
T Consensus 161 -------------------------~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (277)
T 3f3z_A 161 -------------------------PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214 (277)
T ss_dssp -------------------------TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH
Confidence 01122346799999999998765 8999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
....+..+...+|.. ...+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~ 267 (277)
T 3f3z_A 215 VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT---SLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHHH
T ss_pred HHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhc
Confidence 998888877665521 1268999999999999999999999 889999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=398.72 Aligned_cols=263 Identities=29% Similarity=0.432 Sum_probs=213.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-hchhHHHHHHHHHHHHHhc---CCCceEEEeeeecc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-IRKNDIERILAERNILITV---RNPFVVRFFYSFTC 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-~~~~eie~~l~E~~IL~kL---~HPNIVkL~gsfqd 759 (1093)
+..++|++++.||+|+||+||+|+++.+|+.||+|++...... ........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467999999999999999999999999999999955322111 1111123456677766655 59999999999987
Q ss_pred CC-----ceEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEec
Q 001354 760 RD-----NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 760 ~~-----~LyLVMEYm~GGSL~dlL~k~g~--LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
.. .+|+||||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 4899999997 599999987654 999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCC
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
|+++... ........+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 165 g~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 165 GLARIYS----------------------------YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp SCTTTST----------------------------TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred ccccccC----------------------------CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence 9997421 011224568999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCC-----CCCC-------------------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 913 PPFTAESPEIIFDNILNRKI-----PWPC-------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l-----~fP~-------------------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
+||.+.+..+....+..... .+|. ....+++++.+||.+||..||.+||+ +.+
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e 293 (308)
T 3g33_A 217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS---AFR 293 (308)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC---HHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC---HHH
Confidence 99999998888877764211 1110 12368899999999999999999999 889
Q ss_pred HHcCCCCCCC
Q 001354 969 VKAHPFFKGV 978 (1093)
Q Consensus 969 IL~HPFFkgI 978 (1093)
+++||||+..
T Consensus 294 ~l~h~~~~~~ 303 (308)
T 3g33_A 294 ALQHSYLHKD 303 (308)
T ss_dssp HHTSTTC---
T ss_pred HhcCccccCC
Confidence 9999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=416.34 Aligned_cols=290 Identities=28% Similarity=0.432 Sum_probs=217.1
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~---- 760 (1093)
..++|++++.||+|+||+||+|+++.+|+.||+|++.+. .........+.+|+.+|..++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 457899999999999999999999999999999955322 23345567899999999999999999999999876
Q ss_pred -CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..+|+||||+. |+|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.+|.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 56999999986 5999999988889999999999999999999999999999999999999999999999999998642
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeecchhhHHHHHh--------
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFIT-------- 910 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDVWSLGVILYEMLT-------- 910 (1093)
.............. .................+||+.|+|||++. +..|+.++|||||||+||||++
T Consensus 181 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 181 SEKDTNIVNDLEEN-----EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccc-----ccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 11100000000000 000000011122346789999999999874 5679999999999999999998
Q ss_pred ---CCCCCCCCCh-----------------HHHHHHHhc------------------------cCCCCC----CCCCCCC
Q 001354 911 ---GIPPFTAESP-----------------EIIFDNILN------------------------RKIPWP----CVPSDMS 942 (1093)
Q Consensus 911 ---GkpPF~~~s~-----------------~ei~~kIl~------------------------~~l~fP----~ip~~IS 942 (1093)
|.++|.+.+. ......|+. .....+ ...+.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 4555555331 111111111 010000 0124689
Q ss_pred HHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhc
Q 001354 943 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 985 (1093)
Q Consensus 943 ~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~ 985 (1093)
+++.+||.+||+.||.+||| +.++|+||||+++.|.....
T Consensus 336 ~~~~dLl~~mL~~dP~~R~t---a~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRIT---IDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCC---HHHHHTCGGGTTTCCTTTC-
T ss_pred HHHHHHHHHHhcCCcccCCC---HHHHhcChhhhhccCcccCc
Confidence 99999999999999999999 88999999999999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=430.18 Aligned_cols=263 Identities=30% Similarity=0.539 Sum_probs=229.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++++.||+|+||+||+|+++.+++.||+|++. +.. ........+.+|+.+|+.++|||||++++++.+...+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~-~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KAS-AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEE-HHH-HBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEe-ccc-ccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 45578999999999999999999999999999999553 322 2233457789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc---cCCcEEEEecCCcccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD---~dG~VKLsDFGLAk~~~~ 840 (1093)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 175 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ- 175 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC-
Confidence 99999999999999999888999999999999999999999999999999999999995 45689999999997421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.
T Consensus 176 ---------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 176 ---------------------------QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp ---------------------------CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0112234689999999999986 599999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 921 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
.++...+..+...++. ....+|+++++||.+||..||.+||+ +.++++||||+....
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHHHCHHHHHTCC
T ss_pred HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCHhhccCcc
Confidence 9999999887766542 12468999999999999999999999 889999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=403.90 Aligned_cols=261 Identities=29% Similarity=0.490 Sum_probs=232.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|.+.+.||+|+||.||+|++..+++.||+|++ .+.........+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~-~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE-EGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEe-chhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 4567899999999999999999999999999999954 343334455667889999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--- 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--- 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS---
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999975210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|..||......+.
T Consensus 194 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 194 ------------------------DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp ------------------------TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ------------------------CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 01122346799999999999999999999999999999999999999999988888
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+..+......+| ..+++++.+||.+||..||.+||+ +.++++||||...
T Consensus 250 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~ell~~~~~~~~ 298 (335)
T 2owb_A 250 YLRIKKNEYSIP---KHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred HHHHhcCCCCCC---ccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccCC
Confidence 888877766555 689999999999999999999999 7789999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=391.70 Aligned_cols=256 Identities=23% Similarity=0.424 Sum_probs=217.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CC
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RD 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd----~~ 761 (1093)
-..|++.+.||+|+||.||+|.+..++..||+|.+. . ..........+.+|+.+|..++||||++++++|.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~-~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ-D-RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE-G-GGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEec-c-hhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 345899999999999999999999999999999553 2 22344567789999999999999999999998865 35
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEc-cCCcEEEEecCCcccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD-~dG~VKLsDFGLAk~~ 838 (1093)
.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999998889999999999999999999999999 99999999999998 7899999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 183 ~-----------------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 183 R-----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp C-----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c-----------------------------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 1 112234579999999998875 5999999999999999999999999885
Q ss_pred Ch-HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 919 SP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 919 s~-~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.. ......+... ...+..+...++++.+||.+||..||.+||+ +.++++||||++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~f~~ 288 (290)
T 1t4h_A 233 QNAAQIYRRVTSG-VKPASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp SSHHHHHHHHTTT-CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred CcHHHHHHHHhcc-CCccccCCCCCHHHHHHHHHHccCChhhCCC---HHHHhhCccccc
Confidence 54 4444444433 3323345678899999999999999999999 889999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=404.71 Aligned_cols=266 Identities=29% Similarity=0.458 Sum_probs=227.9
Q ss_pred CCCeeEE-EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCce
Q 001354 686 IDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 686 iddFeil-r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~L 763 (1093)
.+.|.+. +.||+|+||.||+|+++.+|+.||+|++. +.. ........+.+|+.++..+. ||||++++++|.+...+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~-~~~-~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK-KRR-RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-SEE-TTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEe-hhh-cchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 4567777 89999999999999999999999999553 322 22334567899999999995 69999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CCcEEEEecCCcccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIG 838 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG~VKLsDFGLAk~~ 838 (1093)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999998643 67999999999999999999999999999999999999998 789999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 185 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 185 G----------------------------HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp -------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C----------------------------CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011123467999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 919 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
+..+.+..+......++. ....+++.+.+||.+||..||.+||+ +.++++||||++++|+.+.
T Consensus 237 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 237 DNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT---AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp SHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTCGGGCCCCTTCC-
T ss_pred CchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhCCHhhccccccccc
Confidence 988888888776554432 34578999999999999999999999 8899999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=430.06 Aligned_cols=257 Identities=26% Similarity=0.465 Sum_probs=211.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .........+.+|+.+|+.++|||||+++++|....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG--GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc--ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 468899999999999999999999999999999965432 234455678899999999999999999999997654
Q ss_pred ---ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 762 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+||||||+.+ +|...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++..
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 57999999976 57776643 4999999999999999999999999999999999999999999999999999842
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. ........+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.
T Consensus 215 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 215 G----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ------------------------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C----------------------------CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011234578999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCC---------------------------CCCCC-CCC-----------CCHHHHHHHHhhccCCcCC
Q 001354 919 SPEIIFDNILNRKI---------------------------PWPCV-PSD-----------MSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 919 s~~ei~~kIl~~~l---------------------------~fP~i-p~~-----------IS~eakDLIkrcL~kDP~K 959 (1093)
+..+.+..|+.... .+|.. +.. .++++.+||.+||..||.+
T Consensus 267 ~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 88777777654210 00000 000 1567999999999999999
Q ss_pred CCChhcHHHHHcCCCCCC
Q 001354 960 RLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFkg 977 (1093)
||| +.|+|+||||+.
T Consensus 347 R~t---a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 347 RIS---VDDALQHPYINV 361 (464)
T ss_dssp SCC---HHHHHTSTTTGG
T ss_pred CCC---HHHHhcChhhhh
Confidence 999 889999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=402.12 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=218.2
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-----CCceEEEee
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-----NPFVVRFFY 755 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-----HPNIVkL~g 755 (1093)
...+..++|++++.||+|+||+||+|++..+++.||+|++ ++ .......+..|..+|..+. |||||++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~-~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-CS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEe-cc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 3345678999999999999999999999999999999954 32 1234456778999999986 999999999
Q ss_pred eeccCCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc----------
Q 001354 756 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---------- 823 (1093)
Q Consensus 756 sfqd~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---------- 823 (1093)
++...+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 899999998754 5999999999999999999999999999999999999975
Q ss_pred ---------------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc
Q 001354 824 ---------------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 888 (1093)
Q Consensus 824 ---------------dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~ 888 (1093)
++.+||+|||+++... ......+||+.|+|||++.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~------------------------------~~~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKS------------------------------DYHGSIINTRQYRAPEVIL 232 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETT------------------------------SCCCSCCSCGGGCCHHHHT
T ss_pred hcccccccccccccCCCCEEEEeccCceecC------------------------------CCCcCccCcccccCcHHHc
Confidence 7899999999997421 1123467999999999999
Q ss_pred CCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCC--------------------------CC-----
Q 001354 889 GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP--------------------------CV----- 937 (1093)
Q Consensus 889 g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP--------------------------~i----- 937 (1093)
+..|+.++|||||||++|||++|++||.+.+..+....+.....++| ..
T Consensus 233 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 312 (360)
T 3llt_A 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312 (360)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHH
T ss_pred CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchh
Confidence 99999999999999999999999999999887777666544322222 10
Q ss_pred ------------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 938 ------------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 938 ------------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
+...++.+.+||.+||+.||.+||+ +.++++||||+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~ 360 (360)
T 3llt_A 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS---PAELLKHKFLE 360 (360)
T ss_dssp HHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGC
T ss_pred hhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC---HHHHhcCcccC
Confidence 0112477889999999999999999 88999999995
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=385.82 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=211.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~Ly 764 (1093)
.++|++++.||+|+||+||+|+++.+++.||+|++... .........+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP--LAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--CTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccc--ccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 46899999999999999999999999999999955322 12233456788999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---------------
Q 001354 765 LVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--------------- 825 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~----g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG--------------- 825 (1093)
+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999999765 6699999999999999999999999999999999999998544
Q ss_pred ----cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeec
Q 001354 826 ----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWS 900 (1093)
Q Consensus 826 ----~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWS 900 (1093)
.+||+|||++.... ......||+.|+|||++.+. .++.++||||
T Consensus 168 ~~~~~~kl~Dfg~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 216 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRIS-------------------------------SPQVEEGDSRFLANEVLQENYTHLPKADIFA 216 (289)
T ss_dssp --CCCEEECCCTTCEETT-------------------------------CSCCCCCCGGGCCHHHHTTCCTTHHHHHHHH
T ss_pred CCceEEEEcccccccccC-------------------------------CccccCCCccccChhHhcCCCCCCchhhHHH
Confidence 79999999987421 11234599999999999876 5678999999
Q ss_pred chhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 901 VGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 901 LGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
|||++|+|++|.+||.... ....+..+.. +.++..+++++.+||.+||..||.+||+ +.++++||||.+.
T Consensus 217 lG~il~~l~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 217 LALTVVCAAGAEPLPRNGD---QWHEIRQGRL--PRIPQVLSQEFTELLKVMIHPDPERRPS---AMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHHTTCCCCCSSSH---HHHHHHTTCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTCTTC---
T ss_pred HHHHHHHHhcCCCCCcchh---HHHHHHcCCC--CCCCcccCHHHHHHHHHHhCCCcccCCC---HHHHhhChHhhhh
Confidence 9999999999998876543 3344444433 4456889999999999999999999999 8899999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=402.49 Aligned_cols=257 Identities=30% Similarity=0.533 Sum_probs=223.5
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|+..+.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|+.+|..++||||+++++++...+.+|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT----TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc----chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 478888999999999999999999999999954322 2234567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||++||+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~------- 193 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK------- 193 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-------
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc-------
Confidence 99999999999865 4699999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kI 927 (1093)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+
T Consensus 194 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 194 --------------------DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp --------------------SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred --------------------CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011223568999999999999999999999999999999999999999999888888777
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 928 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 928 l~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.....+....+..+++++.+||.+||..||.+||+ +.++++||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~ 302 (321)
T 2c30_A 254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELLDHPFLLQTG 302 (321)
T ss_dssp HHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGGGCC
T ss_pred hcCCCCCcCccccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhccCC
Confidence 66544322234568999999999999999999999 88999999997543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=393.58 Aligned_cols=265 Identities=30% Similarity=0.519 Sum_probs=227.7
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~--~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
++|++.+.||+|+||.||+|+++.+|+.||+|++........ ....+.+.+|+.+|..++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999995533221111 123577899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC----cEEEEecCCcccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLI 840 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG----~VKLsDFGLAk~~~~ 840 (1093)
+||||+++++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999999888899999999999999999999999999999999999999887 899999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus 165 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 165 ----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp -----------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----------------------------CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 0112345799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 921 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
.+....+......++. .+..++..+.+||.+||..||.+||+ +.++++||||+.+.+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT---IAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC---HHHHHHCHHHHHHHHCC
T ss_pred HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC---HHHHHhCHHHHHHHHHh
Confidence 8888887766554431 23578999999999999999999999 88999999998765543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=399.14 Aligned_cols=268 Identities=26% Similarity=0.442 Sum_probs=210.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
+++|++++.||+|+||.||+|+++.+|+.||+|++... . .....+.+.+|+.+|..++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP-N--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECC-S--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecC-C--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 46799999999999999999999999999999955322 1 2345578899999999999999999999886543
Q ss_pred -----------------------------------------------------ceEEEEEecCCCChHHHHHhcCC---C
Q 001354 762 -----------------------------------------------------NLYLVMEYLNGGDLYSLLRKVGC---L 785 (1093)
Q Consensus 762 -----------------------------------------------------~LyLVMEYm~GGSL~dlL~k~g~---L 785 (1093)
.+|+||||++||+|.+++.+... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 38999999999999999987543 5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccc
Q 001354 786 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865 (1093)
Q Consensus 786 sEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~ 865 (1093)
++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......... .. .. .
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~-------~~------~~--~ 226 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ-------TV------LT--P 226 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------------------
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhc-------cc------cc--c
Confidence 666789999999999999999999999999999999999999999999998532110000 00 00 0
Q ss_pred ccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHH
Q 001354 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEA 945 (1093)
Q Consensus 866 ~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~ea 945 (1093)
..........+||+.|+|||++.+..|+.++|||||||++|||++|..|+.. .......+... .+|......++++
T Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQKYPQE 302 (332)
T ss_dssp -----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHHCHHH
T ss_pred ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccCChhH
Confidence 0001223456899999999999999999999999999999999999877532 12223333332 3333334567889
Q ss_pred HHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 946 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 946 kDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.+||.+||..||.+||+ +.++++||||+++
T Consensus 303 ~~li~~~l~~~p~~Rps---~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPE---ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHHCSSGGGSCC---HHHHHHSTTCCCC
T ss_pred HHHHHHHccCCCCcCCC---HHHHhhchhhhcC
Confidence 99999999999999999 8899999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=427.05 Aligned_cols=263 Identities=28% Similarity=0.481 Sum_probs=227.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc----------hhHHHHHHHHHHHHHhcCCCceEE
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR----------KNDIERILAERNILITVRNPFVVR 752 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~----------~~eie~~l~E~~IL~kL~HPNIVk 752 (1093)
....++|++++.||+|+||+||+|+++.++..||+|++.+. .... ....+.+.+|+.+|..++|||||+
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKS-QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC-----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhh-hcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34568899999999999999999999999999999955332 2111 133567899999999999999999
Q ss_pred EeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---cEEE
Q 001354 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKL 829 (1093)
Q Consensus 753 L~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG---~VKL 829 (1093)
++++|.+...+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999999888999999999999999999999999999999999999999876 6999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHH
Q 001354 830 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 830 sDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEML 909 (1093)
+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|+
T Consensus 191 ~Dfg~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 241 (504)
T 3q5i_A 191 VDFGLSSFFS----------------------------KDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILL 241 (504)
T ss_dssp CCCTTCEECC----------------------------TTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHH
T ss_pred EECCCCEEcC----------------------------CCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHH
Confidence 9999998521 0112345679999999999874 6999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 910 TGIPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 910 TGkpPF~~~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+|.+||.+.+..++...+..+.+.++. ....+|+++++||.+||..||.+||+ +.++++||||+..
T Consensus 242 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 242 CGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT---AEEALNSRWIKKY 308 (504)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHHT
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC---HHHHhcCHhhhhc
Confidence 999999999999999999888766542 12578999999999999999999999 8899999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=407.56 Aligned_cols=262 Identities=28% Similarity=0.519 Sum_probs=213.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++++.||+|+||+||+|+++.+++.||+|++... . .......+.+|+.+|..++||||+++++++.+...+|+
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE-H--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecc-c--ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 46899999999999999999999999999999955221 1 11112245579999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||++ |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~---- 152 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI---- 152 (324)
T ss_dssp EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC----
Confidence 999997 49999887654 599999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.
T Consensus 153 -----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (324)
T 3mtl_A 153 -----------------------PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209 (324)
T ss_dssp ---------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -----------------------CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112234578999999999987 5789999999999999999999999999988877
Q ss_pred HHHHhccC-----CCCCC----------------------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 924 FDNILNRK-----IPWPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 924 ~~kIl~~~-----l~fP~----------------------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
...+.... ..+|. ....+++++.+||.+||+.||.+||+ +.++++||||.
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~ 286 (324)
T 3mtl_A 210 LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS---AEDAMKHPFFL 286 (324)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGG
T ss_pred HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC---HHHHhcChhhh
Confidence 77665411 01111 12357899999999999999999999 88999999998
Q ss_pred CCCcc
Q 001354 977 GVNWD 981 (1093)
Q Consensus 977 gIdWd 981 (1093)
++...
T Consensus 287 ~~~~~ 291 (324)
T 3mtl_A 287 SLGER 291 (324)
T ss_dssp GGCST
T ss_pred hcccc
Confidence 76543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=425.95 Aligned_cols=260 Identities=32% Similarity=0.553 Sum_probs=224.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.+.|++++.||+|+||+||+|+++.++..||+|++.+. .. .......+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT-SV-STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecc-cc-CchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45799999999999999999999999999999955332 21 22335678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC---CcEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d---G~VKLsDFGLAk~~~~~~ 842 (1093)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||+++...
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~--- 190 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--- 190 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB---
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC---
Confidence 99999999999999988899999999999999999999999999999999999999764 559999999997521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
........+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 191 -------------------------~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (494)
T 3lij_A 191 -------------------------NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244 (494)
T ss_dssp -------------------------TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 011234568999999999986 469999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 923 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 923 i~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
+...+..+...++. ....+++++++||.+||+.||.+||+ +.++++||||+...
T Consensus 245 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS---AQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHHHH
T ss_pred HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc---HHHHhcCcccccCc
Confidence 99999888776543 12478999999999999999999999 88999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=396.66 Aligned_cols=257 Identities=35% Similarity=0.599 Sum_probs=225.9
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++. ... ......+.+|+.+|..++||||+++++++.+...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE-CC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEe-ccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 467999999999999999999999999999999553 221 1233568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE---ccCCcEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL---D~dG~VKLsDFGLAk~~~~~~ 842 (1093)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~--- 160 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--- 160 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC---
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC---
Confidence 99999999999999888889999999999999999999999999999999999999 788999999999987411
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...
T Consensus 161 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 214 (304)
T 2jam_A 161 --------------------------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214 (304)
T ss_dssp --------------------------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred --------------------------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 011234579999999999999999999999999999999999999999999988
Q ss_pred HHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 923 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 923 i~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+...+..+...++. .+..+++++.+||.+||..||.+||+ +.++++||||++.
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 268 (304)
T 2jam_A 215 LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT---CEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHSS
T ss_pred HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCccccCC
Confidence 88888887665542 34678999999999999999999999 8899999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=393.54 Aligned_cols=265 Identities=32% Similarity=0.561 Sum_probs=225.9
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..+.|++++.||+|+||.||+|+++.++..||+|++... .......+.+|+.+|..++||||+++++++...+.+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 457899999999999999999999999999999954322 2334577899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 169 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--- 169 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH---
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc---
Confidence 99999999999999876 45699999999999999999999999999999999999999999999999999763210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
........+||+.|+|||++. +..++.++|||||||++|+|++|.+||...
T Consensus 170 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 170 ------------------------TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp ------------------------HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ------------------------cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 011123457999999999984 677899999999999999999999999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
+.......+.....+....+..++.++.+||.+||..||.+||+ +.++++||||+++.|...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 226 NPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLEHPFVSSITSNKA 287 (302)
T ss_dssp CHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCC---HHHHTTSTTTTTCCCCHH
T ss_pred CHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCC---HHHHhcChHHhhhccchh
Confidence 88888877776654433345678999999999999999999999 889999999999988753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=406.15 Aligned_cols=255 Identities=30% Similarity=0.512 Sum_probs=200.8
Q ss_pred CCeeEE---EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCc
Q 001354 687 DDFEII---KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 687 ddFeil---r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~ 762 (1093)
++|++. +.||+|+||+||+|+++.+|+.||+|++. + .....+.+|+.+|..+. ||||++++++|.+...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~-~------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-K------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEE-G------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEC-h------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 456664 78999999999999999999999999553 2 23356778999999997 9999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---cEEEEecCCccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGL 839 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG---~VKLsDFGLAk~~~ 839 (1093)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999999999988999999999999999999999999999999999999998766 89999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
. ........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 161 ~---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 161 P---------------------------DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp C-------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred C---------------------------CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 0 1112345689999999999999999999999999999999999999998644
Q ss_pred -------hHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 920 -------PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 920 -------~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
..++...+..+...++. ....+++++++||.+||..||.+||+ +.++++||||++.
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~h~w~~~~ 277 (325)
T 3kn6_A 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK---MSGLRYNEWLQDG 277 (325)
T ss_dssp ----CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC---TTTSTTCGGGCTT
T ss_pred cccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC---HHHHhcChhhccC
Confidence 35677777777665442 11368999999999999999999999 6789999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=407.32 Aligned_cols=265 Identities=31% Similarity=0.504 Sum_probs=224.9
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++++.||+|+||+||+|++..++..||+|++... ........+.+|+.+|..++||||+++++++.+.+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc---cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 35567899999999999999999999999999999955322 234455788999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+. ||+||||||+||||+.+|++||+|||+++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~-- 183 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-- 183 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH--
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc--
Confidence 999999999999999999888999999999999999999999996 99999999999999999999999999987421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..
T Consensus 184 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 236 (360)
T 3eqc_A 184 ---------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236 (360)
T ss_dssp ---------------------------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred ---------------------------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 01223468999999999999999999999999999999999999999877654
Q ss_pred HHHHH------------------------------------------HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCC
Q 001354 922 IIFDN------------------------------------------ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 922 ei~~k------------------------------------------Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~K 959 (1093)
++... +.....+ +..+..++.++.+||.+||..||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~ 315 (360)
T 3eqc_A 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAE 315 (360)
T ss_dssp HHHHHHC------------------------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTT
T ss_pred HHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhh
Confidence 43222 2222211 1112458999999999999999999
Q ss_pred CCChhcHHHHHcCCCCCCCCcchh
Q 001354 960 RLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
||+ +.++++||||++.+|+.+
T Consensus 316 Rpt---~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 316 RAD---LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp SCC---HHHHHTSHHHHHHHHSCC
T ss_pred CCC---HHHHhhChHhhcchHhhh
Confidence 999 889999999998776654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=417.46 Aligned_cols=254 Identities=31% Similarity=0.522 Sum_probs=210.1
Q ss_pred ccCCCeeEE-EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHH-hcCCCceEEEeeeecc--
Q 001354 684 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTC-- 759 (1093)
Q Consensus 684 isiddFeil-r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~-kL~HPNIVkL~gsfqd-- 759 (1093)
..+++|.+. +.||+|+||+||+|.++.+|+.||+|++ ++ ...+.+|+.++. ..+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~-~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QD--------CPKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE-EC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEe-Cc--------chhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 456789887 7899999999999999999999999954 22 134567888774 4579999999998875
Q ss_pred --CCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CCcEEEEec
Q 001354 760 --RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDF 832 (1093)
Q Consensus 760 --~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG~VKLsDF 832 (1093)
...+||||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 667999999999999999998754 5999999999999999999999999999999999999998 789999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCC
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
|+++... ........+||+.|+|||++.+..|+.++|||||||+||||++|.
T Consensus 209 G~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 260 (400)
T 1nxk_A 209 GFAKETT----------------------------SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260 (400)
T ss_dssp TTCEECC---------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSS
T ss_pred ccccccC----------------------------CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCC
Confidence 9998421 011224578999999999999999999999999999999999999
Q ss_pred CCCCCCChH----HHHHHHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 913 PPFTAESPE----IIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 913 pPF~~~s~~----ei~~kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+||.+.... .+...+..+.+.+|.. ...++.++.+||.+||..||.+||+ +.++++||||.+
T Consensus 261 ~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 327 (400)
T 1nxk_A 261 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 327 (400)
T ss_dssp CSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHT
T ss_pred CCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccC
Confidence 999876543 2455666666655531 2568999999999999999999999 889999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=390.32 Aligned_cols=263 Identities=27% Similarity=0.455 Sum_probs=222.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee--ccCCce
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF--TCRDNL 763 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf--qd~~~L 763 (1093)
.++|++.+.||+|+||.||+|.+..++..||+|++.+............+.+|+.+|..++||||+++++++ .....+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999554332222234567899999999999999999999998 445689
Q ss_pred EEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k--~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
|+||||+.+| |.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999886 7777765 356999999999999999999999999999999999999999999999999999752100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC--CccceeecchhhHHHHHhCCCCCCCCC
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH--GYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y--s~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
..........||+.|+|||++.+... +.++|||||||++|||++|..||.+.+
T Consensus 163 -------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 163 -------------------------AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp -------------------------CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------------------------ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 00112234579999999999987543 789999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
..+....+......+| ..+++.+.+||.+||..||.+||+ +.++++||||+....
T Consensus 218 ~~~~~~~i~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 218 IYKLFENIGKGSYAIP---GDCGPPLSDLLKGMLEYEPAKRFS---IRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHCCCCCC---SSSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSHHHHSCCC
T ss_pred HHHHHHHHhcCCCCCC---CccCHHHHHHHHHHccCChhhCCC---HHHHhcCcccccCCC
Confidence 9888888888766554 689999999999999999999999 889999999987554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=385.56 Aligned_cols=261 Identities=28% Similarity=0.486 Sum_probs=220.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++++.||+|+||.||+|+++.+++.||+|++... . .....+.+.+|+.++..++||||+++++++.+.+..|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-R--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGG-G--CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeec-c--chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 46899999999999999999999999999999955322 2 12345778999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--- 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--- 159 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT---
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc---
Confidence 99999999999999877789999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCChH-HH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE-II 923 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~-ei 923 (1093)
........+||+.|+|||++.+..+ +.++|||||||++|||++|..||...+.. ..
T Consensus 160 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 217 (276)
T 2yex_A 160 ----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (276)
T ss_dssp ----------------------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH
T ss_pred ----------------------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 0112345679999999999988765 78999999999999999999999876543 33
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+..+.......+ ....+++.+.+||.+||..||.+||+ +.++++||||+..
T Consensus 218 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 268 (276)
T 2yex_A 218 YSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred HHHhhhcccccC-chhhcCHHHHHHHHHHCCCCchhCCC---HHHHhcCccccCh
Confidence 334433332222 23578999999999999999999999 8899999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=408.74 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=209.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
..++|++++.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+|+.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc--cCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 457999999999999999999999999999999955322 223445677889999999999999999999998765
Q ss_pred ---ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 762 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+|+||||+.+ +|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999975 7888885 45899999999999999999999999999999999999999999999999999742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. ........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 178 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 178 G----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ----------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c----------------------------cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011223468999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhccCCC-C------------------CCC--------------CC------CCCHHHHHHHHhhccCCcCC
Q 001354 919 SPEIIFDNILNRKIP-W------------------PCV--------------PS------DMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~-f------------------P~i--------------p~------~IS~eakDLIkrcL~kDP~K 959 (1093)
+..+.+..++..... . |.. +. ..+.++++||.+||+.||.+
T Consensus 230 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 888777776543111 0 000 00 01568999999999999999
Q ss_pred CCChhcHHHHHcCCCCCCC
Q 001354 960 RLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFkgI 978 (1093)
||| +.++++||||+..
T Consensus 310 R~t---~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 310 RIS---VDEALQHPYINVW 325 (371)
T ss_dssp SCC---HHHHHHSHHHHTT
T ss_pred CCC---HHHHhCCcchhhh
Confidence 999 8899999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=402.15 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=220.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc-
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN- 762 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~- 762 (1093)
...++|++.+.||+|+||.||+|++..+++.||+|++ +............+.+|+.++..++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-CTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEe-CccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 3467899999999999999999999999999999954 44333344556788999999999999999999999887654
Q ss_pred ---eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 763 ---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 763 ---LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 49999999999999999988899999999999999999999999999999999999999999999999999997431
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 168 ~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 168 DSG------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp --------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccc------------------------cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 100 00112345679999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 920 PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
.......+.......+. ....++.++.+||.+||..||.+||+ +.+++.|+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 278 (311)
T 3ork_A 224 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ---TAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred hHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh---hHHHHHHHHHH
Confidence 88877777665443221 23568999999999999999999999 66888899885
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=402.81 Aligned_cols=267 Identities=30% Similarity=0.428 Sum_probs=218.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~---- 760 (1093)
.+++|++++.||+|+||+||+|+++.+|+.||+|++.... ........+.+|+.+|..++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSS--CSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 4578999999999999999999999999999999654332 2223345678999999999999999999998874
Q ss_pred ----CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 761 ----DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 761 ----~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
+.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999986 777777654 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
+...... ..........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+|
T Consensus 172 ~~~~~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 228 (351)
T 3mi9_A 172 RAFSLAK-----------------------NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 228 (351)
T ss_dssp EECCCCS-----------------------SSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccc-----------------------cccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 8531100 011122345689999999999986 4689999999999999999999999
Q ss_pred CCCCChHHHHHHHhccCCCCCC-CCCC----------------------------CCHHHHHHHHhhccCCcCCCCChhc
Q 001354 915 FTAESPEIIFDNILNRKIPWPC-VPSD----------------------------MSFEAQDLINRFLIHDPNQRLGANG 965 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~~~l~fP~-ip~~----------------------------IS~eakDLIkrcL~kDP~KRpTa~~ 965 (1093)
|.+.+.......+......++. .... .++++.+||.+||+.||.+||+
T Consensus 229 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t--- 305 (351)
T 3mi9_A 229 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID--- 305 (351)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred CCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC---
Confidence 9999888777776542211111 0011 2788999999999999999999
Q ss_pred HHHHHcCCCCCCCCc
Q 001354 966 AAEVKAHPFFKGVNW 980 (1093)
Q Consensus 966 A~EIL~HPFFkgIdW 980 (1093)
+.++++||||....+
T Consensus 306 ~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 306 SDDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHHTSGGGGSSSC
T ss_pred HHHHhCCCCcCCCCC
Confidence 889999999976543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=413.47 Aligned_cols=258 Identities=27% Similarity=0.490 Sum_probs=219.7
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEe
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 769 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEY 769 (1093)
...+.||+|+||.||+|++..+|..||+|++. ... ....+.+.+|+.+|..++||||+++++++.+.+.+||||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~-~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIK-TRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEE-CCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEc-ccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 33678999999999999999999999999543 221 23456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE--ccCCcEEEEecCCcccccccccccC
Q 001354 770 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 770 m~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL--D~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~------ 241 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP------ 241 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT------
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC------
Confidence 9999999988754 469999999999999999999999999999999999999 5678999999999985210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.......+||+.|+|||++.+..++.++|||||||+||||++|.+||.+.+..+....
T Consensus 242 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 299 (373)
T 2x4f_A 242 ----------------------REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299 (373)
T ss_dssp ----------------------TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ----------------------ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122345799999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 927 ILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 927 Il~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
|+.....++. ....+++++++||.+||..||.+||+ +.++++||||++..|..
T Consensus 300 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 300 ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS---ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp HHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHCHHHHH
T ss_pred HHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC---HHHHhcCcCcCCCchhh
Confidence 8887655442 23578999999999999999999999 88999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=390.89 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=215.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++++.||+|+||.||+|++..++..||+|.+. ............+.+|+.++..++||||+++++++...+.+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEE-CCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEec-cCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 45678999999999999999999999999999999553 32333445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE--- 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999974210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+....
T Consensus 164 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 164 -----------------------TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp ----------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred -----------------------ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 001123346799999999999999999999999999999999999999999888777
Q ss_pred HHHHhccCCCC--CCCCCCCCHHHHHHHHhhccCCcCCCCC
Q 001354 924 FDNILNRKIPW--PCVPSDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 924 ~~kIl~~~l~f--P~ip~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
....+....+. +..+..+++.+.++|.+||..||.+||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp HHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred HHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc
Confidence 66666554332 1134678999999999999999999995
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=412.88 Aligned_cols=257 Identities=32% Similarity=0.475 Sum_probs=212.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 759 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd------ 759 (1093)
..+|++++.||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.++|||||+++++|..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 4579999999999999999999999999999996643221 23469999999999999999988843
Q ss_pred CCceEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecCC
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGL 834 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFGL 834 (1093)
..++++||||+++ +|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 2347899999986 67666643 4679999999999999999999999999999999999999965 6789999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
++.... .......+||+.|+|||++.+. .|+.++|||||||+||||++|++
T Consensus 204 a~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 204 AKQLVR----------------------------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp CEECCT----------------------------TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhhccc----------------------------CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 985210 1122346899999999999865 79999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 914 PFTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
||.+.+..+.+..|+.. .+.+|. ++..+++++.+||.+||.+||.+||+ +.
T Consensus 256 pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t---~~ 332 (420)
T 1j1b_A 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PL 332 (420)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC---HH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC---HH
Confidence 99998877766665431 122332 23467899999999999999999999 88
Q ss_pred HHHcCCCCCCCCcch
Q 001354 968 EVKAHPFFKGVNWDS 982 (1093)
Q Consensus 968 EIL~HPFFkgIdWd~ 982 (1093)
++++||||+++.+..
T Consensus 333 e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 333 EACAHSFFDELRDPN 347 (420)
T ss_dssp HHHTSGGGGGGGCTT
T ss_pred HHhCCHhhccccccc
Confidence 999999998766543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=408.01 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=216.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc-----hhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR-----KNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~-----~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..++|++++.||+|+||+||+|+++.+++.||+|++. +..... ......+.+|+.+|..++||||++++++|.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~-~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEE-STTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEe-hhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3468999999999999999999999999999999553 322111 1233457789999999999999999999999
Q ss_pred CCceEEEEEecCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GG-SL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+.+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999777 99999998889999999999999999999999999999999999999999999999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
. ........+||+.|+|||++.+..+ +.++|||||||++|||++|..||..
T Consensus 181 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 181 E----------------------------RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp C----------------------------TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred C----------------------------CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 1 0112335679999999999998877 8899999999999999999999976
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
... +....... +..+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 233 ~~~------~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~ 280 (335)
T 3dls_A 233 LEE------TVEAAIHP---PYLVSKELMSLVSGLLQPVPERRTT---LEKLVTDPWVTQ 280 (335)
T ss_dssp GGG------GTTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHHCTTTTC
T ss_pred HHH------HHhhccCC---CcccCHHHHHHHHHHccCChhhCcC---HHHHhcCccccC
Confidence 332 22233332 3678999999999999999999999 889999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=393.00 Aligned_cols=257 Identities=29% Similarity=0.450 Sum_probs=211.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc--C
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--R 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd--~ 760 (1093)
...++|++++.||+|+||+||+|++..+++.||+|++ +. .....+.+|+.+|..+. ||||+++++++.+ .
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-CS------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEe-cc------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 3467899999999999999999999999999999944 32 22356889999999997 9999999999988 5
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~~~ 839 (1093)
..+++||||+++++|..++.. +++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++...
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred CceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 679999999999999998853 89999999999999999999999999999999999999777 89999999997521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
. .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 183 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 183 P----------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp T----------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred C----------------------------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 0 112234679999999999987 67899999999999999999999999543
Q ss_pred -ChHHHHHHH-------------hccCCCCC---------------------CCCCCCCHHHHHHHHhhccCCcCCCCCh
Q 001354 919 -SPEIIFDNI-------------LNRKIPWP---------------------CVPSDMSFEAQDLINRFLIHDPNQRLGA 963 (1093)
Q Consensus 919 -s~~ei~~kI-------------l~~~l~fP---------------------~ip~~IS~eakDLIkrcL~kDP~KRpTa 963 (1093)
+..+....+ ......++ ..+..+++++.+||.+||..||.+|||
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt- 313 (330)
T 3nsz_A 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT- 313 (330)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC-
T ss_pred CchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC-
Confidence 222222221 11111111 012237999999999999999999999
Q ss_pred hcHHHHHcCCCCCCCCcc
Q 001354 964 NGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 964 ~~A~EIL~HPFFkgIdWd 981 (1093)
+.++++||||+++.|+
T Consensus 314 --a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 314 --AREAMEHPYFYTVVKD 329 (330)
T ss_dssp --HHHHHTSGGGTTCC--
T ss_pred --HHHHhcCccHhhhccC
Confidence 8899999999999876
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=395.47 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=208.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~ 762 (1093)
...++|++++.||+|+||+||+|+++.+|+.||+|++... . ...........|...+..+ .||||++++++|.+...
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~-~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP-F-RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSS-C-CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccc-c-cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 4447899999999999999999999999999999954322 1 1223334455566555554 89999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+|+||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~- 209 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT- 209 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc-
Confidence 99999999 669999887654 599999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+..
T Consensus 210 ---------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-- 259 (311)
T 3p1a_A 210 ---------------------------AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-- 259 (311)
T ss_dssp --------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--
T ss_pred ---------------------------CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--
Confidence 112234569999999999886 79999999999999999999977765532
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
....+.....+ +.++..+++++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 260 -~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 310 (311)
T 3p1a_A 260 -GWQQLRQGYLP-PEFTAGLSSELRSVLVMMLEPDPKLRAT---AEALLALPVLRQ 310 (311)
T ss_dssp -HHHHHTTTCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGSC
T ss_pred -HHHHHhccCCC-cccccCCCHHHHHHHHHHcCCChhhCcC---HHHHHhCccccC
Confidence 23333333322 2234678999999999999999999999 889999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=387.02 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=204.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++++.||+|+||+||+|++..+|+.||+|++... .........+.++...++.++||||+++++++.+.+.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc--cCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 35678999999999999999999999999999999955322 1222333445555666788899999999999999999
Q ss_pred eEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 763 LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999999975 88777754 46799999999999999999999998 999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh----cCCCCCccceeecchhhHHHHHhCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL----~g~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
... ........||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus 160 ~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 211 (290)
T 3fme_A 160 LVD----------------------------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211 (290)
T ss_dssp --------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSC
T ss_pred ccc----------------------------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCC
Confidence 210 1112334799999999996 55678999999999999999999999
Q ss_pred CCCCC-ChHHHHHHHhccCC-CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 914 PFTAE-SPEIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 914 PF~~~-s~~ei~~kIl~~~l-~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
||... .+......+..... ..+ +..+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 212 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt---~~e~l~hp~f~~ 272 (290)
T 3fme_A 212 PYDSWGTPFQQLKQVVEEPSPQLP--ADKFSAEFVDFTSQCLKKNSKERPT---YPELMQHPFFTL 272 (290)
T ss_dssp SSCCCSCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHH
T ss_pred CccccCchHHHHHHHhccCCCCcc--cccCCHHHHHHHHHHhhcChhhCcC---HHHHHhCccccc
Confidence 99863 34444444444332 222 3678999999999999999999999 889999999963
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=410.70 Aligned_cols=258 Identities=29% Similarity=0.463 Sum_probs=203.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 760 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~----- 760 (1093)
.++|++++.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc--ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 47899999999999999999999999999999955322 22344567888999999999999999999998764
Q ss_pred -CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899999875 679999999999999999999999999999999999999999999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.
T Consensus 184 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 184 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp -------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01234689999999999987 67899999999999999999999999998
Q ss_pred ChHHHHHHHhccC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~----------------------------l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+.......|+... ..++.....+++++.+||.+||..||.+||+ +.++|
T Consensus 234 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t---~~e~L 310 (367)
T 2fst_X 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQAL 310 (367)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC---HHHHh
Confidence 8877766654310 0011112457899999999999999999999 88999
Q ss_pred cCCCCCCCCc
Q 001354 971 AHPFFKGVNW 980 (1093)
Q Consensus 971 ~HPFFkgIdW 980 (1093)
+||||+....
T Consensus 311 ~hp~~~~~~~ 320 (367)
T 2fst_X 311 AHAYFAQYHD 320 (367)
T ss_dssp TSGGGTTTCC
T ss_pred cChhhhhccC
Confidence 9999987643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=403.17 Aligned_cols=267 Identities=28% Similarity=0.444 Sum_probs=223.1
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+++|++++.||+|+||.||+|++..+|+.||+|++... .........+.+|+.+|..++||||+++++++.+...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC--SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC--CCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 4578999999999999999999999999999999965432 22334456788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 176 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--- 176 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC---
Confidence 99999999999999888778899999999999999999999999999999999999999999999999999974210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+
T Consensus 177 ------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (331)
T 4aaa_A 177 ------------------------PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232 (331)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ------------------------CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 01122345799999999999875 78999999999999999999999999988766
Q ss_pred HHHHHhcc-------------------CCCCCCC---------CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCC
Q 001354 923 IFDNILNR-------------------KIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974 (1093)
Q Consensus 923 i~~kIl~~-------------------~l~fP~i---------p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPF 974 (1093)
....+... ...+|.+ ...+++++.+||.+||..||.+||+ +.++++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~ 309 (331)
T 4aaa_A 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF---CAELLHHDF 309 (331)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHH
T ss_pred HHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC---HHHHhcCch
Confidence 66555421 1111211 1367999999999999999999999 778999999
Q ss_pred CCCCCcch
Q 001354 975 FKGVNWDS 982 (1093)
Q Consensus 975 FkgIdWd~ 982 (1093)
|+...|..
T Consensus 310 f~~~~~~~ 317 (331)
T 4aaa_A 310 FQMDGFAE 317 (331)
T ss_dssp HHGGGHHH
T ss_pred hccCChhh
Confidence 98766554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=400.70 Aligned_cols=268 Identities=25% Similarity=0.513 Sum_probs=230.7
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhch--------------hHHHHHHHHHHHHHhcCCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK--------------NDIERILAERNILITVRNP 748 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~--------------~eie~~l~E~~IL~kL~HP 748 (1093)
....++|++.+.||+|+||.||+|++ +|+.||+|++... ..... .....+.+|+.+|..++||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKS-LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHH-HHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecc-cccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 45678999999999999999999999 7999999955432 22111 1127889999999999999
Q ss_pred ceEEEeeeeccCCceEEEEEecCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcE
Q 001354 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSL------LRK--VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNL 819 (1093)
Q Consensus 749 NIVkL~gsfqd~~~LyLVMEYm~GGSL~dl------L~k--~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNI 819 (1093)
||+++++++.+.+.+|+||||+++|+|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 665 5679999999999999999999999 9999999999999
Q ss_pred EEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCc-cce
Q 001354 820 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGY-AAD 897 (1093)
Q Consensus 820 LLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~-ksD 897 (1093)
|++.++.+||+|||++.... ........||+.|+|||++.+. .++. ++|
T Consensus 184 l~~~~~~~kl~dfg~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 234 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMV-----------------------------DKKIKGSRGTYEFMPPEFFSNESSYNGAKVD 234 (348)
T ss_dssp EECTTSCEEECCCTTCEECB-----------------------------TTEECSSCSCGGGCCGGGGSSCCCEEHHHHH
T ss_pred EEcCCCcEEEeccccccccc-----------------------------cccccCCCCCcCccCchhhcCCCCCCcchhh
Confidence 99999999999999997521 0122346799999999999887 6766 999
Q ss_pred eecchhhHHHHHhCCCCCCCCCh-HHHHHHHhccCCCCCCC----------------CCCCCHHHHHHHHhhccCCcCCC
Q 001354 898 WWSVGIILFEFITGIPPFTAESP-EIIFDNILNRKIPWPCV----------------PSDMSFEAQDLINRFLIHDPNQR 960 (1093)
Q Consensus 898 VWSLGVILYEMLTGkpPF~~~s~-~ei~~kIl~~~l~fP~i----------------p~~IS~eakDLIkrcL~kDP~KR 960 (1093)
||||||++|||++|.+||...+. .++...+......+|.. ...+++++.+||.+||+.||.+|
T Consensus 235 i~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 314 (348)
T 2pml_X 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314 (348)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhC
Confidence 99999999999999999998877 78888887776665521 15689999999999999999999
Q ss_pred CChhcHHHHHcCCCCCCCCcchhhc
Q 001354 961 LGANGAAEVKAHPFFKGVNWDSLAL 985 (1093)
Q Consensus 961 pTa~~A~EIL~HPFFkgIdWd~L~~ 985 (1093)
|+ +.++++||||++++|..+..
T Consensus 315 ps---~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 315 IT---SEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp CC---HHHHHTSGGGTTCCHHHHHH
T ss_pred CC---HHHHhcCccccCCCHHHHHH
Confidence 99 88999999999999988654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=403.13 Aligned_cols=260 Identities=32% Similarity=0.530 Sum_probs=225.6
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc----hhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR----KNDIERILAERNILITV-RNPFVVRFFYSFTCR 760 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~----~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~ 760 (1093)
.++|++.+.||+|+||.||+|+++.+|+.||||++........ ....+.+.+|+.++..+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 4679999999999999999999999999999995533221111 12245678999999999 799999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC------CCCCccceeecchhhHHHHHhCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g------~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
.......+||+.|+|||++.+ ..|+.++|||||||+||||++|.+|
T Consensus 253 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 253 ----------------------------GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp ----------------------------TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------------------CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 112235689999999999863 3688999999999999999999999
Q ss_pred CCCCChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 915 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
|.+.+.......+..+...++. ....++..+.+||.+||..||.+||+ +.++++||||+
T Consensus 305 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~ 364 (365)
T 2y7j_A 305 FWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT---AEQALQHPFFE 364 (365)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGC
T ss_pred CCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCcccC
Confidence 9999988888888877665432 12468899999999999999999999 88999999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=405.05 Aligned_cols=256 Identities=31% Similarity=0.513 Sum_probs=212.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC---- 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd---- 759 (1093)
...++|++++.||+|+||+||+|++..+|+.||+|++..... ...+|+.+|+.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 456789999999999999999999999999999996643221 12369999999999999999999843
Q ss_pred ----------------------------------CCceEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 001354 760 ----------------------------------RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLAL 801 (1093)
Q Consensus 760 ----------------------------------~~~LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~AL 801 (1093)
...+|+||||++| +|.+.+.. ...+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3458999999985 87777653 46799999999999999999
Q ss_pred HHHHhcCcEeeecCCCcEEEc-cCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCC
Q 001354 802 EYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 880 (1093)
Q Consensus 802 eYLHs~GIIHRDIKPeNILLD-~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~ 880 (1093)
.|||++||+||||||+|||++ .++.+||+|||+++.... .......+||+.
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~----------------------------~~~~~~~~~t~~ 206 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP----------------------------SEPSVAYICSRF 206 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT----------------------------TSCCCCCCCCSS
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC----------------------------CCCCcCcccCCC
Confidence 999999999999999999998 689999999999985210 112235678999
Q ss_pred CCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhcc-----------------CCCCCC------
Q 001354 881 YLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR-----------------KIPWPC------ 936 (1093)
Q Consensus 881 YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~-----------------~l~fP~------ 936 (1093)
|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....|+.. ...+|.
T Consensus 207 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (383)
T 3eb0_A 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW 286 (383)
T ss_dssp CCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH
T ss_pred ccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH
Confidence 9999999875 4899999999999999999999999999887777766531 112222
Q ss_pred ---CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 937 ---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 937 ---ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
++..+++++.+||.+||..||.+||| +.++++||||+.+.
T Consensus 287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 287 RKILPEGTPSLAIDLLEQILRYEPDLRIN---PYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSGGGHHHH
T ss_pred HhhCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcCHHHHHHH
Confidence 34568999999999999999999999 88999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=400.04 Aligned_cols=267 Identities=28% Similarity=0.457 Sum_probs=216.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh-chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI-RKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~-~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
...++|++++.||+|+||.||+|+++.+|+.||+|++....... .......+.+|+.+|..++||||++++++|.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999999999999999553221111 11123467899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~- 164 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS- 164 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC-
Confidence 9999999986 898888765 4689999999999999999999999999999999999999999999999999974210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.
T Consensus 165 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 165 --------------------------PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp --------------------------CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 01122346899999999999764 589999999999999999999999999998
Q ss_pred HHHHHHHhccC-----CCCCC---------------C-----CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 921 EIIFDNILNRK-----IPWPC---------------V-----PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 921 ~ei~~kIl~~~-----l~fP~---------------i-----p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+.+..+.... ..||. . ...++.++.+||.+||..||.+||+ +.++++||||
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~h~~f 295 (346)
T 1ua2_A 219 LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYF 295 (346)
T ss_dssp HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGG
T ss_pred HHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC---HHHHhcChhh
Confidence 88877776521 11111 0 1456899999999999999999999 8899999999
Q ss_pred CCCCcc
Q 001354 976 KGVNWD 981 (1093)
Q Consensus 976 kgIdWd 981 (1093)
++..|.
T Consensus 296 ~~~~~~ 301 (346)
T 1ua2_A 296 SNRPGP 301 (346)
T ss_dssp TSSSCC
T ss_pred hcCCCC
Confidence 876554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=383.97 Aligned_cols=259 Identities=31% Similarity=0.533 Sum_probs=223.4
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec--cCCc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT--CRDN 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq--d~~~ 762 (1093)
..++|++++.||+|+||.||+|+++.+|+.||+|.+... .......+.+.+|+.++..++||||+++++++. ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECT--TCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcc--cCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 457899999999999999999999999999999955322 223455678999999999999999999999874 4668
Q ss_pred eEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC-----cEeeecCCCcEEEccCCcEEEEecC
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g----~LsEe~ar~yaaQIl~ALeYLHs~G-----IIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999999997643 3999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
+++.... .........||+.|+|||++.+..++.++||||||+++|+|++|.+
T Consensus 162 ~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 214 (279)
T 2w5a_A 162 LARILNH---------------------------DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214 (279)
T ss_dssp HHHHC------------------------------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred hheeecc---------------------------ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 9874210 0011224579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 914 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
||...+..++...+..+.. +.++..++.++.+||.+||..||.+||+ +.++++|+||.+
T Consensus 215 p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~~~~~~ 273 (279)
T 2w5a_A 215 PFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLILE 273 (279)
T ss_dssp SSCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTCCG
T ss_pred CCcccCHHHHHHHHhhccc--ccCCcccCHHHHHHHHHHcCCCcccCCC---HHHHHhChhhhh
Confidence 9999998888888877654 3345789999999999999999999999 889999999964
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=420.14 Aligned_cols=267 Identities=33% Similarity=0.568 Sum_probs=214.4
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI----RKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~----~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
..++|.+.+.||+|+||+||+|.++.+++.||+|++.++.... .......+.+|+.+|..++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3578999999999999999999999999999999554332111 11223457899999999999999999999864
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---cEEEEecCCccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 837 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG---~VKLsDFGLAk~ 837 (1093)
+.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 45899999999999999998888899999999999999999999999999999999999997654 599999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
.. ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+|
T Consensus 292 ~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 292 LG----------------------------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp CC---------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cC----------------------------CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 21 0112345689999999999864 6788999999999999999999999
Q ss_pred CCCCCh-HHHHHHHhccCCCCC-CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 915 FTAESP-EIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 915 F~~~s~-~ei~~kIl~~~l~fP-~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
|..... ..+...+..+...++ .....+++.+.+||.+||..||.+||+ +.++++||||++.+|...
T Consensus 344 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 344 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp SCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCCHHHHHH
T ss_pred CCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcC---HHHHhCCcccCChhHHHH
Confidence 987544 344455555544432 223568999999999999999999999 889999999998877653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=407.09 Aligned_cols=258 Identities=33% Similarity=0.493 Sum_probs=212.4
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
...+|++.+.||+|+||+||+|++..++. +|+|++...... ..+|+.+|+.++||||++++++|....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 34579999999999999999999987766 888867543322 236999999999999999999985543
Q ss_pred ---ceEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc-cCCcEEEEecC
Q 001354 762 ---NLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFG 833 (1093)
Q Consensus 762 ---~LyLVMEYm~GGSL~dlL~----k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD-~dG~VKLsDFG 833 (1093)
.+|+||||++++ +...+. ....+++..++.|+.||+.||.|||++||+||||||+||||+ .+|++||+|||
T Consensus 109 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 389999999875 444333 246799999999999999999999999999999999999999 79999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
+|+.... .......+||+.|+|||++.+. .|+.++|||||||+||||++|+
T Consensus 188 ~a~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 239 (394)
T 4e7w_A 188 SAKILIA----------------------------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239 (394)
T ss_dssp TCEECCT----------------------------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CcccccC----------------------------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9985210 1122356899999999999765 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 913 PPFTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
+||.+.+..+....|+.. ...+|. ++..+++++.+||.+||.+||.+||+ +
T Consensus 240 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~ 316 (394)
T 4e7w_A 240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT---A 316 (394)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC---H
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC---H
Confidence 999999877776665531 111221 23458999999999999999999999 8
Q ss_pred HHHHcCCCCCCCCcchh
Q 001354 967 AEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 967 ~EIL~HPFFkgIdWd~L 983 (1093)
.++++||||+++.|...
T Consensus 317 ~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 317 IEALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHHTSGGGSTTTSSCC
T ss_pred HHHhcChhhhhhccccc
Confidence 89999999999988654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=390.00 Aligned_cols=274 Identities=30% Similarity=0.501 Sum_probs=200.9
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
..+..++|++.+.||+|+||.||+|.+..+++.||+|.+ .... .......+.+|+.++..++||||+++++++...+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECC-C------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEE-Ehhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 456778999999999999999999999989999999944 2221 1234567889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 762 NLYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k--------~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
..|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999974 3569999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
++........ ..........+||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 167 ~~~~~~~~~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 224 (303)
T 2vwi_A 167 VSAFLATGGD----------------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224 (303)
T ss_dssp HHHHCC-------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred chheeccCCC----------------------ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence 9875311000 001112335689999999999976 57899999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCCC-------CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 913 PPFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~-------fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
.||...+.............. .+.....++.++.+||.+||..||.+||+ +.++++||||+...+..+
T Consensus 225 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp CTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSTTC--------
T ss_pred CCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC---HHHHhhChhhhcCCCCcc
Confidence 999988776665555443221 12233578899999999999999999999 889999999998776543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=387.68 Aligned_cols=264 Identities=30% Similarity=0.535 Sum_probs=221.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++++.||+|+||.||+|.+..+|+.||+|.+... .....+.+|+.+|..++||||+++++++.....+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE------SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT------SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch------HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 4467899999999999999999999999999999955322 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~-k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+||||+++|+|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD-- 177 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT--
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh--
Confidence 99999999999999997 456799999999999999999999999999999999999999999999999999974210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 178 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 178 -------------------------TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp -------------------------TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -------------------------hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 0112234679999999999999999999999999999999999999999888766
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
....+..........+..++..+.+||.+||..||.+||+ +.++++||||++..+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~~~~~~~~~~~~ 290 (314)
T 3com_A 233 AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQHPFVRSAKGVSI 290 (314)
T ss_dssp HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHTCCCGGG
T ss_pred HHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhcCCcchH
Confidence 6655554433222234668999999999999999999999 889999999998776654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=394.73 Aligned_cols=273 Identities=27% Similarity=0.420 Sum_probs=219.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 760 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~---- 760 (1093)
..++|++.+.||+|+||.||+|++..+|+.||+|++ ... ........+.+|+.+|..++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-CCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEee-ccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 357999999999999999999999999999999955 221 2234456788999999999999999999887654
Q ss_pred -CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67999999997 599999876 569999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
...... .............+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.
T Consensus 164 ~~~~~~-----------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 164 ESAADN-----------------SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ---------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccc-----------------cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 110000 000001112335689999999999875 67899999999999999999999999998
Q ss_pred ChHHHHHHHhcc--C----------------------CCCCC-----CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 919 SPEIIFDNILNR--K----------------------IPWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 919 s~~ei~~kIl~~--~----------------------l~fP~-----ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
+.......+... . ..++. ....+++++.+||.+||..||.+||+ +.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~el 303 (353)
T 2b9h_A 227 DYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT---AKEA 303 (353)
T ss_dssp SHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC---HHHH
T ss_pred CcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC---HHHH
Confidence 876655544321 0 00010 12468999999999999999999999 8899
Q ss_pred HcCCCCCCCCcch
Q 001354 970 KAHPFFKGVNWDS 982 (1093)
Q Consensus 970 L~HPFFkgIdWd~ 982 (1093)
++||||+...+..
T Consensus 304 l~hp~~~~~~~~~ 316 (353)
T 2b9h_A 304 LEHPYLQTYHDPN 316 (353)
T ss_dssp HTSGGGTTTCCTT
T ss_pred hcCccccccCCcc
Confidence 9999999887654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=398.98 Aligned_cols=260 Identities=28% Similarity=0.488 Sum_probs=217.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----C
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 761 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~-----~ 761 (1093)
++|++++.||+|+||.||+|++..++..||+|++. .. ........+.+|+.+|..++||||+++++++... .
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-CT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEec-cc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 68999999999999999999999999999999553 21 2334457789999999999999999999998765 3
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 68999999974 99999865 56999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
. .........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.
T Consensus 182 ~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 182 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp G------------------------CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred C------------------------CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 0 01112345689999999998765 5589999999999999999999999999887
Q ss_pred HHHHHHHhcc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 921 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 921 ~ei~~kIl~~----------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
.+....|... ..+++.+...+++++.+||.+||..||.+||+ +.++++|
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~h 314 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAH 314 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTS
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcC
Confidence 7766665431 01111123568999999999999999999999 8899999
Q ss_pred CCCCCC
Q 001354 973 PFFKGV 978 (1093)
Q Consensus 973 PFFkgI 978 (1093)
|||+..
T Consensus 315 p~~~~~ 320 (364)
T 3qyz_A 315 PYLEQY 320 (364)
T ss_dssp GGGTTT
T ss_pred cchhhc
Confidence 999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=401.86 Aligned_cols=258 Identities=29% Similarity=0.438 Sum_probs=217.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce--
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL-- 763 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L-- 763 (1093)
.++|.+.+.||+|+||+||+|+++.+|+.||+|++.. ..........+.+|+.+|+.++||||++++++|......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecc--cccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 4789999999999999999999999999999995532 223344567889999999999999999999999887765
Q ss_pred ----EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 764 ----YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 ----yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
|+||||+. |+|..++. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 58888774 349999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 196 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 196 ------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ----------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 11234678999999999987 78899999999999999999999999998
Q ss_pred ChHHHHHHHhccCC----------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRKI----------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~l----------------------------~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+..+....++.... .++..+..+++++.+||.+||+.||.+||+ +.+++
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell 322 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQAL 322 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC---HHHHH
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC---HHHHh
Confidence 87777766643110 001112467999999999999999999999 88999
Q ss_pred cCCCCCCCCcc
Q 001354 971 AHPFFKGVNWD 981 (1093)
Q Consensus 971 ~HPFFkgIdWd 981 (1093)
+||||+.+...
T Consensus 323 ~hp~f~~~~~~ 333 (371)
T 4exu_A 323 THPFFEPFRDP 333 (371)
T ss_dssp TSGGGTTTCCG
T ss_pred cCcccccCCCc
Confidence 99999876544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=398.05 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=213.1
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRD 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H--PNIVkL~gsfqd~~ 761 (1093)
+.-+.|++++.||+|+||.||+|.+. ++..||+|++.. ..........+.+|+.+|..++| |||+++++++.+..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEEC--TTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeec--cccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 44567999999999999999999885 589999995532 22344556788999999999986 99999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+ +|.+||+|||+++.....
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999999 56789999999988999999999999999999999999999999999999996 789999999999753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeecchhhHHHHHh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Ys~ksDVWSLGVILYEMLT 910 (1093)
.........+||+.|+|||++.+ ..|+.++|||||||+||||++
T Consensus 161 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 215 (343)
T 3dbq_A 161 -------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215 (343)
T ss_dssp ----------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred -------------------------cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 00112335689999999999965 678999999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 911 GIPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 911 GkpPF~~~s~-~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
|.+||..... ......++..... ..++...+.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 216 g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~ 279 (343)
T 3dbq_A 216 GKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQI 279 (343)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHS
T ss_pred CCCcchhhhhHHHHHHHHhcCCcc-cCCcccCCHHHHHHHHHHcCCChhHCCC---HHHHHhCccccc
Confidence 9999987543 3444445443333 2244677899999999999999999999 889999999973
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=392.25 Aligned_cols=258 Identities=29% Similarity=0.441 Sum_probs=213.1
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
...+..++|++.+.||+|+||+||+|++ +|..||+|++. +. .........+.+|+.+|..++||||+++++++.+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~-~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILM-EQ-DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEC-CC-CCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEec-CC-CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3456678999999999999999999987 48899999553 22 23445567899999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~---LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
..+|+||||++||+|.+++.+.+. +++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999987653 999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
+.... ........+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 187 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf 239 (309)
T 3p86_A 187 RLKAS---------------------------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239 (309)
T ss_dssp ------------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccc---------------------------cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 74210 011223568999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+.+..+....+...... +.++..+++++.+||.+||..||.+||++.++.+.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 240 GNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp TTSCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999988887776543333 234578999999999999999999999965555544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=389.27 Aligned_cols=264 Identities=32% Similarity=0.495 Sum_probs=218.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEEC-CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc---CCCceEEEeeeec--
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT-- 758 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k-~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL---~HPNIVkL~gsfq-- 758 (1093)
..++|++++.||+|+||.||+|++. .+|+.||+|++..... .......+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC--TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc--cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3478999999999999999999995 6789999995532211 111223455677776655 8999999999987
Q ss_pred ---cCCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 759 ---CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 759 ---d~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5667999999998 59999998754 49999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
+++.... .......+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 166 ~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 166 LARIYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp SCCCCCG----------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccC----------------------------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 9874210 112235679999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhccC-----CCC-------------------CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 914 PFTAESPEIIFDNILNRK-----IPW-------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~-----l~f-------------------P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
||.+.+.......++... ..| ..+...++..+.+||.+||..||.+||+ +.++
T Consensus 218 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~ 294 (326)
T 1blx_A 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSA 294 (326)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC---HHHH
Confidence 999988877777765310 001 1123578999999999999999999999 8899
Q ss_pred HcCCCCCCCCcch
Q 001354 970 KAHPFFKGVNWDS 982 (1093)
Q Consensus 970 L~HPFFkgIdWd~ 982 (1093)
++||||+++++..
T Consensus 295 l~hp~~~~~~~~~ 307 (326)
T 1blx_A 295 LSHPYFQDLERCK 307 (326)
T ss_dssp HTSGGGTTCCCCC
T ss_pred hcCccccccchhh
Confidence 9999999887653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=391.18 Aligned_cols=275 Identities=23% Similarity=0.345 Sum_probs=207.4
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCc---EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk---~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
..+..++|++.+.||+|+||+||+|+++.++. .||+|++ +. ........+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~-~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KA-DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEe-cc-cccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 34567899999999999999999999887765 8999944 32 2223455678999999999999999999999998
Q ss_pred cCCce------EEEEEecCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc
Q 001354 759 CRDNL------YLVMEYLNGGDLYSLLRKVG------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 826 (1093)
Q Consensus 759 d~~~L------yLVMEYm~GGSL~dlL~k~g------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~ 826 (1093)
..... |+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.+|.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 87655 99999999999999997543 5999999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHH
Q 001354 827 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906 (1093)
Q Consensus 827 VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILY 906 (1093)
+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~kl~Dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 230 (323)
T 3qup_A 176 VCVADFGLSRKIYSGD-------------------------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230 (323)
T ss_dssp EEECCCCC------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEEeeccccccccccc-------------------------cccccccccCcccccCchhhcCCCCCCccchhhHHHHHH
Confidence 9999999997531100 011122345788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh----hcHHHHHcCCCCCCCCcc
Q 001354 907 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA----NGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 907 EMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa----~~A~EIL~HPFFkgIdWd 981 (1093)
||++ |.+||.+.+..++...+...... ..+..+++++.+||.+||..||.+||++ ..+.+++.|||+....++
T Consensus 231 ell~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 231 EIMTRGQTPYAGIENAEIYNYLIGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred HHHhCCCCCccccChHHHHHHHhcCCCC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 9999 99999999988888887765432 2357899999999999999999999994 357889999999887766
Q ss_pred hhhc
Q 001354 982 SLAL 985 (1093)
Q Consensus 982 ~L~~ 985 (1093)
.+..
T Consensus 309 pl~~ 312 (323)
T 3qup_A 309 PLYI 312 (323)
T ss_dssp ----
T ss_pred CCCC
Confidence 5543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=400.39 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=220.8
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.|++++.||+|+||+||+|++..+|+.||+|++. ............+.+|+.+|..++||||+++++++.+.+.+|+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~-~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEE-SCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEc-cccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45999999999999999999999999999999553 22222344557889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
|||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 205 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC------
Confidence 99997 588888864 4679999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+...
T Consensus 206 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 260 (348)
T 1u5q_A 206 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260 (348)
T ss_dssp -------------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -------------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 112457999999999985 4678999999999999999999999999988877
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
....+.....+.. .+..+++.+.+||.+||..||.+||+ +.++++||||...
T Consensus 261 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 261 ALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHHSCCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSC
T ss_pred HHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcC---HHHHhhChhhhcc
Confidence 7777766544322 24678999999999999999999999 8899999999653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=416.86 Aligned_cols=251 Identities=15% Similarity=0.189 Sum_probs=204.6
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHH---HHHhcCCCceEEEe-------
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN---ILITVRNPFVVRFF------- 754 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~---IL~kL~HPNIVkL~------- 754 (1093)
..++|++.+.||+|+||+||+|+++.+|+.||+|++ .+.........+.+.+|+. +|..++|||||+++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVP-YFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEE-EECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEE-eeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 457899999999999999999999999999999954 3333334456678899994 55556799999998
Q ss_pred eeeccCC-----------------ceEEEEEecCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCcE
Q 001354 755 YSFTCRD-----------------NLYLVMEYLNGGDLYSLLRKVGCLEE-------DVARIYIAELVLALEYLHSLGIV 810 (1093)
Q Consensus 755 gsfqd~~-----------------~LyLVMEYm~GGSL~dlL~k~g~LsE-------e~ar~yaaQIl~ALeYLHs~GII 810 (1093)
+++.+.+ ..||||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 5554443 389999999 6799999987766666 77778999999999999999999
Q ss_pred eeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC
Q 001354 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 890 (1093)
Q Consensus 811 HRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~ 890 (1093)
||||||+||||+.+|.+||+|||+++.. .......+| +.|+|||++.+.
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~------------------------------~~~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRD------------------------------GARVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEET------------------------------TCEEECCCC-TTCCCHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheec------------------------------CCcccCCCC-cCccChhhhccc
Confidence 9999999999999999999999999841 112235678 999999999987
Q ss_pred -----------CCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCC
Q 001354 891 -----------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 891 -----------~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~K 959 (1093)
.|+.++|||||||+||||++|++||.+.+.......+... ...+++++.+||.+||+.||.+
T Consensus 278 ~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp TSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS-------CCCCCHHHHHHHHHHTCSSGGG
T ss_pred ccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh-------ccCCCHHHHHHHHHHcCCCchh
Confidence 8999999999999999999999999877655444444322 2578899999999999999999
Q ss_pred CCChhcHHHHHcCCCCCCC
Q 001354 960 RLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFkgI 978 (1093)
||+ +.++++||||+++
T Consensus 351 Rpt---~~e~l~hp~f~~~ 366 (377)
T 3byv_A 351 RLL---PLQAMETPEYEQL 366 (377)
T ss_dssp CCC---HHHHHTSHHHHHH
T ss_pred CCC---HHHHhhChHHHHH
Confidence 999 8899999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=394.05 Aligned_cols=258 Identities=29% Similarity=0.444 Sum_probs=216.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc---
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 762 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~--- 762 (1093)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++... .........+.+|+.+|..++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc--ccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 47899999999999999999999999999999955322 2234456788999999999999999999999988764
Q ss_pred ---eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 763 ---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 763 ---LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+|+||||+. |+|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 588887743 59999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.
T Consensus 178 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 178 ------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp ------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred ------------------------------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01224578999999999987 67899999999999999999999999998
Q ss_pred ChHHHHHHHhcc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~----------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+..+....+... ...++.....+++++.+||.+||..||.+||+ +.+++
T Consensus 228 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l 304 (353)
T 3coi_A 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQAL 304 (353)
T ss_dssp CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC---HHHHH
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC---HHHHh
Confidence 876666555431 11233344678999999999999999999999 88999
Q ss_pred cCCCCCCCCcc
Q 001354 971 AHPFFKGVNWD 981 (1093)
Q Consensus 971 ~HPFFkgIdWd 981 (1093)
+||||+.+...
T Consensus 305 ~hp~f~~~~~~ 315 (353)
T 3coi_A 305 THPFFEPFRDP 315 (353)
T ss_dssp TSGGGTTTCCG
T ss_pred cCcchhhccCc
Confidence 99999876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=397.43 Aligned_cols=265 Identities=34% Similarity=0.582 Sum_probs=217.2
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh----hhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD----MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~----~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+... .........+.+|+.+|..++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 4689999999999999999999999999999995532211 111223456889999999999999999999987665
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc---EEEEecCCcccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIG 838 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~---VKLsDFGLAk~~ 838 (1093)
+|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999987665 999999999742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
.. .......+||+.|+|||++. ...++.++|||||||++|+|++|.+||
T Consensus 168 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (322)
T 2ycf_A 168 GE----------------------------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219 (322)
T ss_dssp CC----------------------------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cc----------------------------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 10 11123457999999999984 467899999999999999999999999
Q ss_pred CCCChH-HHHHHHhccCCCC-CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 916 TAESPE-IIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 916 ~~~s~~-ei~~kIl~~~l~f-P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
...... .+...+..+...+ |.....++.++.+||.+||..||.+||+ +.++++||||++.+|..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 220 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMKR 285 (322)
T ss_dssp CSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGCCHHHHH
T ss_pred cccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCC---HHHHhhCcCcCCHHHHH
Confidence 875543 3444455544433 2223578999999999999999999999 88999999999877654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=386.47 Aligned_cols=264 Identities=30% Similarity=0.534 Sum_probs=228.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++++.||+|+||.||+|+++.+++.||+|++. +.. ........+.+|+.++..++||||+++++++.+...+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~-~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KAS-AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-GGG-BSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEec-ccc-cchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 34578999999999999999999999999999999553 222 2234567889999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC---CcEEEEecCCcccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d---G~VKLsDFGLAk~~~~ 840 (1093)
|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999888889999999999999999999999999999999999999764 4799999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
........||+.|+|||++.+. ++.++||||||+++|+|++|.+||.+.+.
T Consensus 177 ----------------------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (287)
T 2wei_A 177 ----------------------------NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (287)
T ss_dssp ----------------------------CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 1112345689999999998764 89999999999999999999999999998
Q ss_pred HHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 921 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
.++...+..+...++. ....+++++.+||.+||..||.+||+ +.++++||||+...|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHHHCCC
T ss_pred HHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC---HHHHhcCHHHhccccC
Confidence 8888888877665432 12578999999999999999999999 8899999999876554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=387.99 Aligned_cols=265 Identities=28% Similarity=0.471 Sum_probs=219.9
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc-
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC- 759 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd- 759 (1093)
.....++|++++.||+|+||.||+|++..+|+.||+|++. .. ......+.+|+.++..+ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-CC----SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEe-cC----cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3456789999999999999999999999999999999542 21 12345788999999998 79999999999977
Q ss_pred -----CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEec
Q 001354 760 -----RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 760 -----~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 46799999999999999999864 56999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHH
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYE 907 (1093)
|++..... ........+||+.|+|||++. +..++.++|||||||++|+
T Consensus 174 g~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 174 GVSAQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp TTTC----------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred cCceecCc---------------------------CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 99874210 001123457999999999997 5678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 908 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 908 MLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
|++|.+||.+.+.......+.....+. ..+..++..+.+||.+||..||.+||+ +.++++||||++..+..
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPA---TEQLMKHPFIRDQPNER 297 (326)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCC-CSCSCSCHHHHHHHHHHCCSSGGGSCC---HHHHHTSHHHHCCTTHH
T ss_pred HHhCCCCCCCCcHHHHHHHhhcCcccc-CCccccCHHHHHHHHHHhccChhhCCC---HHHHhhChHHhhCcccc
Confidence 999999999988877776665544332 224678999999999999999999999 88999999999876654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=396.27 Aligned_cols=258 Identities=19% Similarity=0.285 Sum_probs=210.1
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.+..++|++++.||+|+||+||+|++..++..+++|++++.... ........+.+|+.++..++||||+++++++. ..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 35668999999999999999999999988887554433322211 11223345778999999999999999999886 45
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 689999999999999999864 5799999999999999999999999999999999999999999999999999985311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. ..........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+..
T Consensus 168 ~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 168 D-------------------------DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp C-------------------------TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred c-------------------------cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 0 00112234578899999999999999999999999999999999 999999988
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
..++...+...... ..+..++.++.+||.+||..||.+||++.++.+
T Consensus 223 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~ 269 (325)
T 3kex_A 223 LAEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENIRPTFKELAN 269 (325)
T ss_dssp TTHHHHHHHTTCBC--CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC--CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88887777665332 234678889999999999999999999544433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=396.86 Aligned_cols=262 Identities=28% Similarity=0.443 Sum_probs=204.4
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
....+++|++.+.||+|+||+||+|+++.+|..||+|++.... .......+|+..+..++||||++++++|....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-----cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3466789999999999999999999999999999999654321 12234567788888899999999999986644
Q ss_pred c-------eEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hcCcEeeecCCCcEEEcc-CCcE
Q 001354 762 N-------LYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLH--SLGIVHRDLKPDNLLIAH-DGHI 827 (1093)
Q Consensus 762 ~-------LyLVMEYm~GGSL~dlL~----k~g~LsEe~ar~yaaQIl~ALeYLH--s~GIIHRDIKPeNILLD~-dG~V 827 (1093)
. +|+||||+++ +|...+. ....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 3 8999999987 5544443 4567999999999999999999999 999999999999999997 8999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeecchhhHH
Q 001354 828 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILF 906 (1093)
Q Consensus 828 KLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDVWSLGVILY 906 (1093)
||+|||+++... ........+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 172 kl~Dfg~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 223 (360)
T 3e3p_A 172 KLCDFGSAKKLS----------------------------PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA 223 (360)
T ss_dssp EECCCTTCBCCC----------------------------TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred EEeeCCCceecC----------------------------CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence 999999997421 011223467999999999997654 899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhccCC-----------------------------CCCCCCCCCCHHHHHHHHhhccCCc
Q 001354 907 EFITGIPPFTAESPEIIFDNILNRKI-----------------------------PWPCVPSDMSFEAQDLINRFLIHDP 957 (1093)
Q Consensus 907 EMLTGkpPF~~~s~~ei~~kIl~~~l-----------------------------~fP~ip~~IS~eakDLIkrcL~kDP 957 (1093)
||++|.+||.+.+.......+..... .++..+...++++.+||.+||+.||
T Consensus 224 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 303 (360)
T 3e3p_A 224 EMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP 303 (360)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence 99999999999988777776653100 0122233467899999999999999
Q ss_pred CCCCChhcHHHHHcCCCCCCCCc
Q 001354 958 NQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 958 ~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
.+||+ +.++++||||+++.+
T Consensus 304 ~~Rpt---~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 304 EERMK---PYEALCHPYFDELHD 323 (360)
T ss_dssp GGSCC---HHHHTTSGGGGGGGC
T ss_pred cccCC---HHHHhcCccccccCC
Confidence 99999 889999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=385.66 Aligned_cols=264 Identities=29% Similarity=0.451 Sum_probs=213.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec-------
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT------- 758 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq------- 758 (1093)
.++|++++.||+|+||.||+|.+..+|+.||+|++.. ......+.+.+|+.++..++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL----TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec----CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 4789999999999999999999999999999995532 23445678899999999999999999998874
Q ss_pred -------cCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc-cCCcEEEE
Q 001354 759 -------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLT 830 (1093)
Q Consensus 759 -------d~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD-~dG~VKLs 830 (1093)
....+|+||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999998 599999865 5699999999999999999999999999999999999997 56799999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHH
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEML 909 (1093)
|||+++...... ..........||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 164 Dfg~~~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 164 DFGLARIMDPHY------------------------SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp CCTTCBCC--------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred cCccccccCCCc------------------------ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 999998521000 00112234578999999999876 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccCCC----------------------CC-----CCCCCCCHHHHHHHHhhccCCcCCCCC
Q 001354 910 TGIPPFTAESPEIIFDNILNRKIP----------------------WP-----CVPSDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 910 TGkpPF~~~s~~ei~~kIl~~~l~----------------------fP-----~ip~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
+|.+||.+.+..+....+...... .+ .....++.++.+||.+||..||.+||+
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 999999998887777766543211 01 112468999999999999999999999
Q ss_pred hhcHHHHHcCCCCCCCCcch
Q 001354 963 ANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 963 a~~A~EIL~HPFFkgIdWd~ 982 (1093)
+.++++||||+...|..
T Consensus 300 ---~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 300 ---AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp ---HHHHHTSHHHHTTCC--
T ss_pred ---HHHHhCCcccccccCcc
Confidence 88999999999887754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=397.81 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=218.4
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEEC-------CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k-------~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
+.+..++|++.+.||+|+||.||+|++. .++..||+|++ +.. ........+.+|+.+|..+ +||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDD--ATEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEEC-CTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEe-cCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4566789999999999999999999975 34567999944 332 2345567899999999999 89999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCC
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPe 817 (1093)
+++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999998653 4789999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
||||+.+|++||+|||+++..... ..........||+.|+|||++.+..|+.++|
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 287 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNI-------------------------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCC-------------------------CTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred hEEECCCCCEEEccccCCcccCcc-------------------------cceecccCCCcccceECHhHhcCCCCCcHHH
Confidence 999999999999999999842110 0011223456889999999999999999999
Q ss_pred eecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 898 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 898 VWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
||||||+||||++ |.+||.+.+..+++..+..+.. +..+..++.++.+||.+||..||.+||++.++.+.
T Consensus 288 vwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 288 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999 9999999988888877765532 33457899999999999999999999995544443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=410.76 Aligned_cols=261 Identities=22% Similarity=0.261 Sum_probs=197.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc--CCCceEEEeeeec-----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFFYSFT----- 758 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL--~HPNIVkL~gsfq----- 758 (1093)
..+|++.+.||+|+||+||+|+++.+|+.||+|++. +...........+.+|+.++..+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFT-MGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEE-CCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEE-ecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 456999999999999999999999999999999553 33333445567788886555444 6999998664432
Q ss_pred --cC-----------------CceEEEEEecCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHhcCcEee
Q 001354 759 --CR-----------------DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVA------RIYIAELVLALEYLHSLGIVHR 812 (1093)
Q Consensus 759 --d~-----------------~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~a------r~yaaQIl~ALeYLHs~GIIHR 812 (1093)
.. ..+||||||++ |+|.+++...+ .+++... ..++.||+.||.|||++|||||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 22 34899999999 79999998753 3444443 4566999999999999999999
Q ss_pred ecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--C
Q 001354 813 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--T 890 (1093)
Q Consensus 813 DIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~ 890 (1093)
||||+||||+.+|++||+|||+++... .......||+.|+|||++.+ .
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~ 268 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVG------------------------------TRGPASSVPVTYAPREFLNASTA 268 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETT------------------------------CEEEGGGSCGGGCCHHHHTCSEE
T ss_pred cCCHHHEEECCCCCEEEEecceeeecC------------------------------CCccCccCCcCCcChhhccCCCC
Confidence 999999999999999999999998421 01114567799999999987 7
Q ss_pred CCCccceeecchhhHHHHHhCCCCCCCCChHHH--HHH-----HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh
Q 001354 891 EHGYAADWWSVGIILFEFITGIPPFTAESPEII--FDN-----ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 963 (1093)
Q Consensus 891 ~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei--~~k-----Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa 963 (1093)
.|+.++|||||||+||||++|++||.+..+... +.. .......+|. ...+++++.+||.+||..||.+||+
T Consensus 269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt- 346 (371)
T 3q60_A 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLL- 346 (371)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCC-
T ss_pred CcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCC-
Confidence 799999999999999999999999987743211 111 1112223332 3578999999999999999999999
Q ss_pred hcHHHHHcCCCCCCCCcch
Q 001354 964 NGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 964 ~~A~EIL~HPFFkgIdWd~ 982 (1093)
+.++++||||+++.|..
T Consensus 347 --~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 347 --PLEAMETPEFLQLQNEI 363 (371)
T ss_dssp --HHHHTTSHHHHHHHHHH
T ss_pred --HHHHhcCHHHHHHHHHH
Confidence 88999999999887764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=396.75 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=207.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC--------CCceEEEe
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR--------NPFVVRFF 754 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~--------HPNIVkL~ 754 (1093)
.+..++|++++.||+|+||+||+|++..+++.||+|++ ++ .......+.+|+.+|..+. ||||++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KS----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-CS----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEE-ec----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 34568899999999999999999999999999999954 32 1234567889999999885 78899999
Q ss_pred eeec----cCCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCC--
Q 001354 755 YSFT----CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDG-- 825 (1093)
Q Consensus 755 gsfq----d~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG-- 825 (1093)
++|. ....+|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9998 566899999999 55777766554 4699999999999999999999998 999999999999999776
Q ss_pred -----------------------------------------------cEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 001354 826 -----------------------------------------------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858 (1093)
Q Consensus 826 -----------------------------------------------~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~ 858 (1093)
.+||+|||+++...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~------------------- 247 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH------------------- 247 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT-------------------
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc-------------------
Confidence 79999999997421
Q ss_pred CCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh------HHHHHHHhc--c
Q 001354 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------EIIFDNILN--R 930 (1093)
Q Consensus 859 ~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~------~ei~~kIl~--~ 930 (1093)
......+||+.|+|||++.+..|+.++|||||||+||||++|.+||...+. ......+.. +
T Consensus 248 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 316 (397)
T 1wak_A 248 -----------KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316 (397)
T ss_dssp -----------BCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHC
T ss_pred -----------ccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcC
Confidence 112345799999999999999999999999999999999999999986542 222222211 0
Q ss_pred CCC-------------------CC------------------CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 931 KIP-------------------WP------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 931 ~l~-------------------fP------------------~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
..+ +. ..+...+..+.+||.+||+.||.+||+ +.++++||
T Consensus 317 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp 393 (397)
T 1wak_A 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT---AAECLRHP 393 (397)
T ss_dssp SCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC---HHHHHTSG
T ss_pred CCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC---HHHHhhCc
Confidence 000 00 011234567899999999999999999 88999999
Q ss_pred CCCC
Q 001354 974 FFKG 977 (1093)
Q Consensus 974 FFkg 977 (1093)
||++
T Consensus 394 ~~~~ 397 (397)
T 1wak_A 394 WLNS 397 (397)
T ss_dssp GGGC
T ss_pred cccC
Confidence 9963
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=386.57 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=213.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEE-CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC------ceEEEeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARK-RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP------FVVRFFYS 756 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~-k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP------NIVkL~gs 756 (1093)
...++|++++.||+|+||+||+|.+ +.+++.||+|++ +.. ......+.+|+.++..++|+ +|++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~-~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEE-CSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEE-ecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 4457999999999999999999998 568899999944 321 23456788899999888655 59999999
Q ss_pred eccCCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-----------
Q 001354 757 FTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----------- 823 (1093)
Q Consensus 757 fqd~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~----------- 823 (1093)
+...+.+|+||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred --------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 824 --------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 824 --------dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
++.+||+|||+++... ......+||+.|+|||++.+..|+.+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 214 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDD------------------------------EHHSTLVSTRHYRAPEVILALGWSQP 214 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETT------------------------------SCCCSSCSCGGGCCHHHHTTSCCCTH
T ss_pred ccccccccCCCceEeeCcccccCc------------------------------cccccccCCccccChHHhhCCCCCcc
Confidence 6789999999987421 11234679999999999999999999
Q ss_pred ceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCC----------------------------------------
Q 001354 896 ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP---------------------------------------- 935 (1093)
Q Consensus 896 sDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP---------------------------------------- 935 (1093)
+|||||||++|||++|.+||...+..+....+.....++|
T Consensus 215 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (339)
T 1z57_A 215 CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294 (339)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhh
Confidence 9999999999999999999998877665544432111111
Q ss_pred -CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 936 -CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 936 -~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
..+...++++.+||.+||..||.+||+ +.++++||||+.+.
T Consensus 295 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~ 336 (339)
T 1z57_A 295 MLSQDVEHERLFDLIQKMLEYDPAKRIT---LREALKHPFFDLLK 336 (339)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGGG
T ss_pred cccchhhHHHHHHHHHHHhCcCcccccC---HHHHhcCHHHHHHh
Confidence 011223577899999999999999999 88999999998653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=403.24 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=215.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCCc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~--HPNIVkL~gsfqd~~~ 762 (1093)
...+|++++.||+|+||+||+|.+.. +..||+|++... .........+.+|+.+|..+. |||||++++++...+.
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~--~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLE--EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECT--TCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecc--cccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 34569999999999999999999875 899999955322 224456678999999999997 5999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+||| +.+|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~- 207 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD- 207 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC-
Confidence 999999 56889999999888999999999999999999999999999999999999995 689999999999853110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeecchhhHHHHHhC
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
.........+||+.|+|||++.+ ..|+.++|||||||+||||++|
T Consensus 208 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G 263 (390)
T 2zmd_A 208 ------------------------TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263 (390)
T ss_dssp ------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHC
Confidence 00112345689999999999975 3689999999999999999999
Q ss_pred CCCCCCCC-hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 912 IPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 912 kpPF~~~s-~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.+||.... .......++.....++ ++...+.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~~ 327 (390)
T 2zmd_A 264 KTPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQ 327 (390)
T ss_dssp SCTTTTCCCHHHHHHHHHCTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHSC
T ss_pred CCcchhhhHHHHHHHHHhCccccCC-CCccchHHHHHHHHHHcccChhhCCC---HHHHhhCcCcccc
Confidence 99998754 3455556665444322 34667899999999999999999999 8899999999743
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=390.22 Aligned_cols=263 Identities=22% Similarity=0.411 Sum_probs=211.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|.+.+.||+|+||+||+|.+..+++.||+|.+.. ........+.+|+.+|..++||||+++++++.+...+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 567899999999999999999999999999999995532 2345567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999987 4679999999999999999999999999999999999999999999999999998532111
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.. ..................+||+.|+|||++.+..++.++|||||||++|||++|..||....+..
T Consensus 163 ~~-------------~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 163 TQ-------------PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp ------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred cc-------------ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 00 00000111112233446789999999999999999999999999999999999999997643211
Q ss_pred H-----HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 923 I-----FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 923 i-----~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
. ....... ..+..+++.+.+||.+||..||.+||++.++.+
T Consensus 230 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 230 MDFGLNVRGFLDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TTSSBCHHHHHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhhhhhccccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 1111111 123678889999999999999999999554444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=381.06 Aligned_cols=256 Identities=30% Similarity=0.528 Sum_probs=224.3
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.+.|++++.||+|+||.||+|++..+++.||+|++... . .......+.+|+.++..++||||+++++++.....+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-E--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETT-T--CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccc-c--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 35699999999999999999999999999999954322 2 22346788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~----- 171 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD----- 171 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT-----
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc-----
Confidence 9999999999999865 5799999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~ 925 (1093)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||..........
T Consensus 172 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 229 (303)
T 3a7i_A 172 ----------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229 (303)
T ss_dssp ----------------------TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH
Confidence 0112235679999999999999999999999999999999999999999988877777
Q ss_pred HHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 926 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 926 kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.+..... +.++..++..+.+||.+||..||.+||+ +.++++||||..
T Consensus 230 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~ 276 (303)
T 3a7i_A 230 LIPKNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFILR 276 (303)
T ss_dssp HHHHSCC--CCCCSSCCHHHHHHHHHHCCSSGGGSCC---HHHHTTCHHHHH
T ss_pred HhhcCCC--CCCccccCHHHHHHHHHHcCCChhhCcC---HHHHhhChhhhc
Confidence 6655443 3445789999999999999999999999 889999999953
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=388.43 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=216.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCC-cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc------eEEEeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF------VVRFFYS 756 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TG-k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN------IVkL~gs 756 (1093)
...++|++++.||+|+||+||+|.+..++ ..||+|++ ++. ......+.+|+.+|..+.|++ ++.++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~-~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEE-CSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEE-ccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 44689999999999999999999998877 68999944 321 234467788999999887655 9999999
Q ss_pred eccCCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE-------------
Q 001354 757 FTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI------------- 821 (1093)
Q Consensus 757 fqd~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL------------- 821 (1093)
+...+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 667777776553 69999999999999999999999999999999999999
Q ss_pred ------ccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 822 ------AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 822 ------D~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
+.++.+||+|||+++... ......+||+.|+|||++.+..|+.+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 219 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDH------------------------------EHHTTIVATRHYRPPEVILELGWAQP 219 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETT------------------------------SCCCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred cccccccCCCcEEEeecCcccccc------------------------------ccccCCcCCCcccCCeeeecCCCCCc
Confidence 668899999999997421 11234679999999999999999999
Q ss_pred ceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC---------------------------------------
Q 001354 896 ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC--------------------------------------- 936 (1093)
Q Consensus 896 sDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~--------------------------------------- 936 (1093)
+|||||||+||||++|.+||...+..+....+.....++|.
T Consensus 220 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (355)
T 2eu9_A 220 CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299 (355)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccc
Confidence 99999999999999999999988776655544332111110
Q ss_pred --CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 937 --VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 937 --ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
.....+.++.+||.+||..||.+||+ +.++++||||++++|+...
T Consensus 300 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 300 MLQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGCCHHHHC
T ss_pred ccccchhHHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcCCChhhcc
Confidence 01122457899999999999999999 8899999999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=405.38 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=214.8
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc------CCCceEEEeeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV------RNPFVVRFFYSF 757 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL------~HPNIVkL~gsf 757 (1093)
....+|++++.||+|+||+||+|.+..+++.||+|++ +.. ......+.+|+.+|..+ +||||+++++.+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~-~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEE-CSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEE-CCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 4457899999999999999999999999999999954 321 23345677788888776 578999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc--EEEEecC
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFG 833 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~--VKLsDFG 833 (1093)
.....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++|||||||||+||||+.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999996 59999998654 4999999999999999999999999999999999999999987 9999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
+++.. .....+.+||+.|+|||++.+..|+.++|||||||+||||++|.+
T Consensus 248 ~a~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 248 SSCYE------------------------------HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp TCEET------------------------------TCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cceec------------------------------CCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCC
Confidence 98742 112335689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhccCC--------------------CCCC------------------------------------C
Q 001354 914 PFTAESPEIIFDNILNRKI--------------------PWPC------------------------------------V 937 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~l--------------------~fP~------------------------------------i 937 (1093)
||.+.+..+....++.... .+|. +
T Consensus 298 pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 377 (429)
T 3kvw_A 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNAL 377 (429)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHT
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhc
Confidence 9999888777665543100 0000 1
Q ss_pred CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 938 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 938 p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+...++++.+||.+||+.||.+||| +.++|+||||+..
T Consensus 378 ~~~~~~~~~dli~~~L~~dP~~Rpt---a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 378 KGCDDPLFLDFLKQCLEWDPAVRMT---PGQALRHPWLRRR 415 (429)
T ss_dssp TTCCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSTTTC--
T ss_pred cccchHHHHHHHHHHCCCChhhCCC---HHHHhCChhhccC
Confidence 1234788999999999999999999 8899999999853
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=371.57 Aligned_cols=252 Identities=17% Similarity=0.278 Sum_probs=217.0
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~- 760 (1093)
..+..++|++.+.||+|+||+||+|++. +..||+|++. . ........+.+.+|+.+|..++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~-~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLK-V-RDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEEC-C-TTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEec-c-cccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 3467889999999999999999999985 8899999543 2 223345567899999999999999999999999887
Q ss_pred -CceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
..+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78999999999999999998765 4899999999999999999999999 999999999999999999999999987
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCc---cceeecchhhHHHHHhCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGI 912 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~---ksDVWSLGVILYEMLTGk 912 (1093)
... .....+||+.|+|||++.+..++. ++|||||||++|||++|.
T Consensus 161 ~~~--------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 208 (271)
T 3kmu_A 161 FSF--------------------------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208 (271)
T ss_dssp CTT--------------------------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCS
T ss_pred eee--------------------------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 521 112357899999999998765554 799999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.||.+.+.......+...... +.++..+++++.+||.+||..||.+||++.++.+.+
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 209 VPFADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp CTTTTSCHHHHHHHHHHSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCccccChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999988887777766554 345688999999999999999999999965554443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=387.83 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=210.4
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--c
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--N 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--~ 762 (1093)
..+.|++.+.||+|+||+||+|+++.+|+.||+|++ +.... ....+.+.+|+.+|..++||||+++++++.... .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-CGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEe-ccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 456899999999999999999999999999999954 33222 233567789999999999999999999988765 7
Q ss_pred eEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE----ccCCcEEEEecCCc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 835 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~---LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL----D~dG~VKLsDFGLA 835 (1093)
+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999986543 9999999999999999999999999999999999999 78889999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--------CCCCCccceeecchhhHHH
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--------GTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~--------g~~Ys~ksDVWSLGVILYE 907 (1093)
+.... .......+||+.|+|||++. +..|+.++|||||||++||
T Consensus 164 ~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~e 215 (319)
T 4euu_A 164 RELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (319)
T ss_dssp EECCT----------------------------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHH
T ss_pred eecCC----------------------------CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHH
Confidence 85210 11223467999999999986 5778999999999999999
Q ss_pred HHhCCCCCCCCC----hHHHHHHHhccCC-------------------CCC---CCCCCCCHHHHHHHHhhccCCcCCCC
Q 001354 908 FITGIPPFTAES----PEIIFDNILNRKI-------------------PWP---CVPSDMSFEAQDLINRFLIHDPNQRL 961 (1093)
Q Consensus 908 MLTGkpPF~~~s----~~ei~~kIl~~~l-------------------~fP---~ip~~IS~eakDLIkrcL~kDP~KRp 961 (1093)
|++|..||.... ..++...++.+.. .+| .++..++..+.+||.+||+.||.+||
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~ 295 (319)
T 4euu_A 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295 (319)
T ss_dssp HHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred HHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc
Confidence 999999997433 3445555554332 111 11234566889999999999999999
Q ss_pred ChhcHHHHHcCC
Q 001354 962 GANGAAEVKAHP 973 (1093)
Q Consensus 962 Ta~~A~EIL~HP 973 (1093)
+ +.|+++||
T Consensus 296 s---~~ell~h~ 304 (319)
T 4euu_A 296 G---FDQFFAET 304 (319)
T ss_dssp C---HHHHHHHH
T ss_pred c---HHHhhhcc
Confidence 9 77888886
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=392.25 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=214.2
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEE-----ECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar-----~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~ 754 (1093)
.+.+..++|++.+.||+|+||.||+|+ ...+++.||+|++ ++. ......+.+.+|+.+|..+ +|||||+++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEG--ATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEE-CTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEe-cCc--CCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 455778899999999999999999999 4556789999954 322 2334457799999999999 789999999
Q ss_pred eeeccCCc-eEEEEEecCCCChHHHHHhcCC-------------------------------------------------
Q 001354 755 YSFTCRDN-LYLVMEYLNGGDLYSLLRKVGC------------------------------------------------- 784 (1093)
Q Consensus 755 gsfqd~~~-LyLVMEYm~GGSL~dlL~k~g~------------------------------------------------- 784 (1093)
+++...+. +|+||||++||+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99888654 9999999999999999986532
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 785 -----------------LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 785 -----------------LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~------ 246 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD------ 246 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC------
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc------
Confidence 899999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDN 926 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~k 926 (1093)
..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.........
T Consensus 247 -------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 307 (359)
T 3vhe_A 247 -------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307 (359)
T ss_dssp -------------------TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred -------------------ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence 00112334678999999999999999999999999999999998 9999998775555544
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
.+..... +..+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 308 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 349 (359)
T 3vhe_A 308 RLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 349 (359)
T ss_dssp HHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHcCCC-CCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHHHH
Confidence 4443333 2245789999999999999999999999 4455543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=375.51 Aligned_cols=273 Identities=31% Similarity=0.512 Sum_probs=212.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-------
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------- 759 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd------- 759 (1093)
++|++++.||+|+||.||+|++..+|+.||+|++. . .......+.+|+.++..++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-H----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE-E----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEe-c----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 57999999999999999999999999999999552 2 23456778999999999999999999998755
Q ss_pred ------CCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEec
Q 001354 760 ------RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 760 ------~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 456899999999999999998654 5888999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhC
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTG 911 (1093)
|+++....... .. ....... ..........+||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 161 g~~~~~~~~~~--~~-------~~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 161 GLAKNVHRSLD--IL-------KLDSQNL----PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp CCCSCTTC--------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred cchhhcccccc--hh-------ccccccc----cccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 99975321000 00 0000000 0011233456899999999999865 68999999999999999998
Q ss_pred CCCCCC-CChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 912 IPPFTA-ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 912 kpPF~~-~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
||.. .+.......+......+|. ++...+..+.+||.+||..||.+||+ +.++++||||+...++..
T Consensus 227 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 295 (303)
T 1zy4_A 227 --PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNSGWLPVKHQDEV 295 (303)
T ss_dssp --CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC---HHHHHHSSCSCCCCHHHH
T ss_pred --ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC---HHHHhCCCCcCCCChHHH
Confidence 5643 3445555666555444442 44667888999999999999999999 889999999998776654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=371.74 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=207.5
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++.+.||+|+||.||+|++. |..||+|++............+.+.+|+.++..++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 356789999999999999999999985 889999954332222223445788999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---cEeeecCCCcEEEcc--------CCcEEEEe
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAH--------DGHIKLTD 831 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~G---IIHRDIKPeNILLD~--------dG~VKLsD 831 (1093)
+|+||||++||+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999885 457999999999999999999999999 999999999999986 78899999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhC
Q 001354 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 832 FGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
||+++... ........||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 160 fg~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 160 FGLAREWH-----------------------------RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp CCC------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred CCcccccc-----------------------------cccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99987421 0112245799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 912 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 912 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
..||.+.+.......+.......+ .+..+++.+.+||.+||..||.+||++.++.+.
T Consensus 211 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 211 EVPFRGIDGLAVAYGVAMNKLALP-IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTTTSCHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHhhhcCCCCCC-CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999888887777776665533 467899999999999999999999995544443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=384.44 Aligned_cols=259 Identities=22% Similarity=0.365 Sum_probs=220.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
.+..++|++++.||+|+||.||+|++. .++..||+|++ ++. ........+.+|+.+|..++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEE--ASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEEC-CTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEe-ccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456789999999999999999999997 35589999954 322 1334567899999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeee
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRD 813 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~------------------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRD 813 (1093)
.+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999864 5689999999999999999999999999999
Q ss_pred cCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC
Q 001354 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 893 (1093)
Q Consensus 814 IKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys 893 (1093)
|||+||||+.++.+||+|||+++...... .........||+.|+|||++.+..++
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~ 254 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYT 254 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCc-------------------------cccccCCCcccceecChhhhccCCcC
Confidence 99999999999999999999997531100 01122345789999999999999999
Q ss_pred ccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 894 YAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 894 ~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.++|||||||++|||++ |..||.+.+..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.+.++
T Consensus 255 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 255 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 99999999999999999 9999999998888888877654 2345789999999999999999999999665555543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=378.59 Aligned_cols=262 Identities=30% Similarity=0.426 Sum_probs=213.1
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
....++|.....||+|+||.||+|++..++..||+|.+... .......+.+|+.++..++||||+++++++...+.
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 34556677777999999999999999999999999955322 22345678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-CCcEEEEecCCcccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIG 838 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g---~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-dG~VKLsDFGLAk~~ 838 (1093)
+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 999999999999999998652 4678899999999999999999999999999999999998 899999999998752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeecchhhHHHHHhCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.. .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 174 ~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 174 AG---------------------------INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp CC--------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CC---------------------------CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 10 01112345799999999999764 38899999999999999999999997
Q ss_pred CCChHH-HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 917 AESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 917 ~~s~~e-i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
...... .......... .+.++..+++++.+||.+||..||.+||+ +.++++||||+...
T Consensus 227 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 227 ELGEPQAAMFKVGMFKV-HPEIPESMSAEAKAFILKCFEPDPDKRAC---ANDLLVDEFLKVSS 286 (295)
T ss_dssp GGSSHHHHHHHHHHHCC-CCCCCTTSCHHHHHHHHHTTCSSTTTSCC---HHHHHTSGGGCC--
T ss_pred CCCchhHHHHhhccccc-cccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhhcc
Confidence 654322 2222111111 23455789999999999999999999999 88999999998543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=378.71 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=218.7
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEE-----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 755 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~-----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~g 755 (1093)
.+.+..++|.+.+.||+|+||.||+|.+ +.++..||+|++. .. ......+.+.+|+.+|..++||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-EN--ASPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECC-TT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEecc-CC--CCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 4456778999999999999999999998 3456899999543 21 23455678999999999999999999999
Q ss_pred eeccCCceEEEEEecCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCcEe
Q 001354 756 SFTCRDNLYLVMEYLNGGDLYSLLRKVGC------------------------LEEDVARIYIAELVLALEYLHSLGIVH 811 (1093)
Q Consensus 756 sfqd~~~LyLVMEYm~GGSL~dlL~k~g~------------------------LsEe~ar~yaaQIl~ALeYLHs~GIIH 811 (1093)
++.+.+.+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999986543 899999999999999999999999999
Q ss_pred eecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC
Q 001354 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 891 (1093)
Q Consensus 812 RDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~ 891 (1093)
|||||+|||++.++.+||+|||+++...... .........||+.|+|||++.+..
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTS-------------------------CEECSSCCCSCGGGCCHHHHHHCE
T ss_pred cccchheEEEcCCCCEEEccccccccccccc-------------------------cceeccCCCCcccccChhhhcCCC
Confidence 9999999999999999999999997531100 011223456789999999999989
Q ss_pred CCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 892 HGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 892 Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
++.++|||||||++|||++ |..||.+.+...+...+..... +..+..+++++.+||.+||..||.+||++.++.+
T Consensus 229 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999 9999999988888777765532 3345789999999999999999999999544433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=372.49 Aligned_cols=250 Identities=21% Similarity=0.345 Sum_probs=215.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
+.+..++|++++.||+|+||.||+|++.. +..||+|++. +.. ...+.+.+|+.+|.+++||||+++++++.+..
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~-~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIR-EGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEEC-TTS----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEec-ccc----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 45677899999999999999999999874 7789999553 221 12356889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999999754 4689999999999999999999999999999999999999999999999999975311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 159 ~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 159 D--------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp H--------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred c--------------------------ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 0 0112234567889999999999999999999999999999999 999999999
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~ 965 (1093)
..+....+...... ..+..+++++.+||.+||..||.+||++.+
T Consensus 213 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (269)
T 4hcu_A 213 NSEVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFSR 256 (269)
T ss_dssp HHHHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhcCccC--CCCCcCCHHHHHHHHHHccCCcccCcCHHH
Confidence 98888888765332 235778999999999999999999999443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=374.03 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=215.4
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++++.||+|+||+||+|.+. ++..||+|++ +.... ....+.+|+.+|..++||||+++++++.+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~-~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI-KEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEE-CTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEe-cCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 345677889999999999999999999887 5778999954 32221 23568899999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
...+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999986 467999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
... .........||+.|+|||++.+..++.++||||||+++|||++ |.+||..
T Consensus 171 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 171 LDD--------------------------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp CCH--------------------------HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccc--------------------------ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 110 0112234567889999999999899999999999999999998 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.+..+....+....... .+..+++.+.+||.+||..||.+||+ +.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 273 (283)
T 3gen_A 225 FTNSETAEHIAQGLRLY--RPHLASEKVYTIMYSCWHEKADERPT---FKILLS 273 (283)
T ss_dssp SCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHH
T ss_pred cChhHHHHHHhcccCCC--CCCcCCHHHHHHHHHHccCChhHCcC---HHHHHH
Confidence 99888888887654332 24778999999999999999999999 445554
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=381.37 Aligned_cols=273 Identities=21% Similarity=0.293 Sum_probs=227.3
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEe
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~ 754 (1093)
..+.+..++|++.+.||+|+||.||+|.++ .++..||+|.+. +. ........+.+|+.+|..++||||++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~-~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EA--ASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECC-TT--SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecc-cc--cCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 455677889999999999999999999887 457889999543 22 2234456789999999999999999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 824 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~----------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d 824 (1093)
+++.+....|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 9999999999999999999999999753 356899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhh
Q 001354 825 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 904 (1093)
Q Consensus 825 G~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVI 904 (1093)
|.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 229 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229 (322)
T ss_dssp CCEEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CeEEECcCcccccccccc-------------------------ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHH
Confidence 999999999997432100 0112234568999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC---CCCCCCCc
Q 001354 905 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH---PFFKGVNW 980 (1093)
Q Consensus 905 LYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H---PFFkgIdW 980 (1093)
+|||++ |.+||.+.+..+....+..... +..+..++..+.+||.+||..||.+||++.++.+.++. ++|+.++|
T Consensus 230 l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~ 307 (322)
T 1p4o_A 230 LWEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307 (322)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred HHHHHhcCCCccccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence 999999 8999999998888888876654 23457899999999999999999999995544444332 66666555
Q ss_pred ch
Q 001354 981 DS 982 (1093)
Q Consensus 981 d~ 982 (1093)
..
T Consensus 308 ~~ 309 (322)
T 1p4o_A 308 YY 309 (322)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=385.81 Aligned_cols=260 Identities=24% Similarity=0.317 Sum_probs=218.5
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCc---EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk---~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
..+..++|++.+.||+|+||+||+|+++.++. .||+|++ +.. ........+.+|+.+|..++||||+++++++.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEE-CTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEec-CCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34667899999999999999999999986655 5999954 321 23445678999999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+...+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999999999755 5799999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
..... ..........||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 201 ~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 201 LEDDP------------------------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp CC----------------------------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccCc------------------------cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 32100 00111223457889999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+.+..++...+..... .+ .+..+++++.+||.+||..||.+||++.++.+.|
T Consensus 257 ~~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 257 NMTNRDVISSVEEGYR-LP-APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp TSCHHHHHHHHHTTCC-CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCHHHHHHHHHcCCC-CC-CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9998888888766532 22 3578999999999999999999999966555544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=385.29 Aligned_cols=270 Identities=22% Similarity=0.314 Sum_probs=217.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~L 763 (1093)
..++|++.+.||+|+||+||+|++..+|+.||+|++..+ . ....+.+|+.+|..+ +||||+++++++.+....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-S-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT-C-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc-c-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 457899999999999999999999999999999954322 1 123578999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc-----EEEEecCCccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKI 837 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~-----VKLsDFGLAk~ 837 (1093)
|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 99999999864 67999999999999999999999999999999999999999887 99999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
...... . ...........+||+.|+|||++.+..++.++|||||||+||||++|.+||.+
T Consensus 160 ~~~~~~--------~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 160 YIDPET--------K------------KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp SBCTTT--------C------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eecCCC--------C------------ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 321100 0 00011123467899999999999999999999999999999999999999988
Q ss_pred CC---hHHHHHHHhccCCCCCC--CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc-------CCCCCCCCcch
Q 001354 918 ES---PEIIFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA-------HPFFKGVNWDS 982 (1093)
Q Consensus 918 ~s---~~ei~~kIl~~~l~fP~--ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~-------HPFFkgIdWd~ 982 (1093)
.+ ..+.+..+.......|. ....++ ++.+||..||..||.+||++..+.+++. ..+...++|+.
T Consensus 220 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 220 LKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp CCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred cccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 43 44555555443332221 112344 9999999999999999999766655553 34555688873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=398.02 Aligned_cols=261 Identities=20% Similarity=0.319 Sum_probs=221.1
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEE-----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 756 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~-----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gs 756 (1093)
..+..++|++++.||+|+||+||+|++ ..++..||+|++ +. .........+.+|+.+|..++|||||+++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~-~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PE--VCSEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEEC-CS--SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEec-cc--ccChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 346678999999999999999999994 456789999954 22 1234455678899999999999999999999
Q ss_pred eccCCceEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC---c
Q 001354 757 FTCRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---H 826 (1093)
Q Consensus 757 fqd~~~LyLVMEYm~GGSL~dlL~k~g-------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG---~ 826 (1093)
+.+....|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.+| .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 999999999999999999999998653 489999999999999999999999999999999999999655 5
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHH
Q 001354 827 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906 (1093)
Q Consensus 827 VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILY 906 (1093)
+||+|||+++...... ........+||+.|+|||++.+..|+.++|||||||+||
T Consensus 223 ~kL~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 277 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAG-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 277 (367)
T ss_dssp EEECCCHHHHHHHHHS-------------------------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEECCCcccccccccc-------------------------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHH
Confidence 9999999997432110 011233467899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 907 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 907 EMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
||++ |.+||.+.+..++...+..+... ..+..++..+.+||.+||..||.+||+ +.+|++|.++
T Consensus 278 ellt~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps---~~eil~~l~~ 342 (367)
T 3l9p_A 278 EIFSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN---FAIILERIEY 342 (367)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCCHhHCcC---HHHHHHHHHH
Confidence 9998 99999999999888888776533 235789999999999999999999999 6677777665
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.93 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=215.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
.+..++|++++.||+|+||.||+|+++ ++..||+|++ +... .....+.+|+.+|..++||||+++++++.+...
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~-~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMI-KEGS----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEE-CBTT----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEe-ccCC----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 456789999999999999999999887 4678999954 3222 123568899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999998764 4999999999999999999999999999999999999999999999999999753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~ 920 (1093)
.........||+.|+|||++.+..++.++||||||+++|||++ |.+||...+.
T Consensus 158 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 158 --------------------------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp --------------------------CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred --------------------------hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 0111234567888999999999899999999999999999999 9999999998
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
.+....+....... .+...++.+.+||.+||..||.+||++.++.+
T Consensus 212 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 212 SEVVLKVSQGHRLY--RPHLASDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp HHHHHHHHTTCCCC--CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCC--CCCcChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88888877655432 24678999999999999999999999544433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=389.94 Aligned_cols=262 Identities=25% Similarity=0.420 Sum_probs=210.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-------hchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-------IRKNDIERILAERNILITVRNPFVVRFFYS 756 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-------~~~~eie~~l~E~~IL~kL~HPNIVkL~gs 756 (1093)
...++|++.+.||+|+||.||+|.+.. |..||+|++...... ......+.+.+|+.+|..++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345789999999999999999999865 999999965432211 122335789999999999999999999999
Q ss_pred ec-----cCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEE
Q 001354 757 FT-----CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 830 (1093)
Q Consensus 757 fq-----d~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLs 830 (1093)
|. ....+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 84 3446899999998 5888888754 469999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHH
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEML 909 (1093)
|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 177 Dfg~~~~~~----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 177 DFNLAREDT----------------------------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp CTTC-------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred ecCcccccc----------------------------cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence 999997421 0112234679999999999987 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccC------------------------CCCC-----CCCCCCCHHHHHHHHhhccCCcCCC
Q 001354 910 TGIPPFTAESPEIIFDNILNRK------------------------IPWP-----CVPSDMSFEAQDLINRFLIHDPNQR 960 (1093)
Q Consensus 910 TGkpPF~~~s~~ei~~kIl~~~------------------------l~fP-----~ip~~IS~eakDLIkrcL~kDP~KR 960 (1093)
+|++||.+.+..+....+.... ...+ ..+..+++.+.+||.+||..||.+|
T Consensus 229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence 9999999988777766664310 0111 1234678999999999999999999
Q ss_pred CChhcHHHHHcCCCCCCC
Q 001354 961 LGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 961 pTa~~A~EIL~HPFFkgI 978 (1093)
|+ +.++++||||+.+
T Consensus 309 pt---~~ell~hp~f~~~ 323 (362)
T 3pg1_A 309 IS---TEQALRHPYFESL 323 (362)
T ss_dssp CC---HHHHHTSGGGTTT
T ss_pred CC---HHHHHcCchhhhc
Confidence 99 8899999999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=380.28 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=210.7
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
....+++|++.+.||+|+||.||+|++..+++.||+| ++.+...........+.+|+.++..++||||+++++++...+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK-~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEE-ECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEE-ecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 3456789999999999999999999999999999999 444433334445678999999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
........+||+.|+|||++.+..++.++||||||+++|||++|..||.+.+..
T Consensus 188 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (309)
T 2h34_A 188 --------------------------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS 241 (309)
T ss_dssp -----------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred --------------------------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH
Confidence 011223457999999999999999999999999999999999999999988776
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCC-ChhcHHHHHc
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL-GANGAAEVKA 971 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRp-Ta~~A~EIL~ 971 (1093)
.+...+..........+..+++++.+||.+||..||.+|| +++++.+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 242 VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 5554444333222234578999999999999999999999 6555555443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=387.23 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=218.3
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhch---hHHHHHHHHHHHHHhcC--CCceEEEee
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK---NDIERILAERNILITVR--NPFVVRFFY 755 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~---~eie~~l~E~~IL~kL~--HPNIVkL~g 755 (1093)
......++|++.+.||+|+||.||+|++..+++.||+|++. ....... .....+.+|+.+|..+. ||||+++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEE-GGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEe-cccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 33456788999999999999999999999999999999553 3222111 12245678999999996 599999999
Q ss_pred eeccCCceEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc-cCCcEEEEecC
Q 001354 756 SFTCRDNLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFG 833 (1093)
Q Consensus 756 sfqd~~~LyLVMEYm~G-GSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD-~dG~VKLsDFG 833 (1093)
++...+..|+||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999999976 89999999888999999999999999999999999999999999999999 78999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGk 912 (1093)
+++... ........||+.|+|||++.+..+ +.++|||||||++|||++|.
T Consensus 196 ~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 196 SGALLK-----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp TCEECC-----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred cccccc-----------------------------cccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 987521 011234579999999999987665 78999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
.||.... .+......++ ..+++++.+||.+||..||.+||+ +.++++||||+++.+..
T Consensus 247 ~pf~~~~------~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 247 IPFEHDE------EIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp CSCCSHH------HHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCCCHH
T ss_pred CCCCChh------hhhccccccc---ccCCHHHHHHHHHHccCChhhCcC---HHHHhcCHhhcCccCcc
Confidence 9997642 2333444333 689999999999999999999999 88999999999886654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=369.96 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=210.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhH---HHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKND---IERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~e---ie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+..++|++.+.||+|+||+||+|++..+++.||+|++........... .+.+.+|+.++..++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 4567899999999999999999999999999999995533222111111 2678999999999999999999999977
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEccCCc-----EEEEe
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGH-----IKLTD 831 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~dG~-----VKLsD 831 (1093)
.. ++||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 7999999999999988654 46999999999999999999999999 999999999999998886 99999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--CCCCCccceeecchhhHHHHH
Q 001354 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 832 FGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~--g~~Ys~ksDVWSLGVILYEML 909 (1093)
||+++... ......+||+.|+|||++. ...++.++|||||||++|||+
T Consensus 173 fg~~~~~~------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 173 FGLSQQSV------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp CTTCBCCS------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred CCcccccc------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 99987321 1123467999999999994 456789999999999999999
Q ss_pred hCCCCCCCCChHHH--HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 910 TGIPPFTAESPEII--FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 910 TGkpPF~~~s~~ei--~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+|..||...+.... ...+...... +.++..+++++.+||.+||..||.+||++.++.+.+
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIREEGLR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCccccccHHHHHHHHhccCCC-CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 99999987654433 4444444433 445688999999999999999999999965555444
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=393.91 Aligned_cols=259 Identities=32% Similarity=0.463 Sum_probs=212.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CC-----ceEEEeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NP-----FVVRFFYS 756 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HP-----NIVkL~gs 756 (1093)
....++|++.+.||+|+||+||+|+++.+++.||+|++ +.. ......+..|+.++..+. |+ +|++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~-~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEE-CSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEE-ecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 34578999999999999999999999999999999954 321 233456778888888775 44 59999999
Q ss_pred eccCCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hcCcEeeecCCCcEEEc--cCCcEEEE
Q 001354 757 FTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH--SLGIVHRDLKPDNLLIA--HDGHIKLT 830 (1093)
Q Consensus 757 fqd~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLH--s~GIIHRDIKPeNILLD--~dG~VKLs 830 (1093)
|...+.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.||| +.|||||||||+||||+ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999965 999999865 45999999999999999999999 57999999999999995 47889999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh
Q 001354 831 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910 (1093)
Q Consensus 831 DFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT 910 (1093)
|||+++... ......+||+.|+|||++.+..|+.++|||||||+||||++
T Consensus 204 DFG~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 253 (382)
T 2vx3_A 204 DFGSSCQLG------------------------------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253 (382)
T ss_dssp CCTTCEETT------------------------------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred eccCceecc------------------------------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999997421 11234689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhccCCCCCC---------------C------------------CCC-----------------
Q 001354 911 GIPPFTAESPEIIFDNILNRKIPWPC---------------V------------------PSD----------------- 940 (1093)
Q Consensus 911 GkpPF~~~s~~ei~~kIl~~~l~fP~---------------i------------------p~~----------------- 940 (1093)
|++||.+.+..+....|.......|. + +..
T Consensus 254 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 333 (382)
T 2vx3_A 254 GEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333 (382)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGG
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCc
Confidence 99999999888777776542110000 0 000
Q ss_pred -----------CCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 001354 941 -----------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 941 -----------IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdW 980 (1093)
.++++.+||.+||+.||.+||| +.++|+||||+...+
T Consensus 334 ~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt---a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ---PYYALQHSFFKKTAD 381 (382)
T ss_dssp TTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGCC---
T ss_pred cccccccccchhhHHHHHHHHHhcCCChhhCCC---HHHHhcCcccccCCC
Confidence 0147899999999999999999 889999999987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=387.60 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=207.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-----------CCce
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-----------NPFV 750 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-----------HPNI 750 (1093)
..+..++|++++.||+|+||+||+|++..+++.||+|++ .+ .......+.+|+.++..+. ||||
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-CS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEe-cC----CccchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 345668999999999999999999999999999999954 32 1223456788999988876 8999
Q ss_pred EEEeeeeccCC----ceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEcc
Q 001354 751 VRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAH 823 (1093)
Q Consensus 751 VkL~gsfqd~~----~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~ 823 (1093)
+++++++.... .+++||||+ +|+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 99999998754 789999999 88999999864 4599999999999999999999998 9999999999999953
Q ss_pred ------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 824 ------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 824 ------dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
.+.+||+|||+++... ......+||+.|+|||++.+..|+.++|
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~D 217 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGAD 217 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred cCCCcCcceEEEcccccccccC------------------------------CCCCCCCCCccccCcHHHhCCCCCchHh
Confidence 4489999999997421 0123457999999999999999999999
Q ss_pred eecchhhHHHHHhCCCCCCCCCh------HHHHHHHhc------------------------------------------
Q 001354 898 WWSVGIILFEFITGIPPFTAESP------EIIFDNILN------------------------------------------ 929 (1093)
Q Consensus 898 VWSLGVILYEMLTGkpPF~~~s~------~ei~~kIl~------------------------------------------ 929 (1093)
||||||+||||++|.+||.+.+. ......+..
T Consensus 218 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (373)
T 1q8y_A 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297 (373)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh
Confidence 99999999999999999986542 222222211
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 930 ~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.... ++..++.++.+||.+||+.||.+||+ +.++++||||++.
T Consensus 298 ~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 340 (373)
T 1q8y_A 298 EKYK---FSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDT 340 (373)
T ss_dssp HTTC---CCHHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTC
T ss_pred hccc---CCcchHHHHHHHHHHHhccCccccCC---HHHHhhChhhhcc
Confidence 1111 12455678999999999999999999 8899999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=397.84 Aligned_cols=262 Identities=26% Similarity=0.452 Sum_probs=195.3
Q ss_pred CCeeE-EEeeeccCCeEEEEEEEC--CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee--ccCC
Q 001354 687 DDFEI-IKPISRGAFGRVFLARKR--TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF--TCRD 761 (1093)
Q Consensus 687 ddFei-lr~LGkG~FGeVylar~k--~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf--qd~~ 761 (1093)
+.|++ .++||+|+||+||+|+++ .++..||+|++ .... ....+.+|+.+|+.++|||||+++++| ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~-~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEEC-SSSS-----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEE-CCCC-----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 34555 457999999999999977 46889999954 3221 124578999999999999999999999 4567
Q ss_pred ceEEEEEecCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE----ccCCcEE
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVG---------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIK 828 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g---------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL----D~dG~VK 828 (1093)
.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 89999999975 8888886321 49999999999999999999999999999999999999 7789999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHH
Q 001354 829 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFE 907 (1093)
Q Consensus 829 LsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYE 907 (1093)
|+|||+++..... ..........+||+.|+|||++.+. .|+.++|||||||+|||
T Consensus 173 l~Dfg~a~~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 228 (405)
T 3rgf_A 173 IADMGFARLFNSP------------------------LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 228 (405)
T ss_dssp ECCTTCCC----------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHH
T ss_pred EEECCCceecCCC------------------------CcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHH
Confidence 9999999853100 0001123457899999999999874 58999999999999999
Q ss_pred HHhCCCCCCCCCh---------HHHHHHHhcc-CCC----CCC------------------------------CCCCCCH
Q 001354 908 FITGIPPFTAESP---------EIIFDNILNR-KIP----WPC------------------------------VPSDMSF 943 (1093)
Q Consensus 908 MLTGkpPF~~~s~---------~ei~~kIl~~-~l~----fP~------------------------------ip~~IS~ 943 (1093)
|++|.+||.+... .+....|+.. ..+ |+. .....++
T Consensus 229 ll~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (405)
T 3rgf_A 229 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308 (405)
T ss_dssp HHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTS
T ss_pred HHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCH
Confidence 9999999976543 2333333321 000 000 0112377
Q ss_pred HHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 001354 944 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 944 eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
++.+||.+||+.||.+||| +.++|+||||.+..|..
T Consensus 309 ~~~~Ll~~~L~~dP~~R~t---a~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 309 KAFHLLQKLLTMDPIKRIT---SEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHHHHHHSCSSGGGSCC---HHHHHTSGGGTSSSCCC
T ss_pred HHHHHHHHHccCCcccCCC---HHHHhcChhhccCCCCc
Confidence 8999999999999999999 88999999999876654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=383.28 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=216.4
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~ 754 (1093)
.+.+..++|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+|..+ +||||++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 45677899999999999999999999973 456789999553221 233456789999999999 899999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEe
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------------------CLEEDVARIYIAELVLALEYLHSLGIVH 811 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~g-----------------------~LsEe~ar~yaaQIl~ALeYLHs~GIIH 811 (1093)
+++...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99999999999999999999999997643 3789999999999999999999999999
Q ss_pred eecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC
Q 001354 812 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 891 (1093)
Q Consensus 812 RDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~ 891 (1093)
|||||+||||+.++.+||+|||+++..... ..........||+.|+|||++.+..
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~ 250 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSD-------------------------SNYVVRGNARLPVKWMAPESLFEGI 250 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGC-------------------------TTSEEETTEEECGGGCCHHHHHHCC
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccC-------------------------ccceeccCccCccCccCHHHhccCC
Confidence 999999999999999999999999753210 0011223456889999999999999
Q ss_pred CCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 892 HGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 892 Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
++.++|||||||+||||++ |..||.+......+..++...... ..+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 251 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 251 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999999999999999998 999999887766666666655443 24578899999999999999999999955444443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=374.86 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=218.5
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEE-----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~-----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
..+.+..++|++.+.||+|+||.||+|++ ..++..||+|++. ... .....+.+.+|+.+|..+ +||||+++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC-TTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcC-cch--hHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 44567778999999999999999999985 4567899999543 221 233457889999999999 89999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecC
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLK 815 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g------------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIK 815 (1093)
++++.+.+..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 999999999999999999999999998654 38999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 816 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 816 PeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
|+|||++.++.+||+|||+++..... ..........||+.|+|||++.+..++.+
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 227 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFE 227 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSC-------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHH
T ss_pred cceEEEcCCCCEEEcccccccccccc-------------------------ccceeccCCCCcceeeChHHhcCCCCChH
Confidence 99999999999999999998742100 00111234568899999999999999999
Q ss_pred ceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 896 ADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 896 sDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+|||||||+||||++ |.+||.+.........++......+ .+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 228 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999999999999999 9999998876665555555444322 3578999999999999999999999955444443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=394.66 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=219.6
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
.+.+..++|++.+.||+|+||+||+|+++.++..||+|.+ +.. ........+.+|+.+|..++|||||++++++...
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEC-CTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEc-ccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 4567788999999999999999999999999999999954 321 2334456788999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999998654 59999999999999999999999999999999999999999999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
... + ........+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+.
T Consensus 265 ~~~---------------------~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 265 DGV---------------------Y----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp TSE---------------------E----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred CCc---------------------e----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 000 0 001122346788999999998899999999999999999998 99999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+..+....+..+. .+| .+..+++++.+||.+||..||.+||++.++.+.|
T Consensus 320 ~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 320 SNQQTREFVEKGG-RLP-CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp CHHHHHHHHHTTC-CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 8888777765543 222 3578999999999999999999999965554443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=375.89 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=202.6
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
....+++|++++.||+|+||.||+|+++.+|+.||+|++... . ........+.++..++..++||||+++++++...+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-G-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETT-S-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccc-c-cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 346678999999999999999999999999999999955322 1 12223344555566788889999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+|+||||+ ++.+..++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 5566665544 46799999999999999999999995 99999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
. ........||+.|+|||++. +..++.++|||||||++|||++|..|
T Consensus 177 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (318)
T 2dyl_A 177 D----------------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228 (318)
T ss_dssp --------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred C----------------------------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCC
Confidence 0 11123457999999999994 45788999999999999999999999
Q ss_pred CCC-CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 915 FTA-ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 915 F~~-~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
|.. ....+....+.....+.......+++++.+||.+||..||.+||+ +.++++||||++.
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 229 YKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK---YNKLLEHSFIKRY 290 (318)
T ss_dssp TTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHHH
T ss_pred CCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcC---HHHHhhCHHHHhc
Confidence 987 445566666666544322223568999999999999999999999 8899999999753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=371.60 Aligned_cols=273 Identities=19% Similarity=0.254 Sum_probs=218.5
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~ 761 (1093)
.+..++|++.+.||+|+||.||+|++..+|+.||+|++. ... ....+.+|+.++..+ +||+|+++++++....
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEE-CCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEec-cCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 345678999999999999999999999999999999543 211 223577899999999 7999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc-----EEEEecCCc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLS 835 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~-----VKLsDFGLA 835 (1093)
..|+||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+.+|. +||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 999999998754 5999999999999999999999999999999999999988776 999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
+....... . ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~~~~--------~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 159 KFYRDPVT--------K------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp EESBCTTT--------C------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccccc--------c------------ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence 85321100 0 000112234678999999999999999999999999999999999999999
Q ss_pred CCCC---hHHHHHHHhccCC--CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc-------CCCCCCCCcch
Q 001354 916 TAES---PEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA-------HPFFKGVNWDS 982 (1093)
Q Consensus 916 ~~~s---~~ei~~kIl~~~l--~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~-------HPFFkgIdWd~ 982 (1093)
.+.+ ....+..+..... +.+.....+++++.+||.+||..||.+||++.++.+.++ .......+|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 219 QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp SSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred chhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 8743 4444444443322 222233578999999999999999999999655544432 34455566654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=371.15 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=205.7
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCC---CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~T---Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
..+..++|++.+.||+|+||.||+|.+..+ +..||+|.+ +.. ......+.+.+|+.+|..++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEEC-TTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEec-ccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 346678999999999999999999998754 457999943 322 23345677899999999999999999999985
Q ss_pred cCCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 467899999999999999998654 699999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
.... .........||+.|+|||++.+..++.++|||||||++|||++ |.+||.
T Consensus 166 ~~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 166 MEDS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCcc--------------------------cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 2110 0011223467889999999999999999999999999999997 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
+.+..+....+..... +..+..+++++.+||.+||..||.+||++.++.+
T Consensus 220 ~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 220 GVKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp TCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9888888877766542 2245789999999999999999999999554443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.71 Aligned_cols=259 Identities=20% Similarity=0.344 Sum_probs=222.3
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++.+.||+|+||+||+|.++.++..||+|.+. . .....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-E----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEEC-S----CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecC-c----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 455678899999999999999999999999999999999543 2 22345778999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999999864 3499999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
... ..........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.
T Consensus 161 ~~~--------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~ 214 (288)
T 3kfa_A 161 MTG--------------------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214 (288)
T ss_dssp SCS--------------------------SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccC--------------------------CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 210 00112234567899999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+.+...+...+..... +..+..+++++.+||.+||..||.+||++.++.+.++
T Consensus 215 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 215 GIDLSQVYELLEKDYR--MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp TCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHhccCC--CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 9888777776655422 2235789999999999999999999999666555543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.49 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=207.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCC-------cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 755 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TG-------k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~g 755 (1093)
++..++|++.+.||+|+||+||+|+++.++ ..||+|.+ .+. .....+.+.+|+.+|..++||||+++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~-~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKA---HRNYSESFFEAASMMSKLSHKHLVLNYG 79 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEE-CGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhc-ccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 456789999999999999999999998877 46999944 332 2345577899999999999999999999
Q ss_pred eeccCCceEEEEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc--------
Q 001354 756 SFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-------- 826 (1093)
Q Consensus 756 sfqd~~~LyLVMEYm~GGSL~dlL~k~g~-LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~-------- 826 (1093)
++.+.+..|+||||++||+|.+++.+.+. +++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999999999987654 999999999999999999999999999999999999999887
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhH
Q 001354 827 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIIL 905 (1093)
Q Consensus 827 VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVIL 905 (1093)
+||+|||++.... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 160 ~kl~Dfg~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 160 IKLSDPGISITVL-------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp EEECCCCSCTTTS-------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred eeeccCccccccc-------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 9999999987421 1123468999999999987 7799999999999999
Q ss_pred HHHHhC-CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 906 FEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 906 YEMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
|||++| .+||...+..... .+......+| ...++++.+||.+||..||.+||++.++.+.+
T Consensus 209 ~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 209 WEICSGGDKPLSALDSQRKL-QFYEDRHQLP---APKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp HHHHTTTCCTTTTSCHHHHH-HHHHTTCCCC---CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCccccchHHHH-HHhhccCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999995 5566555544443 3334433333 56788999999999999999999955444433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=383.81 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=205.7
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.+..++|++++.||+|+||+||+|++..+++.+++|++++.... ........+.+|+.+|..++||||+++++++....
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 35668899999999999999999999988887654433333211 22344578999999999999999999999998765
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 78999999999999999874 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
.. .........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+
T Consensus 170 ~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 170 EE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TC-------------------------C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Cc-------------------------ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 00 0112233567889999999999999999999999999999999 999999988
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~ 965 (1093)
..++...+..... .+ .+..++.++.+||.+||..||.+||++.+
T Consensus 225 ~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e 268 (327)
T 3poz_A 225 ASEISSILEKGER-LP-QPPICTIDVYMIMVKCWMIDADSRPKFRE 268 (327)
T ss_dssp GGGHHHHHHTTCC-CC-CCTTBCHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred HHHHHHHHHcCCC-CC-CCccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 8777766655432 22 35778999999999999999999999443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=386.21 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=219.1
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCC-------CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVV 751 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~T-------Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIV 751 (1093)
..+.+..++|.+.+.||+|+||+||+|++..+ +..||+|++ +.. ........+.+|+.++..+ +|||||
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSD--ATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEE-CTT--CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEee-ccc--cCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 44567788999999999999999999997543 357999954 322 2345567899999999999 899999
Q ss_pred EEeeeeccCCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecC
Q 001354 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLK 815 (1093)
Q Consensus 752 kL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIK 815 (1093)
++++++...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999999999999999999999999998653 48999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 816 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 816 PeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
|+||||+.++.+||+|||+++..... ..........||+.|+|||++.+..++.+
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 273 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQ 273 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCC-------------------------CTTCCCTTCCCGGGGSCHHHHHSCCCCHH
T ss_pred cceEEEcCCCcEEEcccCcccccccc-------------------------cccccccCCCCCcceeCHHHhcCCCCCch
Confidence 99999999999999999999742100 00112234567899999999999999999
Q ss_pred ceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 896 ADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 896 sDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
+|||||||++|||++ |..||.+.+..++...+..... +..+..+++++.+||.+||..||.+||++.++.
T Consensus 274 ~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 274 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 999999999999999 9999999998888887766543 233578999999999999999999999944333
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=376.99 Aligned_cols=262 Identities=20% Similarity=0.321 Sum_probs=218.9
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCc-----EEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk-----~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
....+..++|++.+.||+|+||.||+|.+..++. .||+|.+. .. ........+.+|+.+|..+ +||||+++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~-~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-ST--AHADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEEC-TT--CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcc-cc--cChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 3566788999999999999999999999987665 79999543 22 1234567889999999999 89999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcE
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKV--------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 819 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~--------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNI 819 (1093)
++++...+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195 (333)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence 99999999999999999999999999753 3579999999999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001354 820 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 899 (1093)
Q Consensus 820 LLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVW 899 (1093)
||+.++.+||+|||+++..... ..........||+.|+|||++.+..++.++|||
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 250 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMND-------------------------SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGC-------------------------TTSEECSSCEECGGGSCHHHHHHCCCCHHHHHH
T ss_pred EECCCCeEEECccccccccccc-------------------------cceeecCCCCCCccccCHHHhccCCCChHHHHH
Confidence 9999999999999999743110 001112345678999999999999999999999
Q ss_pred cchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 900 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 900 SLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
||||++|||++ |.+||.+.........++......+ .+...++.+.+||.+||..||.+||++.++.+.|
T Consensus 251 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 251 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA-QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 99999999998 9999998776666666665544432 3567899999999999999999999955444433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=363.24 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=215.4
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
+.+..++|++.+.||+|+||.||+|.+. ++..||+|.+. .... ..+.+.+|+.++..++||||+++++++.+.+
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~-~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR-EGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEEC-TTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEcc-ccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3456789999999999999999999987 57889999543 2221 2356889999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999999999865 4689999999999999999999999999999999999999999999999999875311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. .........||+.|+|||++.+..++.++|+||||+++|+|++ |.+||...+
T Consensus 157 ~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 157 D--------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp H--------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred c--------------------------cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 0 0111234567889999999998999999999999999999999 999999999
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
..+....+..+... ..+..++..+.+||.+||..||.+||++.++.
T Consensus 211 ~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 256 (267)
T 3t9t_A 211 NSEVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFSRLL 256 (267)
T ss_dssp HHHHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCcC--CCCccCcHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88888887765432 23467899999999999999999999954333
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=376.49 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=205.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhch---hHHHHHHHHHHHHHhc----CCCceEEEee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK---NDIERILAERNILITV----RNPFVVRFFY 755 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~---~eie~~l~E~~IL~kL----~HPNIVkL~g 755 (1093)
....++|++.+.||+|+||.||+|+++.+++.||+|++ ........ .....+.+|+.++..+ +||||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEEC-CSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEE-ecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 45567899999999999999999999999999999954 32221111 1233456789999888 8999999999
Q ss_pred eeccCCceEEEEEe-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc-cCCcEEEEecC
Q 001354 756 SFTCRDNLYLVMEY-LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFG 833 (1093)
Q Consensus 756 sfqd~~~LyLVMEY-m~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD-~dG~VKLsDFG 833 (1093)
++...+..|+|||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 78999999999888899999999999999999999999999999999999999 88999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGk 912 (1093)
+++... ........||+.|+|||++.+..+ +.++|||||||++|||++|+
T Consensus 186 ~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 236 (312)
T 2iwi_A 186 SGALLH-----------------------------DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236 (312)
T ss_dssp SCEECC-----------------------------SSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred hhhhcc-----------------------------cCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC
Confidence 987521 011234579999999999987666 45899999999999999999
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
.||.... .+......++ ..++.++.+||.+||..||.+||+ +.++++||||+...
T Consensus 237 ~pf~~~~------~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 237 IPFERDQ------EILEAELHFP---AHVSPDCCALIRRCLAPKPSSRPS---LEEILLDPWMQTPA 291 (312)
T ss_dssp CSCCSHH------HHHHTCCCCC---TTSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSTTTCC--
T ss_pred CCCCChH------HHhhhccCCc---ccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhcCch
Confidence 9997632 2334444444 789999999999999999999999 88999999998653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=374.47 Aligned_cols=262 Identities=28% Similarity=0.421 Sum_probs=213.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC--CCceEEEeeeecc
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTC 759 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~--HPNIVkL~gsfqd 759 (1093)
..+..++|++++.||+|+||.||+|.+. ++..||+|++.. ..........+.+|+.+|..+. ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEEC--SSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecc--ccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3455678999999999999999999986 489999995532 2223455678899999999997 5999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
...+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++...
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999999999 56889999999888999999999999999999999999999999999999996 5999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeecchhhHHHH
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEF 908 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Ys~ksDVWSLGVILYEM 908 (1093)
.. .........+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 178 ~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 232 (313)
T 3cek_A 178 PD-------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232 (313)
T ss_dssp -------------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred Cc-------------------------cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence 10 00112234679999999999976 4688899999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 909 ITGIPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 909 LTGkpPF~~~s~-~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
++|..||..... ......+...... +.++...+.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 233 ~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~~~~ 298 (313)
T 3cek_A 233 TYGKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQI 298 (313)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHC
T ss_pred HhCCCchhhHHHHHHHHHHHHhcccc-cCCcccchHHHHHHHHHHccCCcccCcC---HHHHhcCccccC
Confidence 999999987543 3444444444333 2234677899999999999999999999 889999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.95 Aligned_cols=257 Identities=29% Similarity=0.499 Sum_probs=204.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++.+.||+|+||.||+|.+..+|+.||+|++ +............+.+|+.+|..++||||+++++++...+.+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEE-CTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEee-ehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 4567899999999999999999999999999999944 333333455667889999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 764 YLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999874 3568999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 188 ~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 188 S---------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp --------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred C---------------------------CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 0 0112234579999999999999999999999999999999999999997653
Q ss_pred --hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 920 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 920 --~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
.......+.....+ +..+..++.++.+||.+||..||.+||++.++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 241 MNLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CCHHHHHHHHHTTCSC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHhhcccCC-CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 34455555444332 11236789999999999999999999995544443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=370.74 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=206.5
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEE----ECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar----~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
.+..++|++++.||+|+||+||+|+ ...+++.||+|++. . ......+.+.+|+.+|..++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~-~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-H---STEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEES-C---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcc-c---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4567899999999999999999999 56689999999542 2 23445678899999999999999999999886
Q ss_pred cC--CceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 759 CR--DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 759 d~--~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
.. ..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 54 56999999999999999998754 5999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
+...... ..........||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 162 ~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 217 (295)
T 3ugc_A 162 KVLPQDK------------------------EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217 (295)
T ss_dssp C-------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred ccccCCc------------------------ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccccc
Confidence 8531100 0011122345788899999999999999999999999999999999998
Q ss_pred CCCChH----------------HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 916 TAESPE----------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 916 ~~~s~~----------------ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
...... .....+. .....+ .+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp CSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCChHHHHhhhcCccccchhHHHHHHHHh-ccCcCC-CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 653221 1122222 222222 3578999999999999999999999965544433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=382.08 Aligned_cols=267 Identities=23% Similarity=0.403 Sum_probs=197.3
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHH-HHHhcCCCceEEEeeeec
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~-IL~kL~HPNIVkL~gsfq 758 (1093)
..+.+..++|++++.||+|+||.||+|.++.+|+.||+|++.... .......+..|.. +++.++||||+++++++.
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 455678899999999999999999999999999999999553221 2233345555655 677789999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeeecCCCcEEEccCCcEEEEec
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k-----~g~LsEe~ar~yaaQIl~ALeYLHs~-GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
..+.+|+||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||||+.+|.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence 99999999999986 88888763 46799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh----cCCCCCccceeecchhhHHHH
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEF 908 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL----~g~~Ys~ksDVWSLGVILYEM 908 (1093)
|+++.... ........||+.|+|||++ .+..++.++|||||||++|||
T Consensus 171 g~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l 222 (327)
T 3aln_A 171 GISGQLVD----------------------------SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222 (327)
T ss_dssp SSSCC----------------------------------------------------------CCSHHHHHHHHHHHHHH
T ss_pred CCceeccc----------------------------ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHH
Confidence 99874210 0112234799999999999 456789999999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHHhccCCC-CCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 909 ITGIPPFTAESP-EIIFDNILNRKIP-WPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 909 LTGkpPF~~~s~-~ei~~kIl~~~l~-fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
++|..||.+.+. .+....+..+..+ ++. ....+++++.+||.+||..||.+||+ +.++++||||....+.
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 223 ATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK---YKELLKHPFILMYEER 295 (327)
T ss_dssp HHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHHHHHS
T ss_pred HHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC---HHHHHhChHHHHhHhh
Confidence 999999987543 2233333332221 111 12468999999999999999999999 8899999999765544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=373.59 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=212.7
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEE-----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~-----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~ 754 (1093)
.+.+..++|++.+.||+|+||+||+|++ ..+++.||+|++ ++. ........+.+|+.+|..+ +||||++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEG--ATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEE-CTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEec-ccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3456678999999999999999999985 356789999954 322 2234556789999999999 699999999
Q ss_pred eeeccCC-ceEEEEEecCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCC
Q 001354 755 YSFTCRD-NLYLVMEYLNGGDLYSLLRKVGC----------------LEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817 (1093)
Q Consensus 755 gsfqd~~-~LyLVMEYm~GGSL~dlL~k~g~----------------LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPe 817 (1093)
+++...+ .+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9988765 59999999999999999987543 889999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
||||+.++++||+|||+++..... ..........||+.|+|||++.+..++.++|
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 232 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSD 232 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTC-------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred eEEECCCCCEEECCCccccccccC-------------------------ccceeccCCCcceeecCchhhccccccchhH
Confidence 999999999999999999742100 0011223457899999999999999999999
Q ss_pred eecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 898 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 898 VWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
||||||++|||++ |..||.+..........+..... +..+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 233 i~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~~ 304 (316)
T 2xir_A 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 304 (316)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 9999999999998 99999887654444443333322 2235778999999999999999999999 4455543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=386.46 Aligned_cols=279 Identities=15% Similarity=0.197 Sum_probs=209.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCC-----CcEEEEEEeehhhhh-------hchhHHHHHHHHHHHHHhcCCCceE
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKQVLKKLDM-------IRKNDIERILAERNILITVRNPFVV 751 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~T-----Gk~VAIKkILkK~~~-------~~~~eie~~l~E~~IL~kL~HPNIV 751 (1093)
+..++|++.+.||+|+||+||+|.++.+ ++.||+|++...... ........+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4567999999999999999999999765 588999954332111 1111112345666777888999999
Q ss_pred EEeeeeccC----CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc--cC
Q 001354 752 RFFYSFTCR----DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HD 824 (1093)
Q Consensus 752 kL~gsfqd~----~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD--~d 824 (1093)
++++++... ..+||||||+ ||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998775 4589999999 99999999876 5799999999999999999999999999999999999999 88
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhh
Q 001354 825 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 904 (1093)
Q Consensus 825 G~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVI 904 (1093)
+.+||+|||+++........ ...........+||+.|||||++.+..|+.++|||||||+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVH--------------------KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp TCEEECCCTTCEESSGGGCC--------------------CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeEEEEECCcceecccCCcc--------------------cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 99999999999853211100 0001112345679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhcc----CC------CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc---
Q 001354 905 LFEFITGIPPFTAESPEIIFDNILNR----KI------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--- 971 (1093)
Q Consensus 905 LYEMLTGkpPF~~~s~~ei~~kIl~~----~l------~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~--- 971 (1093)
||||++|+.||.+............. .+ .++ ...++.++.+||..||..||.+||++.++.+++.
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 99999999999864332222211110 00 011 2578899999999999999999999765555443
Q ss_pred ----CCCCCCCCcchhhc
Q 001354 972 ----HPFFKGVNWDSLAL 985 (1093)
Q Consensus 972 ----HPFFkgIdWd~L~~ 985 (1093)
.++...++|.....
T Consensus 329 ~~~~~~~~~~~dw~~~~~ 346 (364)
T 3op5_A 329 KAIGSKDDGKLDLSVVEN 346 (364)
T ss_dssp HHTTCCCCCCCCC-----
T ss_pred HHcCCCcCCccceEeccC
Confidence 45666778876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=374.37 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=217.0
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEEC-------CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVV 751 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k-------~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIV 751 (1093)
..+.+..++|++.+.||+|+||.||+|++. .++..||+|++ +.. ........+.+|+.+|..+ +||||+
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDD--ATEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEEC-CTT--CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeee-ccC--CcHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 344567789999999999999999999986 45778999954 322 2344567889999999999 899999
Q ss_pred EEeeeeccCCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecC
Q 001354 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLK 815 (1093)
Q Consensus 752 kL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIK 815 (1093)
++++++...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 99999999999999999999999999998653 38999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 816 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 816 PeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
|+||||+.+|.+||+|||+++..... ..........||+.|+|||++.+..++.+
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 239 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNI-------------------------DYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTT-------------------------SSEECCSCCCCCGGGCCHHHHHHCEECHH
T ss_pred cceEEEcCCCCEEEcccccccccccc-------------------------ccccccCCCCcccceeChHHhcCCCcChH
Confidence 99999999999999999999752110 00011233467899999999998889999
Q ss_pred ceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 896 ADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 896 sDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
+|||||||++|||++ |..||.+.+..++...+..... +..+..++.++.+||.+||..||.+||++.++.+
T Consensus 240 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 240 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999 9999999988888877766542 2345789999999999999999999999544433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=380.46 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=210.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.+..++|++++.||+|+||+||+|++..+++.+++|++++.... ........+.+|+.+|..++||||+++++++....
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 35678999999999999999999999999988766644433221 22345678899999999999999999999998765
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
.++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 88999999999999999864 5699999999999999999999999999999999999999999999999999985311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
. ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 170 ~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 170 E-------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp -----------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred c-------------------------cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 0 00112233567889999999999999999999999999999999 999999988
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
..++...+..... .+ .+..++.++.+||.+||..||.+||++.++.+
T Consensus 225 ~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 225 ASEISSILEKGER-LP-QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp GGGHHHHHHTTCC-CC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCC-CC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8877776655432 22 35789999999999999999999999554443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.73 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=216.0
Q ss_pred cccCCCeeEEE-eeeccCCeEEEEEEE--CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIK-PISRGAFGRVFLARK--RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr-~LGkG~FGeVylar~--k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+..++|++.+ .||+|+||+||+|.+ ..+++.||+|++ +.. .......+.+.+|+.++..++||||+++++++ .
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~-~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNE-ANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEE-C------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEee-ccc-ccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 34567899998 999999999999954 567889999954 332 22334467899999999999999999999999 5
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 66789999999999999999988889999999999999999999999999999999999999999999999999997531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
... ..........||+.|+|||++.+..++.++||||||+++|||++ |..||.+.
T Consensus 169 ~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 169 ADE------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp TTC------------------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cCC------------------------CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 100 00011223457899999999998889999999999999999999 99999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+..++...+..... +..+..+++++.+||.+||..||.+||++.++.+.++
T Consensus 225 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 225 KGSEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 88888777766532 3345789999999999999999999999666665554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=376.93 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=212.1
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEE--EEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~V--AIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd 759 (1093)
.+..++|++.+.||+|+||.||+|+++.+|..+ |+|.+. . .........+.+|+.+|..+ +||||+++++++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~-~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-E--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEE-C--C------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeec-c--ccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 366789999999999999999999999888866 888543 2 12234456788999999999 89999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~ 823 (1093)
.+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 999999999999999999997654 6999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchh
Q 001354 824 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903 (1093)
Q Consensus 824 dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGV 903 (1093)
++.+||+|||+++.... ........+|+.|+|||++.+..++.++|||||||
T Consensus 178 ~~~~kL~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 229 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229 (327)
T ss_dssp GGCEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHH
T ss_pred CCeEEEcccCcCccccc----------------------------cccccCCCCCccccChhhhccccCCchhcchHHHH
Confidence 99999999999873110 11122346789999999999888999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 904 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 904 ILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
++|||++ |.+||.+.+..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.
T Consensus 230 il~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 292 (327)
T 1fvr_A 230 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292 (327)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCCCCCCCCcHHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999998 9999999998888888766532 223578899999999999999999999944333
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=383.61 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=183.9
Q ss_pred ccCCCeeEEE-eeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc---
Q 001354 684 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--- 759 (1093)
Q Consensus 684 isiddFeilr-~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd--- 759 (1093)
...++|.+++ .||+|+||+||+|+++.+|+.||+|++... . ....+....+..+.||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----P---KARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----H---HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 4568999965 699999999999999999999999955321 1 111222334567789999999999876
Q ss_pred -CCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CCcEEEEecC
Q 001354 760 -RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 833 (1093)
Q Consensus 760 -~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG~VKLsDFG 833 (1093)
...+|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 455899999999999999998764 6999999999999999999999999999999999999986 4569999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCC
Q 001354 834 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 834 LAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
+++... .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+
T Consensus 177 ~~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 177 FAKETT-----------------------------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp TCEEC---------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred cceecc-----------------------------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 997421 112234678999999999998899999999999999999999999
Q ss_pred CCCCCChHHH----HHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 914 PFTAESPEII----FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 914 PF~~~s~~ei----~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
||.+...... ...+......+|. ....+++++.+||.+||..||.+||+ +.++++||||++
T Consensus 228 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 293 (336)
T 3fhr_A 228 PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT---ITQFMNHPWINQ 293 (336)
T ss_dssp CC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHHSHHHHT
T ss_pred CCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccc
Confidence 9987665443 2233333333332 22578999999999999999999999 889999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=393.69 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=213.0
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
+.+..++|++.+.||+|+||+||+|.+. |+.||+|.+ +.. ...+.+.+|+.+|..++|||||++++++....
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~-~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEE-SSC-----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEe-CCc-----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 4567889999999999999999999986 789999954 322 13467899999999999999999999976655
Q ss_pred -ceEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 762 -NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 762 -~LyLVMEYm~GGSL~dlL~k~g~--LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+|+||||+++|+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999987654 799999999999999999999999999999999999999999999999999742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
. .......+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+
T Consensus 340 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 340 S------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp C------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred c------------------------------ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 01122367899999999999999999999999999999998 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+..++...+..+. . +..|..+++++.+||.+||..||.+||++.++.+.|
T Consensus 390 ~~~~~~~~~i~~~~-~-~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 390 IPLKDVVPRVEKGY-K-MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp SCTTTHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHcCC-C-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 88888877776543 2 224578999999999999999999999966554444
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.29 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=209.3
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECC-CCc--EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-TGD--LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~-TGk--~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+..++|++++.||+|+||+||+|++.. ++. .||+| +++..........+.+.+|+.++..++||||+++++++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK-~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEE-C--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEE-EEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 3556799999999999999999998753 333 68999 4443333334566789999999999999999999999987
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.. .++||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 65 89999999999999999864 56999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.... ..........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+
T Consensus 172 ~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 172 PQND------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CC-C------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccc------------------------cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 1100 00112234568889999999998889999999999999999999 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+..+....+......++ .+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 228 LNGSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp CCHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHccCCCCC-CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 999888888877655544 4578999999999999999999999955444433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=364.13 Aligned_cols=260 Identities=25% Similarity=0.338 Sum_probs=207.7
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEE----ECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar----~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
.+....|++++.||+|+||.||+|+ ...+++.||+|++... . .......+.+|+.+|..++||||+++++++.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-S--GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccc-c--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3455679999999999999999999 4668999999955322 1 2334577899999999999999999999998
Q ss_pred cC--CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 759 CR--DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 759 d~--~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
.. ..+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 87 6789999999999999999554 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
+...... ..........||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 174 ~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 174 KAIETDK------------------------EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp EECCTTC------------------------CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred ccccCCC------------------------cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence 8531100 0011233457899999999999999999999999999999999999986
Q ss_pred CCC--------------ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 916 TAE--------------SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 916 ~~~--------------s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
... .........+......+ .+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 230 SSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP-CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp GSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cchhhHHhhccCCcccccCHHHHHHHHhccCCCC-CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 432 11122222222222322 4578999999999999999999999966555544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=375.31 Aligned_cols=261 Identities=20% Similarity=0.313 Sum_probs=216.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEE-----ECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 756 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar-----~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gs 756 (1093)
..+..++|++++.||+|+||.||+|+ ...++..||+|.+. .. ........+.+|+.+|..++||||++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~-~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EV--CSEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECC-SS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEec-cc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 34667899999999999999999999 55678899999542 21 233455678999999999999999999999
Q ss_pred eccCCceEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC---Cc
Q 001354 757 FTCRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GH 826 (1093)
Q Consensus 757 fqd~~~LyLVMEYm~GGSL~dlL~k~g-------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d---G~ 826 (1093)
+.....+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.+ +.
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 999999999999999999999998753 48999999999999999999999999999999999999954 46
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHH
Q 001354 827 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906 (1093)
Q Consensus 827 VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILY 906 (1093)
+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 182 ~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 236 (327)
T 2yfx_A 182 AKIGDFGMARDIYRAS-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236 (327)
T ss_dssp EEECCCHHHHHHHC-------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEECcccccccccccc-------------------------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHH
Confidence 9999999987431100 011223457899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 907 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 907 EMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
||++ |.+||...+..+....+...... ..+..++..+.+||.+||..||.+||+ +.++++|.|+
T Consensus 237 ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~l~~ 301 (327)
T 2yfx_A 237 EIFSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN---FAIILERIEY 301 (327)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HHHcCCCCCCCCcCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcC---HHHHHHHHHH
Confidence 9998 99999999888888877765432 235789999999999999999999999 7788887765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=359.83 Aligned_cols=256 Identities=22% Similarity=0.353 Sum_probs=215.8
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
.+.+..++|++++.||+|+||.||+|.+. ++..||+|.+ +... ...+.+.+|+.+|..++||||+++++++..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~-~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEE-CTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEe-cCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 45667789999999999999999999976 4678999954 3221 234678899999999999999999998874
Q ss_pred CceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+..|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 46899999999999999997543 6999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
... .........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 160 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 160 EDN--------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp SSS--------------------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCc--------------------------ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 110 0111234567899999999998889999999999999999999 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.+..++...+..... +..+..++.++.+||.+||..||.+||++.++.+.++
T Consensus 214 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 214 MTNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp CCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCHHHHHHHHhcccC--CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 988888877765432 2235789999999999999999999999766666554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=362.35 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=210.5
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECC---CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~---TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
..+..++|++.+.||+|+||+||+|++.. ++..||+|.+. +. ......+.+.+|+.+|..++||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~-~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KD--CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECC-TT--SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecc-cc--cCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 35677899999999999999999998754 34469999543 22 12345678999999999999999999999987
Q ss_pred cCCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+. ..|+||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 54 5799999999999999997654 599999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
.... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 163 ~~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 163 IEDE--------------------------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp C-----------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccc--------------------------cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 2100 0111233567889999999998999999999999999999998 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
..........+..... +..+..+++.+.+||.+||..||.+||++.++.+
T Consensus 217 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 217 WLENKDVIGVLEKGDR--LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp TSCGGGHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCChHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8877777766655432 2235778999999999999999999999544433
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=359.98 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=209.7
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCc---EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce-
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL- 763 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk---~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L- 763 (1093)
.|++.+.||+|+||+||+|.+..++. .||+|.+ .+ .......+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~-~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SR--ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEE-TT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeec-cc--cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 56778999999999999999866554 7999944 32 22345567889999999999999999999999877765
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999986 3568999999999999999999999999999999999999999999999999997431100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ 921 (1093)
. ..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..
T Consensus 179 ~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 179 Y-----------------------YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp G-----------------------GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred c-----------------------cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 0 01122334578999999999999999999999999999999999 66777777777
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
++...+..... +..+..+++.+.+||.+||..||.+||++.++.+.
T Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 236 DLTHFLAQGRR--LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp GHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCC--CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77766655442 22357899999999999999999999995544443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=362.96 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=215.3
Q ss_pred cccCCCeeEEE-eeeccCCeEEEEEEEC--CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIK-PISRGAFGRVFLARKR--TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr-~LGkG~FGeVylar~k--~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+..++|.+.. .||+|+||.||+|.++ .++..||+|++ +.. ......+.+.+|+.+|..++||||+++++++ .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEE-CSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEec-CCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 35567888887 9999999999999864 46788999954 332 2345567899999999999999999999999 4
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 56699999999999999999754 46999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.... ..........||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 161 ~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 161 GADD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp TTCS------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCc------------------------ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 1100 00112234467899999999998889999999999999999998 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.+..++...+..+.. +.++..+++++.+||.+||..||.+||++.++.+.+.
T Consensus 217 ~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 217 MKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCTHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHhcCCc--CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 888888877766542 3345789999999999999999999999554444443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=362.56 Aligned_cols=271 Identities=22% Similarity=0.307 Sum_probs=210.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEee-eeccCCceE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY-SFTCRDNLY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~g-sfqd~~~Ly 764 (1093)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+|+.++..++|++++..++ ++......|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc------cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 478999999999999999999999999999999543221 1234788999999999877666554 446677889
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE---ccCCcEEEEecCCcccccc
Q 001354 765 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL---D~dG~VKLsDFGLAk~~~~ 840 (1093)
+||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 8999999985 4569999999999999999999999999999999999999 7899999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.... ............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccC--------------------ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 1000 00011223457899999999999999999999999999999999999999987443
Q ss_pred ---HHHHHHHhccCCCCC--CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc-------CCCCCCCCcchh
Q 001354 921 ---EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA-------HPFFKGVNWDSL 983 (1093)
Q Consensus 921 ---~ei~~kIl~~~l~fP--~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~-------HPFFkgIdWd~L 983 (1093)
...+..+.......| .....+++++.+||.+||..||.+||++.++.+.++ .++...++|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 233333333222211 123578999999999999999999999665555443 456666778764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=365.07 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=198.2
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHh--cCCCceEEEeeeecc--
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTC-- 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~k--L~HPNIVkL~gsfqd-- 759 (1093)
...++|++++.||+|+||+||+|++ +|+.||+|++ .. .....+..|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~-~~------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIF-SS------RDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEE-CG------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEe-cc------ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 4567999999999999999999988 5899999954 22 223456677777776 789999999988554
Q ss_pred --CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcEeeecCCCcEEEccCCcEEE
Q 001354 760 --RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------SLGIVHRDLKPDNLLIAHDGHIKL 829 (1093)
Q Consensus 760 --~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLH--------s~GIIHRDIKPeNILLD~dG~VKL 829 (1093)
...+|+||||+++|+|.++++. ..+++..+..++.||+.||.||| +.||+||||||+||||+.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999954 56999999999999999999999 999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeecchh
Q 001354 830 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGI 903 (1093)
Q Consensus 830 sDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Ys~ksDVWSLGV 903 (1093)
+|||+++....... .........+||+.|+|||++.+. .++.++|||||||
T Consensus 155 ~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 155 ADLGLAVMHSQSTN-----------------------QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp CCCTTCEEEETTTT-----------------------EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred eeCCCeeecccccc-----------------------cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHH
Confidence 99999975321000 001112345899999999999876 4557999999999
Q ss_pred hHHHHHhC----------CCCCCCCC----hHHHHHHHhccCCCCCCCC-----CCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 904 ILFEFITG----------IPPFTAES----PEIIFDNILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 904 ILYEMLTG----------kpPF~~~s----~~ei~~kIl~~~l~fP~ip-----~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
++|||++| .+||.... .......+.......|.++ ...++++.+||.+||..||.+||++.
T Consensus 212 il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 291 (301)
T 3q4u_A 212 VLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291 (301)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence 99999999 89996532 2233333333222223222 23557899999999999999999965
Q ss_pred cHHHHH
Q 001354 965 GAAEVK 970 (1093)
Q Consensus 965 ~A~EIL 970 (1093)
++.+.|
T Consensus 292 ~i~~~L 297 (301)
T 3q4u_A 292 RIKKTL 297 (301)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 554443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=391.00 Aligned_cols=258 Identities=22% Similarity=0.355 Sum_probs=219.5
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++.+.||+|+||+||+|.+.. +..||+|.+ +... ...+.+.+|+.+|..++|||||++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~-~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEE-CTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEe-cCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 3456788999999999999999999999864 678999954 3322 23578999999999999999999999987
Q ss_pred CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 56799999999999999999754 3689999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
..... ........+|+.|+|||++.+..|+.++|||||||+||||++ |.+||.
T Consensus 334 ~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 334 IEDNE--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp BCCHH--------------------------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCCc--------------------------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 31100 011223457889999999998899999999999999999999 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
+.+..++...+..+. .+| .+..+++++.+||.+||..||.+||++.++.+.|+.
T Consensus 388 ~~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~ 441 (454)
T 1qcf_A 388 GMSNPEVIRALERGY-RMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441 (454)
T ss_dssp TCCHHHHHHHHHHTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 999888888776542 323 357899999999999999999999997777776653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=386.16 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=207.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEEC---CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k---~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+..++|++.+.||+|+||+||+|+++ .++..||+|.+ +.. ......+.+.+|+.+|..++||||+++++++..
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEEC-CTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEe-cCc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 456779999999999999999999987 46778999954 321 234456789999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
...+|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999998754 6999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.... ..........+|+.|+|||++.+..++.++|||||||+||||++ |..||.+
T Consensus 198 ~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~ 253 (373)
T 2qol_A 198 EDDP------------------------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253 (373)
T ss_dssp ----------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred ccCC------------------------ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 1100 00011123346889999999999999999999999999999998 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+..++...+..+. ..| .+..++..+.+||.+||..||.+||++.++.+.|
T Consensus 254 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 254 MSNQDVIKAVDEGY-RLP-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp CCHHHHHHHHHTTE-ECC-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHcCC-CCC-CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 98888887776542 222 2467899999999999999999999966555544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=366.71 Aligned_cols=246 Identities=29% Similarity=0.449 Sum_probs=200.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++.+.||+|+||+||+|++. ++.||+|++. . ....+.+.+|+.+|..++||||+++++++.+ ..
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~-~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIE-S-----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PV 74 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECS-S-----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEec-C-----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence 45679999999999999999999985 7889999542 2 2345678999999999999999999999874 48
Q ss_pred EEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCcEeeecCCCcEEEccCCc-EEEEecCCcc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHS---LGIVHRDLKPDNLLIAHDGH-IKLTDFGLSK 836 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g---~LsEe~ar~yaaQIl~ALeYLHs---~GIIHRDIKPeNILLD~dG~-VKLsDFGLAk 836 (1093)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 99999999999999998654 47889999999999999999999 89999999999999999886 7999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 155 ~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 204 (307)
T 2eva_A 155 DIQ------------------------------THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204 (307)
T ss_dssp ----------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred ccc------------------------------cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCch
Confidence 421 01123469999999999999999999999999999999999999998
Q ss_pred CCCh--HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 917 AESP--EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 917 ~~s~--~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.... ......+.... .+..+..++..+.+||.+||..||.+||++.++.+.+.
T Consensus 205 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 205 EIGGPAFRIMWAVHNGT--RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp TTCSSHHHHHHHHHTTC--CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhCccHHHHHHHHhcCC--CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 6433 23333333322 23345789999999999999999999999665555544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=398.57 Aligned_cols=260 Identities=20% Similarity=0.350 Sum_probs=222.2
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++.+.||+|+||+||+|+++.++..||+|.+ +... ...+.+.+|+.+|..++|||||++++++..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~-~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEEC-CSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEe-cCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34567788999999999999999999999999999999944 3221 235679999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
...+||||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccccee
Confidence 99999999999999999999864 3589999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
.... .........+|+.|+|||++.+..|+.++|||||||+||||++ |.+||.
T Consensus 368 ~~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 368 MTGD--------------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp CTTC--------------------------CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccCC--------------------------ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence 2100 0011223457889999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
+.+..++...+... ... ..+..+++++.+||.+||..||.+||++.++.+.|+.
T Consensus 422 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 475 (495)
T 1opk_A 422 GIDLSQVYELLEKD-YRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475 (495)
T ss_dssp TCCGGGHHHHHHTT-CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCHHHHHHHHHcC-CCC-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 98888777766543 222 2457899999999999999999999997766666653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=367.92 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=207.7
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECC---CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~---TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+ +. ........+.+.+|+.+|..++||||+++++++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~-~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KL-DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC-----CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEE-ec-cccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 4566899999999999999999998765 4568999954 22 22334556789999999999999999999999887
Q ss_pred CC-----ceEEEEEecCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEE
Q 001354 760 RD-----NLYLVMEYLNGGDLYSLLRK------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 828 (1093)
Q Consensus 760 ~~-----~LyLVMEYm~GGSL~dlL~k------~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VK 828 (1093)
.. ..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 65 35999999999999999953 34699999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHH
Q 001354 829 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 908 (1093)
Q Consensus 829 LsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEM 908 (1093)
|+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||
T Consensus 188 l~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 242 (313)
T 3brb_A 188 VADFGLSKKIYSGD-------------------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242 (313)
T ss_dssp ECSCSCC-----------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHH
T ss_pred EeecCcceeccccc-------------------------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHH
Confidence 99999987431100 00112334678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 909 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 909 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
++ |.+||.+.+...+...+..... +..+..+++++.+||.+||..||.+||++.++.+
T Consensus 243 ~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 243 ATRGMTPYPGVQNHEMYDYLLHGHR--LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCC--CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCccCCHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99 9999999988888888776543 2345789999999999999999999999544433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=362.20 Aligned_cols=257 Identities=20% Similarity=0.270 Sum_probs=209.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCC---cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee-ccCC
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRD 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TG---k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf-qd~~ 761 (1093)
...|++.+.||+|+||.||+|++..++ ..+|+|.+ .. .........+.+|+.+|+.++||||+++++++ ...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~-~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEE-TT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEec-cc--CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 456999999999999999999976433 35888844 32 22345567899999999999999999999984 5566
Q ss_pred ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 899999999999999999764 4589999999999999999999999999999999999999999999999999975311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s 919 (1093)
.. ...........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 181 ~~-----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 181 KE-----------------------YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp GG-----------------------GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cc-----------------------hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 00 001122344578999999999999999999999999999999999 788888888
Q ss_pred hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
..+....+....... .+..+++.+.+||.+||..||.+||++.++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 238 TFDITVYLLQGRRLL--QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp TTTHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 777777776655432 3577899999999999999999999955444433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=364.31 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=201.2
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
...+..++|++.+.||+|+||+||+|++.. .+|+|++ +. ........+.+.+|+.+|+.++||||+++++++ ..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~-~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKML-NV-TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEE-SC-SSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEE-ec-cCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 345778899999999999999999998653 5999944 22 233455667899999999999999999999955 55
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..+++||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 6789999999999999999644 569999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHhCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.. ..........||+.|+|||++. +..++.++|||||||++|||++|..||.
T Consensus 172 ~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 172 RW-------------------------SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp -------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cc-------------------------cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 00 0011223467999999999997 5678899999999999999999999998
Q ss_pred CCChHHHHHHHhc-cCC--CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 917 AESPEIIFDNILN-RKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 917 ~~s~~ei~~kIl~-~~l--~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+.........++. ... .++.....+++++.+||.+||..||.+||++.++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 227 NINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp SCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 8665554444443 322 22234467899999999999999999999955544443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=362.11 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=207.3
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEe-eeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~-gsfqd~~~L 763 (1093)
..++|++.+.||+|+||.||+|++..+|+.||+|++... . ....+.+|+.++..++|++++..+ .++......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-T-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC-S-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC-c-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 357899999999999999999999999999999954322 1 123578999999999987766555 444666788
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE---ccCCcEEEEecCCccccc
Q 001354 764 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL---D~dG~VKLsDFGLAk~~~ 839 (1093)
|+||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 8999999974 4579999999999999999999999999999999999999 588999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
..... ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 160 ~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 160 DARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTC--------------------CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccc--------------------cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 11000 0001112345689999999999999999999999999999999999999998743
Q ss_pred ---hHHHHHHHhccCCCCC--CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 920 ---PEIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 920 ---~~ei~~kIl~~~l~fP--~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
....+..+.......| .++..+++++.+||.+||+.||.+||++.++.+.++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 220 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp CSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred chhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 2334444443322222 1236789999999999999999999997666665543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=376.24 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=201.3
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
..+..++|++++.||+|+||+||+|++. ++.||+|++ +.. .........|+.+|..++|||||++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~-~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF-PIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEE-CGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEe-ecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 3467789999999999999999999886 799999954 321 223345566888999999999999999998855
Q ss_pred ----ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CcEeeecCCCcEEEccCCcE
Q 001354 762 ----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL----------GIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 762 ----~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~----------GIIHRDIKPeNILLD~dG~V 827 (1093)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 37999999999999999976 4599999999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-----CCCccceeecch
Q 001354 828 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVG 902 (1093)
Q Consensus 828 KLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-----~Ys~ksDVWSLG 902 (1093)
||+|||+++..... .........+||+.|+|||++.+. .++.++||||||
T Consensus 171 kL~DFg~a~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 225 (322)
T 3soc_A 171 CIADFGLALKFEAG-------------------------KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225 (322)
T ss_dssp EECCCTTCEEECTT-------------------------SCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred EEccCCcccccccc-------------------------cCccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence 99999999753110 001123346899999999999873 456789999999
Q ss_pred hhHHHHHhCCCCCCCCC----------------hHHHHHHHhccCCCCCCCCC-----CCCHHHHHHHHhhccCCcCCCC
Q 001354 903 IILFEFITGIPPFTAES----------------PEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRL 961 (1093)
Q Consensus 903 VILYEMLTGkpPF~~~s----------------~~ei~~kIl~~~l~fP~ip~-----~IS~eakDLIkrcL~kDP~KRp 961 (1093)
|++|||++|.+||.+.. ...+...+...... |.++. ..++++.+||.+||..||.+||
T Consensus 226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (322)
T 3soc_A 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR-PVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304 (322)
T ss_dssp HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCC-CCccccccccchHHHHHHHHHHHccCChhhCc
Confidence 99999999999997642 22333333333222 22222 2245699999999999999999
Q ss_pred ChhcHHHHH
Q 001354 962 GANGAAEVK 970 (1093)
Q Consensus 962 Ta~~A~EIL 970 (1093)
++.++.+.|
T Consensus 305 s~~ell~~L 313 (322)
T 3soc_A 305 SAGCVGERI 313 (322)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 965554443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=362.40 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=207.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~- 760 (1093)
+.+..++|++.+.||+|+||.||+|++. |+.||+|.+ +. ....+.+.+|+.++..++||||+++++++...
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~-~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KN-----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEEC-CC-----CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEe-cc-----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4567789999999999999999999875 889999944 32 12456789999999999999999999986554
Q ss_pred CceEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~--LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+.+|+||||+++|+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 479999999999999999986543 899999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
. .......||+.|+|||++.+..++.++||||||+++|||++ |.+||..
T Consensus 168 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 168 S------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp --------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred c------------------------------ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 1 01123467899999999999999999999999999999998 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+..+....+..... +..+..+++.+.+||.+||..||.+||++.++.+.+
T Consensus 218 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 218 IPLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp SCGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHhcCCC--CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 888877777765432 234578999999999999999999999966555544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=372.51 Aligned_cols=269 Identities=26% Similarity=0.368 Sum_probs=214.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEE----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec-
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT- 758 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq- 758 (1093)
+..++|++++.||+|+||.||+|++ ..++..||+|++. .. .....+.+.+|+.+|..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~-~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEES-SC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEec-cC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 4567999999999999999999994 6789999999543 22 3345577899999999999999999999886
Q ss_pred -cCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcc
Q 001354 759 -CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836 (1093)
Q Consensus 759 -d~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk 836 (1093)
....+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 455699999999999999999864 569999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
...... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 176 ~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 176 LLPLDK------------------------DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp ECCTTC------------------------SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ecccCC------------------------ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 531100 00112234568999999999999999999999999999999999999997
Q ss_pred CCChH--------------HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 917 AESPE--------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 917 ~~s~~--------------ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
..... ......+..... +..+..+++++.+||.+||..||.+||++.++.+.|+..|.....|.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 232 SPSAEFLRMMGCERDVPALSRLLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp SHHHHHHHHCC----CCHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred cccchhhhhcccccccccHHHHHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 54332 111122222222 22457899999999999999999999998777777877777655444
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=360.21 Aligned_cols=244 Identities=24% Similarity=0.419 Sum_probs=205.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 759 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd------ 759 (1093)
.++|++++.||+|+||.||+|++..+|+.||+|.+... . ..+.+|+.++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-N-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-S-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-c-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 46799999999999999999999999999999955322 1 246789999999999999999998864
Q ss_pred ----------CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcE
Q 001354 760 ----------RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 760 ----------~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~V 827 (1093)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 44589999999999999999754 579999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHH
Q 001354 828 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 828 KLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYE 907 (1093)
||+|||++..... ........||+.|+|||++.+..++.++|||||||++||
T Consensus 162 kl~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 213 (284)
T 2a19_B 162 KIGDFGLVTSLKN----------------------------DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213 (284)
T ss_dssp EECCCTTCEESSC----------------------------CSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHH
T ss_pred EECcchhheeccc----------------------------cccccccCCcccccChhhhccCCCcchhhhHHHHHHHHH
Confidence 9999999875210 011234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 908 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 908 MLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
|++|..||... ......+.... ++..++..+.+||.+||..||.+||+ +.++++|.++
T Consensus 214 l~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~~l~~ 271 (284)
T 2a19_B 214 LLHVCDTAFET--SKFFTDLRDGI-----ISDIFDKKEKTLLQKLLSKKPEDRPN---TSEILRTLTV 271 (284)
T ss_dssp HHSCCSSHHHH--HHHHHHHHTTC-----CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HHhcCCcchhH--HHHHHHhhccc-----ccccCCHHHHHHHHHHccCChhhCcC---HHHHHHHHHH
Confidence 99999998532 23333333322 23678999999999999999999999 7778877654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=376.36 Aligned_cols=271 Identities=18% Similarity=0.201 Sum_probs=207.1
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECC---CCcEEEEEEeehhhhh-------hchhHHHHHHHHHHHHHhcCCCceEEE
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKQVLKKLDM-------IRKNDIERILAERNILITVRNPFVVRF 753 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~---TGk~VAIKkILkK~~~-------~~~~eie~~l~E~~IL~kL~HPNIVkL 753 (1093)
+..++|++.+.||+|+||+||+|++.. ++..+|+|++...... ........+.+|+.++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999987 7889999965432211 111122346788899999999999999
Q ss_pred eeeecc----CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC--cE
Q 001354 754 FYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HI 827 (1093)
Q Consensus 754 ~gsfqd----~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG--~V 827 (1093)
++++.. ...+|+||||+ ||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999888 67899999999 999999998888999999999999999999999999999999999999999887 99
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHH
Q 001354 828 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 828 KLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYE 907 (1093)
||+|||+++........ ...........+||+.|+|||++.+..++.++|||||||+|||
T Consensus 193 kL~Dfg~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 252 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNH--------------------KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252 (345)
T ss_dssp EECCCTTCEESSGGGCC--------------------CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred EEEeCCCceeccccccc--------------------ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 99999999853211100 0001112345689999999999999999999999999999999
Q ss_pred HHhCCCCCCCC--ChHHHHHHHhccCCCCCC------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 908 FITGIPPFTAE--SPEIIFDNILNRKIPWPC------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 908 MLTGkpPF~~~--s~~ei~~kIl~~~l~fP~------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
|++|..||.+. +..............+|. ....++.++.+||.+||..||.+||++.++.+.++...+
T Consensus 253 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 253 WLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 99999999653 222222211111111111 012789999999999999999999998777777765444
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.82 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=212.2
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCC----cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TG----k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
..+..++|++.+.||+|+||+||+|.++.++ ..||+|.+ +.. ........+.+|+.++..++||||+++++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~-~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEE-CTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEc-CCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3567789999999999999999999987654 35999954 321 1334456789999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcc
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk 836 (1093)
...+.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999999865 579999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 915 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF 915 (1093)
...... ..........||+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 196 ~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 251 (333)
T 1mqb_A 196 VLEDDP------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251 (333)
T ss_dssp ---------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred hhcccc------------------------ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCc
Confidence 531100 00011223457889999999999999999999999999999999 99999
Q ss_pred CCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.+.+..++...+..+. ..| .+..++..+.+||.+||..||.+||++.++.+.+
T Consensus 252 ~~~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 252 WELSNHEVMKAINDGF-RLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp TTCCHHHHHHHHHTTC-CCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred ccCCHHHHHHHHHCCC-cCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9998888888776653 222 3578999999999999999999999955544443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=363.97 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=187.8
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeee---
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSF--- 757 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsf--- 757 (1093)
..+...+|++.+.||+|+||.||+|++..+|+.||+|++... .......+.+|+.+|..+. ||||+++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 345566899999999999999999999999999999965332 2344567889999999996 99999999998
Q ss_pred -----ccCCceEEEEEecCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEccCCcE
Q 001354 758 -----TCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHI 827 (1093)
Q Consensus 758 -----qd~~~LyLVMEYm~GGSL~dlL~k---~g~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD~dG~V 827 (1093)
.....+|+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 34456899999996 699998865 456999999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---cCCCCCccceeecchhh
Q 001354 828 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGII 904 (1093)
Q Consensus 828 KLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL---~g~~Ys~ksDVWSLGVI 904 (1093)
||+|||+++........ .+..............+||+.|+|||++ .+..++.++|||||||+
T Consensus 178 kl~Dfg~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDY---------------SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242 (337)
T ss_dssp EBCCCTTCBCCSSCC----------------------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred EEecCccceeccccCcc---------------cccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence 99999999853211000 0000000011123356799999999998 56678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 905 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 905 LYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
+|||++|..||.......+. .....++ .+...+..+.+||.+||..||.+||+ +.++++|
T Consensus 243 l~el~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~ 302 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKLRIV----NGKYSIP-PHDTQYTVFHSLIRAMLQVNPEERLS---IAEVVHQ 302 (337)
T ss_dssp HHHHHHSSCCC----------------CCCC-TTCCSSGGGHHHHHHHSCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhCCCCCcchhHHHhh----cCcccCC-cccccchHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 99999999999876544333 3333333 23567888999999999999999999 5566554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=374.37 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=206.6
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~ 761 (1093)
.....++|++.+.||+|+||.||+|+++ +|..||+|++... .....+.+.+|+.+|..++||||+++++++...+
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 3456789999999999999999999965 6899999954322 2345677899999999999999999999999999
Q ss_pred ceEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g----~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999986543 489999999999999999999999999999999999999999999999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 189 ~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 189 GTEL-------------------------DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp CSSS-------------------------SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred cccc-------------------------cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 2100 001122345799999999999998999999999999999999999999987
Q ss_pred CChHHHH-------HHHhccCCC---CC----CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 918 ESPEIIF-------DNILNRKIP---WP----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 918 ~s~~ei~-------~kIl~~~l~---fP----~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
..+.+.. .......+. -+ .++...+..+.+||.+||..||.+||++ .++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~ 308 (321)
T 2qkw_B 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM---GDVLW 308 (321)
T ss_dssp SSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH---HHHHH
T ss_pred cCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH---HHHHH
Confidence 5442211 111111110 01 1223345678999999999999999994 45544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=382.93 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=204.0
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--c
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--N 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~--~ 762 (1093)
..+.|++.+.||+|+||+||+|+++.+|+.||+|++ +.... ....+.+.+|+.+|..++||||+++++++.... .
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~-~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-CGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEe-ccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 456899999999999999999999999999999954 33222 233567789999999999999999999988765 7
Q ss_pred eEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE----ccCCcEEEEecCCc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 835 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~---LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL----D~dG~VKLsDFGLA 835 (1093)
+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999999976543 9999999999999999999999999999999999999 77888999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--------CCCCccceeecchhhHHH
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--------TEHGYAADWWSVGIILFE 907 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--------~~Ys~ksDVWSLGVILYE 907 (1093)
+.... .......+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 164 ~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~e 215 (396)
T 4eut_A 164 RELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (396)
T ss_dssp EECCC----------------------------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHH
T ss_pred eEccC----------------------------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHH
Confidence 85210 112234679999999999875 567889999999999999
Q ss_pred HHhCCCCCCCC----ChHHHHHHHhccCCC-------------------CC---CCCCCCCHHHHHHHHhhccCCcCCCC
Q 001354 908 FITGIPPFTAE----SPEIIFDNILNRKIP-------------------WP---CVPSDMSFEAQDLINRFLIHDPNQRL 961 (1093)
Q Consensus 908 MLTGkpPF~~~----s~~ei~~kIl~~~l~-------------------fP---~ip~~IS~eakDLIkrcL~kDP~KRp 961 (1093)
|++|..||... ...++...++.+... +| .++..++..+.+||.+||..||.+||
T Consensus 216 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~ 295 (396)
T 4eut_A 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295 (396)
T ss_dssp HHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred HHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc
Confidence 99999999742 334555555544321 11 11233556788999999999999999
Q ss_pred Chh
Q 001354 962 GAN 964 (1093)
Q Consensus 962 Ta~ 964 (1093)
++.
T Consensus 296 s~~ 298 (396)
T 4eut_A 296 GFD 298 (396)
T ss_dssp CHH
T ss_pred cHH
Confidence 954
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=384.31 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=213.6
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++.+.||+|+||+||+|.+.. +..||+|.+ +... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~-~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEC-CTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEe-ccCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3456778899999999999999999999975 466999944 3322 124578999999999999999999999876
Q ss_pred CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 6799999999999999999753 4699999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
.... .........||+.|+|||++.+..++.++|||||||+||||++ |.+||.
T Consensus 330 ~~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 330 IEDN--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp ---------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cCCC--------------------------ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence 3100 0011223457889999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+.+..++...+..+. ..| .+..+++.+.+||.+||..||.+||++.++.+.|+
T Consensus 384 ~~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~ 436 (452)
T 1fmk_A 384 GMVNREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436 (452)
T ss_dssp TCCHHHHHHHHHTTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999888888776542 222 35789999999999999999999999776666554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=380.56 Aligned_cols=255 Identities=28% Similarity=0.393 Sum_probs=195.2
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCceEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~LyL 765 (1093)
+.|.+.+.||+|+||+||.+. ..+|+.||+|++... ..+.+.+|+.+|..+ +|||||++++++.+...+|+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 445667889999999998754 457999999965322 234578899999876 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-------------C
Q 001354 766 VMEYLNGGDLYSLLRKVGCLE-------EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-------------G 825 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~Ls-------Ee~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-------------G 825 (1093)
||||+. |+|.+++....... +..+..++.||+.||.|||++||+||||||+||||+.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999996 59999998654332 23456799999999999999999999999999999754 4
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCcccee
Q 001354 826 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADW 898 (1093)
Q Consensus 826 ~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Ys~ksDV 898 (1093)
++||+|||+++....... .........+||+.|+|||++.+ ..++.++||
T Consensus 166 ~~kL~DFG~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 222 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQS-----------------------SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222 (434)
T ss_dssp EEEECCCTTCEECCC-------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred EEEEcccccceecCCCCc-----------------------cceeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence 899999999985311000 00111235689999999999976 678999999
Q ss_pred ecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCC----CCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 899 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVP----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 899 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip----~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
|||||++|||++ |.+||.+....+ ..++.....++..+ ..+++++.+||.+||+.||.+||+ +.++++||
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~hp 297 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT---AMKVLRHP 297 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC---HHHHHTSG
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC---HHHHHhCC
Confidence 999999999999 999998765443 34444444433221 234688999999999999999999 88999999
Q ss_pred CCCCC
Q 001354 974 FFKGV 978 (1093)
Q Consensus 974 FFkgI 978 (1093)
||...
T Consensus 298 ~f~~~ 302 (434)
T 2rio_A 298 LFWPK 302 (434)
T ss_dssp GGSCH
T ss_pred ccCCc
Confidence 99753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=366.09 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=205.2
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.......++|++.+.||+|+||.||+|+.. +|+.||+|++... .. ......+.+|+.++..++||||+++++++.+
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEE-RT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccc-cC--chHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 344567889999999999999999999854 6899999954322 11 1122358899999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc---CcEeeecCCCcEEEccCCcEEEEec
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g----~LsEe~ar~yaaQIl~ALeYLHs~---GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
....|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999998653 399999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCC
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
|+++.... .........+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 179 g~~~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (326)
T 3uim_A 179 GLAKLMDY--------------------------KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232 (326)
T ss_dssp SSCEECCS--------------------------SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCC
T ss_pred ccccccCc--------------------------ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCC
Confidence 99985310 0111233456999999999999888999999999999999999999
Q ss_pred CCCCCC-----Ch---HHHHHHHhccC-CC---C----CCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 913 PPFTAE-----SP---EIIFDNILNRK-IP---W----PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 913 pPF~~~-----s~---~ei~~kIl~~~-l~---f----P~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
.||... .. ........... .. - +..+...+..+.+||.+||..||.+||++.++.+.|+-
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred CcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 999521 11 11111111110 00 0 01112334779999999999999999995555554443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=362.55 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=189.6
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHH--HhcCCCceEEEeeee-
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL--ITVRNPFVVRFFYSF- 757 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL--~kL~HPNIVkL~gsf- 757 (1093)
...+.+++|++++.||+|+||.||+|+. +++.||+|++ ... ....+..|..++ ..++||||+++++.+
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~-~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVF-SFA------NRQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEE-EGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEe-ecc------chhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 3457789999999999999999999977 5899999954 221 123344455554 458899999998743
Q ss_pred ----ccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcEeeecCCCcEEEccC
Q 001354 758 ----TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHD 824 (1093)
Q Consensus 758 ----qd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~---------GIIHRDIKPeNILLD~d 824 (1093)
.....+|+||||+++|+|.+++.... +++..+..++.||+.||.|||+. ||+||||||+||||+.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 33346899999999999999997654 58899999999999999999999 99999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccce
Q 001354 825 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAAD 897 (1093)
Q Consensus 825 G~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Ys~ksD 897 (1093)
|.+||+|||+++......... ...........+||+.|+|||++.+ ..++.++|
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~-------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 217 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVR-------------------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC----------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred CcEEEeeccceeecccccccC-------------------ccccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence 999999999998532110000 0011122345689999999999987 35667899
Q ss_pred eecchhhHHHHHhCCCCCCCC-C----------------hHHHHHHHhccCCCCCCCCCC------CCHHHHHHHHhhcc
Q 001354 898 WWSVGIILFEFITGIPPFTAE-S----------------PEIIFDNILNRKIPWPCVPSD------MSFEAQDLINRFLI 954 (1093)
Q Consensus 898 VWSLGVILYEMLTGkpPF~~~-s----------------~~ei~~kIl~~~l~fP~ip~~------IS~eakDLIkrcL~ 954 (1093)
||||||+||||++|..||... . .......+.......|.++.. +++++.+||.+||.
T Consensus 218 iwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (336)
T 3g2f_A 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297 (336)
T ss_dssp HHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhc
Confidence 999999999999997665432 1 111122222222222333333 34589999999999
Q ss_pred CCcCCCCChhcHHH
Q 001354 955 HDPNQRLGANGAAE 968 (1093)
Q Consensus 955 kDP~KRpTa~~A~E 968 (1093)
.||.+||++.++.+
T Consensus 298 ~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 298 QDAEARLTAQXAEE 311 (336)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcchHHHHH
Confidence 99999999554433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=369.65 Aligned_cols=243 Identities=15% Similarity=0.207 Sum_probs=197.9
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEE-----EECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC---CCceEE
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLA-----RKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR---NPFVVR 752 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVyla-----r~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~---HPNIVk 752 (1093)
...+..++|.+.+.||+|+||+||+| ....+++.||+|++ +. .....+..|..++..++ |+||++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~-~~------~~~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-KP------ANPWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEE-SS------CCHHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEe-CC------CChhHHHHHHHHHHHhhhhhhhhhhh
Confidence 44567789999999999999999999 46778999999944 32 12345777888888887 999999
Q ss_pred EeeeeccCCceEEEEEecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc----
Q 001354 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---- 823 (1093)
Q Consensus 753 L~gsfqd~~~LyLVMEYm~GGSL~dlL~k-----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---- 823 (1093)
+++++...+..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001354 824 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 896 (1093)
Q Consensus 824 -------dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 896 (1093)
++.+||+|||+|+..... .........+||+.|||||++.+..|+.++
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 266 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLF-------------------------PKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGS-------------------------CTTEEECCSSCTTSCCCHHHHTTCCBSTHH
T ss_pred ccccccccCCEEEeeCchhhhhhcc-------------------------CCCceeeeecCCCCCCChHHhcCCCCCccc
Confidence 899999999999742100 011223457899999999999999999999
Q ss_pred eeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q 001354 897 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 897 DVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
|||||||+||||++|+.||....... ......++. ...++...+++..||+.+|.+|+.
T Consensus 267 DiwslG~il~elltg~~pf~~~~~~~-----~~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 267 DYFGVAATVYCMLFGTYMKVKNEGGE-----CKPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHHHHHHHHHHHSSCCCEEEETTE-----EEECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred cHHHHHHHHHHHHhCCCccccCCCCc-----eeechhccc--cCcHHHHHHHHHHHcCCCCCCcch
Confidence 99999999999999999996543211 011111221 234678999999999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=400.41 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=216.8
Q ss_pred cccCCCeeEEE-eeeccCCeEEEEEEEC--CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIK-PISRGAFGRVFLARKR--TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr-~LGkG~FGeVylar~k--~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
.+..+++.+.+ .||+|+||+||+|.++ .++..||+|++ ++. ......+.+.+|+.+|..++|||||++++++..
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~-~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEEC-CCC--CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEc-CCC--CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 34556777777 8999999999999876 35667999944 332 223456789999999999999999999999976
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5699999999999999999754 45999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
..... .........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+
T Consensus 487 ~~~~~------------------------~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 487 GADDS------------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp C--------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCCc------------------------eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 11000 0011123456789999999999999999999999999999998 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
.+..++...|..+.. +..+..+++++.+||.+||..||.+||++.++.+.|++.|+
T Consensus 543 ~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 543 MKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp CCSHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 998888888876542 23457899999999999999999999998888777777655
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=387.91 Aligned_cols=262 Identities=25% Similarity=0.343 Sum_probs=202.4
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~ 762 (1093)
+...+|++.+.||+|+||+|+. ....+|+.||||++.... ...+.+|+.+|+.+ +|||||++++++.+...
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-------FSFADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 4455799999999999999764 334578999999653321 12346799999999 79999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---C--CcEEEEecCCcc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---D--GHIKLTDFGLSK 836 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---d--G~VKLsDFGLAk 836 (1093)
+|+||||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+. + ..+||+|||+|+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 999999996 59999998654 4666677889999999999999999999999999999953 2 358899999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeecchhhHHHHHh-CC
Q 001354 837 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT-GI 912 (1093)
Q Consensus 837 ~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDVWSLGVILYEMLT-Gk 912 (1093)
...... .........+||+.|+|||++. +..++.++|||||||++|||++ |.
T Consensus 172 ~~~~~~------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 172 KLAVGR------------------------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp CC------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred eccCCC------------------------cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 531100 0011234568999999999998 4567889999999999999999 99
Q ss_pred CCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 913 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 913 pPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
+||...........+..........+...+..+.+||.+||+.||.+||+ +.++++||||.+++|.
T Consensus 228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 228 HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS---AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp BTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC---HHHHHTSTTTCCHHHH
T ss_pred CCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCC---HHHHHhCccccChHHH
Confidence 99977655544433322222222222345667899999999999999999 8899999999998884
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=370.02 Aligned_cols=256 Identities=18% Similarity=0.209 Sum_probs=201.3
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCC--------CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEE----
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTT--------GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVR---- 752 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~T--------Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVk---- 752 (1093)
..++|++.+.||+|+||.||+|+++.+ ++.||+|.+. +. ..+.+|+.++..++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~-~~--------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA-KD--------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEE-TT--------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEec-cc--------chHHHHHHHHHHhcccchhhhhhh
Confidence 357999999999999999999999874 8899999543 21 35789999999999999988
Q ss_pred -----------Eeeeecc-CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCc
Q 001354 753 -----------FFYSFTC-RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 818 (1093)
Q Consensus 753 -----------L~gsfqd-~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeN 818 (1093)
+++++.. ...+|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 4555554 67899999999 99999999876 679999999999999999999999999999999999
Q ss_pred EEEccCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001354 819 LLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 896 (1093)
Q Consensus 819 ILLD~dG--~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 896 (1093)
||++.++ .+||+|||+++........ ............||+.|+|||++.+..++.++
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 249 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKH--------------------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS 249 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCC--------------------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHH
T ss_pred EEEcCCCCceEEEecCcceeeccCCCcc--------------------ccccccccccccCCccccCHHHHccCCCCchh
Confidence 9999998 9999999999853211000 00001122345899999999999999999999
Q ss_pred eeecchhhHHHHHhCCCCCCCCC--hHHHHHHHh---ccCCCCCC---CCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 897 DWWSVGIILFEFITGIPPFTAES--PEIIFDNIL---NRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 897 DVWSLGVILYEMLTGkpPF~~~s--~~ei~~kIl---~~~l~fP~---ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
|||||||+||||++|..||.... ...+...+. .....++. ....+++++.+||.+||..||.+||++.++.+
T Consensus 250 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 250 DLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 99999999999999999998764 333332222 22222111 01257899999999999999999999655544
Q ss_pred HH
Q 001354 969 VK 970 (1093)
Q Consensus 969 IL 970 (1093)
.+
T Consensus 330 ~L 331 (352)
T 2jii_A 330 NL 331 (352)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.02 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=200.6
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEec
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
..+.||+|+||.||+|.+ ++..||+|++............+.+.+|+.+|..++||||+++++++.+.+.+|+||||+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 347899999999999986 588999996544333333455678999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 771 NGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 771 ~GGSL~dlL~k~---g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 186 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF------ 186 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC------
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc------
Confidence 999999999743 45899999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH----H
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----I 923 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e----i 923 (1093)
.........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||....... +
T Consensus 187 -------------------~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 187 -------------------AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp -------------------SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred -------------------cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 00112234679999999999875 48899999999999999999999998755332 2
Q ss_pred HHHHhccCC--------CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 924 FDNILNRKI--------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 924 ~~kIl~~~l--------~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
...+..... .++..+...+..+.+||.+||..||.+||++.++.+.|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 222211111 11222344567899999999999999999955444443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.95 Aligned_cols=262 Identities=22% Similarity=0.364 Sum_probs=204.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec----
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT---- 758 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq---- 758 (1093)
.+..++|++++.||+|+||.||+|+++.+|+.||+|++... .......+.+|+.++..++||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 45667899999999999999999999999999999955322 2345677899999999999999999999987
Q ss_pred cCCceEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCC
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
....+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 34578999999999999999976 35699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccceeecchhhHHHHHhC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Ys~ksDVWSLGVILYEMLTG 911 (1093)
+........ ...............||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 181 ~~~~~~~~~------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 242 (317)
T 2buj_A 181 MNQACIHVE------------------GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242 (317)
T ss_dssp CEESCEEEE------------------SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHS
T ss_pred chhcccccc------------------cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhC
Confidence 874210000 000000001112456899999999998654 68899999999999999999
Q ss_pred CCCCCCCC--hHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 912 IPPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 912 kpPF~~~s--~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
..||.... .......+ .....+|. +..++.++.+||.+||..||.+||+ +.++++
T Consensus 243 ~~p~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~ 299 (317)
T 2buj_A 243 EGPYDMVFQKGDSVALAV-QNQLSIPQ-SPRHSSALWQLLNSMMTVDPHQRPH---IPLLLS 299 (317)
T ss_dssp SCTTHHHHHTTSCHHHHH-HCC--CCC-CTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred CCChhhhhcccchhhHHh-hccCCCCc-cccCCHHHHHHHHHHhhcChhhCCC---HHHHHH
Confidence 99995421 11122222 22333332 4678999999999999999999999 445554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=358.96 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=194.8
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc--CCCceEEEeeeeccC
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFFYSFTCR 760 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL--~HPNIVkL~gsfqd~ 760 (1093)
....++|++++.||+|+||.||+|++. |+.||+|++... .......|..++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 445678999999999999999999886 899999955321 223445566666554 899999999998887
Q ss_pred ----CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeeecCCCcEEEccCCcEE
Q 001354 761 ----DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIK 828 (1093)
Q Consensus 761 ----~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~--------GIIHRDIKPeNILLD~dG~VK 828 (1093)
..+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+||||+.++.+|
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 6799999999999999999654 699999999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc------ceeecch
Q 001354 829 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA------ADWWSVG 902 (1093)
Q Consensus 829 LsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k------sDVWSLG 902 (1093)
|+|||+++....... .........+||+.|+|||++.+..++.. +||||||
T Consensus 183 l~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 239 (337)
T 3mdy_A 183 IADLGLAVKFISDTN-----------------------EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239 (337)
T ss_dssp ECCCTTCEECC--------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHH
T ss_pred EEeCCCceeeccccc-----------------------cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHH
Confidence 999999975311000 00111235689999999999988776655 9999999
Q ss_pred hhHHHHHhC----------CCCCCCCCh-----HHHHHHHhccCCCCCCCCC-----CCCHHHHHHHHhhccCCcCCCCC
Q 001354 903 IILFEFITG----------IPPFTAESP-----EIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 903 VILYEMLTG----------kpPF~~~s~-----~ei~~kIl~~~l~fP~ip~-----~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
|++|||++| ..||....+ ......+...... +.++. .+++++.+||.+||..||.+||+
T Consensus 240 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (337)
T 3mdy_A 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR-PSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318 (337)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccC-ccccccchhhHHHHHHHHHHHHhhhhChhhCCC
Confidence 999999999 777765321 2222222222222 22222 45677999999999999999999
Q ss_pred hhcHHH
Q 001354 963 ANGAAE 968 (1093)
Q Consensus 963 a~~A~E 968 (1093)
+.++.+
T Consensus 319 ~~ell~ 324 (337)
T 3mdy_A 319 ALRVKK 324 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 444333
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=376.36 Aligned_cols=255 Identities=20% Similarity=0.273 Sum_probs=201.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCC---cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec-cCCc
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDN 762 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TG---k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq-d~~~ 762 (1093)
..|++.+.||+|+||+||+|++..++ ..||+|.+ +. .......+.+.+|+.+|..++||||+++++++. ..+.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~-~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEEC-CS--CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEc-CC--CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 45889999999999999999986443 46888843 32 223455678999999999999999999999854 4568
Q ss_pred eEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
.|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 89999999999999999865 45889999999999999999999999999999999999999999999999999843110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCCh
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~ 920 (1093)
.. ..........||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.+.
T Consensus 246 ~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 246 EF-----------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp -----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred cc-----------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 00 00112234568899999999999999999999999999999999 7899988877
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
.++...+..+... ..+..++..+.+||.+||..||.+||++.++.+.
T Consensus 303 ~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 303 FDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp SCHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7777776665432 2357899999999999999999999995544443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=398.78 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=211.3
Q ss_pred CCeeEE-EeeeccCCeEEEEEEE--CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 687 DDFEII-KPISRGAFGRVFLARK--RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 687 ddFeil-r~LGkG~FGeVylar~--k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+.+. +.||+|+||+||+|.+ +.+++.||+|++ +.. .......+.+.+|+.+|..++|||||++++++.. +.+
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~-~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNE-ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 444 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEE-CGG-GGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEe-ccc-cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCE
Confidence 334443 4899999999999955 456789999944 332 2334456789999999999999999999999865 468
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||+++|+|.+++.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~- 523 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE- 523 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999998532100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~e 922 (1093)
..........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..+
T Consensus 524 -----------------------~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 580 (635)
T 4fl3_A 524 -----------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580 (635)
T ss_dssp ----------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred -----------------------cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 00111223457899999999999999999999999999999998 999999999988
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+...+..+.. +..+..+++++.+||.+||..||.+||++.++.+.|+
T Consensus 581 ~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 581 VTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp HHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 8888776543 2345789999999999999999999999776666654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=365.54 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=212.7
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++.+.||+|+||.||+|++.. .+|+|++. .. .......+.+.+|+.++..++||||+++++++.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~-~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLID-IE-RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECC-CC-SCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEee-cC-CCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 4566888999999999999999999999864 48999542 22 1222334557789999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++..
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999998755 699999999999999999999999999999999999998 789999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---------CCCCccceeecchhhHHHHH
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---------TEHGYAADWWSVGIILFEFI 909 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---------~~Ys~ksDVWSLGVILYEML 909 (1093)
..... ...........||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 180 ~~~~~----------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 237 (319)
T 2y4i_B 180 GVLQA----------------------GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237 (319)
T ss_dssp ------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred ccccc----------------------cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence 10000 001122334579999999999975 45788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 910 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 910 TGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+|..||...+.......+.....+.. .+..++.++.+||.+||..||.+||++.++.+.++
T Consensus 238 ~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 238 AREWPFKTQPAEAIIWQMGTGMKPNL-SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp HSSCSSSSCCHHHHHHHHHTTCCCCC-CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred hCCCCCCCCCHHHHHHHhccCCCCCC-CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 99999999988888877766544322 23468899999999999999999999666655554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=388.12 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=217.4
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++.+.||+|+||+||+|.+.. +..||+|++ +... ...+.+++|+.+|+.++|||||++++++..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~-~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEE-CTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEe-CCCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3456778899999999999999999999975 466999954 3322 124578999999999999999999999876
Q ss_pred CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+.+||||||+++|+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 6799999999999999999753 4699999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
.... .........+|+.|+|||++.+..|+.++|||||||+||||++ |..||.
T Consensus 413 ~~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~ 466 (535)
T 2h8h_A 413 IEDN--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466 (535)
T ss_dssp CCCH--------------------------HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSST
T ss_pred cCCC--------------------------ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2110 0011223457889999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
+....++...+..+. .++ .+..++.++.+||.+||..||.+||++.++.+.|+
T Consensus 467 ~~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 467 GMVNREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519 (535)
T ss_dssp TCCHHHHHHHHHTTC-CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999888888776542 222 35789999999999999999999999776666664
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=360.84 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=204.3
Q ss_pred CCeeEEEeeeccCCeEEEEEEEC----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--
Q 001354 687 DDFEIIKPISRGAFGRVFLARKR----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 760 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~-- 760 (1093)
..|++++.||+|+||+||++.++ .+++.||+|++. .. ........+.+|+.+|..++||||+++++++.+.
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~-~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-AD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEEC-TT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEec-cc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34599999999999999888653 478899999543 22 2334567789999999999999999999999874
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..+|+||||+++|+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 5789999999999999999764 499999999999999999999999999999999999999999999999999985311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
.. ..........||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 187 ~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 187 GH------------------------EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp TC------------------------SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred cc------------------------cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence 00 001122345688999999999998999999999999999999999999976432
Q ss_pred HH--------------HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 921 EI--------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 921 ~e--------------i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.. .....+..... +..+..+++++.+||.+||..||.+||++.++.+.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhhhhcccccchhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 10 11122222222 234578999999999999999999999966555544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=384.85 Aligned_cols=275 Identities=22% Similarity=0.309 Sum_probs=219.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNIVkL~gsfqd~~~L 763 (1093)
..++|++++.||+|+||.||+|++..+++.||||++ ..... ...+..|+.++..+.| ++|+.+..++......
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~-~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE-NVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEE-ETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEe-ccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 457899999999999999999999999999999944 22211 1347889999999986 5666677777788889
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEE---ccCCcEEEEecCCccccc
Q 001354 764 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILL---D~dG~VKLsDFGLAk~~~ 839 (1093)
||||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8999999985 4579999999999999999999999999999999999999 688999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
..... ...........+||+.|+|||++.+..++.++|||||||+||||++|..||.+..
T Consensus 158 ~~~~~--------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 158 DTSTH--------------------QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp CTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCccc--------------------cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 11000 0001112346789999999999999999999999999999999999999998754
Q ss_pred h---HHHHHHHhccCCC--CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH-------HcCCCCCCCCcchhhcc
Q 001354 920 P---EIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-------KAHPFFKGVNWDSLALQ 986 (1093)
Q Consensus 920 ~---~ei~~kIl~~~l~--fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI-------L~HPFFkgIdWd~L~~~ 986 (1093)
. ...+..+...... .+.+...++.++.+||.+||..||.+||++.++.++ +.++|+..++|+.+...
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 218 AGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp CSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred chhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 3 3444444432221 111235788999999999999999999996544443 45899999999987654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=379.54 Aligned_cols=249 Identities=20% Similarity=0.272 Sum_probs=194.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh----hchhHHHHHHHHHHHHHhcC---------C---
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM----IRKNDIERILAERNILITVR---------N--- 747 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~----~~~~eie~~l~E~~IL~kL~---------H--- 747 (1093)
+..++|++++.||+|+||+||+|++ +|+.||+|++...... ......+.+.+|+.+|+.++ |
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4567899999999999999999998 6899999965433211 12334477889999998886 4
Q ss_pred --------------CceEEEeeeecc-------------CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 001354 748 --------------PFVVRFFYSFTC-------------RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800 (1093)
Q Consensus 748 --------------PNIVkL~gsfqd-------------~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~A 800 (1093)
|||++++++|.+ ...+||||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 555555555554 6789999999999987776644 568999999999999999
Q ss_pred HHHHH-hcCcEeeecCCCcEEEccCC--------------------cEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001354 801 LEYLH-SLGIVHRDLKPDNLLIAHDG--------------------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 859 (1093)
Q Consensus 801 LeYLH-s~GIIHRDIKPeNILLD~dG--------------------~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~ 859 (1093)
|.||| ++|||||||||+||||+.+| .+||+|||+|+...
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-------------------- 233 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-------------------- 233 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE--------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC--------------------
Confidence 99999 99999999999999999987 99999999998521
Q ss_pred CCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhh-HHHHHhCCCCCCCCCh-HHHHHHHhcc-CC---C
Q 001354 860 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII-LFEFITGIPPFTAESP-EIIFDNILNR-KI---P 933 (1093)
Q Consensus 860 ~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVI-LYEMLTGkpPF~~~s~-~ei~~kIl~~-~l---~ 933 (1093)
....+||+.|||||++.+.. +.++||||||++ .++++.|..||.+... ......+... .. .
T Consensus 234 ------------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 300 (336)
T 2vuw_A 234 ------------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300 (336)
T ss_dssp ------------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCC
T ss_pred ------------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCccc
Confidence 11358999999999999776 899999998776 7889999999954321 2233333321 11 1
Q ss_pred CCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH-cCCCCC
Q 001354 934 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-AHPFFK 976 (1093)
Q Consensus 934 fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL-~HPFFk 976 (1093)
.+..+..+++++++||.+||++| | |.++| +||||+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----s---a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----S---ATDLLCQHSLFK 336 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----S---HHHHHHHCGGGC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----C---HHHHHhcCCCcC
Confidence 11112357889999999999976 5 88999 999995
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.81 Aligned_cols=234 Identities=31% Similarity=0.542 Sum_probs=191.8
Q ss_pred cccCCCeeEE-EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHH-HhcCCCceEEEeeeecc-
Q 001354 683 RTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTC- 759 (1093)
Q Consensus 683 ~isiddFeil-r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL-~kL~HPNIVkL~gsfqd- 759 (1093)
...+++|.++ +.||+|+||.||+|.++.+++.||+|++ +. ...+.+|+.++ +..+||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QD--------CPKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE-EC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEe-cc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 4567889998 7899999999999999999999999954 22 13456788887 56689999999999887
Q ss_pred ---CCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CCcEEEEe
Q 001354 760 ---RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTD 831 (1093)
Q Consensus 760 ---~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG~VKLsD 831 (1093)
...+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 678999999999999999998764 6999999999999999999999999999999999999998 78999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhC
Q 001354 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 832 FGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
||++... .+..|+.++|||||||++|||++|
T Consensus 164 fg~a~~~-------------------------------------------------~~~~~~~~~DiwslG~il~el~tg 194 (299)
T 3m2w_A 164 FGFAKET-------------------------------------------------TGEKYDKSCDMWSLGVIMYILLCG 194 (299)
T ss_dssp CTTCEEC-------------------------------------------------TTCGGGGHHHHHHHHHHHHHHHHS
T ss_pred ccccccc-------------------------------------------------ccccCCchhhHHHHHHHHHHHHHC
Confidence 9998741 013477899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhc----cCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 912 IPPFTAESPEIIFDNILN----RKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 912 kpPF~~~s~~ei~~kIl~----~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.+||.+.+.......+.. ....+|. ....+++++.+||.+||..||.+||+ +.++++||||++
T Consensus 195 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~e~l~hp~~~~ 262 (299)
T 3m2w_A 195 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 262 (299)
T ss_dssp SCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHT
T ss_pred CCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCC---HHHHhcChhhcc
Confidence 999987765443322221 2222221 01468999999999999999999999 889999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.62 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=206.7
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEE----CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~----k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
.+..++|++++.||+|+||.||+|++ ..+|+.||+|++. . ......+.+.+|+.+|..++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~-~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-H---STEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEES-S---CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEec-c---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 45567899999999999999999994 5689999999543 2 23345678999999999999999999999887
Q ss_pred cCC--ceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 759 CRD--NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 759 d~~--~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
..+ .+|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 654 789999999999999999876 45999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
+...... ..........||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 193 ~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~ 248 (326)
T 2w1i_A 193 KVLPQDK------------------------EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 248 (326)
T ss_dssp EECCSSC------------------------SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred hhccccc------------------------cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence 8531100 0001122346788899999999988999999999999999999999998
Q ss_pred CCCChH------------HH---HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 916 TAESPE------------II---FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 916 ~~~s~~------------ei---~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
...... .. ....+......+ .+..+++++.+||.+||..||.+||++.++.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 249 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp GSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 643110 11 111222222222 357899999999999999999999995544443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.87 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=199.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHh--cCCCceEEEeeeeccCC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD 761 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~k--L~HPNIVkL~gsfqd~~ 761 (1093)
...++|++.+.||+|+||.||+|++ +|+.||+|++ .. .....+.+|..++.. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~-~~------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF-SS------REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEE-CG------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEe-Cc------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3457899999999999999999998 4899999954 22 223567789999887 78999999999998876
Q ss_pred ----ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcEeeecCCCcEEEccCCcEEE
Q 001354 762 ----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------SLGIVHRDLKPDNLLIAHDGHIKL 829 (1093)
Q Consensus 762 ----~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLH--------s~GIIHRDIKPeNILLD~dG~VKL 829 (1093)
.+|+||||+++|+|.+++.+ ..+++..++.++.||+.||.||| +.||+||||||+||||+.++.+||
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred CccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 79999999999999999976 46899999999999999999999 899999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC------CCccceeecchh
Q 001354 830 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGI 903 (1093)
Q Consensus 830 sDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~------Ys~ksDVWSLGV 903 (1093)
+|||+++....... .........+||+.|+|||++.+.. ++.++|||||||
T Consensus 189 ~Dfg~~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 189 ADLGLAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245 (342)
T ss_dssp CCCTTCEEEETTTT-----------------------EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred EECCCceecccccc-----------------------ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence 99999975321000 0001234568999999999998752 346899999999
Q ss_pred hHHHHHhC----------CCCCCCCC-----hHHHHHHHhccCCCCCCCCC-----CCCHHHHHHHHhhccCCcCCCCCh
Q 001354 904 ILFEFITG----------IPPFTAES-----PEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLGA 963 (1093)
Q Consensus 904 ILYEMLTG----------kpPF~~~s-----~~ei~~kIl~~~l~fP~ip~-----~IS~eakDLIkrcL~kDP~KRpTa 963 (1093)
++|||++| ..||.... ...+...+...... |.++. ..+..+.+||.+||..||.+||++
T Consensus 246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 324 (342)
T 1b6c_B 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324 (342)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC-CCCcccccchhHHHHHHHHHHHHhccChhhCCCH
Confidence 99999999 78997653 24444444444332 22222 334678999999999999999995
Q ss_pred hcHHH
Q 001354 964 NGAAE 968 (1093)
Q Consensus 964 ~~A~E 968 (1093)
.++.+
T Consensus 325 ~~i~~ 329 (342)
T 1b6c_B 325 LRIKK 329 (342)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=377.67 Aligned_cols=253 Identities=17% Similarity=0.175 Sum_probs=197.5
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-Cce------------
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFV------------ 750 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNI------------ 750 (1093)
.....|...+.||+|+||+||+|++..+|+.||||+ ++..........+.+.+|..++..+.| +++
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~-~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHV-PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEE-ECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEE-EecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 345678999999999999999999999999999994 432222333446778899999998876 211
Q ss_pred ---EE------Eeeeecc-----CCceEEEEEecCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 001354 751 ---VR------FFYSFTC-----RDNLYLVMEYLNGGDLYSLLRK-------VGCLEEDVARIYIAELVLALEYLHSLGI 809 (1093)
Q Consensus 751 ---Vk------L~gsfqd-----~~~LyLVMEYm~GGSL~dlL~k-------~g~LsEe~ar~yaaQIl~ALeYLHs~GI 809 (1093)
+. ++..+.. ...++++|+++ +|+|.+++.. ...+++..+..++.||+.||.|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 11 1111111 12467777765 6799999852 2347778888888999999999999999
Q ss_pred EeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh--
Q 001354 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-- 887 (1093)
Q Consensus 810 IHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL-- 887 (1093)
|||||||+||||+.+|.+||+|||+++... ......+| +.|||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~g-~~y~aPE~~~~ 281 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------------------------------ASAVSPIG-RGFAPPETTAE 281 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT------------------------------EEECCCCC-TTTCCHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecC------------------------------CccccCCC-CceeCchhhhc
Confidence 999999999999999999999999987421 11345678 999999999
Q ss_pred --------cCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCC
Q 001354 888 --------LGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 888 --------~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~K 959 (1093)
.+..|+.++|||||||+||||++|+.||.+.+.......++... ..+++++.+||.+||..||.+
T Consensus 282 ~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dP~~ 354 (413)
T 3dzo_A 282 RMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC-------KNIPQPVRALLEGFLRYPKED 354 (413)
T ss_dssp HTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSC-------CCCCHHHHHHHHHHTCSSGGG
T ss_pred cccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhc-------ccCCHHHHHHHHHHccCChhh
Confidence 55568889999999999999999999999887666555554422 357899999999999999999
Q ss_pred CCChhcHHHHHcCCCCCCCC
Q 001354 960 RLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFkgId 979 (1093)
||+ +.++++||||+.+.
T Consensus 355 Rpt---~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 355 RLL---PLQAMETPEYEQLR 371 (413)
T ss_dssp SCC---HHHHTTSHHHHHHH
T ss_pred CcC---HHHHHhCHHHHHHH
Confidence 999 88999999998653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=387.31 Aligned_cols=256 Identities=24% Similarity=0.340 Sum_probs=212.3
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCC---CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~T---Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
..+..++|++.+.||+|+||+||+|.+..+ +..+|+|.+ +.. ......+.+.+|+.+|..++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~-~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEEC-SST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEe-ccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 345668899999999999999999998754 457899943 221 23344578999999999999999999999985
Q ss_pred cCCceEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+.+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 456899999999999999998654 689999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
.... .........||+.|||||++.+..|+.++|||||||+||||++ |.+||.
T Consensus 541 ~~~~--------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 541 MEDS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp CCC------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCC--------------------------cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 2100 0011223467889999999999999999999999999999997 999999
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHH
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EI 969 (1093)
+.+..++...+..+.. +..+..+++.+.+||.+||..||.+||++.++.+.
T Consensus 595 ~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 595 GVKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp TCCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9998888888876543 22457899999999999999999999995544443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=393.77 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=207.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC---- 759 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd---- 759 (1093)
...++|++.+.||+|+||.||+|.++.+|+.||+|++ +.. ........+.+|+.+|..++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi-~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCC-CSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEe-ccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 4568999999999999999999999999999999944 321 234556789999999999999999999998776
Q ss_pred --CCceEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCc---EEEEe
Q 001354 760 --RDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTD 831 (1093)
Q Consensus 760 --~~~LyLVMEYm~GGSL~dlL~k~g---~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~---VKLsD 831 (1093)
.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|. +||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 667899999999999999998754 5999999999999999999999999999999999999997765 99999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhC
Q 001354 832 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911 (1093)
Q Consensus 832 FGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTG 911 (1093)
||+++... ........+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 168 FG~a~~~~----------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG 219 (676)
T 3qa8_A 168 LGYAKELD----------------------------QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219 (676)
T ss_dssp CCCCCBTT----------------------------SCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSS
T ss_pred cccccccc----------------------------cccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHC
Confidence 99997421 01122346899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHH--------------HHhccCCCCCC-------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 912 IPPFTAESPEIIFD--------------NILNRKIPWPC-------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 912 kpPF~~~s~~ei~~--------------kIl~~~l~fP~-------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
..||.+........ ....+...++. +...+++.+.+||.+||..||.+||+ +.+++
T Consensus 220 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT---a~elL 296 (676)
T 3qa8_A 220 FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT---DPQNP 296 (676)
T ss_dssp CSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C---CTTCC
T ss_pred CCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC---HHHHh
Confidence 99997653322110 01112222211 22346789999999999999999999 66889
Q ss_pred cCCCCCCC
Q 001354 971 AHPFFKGV 978 (1093)
Q Consensus 971 ~HPFFkgI 978 (1093)
+||||+.+
T Consensus 297 ~hp~F~~l 304 (676)
T 3qa8_A 297 NVGCFQAL 304 (676)
T ss_dssp CCTTHHHH
T ss_pred cCHHHHHH
Confidence 99999863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.06 Aligned_cols=229 Identities=15% Similarity=0.154 Sum_probs=187.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..+.|++.+.||+|+||.||+|++..+|+.||+|++ .............+.+|..++..++||||+++++++.+.+.+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFV-DPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEES-CTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEE-CcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence 4457899999999999999999999999999999944 433333345567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|.+++.+ + ..+..+..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999999954 3 4566788899999999999999999999999999999999999987544
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
|++ .++.++|||||||+||||++|+.||.+.+....
T Consensus 175 -------------------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~ 210 (286)
T 3uqc_A 175 -------------------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210 (286)
T ss_dssp -------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC
T ss_pred -------------------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh
Confidence 233 278899999999999999999999998765432
Q ss_pred HH---HHhccCCCCC-CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 924 FD---NILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 924 ~~---kIl~~~l~fP-~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
.. ++.......+ .....+++++.+||.+||..||.+| ++.++.+.|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 211 LAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp SEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred hHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 21 1112222111 1236789999999999999999999 955444433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=379.50 Aligned_cols=243 Identities=28% Similarity=0.398 Sum_probs=197.8
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECC-CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~-TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
+..++|++.+.||+|+||+||+|.+.. +|+.||+|++... ........+.+|+.+|..++|||||+++++|...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 445899999999999999999999976 7899999954322 223445678999999999999999999999988766
Q ss_pred -----eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 763 -----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 763 -----LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+||||||++||+|.+++.. .+++..++.++.||+.||.|||++|||||||||+||||+.+ .+||+|||+++.
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999998765 79999999999999999999999999999999999999875 999999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~ 917 (1093)
.. .....+||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+
T Consensus 231 ~~-------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 231 IN-------------------------------SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TT-------------------------------CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cc-------------------------------cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 21 01346799999999999765 58899999999999999999999876
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
.... .++........++.+.+||.+||..||.+||+ ..+.+.|+|+.
T Consensus 279 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 325 (681)
T 2pzi_A 279 RYVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT---TAEEMSAQLTG 325 (681)
T ss_dssp EECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred cccc---------cccccccccccCHHHHHHHhhhccCChhhCCC---HHHHHHHHHHH
Confidence 3211 11100001124678999999999999999998 45667777764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=320.68 Aligned_cols=194 Identities=18% Similarity=0.150 Sum_probs=139.4
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh------hhchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCce
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD------MIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~------~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd~~~L 763 (1093)
.....+.|++|.+..++....|+.||+|++.+... .......+.+.+|+++|+++ .|+||++++++++++..+
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 33457788899888888888899999996543321 11233456799999999999 699999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||||||++||+|.++|.+.+.+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--- 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--- 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC---
Confidence 9999999999999999998888765 4789999999999999999999999999999999999999999985210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
......+.+||+.|||||++.+. +..++|+||+|+++|+|.++..||
T Consensus 392 ------------------------~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 ------------------------DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ------------------------CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 11234567999999999999764 677899999999999887765544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=277.72 Aligned_cols=195 Identities=18% Similarity=0.133 Sum_probs=146.4
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh----hchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM----IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~----~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
...+.||+|+||+||+|.. .+..+++|+...+... ......+.+.+|+.+|.+++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3456899999999999944 4788999965443211 112234668999999999999999965555556777899
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++||+|.+++.+ +..++.||+.||.|||++||+||||||+|||++. ++||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~-- 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED-- 484 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH--
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc--
Confidence 9999999999999876 5688999999999999999999999999999998 999999999985311000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
..........+.+||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 485 ------------------~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 ------------------KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ------------------HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ------------------cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 00000001246789999999999987 678889999999999888888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=234.07 Aligned_cols=135 Identities=21% Similarity=0.187 Sum_probs=108.3
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhch---------------hHHHHHHHHHHHHHhcCCCceEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK---------------NDIERILAERNILITVRNPFVVR 752 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~---------------~eie~~l~E~~IL~kL~HPNIVk 752 (1093)
.|.+.+.||+|+||.||+|++ .+|+.||+|.+ +....... .....+.+|+.+|..++| ++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~-~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFH-KVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEE-CC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEE-ECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 355669999999999999999 78999999954 22111000 235678999999999994 55
Q ss_pred EeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEec
Q 001354 753 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 753 L~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
++.++.. +.+|+||||++||+|.+ +. ......++.||+.||.|||++||+||||||+||||+ +|++||+||
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 5555433 56799999999999988 42 123557999999999999999999999999999999 999999999
Q ss_pred CCcc
Q 001354 833 GLSK 836 (1093)
Q Consensus 833 GLAk 836 (1093)
|+|+
T Consensus 237 G~a~ 240 (282)
T 1zar_A 237 PQSV 240 (282)
T ss_dssp TTCE
T ss_pred CCCe
Confidence 9987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=9.1e-20 Score=193.23 Aligned_cols=139 Identities=21% Similarity=0.178 Sum_probs=107.3
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcE--EEEEEeehhhh-hhc--------------------hhHHHHHHHHHHHHHhc
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDL--FAIKQVLKKLD-MIR--------------------KNDIERILAERNILITV 745 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~--VAIKkILkK~~-~~~--------------------~~eie~~l~E~~IL~kL 745 (1093)
|++.+.||+|+||.||+|.+..+|+. ||+|++ +... ... ......+.+|+.+|..+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIY-RIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEE-CCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEE-ECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 68899999999999999999778999 999943 2211 000 11224678999999999
Q ss_pred CCCce--EEEeeeeccCCceEEEEEecCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeeecCCC
Q 001354 746 RNPFV--VRFFYSFTCRDNLYLVMEYLNG-G----DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPD 817 (1093)
Q Consensus 746 ~HPNI--VkL~gsfqd~~~LyLVMEYm~G-G----SL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLH-s~GIIHRDIKPe 817 (1093)
.|++| +.++.. ...||||||+.+ | +|.++... .++..+..++.||+.||.||| +.|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87753 333332 357999999942 4 66665432 335577889999999999999 999999999999
Q ss_pred cEEEccCCcEEEEecCCccc
Q 001354 818 NLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~ 837 (1093)
|||++. .++|+|||+|..
T Consensus 201 NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SEEESS--SEEECCCTTCEE
T ss_pred HEEEcC--cEEEEECccccc
Confidence 999998 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-16 Score=181.67 Aligned_cols=136 Identities=13% Similarity=0.163 Sum_probs=97.8
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-----------hchhHH--------HHHHHHHHHHHhcCCCc
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-----------IRKNDI--------ERILAERNILITVRNPF 749 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-----------~~~~ei--------e~~l~E~~IL~kL~HPN 749 (1093)
|++.+.||.|+||.||+|... +|+.|||| +++.... ...... .....|...|.++.+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvK-i~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLK-IHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEE-EECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEE-EEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 899999999999999999975 59999999 4332110 000000 11235666676665443
Q ss_pred eE--EEeeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC--
Q 001354 750 VV--RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-- 825 (1093)
Q Consensus 750 IV--kL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-- 825 (1093)
+. ..+.. ...+|||||++|++|..+. ..+.+..++.||+.||.|||+.|||||||||.||||+.+|
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 32 12211 1247999999999886542 2234567789999999999999999999999999999877
Q ss_pred --------cEEEEecCCcc
Q 001354 826 --------HIKLTDFGLSK 836 (1093)
Q Consensus 826 --------~VKLsDFGLAk 836 (1093)
.+.|+||+-+.
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 48999999876
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=128.21 Aligned_cols=142 Identities=15% Similarity=0.134 Sum_probs=111.2
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~L 763 (1093)
.++.|++...+|.|+++.||++... +..+++|.. ..... .....+.+|..+|..+. +..+.++++++.+.+..
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~-~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMT-DSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEE-CGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeC-CcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3567999999999999999999743 688999943 22111 11235788999999885 67788899888888899
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------- 806 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs------------------------------------- 806 (1093)
|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999999876531 222334678899999999998
Q ss_pred ----------------------cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 ----------------------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 ----------------------~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765667999998874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-10 Score=119.45 Aligned_cols=137 Identities=15% Similarity=0.140 Sum_probs=99.1
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc--eEEEeeeeccCCc
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYSFTCRDN 762 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN--IVkL~gsfqd~~~ 762 (1093)
...+|.+..+.+.|..+.||++.. .+|..+++|.. ... ....+..|..+|..+.+.+ +.++++++...+.
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~-~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTD-LSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEE-CSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeC-Ccc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 345677655555667799999964 45778999943 221 1234678888888886433 5668888888888
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG---------------------------------- 808 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~G---------------------------------- 808 (1093)
.|+||||++|.+|. . .... ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999999998884 1 1112 1245667777777777643
Q ss_pred ------------------------cEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 809 ------------------------IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 809 ------------------------IIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=9.3e-10 Score=120.80 Aligned_cols=142 Identities=17% Similarity=0.290 Sum_probs=105.2
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeeh-hhhhhchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccC---CceE
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLK-KLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCR---DNLY 764 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILk-K~~~~~~~eie~~l~E~~IL~kL~--HPNIVkL~gsfqd~---~~Ly 764 (1093)
.++.|+.|.++.||++... +..+++|+... .... ......+.+|..+|..+. +..+++++..+.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4678999999999998764 46788883320 1111 112346778999999887 45678888888776 4589
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-------------------------------------- 806 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-------------------------------------- 806 (1093)
+||||++|..+.+. ....+++.....++.+++.+|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999877541 12346788888889999999999997
Q ss_pred --------------------cCcEeeecCCCcEEEccCCc--EEEEecCCcccc
Q 001354 807 --------------------LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIG 838 (1093)
Q Consensus 807 --------------------~GIIHRDIKPeNILLD~dG~--VKLsDFGLAk~~ 838 (1093)
..++|+|++|.|||++.++. +.|+||+++..+
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999998763 689999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=7.8e-10 Score=118.91 Aligned_cols=133 Identities=20% Similarity=0.221 Sum_probs=96.7
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CC--ceEEEeeeeccCC---ceEEE
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NP--FVVRFFYSFTCRD---NLYLV 766 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HP--NIVkL~gsfqd~~---~LyLV 766 (1093)
+.++.|.+..||++. ..+++|. ... ......+.+|..+|..+. +. .+.+++....... ..|+|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~-~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKF-PKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEE-ESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEe-cCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 358999999999863 4588883 221 133567889999998873 32 2444554443333 35899
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS---------------------------------------- 806 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs---------------------------------------- 806 (1093)
|++++|.+|..... ..++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875432 346777777888888888888885
Q ss_pred ------------------cCcEeeecCCCcEEEcc--CCcEEEEecCCcccc
Q 001354 807 ------------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIG 838 (1093)
Q Consensus 807 ------------------~GIIHRDIKPeNILLD~--dG~VKLsDFGLAk~~ 838 (1093)
..++|+|++|.|||++. .+.+.|+||+.+..+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13799999999999998 456889999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.7e-06 Score=87.86 Aligned_cols=133 Identities=19% Similarity=0.203 Sum_probs=93.5
Q ss_pred eeeccCCe-EEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEEEecC
Q 001354 694 PISRGAFG-RVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLN 771 (1093)
Q Consensus 694 ~LGkG~FG-eVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVMEYm~ 771 (1093)
.+..|..| .||+......+..+++|.- . ......+.+|..+|+.+. +--|.+++.++.+.+..|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~-~------~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHG-K------GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEE-E------THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEEC-C------CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 45556555 6999887777788999932 1 123456788999998775 3336677888888889999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 001354 772 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-------------------------------------------- 807 (1093)
Q Consensus 772 GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~-------------------------------------------- 807 (1093)
|.++.+..... ......+..++...|.-||..
T Consensus 104 G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 98877654321 111223344455555555521
Q ss_pred --------------CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 808 --------------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 808 --------------GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 278999999999999877778999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=6.1e-06 Score=89.54 Aligned_cols=134 Identities=17% Similarity=0.241 Sum_probs=89.8
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC---ceEEEeeeec-cCCceEEEE
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFT-CRDNLYLVM 767 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP---NIVkL~gsfq-d~~~LyLVM 767 (1093)
++.++.|....||++ |..+++| +.. .......+.+|..+|..+.+. .|.+++.+.. ..+..|+||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR-~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFR-FPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEE-EES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEE-ecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 346789999999988 5668888 322 123356788999999998742 2455555553 445689999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------------------------------------- 807 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~---------------------------------------- 807 (1093)
||++|..|....- ..++......++.++...|..||+.
T Consensus 93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9999988865321 1233333444444444444444431
Q ss_pred --------------------CcEeeecCCCcEEEcc---CCc-EEEEecCCcccc
Q 001354 808 --------------------GIVHRDLKPDNLLIAH---DGH-IKLTDFGLSKIG 838 (1093)
Q Consensus 808 --------------------GIIHRDIKPeNILLD~---dG~-VKLsDFGLAk~~ 838 (1093)
.++|+|++|.|||++. ++. +.|+||+.+..+
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3699999999999987 455 489999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=4.7e-06 Score=92.82 Aligned_cols=81 Identities=27% Similarity=0.328 Sum_probs=50.0
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhch---hHHHHHHHHHHHHHhcCC--C-ceEEEeeeeccCCceE
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK---NDIERILAERNILITVRN--P-FVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~---~eie~~l~E~~IL~kL~H--P-NIVkL~gsfqd~~~Ly 764 (1093)
..+.||.|.++.||++....++..+++|........... ....++..|..+|..+.. | .+.+++++ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356899999999999976666788999965322210111 123456778888887642 3 34455543 344568
Q ss_pred EEEEecCCC
Q 001354 765 LVMEYLNGG 773 (1093)
Q Consensus 765 LVMEYm~GG 773 (1093)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=8.7e-05 Score=79.38 Aligned_cols=31 Identities=19% Similarity=0.349 Sum_probs=28.3
Q ss_pred cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 ~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4799999999999998888999999998874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=9.4e-05 Score=80.77 Aligned_cols=85 Identities=14% Similarity=0.129 Sum_probs=52.7
Q ss_pred eEEEee-eccCCeEEEEEEEC---C---CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-C--CceEEEeeeecc
Q 001354 690 EIIKPI-SRGAFGRVFLARKR---T---TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-N--PFVVRFFYSFTC 759 (1093)
Q Consensus 690 eilr~L-GkG~FGeVylar~k---~---TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-H--PNIVkL~gsfqd 759 (1093)
..++.| +.|....+|++... . ++..+++| +..............+.+|..+|..+. + ..+.+++.+..+
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR-~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVAR-VAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEE-ECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEE-eCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 445778 88999999998753 1 15678888 322211000000134567777777664 2 346667776665
Q ss_pred C---CceEEEEEecCCCCh
Q 001354 760 R---DNLYLVMEYLNGGDL 775 (1093)
Q Consensus 760 ~---~~LyLVMEYm~GGSL 775 (1093)
. +..|+||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 5 357899999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00038 Score=78.58 Aligned_cols=33 Identities=21% Similarity=0.461 Sum_probs=28.8
Q ss_pred HhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 805 Hs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+...++|+|++|.|||++.++ ++|+||+.+..+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 345799999999999998877 999999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0024 Score=70.46 Aligned_cols=76 Identities=14% Similarity=0.127 Sum_probs=57.8
Q ss_pred EEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCceEEEE
Q 001354 691 IIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~---HPNIVkL~gsfqd~~~LyLVM 767 (1093)
-.+.|+.|.+..+|++.. ++..|++|.. .. .....+..|...|+.+. ...+++++......+..|+||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~-~~------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKIN-ER------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEE-EG------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeC-Cc------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 356799999999999874 4678888933 21 12456788988888774 356778888877778899999
Q ss_pred EecCCCCh
Q 001354 768 EYLNGGDL 775 (1093)
Q Consensus 768 EYm~GGSL 775 (1093)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0037 Score=67.01 Aligned_cols=132 Identities=14% Similarity=0.089 Sum_probs=72.4
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceEEEEEec
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
++.|+.|....+|++ ..|++| +...... ......+|..++..+. +....++++.+. +.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR-~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLR-IPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEE-EECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEE-CCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeec
Confidence 678999999999998 447888 3322110 0111245776666654 222245555443 3347899999
Q ss_pred -CCCChHH---------------HH---HhcC-CCC-----HHHHHHHHHH--------------HHHHHHHHH----h-
Q 001354 771 -NGGDLYS---------------LL---RKVG-CLE-----EDVARIYIAE--------------LVLALEYLH----S- 806 (1093)
Q Consensus 771 -~GGSL~d---------------lL---~k~g-~Ls-----Ee~ar~yaaQ--------------Il~ALeYLH----s- 806 (1093)
+|.+|.. .| +..+ .++ ...+..+... +...+..|. .
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 6644421 01 1111 011 1111112111 111222221 1
Q ss_pred ---cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 ---LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 ---~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
..++|+|+.|.||| ..++.+.|+||..+..
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 23899999999999 5677889999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0022 Score=68.82 Aligned_cols=142 Identities=16% Similarity=0.145 Sum_probs=77.9
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc--eEEEeee------ecc
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYS------FTC 759 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN--IVkL~gs------fqd 759 (1093)
...-++.|+.|....||++.... | .|++|.. ... .....+..|..++..+.... +.+++.. ...
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~-~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLY-EKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESS-C-CEEEEEE-CC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred cceEeeccCCCcccceEEEEeCC-c-cEEEEEe-CCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 34456788889999999997642 3 6888943 221 11123455666666553111 2333321 122
Q ss_pred CCceEEEEEecCCCChH-----------H---HHHhc-CCC--------CHH-HHHH--------------HHHHHHHHH
Q 001354 760 RDNLYLVMEYLNGGDLY-----------S---LLRKV-GCL--------EED-VARI--------------YIAELVLAL 801 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~-----------d---lL~k~-g~L--------sEe-~ar~--------------yaaQIl~AL 801 (1093)
.+..++||+|++|..+. . .++.. ..+ ... .... +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 35678999999986431 0 11211 011 000 0000 001234455
Q ss_pred HHHHh-------cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 802 EYLHS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 802 eYLHs-------~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+++. .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 55553 3699999999999998776668999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0049 Score=66.77 Aligned_cols=32 Identities=34% Similarity=0.607 Sum_probs=28.0
Q ss_pred cCcEeeecCCCcEEEccC----CcEEEEecCCcccc
Q 001354 807 LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIG 838 (1093)
Q Consensus 807 ~GIIHRDIKPeNILLD~d----G~VKLsDFGLAk~~ 838 (1093)
..++|+|+.+.|||++.+ +.+.|+||+.+..+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999875 68999999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.024 Score=60.30 Aligned_cols=79 Identities=11% Similarity=-0.049 Sum_probs=52.6
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC---CceEEEeeeeccCCceE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H---PNIVkL~gsfqd~~~Ly 764 (1093)
...-++.+|.|..+.||+++.. +|+.|.+|+- .... ......+..|...|+.+.- -.+.+++... .-+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~-~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKAL-PDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEEC-CTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEe-CCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 4566788999999999999865 5889999932 2111 1112346789988887742 2344455432 248
Q ss_pred EEEEecCCCCh
Q 001354 765 LVMEYLNGGDL 775 (1093)
Q Consensus 765 LVMEYm~GGSL 775 (1093)
+||||+.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 99999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0071 Score=69.15 Aligned_cols=74 Identities=18% Similarity=0.217 Sum_probs=48.4
Q ss_pred EEEeeeccCCeEEEEEEECC-------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCc
Q 001354 691 IIKPISRGAFGRVFLARKRT-------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~-------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~ 762 (1093)
-++.|+.|....||++.... .+..|++| +.... .....+..|..++..+. +....++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlR-i~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLR-VYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEE-EECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEE-EeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 35678888899999998753 25788899 43211 01134557888888775 3334567776653
Q ss_pred eEEEEEecCCCC
Q 001354 763 LYLVMEYLNGGD 774 (1093)
Q Consensus 763 LyLVMEYm~GGS 774 (1093)
.+||||++|-+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 38999998743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0084 Score=64.44 Aligned_cols=136 Identities=14% Similarity=0.154 Sum_probs=74.7
Q ss_pred EeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC--CceEEEeee-----eccCCceEE
Q 001354 693 KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYS-----FTCRDNLYL 765 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H--PNIVkL~gs-----fqd~~~LyL 765 (1093)
..|+ |....||++... +|+.|++|.. .... .....+..|..++..+.. -.+++++.. ....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~-~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFY-RPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEE-CTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEc-CCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 3566 888899987643 4667899943 2111 112345667777766641 124444433 112345688
Q ss_pred EEEecCCCChH-----------HH---HHhc----C-----CCCHHH----HHHHH---------------HHHHHHHHH
Q 001354 766 VMEYLNGGDLY-----------SL---LRKV----G-----CLEEDV----ARIYI---------------AELVLALEY 803 (1093)
Q Consensus 766 VMEYm~GGSL~-----------dl---L~k~----g-----~LsEe~----ar~ya---------------aQIl~ALeY 803 (1093)
||+|++|..+. .. ++.. . .++... .+.++ ..+-..++.
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999885431 11 1111 0 111111 01111 111112233
Q ss_pred HH-------hcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 804 LH-------SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 804 LH-------s~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+. ...++|+|++|.|||++ + .+.|+||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 32 23589999999999998 4 899999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0097 Score=65.61 Aligned_cols=74 Identities=15% Similarity=0.226 Sum_probs=41.8
Q ss_pred EEeeeccCCeEEEEEEECC--------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCc
Q 001354 692 IKPISRGAFGRVFLARKRT--------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~--------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~ 762 (1093)
++.|+.|....+|++.... .+..|++| +..... ........|..+|..+. +..+.++++.+.
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlR-i~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFR-IYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTFN---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEE-ECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEE-ecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEecC----
Confidence 4577888888999998653 13678888 432211 11112356777777664 222445665542
Q ss_pred eEEEEEecCCCC
Q 001354 763 LYLVMEYLNGGD 774 (1093)
Q Consensus 763 LyLVMEYm~GGS 774 (1093)
-++||||++|..
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 378999999854
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0089 Score=67.76 Aligned_cols=136 Identities=13% Similarity=0.224 Sum_probs=80.8
Q ss_pred EeeeccCCeEEEEEEECC-------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceE
Q 001354 693 KPISRGAFGRVFLARKRT-------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~-------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~Ly 764 (1093)
+.|..|-...+|++.... ++..|++| +.... ......+.+|..+++.+. +....++++.+.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR-~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLR-LYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEE-ECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEE-ECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 456667778888887642 35778888 33221 112345568988888775 3334666777654 2
Q ss_pred EEEEecCCCChH--------------HHH---HhcC-----CC--CHHHHHHHHHHHHH-------------------HH
Q 001354 765 LVMEYLNGGDLY--------------SLL---RKVG-----CL--EEDVARIYIAELVL-------------------AL 801 (1093)
Q Consensus 765 LVMEYm~GGSL~--------------dlL---~k~g-----~L--sEe~ar~yaaQIl~-------------------AL 801 (1093)
+||||++|..|. ..| +... .. -...+..|..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 999999985542 111 1111 11 13445555544322 23
Q ss_pred HHHHh--------cCcEeeecCCCcEEEccC----CcEEEEecCCccc
Q 001354 802 EYLHS--------LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKI 837 (1093)
Q Consensus 802 eYLHs--------~GIIHRDIKPeNILLD~d----G~VKLsDFGLAk~ 837 (1093)
..|.+ ..++|+|+.+.|||++.+ +.+.|+||.+|..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 248999999999999876 7899999999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.48 E-value=0.051 Score=58.08 Aligned_cols=122 Identities=17% Similarity=0.128 Sum_probs=81.4
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH-HhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCC
Q 001354 773 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850 (1093)
Q Consensus 773 GSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYL-Hs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~ 850 (1093)
-+|.++|... .+++|++++-++.|.+.+|.-+ +...-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 3799999855 5799999999999999998776 211212334467999999999988663 2110
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHHHhcc
Q 001354 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 930 (1093)
Q Consensus 851 td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~ 930 (1093)
.....+.|||.+. ...+.+.=|||||+++|.-+-=..|
T Consensus 98 -------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------- 135 (229)
T 2yle_A 98 -------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------- 135 (229)
T ss_dssp ----------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC----------------
T ss_pred -------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC----------------
Confidence 0122456787763 3456788899999999998741111
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccC
Q 001354 931 KIPWPCVPSDMSFEAQDLINRFLIH 955 (1093)
Q Consensus 931 ~l~fP~ip~~IS~eakDLIkrcL~k 955 (1093)
+..+..+|+.+..||..|..-
T Consensus 136 ----e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 136 ----ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----TTEEECCCHHHHHHHHHHTTC
T ss_pred ----cccchhhCHHHHHHHHHHHhc
Confidence 223467999999999999865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.23 E-value=0.1 Score=60.53 Aligned_cols=75 Identities=16% Similarity=0.238 Sum_probs=46.8
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeccCCceEEEEEec
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HP-NIVkL~gsfqd~~~LyLVMEYm 770 (1093)
++.|+.|-...+|++.....+..|++| +..... .. .-...+|..+|..+... ...++++.+. + .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLR-i~g~~~---~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIR-LYGPKT---DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEE-EECC-C---CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEE-ECCCCh---hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 567888889999999876545788898 432211 00 11124788888888643 3456777763 2 3599999
Q ss_pred CCCCh
Q 001354 771 NGGDL 775 (1093)
Q Consensus 771 ~GGSL 775 (1093)
+|-.|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.17 E-value=0.11 Score=57.14 Aligned_cols=31 Identities=19% Similarity=0.452 Sum_probs=28.1
Q ss_pred CcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 808 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 808 GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.++|+|+.|.|||++.++.+.|+||+.+..+
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5999999999999998889999999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.97 E-value=0.19 Score=57.81 Aligned_cols=76 Identities=13% Similarity=0.156 Sum_probs=46.4
Q ss_pred EEEeeeccCCeEEEEEEECCC-------CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCc
Q 001354 691 IIKPISRGAFGRVFLARKRTT-------GDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~T-------Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~ 762 (1093)
-++.|..|-...+|++..... +..|+++ +..... ...-...+|..++..+. +....++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR-i~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~---- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFR-IYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP---- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEE-ECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEE-ECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----
Confidence 345677788889999987531 5778888 332211 11112346777777664 333455565443
Q ss_pred eEEEEEecCCCCh
Q 001354 763 LYLVMEYLNGGDL 775 (1093)
Q Consensus 763 LyLVMEYm~GGSL 775 (1093)
-++||||++|..|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.70 E-value=2.2 Score=47.90 Aligned_cols=30 Identities=27% Similarity=0.493 Sum_probs=26.0
Q ss_pred cEeeecCCCcEEE------ccCCcEEEEecCCcccc
Q 001354 809 IVHRDLKPDNLLI------AHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 809 IIHRDIKPeNILL------D~dG~VKLsDFGLAk~~ 838 (1093)
++|.|+.+.|||+ ++++.+.++||-+|...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6799999999999 45678999999999853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1093 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-88 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-86 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-85 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-83 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-82 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-81 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-78 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-77 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-76 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-75 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-75 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-74 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-74 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-74 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-71 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-70 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-69 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-69 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-65 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-61 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-61 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-61 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-61 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-57 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-57 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-50 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-44 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 6e-04 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 284 bits (728), Expect = 2e-88
Identities = 101/313 (32%), Positives = 170/313 (54%), Gaps = 32/313 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
+ +DF+ K + G+F V LAR+ T +AIK +L+K +I++N + + ER+++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM 62
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+ +PF V+ +++F + LY + Y G+L +RK+G +E R Y AE+V ALE
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------------------------- 157
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
++ +S VGT Y++PE+L ++D W++G I+++ + G+PPF A + +
Sbjct: 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVN 979
IF I+ + + P +A+DL+ + L+ D +RLG G +KAHPFF+ V
Sbjct: 218 IFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274
Query: 980 WDSLALQKAVFVP 992
W++L Q +
Sbjct: 275 WENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 280 bits (716), Expect = 2e-86
Identities = 116/344 (33%), Positives = 183/344 (53%), Gaps = 36/344 (10%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL-IT 744
I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLA 59
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
+PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE++L L++L
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
HS GIV+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN-------------------------- 153
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF + E +F
Sbjct: 154 -MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984
+I + P + EA+DL+ + + +P +RLG +++ HP F+ +NW+ L
Sbjct: 213 HSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGV--RGDIRQHPLFREINWEELE 267
Query: 985 LQK--AVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 1026
++ F P+ +S D S F F L + D
Sbjct: 268 RKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMD 311
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 278 bits (712), Expect = 1e-85
Identities = 126/357 (35%), Positives = 191/357 (53%), Gaps = 36/357 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNIL 742
+ +++DF+ +K + +G FG+V L R++ TG +A+K +L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVL 59
Query: 743 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALE
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
YLHS +V+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------------ 155
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E
Sbjct: 156 ---ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNW 980
+F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 213 LFELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269
Query: 981 DSLALQKAV--FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDSSSNS 1034
+ +K + F PQ S DT YF F+ S + P D+ S +
Sbjct: 270 QDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQE 326
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (690), Expect = 1e-83
Identities = 92/293 (31%), Positives = 148/293 (50%), Gaps = 36/293 (12%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
+++DFEI +P+ +G FG V+LAR++ + + A+K VL K + + ++ E I
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
+R+P ++R + F +YL++EY G +Y L+K+ +E YI EL AL Y
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
HS ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSV---------------------------- 154
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
+ R + GT DYL PE++ G H D WS+G++ +EF+ G PPF A + + +
Sbjct: 155 -HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
I + + P ++ A+DLI+R L H+P+QR EV HP+
Sbjct: 214 KRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 270 bits (690), Expect = 3e-82
Identities = 104/334 (31%), Positives = 163/334 (48%), Gaps = 39/334 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
+++DF + + I RG FG V+ RK TG ++A+K L K + K L ER +L
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSL 60
Query: 745 VRN---PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 801
V PF+V Y+F D L +++ +NGGDL+ L + G E R Y AE++L L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
E++H+ +V+RDLKP N+L+ GH++++D GL+
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC------------------------- 155
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF
Sbjct: 156 ----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGV 978
+ + +P S E + L+ L D N+RLG GA EVK PFF+ +
Sbjct: 212 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271
Query: 979 NWDSLALQK--AVFVPQPESVDDTSYF-LSRFSQ 1009
+W + LQK +P V+ F + F +
Sbjct: 272 DWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDE 305
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 266 bits (681), Expect = 2e-81
Identities = 115/324 (35%), Positives = 180/324 (55%), Gaps = 39/324 (12%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
S+ DF+I++ + G+FGRV L R R G +A+K VLKK ++R +E ER +L
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMK-VLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
V +PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEYL
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
HS I++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-------------------------- 154
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
++ GTPDY+APE++ + + DWWS GI+++E + G PF + +
Sbjct: 155 ----PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDS 982
+ ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+
Sbjct: 211 EKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267
Query: 983 LALQK--AVFVPQPE-SVDDTSYF 1003
L + + P + DTS F
Sbjct: 268 LLSRNIETPYEPPIQQGQGDTSQF 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (653), Expect = 3e-78
Identities = 75/292 (25%), Positives = 133/292 (45%), Gaps = 32/292 (10%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
++D+++++ + GA+G V LA R T + A+K V K + E I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKML 60
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN----------------------- 157
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
R + GT Y+APE+L E H D WS GI+L + G P+ S
Sbjct: 158 --RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ K + + L+++ L+ +P+ R+ ++K ++
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (652), Expect = 7e-78
Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 40/297 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D +EII + GAFG+V+ A+ + T L A K +D + ++E + E +IL +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAK----VIDTKSEEELEDYMVEIDILASCD 67
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 805
+P +V+ +F +NL++++E+ GG + +++ ++ L E ++ + + AL YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
I+HRDLK N+L DG IKL DFG+S
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--------------------------- 160
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESP 920
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+ I + P PS S +D + + L + + R +++ HPF
Sbjct: 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 256 bits (655), Expect = 2e-77
Identities = 77/343 (22%), Positives = 142/343 (41%), Gaps = 39/343 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE 733
P K +D ++I + + GAFG V +R TG+ FA K V+ ++D E
Sbjct: 13 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKE 68
Query: 734 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARI 792
+ E + +R+P +V +F + + ++ E+++GG+L+ + + + ED A
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPE 850
Y+ ++ L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------------- 174
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
++ GT ++ APE+ G GY D WSVG++ + ++
Sbjct: 175 --------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 220
Query: 911 GIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969
G+ PF E+ + N+ + S +S + +D I + L+ DPN R+ +
Sbjct: 221 GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQA 277
Query: 970 KAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1012
HP+ N Q + + + +
Sbjct: 278 LEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPP 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (646), Expect = 1e-76
Identities = 120/333 (36%), Positives = 185/333 (55%), Gaps = 37/333 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKQVLKKLDMIRKNDIER 734
+ H E+ I++FE++K + GA+G+VFL RK TG L+A+K + K + + E
Sbjct: 15 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 74
Query: 735 ILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 793
ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L + E +IY
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 794 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 853
+ E+VLALE+LH LGI++RD+K +N+L+ +GH+ LTDFGLS
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS------------------ 176
Query: 854 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG 911
E+ + + GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG
Sbjct: 177 --------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 912 IPPFTAESPEIIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAE 968
PFT + + I R + P P +MS A+DLI R L+ DP +RLG A E
Sbjct: 229 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 969 VKAHPFFKGVNWDSLALQK--AVFVPQPESVDD 999
+K H FF+ +NWD LA +K A F P D
Sbjct: 289 IKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 253 bits (648), Expect = 2e-76
Identities = 116/327 (35%), Positives = 183/327 (55%), Gaps = 38/327 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN 740
+ +D F+ IK + G+FGRV L + + +G+ +A+K +L K +++ IE L E+
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK-ILDKQKVVKLKQIEHTLNEKR 93
Query: 741 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
IL V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
EYLHSL +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----------------------- 190
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 191 -------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGV 978
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F
Sbjct: 244 IQIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 979 NWDSLALQK--AVFVPQPESVDDTSYF 1003
+W ++ +K A F+P+ + DTS F
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 2e-75
Identities = 89/300 (29%), Positives = 140/300 (46%), Gaps = 39/300 (13%)
Query: 681 KERTSIDD----FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERIL 736
+ S+ D + + I +GA G V+ A TG AI+ ++++ ++ E I+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIR----QMNLQQQPKKELII 65
Query: 737 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 796
E ++ +NP +V + S+ D L++VMEYL GG L ++ + C++E E
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRE 124
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
+ ALE+LHS ++HRD+K DN+L+ DG +KLTDFG
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-------------------- 164
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 916
+ R + VGTP ++APE++ +G D WS+GI+ E I G PP+
Sbjct: 165 -------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
Query: 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
E+P I P P +S +D +NR L D +R A E+ H F K
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLK 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 248 bits (633), Expect = 2e-75
Identities = 82/303 (27%), Positives = 129/303 (42%), Gaps = 44/303 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-----IRKNDIERILAERNI 741
+++E + + RG V + T +A+K + + E L E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 742 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 914
Q GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 159 ----QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
Query: 915 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973
F ++ I++ + D S +DL++RFL+ P +R A E AHP
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHP 271
Query: 974 FFK 976
FF+
Sbjct: 272 FFQ 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 6e-75
Identities = 82/345 (23%), Positives = 135/345 (39%), Gaps = 77/345 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
DDFE I + G G VF + +G + A K + ++ +I+ E +L
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECN 62
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 807 -LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 153
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
Q + +S VGT Y++PE L GT + +D WS+G+ L E G P + +
Sbjct: 154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
Query: 926 NILNR----------------------------------------KIPWPCVPSD-MSFE 944
+ P P +PS S E
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273
Query: 945 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV 989
QD +N+ LI +P +R ++ H F K + + + +
Sbjct: 274 FQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVDFAGWL 315
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 249 bits (636), Expect = 1e-74
Identities = 74/368 (20%), Positives = 146/368 (39%), Gaps = 50/368 (13%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIE 733
P K+ + D ++I++ + GAFG V ++ TG +F K + D
Sbjct: 16 VPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY 71
Query: 734 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARI 792
+ E +I+ + +P ++ +F + + L++E+L+GG+L+ + + E
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLINNTIDLSGPE 850
Y+ + L+++H IVH D+KP+N++ +K+ DFGL+
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-------------- 177
Query: 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 910
+ + T ++ APEI+ G+ D W++G++ + ++
Sbjct: 178 --------------KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 911 GIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 969
G+ PF E N+ + S +S EA+D I L +P +RL +
Sbjct: 224 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDA 280
Query: 970 KAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF-----------LSRFSQISSGLPDDQ 1018
HP+ KG + + + + + Y ++ FS + P +
Sbjct: 281 LEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEY 340
Query: 1019 NGSYSDAD 1026
S D
Sbjct: 341 QIYDSYFD 348
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 3e-74
Identities = 81/299 (27%), Positives = 139/299 (46%), Gaps = 45/299 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+D+E++ I G++GR R+++ G + K++ + + + + +++E N+L ++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELK 61
Query: 747 NPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLA 800
+P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L LA
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 801 LEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 855
L+ H ++HRDLKP N+ + ++KL DFGL++I
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI------------------ 163
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915
D + VGTP Y++PE + + +D WS+G +L+E +PPF
Sbjct: 164 ---------LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214
Query: 916 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
TA S + + I K P S E ++I R L R E+ +P
Sbjct: 215 TAFSQKELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRP---SVEEILENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 244 bits (625), Expect = 7e-74
Identities = 92/329 (27%), Positives = 150/329 (45%), Gaps = 39/329 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D ++ + GAF V LA + T L AIK + KK + + E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIK 65
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P +V + +LYL+M+ ++GG+L+ + + G E A I +++ A++YLH
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 807 LGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
LGIVHRDLKP+NLL D I ++DFGLSK+
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-------------------------- 159
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
+ +A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +
Sbjct: 160 --EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217
Query: 924 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 982
F+ IL + + D+S A+D I + DP +R + HP+ G
Sbjct: 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDTALD 274
Query: 983 LALQKAVFVPQPESVDDTSYFLSRFSQIS 1011
+ ++V Q + S + F+ +
Sbjct: 275 KNIHQSV-SEQIKKNFAKSKWKQAFNATA 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 237 bits (605), Expect = 4e-71
Identities = 69/293 (23%), Positives = 111/293 (37%), Gaps = 39/293 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIK-KMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
++HRD+K N+L++ G +KL DFG + I
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASI----------------------------- 164
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEII 923
+S VGTP ++APE++L + G D WS+GI E PP +
Sbjct: 165 --MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222
Query: 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+I + P S ++ ++ L P R + + H F
Sbjct: 223 LYHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 9e-70
Identities = 71/294 (24%), Positives = 130/294 (44%), Gaps = 40/294 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + I + + RG FG V + ++ + K V K D + E +IL R
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIAR 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLH 805
+ ++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 806 SLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 863
S I H D++P+N++ IK+ +FG ++
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--------------------------- 152
Query: 864 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923
Q N P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 153 -QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211
Query: 924 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+NI+N + + ++S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLK 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 4e-69
Identities = 81/314 (25%), Positives = 143/314 (45%), Gaps = 39/314 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL--DMIRKNDIERILAERNILIT 744
D ++ + + G F V R+++TG +A K + K+ R E I E +IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 745 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 804
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 805 HSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
HSL I H DLKP+N+++ IK+ DFGL+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 165
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920
+ + GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 166 ----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 921 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979
+ N+ + S+ S A+D I R L+ DP +R+ + HP+ K +
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKD 278
Query: 980 WDSLALQKAVFVPQ 993
AL A PQ
Sbjct: 279 TQQ-ALSSAWSHPQ 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 5e-69
Identities = 60/302 (19%), Positives = 125/302 (41%), Gaps = 44/302 (14%)
Query: 684 TSIDD--FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
S D + I RG+F V+ T A ++ + + K++ +R E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR--KLTKSERQRFKEEAEM 61
Query: 742 LITVRNPFVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
L +++P +VRF+ S+ + + LV E + G L + L++ ++ V R + ++
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 121
Query: 798 VLALEYLHSLG--IVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+ L++LH+ I+HRDLK DN+ I G +K+ D GL+ +
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----------------- 164
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
+ +GTP+++APE+ ++ + D ++ G+ + E T P
Sbjct: 165 ------------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 211
Query: 915 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 974
++ + + E +++I + + ++R ++ H F
Sbjct: 212 YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAF 268
Query: 975 FK 976
F+
Sbjct: 269 FQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 219 bits (560), Expect = 2e-65
Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 32/290 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D +E+ + + G V LAR A+K VL+ + R E +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN 65
Query: 747 NPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+P +V + + Y+VMEY++G L ++ G + A IA+ AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+ H GI+HRD+KP N++I+ +K+ DFG+++
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR------------------------AI 161
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
+ +GT YL+PE G +D +S+G +L+E +TG PPFT +SP
Sbjct: 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 923 IFDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971
+ + IP +S + ++ + L +P R AAE++A
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRA 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 9e-64
Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL--DMIRKNDIERILAERNILIT 744
+++ + G FG V+ + + AIK V K D + R+ E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 745 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLAL 801
V + V+R F D+ L++E DL+ + + G L+E++AR + +++ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 802 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+ H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------------------- 160
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 919
+ GT Y PE + HG +A WS+GI+L++ + G PF +
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 213
Query: 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
+ I+ ++ + +S E Q LI L P+ R E++ HP+ + V
Sbjct: 214 -----EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDV 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 4e-63
Identities = 53/281 (18%), Positives = 112/281 (39%), Gaps = 38/281 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + I G+FG V+ + A+K + + ++ E +L R
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKML--NVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 805
+ ++ F ++ L +V ++ G LY L + E + ++YLH
Sbjct: 63 HVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+ I+HRDLK +N+ + D +K+ DFGL+ + + +
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-------------------------KSR 156
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEI 922
+ + G+ ++APE++ + + +D ++ GI+L+E +TG P++ +
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
Query: 923 IFDNILNRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQR 960
++ R P V S+ + L+ L ++R
Sbjct: 217 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 6e-63
Identities = 81/312 (25%), Positives = 137/312 (43%), Gaps = 56/312 (17%)
Query: 681 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAER 739
K+ IDD+++ + + G G+V + T + FA+K + D + E
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---------QDCPKARREV 55
Query: 740 NILITV-RNPFVVRFFYSF----TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARI 792
+ + P +VR + R L +VME L+GG+L+S ++ G E A
Sbjct: 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 793 YIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGP 849
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG +K
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------- 162
Query: 850 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 909
+ T + + + TP Y+APE+L ++ + D WS+G+I++ +
Sbjct: 163 ---------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207
Query: 910 TGIPPFTAESP----EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGAN 964
G PPF + + I + +P S++S E + LI L +P QR+
Sbjct: 208 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM--- 264
Query: 965 GAAEVKAHPFFK 976
E HP+
Sbjct: 265 TITEFMNHPWIM 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-61
Identities = 60/304 (19%), Positives = 118/304 (38%), Gaps = 36/304 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLA--RKRTTGDLFAIKQVLKKLDMIRKNDIERILAE 738
++ +++D K + G FG V + + A+K + K + + +LAE
Sbjct: 5 RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALKDELLAE 58
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
N++ + NP++VR ++ LVME G L L++ +++ + ++
Sbjct: 59 ANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 799 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 858
+ ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-------------------- 157
Query: 859 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917
+ + + + APE + + +D WS G++++E + G P+
Sbjct: 158 ----RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213
Query: 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977
+ + + P+ E DL+N +D R G + ++
Sbjct: 214 MKGSEVTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
Query: 978 VNWD 981
VN
Sbjct: 272 VNEG 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-61
Identities = 75/314 (23%), Positives = 118/314 (37%), Gaps = 57/314 (18%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDMIRKNDIERILAERNILITVRNP 748
E + + G F V+ AR + T + AIK++ L + L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 749 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 808
++ +F + N+ LV +++ + L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 809 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 868
I+HRDLKP+NLL+ +G +KL DFGL+K +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 869 NRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 927
NR V T Y APE+L G +G D W+VG IL E + +P +S I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 928 LN-------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 962
IP + S + DLI + +P R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 272
Query: 963 ANGAAEVKAHPFFK 976
A + +F
Sbjct: 273 --TATQALKMKYFS 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 209 bits (533), Expect = 1e-61
Identities = 76/317 (23%), Positives = 130/317 (41%), Gaps = 60/317 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + ++ I G +G V+ A+ G+ FA+K++ +L+ + + E +IL ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKI--RLEKEDEGIPSTTIREISILKELK 58
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+ +V+ + + L LV E+L+ L G LE A+ ++ +L+ + Y H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARA---------------------------FG 151
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 925
R + T Y AP++L+G++ + D WSVG I E + G P F S
Sbjct: 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211
Query: 926 NILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959
I +PW + DL+++ L DPNQ
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
Query: 960 RLGANGAAEVKAHPFFK 976
R+ A + H +FK
Sbjct: 272 RI---TAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-61
Identities = 78/330 (23%), Positives = 124/330 (37%), Gaps = 66/330 (20%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
+ +E + I +G FG VF AR R TG A+K+VL + + ++ L E IL
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQL 65
Query: 745 VRNPFVVRFFYSFT--------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 796
+++ VV C+ ++YLV ++ L + + +
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 797 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 856
L+ L Y+H I+HRD+K N+LI DG +KL DFGL++
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA------------------- 166
Query: 857 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 915
+ + + + V T Y PE+LLG ++G D W G I+ E T P
Sbjct: 167 ----FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222
Query: 916 TAESPEIIFDNILN-----------------------------RKIPWPCVPSDMSFEAQ 946
+ + I RK+ A
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282
Query: 947 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
DLI++ L+ DP QR+ + + H FF
Sbjct: 283 DLIDKLLVLDPAQRI---DSDDALNHDFFW 309
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-59
Identities = 82/322 (25%), Positives = 138/322 (42%), Gaps = 60/322 (18%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV 745
+++F+ ++ I G +G V+ AR + TG++ A+K++ +LD + + E ++L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL 58
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 804
+P +V+ + LYLV E+L+ + + + + Y+ +L+ L +
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
HS ++HRDLKP NLLI +G IKL DFGL++
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARA--------------------------- 151
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEII 923
R V T Y APEILLG ++ A D WS+G I E +T F +S
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
Query: 924 FDNILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDP 957
I + + V + + + L+++ L +DP
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 958 NQRLGANGAAEVKAHPFFKGVN 979
N+R+ A AHPFF+ V
Sbjct: 272 NKRI---SAKAALAHPFFQDVT 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-58
Identities = 62/292 (21%), Positives = 113/292 (38%), Gaps = 47/292 (16%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
++ + ++++ I +G FG V L R G+ A+K +K + LAE +++
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVK-CIKN-----DATAQAFLAEASVMTQ 56
Query: 745 VRNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLAL 801
+R+ +V+ + LY+V EY+ G L LR G L D + ++ A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
EYL VHRDL N+L++ D K++DFGL+K
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----------------------- 153
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 920
+ + + + APE L + +D WS GI+L+E + G P+
Sbjct: 154 -------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206
Query: 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972
+ + + P +++ D R +++
Sbjct: 207 KDVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-58
Identities = 64/300 (21%), Positives = 110/300 (36%), Gaps = 38/300 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKQVLKKLDMIRKNDIERILAE 738
++ I D E+ G FG V R AIK + + + K D E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMRE 59
Query: 739 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAEL 797
I+ + NP++VR L LVME GG L+ L K + + ++
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA-------------------- 158
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916
+ R + + APE + + +D WS G+ ++E ++ G P+
Sbjct: 159 ----LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214
Query: 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ I K P + E L++ I+ R + ++
Sbjct: 215 KMKGPEVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 7e-58
Identities = 74/323 (22%), Positives = 127/323 (39%), Gaps = 64/323 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + I GA+G V A AIK++ + +R L E IL+ R
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRTLREIKILLRFR 64
Query: 747 NPFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 802
+ ++ ++ +L G DLY LL+ L D ++ +++ L+
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLK 123
Query: 803 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
Y+HS ++HRDLKP NLL+ +K+ DFGL+++
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA------------------------ 159
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921
+ V T Y APEI+L + + D WSVG IL E ++ P F +
Sbjct: 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219
Query: 922 IIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFL 953
++IL K+PW + + +A DL+++ L
Sbjct: 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279
Query: 954 IHDPNQRLGANGAAEVKAHPFFK 976
+P++R+ + AHP+ +
Sbjct: 280 TFNPHKRI---EVEQALAHPYLE 299
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-57
Identities = 82/330 (24%), Positives = 129/330 (39%), Gaps = 67/330 (20%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI-- 741
+ +E + I GA+G+VF AR + G A+K+V ++ + + E +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLR 62
Query: 742 -LITVRNPFVVRFFYSFTC-----RDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYI 794
L T +P VVR F T L LV E+++ Y + + + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 795 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 854
+L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI----------------- 165
Query: 855 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
+ S V T Y APE+LL + + D WSVG I E P
Sbjct: 166 -----------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
Query: 915 FTAESPEIIFDNILN------------------------RKIPWPCVPSDMSFEAQDLIN 950
F S IL+ P +D+ +DL+
Sbjct: 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274
Query: 951 RFLIHDPNQRLGANGAAEVKAHPFFKGVNW 980
+ L +P +R+ A +HP+F+ +
Sbjct: 275 KCLTFNPAKRI---SAYSALSHPYFQDLER 301
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 6e-57
Identities = 56/305 (18%), Positives = 100/305 (32%), Gaps = 36/305 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + + + I G+FG ++L G+ AIK K ++ E I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMMQ 60
Query: 747 NP-FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
+ + D +VME L + +++ +EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 806 SLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
S +HRD+KPDN L+ + + DFGL+K T
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART------------------- 161
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922
+Q R + GT Y + LG E D S+G +L F G P+
Sbjct: 162 -HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 923 IFDNILNRK-----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK- 976
P + E +N + + + ++ + F +
Sbjct: 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
Query: 977 GVNWD 981
G ++D
Sbjct: 281 GFSYD 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 6e-57
Identities = 90/368 (24%), Positives = 137/368 (37%), Gaps = 78/368 (21%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR 728
++ V+TP +R + K I G+FG V+ A+ +G+L AIK+VL+
Sbjct: 4 TTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------ 55
Query: 729 KNDIERILAERNILITVRNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLL--- 779
D E I+ + + +VR Y F L LV++Y+
Sbjct: 56 --DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 780 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIG 838
R L ++Y+ +L +L Y+HS GI HRD+KP NLL+ D +KL DFG +K
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK-- 171
Query: 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAAD 897
Q S + + Y APE++ G ++ + D
Sbjct: 172 --------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 205
Query: 898 WWSVGIILFEFITGIPPFTAESPEIIFDNILN-------------------------RKI 932
WS G +L E + G P F +S I+ +
Sbjct: 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265
Query: 933 PWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFV 991
PW V EA L +R L + P RL E AH FF + ++ L
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNVKLPNGRDT 322
Query: 992 PQPESVDD 999
P +
Sbjct: 323 PALFNFTT 330
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 7e-57
Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 32/281 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNI 741
D +++ + G+FG V A+K LK + + ++ + E N
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNA 64
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLA 800
+ ++ + ++R + + +V E G L L + G Y ++
Sbjct: 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
+ YL S +HRDL NLL+A +K+ DFGL + + +D H
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQNDDH 167
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919
Y + + APE L +A+D W G+ L+E T G P+ +
Sbjct: 168 Y--------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
I I P P D + +++ + H P R
Sbjct: 220 GSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 8e-57
Identities = 84/349 (24%), Positives = 136/349 (38%), Gaps = 72/349 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++P+ GA+G V A TG AIK++ + + +R E +L +R
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMR 75
Query: 747 NPFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
+ V+ FT + + YLVM ++ G L K L ED + + +++
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKG 133
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
L Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---------------------- 171
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 919
+ V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 172 --------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223
Query: 920 PEIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINR 951
I+ K + + ++ S A +L+ +
Sbjct: 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 283
Query: 952 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 1000
L+ D QR+ A E AHP+F+ ++ Q + + VD T
Sbjct: 284 MLVLDAEQRV---TAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 196 bits (499), Expect = 2e-56
Identities = 77/340 (22%), Positives = 135/340 (39%), Gaps = 81/340 (23%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
E + DD+++++ + RG + VF A T + +K +++ ++I E I
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-------ILKPVKKKKIKREIKI 82
Query: 742 LITVR-NPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 798
L +R P ++ + LV E++N D L + L + R Y+ E++
Sbjct: 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEIL 139
Query: 799 LALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
AL+Y HS+GI+HRD+KP N++I H+ ++L D+GL++
Sbjct: 140 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY------------------- 180
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 916
+ + V + + PE+L+ + + Y+ D WS+G +L I PF
Sbjct: 181 ---------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231
Query: 917 AESPEI----------------------------IFDNILNR-------KIPWPCVPSDM 941
F++IL R + +
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291
Query: 942 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981
S EA D +++ L +D RL A E HP+F V D
Sbjct: 292 SPEALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-56
Identities = 60/301 (19%), Positives = 112/301 (37%), Gaps = 53/301 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL--DMIRKNDIERILAERNILIT 744
++ E K + GAFG+V A QV K+ + ++ E +++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 745 VRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------------------- 781
+ + +V + T +YL+ EY GDL + LR
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 782 -VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840
+ L + + ++ +E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--- 213
Query: 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 900
++ R +A ++APE L + +D WS
Sbjct: 214 ----------------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 901 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 959
GI+L+E + G+ P+ + F ++ P + E ++ D +
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRK 310
Query: 960 R 960
R
Sbjct: 311 R 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 73/318 (22%), Positives = 121/318 (38%), Gaps = 60/318 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+E ++ I G +G VF A+ R T ++ A+K+V +LD + L E +L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELK 59
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 806
+ +VR L LV E+ + G L+ ++ + ++ +L+ L + HS
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 866
++HRDLKP NLLI +G +KL +FGL++
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARA---------------------------FG 152
Query: 867 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITG-IPPFTAESPEIIF 924
R + V T Y P++L G + + + D WS G I E P F +
Sbjct: 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 925 DNILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPN 958
I V ++ +DL+ L +P
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV 272
Query: 959 QRLGANGAAEVKAHPFFK 976
QR+ A E HP+F
Sbjct: 273 QRI---SAEEALQHPYFS 287
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-54
Identities = 55/294 (18%), Positives = 113/294 (38%), Gaps = 43/294 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++++ + G FG V++ A+K + + + LAE N++ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQG-----SMSPDAFLAEANLMKQLQ 66
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYL 804
+ +VR Y+ ++ +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 67 HQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARL--------------------------I 159
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 923
+ + R A + APE + +D WS GI+L E +T G P+ + +
Sbjct: 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFF 975
N+ + P + E L+ P R +++ FF
Sbjct: 220 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 52/276 (18%), Positives = 110/276 (39%), Gaps = 36/276 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D +K + G FG V + R AIK ++K+ M + + E +++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIK-MIKEGSMSE----DEFIEEAKVMMNLS 57
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLH 805
+ +V+ + T + ++++ EY+ G L + LR + ++ A+EYL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S +HRDL N L+ G +K++DFGLS+
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--------------------------YVL 151
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 924
+ + + + PE+L+ ++ +D W+ G++++E + G P+ +
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
++I + P S + ++ ++R
Sbjct: 212 EHIAQGLRLYR--PHLASEKVYTIMYSCWHEKADER 245
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (482), Expect = 2e-54
Identities = 59/281 (20%), Positives = 102/281 (36%), Gaps = 26/281 (9%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
+ I +I + I G FG V + G + + L+E +I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLA 800
+ +P V+ T + ++ E++ G L S LR G + +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 801 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 860
++YL + VHRDL N+L+ + K++DFGLS+ + D
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----------------FLEDDTS 183
Query: 861 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 919
P Y + APE + + A+D WS GI+++E ++ G P+ +
Sbjct: 184 DPTYTSALGG-----KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 920 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ + + I P P D L+ D N R
Sbjct: 239 NQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 2e-54
Identities = 58/304 (19%), Positives = 105/304 (34%), Gaps = 60/304 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
++ E ++ I GAFGRVF AR + A+K + ++ + E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAAL 69
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------ 783
+ NP +V+ + L+ EY+ GDL LR +
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 784 ------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837
L ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897
Y + + ++ PE + + +D
Sbjct: 190 -------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224
Query: 898 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 956
W+ G++L+E + G+ P+ + E + + + I P + E +L+
Sbjct: 225 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKL 282
Query: 957 PNQR 960
P R
Sbjct: 283 PADR 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-54
Identities = 51/276 (18%), Positives = 101/276 (36%), Gaps = 36/276 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++ I G FG V L D AIK + + E + E +++ +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-----AMSEEDFIEEAEVMMKLS 58
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLH 805
+P +V+ + + + LV E++ G L LR L + ++ + YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
++HRDL N L+ + IK++DFG+++
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRF--------------------------VL 152
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 924
+ + +PE+ + + +D WS G++++E + G P+ S +
Sbjct: 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
++I + P S ++N P R
Sbjct: 213 EDISTGFRLYK--PRLASTHVYQIMNHCWKERPEDR 246
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-54
Identities = 59/295 (20%), Positives = 107/295 (36%), Gaps = 43/295 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ + + +G FG V++ T AIK + E L E ++ +R
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPG-----TMSPEAFLQEAQVMKKLR 70
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALEYL 804
+ +V+ Y+ + +Y+V EY++ G L L A++ + Y+
Sbjct: 71 HEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+ VHRDL+ N+L+ + K+ DFGL+++
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARL--------------------------I 163
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 923
+ + R A + APE L +D WS GI+L E T G P+ +
Sbjct: 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 223
Query: 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFK 976
D + P + DL+ + +P +R ++A +F
Sbjct: 224 LDQVERGYRMP--CPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFT 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-54
Identities = 57/324 (17%), Positives = 113/324 (34%), Gaps = 32/324 (9%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL-DMIRKNDIERILAERNILITV 745
+F+ IK + GAFG V+ G+ I +K+L + + IL E ++ +V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
NP V R + G L + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 924
+ ++A E +L + + +D WS G+ ++E +T G P+ I
Sbjct: 167 ---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984
+ + P + + ++ + + D + R E+ +
Sbjct: 224 SILEKGERLPQ--PPICTIDVYMIMVKCWMIDADSRP---KFRELIIEFSKMARDPQRYL 278
Query: 985 LQKAVFVPQPESVDDTSYFLSRFS 1008
+ + S D++++ +
Sbjct: 279 VIQGDERMHLPSPTDSNFYRALMD 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 6e-54
Identities = 60/288 (20%), Positives = 111/288 (38%), Gaps = 34/288 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ E+ + I G FG V + + + + + E+ L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLH 805
+P +V+ T + ++++ME G+L S L + L+ +Y +L AL YL
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
S VHRD+ N+L++ + +KL DFGLS+ +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------------------ME 159
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 924
+ ++APE + A+D W G+ ++E + G+ PF +
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972
I N + +P + L+ + +DP++R E+KA
Sbjct: 220 GRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-53
Identities = 59/294 (20%), Positives = 107/294 (36%), Gaps = 49/294 (16%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT 744
+D + I G FG+V AR + G + + + K+D E +L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA-IKRMKEYASKDDHRDFAGELEVLCK 66
Query: 745 VRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCLEE 787
+ + P ++ + R LYL +EY G+L LRK L
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 788 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---------- 176
Query: 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 907
Q + ++A E L + + +D WS G++L+E
Sbjct: 177 ------------------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 218
Query: 908 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
++ G P+ + +++ + P + E DL+ + P +R
Sbjct: 219 IVSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYER 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 182 bits (463), Expect = 5e-52
Identities = 49/283 (17%), Positives = 96/283 (33%), Gaps = 37/283 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN- 747
+++ + I G+FG +F AIK R++D ++ E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------EPRRSDAPQLRDEYRTYKLLAGC 60
Query: 748 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 807
+ +Y + LV++ L L + +++ ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 808 GIVHRDLKPDNLLIA-----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 862
+V+RD+KPDN LI + I + DFG+ K T
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT------------------- 161
Query: 863 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAES 919
Q R + + GT Y++ LG E D ++G + F+ G A +
Sbjct: 162 -KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
Query: 920 PEIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 960
+ ++ I +K P + + E ++ +
Sbjct: 221 NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 1e-50
Identities = 52/277 (18%), Positives = 104/277 (37%), Gaps = 36/277 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
D + + G +G V+ + A+K + + ++E L E ++ ++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIK 71
Query: 747 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYL 804
+P +V+ T Y++ E++ G+L LR+ + V ++ A+EYL
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
+HRDL N L+ + +K+ DFGLS++
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------------------------M 165
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 923
A + APE L + +D W+ G++L+E T G+ P+ +
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225
Query: 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
++ + P + +L+ +P+ R
Sbjct: 226 YELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDR 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 2e-50
Identities = 80/348 (22%), Positives = 132/348 (37%), Gaps = 70/348 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR 746
+ ++ + P+ GA+G V A TG A+K++ +R E +L ++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMK 75
Query: 747 NPFVVRFFYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 801
+ V+ FT N ++ +L G DL ++++ L +D + I +++ L
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGL 134
Query: 802 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 861
+Y+HS I+HRDLKP NL + D +K+ DFGL+
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------------- 168
Query: 862 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 920
+ + V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 169 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 921 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRF 952
IL K+ + V + A DL+ +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284
Query: 953 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 1000
L+ D ++R+ AA+ AH +F + + ES D
Sbjct: 285 LVLDSDKRI---TAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLL 329
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-50
Identities = 67/338 (19%), Positives = 129/338 (38%), Gaps = 81/338 (23%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI 743
T + ++ +KPI GA G V A AIK++ + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMK 71
Query: 744 TVRNPFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 797
V + ++ FT + ++YLVME ++ + ++ + + + ++
Sbjct: 72 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQM 128
Query: 798 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 857
+ +++LHS GI+HRDLKP N+++ D +K+ DFGL++
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------------------- 168
Query: 858 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 917
+ V T Y APE++LG + D WSVG I+ E + F
Sbjct: 169 --------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 918 ESPEIIFDNILN---------------------------RKIPWPCVPSD---------- 940
++ ++ + +P + D
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 941 --MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN 315
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 60/312 (19%), Positives = 108/312 (34%), Gaps = 49/312 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
+ + + + +G+FG V+ K AIK V + M + L E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASV 76
Query: 742 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----------KVGCLEEDVAR 791
+ VVR + ++ME + GDL S LR +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 792 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 851
E+ + YL++ VHRDL N ++A D +K+ DFG+
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM----------------- 179
Query: 852 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 911
Y+ R + +++PE L +D WS G++L+E T
Sbjct: 180 --------TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
Query: 912 I-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV- 969
P+ S E + ++ + P + +L+ ++P R
Sbjct: 232 AEQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 970 --KAHPFFKGVN 979
+ P F+ V+
Sbjct: 290 KEEMEPGFREVS 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-49
Identities = 58/299 (19%), Positives = 108/299 (36%), Gaps = 54/299 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNI 741
+ K + GAFG+V A K A+K + + + E +++E +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKV 79
Query: 742 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC---------------- 784
L + N +V + T ++ EY GDL + LR+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 785 --LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
L+ + + ++ + +L S +HRDL N+L+ H K+ DFGL++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI---- 195
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902
++ + +A ++APE + + + +D WS G
Sbjct: 196 ---------------------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234
Query: 903 IILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
I L+E + G P+ + F ++ P E D++ DP +R
Sbjct: 235 IFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 60/299 (20%), Positives = 113/299 (37%), Gaps = 55/299 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-------LFAIKQVLKKLDMIRKNDIERILAER 739
D + KP+ GAFG+V LA A+K + + D+ +++E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEM 69
Query: 740 NILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-------------- 784
++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 785 --LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842
L ++ +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI---- 185
Query: 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 902
+ + + ++APE L + + +D WS G
Sbjct: 186 ---------------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 903 IILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
++L+E T G P+ E +F + PS+ + E ++ P+QR
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 53/276 (19%), Positives = 94/276 (34%), Gaps = 27/276 (9%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-IRKNDIERILAERNILITV 745
K I G FG V+ +T+ + +K L + L E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 746 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALEYL 804
+ ++R + + ++ EY+ G L K G + + ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 805 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 864
++ VHRDL N+L+ + K++DFGLS++ E
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL------------------------ED 162
Query: 865 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924
+ APE + + A+D WS GI+++E +T E
Sbjct: 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222
Query: 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+N P P D L+ + + +R
Sbjct: 223 MKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-46
Identities = 62/307 (20%), Positives = 114/307 (37%), Gaps = 50/307 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQV-LKKLDM-IRKNDIERILAERNILIT 744
D ++ KP+ RGAFG+V A + V +K L ++ +++E ILI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 745 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----------------CLE 786
+ + V + L +++E+ G+L + LR L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 787 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846
+ Y ++ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--------- 183
Query: 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 906
Y+ D + A ++APE + + +D WS G++L+
Sbjct: 184 ----------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227
Query: 907 EFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 965
E + P+ + F L P + E + +P+QR
Sbjct: 228 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRP---T 283
Query: 966 AAEVKAH 972
+E+ H
Sbjct: 284 FSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-45
Identities = 55/316 (17%), Positives = 105/316 (33%), Gaps = 72/316 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT-- 744
+ + I +G FG V+ + G+ A+K + + E I T
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVK-------IFSSREERSWFREAEIYQTVM 53
Query: 745 VRNPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 800
+R+ ++ F + + L+LV +Y G L+ L + E + ++ +
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASG 112
Query: 801 LEYLHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 852
L +LH I HRDLK N+L+ +G + D GL+
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---------------- 156
Query: 853 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH------GYAADWWSVGIILF 906
+ T + + VGT Y+APE+L + + AD +++G++ +
Sbjct: 157 -------RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209
Query: 907 EFITGIPPFTAESP-------------------EIIFDNILNRKIPWPCVPSDMSFEAQD 947
E +++ + L IP +
Sbjct: 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 269
Query: 948 LINRFLIHDPNQRLGA 963
++ + RL A
Sbjct: 270 IMRECWYANGAARLTA 285
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-44
Identities = 53/272 (19%), Positives = 99/272 (36%), Gaps = 34/272 (12%)
Query: 695 ISRGAFGRVFLAR---KRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVV 751
I RG FG V+ A+K + + D ++ + L E I+ +P V+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPNVL 91
Query: 752 RFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGI 809
+ +V+ Y+ GDL + +R I ++ +++L S
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 810 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 869
VHRDL N ++ +K+ DFGL++ + +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARD-----------------------MYDKEFDSV 188
Query: 870 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNIL 928
N+ A ++A E L + +D WS G++L+E +T G PP+ + I +L
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248
Query: 929 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 960
+ P +++ + R
Sbjct: 249 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (353), Expect = 9e-37
Identities = 58/348 (16%), Positives = 118/348 (33%), Gaps = 86/348 (24%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKL----DMIRKNDIERILAERNI--L 742
+ +++ + G F V+LA+ A+K V + + + + + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 743 ITVRNPFVVRFFYSFT--CRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAEL 797
++ +++ F + +++VM + G + + + +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 798 VLALEYLH-SLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 855
+L L+Y+H GI+H D+KP+N+L+ L ++ +G +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---------- 184
Query: 856 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915
+ +++ T +Y +PE+LLG G AD WS ++FE ITG F
Sbjct: 185 ---------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 916 TAESPEIIFDNI------------------------------------LNRKIPWPC--- 936
+ + +++ WP
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 937 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978
D + E D ++ L DP +R A + HP+ K
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 334
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.4 bits (208), Expect = 4e-19
Identities = 26/161 (16%), Positives = 52/161 (32%), Gaps = 27/161 (16%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERN--------- 740
I K + G VF +K +K +R + +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 741 -----ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 795
L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 796 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 836
++ + + GIVH DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 41.0 bits (95), Expect = 6e-04
Identities = 35/229 (15%), Positives = 69/229 (30%), Gaps = 10/229 (4%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKN---DIERILAERNILITVRN- 747
+ I G VF + IKQ + ++ ++ I+R E + LI
Sbjct: 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEH 90
Query: 748 --PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 805
V R FYS + VME L+ + G +++ L L Y
Sbjct: 91 VPHLVPRVFYS--DTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSS 148
Query: 806 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 865
+ + K + +T+ + ++ + E + + +
Sbjct: 149 DYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTNDFEEELRPFVEKLWNNDSVK 208
Query: 866 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914
+ + S + + + L L + +I EF P
Sbjct: 209 IEAAKLKKSFLTSAETLIHGDLHTGSIFASEH--ETKVIDPEFAFYGPI 255
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1093 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.43 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.76 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-65 Score=560.68 Aligned_cols=300 Identities=41% Similarity=0.752 Sum_probs=272.3
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 762 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~ 762 (1093)
++++++|++++.||+|+||+||+|+++.+|+.||||+ +++...........+.+|+.+|+.++|||||+++++|++.+.
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~-i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKI-LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEE-EEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEE-EchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc
Confidence 4678999999999999999999999999999999994 444444455567889999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+|+|||||+||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~--- 156 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--- 156 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC---
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.......+.+||+.|||||++.+.+|+.++|||||||+||||++|++||.+.+..+
T Consensus 157 ------------------------~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 157 ------------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp ------------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 11223456899999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 998 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~ 998 (1093)
++..+....+.+| ..+|+++++||.+||++||.+|++. .++.+|++||||++++|+.+..+ .||++|.+.+..
T Consensus 213 ~~~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~ 289 (337)
T d1o6la_ 213 LFELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289 (337)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTT
T ss_pred HHHHHhcCCCCCC---ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChh
Confidence 9999999887766 7899999999999999999999973 35899999999999999998765 789999999999
Q ss_pred CCcccccccccCCCC
Q 001354 999 DTSYFLSRFSQISSG 1013 (1093)
Q Consensus 999 Dts~Fds~fs~~~~~ 1013 (1093)
|+++|+..|......
T Consensus 290 ~~~~f~~~~~~~~~~ 304 (337)
T d1o6la_ 290 DTRYFDDEFTAQSIT 304 (337)
T ss_dssp CCTTSCHHHHTSCCC
T ss_pred hhhhcCchhhhccCC
Confidence 999999887665443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=524.08 Aligned_cols=280 Identities=36% Similarity=0.712 Sum_probs=248.8
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++++.||+|+||+||+|+++.+|+.||||+ +++.........+.+.+|+.+|++++|||||+++++|.+.+.+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~-i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI-LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEE-EEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEE-EehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 345789999999999999999999999999999994 4444444455678899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||||||++||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~-- 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-- 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999853110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..++
T Consensus 162 -----------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 218 (288)
T d1uu3a_ 162 -----------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218 (288)
T ss_dssp -------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -----------------------CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence 011233457899999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhc---HHHHHcCCCCCCCCcchhhcccCcccC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG---AAEVKAHPFFKGVNWDSLALQKAVFVP 992 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~---A~EIL~HPFFkgIdWd~L~~~~pPf~P 992 (1093)
+.+|.+..+.+| ..+++++++||.+||++||.+|||+++ ...|++||||++++|+.+..+.||-.|
T Consensus 219 ~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 219 FQKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHHTTCCCCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 999999887766 689999999999999999999999654 456899999999999999988777554
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-61 Score=529.94 Aligned_cols=291 Identities=39% Similarity=0.760 Sum_probs=241.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHH-hcCCCceEEEeeeeccCCceE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~-kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
+++|++++.||+|+||+||+|+++.+|+.||||++ ++.........+.+..|..++. .++|||||+++++|.+.+.+|
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i-~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEE-EHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEE-chhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 47999999999999999999999999999999954 4444444556677788888765 689999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
||||||+||+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~---- 155 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML---- 155 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC----
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999984210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
........+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++
T Consensus 156 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 212 (320)
T d1xjda_ 156 -----------------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212 (320)
T ss_dssp -----------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred -----------------------ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 112234568999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCCcc
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 1002 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dts~ 1002 (1093)
.+|..+...+| ..+|+++++||.+||++||.+||++. .++++||||++++|+.+..+ .||++|...++.|+++
T Consensus 213 ~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~s~~--~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~ 287 (320)
T d1xjda_ 213 HSIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSN 287 (320)
T ss_dssp HHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC--------------
T ss_pred HHHHcCCCCCC---ccCCHHHHHHHHHhcccCCCCCcCHH--HHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhh
Confidence 99988876655 78999999999999999999999942 26899999999999988655 7899999999999999
Q ss_pred ccccccc
Q 001354 1003 FLSRFSQ 1009 (1093)
Q Consensus 1003 Fds~fs~ 1009 (1093)
|+..+..
T Consensus 288 f~~~~~~ 294 (320)
T d1xjda_ 288 FDKEFLN 294 (320)
T ss_dssp -------
T ss_pred cChHhhh
Confidence 9876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-61 Score=523.44 Aligned_cols=287 Identities=40% Similarity=0.762 Sum_probs=251.3
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
++++|++++.||+|+||+||+|+++.+|+.||||+ +++.........+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~-i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 80 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV-LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 80 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEE-EEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEE-EchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence 46899999999999999999999999999999994 44444444556788999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
+||||++||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~----- 155 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 155 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++
T Consensus 156 -------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 210 (316)
T d1fota_ 156 -------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210 (316)
T ss_dssp -------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -------------------------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH
Confidence 1234578999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCC-CCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-VDD 999 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s-~~D 999 (1093)
.+|..+...+| ..+|+++++||.+||.+||.+|++. ..+.+||+||||++++|+.+..+ .+||.|.... ..|
T Consensus 211 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d 287 (316)
T d1fota_ 211 EKILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGD 287 (316)
T ss_dssp HHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC------
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcch
Confidence 99999887765 7899999999999999999999852 24889999999999999998655 7788887544 568
Q ss_pred Cccccc
Q 001354 1000 TSYFLS 1005 (1093)
Q Consensus 1000 ts~Fds 1005 (1093)
+++|+.
T Consensus 288 ~~~f~~ 293 (316)
T d1fota_ 288 TSQFDK 293 (316)
T ss_dssp ------
T ss_pred hhhcCC
Confidence 888865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-60 Score=528.56 Aligned_cols=288 Identities=40% Similarity=0.773 Sum_probs=261.6
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
.+++|++++.||+|+||+||+|+++.+|+.||||+ +.+.........+.+++|+.+|+.++|||||+++++|.+...+|
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~-i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI-LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEE-EEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEE-EchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 46899999999999999999999999999999995 44444444556778999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 844 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~ 844 (1093)
+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~----- 192 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc-----
Confidence 999999999999999998999999999999999999999999999999999999999999999999999998521
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 845 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 845 dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+...++
T Consensus 193 -------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 247 (350)
T d1rdqe_ 193 -------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp -------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred -------------------------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH
Confidence 1223578999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccCCCCCCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 1000 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P~~~s~~Dt 1000 (1093)
.+|......+| ..+|+++.+||++||++||.+|+.. ..+.+|++||||++++|+.+..+ .|||+|...++.|+
T Consensus 248 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~ 324 (350)
T d1rdqe_ 248 EKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDT 324 (350)
T ss_dssp HHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCC
T ss_pred HHHhcCCCCCC---ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchh
Confidence 99998877655 7899999999999999999999631 24889999999999999998765 78999999999999
Q ss_pred cccccc
Q 001354 1001 SYFLSR 1006 (1093)
Q Consensus 1001 s~Fds~ 1006 (1093)
+||++.
T Consensus 325 s~~~~~ 330 (350)
T d1rdqe_ 325 SNFDDY 330 (350)
T ss_dssp TTSCCC
T ss_pred hhcCCC
Confidence 998763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-59 Score=518.27 Aligned_cols=288 Identities=35% Similarity=0.620 Sum_probs=237.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHH---HHHHHhcCCCceEEEeeeeccC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAE---RNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E---~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
+++++|++++.||+|+||+||+|+++.+|+.||||++ .+...........+.+| +.++..++|||||+++++|.+.
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i-~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE-EHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEE-chHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 4689999999999999999999999999999999954 33333333333344444 5666677899999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
+.+||||||++||+|.++|.+...+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~- 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS- 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS-
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+
T Consensus 159 ----------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 159 ----------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp ----------------------------SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ----------------------------CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 112345689999999999974 579999999999999999999999998765
Q ss_pred hH---HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cCcccC
Q 001354 920 PE---IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVP 992 (1093)
Q Consensus 920 ~~---ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~pPf~P 992 (1093)
.. .+...+...... ++..+|+++++||.+||.+||.+|||. ..|.++++||||++++|+.+..+ +||++|
T Consensus 211 ~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p 287 (364)
T d1omwa3 211 TKDKHEIDRMTLTMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 287 (364)
T ss_dssp SSCHHHHHHHSSSCCCC---CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHHhcccCCCC---CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCC
Confidence 43 334444444433 347899999999999999999999994 35899999999999999998765 788998
Q ss_pred CCCCCCCCcccc
Q 001354 993 QPESVDDTSYFL 1004 (1093)
Q Consensus 993 ~~~s~~Dts~Fd 1004 (1093)
........++|+
T Consensus 288 ~~~~~~~~~~~d 299 (364)
T d1omwa3 288 PRGEVNAADAFD 299 (364)
T ss_dssp CCC---------
T ss_pred CCCCCCcCCccc
Confidence 777666555554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-59 Score=496.68 Aligned_cols=257 Identities=35% Similarity=0.641 Sum_probs=234.9
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..+++|++++.||+|+||+||+|+++.+|+.||+|++ .+...........+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i-~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-EHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEE-chHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 4578999999999999999999999999999999954 444444445567889999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
|+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~---- 157 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 157 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999997421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 923 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei 923 (1093)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..++
T Consensus 158 -------------------------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 212 (263)
T d2j4za1 158 -------------------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212 (263)
T ss_dssp -------------------------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH
Confidence 1122356899999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 924 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 924 ~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
+..|......+| ..+|+++++||.+||++||.+||| +.|+|+||||.
T Consensus 213 ~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~ 259 (263)
T d2j4za1 213 YKRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWIT 259 (263)
T ss_dssp HHHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHH
T ss_pred HHHHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcC---HHHHHcCcCcC
Confidence 999988877665 689999999999999999999999 88999999995
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=488.20 Aligned_cols=260 Identities=28% Similarity=0.472 Sum_probs=220.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++++.||+|+||+||+|+++.+|+.||+|++-++ .. ....+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehh-hc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 57899999999999999999999999999999955322 21 2234568999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++||+|.++|.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....+
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~---- 156 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN---- 156 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET----
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC----
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999853211
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.......+.+||+.|||||++.+..| +.++|||||||+||||++|++||...+.....
T Consensus 157 ---------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 215 (271)
T d1nvra_ 157 ---------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215 (271)
T ss_dssp ---------------------TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred ---------------------CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH
Confidence 01123346789999999999998776 67899999999999999999999876544333
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
..+.......+.....+|+++.+||.+||+.||.+||| +.|+++||||+
T Consensus 216 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~ 264 (271)
T d1nvra_ 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYN 264 (271)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTT
T ss_pred HHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhC
Confidence 33333333333334678999999999999999999999 88999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-57 Score=483.71 Aligned_cols=266 Identities=29% Similarity=0.495 Sum_probs=231.9
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhh---chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMI---RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~---~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+.|++++.||+|+||+||+|+++.+|+.||||++. +.... .....+.+.+|+.+|++++|||||+++++|.+.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~-~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE-BCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEE-hhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 56999999999999999999999999999999553 32221 122357899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC----cEEEEecCCccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGL 839 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG----~VKLsDFGLAk~~~ 839 (1093)
|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999888999999999999999999999999999999999999999877 59999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+
T Consensus 169 ----------------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 169 ----------------------------FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp ----------------------------TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 1122345689999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 001354 920 PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 984 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L~ 984 (1093)
..+++..|......++. .+..+|+++++||++||+.||.+||| +.++++||||++.+|+...
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC-------
T ss_pred HHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCChhHhh
Confidence 99999999888776542 34678999999999999999999999 8899999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=485.56 Aligned_cols=256 Identities=34% Similarity=0.546 Sum_probs=226.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
++|++++.||+|+||+||+|+++.+|+.||+|++. +... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~-~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEE-GGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEe-cccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 46999999999999999999999999999999553 3222 2346789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccC
Q 001354 767 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 846 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dl 846 (1093)
||||+||+|.+++.+ +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~------ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc------
Confidence 999999999998765 5699999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 847 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 847 s~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
........+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+.......
T Consensus 169 ---------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 227 (293)
T d1yhwa1 169 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (293)
T ss_dssp ---------------------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ---------------------ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 11223456899999999999999999999999999999999999999999988887777
Q ss_pred HhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 927 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 927 Il~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+.....+.+..+..+|+++++||.+||..||.+||| +.|+|+||||+.
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp HHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCC
Confidence 776554434456789999999999999999999999 889999999973
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-56 Score=486.83 Aligned_cols=258 Identities=34% Similarity=0.597 Sum_probs=216.5
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+. .. ......+.+|+.+|..++|||||+++++|.+.+.+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKK-AL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchH-Hh--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35699999999999999999999999999999955432 22 1223568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc---cCCcEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD---~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||+. .+|++||+|||+|+...
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~--- 161 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--- 161 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc---
Confidence 999999999999999988999999999999999999999999999999999999995 57899999999998421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+
T Consensus 162 -------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 216 (307)
T d1a06a_ 162 -------------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 216 (307)
T ss_dssp ------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -------------------------CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 1112345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+...|......++. .+..+|+++++||.+||.+||.+||| +.|+++||||++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 269 (307)
T d1a06a_ 217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTS
T ss_pred HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCC
Confidence 99999988766542 34689999999999999999999999 889999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=481.61 Aligned_cols=257 Identities=32% Similarity=0.542 Sum_probs=228.1
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 766 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLV 766 (1093)
+.|++++.||+|+||+||+|+++.+|..||+|++.++ .....+.+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 4689999999999999999999999999999955322 234456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||+||+|.+++.+. +.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~----- 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----- 162 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH-----
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC-----
Confidence 9999999999998754 5699999999999999999999999999999999999999999999999999974211
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
......+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+.++
T Consensus 163 ----------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 163 ----------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp ----------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred ----------------------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 011234578999999999984 45689999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.+++.+|.....+....+..+|+++++||.+||+.||.+||| +.|+++||||+.
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~ 274 (288)
T d2jfla1 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTV 274 (288)
T ss_dssp GGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCC
T ss_pred HHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCC
Confidence 999999988766554456789999999999999999999999 889999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-56 Score=474.08 Aligned_cols=256 Identities=31% Similarity=0.545 Sum_probs=216.9
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCce
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNL 763 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd--~~~L 763 (1093)
.++|++++.||+|+||+||+|+++.+|+.||+|++ .+.. ......+.+.+|+.+|++++|||||++++++.+ ...+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i-~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-CCTT-SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEE-Chhh-CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 47899999999999999999999999999999954 3322 344566789999999999999999999999865 4568
Q ss_pred EEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----cEeeecCCCcEEEccCCcEEEEecCC
Q 001354 764 YLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGL 834 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k----~g~LsEe~ar~yaaQIl~ALeYLHs~G-----IIHRDIKPeNILLD~dG~VKLsDFGL 834 (1093)
|+|||||+||+|.+++.+ ...+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999999864 356999999999999999999999987 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCC
Q 001354 835 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 914 (1093)
Q Consensus 835 Ak~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpP 914 (1093)
|+.... ......+.+||+.|||||++.+..|+.++|||||||++|||++|++|
T Consensus 161 a~~~~~---------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~P 213 (269)
T d2java1 161 ARILNH---------------------------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213 (269)
T ss_dssp HHHC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eeeccc---------------------------CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCC
Confidence 985310 11223457899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCC
Q 001354 915 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 975 (1093)
Q Consensus 915 F~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFF 975 (1093)
|.+.+..++..+|..+..+ .++..+|+++++||.+||+.||.+||+ +.||++|||.
T Consensus 214 f~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 214 FTAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp CCCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CCCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHcCCChhHCcC---HHHHHhCCcC
Confidence 9999999999999887653 346789999999999999999999999 8899999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=488.87 Aligned_cols=262 Identities=32% Similarity=0.528 Sum_probs=222.3
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++++.||+|+||+||+|+++.+|+.||+|++.+. ........+.+|+.+|+.++|||||+++++|.+...+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC---CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh---hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4568999999999999999999999999999999955322 1234456789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
||||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~--- 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH---
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC---
Confidence 9999999999999999998999999999999999999999997 599999999999999999999999999998531
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 157 --------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 157 --------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp --------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred --------------------------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 112345799999999999999999999999999999999999999998765432
Q ss_pred HHHH------------------------------------------HhccCCCCCCCC-CCCCHHHHHHHHhhccCCcCC
Q 001354 923 IFDN------------------------------------------ILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQ 959 (1093)
Q Consensus 923 i~~k------------------------------------------Il~~~l~fP~ip-~~IS~eakDLIkrcL~kDP~K 959 (1093)
.... +... ..|.++ ..+|.+++|||.+||+.||.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~ 288 (322)
T d1s9ja_ 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAE 288 (322)
T ss_dssp HHHHC------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhH
Confidence 2111 1111 111111 346899999999999999999
Q ss_pred CCChhcHHHHHcCCCCCCCCcch
Q 001354 960 RLGANGAAEVKAHPFFKGVNWDS 982 (1093)
Q Consensus 960 RpTa~~A~EIL~HPFFkgIdWd~ 982 (1093)
||| |.|+|+||||+..+|+.
T Consensus 289 R~t---a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 289 RAD---LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp SCC---HHHHHTSHHHHHHHHSC
T ss_pred CcC---HHHHhhCHhhCcCCccc
Confidence 999 88999999998776654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-55 Score=487.92 Aligned_cols=264 Identities=28% Similarity=0.516 Sum_probs=234.5
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+. . ....+.+.+|+.+|..++|||||+++++|.+.+.+|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-H---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-S---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-c---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467999999999999999999999999999999955332 2 234567899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc--CCcEEEEecCCccccccc
Q 001354 765 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~--dG~VKLsDFGLAk~~~~~ 841 (1093)
||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+||||+. +|.+||+|||+|+...
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-- 177 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 177 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC--
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc--
Confidence 99999999999999954 467999999999999999999999999999999999999964 6899999999998521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 178 --------------------------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 178 --------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp --------------------------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 112234578999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 001354 922 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 983 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd~L 983 (1093)
+++..|......++. ....+|+++++||.+||++||.+||| +.|+|+||||+..+|...
T Consensus 232 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTCCSC
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCCCCCc
Confidence 999999887766543 23578999999999999999999999 889999999998877543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=470.20 Aligned_cols=252 Identities=24% Similarity=0.460 Sum_probs=217.4
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCceE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLY 764 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd----~~~Ly 764 (1093)
|++.+.||+|+||+||+|+++.++..||+|++..+ . ......+.+.+|+++|++++|||||+++++|.+ ...+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~-~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR-K-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG-G-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh-h-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 47778999999999999999999999999965432 2 234556789999999999999999999999865 34689
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeeecCCCcEEEc-cCCcEEEEecCCccccccc
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~G--IIHRDIKPeNILLD-~dG~VKLsDFGLAk~~~~~ 841 (1093)
|||||++||+|.+++.+...+++..++.++.||+.||+|||++| ||||||||+||||+ .+|++||+|||+|+...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-- 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-- 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc--
Confidence 99999999999999999899999999999999999999999999 99999999999996 58999999999997421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC-h
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-P 920 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s-~ 920 (1093)
.....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.. .
T Consensus 167 ---------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~ 218 (270)
T d1t4ha_ 167 ---------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA 218 (270)
T ss_dssp ---------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred ---------------------------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH
Confidence 112345789999999999876 59999999999999999999999998754 4
Q ss_pred HHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 921 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
..+++.+..+..+ +.++..+++++++||.+||.+||++||| +.|+|+||||+
T Consensus 219 ~~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 219 AQIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred HHHHHHHHcCCCC-cccCccCCHHHHHHHHHHccCCHhHCcC---HHHHhCCcccC
Confidence 5556666554332 3345678999999999999999999999 88999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-55 Score=479.02 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=226.9
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
.|++++.||+|+||+||+|+++.+|+.||||++ .+.........+.+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i-~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEE-ECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEE-chhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 399999999999999999999999999999954 3333334455678999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
|||.||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-------- 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------- 166 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS--------
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC--------
Confidence 999999998888888889999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+..
T Consensus 167 -----------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~ 223 (309)
T d1u5ra_ 167 -----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (309)
T ss_dssp -----------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred -----------------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 1234689999999999974 45899999999999999999999999999988888
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
..+.....+.+ .+..+|+++++||.+||+.||.+||| +.++|+||||..
T Consensus 224 ~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 224 YHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHS
T ss_pred HHHHhCCCCCC-CCCCCCHHHHHHHHHHCcCChhHCcC---HHHHHhCHHhcC
Confidence 88887765433 24678999999999999999999999 889999999963
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-54 Score=481.57 Aligned_cols=260 Identities=25% Similarity=0.474 Sum_probs=231.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
...++|++++.||+|+||+||+|+++.+|+.||+|++. +.. ......+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~-~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-TPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-CCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEC-Ccc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34578999999999999999999999999999999543 322 22345788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEc--cCCcEEEEecCCcccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD--~dG~VKLsDFGLAk~~~~ 840 (1093)
|||||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+...
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~- 180 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN- 180 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC-
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC-
Confidence 99999999999999876654 699999999999999999999999999999999999998 57899999999998531
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCCh
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 920 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~ 920 (1093)
......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+.
T Consensus 181 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 233 (352)
T d1koba_ 181 ---------------------------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233 (352)
T ss_dssp ---------------------------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ---------------------------CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 11233457899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 921 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 921 ~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
.+++..|......+|. .+..+|+++++||.+||++||.+||| +.|+|+||||++.
T Consensus 234 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~ 289 (352)
T d1koba_ 234 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSC
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCCC
Confidence 9999999988776653 34679999999999999999999999 8899999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8e-54 Score=459.69 Aligned_cols=261 Identities=31% Similarity=0.492 Sum_probs=229.9
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh-----hchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM-----IRKNDIERILAERNILITVR-NPFVVRFFYSFTC 759 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~-----~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd 759 (1093)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.... ..+...+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999955432211 11223457889999999997 9999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+.+|||||||+||+|.++|...+.+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC------CCCCccceeecchhhHHHHHhCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIP 913 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g------~~Ys~ksDVWSLGVILYEMLTGkp 913 (1093)
. .......+||+.|+|||++.+ ..|+.++||||+||++|||++|++
T Consensus 162 ~----------------------------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 162 P----------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp T----------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred C----------------------------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence 0 112234689999999999863 457889999999999999999999
Q ss_pred CCCCCChHHHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 914 PFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 914 PF~~~s~~ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
||.+.+.......|..+...++. ....+|+++++||.+||++||.+||+ +.++|+||||+.
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~ 275 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQ 275 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCT
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHHHH
Confidence 99999999999999988766543 23479999999999999999999999 889999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=473.74 Aligned_cols=288 Identities=40% Similarity=0.750 Sum_probs=242.0
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEE---CCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-CceEEEeeeec
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFT 758 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~---k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNIVkL~gsfq 758 (1093)
++.+++|++++.||+|+||+||+|++ +.+|+.||+|++-++.........+.+.+|+.+|++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 46789999999999999999999987 447899999954322212222345678899999999976 89999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+...+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeecchhhHHHHHhCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.. .......+..||+.|+|||++.+. .++.++|||||||+||||++|..||.
T Consensus 180 ~~--------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 180 VA--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CG--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cc--------------------------cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 11 111233467899999999999864 46789999999999999999999998
Q ss_pred CCChHHHHHHHh----ccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhcc--cC
Q 001354 917 AESPEIIFDNIL----NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KA 988 (1093)
Q Consensus 917 ~~s~~ei~~kIl----~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa--~~A~EIL~HPFFkgIdWd~L~~~--~p 988 (1093)
+.+.......+. ....+ ++..+|+++.+||.+||.+||.+||+. ..|.|+++||||++++|+.+..+ ++
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~~---~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~ 310 (322)
T d1vzoa_ 234 VDGEKNSQAEISRRILKSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310 (322)
T ss_dssp CTTSCCCHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCHHHHHHHHHHhcccCCCC---CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCc
Confidence 876544444443 33333 347899999999999999999999984 35899999999999999999876 78
Q ss_pred cccCCCCCCCC
Q 001354 989 VFVPQPESVDD 999 (1093)
Q Consensus 989 Pf~P~~~s~~D 999 (1093)
|++|...+..|
T Consensus 311 p~~p~~~~~~~ 321 (322)
T d1vzoa_ 311 PFKPVIRDELD 321 (322)
T ss_dssp SCCCCCCC-CC
T ss_pred CCCCCCCCCCC
Confidence 99998887665
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=460.46 Aligned_cols=258 Identities=29% Similarity=0.438 Sum_probs=215.8
Q ss_pred eEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEE
Q 001354 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 767 (1093)
Q Consensus 690 eilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~--~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVM 767 (1093)
+.+++||+|+||+||+|+++.+|+.||||++ ++..... ......+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i-~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEE-ehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence 3578999999999999999999999999954 3322211 112356889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCC
Q 001354 768 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 847 (1093)
Q Consensus 768 EYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls 847 (1093)
||+.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~-------- 151 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-------- 151 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT--------
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccC--------
Confidence 999998888777777789999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCCCCChHHHHHH
Q 001354 848 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 926 (1093)
Q Consensus 848 ~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~~k 926 (1093)
.......+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..++..+
T Consensus 152 -------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~ 212 (299)
T d1ua2a_ 152 -------------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212 (299)
T ss_dssp -------------------SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -------------------CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH
Confidence 01122345689999999999875 4689999999999999999999999999998888877
Q ss_pred HhccCC-----C---------------CCC-----CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 927 ILNRKI-----P---------------WPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 927 Il~~~l-----~---------------fP~-----ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
|..... . +|. +...+++++.+||.+||+.||++||| |.|+|+||||++.
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGGTSS
T ss_pred HHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC---HHHHhCCHhhCCC
Confidence 764200 0 011 11357899999999999999999999 8899999999854
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=468.65 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=228.6
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
.++|++++.||+|+||+||+|+++.+|+.||+|++ ++. ......+.+|+.+|..++|||||+++++|.+.+.+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i-~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-CCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEE-cCC----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999999999999999955 322 2234568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC--CcEEEEecCCcccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d--G~VKLsDFGLAk~~~~~~ 842 (1093)
|||||+||+|.+++.+.+ .+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998765 69999999999999999999999999999999999999854 489999999998521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
......+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 156 -------------------------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 156 -------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------------------------cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 1122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 923 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 923 i~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
++..|......+|. .+..+|+++++||.+||.+||.+||| +.|+++||||+.
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~ 263 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred HHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhcc
Confidence 99999998877653 22478999999999999999999999 889999999964
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=449.87 Aligned_cols=263 Identities=31% Similarity=0.442 Sum_probs=216.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCC-CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc---CCCceEEEeeeecc--
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKQVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTC-- 759 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~T-Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL---~HPNIVkL~gsfqd-- 759 (1093)
.++|++++.||+|+||+||+|++..+ ++.||||++.... ........+.+|+.+|+.+ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEB--CTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhh--ccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 47899999999999999999999765 6789999553221 1122223455677776655 79999999999853
Q ss_pred ---CCceEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCc
Q 001354 760 ---RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 835 (1093)
Q Consensus 760 ---~~~LyLVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLA 835 (1093)
...+|++|||+.+|.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3468999999999877655443 356999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCC
Q 001354 836 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 915 (1093)
Q Consensus 836 k~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF 915 (1093)
+... ........+||+.|||||++.+..|+.++|||||||+||||++|++||
T Consensus 164 ~~~~----------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 164 RIYS----------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCC----------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred hhhc----------------------------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 7421 112334678999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhccC------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 916 TAESPEIIFDNILNRK------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 916 ~~~s~~ei~~kIl~~~------------------------l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.+.+..++...|+... .+.+.++..+++++++||.+||++||.+||| |.|+|+
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s---a~e~L~ 292 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALS 292 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHHT
T ss_pred CCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC---HHHHhc
Confidence 9999888877775310 0111234578999999999999999999999 889999
Q ss_pred CCCCCCCCcc
Q 001354 972 HPFFKGVNWD 981 (1093)
Q Consensus 972 HPFFkgIdWd 981 (1093)
||||+++++.
T Consensus 293 Hpff~~i~~~ 302 (305)
T d1blxa_ 293 HPYFQDLERC 302 (305)
T ss_dssp SGGGTTCCCC
T ss_pred ChhhcCchhh
Confidence 9999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=448.72 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=215.6
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhch---hHHHHHHHHHHHHHhcC--CCceEEEeeeeccCC
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRK---NDIERILAERNILITVR--NPFVVRFFYSFTCRD 761 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~---~eie~~l~E~~IL~kL~--HPNIVkL~gsfqd~~ 761 (1093)
++|++.+.||+|+||+||+|+++.+|+.||+|++. +...... .....+.+|+.+|++++ |||||+++++|.+.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~-~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-GGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEe-hHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 67999999999999999999999999999999553 3222111 12234678999999987 899999999999999
Q ss_pred ceEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC-CcEEEEecCCccccc
Q 001354 762 NLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 ~LyLVMEYm~G-GSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d-G~VKLsDFGLAk~~~ 839 (1093)
.+|+||||+.+ +++.+++.+...+++..++.++.||+.||.|||++|||||||||+||||+.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6889999888899999999999999999999999999999999999999854 799999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
.....+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.
T Consensus 163 -----------------------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 -----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp -----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred -----------------------------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 112245789999999999987665 67899999999999999999999764
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 979 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgId 979 (1093)
+ .+......++ ..+|+++++||.+||..||.+||| +.|+++||||+++.
T Consensus 214 ~------~i~~~~~~~~---~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 214 E------EIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVL 262 (273)
T ss_dssp H------HHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCC
T ss_pred h------HHhhcccCCC---CCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCCC
Confidence 2 3555555555 789999999999999999999999 88999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=449.04 Aligned_cols=261 Identities=32% Similarity=0.532 Sum_probs=216.8
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++++.||+|+||+||+|+++.+|+.||+|++ +. ..........+.+|+.+|++++|||||+++++|.+.+.+|+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i-~~-~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RL-DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEE-C--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEE-eh-hhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 47999999999999999999999999999999955 32 22233345788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 766 VMEYLNGGDLYSLLR-K-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~-k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
||||+.++ +.+++. . ...+++..++.|+.||+.||.|||++|||||||||+|||++.++++||+|||+|+...
T Consensus 79 v~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~---- 153 (298)
T d1gz8a_ 79 VFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---- 153 (298)
T ss_dssp EEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC----
T ss_pred EEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc----
Confidence 99999764 444443 3 3569999999999999999999999999999999999999999999999999998531
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeecchhhHHHHHhCCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDVWSLGVILYEMLTGkpPF~~~s~~e 922 (1093)
.........+||+.|+|||++....+ +.++|+|||||++|+|++|++||.+.+..+
T Consensus 154 -----------------------~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~ 210 (298)
T d1gz8a_ 154 -----------------------VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210 (298)
T ss_dssp -----------------------CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence 11223445689999999999887664 789999999999999999999999988877
Q ss_pred HHHHHhccCC-----C-------------CCC--------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 923 IFDNILNRKI-----P-------------WPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 923 i~~kIl~~~l-----~-------------fP~--------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
...++..... . ++. ....+|+++++||.+||..||.+||| +.|+|+||||+
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t---~~ell~H~ff~ 287 (298)
T d1gz8a_ 211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS---AKAALAHPFFQ 287 (298)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGT
T ss_pred HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhCCHhhc
Confidence 7666543110 0 010 11367899999999999999999999 88999999998
Q ss_pred CCC
Q 001354 977 GVN 979 (1093)
Q Consensus 977 gId 979 (1093)
++.
T Consensus 288 ~~~ 290 (298)
T d1gz8a_ 288 DVT 290 (298)
T ss_dssp TCC
T ss_pred cCC
Confidence 763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-51 Score=437.56 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=213.5
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCc---
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 762 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~--- 762 (1093)
.++|++++.||+|+||+||+|+++.+|+.|||| ++++...........+.+|+.+|+.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK-~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEE-EECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEE-EEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 367999999999999999999999999999999 4444444445566789999999999999999999999987653
Q ss_pred -eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccc
Q 001354 763 -LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 763 -LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~ 841 (1093)
+||||||++||+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.++.++|+|||+++.....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 8999999999999999999999999999999999999999999999999999999999999999999999998743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
........+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++.
T Consensus 165 ------------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 220 (277)
T d1o6ya_ 165 ------------------------GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 220 (277)
T ss_dssp --------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ------------------------cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH
Confidence 01122345678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCC-CCCCCCHHHHHHHHhhccCCcCCCCC
Q 001354 922 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLG 962 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~-ip~~IS~eakDLIkrcL~kDP~KRpT 962 (1093)
++..+++......|. ....+|+++.+||.+||.+||.+||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 221 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh
Confidence 988888877654432 34689999999999999999999994
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.6e-52 Score=440.76 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=217.9
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++++.||+|+||+||+|+++ +|+.||||++... .........+.+|+.+|++++|||||+++++|.+.+..|+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCS--SGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehh--hcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 478999999999999999999986 7899999965322 2233445789999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
+|||+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|....
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~------ 151 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG------ 151 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC------
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc------
Confidence 99999998888887778889999999999999999999999999999999999999999999999999997531
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ei~ 924 (1093)
.........+||+.|+|||++.+. .++.++|+|||||+||||++|++||.+.+..+..
T Consensus 152 ---------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~ 210 (286)
T d1ob3a_ 152 ---------------------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (286)
T ss_dssp ---------------------C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ---------------------cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH
Confidence 011123456799999999999764 5699999999999999999999999998887777
Q ss_pred HHHhcc--------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 925 DNILNR--------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 925 ~kIl~~--------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
.++... ..+++.....+++++.|||++||++||++||| +.|+|+||||+.
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC
T ss_pred HHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCc
Confidence 765431 00111234568999999999999999999999 889999999973
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-52 Score=450.95 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=217.5
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCc-----EEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk-----~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
.++++..++|++.+.||+|+||+||+|+++.+++ .||+|.+.... .......+.+|+.+|.++ +|||||++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 3456777899999999999999999999876554 58888553322 233446789999999998 89999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcE
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKV-----------------------GCLEEDVARIYIAELVLALEYLHSLGIV 810 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~-----------------------g~LsEe~ar~yaaQIl~ALeYLHs~GII 810 (1093)
+++|.+.+.+|+|||||+||+|.++|+.. +.+++..++.|+.||+.||.|||++|||
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~Ii 186 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 186 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99999999999999999999999999754 2489999999999999999999999999
Q ss_pred eeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC
Q 001354 811 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 890 (1093)
Q Consensus 811 HRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~ 890 (1093)
||||||+|||++.+|++||+|||+|+..... .......+.+||+.|||||++.+.
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~l~~~ 241 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSD-------------------------SNYVVRGNARLPVKWMAPESLFEG 241 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGC-------------------------TTSEEETTEEECGGGCCHHHHHHC
T ss_pred eccCchhccccccCCeEEEeeccccccccCC-------------------------CceeeeccccCCCccCChHHHcCC
Confidence 9999999999999999999999999853210 011122356789999999999999
Q ss_pred CCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 891 EHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 891 ~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
.|+.++|||||||+||||++ |.+||.+.+....+.+++.....++ .|..+|+++++||.+||+.||.+|||+.++.+
T Consensus 242 ~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999998 8999999887777777777665533 56889999999999999999999999444433
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=444.20 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=217.6
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+++..++|++.+.||+|+||+||+|+++.+|+.||+|++ ++. ....+.+.+|+.+|++++|||||+++++|.+
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i-~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEEC-CTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEE-CCc----cchHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 45678889999999999999999999999999999999954 332 2235678999999999999999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.+.+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999999764 4689999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCC-CCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkp-PF~ 916 (1093)
... ..........||+.|||||++.+..|+.++|||||||++|||++|.. ||.
T Consensus 165 ~~~--------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 165 MTG--------------------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp CCS--------------------------SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCC--------------------------CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 311 00112234568999999999999999999999999999999999655 555
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+.+...++..+.. ... +..+..+++++.+||.+||..||.+||++.++.+.|
T Consensus 219 ~~~~~~~~~~i~~-~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 219 GIDLSQVYELLEK-DYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp TCCHHHHHHHHHT-TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchHHHHHHHHhc-CCC-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 6666666655544 333 335678999999999999999999999955444433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=457.49 Aligned_cols=254 Identities=31% Similarity=0.522 Sum_probs=212.7
Q ss_pred ccCCCeeEEE-eeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHh-cCCCceEEEeeeecc--
Q 001354 684 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC-- 759 (1093)
Q Consensus 684 isiddFeilr-~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~k-L~HPNIVkL~gsfqd-- 759 (1093)
..+++|+++. +||+|+||+||+|+++.+|+.||||++ ++ ...+.+|+.++.+ .+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i-~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QD--------CPKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE-EC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEE-CC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 4568999985 699999999999999999999999954 32 1346678988765 479999999999876
Q ss_pred --CCceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CCcEEEEec
Q 001354 760 --RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDF 832 (1093)
Q Consensus 760 --~~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG~VKLsDF 832 (1093)
...+|||||||+||+|.++|.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++. ++++||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 467999999999999999998753 6999999999999999999999999999999999999986 568999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCC
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 912 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGk 912 (1093)
|+|+.... .......+||+.|||||++.+..|+.++|||||||+||+|++|+
T Consensus 159 G~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~ 210 (335)
T d2ozaa1 159 GFAKETTS----------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210 (335)
T ss_dssp TTCEECCC----------------------------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSS
T ss_pred ceeeeccC----------------------------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCC
Confidence 99985311 11234568999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHH----HHhccCCCCCCC-CCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 913 PPFTAESPEIIFD----NILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 913 pPF~~~s~~ei~~----kIl~~~l~fP~i-p~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+||.+.+...... .+......+|.. ...+|+++++||.+||++||.+||+ +.++++||||..
T Consensus 211 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 277 (335)
T d2ozaa1 211 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 277 (335)
T ss_dssp CSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHHT
T ss_pred CCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHhhC
Confidence 9998876554443 344455555521 1358999999999999999999999 889999999953
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=441.42 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=216.2
Q ss_pred EeeeccCCeEEEEEEECC--CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEEEEEec
Q 001354 693 KPISRGAFGRVFLARKRT--TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 693 r~LGkG~FGeVylar~k~--TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
+.||+|+||+||+|.++. +++.||+|++ +.. .......+.+++|+.+|++++|||||++++++.+ +.+||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~-~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNE-ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEE-C------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEE-Chh-hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 479999999999998653 5678999954 322 2334456789999999999999999999999865 4679999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccccccCCCCC
Q 001354 771 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 850 (1093)
Q Consensus 771 ~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~ 850 (1093)
++|+|.+++.+...+++..+..++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~-------- 161 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-------- 161 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC--------
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc--------
Confidence 999999999998899999999999999999999999999999999999999999999999999998532100
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhc
Q 001354 851 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 929 (1093)
Q Consensus 851 td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~ 929 (1093)
..........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++...|..
T Consensus 162 ----------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~ 225 (277)
T d1xbba_ 162 ----------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225 (277)
T ss_dssp ----------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred ----------------cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc
Confidence 01112334679999999999999999999999999999999998 9999999998888888776
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCC
Q 001354 930 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 978 (1093)
Q Consensus 930 ~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgI 978 (1093)
+.. +..|..+|+++.+||.+||+.||.+||++.++.+.|+|+||.-+
T Consensus 226 ~~~--~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 226 GER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp TCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCC--CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 532 33468899999999999999999999998878888888887543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=441.36 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=210.4
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
.|++..++|++.+.||+|+||+||+|+++ ..||||++ +.. .......+.+.+|+.+|.+++|||||++++++. .
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~-~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~ 75 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKML-NVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A 75 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEEC-CCS-SCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEE-Ecc-cCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-c
Confidence 34677889999999999999999999864 35999944 332 234456788999999999999999999998765 4
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+.+|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 5689999999999999999765 569999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.. .......+.+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.
T Consensus 156 ~~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 156 RW-------------------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp -----------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cc-------------------------CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 10 01122345689999999999975 358999999999999999999999999
Q ss_pred CCChHHHHHHHhccCCCCC---CCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 917 AESPEIIFDNILNRKIPWP---CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP---~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
+.+.......++......| .++..+++++.+||.+||..||.+||| +.+|++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~~il~~ 266 (276)
T d1uwha_ 211 NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL---FPQILAS 266 (276)
T ss_dssp TCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 8877665555554433323 345789999999999999999999999 4455543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=440.91 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=223.1
Q ss_pred ccCCCeeEEEe-eeccCCeEEEEEEECCC--CcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 684 TSIDDFEIIKP-ISRGAFGRVFLARKRTT--GDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 684 isiddFeilr~-LGkG~FGeVylar~k~T--Gk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
+..++|.+.+. ||+|+||+||+|.++.+ +..||||++ ++. ......+.+.+|+.+|.+++|||||++++++.+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l-~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEE-CSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEE-Chh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 44567888885 99999999999987644 457999954 332 234556789999999999999999999999875
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+.+||||||++||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 4689999999999999998654 579999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
... .........+||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.
T Consensus 161 ~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 161 ADD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp TCS------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccc------------------------cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 100 00112234679999999999999999999999999999999998 99999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
+..++...|..+.. |.+|..+|+++.+||.+||..||.+||++.++.+.|+|+|+.
T Consensus 217 ~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 217 KGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CTHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 88888888876543 345688999999999999999999999988888989999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=443.77 Aligned_cols=259 Identities=31% Similarity=0.491 Sum_probs=213.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
.+.|++++.||+|+||+||+|+++.+|+.||||++ ++ ........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i-~~-~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YR-PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEEC-SS-TTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEE-ch-hhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 47899999999999999999999999999999955 33 2334556678999999999999999999999998765
Q ss_pred --ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 762 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 762 --~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
.+|+||||+ |++|..+++ .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 479999999 567777664 4679999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.
T Consensus 173 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 173 ------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp ------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 122356899999999999874 5689999999999999999999999988
Q ss_pred ChHHHHHHHhcc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~----------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+.......+... ...++.+...+++++.|||.+||..||.+||| |.|+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~eiL 299 (346)
T d1cm8a_ 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEAL 299 (346)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC---HHHHh
Confidence 766655444321 11222234678999999999999999999999 88999
Q ss_pred cCCCCCCCCcc
Q 001354 971 AHPFFKGVNWD 981 (1093)
Q Consensus 971 ~HPFFkgIdWd 981 (1093)
+||||+++.+.
T Consensus 300 ~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 300 AHPYFESLHDT 310 (346)
T ss_dssp HSGGGTTTC--
T ss_pred cChhhCcCCCc
Confidence 99999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=429.20 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=207.6
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
+..++|++++.||+|+||+||+|+++ ++..||||++ ++.. ...+.+.+|+.+|.+++|||||++++++...+.+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i-~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEEC-CSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEE-CCCc----CcHHHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence 34578999999999999999999987 4678999954 3321 2235689999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~-- 153 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-- 153 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC--
Confidence 9999999999999998765 5689999999999999999999999999999999999999999999999999985311
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ 921 (1093)
..........||+.|||||++.+..|+.++|||||||+||||+| |.+||...+..
T Consensus 154 ------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 154 ------------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp -----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred ------------------------CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 01112234679999999999999999999999999999999999 68888888888
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
++...+..+.. +..|...++++.+||.+||..||.+||+ +.+|++|
T Consensus 210 ~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~Rps---~~~il~~ 255 (263)
T d1sm2a_ 210 EVVEDISTGFR--LYKPRLASTHVYQIMNHCWKERPEDRPA---FSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHhcCC--CCCccccCHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 88888877533 2235788999999999999999999999 5555543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=437.98 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=206.7
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCCCc---EEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~TGk---~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
+..++|++.+.||+|+||+||+|+++.+|+ .||+|.+... ......+.+.+|+.+|++++|||||++++++...
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 456789999999999999999999987765 5788844221 2344567899999999999999999999999999
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988764 569999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
..... ..........||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.
T Consensus 180 ~~~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 180 DDTSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp --------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCCc----------------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 11000 00111223568999999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
+..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.
T Consensus 238 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~ 284 (299)
T d1jpaa_ 238 TNQDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284 (299)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 99988888876532 223578999999999999999999999965443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=436.01 Aligned_cols=264 Identities=29% Similarity=0.395 Sum_probs=215.7
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 759 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd------ 759 (1093)
+++|++++.||+|+||+||+|+++.+|+.||||++... .........+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC------CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehh--hcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 68999999999999999999999999999999955322 2233445678899999999999999999998865
Q ss_pred --CCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 --RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 --~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
...+|+||||+.++.+..+......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 346899999999877776666667899999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
..... ........+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.
T Consensus 167 ~~~~~-----------------------~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 167 FSLAK-----------------------NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccc-----------------------ccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 32100 0111233457899999999999865 68999999999999999999999999
Q ss_pred CCChHHHHHHHhccCCCCCC-CC----------------------------CCCCHHHHHHHHhhccCCcCCCCChhcHH
Q 001354 917 AESPEIIFDNILNRKIPWPC-VP----------------------------SDMSFEAQDLINRFLIHDPNQRLGANGAA 967 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~-ip----------------------------~~IS~eakDLIkrcL~kDP~KRpTa~~A~ 967 (1093)
+.+.......+......++. .. ...++++.|||.+||+.||++||| |.
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---a~ 300 (318)
T d3blha1 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---SD 300 (318)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC---HH
T ss_pred CCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC---HH
Confidence 98887777666542111110 00 013778999999999999999999 88
Q ss_pred HHHcCCCCCC
Q 001354 968 EVKAHPFFKG 977 (1093)
Q Consensus 968 EIL~HPFFkg 977 (1093)
|+|+||||+.
T Consensus 301 elL~Hpff~~ 310 (318)
T d3blha1 301 DALNHDFFWS 310 (318)
T ss_dssp HHHHSGGGSS
T ss_pred HHHcChhhcc
Confidence 9999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=431.99 Aligned_cols=261 Identities=22% Similarity=0.358 Sum_probs=217.4
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++++.||+|+||+||+|+++ ++..||||++ ++.. ...+.+.+|+.+|.+++|||||++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~-~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEE-CTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEE-ccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 345577789999999999999999999986 5788999954 3322 234578999999999999999999998754
Q ss_pred CCceEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~--g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence 5689999999999999987643 3599999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
.... .........||+.|||||++.+..|+.++|||||||+||||+| |.+||.
T Consensus 159 ~~~~--------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 159 IEDN--------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp CSSS--------------------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccCC--------------------------ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 3210 1112335679999999999999999999999999999999999 567777
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
..+..++...+..+.. +..|..+++++.+||.+||..||.+|||+.++.+.| |+||.
T Consensus 213 ~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L-~~~ft 269 (272)
T d1qpca_ 213 GMTNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL-EDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH-HHHHH
T ss_pred CCCHHHHHHHHHhcCC--CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHh-hhhhh
Confidence 8888888888766532 334688999999999999999999999955444433 56664
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=422.49 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=222.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceEE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~LyL 765 (1093)
+++|++++.||+|+||+||+|+++.+|+.||+|++ +. ..........+.+|+.+|+.++|||||+++++|.+...+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i-~~-~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RL-DDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEE-ES-SCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEE-eh-hhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 46899999999999999999999999999999955 33 22344567889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 766 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||+++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~----- 153 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI----- 153 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC-----
Confidence 999999999999998888999999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeecchhhHHHHHhCCCCC-CCCChHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEII 923 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDVWSLGVILYEMLTGkpPF-~~~s~~ei 923 (1093)
.........+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+.
T Consensus 154 ----------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~ 211 (292)
T d1unla_ 154 ----------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp ----------------------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred ----------------------CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH
Confidence 111223456889999999998765 699999999999999999998885 55566666
Q ss_pred HHHHhccC--------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 924 FDNILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 924 ~~kIl~~~--------------------------l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+.++.... .........+++++.+||.+||+.||.+||| |.|+|+||||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s---a~e~L~Hp~f~~ 288 (292)
T d1unla_ 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSD 288 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGSS
T ss_pred HHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC---HHHHhcChhhcC
Confidence 66553210 0111234568999999999999999999999 889999999985
Q ss_pred C
Q 001354 978 V 978 (1093)
Q Consensus 978 I 978 (1093)
.
T Consensus 289 ~ 289 (292)
T d1unla_ 289 F 289 (292)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.8e-50 Score=434.01 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=210.4
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC--C
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--D 761 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~--~ 761 (1093)
..++|++++.||+|+||+||+|+++.+|+.||||++ ++. ..+.+.+|+.+|..+. ||||++++++|... .
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i-~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-CSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEE-CHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 347899999999999999999999999999999944 332 2356889999999996 99999999998754 5
Q ss_pred ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEEecCCcccccc
Q 001354 762 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~~~~ 840 (1093)
.+|+||||+.+|+|..+. ..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 106 ~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~- 181 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH- 181 (328)
T ss_dssp SEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC-
T ss_pred ceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc-
Confidence 699999999999997764 4699999999999999999999999999999999999999765 69999999998521
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
........+||+.|+|||++.+. .|+.++|+|||||++|||++|..||....
T Consensus 182 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 182 ---------------------------PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp ---------------------------TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ---------------------------CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 01123456899999999998865 57999999999999999999999997654
Q ss_pred h-HHHHHHHhc-------------cCC---------------------CCCCCCCCCCHHHHHHHHhhccCCcCCCCChh
Q 001354 920 P-EIIFDNILN-------------RKI---------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 964 (1093)
Q Consensus 920 ~-~ei~~kIl~-------------~~l---------------------~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~ 964 (1093)
. ......+.. ... ........+++++.|||++||++||.+|||
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-- 312 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-- 312 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC--
T ss_pred hhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC--
Confidence 3 222211110 000 001112357899999999999999999999
Q ss_pred cHHHHHcCCCCCCCCcc
Q 001354 965 GAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 965 ~A~EIL~HPFFkgIdWd 981 (1093)
|.|+|+||||+++.|+
T Consensus 313 -a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 -AREAMEHPYFYTVVKD 328 (328)
T ss_dssp -HHHHHTSGGGTTSCCC
T ss_pred -HHHHhcCcccCCCCCC
Confidence 8899999999999996
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=436.37 Aligned_cols=252 Identities=32% Similarity=0.473 Sum_probs=208.8
Q ss_pred CeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------CC
Q 001354 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------RD 761 (1093)
Q Consensus 688 dFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd------~~ 761 (1093)
+|+.+++||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|++++|||||+++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 79999999999999999999999999999996543221 12469999999999999999999854 33
Q ss_pred ceEEEEEecCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCC-cEEEEecCCccc
Q 001354 762 NLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKI 837 (1093)
Q Consensus 762 ~LyLVMEYm~GGSL~dlL---~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG-~VKLsDFGLAk~ 837 (1093)
++|||||||++|.+..+. .....+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+++.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 589999999876444333 2345799999999999999999999999999999999999999876 899999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeecchhhHHHHHhCCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDVWSLGVILYEMLTGkpPF~ 916 (1093)
.. ......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus 173 ~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 173 LV----------------------------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CC----------------------------TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cc----------------------------CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 21 1122345789999999999875 578999999999999999999999999
Q ss_pred CCChHHHHHHHhcc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 917 AESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
..+..+.+..|+.. ...++. ....+++++.+||.+||++||.+||| |.|+|
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L 301 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLEAC 301 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred CCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC---HHHHh
Confidence 98887777666431 111121 12458999999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001354 971 AHPFFKGV 978 (1093)
Q Consensus 971 ~HPFFkgI 978 (1093)
+||||+.+
T Consensus 302 ~Hp~f~~~ 309 (350)
T d1q5ka_ 302 AHSFFDEL 309 (350)
T ss_dssp TSGGGGGG
T ss_pred cCHhhccc
Confidence 99999765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=423.58 Aligned_cols=251 Identities=21% Similarity=0.344 Sum_probs=217.8
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCceE
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~Ly 764 (1093)
..++|++++.||+|+||+||+|+++ ++..||+|++ ++... ..+.+++|+.++.+++|||||+++++|.+.+.+|
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l-~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI-KEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEE-ESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEE-CcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence 4579999999999999999999986 6789999944 43222 2357899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccc
Q 001354 765 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 843 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k-~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s 843 (1093)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+++....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~--- 152 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--- 152 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS---
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC---
Confidence 99999999999999764 45699999999999999999999999999999999999999999999999999974211
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChHH
Q 001354 844 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 922 (1093)
Q Consensus 844 ~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~e 922 (1093)
..........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+
T Consensus 153 -----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 153 -----------------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp -----------------------SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred -----------------------CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 01112234679999999999999999999999999999999998 899999999999
Q ss_pred HHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 923 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 923 i~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
+..+|..+.. +..|...++++.+||.+||+.||.+||+ +.+|++|
T Consensus 210 ~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 254 (258)
T d1k2pa_ 210 TAEHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERPT---FKILLSN 254 (258)
T ss_dssp HHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHhCCC--CCCcccccHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 9988877532 2346889999999999999999999999 6676665
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=422.58 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=207.6
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCC---cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TG---k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
++..++|++.+.||+|+||+||+|++..++ ..||+|.+ +. .......+.+.+|+.+|++++|||||++++++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~-~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEEC-TT--TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEe-cc--ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 456689999999999999999999987654 46888843 22 223445678999999999999999999999996
Q ss_pred CCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 46789999999999999987654 56999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
.. .........+||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+
T Consensus 159 ~~--------------------------~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 159 ED--------------------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp --------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cC--------------------------CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 11 01112334678999999999999999999999999999999998 9999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
.+..+++..+..+.. +.++..+|+++.+||.+||..||.+||+ +.+|++|
T Consensus 213 ~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ei~~~ 262 (273)
T d1mp8a_ 213 VKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPR---FTELKAQ 262 (273)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 999999998877643 2356889999999999999999999999 5555543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=419.92 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=208.4
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCC----cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 758 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TG----k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfq 758 (1093)
++..+.|++.++||+|+||+||+|.++.++ ..||||++. .. ........+++|+.+|.+++|||||++++++.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~-~~--~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEEC-TT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEEC-cc--cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 356688999999999999999999988655 479999552 21 22344567899999999999999999999999
Q ss_pred cCCceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 759 CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+.+.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+||||+.++++||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999988755 5699999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
..... ..........||+.|||||++.+..|+.++|||||||+||||++ |.+||.
T Consensus 160 ~~~~~------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 160 LEDDP------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp --------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCC------------------------ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 32100 00112234578999999999999999999999999999999999 566677
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
..+..+++..+..+. . +..+..++.++.+||.+||..||.+||++.++.+
T Consensus 216 ~~~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 216 ELSNHEVMKAINDGF-R-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCCHHHHHHHHHTTC-C-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHhccC-C-CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 777777777766543 2 2346789999999999999999999999554443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=432.35 Aligned_cols=261 Identities=28% Similarity=0.475 Sum_probs=211.9
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----c
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----N 762 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~----~ 762 (1093)
+.|++++.||+|+||+||+|+++.+|+.||||++ ++.. .....+.+++|+.+|+.++|||||++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i-~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEE-CCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEE-ehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 4699999999999999999999999999999954 3322 3445678899999999999999999999987654 2
Q ss_pred eEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 763 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 763 LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
.+++|+|+.||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 3555667779999999975 469999999999999999999999999999999999999999999999999998532111
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
.........+||+.|+|||++. +..|+.++||||+||++|||++|++||.+.+..
T Consensus 164 ------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~ 219 (345)
T d1pmea_ 164 ------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219 (345)
T ss_dssp ------------------------CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ------------------------ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH
Confidence 1112234578999999999985 456799999999999999999999999988776
Q ss_pred HHHHHHhcc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCC
Q 001354 922 IIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 973 (1093)
Q Consensus 922 ei~~kIl~~----------------------------~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HP 973 (1093)
+....+... ..++......+++++++||.+||++||.+||+ |.++|+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---a~e~L~hp 296 (345)
T d1pmea_ 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAHP 296 (345)
T ss_dssp HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSG
T ss_pred HHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCH
Confidence 555544321 01111123568899999999999999999999 88999999
Q ss_pred CCCCC
Q 001354 974 FFKGV 978 (1093)
Q Consensus 974 FFkgI 978 (1093)
||+..
T Consensus 297 f~~~~ 301 (345)
T d1pmea_ 297 YLEQY 301 (345)
T ss_dssp GGTTT
T ss_pred hhccC
Confidence 99743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=429.28 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=207.6
Q ss_pred cCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhh-hhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCce
Q 001354 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 763 (1093)
Q Consensus 685 siddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~-~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~~L 763 (1093)
..++|+++++||+|+||+||+|+++.+|+.+|+|+++|+.. .......+.+.+|+.+|.+++|||||++++++.+. ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 34689999999999999999999998887544443332221 12234467899999999999999999999999865 57
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccccc
Q 001354 764 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 842 (1093)
Q Consensus 764 yLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~ 842 (1093)
+++|||+.+|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~- 164 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE- 164 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT-
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc-
Confidence 8899999999999988765 57999999999999999999999999999999999999999999999999999853210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCCChH
Q 001354 843 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 921 (1093)
Q Consensus 843 s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~s~~ 921 (1093)
..........||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..
T Consensus 165 ------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 165 ------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp ------------------------CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred ------------------------cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 01112334579999999999999999999999999999999998 89999998888
Q ss_pred HHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 922 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 922 ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
++...+..+.. +..|..+++++.+||.+||..||.+||+ +.+|+.|
T Consensus 221 ~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 266 (317)
T d1xkka_ 221 EISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 266 (317)
T ss_dssp GHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHcCCC--CCCCcccCHHHHHHHHHhCCCChhhCcC---HHHHHHH
Confidence 88777766532 2345789999999999999999999999 6677766
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=431.88 Aligned_cols=257 Identities=30% Similarity=0.429 Sum_probs=214.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 761 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~~---- 761 (1093)
.++|++++.||+|+||+||+|+++.+|+.||||++ ++. .........+.+|+.+|+.++|||||+++++|....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i-~~~-~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEEC-SCT-TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEE-Cch-hcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 46799999999999999999999999999999954 332 233445677899999999999999999999987543
Q ss_pred -ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccccc
Q 001354 762 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 840 (1093)
Q Consensus 762 -~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~ 840 (1093)
..++||+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+|++|||++...
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~-- 171 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-- 171 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC--
T ss_pred CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc--
Confidence 34677788889999999854 56999999999999999999999999999999999999999999999999998742
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 841 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 841 ~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
.....+.+||+.|+|||++.+.. ++.++|||||||+||+|++|.+||.+.+
T Consensus 172 ----------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 172 ----------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp ----------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----------------------------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 11234568999999999987754 6899999999999999999999999998
Q ss_pred hHHHHHHHhccCCCC-----------------------CC-----CCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 920 PEIIFDNILNRKIPW-----------------------PC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 920 ~~ei~~kIl~~~l~f-----------------------P~-----ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.......|+...... +. ....++++++|||.+||+.||.+||| |.|+|+
T Consensus 224 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~elL~ 300 (348)
T d2gfsa1 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALA 300 (348)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHT
T ss_pred HHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC---HHHHhc
Confidence 877777765421111 10 12468999999999999999999999 889999
Q ss_pred CCCCCCC
Q 001354 972 HPFFKGV 978 (1093)
Q Consensus 972 HPFFkgI 978 (1093)
||||+..
T Consensus 301 Hp~f~~~ 307 (348)
T d2gfsa1 301 HAYFAQY 307 (348)
T ss_dssp SGGGTTT
T ss_pred CHhhCCC
Confidence 9999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=421.46 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=211.0
Q ss_pred ccCCCeeEEEeeeccCCeEEEEEEECCC-C--cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001354 684 TSIDDFEIIKPISRGAFGRVFLARKRTT-G--DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 760 (1093)
Q Consensus 684 isiddFeilr~LGkG~FGeVylar~k~T-G--k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~ 760 (1093)
+..++|++++.||+|+||+||+|++..+ + ..||+| ++++.........+.+.+|+.+|..++|||||++|++|.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK-~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEE-C--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEE-EEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 4457899999999999999999987533 3 368999 5544444445566789999999999999999999999976
Q ss_pred CceEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~-g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
+.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 4689999999999999987654 569999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 918 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~~ 918 (1093)
... ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 163 ~~~------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 163 QND------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp C-C------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCC------------------------CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 100 01112334568899999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+..++...+......+| .+..+|+++.+||.+||..||++|||+.++.++|
T Consensus 219 ~~~~~~~~i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 219 NGSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp CHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHhCCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999988776543 5688999999999999999999999966665554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=421.42 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=205.9
Q ss_pred cccccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001354 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 754 (1093)
Q Consensus 681 ~~~isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~ 754 (1093)
++.+..++|++++.||+|+||+||+|++.. +++.||+|++ ++. ......+.+.+|..++.++ +|||||.++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l-~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEG--ATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEE-ccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 345666899999999999999999999764 3468999954 322 2234456778888888776 589999999
Q ss_pred eeeccC-CceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCC
Q 001354 755 YSFTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 817 (1093)
Q Consensus 755 gsfqd~-~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPe 817 (1093)
+++... ..+|+|||||+||+|.++|... ..+++..++.|+.||+.||.|||++|||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 887665 4689999999999999999753 24889999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001354 818 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 897 (1093)
Q Consensus 818 NILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 897 (1093)
||||+.+|++||+|||+|+..... .........+||+.|||||++.+..|+.++|
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD 218 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSD 218 (299)
T ss_dssp GEEECGGGCEEECC------CCSC-------------------------TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHH
T ss_pred ceeECCCCcEEEccCcchhhcccc-------------------------ccccccCceeeCccccchhHhhcCCCCcccc
Confidence 999999999999999999852110 0111234568999999999999999999999
Q ss_pred eecchhhHHHHHhC-CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 898 WWSVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 898 VWSLGVILYEMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
||||||++|||++| .+||.+.+..+.+..++..... +..+..+++++.+||.+||+.||.+||| +.+|++|
T Consensus 219 iwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~eil~~ 290 (299)
T d1ywna1 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 290 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred eeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 99999999999986 6789887766666555554444 3456889999999999999999999999 5566554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=420.75 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=213.6
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 759 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd 759 (1093)
..+.+..++|++.+.||+|+||+||+|+++.+ ..||||++ +... ...+.+.+|+.+|.+++|||||++|+++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l-~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTL-KPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEEC-CTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEE-Cccc----CCHHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 44567789999999999999999999999765 56999954 3322 123578999999999999999999999865
Q ss_pred CCceEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k--~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+.+|+||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 568999999999999998864 35699999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCC
Q 001354 838 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 916 (1093)
Q Consensus 838 ~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~ 916 (1093)
... ..........||+.|+|||++.+..++.++|||||||+||||++ |.+||.
T Consensus 163 ~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 163 IED--------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ---------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccC--------------------------CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 210 01112334679999999999999999999999999999999999 566677
Q ss_pred CCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCC
Q 001354 917 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 977 (1093)
Q Consensus 917 ~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkg 977 (1093)
+....++...+..+. . +..+..+++++++||.+||+.||++||+++++.+.| |+||..
T Consensus 217 ~~~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L-~~~~~~ 274 (285)
T d1fmka3 217 GMVNREVLDQVERGY-R-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL-EDYFTS 274 (285)
T ss_dssp TCCHHHHHHHHHTTC-C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH-HTTTSC
T ss_pred CCCHHHHHHHHHhcC-C-CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHH-hhhhcC
Confidence 777777887776543 2 224688999999999999999999999955443333 678764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=421.41 Aligned_cols=259 Identities=22% Similarity=0.349 Sum_probs=220.2
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 757 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsf 757 (1093)
+...++|++++.||+|+||+||+|+++. ++..||||++ ++. ........+.+|+.+|+.++||||+++++++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i-~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEE--ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEEC-CTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEE-Chh--cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3456789999999999999999999863 5678999954 321 2334567899999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeee
Q 001354 758 TCRDNLYLVMEYLNGGDLYSLLRKVG------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRD 813 (1093)
Q Consensus 758 qd~~~LyLVMEYm~GGSL~dlL~k~g------------------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRD 813 (1093)
.....+++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999996532 388899999999999999999999999999
Q ss_pred cCCCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC
Q 001354 814 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 893 (1093)
Q Consensus 814 IKPeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys 893 (1093)
|||+|||||.++++||+|||+|+..... .......+.+||+.|||||++.+..|+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~t 220 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSA-------------------------DYYKADGNDAIPIRWMPPESIFYNRYT 220 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGG-------------------------GCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred EcccceEECCCCcEEEccchhheeccCC-------------------------ccccccCCCCcCcCcCCHHHHccCCCC
Confidence 9999999999999999999999853211 111223457899999999999999999
Q ss_pred ccceeecchhhHHHHHhC-CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc
Q 001354 894 YAADWWSVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 971 (1093)
Q Consensus 894 ~ksDVWSLGVILYEMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~ 971 (1093)
.++|||||||+||||++| .+||.+.+..++...+..+.. |.+|..+++++.+||.+||+.||.+||++.++.+.|+
T Consensus 221 ~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 221 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999999999999999998 478999999999998877653 4556889999999999999999999999666555443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=432.32 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=206.4
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 760 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd~----- 760 (1093)
+++|++++.||+|+||+||+|+++.+|+.||||++.+. .........+.+|+.+|+.++|||||+++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh--hcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 47899999999999999999999999999999965332 23455567899999999999999999999999643
Q ss_pred -CceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccc
Q 001354 761 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 839 (1093)
Q Consensus 761 -~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~ 839 (1093)
..+|+||||+.|+ +...+ ...+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 6789999999765 44444 3569999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCC
Q 001354 840 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 919 (1093)
Q Consensus 840 ~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s 919 (1093)
........+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+
T Consensus 171 ----------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 171 ----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp --------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 1122345689999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHhcc----------------------CCCCCCC-----------------CCCCCHHHHHHHHhhccCCcCCC
Q 001354 920 PEIIFDNILNR----------------------KIPWPCV-----------------PSDMSFEAQDLINRFLIHDPNQR 960 (1093)
Q Consensus 920 ~~ei~~kIl~~----------------------~l~fP~i-----------------p~~IS~eakDLIkrcL~kDP~KR 960 (1093)
......+++.. ....... ...+++++.+||++||..||++|
T Consensus 223 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 302 (355)
T d2b1pa1 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHC
Confidence 77666655421 1110000 01246789999999999999999
Q ss_pred CChhcHHHHHcCCCCCCCCc
Q 001354 961 LGANGAAEVKAHPFFKGVNW 980 (1093)
Q Consensus 961 pTa~~A~EIL~HPFFkgIdW 980 (1093)
|| |.|+|+||||+..-+
T Consensus 303 ~t---a~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 303 IS---VDDALQHPYINVWYD 319 (355)
T ss_dssp CC---HHHHHTSTTTGGGCC
T ss_pred cC---HHHHhcCcccCCCCC
Confidence 99 889999999986433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=425.37 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=214.1
Q ss_pred cccCCCeeEEEeeeccCCeEEEEEEECCCCcE--EEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc
Q 001354 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC 759 (1093)
Q Consensus 683 ~isiddFeilr~LGkG~FGeVylar~k~TGk~--VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL~gsfqd 759 (1093)
.+..++|++.++||+|+||+||+|+++.+|.. ||||++. ........+.+.+|+.+|.++ +|||||++++++.+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~---~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEE---CC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEEC---cccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 46778999999999999999999999988875 5566332 122334456799999999998 69999999999999
Q ss_pred CCceEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc
Q 001354 760 RDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 823 (1093)
Q Consensus 760 ~~~LyLVMEYm~GGSL~dlL~k~----------------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~ 823 (1093)
.+.+|+||||++||+|.++|++. ..+++..+..++.||+.||.|||++|||||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 99999999999999999999754 46999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchh
Q 001354 824 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903 (1093)
Q Consensus 824 dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGV 903 (1093)
++.+||+|||+|+... ........+||+.|+|||.+.+..|+.++|||||||
T Consensus 163 ~~~~kl~DfG~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGv 214 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQE----------------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 214 (309)
T ss_dssp GGCEEECCTTCEESSC----------------------------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHH
T ss_pred CCceEEcccccccccc----------------------------ccccccceecCCcccchHHhccCCCCccceeehhHH
Confidence 9999999999997421 011223457999999999999999999999999999
Q ss_pred hHHHHHhC-CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 904 ILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 904 ILYEMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
++|||++| .+||.+.+..+++..+..+.. |..+..+++++++||.+||..||++||+ +.+|++|
T Consensus 215 il~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 279 (309)
T d1fvra_ 215 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 279 (309)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 99999996 578999999999988876532 3456889999999999999999999999 5566655
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=415.41 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=207.8
Q ss_pred ccccCCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-C
Q 001354 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 760 (1093)
Q Consensus 682 ~~isiddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd-~ 760 (1093)
|.+..++|++++.||+|+||.||+|+++ |..||+|++ ++. ...+.+.+|+.+|++++|||||++++++.+ .
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i-~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEEC-CCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEE-CcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 5678899999999999999999999985 788999954 332 234678999999999999999999998855 4
Q ss_pred CceEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCcccc
Q 001354 761 DNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 838 (1093)
Q Consensus 761 ~~LyLVMEYm~GGSL~dlL~k~g--~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~ 838 (1093)
+.+|+||||+++|+|.++|.+.. .+++..++.++.||+.||.|||+++||||||||+|||++.+|++||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 67899999999999999997643 5899999999999999999999999999999999999999999999999999842
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHh-CCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 917 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLT-GkpPF~~ 917 (1093)
. .......||+.|+|||++.+..|+.++|||||||++|||++ |++||..
T Consensus 154 ~------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 154 S------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp --------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred C------------------------------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 1 11234568999999999999999999999999999999998 8999999
Q ss_pred CChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHH
Q 001354 918 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 968 (1093)
Q Consensus 918 ~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~E 968 (1093)
.+..++...|.++.. |.++..+++++.+||.+||..||.+||++.++.+
T Consensus 204 ~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 204 IPLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp SCGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 999888888876432 3456889999999999999999999999544333
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=414.81 Aligned_cols=261 Identities=24% Similarity=0.346 Sum_probs=215.9
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECCCC-------cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVV 751 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~TG-------k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIV 751 (1093)
..+.+..++|++++.||+|+||.||+|+...++ ..||+|++ ++. ........+.+|...+.++ +|||||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~-~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSD--ATEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECC-CTT--CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEE-Ccc--cChHHHHHHHHHHHHHHHhcCCCeEE
Confidence 345677899999999999999999999987654 37999944 321 2344567788999999888 799999
Q ss_pred EEeeeeccCCceEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecC
Q 001354 752 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLK 815 (1093)
Q Consensus 752 kL~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g----------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIK 815 (1093)
+++++|.+++.+|+||||+++|+|.++|.... .+++..+..++.||+.||.|||++||||||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence 99999999999999999999999999997542 48999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 816 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 816 PeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
|+|||++.+|.+||+|||+++..... .........+||+.|+|||++.++.|+.+
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k 217 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGC-------------------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHH
T ss_pred ccceeecCCCCeEeccchhhcccccc-------------------------ccccccccCCCChhhhhhhHhcCCCCCch
Confidence 99999999999999999999853210 11123345689999999999999999999
Q ss_pred ceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 896 ADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 896 sDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+|||||||++|||++ |.+||.+.+...++..+..+. . |..|..+++++++||.+||+.||.+|||+.++.+.|
T Consensus 218 ~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~-~-~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 218 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-R-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC-C-CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 999999999999998 799999999988888776643 2 345688999999999999999999999955554443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=416.95 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=222.0
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKQVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 753 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k-----~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL-~HPNIVkL 753 (1093)
.++.+..++|++.+.||+|+||.||+|+++ .+++.||+|++ ++.. .......+.+|+.++..+ +|||||++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i-~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEE-CTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEE-Cccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 456677899999999999999999999874 46678999954 3322 234556799999999999 69999999
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecC
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLK 815 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g------------------~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIK 815 (1093)
++++.+.+.+|+|||||++|+|.+++.+.. .+++..++.|+.||+.||+|||++||||||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 999999999999999999999999997543 58999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc
Q 001354 816 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 895 (1093)
Q Consensus 816 PeNILLD~dG~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k 895 (1093)
|+|||++.++.+||+|||+++..... .........+||+.|||||++.+..++.+
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 227 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFE 227 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSC-------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHH
T ss_pred cccccccccCcccccccchheeccCC-------------------------CcceEeeecccChHHcCHHHhcCCCCCCc
Confidence 99999999999999999999853110 00112334689999999999999999999
Q ss_pred ceeecchhhHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 896 ADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 896 sDVWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
+|||||||++|||+| |.+||.+.+..+.+.+++....+ |..+..+++++.+||.+||+.||.+||++.++.++|
T Consensus 228 ~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999999999999998 78888888877777777766654 335678999999999999999999999966555544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=417.08 Aligned_cols=269 Identities=21% Similarity=0.293 Sum_probs=226.7
Q ss_pred ccccccCCCeeEEEeeeccCCeEEEEEEECC-----CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEe
Q 001354 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 754 (1093)
Q Consensus 680 ~~~~isiddFeilr~LGkG~FGeVylar~k~-----TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~ 754 (1093)
..+.+..++|++.+.||+|+||+||+|.++. ++..||||++ ++. ........+.+|+.+|.+++|||||+++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~-~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEA--ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEEC-CTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEE-Ccc--cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 3567788999999999999999999998863 3578999954 332 2334556799999999999999999999
Q ss_pred eeeccCCceEEEEEecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccC
Q 001354 755 YSFTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 824 (1093)
Q Consensus 755 gsfqd~~~LyLVMEYm~GGSL~dlL~k~----------g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~d 824 (1093)
+++...+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||||+.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 9999999999999999999999998643 236889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhh
Q 001354 825 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 904 (1093)
Q Consensus 825 G~VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVI 904 (1093)
+++||+|||+|+..... .........+||+.|||||.+.+..|+.++|||||||+
T Consensus 170 ~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYET-------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224 (308)
T ss_dssp CCEEECCTTCCCGGGGG-------------------------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred ceEEEeecccceeccCC-------------------------cceeeccceecccccCCHHHHccCCCCcccccccHHHH
Confidence 99999999999853211 01112334579999999999999999999999999999
Q ss_pred HHHHHhC-CCCCCCCChHHHHHHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHc---CCCCCCC
Q 001354 905 LFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGV 978 (1093)
Q Consensus 905 LYEMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~---HPFFkgI 978 (1093)
||||++| .+||.+.+..+++..+..+.. +..+..+++.+.+||.+||+.||.+||++.++.+.|+ +|+|+.+
T Consensus 225 l~El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 225 LWEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 9999998 689999999999998887653 4456889999999999999999999999555444443 6666543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-47 Score=404.08 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=205.4
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCceEE
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN-IVkL~gsfqd~~~LyL 765 (1093)
+.|++++.||+|+||+||+|+++.+|+.||||++. ... ....+..|+.+++.++|++ |+.+++++.+.+..|+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~-~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEE-SCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEc-hhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 46999999999999999999999999999999543 221 1234778999999998665 5556677778888999
Q ss_pred EEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc---CCcEEEEecCCccccccc
Q 001354 766 VMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 841 (1093)
Q Consensus 766 VMEYm~GGSL~dlL~-k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~---dG~VKLsDFGLAk~~~~~ 841 (1093)
||||+.+ +|...+. ....+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+.....
T Consensus 81 vme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999954 6666654 4567999999999999999999999999999999999999864 457999999999864211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCCChH
Q 001354 842 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 921 (1093)
Q Consensus 842 ~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~s~~ 921 (1093)
... .........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||......
T Consensus 160 ~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 160 RTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp TTC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred ccc--------------------cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 100 001122345678999999999999999999999999999999999999999876654
Q ss_pred HHHHHHh---ccC--CCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCC
Q 001354 922 IIFDNIL---NRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 976 (1093)
Q Consensus 922 ei~~kIl---~~~--l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFk 976 (1093)
.....+. ... .+.+.....+|+++.+||.+||..||.+||++..+.++|+|+|.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 4333221 111 122223467899999999999999999999988888999887653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=396.80 Aligned_cols=251 Identities=20% Similarity=0.257 Sum_probs=201.1
Q ss_pred EEEeeeccCCeEEEEEEECCCC---cEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CCceEEE
Q 001354 691 IIKPISRGAFGRVFLARKRTTG---DLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLYLV 766 (1093)
Q Consensus 691 ilr~LGkG~FGeVylar~k~TG---k~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPNIVkL~gsfqd-~~~LyLV 766 (1093)
+.++||+|+||+||+|++..++ ..||||.+ ++ .......+.+.+|+++|.+++|||||++++++.. +..+|+|
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~-~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEE-CC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEE-Cc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 3578999999999999987643 36899954 32 2345567889999999999999999999998765 5679999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecCCccccccccccc
Q 001354 767 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 845 (1093)
Q Consensus 767 MEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~~~~~~s~d 845 (1093)
||||++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~-- 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF-- 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC--
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc--
Confidence 99999999999987544 577888999999999999999999999999999999999999999999999985321100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCC-CCChHHHH
Q 001354 846 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT-AESPEIIF 924 (1093)
Q Consensus 846 ls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~-~~s~~ei~ 924 (1093)
..........||+.|+|||++.+..|+.++||||||++||||++|..||. ..+..++.
T Consensus 186 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~ 244 (311)
T d1r0pa_ 186 ---------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244 (311)
T ss_dssp ---------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH
T ss_pred ---------------------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 01112234579999999999999999999999999999999999666654 44555666
Q ss_pred HHHhccCCCCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcC
Q 001354 925 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 972 (1093)
Q Consensus 925 ~kIl~~~l~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~H 972 (1093)
..+..+.. |..|..+++++.+||.+||..||++||+ +.||++|
T Consensus 245 ~~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs---~~ei~~~ 287 (311)
T d1r0pa_ 245 VYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPS---FSELVSR 287 (311)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHcCCC--CCCcccCcHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 66665542 3456889999999999999999999999 5566654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9e-45 Score=389.89 Aligned_cols=258 Identities=20% Similarity=0.257 Sum_probs=208.1
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCceE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~H-PNIVkL~gsfqd~~~Ly 764 (1093)
-++|++++.||+|+||+||+|+++.+|+.||||++ .+.. ....+.+|++++..+.| +||+.+++++......|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~-~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEE-ECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEE-cccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 36899999999999999999999999999999944 3221 12346788899998875 89999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEcc-----CCcEEEEecCCcccc
Q 001354 765 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-----DGHIKLTDFGLSKIG 838 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g-~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~-----dG~VKLsDFGLAk~~ 838 (1093)
+||||+ +|+|.+++...+ .+++..+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 679999987654 6999999999999999999999999999999999999975 578999999999863
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchhhHHHHHhCCCCCCCC
Q 001354 839 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 918 (1093)
Q Consensus 839 ~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGVILYEMLTGkpPF~~~ 918 (1093)
...... .........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 157 ~~~~~~--------------------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 157 RDPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp BCTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCccc--------------------cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 211000 001112344678999999999999999999999999999999999999999865
Q ss_pred C---hHHHHHHHhccCC--CCCCCCCCCCHHHHHHHHhhccCCcCCCCChhcHHHHH
Q 001354 919 S---PEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 970 (1093)
Q Consensus 919 s---~~ei~~kIl~~~l--~fP~ip~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL 970 (1093)
. ....+..+..... +.+.+...+|+++.+||..|+..+|.+||++..+.+++
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l 273 (293)
T d1csna_ 217 KAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273 (293)
T ss_dssp CSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred cchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 4 3333444433221 11223467899999999999999999999966555544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=384.05 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=189.0
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHH--HHHHhcCCCceEEEeeeeccCC---
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAER--NILITVRNPFVVRFFYSFTCRD--- 761 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~--~IL~kL~HPNIVkL~gsfqd~~--- 761 (1093)
.+|.+.+.||+|+||+||+|++ +|+.||||++ +.. ....+..|. ..+..++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~-~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF-SSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEE-CGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEE-Ccc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 4688999999999999999987 4899999954 221 123344444 4455789999999999998764
Q ss_pred -ceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCcEeeecCCCcEEEccCCcEEEEec
Q 001354 762 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIVHRDLKPDNLLIAHDGHIKLTDF 832 (1093)
Q Consensus 762 -~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs--------~GIIHRDIKPeNILLD~dG~VKLsDF 832 (1093)
.+|+|||||++|+|.++|++. .+++.....++.|++.||.|||+ +|||||||||+||||+.+|++||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 589999999999999999764 58999999999999999999996 59999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC------CCccceeecchhhHH
Q 001354 833 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILF 906 (1093)
Q Consensus 833 GLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~------Ys~ksDVWSLGVILY 906 (1093)
|+++....... .........+||+.|||||++.+.. ++.++|||||||+||
T Consensus 153 Gl~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~ 209 (303)
T d1vjya_ 153 GLAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209 (303)
T ss_dssp TTCEEEETTTT-----------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred CccccccCCCc-----------------------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHH
Confidence 99986421110 0011233578999999999997643 567899999999999
Q ss_pred HHHhCCCCCCCC---------------ChHHHHHHHhccCCCCCCCCCC-----CCHHHHHHHHhhccCCcCCCCChhcH
Q 001354 907 EFITGIPPFTAE---------------SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGA 966 (1093)
Q Consensus 907 EMLTGkpPF~~~---------------s~~ei~~kIl~~~l~fP~ip~~-----IS~eakDLIkrcL~kDP~KRpTa~~A 966 (1093)
||+||.+||... ........+...... |.++.. ....+.+||.+||..||.+||++.++
T Consensus 210 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 288 (303)
T d1vjya_ 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred HHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccC-CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 999999887432 123333333333332 322222 23458899999999999999995544
Q ss_pred HH
Q 001354 967 AE 968 (1093)
Q Consensus 967 ~E 968 (1093)
.+
T Consensus 289 ~~ 290 (303)
T d1vjya_ 289 KK 290 (303)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-43 Score=382.36 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=196.4
Q ss_pred CCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-----------CCceEEEee
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-----------NPFVVRFFY 755 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-----------HPNIVkL~g 755 (1093)
+.|++++.||+|+||+||+|+++.+|+.||||++ ++.. ...+.+.+|+.+|+.++ |||||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi-~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-CSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEE-eccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 4699999999999999999999999999999954 3322 22356678888887764 578999998
Q ss_pred eecc--CCceEEEEEecCCCChHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeeecCCCcEEEccCCc---
Q 001354 756 SFTC--RDNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGH--- 826 (1093)
Q Consensus 756 sfqd--~~~LyLVMEYm~GGSL~dlL~---k~g~LsEe~ar~yaaQIl~ALeYLHs-~GIIHRDIKPeNILLD~dG~--- 826 (1093)
++.. ....+++|+++..+....... ....+++..++.++.||+.||.|||+ .||+||||||+||||+.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 8765 356777888776655433332 33568999999999999999999998 89999999999999987664
Q ss_pred ---EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeecchh
Q 001354 827 ---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 903 (1093)
Q Consensus 827 ---VKLsDFGLAk~~~~~~s~dls~~~td~~~p~~~~~~e~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDVWSLGV 903 (1093)
+||+|||.++.. .......+||+.|+|||++.+..|+.++|+|||||
T Consensus 168 ~~~~kl~dfg~s~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 217 (362)
T d1q8ya_ 168 LIQIKIADLGNACWY------------------------------DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 217 (362)
T ss_dssp EEEEEECCCTTCEET------------------------------TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHH
T ss_pred cceeeEeeccccccc------------------------------ccccccccccccccChhhccccCCCccccccchHH
Confidence 999999998742 11234578999999999999999999999999999
Q ss_pred hHHHHHhCCCCCCCCChH------HHHHHHhc--cC------------------C----CC---------------CCCC
Q 001354 904 ILFEFITGIPPFTAESPE------IIFDNILN--RK------------------I----PW---------------PCVP 938 (1093)
Q Consensus 904 ILYEMLTGkpPF~~~s~~------ei~~kIl~--~~------------------l----~f---------------P~ip 938 (1093)
++++|++|++||...+.. .....++. +. . .+ ...+
T Consensus 218 il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (362)
T d1q8ya_ 218 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297 (362)
T ss_dssp HHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC
T ss_pred HHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccC
Confidence 999999999999754321 11111000 00 0 00 0011
Q ss_pred CCCCHHHHHHHHhhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 001354 939 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 981 (1093)
Q Consensus 939 ~~IS~eakDLIkrcL~kDP~KRpTa~~A~EIL~HPFFkgIdWd 981 (1093)
...+++++|||.+||.+||.+||| |.|+|+||||+++.+.
T Consensus 298 ~~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 298 KDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTLGM 337 (362)
T ss_dssp HHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCTTC
T ss_pred cccCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccCCCCCc
Confidence 335678999999999999999999 8899999999976543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.1e-23 Score=209.06 Aligned_cols=135 Identities=20% Similarity=0.159 Sum_probs=106.4
Q ss_pred eeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhh---------------hchhHHHHHHHHHHHHHhcCCCceEEE
Q 001354 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDM---------------IRKNDIERILAERNILITVRNPFVVRF 753 (1093)
Q Consensus 689 Feilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~---------------~~~~eie~~l~E~~IL~kL~HPNIVkL 753 (1093)
+.+.+.||+|+||+||+|++. +|+.||+|++ +.... ...........|...|.++.|++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~-r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFH-KVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEE-CC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEE-ecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 457899999999999999985 6899999943 21100 001122445678899999999999988
Q ss_pred eeeeccCCceEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeeecCCCcEEEccCCcEEEEecC
Q 001354 754 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 833 (1093)
Q Consensus 754 ~gsfqd~~~LyLVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLHs~GIIHRDIKPeNILLD~dG~VKLsDFG 833 (1093)
+++.. .++||||++++.+. .+++..+..++.|++.||.|||++||+||||||+|||++++ .++|+|||
T Consensus 80 ~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred EEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence 76532 37999999986553 25566678899999999999999999999999999999865 58999999
Q ss_pred Cccc
Q 001354 834 LSKI 837 (1093)
Q Consensus 834 LAk~ 837 (1093)
+|+.
T Consensus 148 ~a~~ 151 (191)
T d1zara2 148 QSVE 151 (191)
T ss_dssp TCEE
T ss_pred Cccc
Confidence 9874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.18 E-value=1.9e-06 Score=87.22 Aligned_cols=141 Identities=14% Similarity=0.138 Sum_probs=90.0
Q ss_pred CCCeeEEEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCceE
Q 001354 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 764 (1093)
Q Consensus 686 iddFeilr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfqd~~~Ly 764 (1093)
+..|+..+..+.++.+.||++.. .+..+++|...... ......+.+|..+|..+. +--+.+++++...++..|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~----~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRY----KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGG----TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCc----ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 45777777766566679998863 46667888432221 122334677888887664 333566777777888899
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 001354 765 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------------------------------------- 805 (1093)
Q Consensus 765 LVMEYm~GGSL~dlL~k~g~LsEe~ar~yaaQIl~ALeYLH--------------------------------------- 805 (1093)
+||++++|.++....... .....++.++...|..||
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999998775432110 001111222222222222
Q ss_pred --------------h------cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 806 --------------S------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 806 --------------s------~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
+ ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 1279999999999998776677999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=1e-05 Score=88.55 Aligned_cols=81 Identities=26% Similarity=0.290 Sum_probs=50.7
Q ss_pred EEeeeccCCeEEEEEEECCCCcEEEEEEeehhhhhhc---hhHHHHHHHHHHHHHhcC-C--CceEEEeeeeccCCceEE
Q 001354 692 IKPISRGAFGRVFLARKRTTGDLFAIKQVLKKLDMIR---KNDIERILAERNILITVR-N--PFVVRFFYSFTCRDNLYL 765 (1093)
Q Consensus 692 lr~LGkG~FGeVylar~k~TGk~VAIKkILkK~~~~~---~~eie~~l~E~~IL~kL~-H--PNIVkL~gsfqd~~~LyL 765 (1093)
.+.||.|....||++....+++.+++|+.....+... .....+...|...|..+. + ..++++|++ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999999887888999996554332211 112344566887777653 2 345566554 4445689
Q ss_pred EEEecCCCC
Q 001354 766 VMEYLNGGD 774 (1093)
Q Consensus 766 VMEYm~GGS 774 (1093)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.43 E-value=0.0001 Score=73.81 Aligned_cols=136 Identities=14% Similarity=0.118 Sum_probs=80.0
Q ss_pred eeeccC-CeEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCCceEEEEEec
Q 001354 694 PISRGA-FGRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYL 770 (1093)
Q Consensus 694 ~LGkG~-FGeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~--HPNIVkL~gsfqd~~~LyLVMEYm 770 (1093)
.+..|. -+.||++... ++..+++|.. ... ....+..|...|+.+. .-.+.+++....+.+..|+||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~-~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTD-LSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEE-CSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeC-Ccc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 344454 3688988754 4666888832 211 1223566777776654 233666777788888899999999
Q ss_pred CCCChHH--------------HHHhcC-------CCCHHHH-------HHHH---------------HHHHHHHHHHHhc
Q 001354 771 NGGDLYS--------------LLRKVG-------CLEEDVA-------RIYI---------------AELVLALEYLHSL 807 (1093)
Q Consensus 771 ~GGSL~d--------------lL~k~g-------~LsEe~a-------r~ya---------------aQIl~ALeYLHs~ 807 (1093)
+|-++.. .|.+-. .+..... ..+. ......+..+...
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 9865421 111100 0000000 0000 0011223333322
Q ss_pred -------CcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 808 -------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 808 -------GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 389999999999999876678999998874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.97 E-value=0.0064 Score=63.88 Aligned_cols=129 Identities=13% Similarity=0.196 Sum_probs=70.9
Q ss_pred eEEEEEEECCCCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcCCCc--eEEEe-----eeeccCCceEEEEEecCCC
Q 001354 701 GRVFLARKRTTGDLFAIKQVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFF-----YSFTCRDNLYLVMEYLNGG 773 (1093)
Q Consensus 701 GeVylar~k~TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~HPN--IVkL~-----gsfqd~~~LyLVMEYm~GG 773 (1093)
-.||+++.. +|..|++| +.+... ...+.+..|...|..+.... ++... ..+...+..+.++++++|.
T Consensus 36 N~vy~v~~~-dg~~~VlK-~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVK-FYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCT-TCCCEEEE-EECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcC-CCCEEEEE-EeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 579998864 58889999 543221 12345667777776654211 11111 1223345678999999874
Q ss_pred ChH-----------HH---HHhc----------------------------CCCCHHHHHHHHHHHHHHHHHHHh-----
Q 001354 774 DLY-----------SL---LRKV----------------------------GCLEEDVARIYIAELVLALEYLHS----- 806 (1093)
Q Consensus 774 SL~-----------dl---L~k~----------------------------g~LsEe~ar~yaaQIl~ALeYLHs----- 806 (1093)
.+. .. ++.. ..++......+...+-..++.+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 320 01 1110 011111122222223333333332
Q ss_pred --cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 --LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 --~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.++||+|+.|.|||++. | ..++||+-|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 25899999999999974 4 45899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.90 E-value=0.013 Score=63.07 Aligned_cols=78 Identities=18% Similarity=0.264 Sum_probs=50.5
Q ss_pred CCeeEEEeeeccCCeEEEEEEECC-------CCcEEEEEEeehhhhhhchhHHHHHHHHHHHHHhcC-CCceEEEeeeec
Q 001354 687 DDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKQVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFT 758 (1093)
Q Consensus 687 ddFeilr~LGkG~FGeVylar~k~-------TGk~VAIKkILkK~~~~~~~eie~~l~E~~IL~kL~-HPNIVkL~gsfq 758 (1093)
+++++ +.|+.|-.=.+|++.... ....|.++ +..... ......+|..+++.+. +....+++++|.
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllR-i~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLR-VYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEE-EECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEE-ecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 34444 578888888999998753 23557677 432211 1223457888888775 544567788775
Q ss_pred cCCceEEEEEecCCCCh
Q 001354 759 CRDNLYLVMEYLNGGDL 775 (1093)
Q Consensus 759 d~~~LyLVMEYm~GGSL 775 (1093)
. .+||||++|..|
T Consensus 116 ~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPL 128 (395)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----ceEEEEeccccC
Confidence 3 689999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.76 E-value=0.11 Score=53.32 Aligned_cols=31 Identities=32% Similarity=0.438 Sum_probs=27.8
Q ss_pred cCcEeeecCCCcEEEccCCcEEEEecCCccc
Q 001354 807 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 837 (1093)
Q Consensus 807 ~GIIHRDIKPeNILLD~dG~VKLsDFGLAk~ 837 (1093)
.|+||+|+.++|||++.++..-|.||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999999874
|